interactions:
- request:
    body: db=pubmed&term=%28monomethyl+OR+MEP+OR+mono-n-butyl+OR+MBP+OR+mono+%283-carboxypropyl%29+OR+mcpp+OR+monobenzyl+OR+mbzp+OR+mono-isobutyl+OR+mibp+OR+mono+%282-ethylhexyl%29+OR+mono+%282-ethyl-5-oxohexyl%29+OR+meoph+OR+mono+%282-ethyl-5-carboxypentyl%29+OR+mecpp+OR+mepp+OR+mono+%282-ethyl-5-hydroxyhexyl%29+OR+mehp+OR+mono+%282-ethyl-5-oxyhexyl%29+OR+mono+%282-ethyl-4-hydroxyhexyl%29+OR+mono+%282-ethyl-4-oxyhexyl%29+OR+mono+%282-carboxymethyl%29+OR+mmhp+OR+mehp+OR+dehp+OR+2-ethylhexanol+OR+%28phthalic+acid%29%29+AND+%28liver+OR+hepato%2A+OR+hepat%2A%29+AND+%28%28cell+proliferation%29+OR+%28cell+growth%29+OR+%28dna+replication%29+OR+%28dna+synthesis%29+OR+%28replicative+dna+synthesis%29+OR+mitosis+OR+%28cell+division%29+OR+%28growth+response%29+OR+hyperplasia+OR+hepatomegaly%29+AND+%28mouse+OR+rat+OR+hamster+OR+rodent+OR+murine+OR+Mus+musculus+or+Rattus%29&rettype=count
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      Content-Length:
      - '877'
      Content-Type:
      - application/x-www-form-urlencoded
      User-Agent:
      - python-requests/2.31.0
    method: POST
    uri: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi
  response:
    body:
      string: "<?xml version=\"1.0\" encoding=\"UTF-8\" ?>\n<!DOCTYPE eSearchResult
        PUBLIC \"-//NLM//DTD esearch 20060628//EN\" \"https://eutils.ncbi.nlm.nih.gov/eutils/dtd/20060628/esearch.dtd\">\n<eSearchResult>\n\t<Count>256</Count>\n</eSearchResult>\n"
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - X-RateLimit-Limit,X-RateLimit-Remaining
      Cache-Control:
      - private
      Connection:
      - Keep-Alive
      Content-Security-Policy:
      - upgrade-insecure-requests
      Content-Type:
      - text/xml; charset=UTF-8
      Date:
      - Tue, 20 Feb 2024 16:38:14 GMT
      Keep-Alive:
      - timeout=4, max=40
      NCBI-PHID:
      - D0BD9F070703C0B5000038D725B7A0C4.1.1.m_1
      NCBI-SID:
      - 4BCA8694DDFD69F6_827FSID
      Referrer-Policy:
      - origin-when-cross-origin
      Server:
      - Finatra
      Set-Cookie:
      - ncbi_sid=4BCA8694DDFD69F6_827FSID; domain=.nih.gov; path=/; expires=Thu, 20
        Feb 2025 16:38:15 GMT
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains; preload
      Transfer-Encoding:
      - chunked
      X-RateLimit-Limit:
      - '3'
      X-RateLimit-Remaining:
      - '2'
      X-UA-Compatible:
      - IE=Edge
      X-XSS-Protection:
      - 1; mode=block
      content-encoding:
      - gzip
    status:
      code: 200
      message: OK
- request:
    body: retmax=5000&db=pubmed&api_key=<omitted>&term=%28monomethyl+OR+MEP+OR+mono-n-butyl+OR+MBP+OR+mono+%283-carboxypropyl%29+OR+mcpp+OR+monobenzyl+OR+mbzp+OR+mono-isobutyl+OR+mibp+OR+mono+%282-ethylhexyl%29+OR+mono+%282-ethyl-5-oxohexyl%29+OR+meoph+OR+mono+%282-ethyl-5-carboxypentyl%29+OR+mecpp+OR+mepp+OR+mono+%282-ethyl-5-hydroxyhexyl%29+OR+mehp+OR+mono+%282-ethyl-5-oxyhexyl%29+OR+mono+%282-ethyl-4-hydroxyhexyl%29+OR+mono+%282-ethyl-4-oxyhexyl%29+OR+mono+%282-carboxymethyl%29+OR+mmhp+OR+mehp+OR+dehp+OR+2-ethylhexanol+OR+%28phthalic+acid%29%29+AND+%28liver+OR+hepato%2A+OR+hepat%2A%29+AND+%28%28cell+proliferation%29+OR+%28cell+growth%29+OR+%28dna+replication%29+OR+%28dna+synthesis%29+OR+%28replicative+dna+synthesis%29+OR+mitosis+OR+%28cell+division%29+OR+%28growth+response%29+OR+hyperplasia+OR+hepatomegaly%29+AND+%28mouse+OR+rat+OR+hamster+OR+rodent+OR+murine+OR+Mus+musculus+or+Rattus%29&retstart=0
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      Content-Length:
      - '931'
      Content-Type:
      - application/x-www-form-urlencoded
      User-Agent:
      - python-requests/2.31.0
    method: POST
    uri: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi
  response:
    body:
      string: "<?xml version=\"1.0\" encoding=\"UTF-8\" ?>\n<!DOCTYPE eSearchResult
        PUBLIC \"-//NLM//DTD esearch 20060628//EN\" \"https://eutils.ncbi.nlm.nih.gov/eutils/dtd/20060628/esearch.dtd\">\n<eSearchResult>\n<Count>256</Count><RetMax>256</RetMax><RetStart>0</RetStart>\n<IdList>\n\t<Id>38056127</Id>\n\t<Id>35810816</Id>\n\t<Id>34588381</Id>\n\t<Id>34303773</Id>\n\t<Id>33166671</Id>\n\t<Id>32540476</Id>\n\t<Id>32471116</Id>\n\t<Id>32435917</Id>\n\t<Id>31262386</Id>\n\t<Id>31152848</Id>\n\t<Id>30884453</Id>\n\t<Id>30878739</Id>\n\t<Id>30826316</Id>\n\t<Id>30384071</Id>\n\t<Id>29474903</Id>\n\t<Id>29197930</Id>\n\t<Id>28426879</Id>\n\t<Id>28284729</Id>\n\t<Id>28267557</Id>\n\t<Id>28115639</Id>\n\t<Id>27454254</Id>\n\t<Id>27040317</Id>\n\t<Id>26585812</Id>\n\t<Id>26519955</Id>\n\t<Id>26252616</Id>\n\t<Id>26188368</Id>\n\t<Id>25913319</Id>\n\t<Id>25789634</Id>\n\t<Id>25683344</Id>\n\t<Id>25270622</Id>\n\t<Id>24769090</Id>\n\t<Id>24180432</Id>\n\t<Id>24180374</Id>\n\t<Id>23899473</Id>\n\t<Id>23625783</Id>\n\t<Id>23001933</Id>\n\t<Id>22936646</Id>\n\t<Id>22588786</Id>\n\t<Id>22484601</Id>\n\t<Id>22333284</Id>\n\t<Id>22198209</Id>\n\t<Id>21856391</Id>\n\t<Id>21721021</Id>\n\t<Id>21714771</Id>\n\t<Id>21616130</Id>\n\t<Id>20954081</Id>\n\t<Id>20854900</Id>\n\t<Id>20600714</Id>\n\t<Id>20358181</Id>\n\t<Id>20307648</Id>\n\t<Id>20123618</Id>\n\t<Id>20077217</Id>\n\t<Id>19756843</Id>\n\t<Id>18639561</Id>\n\t<Id>18403868</Id>\n\t<Id>17929048</Id>\n\t<Id>17326724</Id>\n\t<Id>17098345</Id>\n\t<Id>16954067</Id>\n\t<Id>16855774</Id>\n\t<Id>16476687</Id>\n\t<Id>16326419</Id>\n\t<Id>16326050</Id>\n\t<Id>15914576</Id>\n\t<Id>15901911</Id>\n\t<Id>15838709</Id>\n\t<Id>15664438</Id>\n\t<Id>15588926</Id>\n\t<Id>15564602</Id>\n\t<Id>15486947</Id>\n\t<Id>15364543</Id>\n\t<Id>15297022</Id>\n\t<Id>14727734</Id>\n\t<Id>14630134</Id>\n\t<Id>12851149</Id>\n\t<Id>12805656</Id>\n\t<Id>12802597</Id>\n\t<Id>12668284</Id>\n\t<Id>12505296</Id>\n\t<Id>12498735</Id>\n\t<Id>12215663</Id>\n\t<Id>12151626</Id>\n\t<Id>12036039</Id>\n\t<Id>11995694</Id>\n\t<Id>11950162</Id>\n\t<Id>11940454</Id>\n\t<Id>11719701</Id>\n\t<Id>11597582</Id>\n\t<Id>11581012</Id>\n\t<Id>11560248</Id>\n\t<Id>11452036</Id>\n\t<Id>11428750</Id>\n\t<Id>11401753</Id>\n\t<Id>11341945</Id>\n\t<Id>11312035</Id>\n\t<Id>11246142</Id>\n\t<Id>11099649</Id>\n\t<Id>11091278</Id>\n\t<Id>11029268</Id>\n\t<Id>10930035</Id>\n\t<Id>10889518</Id>\n\t<Id>10869467</Id>\n\t<Id>10869455</Id>\n\t<Id>10839475</Id>\n\t<Id>10828276</Id>\n\t<Id>10728921</Id>\n\t<Id>10650916</Id>\n\t<Id>10581215</Id>\n\t<Id>10547627</Id>\n\t<Id>10536109</Id>\n\t<Id>10502499</Id>\n\t<Id>10499774</Id>\n\t<Id>10485824</Id>\n\t<Id>10478855</Id>\n\t<Id>10478332</Id>\n\t<Id>10388618</Id>\n\t<Id>10357793</Id>\n\t<Id>20654484</Id>\n\t<Id>10086319</Id>\n\t<Id>9950075</Id>\n\t<Id>9934846</Id>\n\t<Id>9538047</Id>\n\t<Id>9547862</Id>\n\t<Id>9465269</Id>\n\t<Id>9398495</Id>\n\t<Id>9367824</Id>\n\t<Id>9274804</Id>\n\t<Id>9207284</Id>\n\t<Id>9194412</Id>\n\t<Id>9013627</Id>\n\t<Id>9146736</Id>\n\t<Id>8914623</Id>\n\t<Id>8887448</Id>\n\t<Id>8761421</Id>\n\t<Id>8817083</Id>\n\t<Id>8998951</Id>\n\t<Id>8838637</Id>\n\t<Id>7590545</Id>\n\t<Id>8540215</Id>\n\t<Id>12209194</Id>\n\t<Id>8785518</Id>\n\t<Id>7538465</Id>\n\t<Id>7873979</Id>\n\t<Id>7918596</Id>\n\t<Id>7915705</Id>\n\t<Id>7800660</Id>\n\t<Id>8209376</Id>\n\t<Id>8020155</Id>\n\t<Id>8162897</Id>\n\t<Id>8269617</Id>\n\t<Id>8104013</Id>\n\t<Id>8472324</Id>\n\t<Id>12209168</Id>\n\t<Id>8352887</Id>\n\t<Id>1469623</Id>\n\t<Id>1458550</Id>\n\t<Id>1473784</Id>\n\t<Id>1336490</Id>\n\t<Id>1423834</Id>\n\t<Id>1516773</Id>\n\t<Id>1632818</Id>\n\t<Id>1600604</Id>\n\t<Id>1625184</Id>\n\t<Id>1591274</Id>\n\t<Id>1610294</Id>\n\t<Id>1755031</Id>\n\t<Id>2274965</Id>\n\t<Id>2260097</Id>\n\t<Id>2125992</Id>\n\t<Id>1979936</Id>\n\t<Id>1965743</Id>\n\t<Id>2274048</Id>\n\t<Id>2210515</Id>\n\t<Id>2311188</Id>\n\t<Id>2404574</Id>\n\t<Id>2097173</Id>\n\t<Id>2489351</Id>\n\t<Id>2804110</Id>\n\t<Id>2635147</Id>\n\t<Id>2781555</Id>\n\t<Id>2772924</Id>\n\t<Id>2731665</Id>\n\t<Id>2924396</Id>\n\t<Id>2917345</Id>\n\t<Id>3206528</Id>\n\t<Id>3180084</Id>\n\t<Id>3383337</Id>\n\t<Id>3173343</Id>\n\t<Id>3354005</Id>\n\t<Id>3378278</Id>\n\t<Id>3690505</Id>\n\t<Id>2443263</Id>\n\t<Id>3621460</Id>\n\t<Id>2887302</Id>\n\t<Id>3657395</Id>\n\t<Id>3617093</Id>\n\t<Id>3594721</Id>\n\t<Id>3617071</Id>\n\t<Id>3617070</Id>\n\t<Id>3617068</Id>\n\t<Id>3617066</Id>\n\t<Id>3303447</Id>\n\t<Id>3303446</Id>\n\t<Id>3303445</Id>\n\t<Id>3574334</Id>\n\t<Id>3564055</Id>\n\t<Id>3564043</Id>\n\t<Id>3815733</Id>\n\t<Id>3798454</Id>\n\t<Id>3594641</Id>\n\t<Id>3554467</Id>\n\t<Id>3802057</Id>\n\t<Id>3769136</Id>\n\t<Id>2877511</Id>\n\t<Id>3583306</Id>\n\t<Id>3536893</Id>\n\t<Id>3715859</Id>\n\t<Id>3770794</Id>\n\t<Id>3709461</Id>\n\t<Id>3709458</Id>\n\t<Id>3709451</Id>\n\t<Id>4091660</Id>\n\t<Id>3934796</Id>\n\t<Id>2867621</Id>\n\t<Id>4024105</Id>\n\t<Id>2859109</Id>\n\t<Id>4004798</Id>\n\t<Id>2863135</Id>\n\t<Id>3919955</Id>\n\t<Id>3966235</Id>\n\t<Id>2857115</Id>\n\t<Id>6517701</Id>\n\t<Id>6488454</Id>\n\t<Id>6147206</Id>\n\t<Id>12748680</Id>\n\t<Id>6732809</Id>\n\t<Id>6719482</Id>\n\t<Id>6143560</Id>\n\t<Id>6716514</Id>\n\t<Id>6710484</Id>\n\t<Id>6872148</Id>\n\t<Id>6355494</Id>\n\t<Id>6845354</Id>\n\t<Id>6677511</Id>\n\t<Id>7161829</Id>\n\t<Id>12778222</Id>\n\t<Id>6182138</Id>\n\t<Id>7115078</Id>\n\t<Id>6178713</Id>\n\t<Id>7397231</Id>\n\t<Id>548985</Id>\n\t<Id>734683</Id>\n\t<Id>99598</Id>\n\t<Id>598790</Id>\n\t<Id>996879</Id>\n\t<Id>769879</Id>\n</IdList>\n<TranslationSet><Translation>
        \    <From>meoph</From>     <To>\"methylphosphite\"[Supplementary Concept]
        OR \"methylphosphite\"[All Fields] OR \"meoph\"[All Fields]</To>    </Translation><Translation>
        \    <From>mecpp</From>     <To>\"2-methyl-5,6-cyclopentapyrimidine\"[Supplementary
        Concept] OR \"2-methyl-5,6-cyclopentapyrimidine\"[All Fields] OR \"mecpp\"[All
        Fields]</To>    </Translation><Translation>     <From>mehp</From>     <To>\"mono-(2-ethylhexyl)phthalate\"[Supplementary
        Concept] OR \"mono-(2-ethylhexyl)phthalate\"[All Fields] OR \"mehp\"[All Fields]</To>
        \   </Translation><Translation>     <From>mmhp</From>     <To>\"mono-5-methylhexylphthalate\"[Supplementary
        Concept] OR \"mono-5-methylhexylphthalate\"[All Fields] OR \"mmhp\"[All Fields]</To>
        \   </Translation><Translation>     <From>dehp</From>     <To>\"diethylhexyl
        phthalate\"[MeSH Terms] OR (\"diethylhexyl\"[All Fields] AND \"phthalate\"[All
        Fields]) OR \"diethylhexyl phthalate\"[All Fields] OR \"dehp\"[All Fields]</To>
        \   </Translation><Translation>     <From>2-ethylhexanol</From>     <To>\"2-ethylhexanol\"[Supplementary
        Concept] OR \"2-ethylhexanol\"[All Fields] OR \"2 ethylhexanol\"[All Fields]</To>
        \   </Translation><Translation>     <From>phthalic acid</From>     <To>\"phthalic
        acid\"[Supplementary Concept] OR \"phthalic acid\"[All Fields]</To>    </Translation><Translation>
        \    <From>liver</From>     <To>\"liver\"[MeSH Terms] OR \"liver\"[All Fields]
        OR \"livers\"[All Fields] OR \"liver's\"[All Fields]</To>    </Translation><Translation>
        \    <From>cell proliferation</From>     <To>\"cell proliferation\"[MeSH Terms]
        OR (\"cell\"[All Fields] AND \"proliferation\"[All Fields]) OR \"cell proliferation\"[All
        Fields]</To>    </Translation><Translation>     <From>cell</From>     <To>\"cells\"[MeSH
        Terms] OR \"cells\"[All Fields] OR \"cell\"[All Fields]</To>    </Translation><Translation>
        \    <From>growth</From>     <To>\"growth and development\"[Subheading] OR
        (\"growth\"[All Fields] AND \"development\"[All Fields]) OR \"growth and development\"[All
        Fields] OR \"growth\"[All Fields] OR \"growth\"[MeSH Terms] OR \"growths\"[All
        Fields]</To>    </Translation><Translation>     <From>dna replication</From>
        \    <To>\"dna replication\"[MeSH Terms] OR (\"dna\"[All Fields] AND \"replication\"[All
        Fields]) OR \"dna replication\"[All Fields]</To>    </Translation><Translation>
        \    <From>dna synthesis</From>     <To>\"dna replication\"[MeSH Terms] OR
        (\"dna\"[All Fields] AND \"replication\"[All Fields]) OR \"dna replication\"[All
        Fields] OR (\"dna\"[All Fields] AND \"synthesis\"[All Fields]) OR \"dna synthesis\"[All
        Fields]</To>    </Translation><Translation>     <From>replicative</From>     <To>\"dna
        replication\"[MeSH Terms] OR (\"dna\"[All Fields] AND \"replication\"[All
        Fields]) OR \"dna replication\"[All Fields] OR \"replication\"[All Fields]
        OR \"replicability\"[All Fields] OR \"replicable\"[All Fields] OR \"replicate\"[All
        Fields] OR \"replicated\"[All Fields] OR \"replicates\"[All Fields] OR \"replicating\"[All
        Fields] OR \"replicational\"[All Fields] OR \"replications\"[All Fields] OR
        \"replicative\"[All Fields] OR \"replicatively\"[All Fields] OR \"replicator\"[All
        Fields] OR \"replicators\"[All Fields]</To>    </Translation><Translation>
        \    <From>mitosis</From>     <To>\"mitose\"[All Fields] OR \"mitosis\"[MeSH
        Terms] OR \"mitosis\"[All Fields] OR \"mitoses\"[All Fields]</To>    </Translation><Translation>
        \    <From>cell division</From>     <To>\"cell division\"[MeSH Terms] OR (\"cell\"[All
        Fields] AND \"division\"[All Fields]) OR \"cell division\"[All Fields]</To>
        \   </Translation><Translation>     <From>response</From>     <To>\"response\"[All
        Fields] OR \"responses\"[All Fields] OR \"responsive\"[All Fields] OR \"responsiveness\"[All
        Fields] OR \"responsivenesses\"[All Fields] OR \"responsives\"[All Fields]
        OR \"responsivities\"[All Fields] OR \"responsivity\"[All Fields]</To>    </Translation><Translation>
        \    <From>hyperplasia</From>     <To>\"hyperplasia\"[MeSH Terms] OR \"hyperplasia\"[All
        Fields] OR \"hyperplasias\"[All Fields]</To>    </Translation><Translation>
        \    <From>hepatomegaly</From>     <To>\"hepatomegaly\"[MeSH Terms] OR \"hepatomegaly\"[All
        Fields]</To>    </Translation><Translation>     <From>mouse</From>     <To>\"mice\"[MeSH
        Terms] OR \"mice\"[All Fields] OR \"mouse\"[All Fields] OR \"mouse's\"[All
        Fields] OR \"mouses\"[All Fields]</To>    </Translation><Translation>     <From>rat</From>
        \    <To>\"rats\"[MeSH Terms] OR \"rats\"[All Fields] OR \"rat\"[All Fields]</To>
        \   </Translation><Translation>     <From>hamster</From>     <To>\"cricetinae\"[MeSH
        Terms] OR \"cricetinae\"[All Fields] OR \"hamster\"[All Fields] OR \"hamsters\"[All
        Fields] OR \"hamster's\"[All Fields]</To>    </Translation><Translation>     <From>rodent</From>
        \    <To>\"rodent's\"[All Fields] OR \"rodentia\"[MeSH Terms] OR \"rodentia\"[All
        Fields] OR \"rodent\"[All Fields] OR \"rodents\"[All Fields]</To>    </Translation><Translation>
        \    <From>murine</From>     <To>\"mice\"[MeSH Terms] OR \"mice\"[All Fields]
        OR \"murine\"[All Fields] OR \"muridae\"[MeSH Terms] OR \"muridae\"[All Fields]
        OR \"murines\"[All Fields] OR \"murin\"[All Fields]</To>    </Translation><Translation>
        \    <From>Mus musculus</From>     <To>\"mice\"[MeSH Terms] OR \"mice\"[All
        Fields] OR (\"mus\"[All Fields] AND \"musculus\"[All Fields]) OR \"mus musculus\"[All
        Fields]</To>    </Translation><Translation>     <From>Rattus</From>     <To>\"rats\"[MeSH
        Terms] OR \"rats\"[All Fields] OR \"rattus\"[All Fields]</To>    </Translation></TranslationSet><QueryTranslation>(monomethyl
        OR MEP OR mono-n-butyl OR MBP OR mono (3-carboxypropyl) OR mcpp OR monobenzyl
        OR mbzp OR mono-isobutyl OR mibp OR mono (2-ethylhexyl) OR mono (2-ethyl-5-oxohexyl)
        OR meoph OR mono (2-ethyl-5-carboxypentyl) OR mecpp OR mepp OR mono (2-ethyl-5-hydroxyhexyl)
        OR mehp OR mono (2-ethyl-5-oxyhexyl) OR mono (2-ethyl-4-hydroxyhexyl) OR mono
        (2-ethyl-4-oxyhexyl) OR mono (2-carboxymethyl) OR mmhp OR mehp OR dehp OR
        2-ethylhexanol OR (phthalic acid)) AND (liver OR hepato* OR hepat*) AND ((cell
        proliferation) OR (cell growth) OR (dna replication) OR (dna synthesis) OR
        (replicative dna synthesis) OR mitosis OR (cell division) OR (growth response)
        OR hyperplasia OR hepatomegaly) AND (mouse OR rat OR hamster OR rodent OR
        murine OR Mus musculus or Rattus)</QueryTranslation><ErrorList><PhraseNotFound>2-ethyl-5-oxyhexyl</PhraseNotFound><PhraseNotFound>2-ethyl-4-hydroxyhexyl</PhraseNotFound><PhraseNotFound>2-ethyl-4-oxyhexyl</PhraseNotFound></ErrorList>\n\n</eSearchResult>\n"
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - X-RateLimit-Limit,X-RateLimit-Remaining
      Cache-Control:
      - private
      Connection:
      - Keep-Alive
      Content-Security-Policy:
      - upgrade-insecure-requests
      Content-Type:
      - text/xml; charset=UTF-8
      Date:
      - Tue, 20 Feb 2024 16:38:15 GMT
      Keep-Alive:
      - timeout=4, max=40
      NCBI-PHID:
      - D0BD9F070703C0B5000039D72A9F59BF.1.1.m_1
      NCBI-SID:
      - 9E16AFF3DA054EDC_AFABSID
      Referrer-Policy:
      - origin-when-cross-origin
      Server:
      - Finatra
      Set-Cookie:
      - ncbi_sid=9E16AFF3DA054EDC_AFABSID; domain=.nih.gov; path=/; expires=Thu, 20
        Feb 2025 16:38:15 GMT
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains; preload
      Transfer-Encoding:
      - chunked
      X-RateLimit-Limit:
      - '10'
      X-RateLimit-Remaining:
      - '9'
      X-UA-Compatible:
      - IE=Edge
      X-XSS-Protection:
      - 1; mode=block
      content-encoding:
      - gzip
    status:
      code: 200
      message: OK
- request:
    body: retmax=1000&db=pubmed&retmode=xml&api_key=<omitted>&id=7918596&id=2489351&id=6677511&id=3690505&id=6732809&id=12209168&id=30878739&id=2311188&id=11719701&id=2097173&id=3303447&id=3303446&id=3303445&id=2863135&id=10357793&id=28267557&id=20358181&id=8998951&id=3383337&id=12209194&id=23625783&id=8540215&id=10485824&id=22936646&id=2877511&id=32471116&id=8761421&id=8104013&id=11950162&id=3919955&id=6872148&id=9547862&id=29474903&id=1600604&id=1625184&id=6716514&id=2859109&id=3378278&id=20854900&id=8352887&id=11341945&id=548985&id=2260097&id=6147206&id=21856391&id=10388618&id=8887448&id=2857115&id=3554467&id=2125992&id=1336490&id=10536109&id=1469623&id=7915705&id=8020155&id=38056127&id=25789634&id=12505296&id=6710484&id=15901911&id=2404574&id=10581215&id=9398495&id=1516773&id=14630134&id=1473784&id=6182138&id=10478855&id=99598&id=9367824&id=3966235&id=10650916&id=3617066&id=3617068&id=10889518&id=3617071&id=3617070&id=3815733&id=15664438&id=11560248&id=3617093&id=7115078&id=26252616&id=3583306&id=11091278&id=33166671&id=23899473&id=25270622&id=10502499&id=12215663&id=9146736&id=22588786&id=2781555&id=1458550&id=9013627&id=12668284&id=3206528&id=6488454&id=2635147&id=2804110&id=25683344&id=3594641&id=26519955&id=20654484&id=3354005&id=16326050&id=2867621&id=3770794&id=10547627&id=10839475&id=9274804&id=9465269&id=3798454&id=8817083&id=7873979&id=15364543&id=10728921&id=1423834&id=734683&id=3594721&id=8838637&id=10828276&id=15838709&id=9207284&id=15297022&id=9538047&id=35810816&id=11099649&id=21616130&id=3564043&id=3709451&id=16476687&id=996879&id=3709458&id=3709461&id=3564055&id=12805656&id=11401753&id=18403868&id=1979936&id=12802597&id=6355494&id=11995694&id=1632818&id=3180084&id=14727734&id=1610294&id=27040317&id=15588926&id=11246142&id=3574334&id=24769090&id=6143560&id=3934796&id=15914576&id=26188368&id=8162897&id=11581012&id=3621460&id=30884453&id=11940454&id=17098345&id=29197930&id=8785518&id=22484601&id=28426879&id=17326724&id=11452036&id=2887302&id=7590545&id=2731665&id=2274965&id=24180374&id=20077217&id=1965743&id=31262386&id=3657395&id=28115639&id=10499774&id=8914623&id=20307648&id=18639561&id=32435917&id=10869455&id=31152848&id=24180432&id=16954067&id=26585812&id=2210515&id=10869467&id=34588381&id=16855774&id=12778222&id=10478332&id=2274048&id=8472324&id=598790&id=4091660&id=11597582&id=16326419&id=11029268&id=3715859&id=34303773&id=7538465&id=4024105&id=19756843&id=27454254&id=12498735&id=3769136&id=8269617&id=28284729&id=15564602&id=32540476&id=12151626&id=30826316&id=23001933&id=21714771&id=7800660&id=769879&id=17929048&id=22333284&id=2924396&id=7397231&id=10930035&id=9950075&id=12748680&id=20600714&id=11428750&id=1755031&id=6178713&id=11312035&id=6845354&id=9194412&id=10086319&id=2772924&id=21721021&id=4004798&id=22198209&id=6517701&id=30384071&id=12036039&id=3802057&id=12851149&id=3173343&id=8209376&id=20954081&id=20123618&id=15486947&id=2917345&id=7161829&id=25913319&id=1591274&id=6719482&id=3536893&id=9934846&id=2443263
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      Content-Length:
      - '3010'
      Content-Type:
      - application/x-www-form-urlencoded
      User-Agent:
      - python-requests/2.31.0
    method: POST
    uri: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi
  response:
    body:
      string: '<?xml version="1.0" ?>

        <!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January
        2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">

        <PubmedArticleSet>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7918596</PMID><DateCompleted><Year>1994</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-3002</ISSN><JournalIssue
        CitedMedium="Print"><Volume>1214</Volume><Issue>2</Issue><PubDate><Year>1994</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Biochimica
        et biophysica acta</Title><ISOAbbreviation>Biochim Biophys Acta</ISOAbbreviation></Journal><ArticleTitle>Clofibrate
        and other peroxisomal proliferating agents relatively specifically inhibit
        synthesis of ethanolamine phosphoglycerides in cultured human fibroblasts.</ArticleTitle><Pagination><StartPage>161</StartPage><EndPage>170</EndPage><MedlinePgn>161-70</MedlinePgn></Pagination><Abstract><AbstractText>Effects
        of several classes of peroxisomal proliferators on peroxisomal functions,
        hepatomegaly, hepatocarcinogenesis and lipid metabolism have been extensively
        investigated in rodents. Less is known about influences of these agents, some
        used as hypolipidemic drugs, on various metabolic parameters in humans. We
        examined effects of clofibrate, di(2-ethyl-hexyl)phthalate (DEHP) and pirinixic
        acid (WY-14,643) on phospholipid metabolism in human fibroblasts in culture.
        Clofibrate inhibited incorporation of [1-14C]hexadecanol and [1-14C]linolenic
        acid into ethanolamine phosphoglycerides in a time- and concentration-dependent
        manner; labeling of plasmalogens and non-plasmalogen ethanolamine phosphoglycerides
        was reduced by 40-80% compared to a generalized 10-30% inhibition of labeling
        of other phospholipids, including phosphatidylcholine. In pulse and pulse-chase
        experiments, selective inhibition of incorporation of [1,2-14C]ethanolamine,
        compared to [methyl-3H]choline, confirmed relative specificity of inhibition
        of ethanolamine phosphoglycerides. Similar concentration dependence and specificity
        for inhibition of phospholipid turnover was observed for DEHP and WY-14,643,
        in both control and mutant (Zellweger and adrenoleukodystrophy) fibroblasts,
        in the absence of major effects on peroxisomal markers. These observations
        that peroxisomal proliferators specifically inhibit ethanolamine phosphoglyceride
        turnover in human fibroblasts should be considered when assessing the efficacy
        and safety of such agents as hypolipidemic drugs or when evaluating mechanisms
        of proliferator action at the cellular level.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Thorne</LastName><ForeName>P
        C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Atlantic
        Research Centre, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Byers</LastName><ForeName>D M</ForeName><Initials>DM</Initials></Author><Author
        ValidYN="Y"><LastName>Palmer</LastName><ForeName>F B</ForeName><Initials>FB</Initials></Author><Author
        ValidYN="Y"><LastName>Cook</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biochim
        Biophys Acta</MedlineTA><NlmUniqueID>0217513</NlmUniqueID><ISSNLinking>0006-3002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004983">Ethanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005233">Fatty Alcohols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008042">Linolenic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010714">Phosphatidylethanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010955">Plasmalogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>5KV86114PT</RegistryNumber><NameOfSubstance
        UI="D019856">Ethanolamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>936JST6JCN</RegistryNumber><NameOfSubstance
        UI="C005031">cetyl alcohol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>N91BDP6H0X</RegistryNumber><NameOfSubstance
        UI="D002794">Choline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002794" MajorTopicYN="N">Choline</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D019856" MajorTopicYN="N">Ethanolamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004983" MajorTopicYN="N">Ethanolamines</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005233" MajorTopicYN="N">Fatty Alcohols</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008042" MajorTopicYN="N">Linolenic Acids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010714" MajorTopicYN="N">Phosphatidylethanolamines</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010955" MajorTopicYN="N">Plasmalogens</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1994</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1994</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1994</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7918596</ArticleId><ArticleId IdType="doi">10.1016/0005-2760(94)90040-x</ArticleId><ArticleId
        IdType="pii">0005-2760(94)90040-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2489351</PMID><DateCompleted><Year>1991</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0029-8484</ISSN><JournalIssue
        CitedMedium="Print"><Volume>77</Volume><Issue>4</Issue><PubDate><Year>1989</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Shigaku
        = Odontology; journal of Nihon Dental College</Title><ISOAbbreviation>Shigaku</ISOAbbreviation></Journal><ArticleTitle>[Correlation
        of the ability of Di(2-ethylhexyl)phthalate to induce cell transformation,
        chromosome aberrations, and peroxisome proliferation in cultured Syrian hamster
        embryo cells].</ArticleTitle><Pagination><StartPage>1371</StartPage><EndPage>1390</EndPage><MedlinePgn>1371-90</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)phthalate
        (DEHP), a commonly used plasticizer, induces peroxisome proliferation in liver
        cells and hepatocellular carcinomas in rodents. To study possible mechanisms
        for DEHP-associated cancer, we have measured induction of morphological transformation,
        chromosome aberrations, and peroxisome proliferation of cultured Syrian hamster
        embryo (SHE) cells. Molphological transformation was weakly induced by treatment
        with DEHP. The transformation frequency of DEHP was enhanced in the presence
        of rat liver postmitochondrial supernatant. DEHP induced chromosome aberrations
        in the cells only in the presence of exogenous metabolic activation. Clofibrate,
        a widely used hypolipidemic drug, failed to induce morphological transformation
        or chromosome aberrations. Treatment with [4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio]acetic
        acid (Wy-14, 643), which is a more potent carcinogen than DEHP or clofibrate,
        elicited a lower frequency of morphological transformation than DEHP in the
        presence of exogenous metabolic activation. Similar levels of peroxisome proliferation,
        as determined by an intensity of diaminobenzidine (DAB) staining, were observed
        in cultures treated for 2 hr with DEHP, clofibrate or Wy-14, 643. The results
        suggest a possible involvement of genetic damage by DEHP metabolites in induction
        of transformation of SHE cells. No clear relationship between inductions of
        peroxisome proliferation and cell transformation was observed.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Tsutsui</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>jpn</Language><PublicationTypeList><PublicationType
        UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Shigaku</MedlineTA><NlmUniqueID>1275704</NlmUniqueID><ISSNLinking>0029-8484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002869" MajorTopicYN="N">Chromosome Aberrations</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002875" MajorTopicYN="N">Chromosomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1989</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1989</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1989</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2489351</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6677511</PMID><DateCompleted><Year>1984</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0165-2214</ISSN><JournalIssue
        CitedMedium="Print"><Volume>11</Volume><PubDate><Year>1983</Year></PubDate></JournalIssue><Title>Developments
        in toxicology and environmental science</Title><ISOAbbreviation>Dev Toxicol
        Environ Sci</ISOAbbreviation></Journal><ArticleTitle>Species differences in
        di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation.</ArticleTitle><Pagination><StartPage>595</StartPage><EndPage>598</EndPage><MedlinePgn>595-8</MedlinePgn></Pagination><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Gray</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Author><Author
        ValidYN="Y"><LastName>Foster</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Stubberfield</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Dev
        Toxicol Environ Sci</MedlineTA><NlmUniqueID>7706742</NlmUniqueID><ISSNLinking>0165-2214</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1983</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1983</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1983</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6677511</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3690505</PMID><DateCompleted><Year>1988</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0304-3835</ISSN><JournalIssue
        CitedMedium="Print"><Volume>38</Volume><Issue>1-2</Issue><PubDate><Year>1987</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cancer
        letters</Title><ISOAbbreviation>Cancer Lett</ISOAbbreviation></Journal><ArticleTitle>Association
        of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity
        in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years.</ArticleTitle><Pagination><StartPage>15</StartPage><EndPage>22</EndPage><MedlinePgn>15-22</MedlinePgn></Pagination><Abstract><AbstractText>Female
        F-344 rats were fed a diet containing up to 1.2% di(2-ethylhexyl)phthalate
        (DEHP) for 2 years, which previously resulted in hepatocarcinogenesis under
        bioassay conditions. Peroxisome proliferation, decreased glutathione peroxidase
        activity, and lipofuscin accumulation were all associated with prolonged feeding
        of 1.2% DEHP and induction of hepatic neoplasia. These results establish a
        potential role for persistent peroxisome proliferation and oxidative injury
        in the hepatocarcinogenicity of dietary DEHP. Increased hepatocellular proliferation
        and hepatomegaly were not detected. DEHP feeding did not increase the volume
        density of basophilic or ATPase-deficient foci of altered hepatocytes, suggesting
        that these lesions are not suitable indicators of DEHP carcinogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Cattley</LastName><ForeName>R
        C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, NC 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Conway</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 07945</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES
        07017</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Cancer
        Lett</MedlineTA><NlmUniqueID>7600053</NlmUniqueID><ISSNLinking>0304-3835</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008062">Lipofuscin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008062" MajorTopicYN="N">Lipofuscin</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3690505</ArticleId><ArticleId IdType="doi">10.1016/0304-3835(87)90195-9</ArticleId><ArticleId
        IdType="pii">0304-3835(87)90195-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6732809</PMID><DateCompleted><Year>1984</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>12</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-291X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>121</Volume><Issue>1</Issue><PubDate><Year>1984</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Biochemical
        and biophysical research communications</Title><ISOAbbreviation>Biochem Biophys
        Res Commun</ISOAbbreviation></Journal><ArticleTitle>Induction of laurate omega-hydroxylase
        by di (2-ethylhexyl)phthalate in rat liver microsomes.</ArticleTitle><Pagination><StartPage>304</StartPage><EndPage>309</EndPage><MedlinePgn>304-9</MedlinePgn></Pagination><Abstract><AbstractText>Liver
        microsomes, prepared from rats fed a diet containing di (2-ethylhexyl)phthalate,
        were observed to hydroxylate lauric acid at carbon 12 at a specific activity
        6 times greater than control rats. There was no increase in the specific activity
        of the laurate 11-hydroxylase. The specific activity of hepatic microsomal
        NADPH-cytochrome c reductase was increased 2-fold by phthalate feeding, but
        no effect was observed in the specific contents of cytochromes b5 or P-450.
        These results indicate that di (2-ethylhexyl)phthalate is similar to the hypolipidemic
        agent and peroxisomal proliferator , clofibrate, which was previously reported
        to be a novel inducer of the cytochrome P-450 mediated omega-hydroxylation
        of fatty acids.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Okita</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Chance</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>S07-RR05434</GrantID><Acronym>RR</Acronym><Agency>NCRR
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Biochem Biophys Res Commun</MedlineTA><NlmUniqueID>0372516</NlmUniqueID><ISSNLinking>0006-291X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D003580">Cytochromes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D006899">Mixed Function Oxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.15.3</RegistryNumber><NameOfSubstance UI="D042926">Cytochrome P-450 CYP4A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D042926" MajorTopicYN="N">Cytochrome P-450 CYP4A</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003580" MajorTopicYN="N">Cytochromes</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006899" MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6732809</ArticleId><ArticleId IdType="doi">10.1016/0006-291x(84)90723-x</ArticleId><ArticleId
        IdType="pii">0006-291X(84)90723-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="Publisher" Owner="NLM"><PMID Version="1">12209168</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1521-4621</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>18</Volume><PubDate><Year>1993</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Toxicity
        report series</Title><ISOAbbreviation>Toxic Rep Ser</ISOAbbreviation></Journal><ArticleTitle>NTP
        technical report on the toxicity studies of Methyl Ethyl Ketone Peroxide (CAS
        No. 1338-23-4) in Dimethyl Phthalate (CAS No. 131-11-3) (45:55) Administered
        Topically in F344/N Rats and B6C3F1 Mice.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>C10</EndPage><MedlinePgn>1-C10</MedlinePgn></Pagination><Abstract><AbstractText>Methyl
        ethyl ketone peroxide (MEKP) is an unstable organic peroxide used in the manufacture
        of acrylic resins, as a hardening agent for fiberglass-reinforced plastics,
        and as a curing agent for unsaturated polyester resins. It is commercially
        available as a 40% to 60% solution in dimethyl phthalate (DMP). Because exposure
        to MEKP is typically through dermal contact, 2-week and 13-week toxicity studies
        were conducted by topical application of MEKP in DMP (45:55 w/w) to the clipped
        dorsal region of male and female Fischer 344/N rats and mice. Animals were
        evaluated for histopathology and for reproductive endpoints. In vitro genetic
        toxicity studies of MEKP included assessments of mutagenicity in Salmonella
        typhimurium and in mouse lymphoma L5178Y cells and analysis of chromosomal
        aberrations and sister chromatid exchanges in Chinese hamster ovary cells.
        In addition, the peripheral blood of mice from the 13-week study was evaluated
        in the micronucleus assay. In the 2-week studies, groups of 5 animals of each
        species and sex were administered MEKP in DMP for 5 days per week at doses
        of 50.6, 101.3, 202.5, 405, and 810 mg/kg body weight per day for rats and
        112.5, 225, 450, 900, and 1800 mg/kg body weight per day for mice. Control
        groups received DMP or no treatment. No rats died during the studies, but
        at least 1 mouse in each group receiving MEKP died. Body weight gains of rats
        decreased with increasing doses of MEKP; body weight gains of mice were not
        affected by treatment. The primary effects of topical administration of MEKP
        in both rats and mice were an extensive coagulative necrosis of the epidermis
        and dermis, variable degrees of inflammation of the adnexa, and epidermal
        regeneration and hyperplasia at the application site. Lesions considered secondary
        to the dermal lesions included increased hematopoiesis in the spleen in rats
        and mice and increased myeloid hyperplasia of the bone marrow in mice, primarily
        at the higher doses. Mice showed a marked, dose-related increase in liver
        weight. In the 13-week dermal studies, groups of 10 rats and 10 mice of each
        sex were administered MEKP in DMP for 5 days per week at doses of 1.07, 3.57,
        10.7, 35.7, and 107 mg/rat and 0.357, 1.19, 3.57, 11.9, and 35.7 mg/mouse.
        All high-dose mice, 3 high-dose female rats, and 1 female mouse in the 11.9
        mg/animal group died or were sacrificed during the first week of the studies.
        Skin lesions similar to those seen in the 2-week studies were judged of sufficient
        severity to warrant early termination of surviving rats and mice in the 2
        highest dose groups. All rats and mice in the remaining dose groups survived
        to the end of the studies, and weight gains were generally lower with increasing
        doses of MEKP. Skin lesions at the application site for the remaining animals
        (rats and mice) in the 10.7 mg/rat and 3.57 mg/mouse dose groups involved
        a spectrum of necrosis, inflammation, and acanthosis (epidermal hyperplasia).
        Lesions in the lower dose groups were limited to acanthosis and hyperkeratosis
        in rats (1.07 and 3.57 mg/rat) and acanthosis in mice (0.357 and 1.19 mg/mouse).
        While splenic and bone marrow lesions similar to those described in the 2-week
        studies were seen in animals that died early in the 13-week studies and in
        the rats and mice that showed ulcerative or necrotic injury, no other systemic
        changes were noted in animals that did not show ulcerative skin lesions. In
        genetic toxicity studies, MEKP in DMP (45:55 w/w) was not mutagenic in Salmonella
        typhimurium strains TA100, TA1535, TA1537, or TA98, with or without S9activation.
        A positive response was obtained in the mouse lymphoma assay for induction
        of trifluorothymidine resistance in L5178Y cells without S9. In cytogenetic
        tests with Chinese hamster ovary cells, MEKP induced sister chromatid exchanges
        and chromosomal aberrations, with and without S9. No increase in the frequency
        of micronucleated erythrocytes was observed in peripheral blood samples obtained
        from male and female mice at the termination of the 13-week toxicity study.
        In summary, topical administration of MEKP in DM of MEKP in DMP resulted in
        a spectrum of necrotic, inflammatory, and regenerative skin lesions limited
        to the application site. Histopathologic changes in the spleen and bone marrow
        were also seen in rats and mice with ulcerative skin lesions, and were considered
        a secondary response. A no-observed-adverse-effect level (NOAEL) for histopathologic
        skin lesions could not be determined from these studies, as lesions were observed
        with administration of daily doses as low as 1.07 mg for rats and 0.357 mg
        for mice. Methyl Ethyl Ketone Peroxide Synonyms: 2-Butanone Peroxide. Dimethyl
        Phthalate Synonyms: 1,2-Benzenedicarboxylic acid dimethyl ester; phthalic
        acid dimethyl ester; methyl phthalate; dimethyl 1,2-benzene- dicarboxylate;
        DMP</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeiger</LastName><ForeName>Errol</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxic Rep Ser</MedlineTA><NlmUniqueID>101122696</NlmUniqueID><ISSNLinking>1521-4621</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1993</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>9</Month><Day>5</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1993</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12209168</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30878739</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>18</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0953</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>172</Volume><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Environmental
        research</Title><ISOAbbreviation>Environ Res</ISOAbbreviation></Journal><ArticleTitle>Effects
        of citrate ester plasticizers and bis (2-ethylhexyl) phthalate in the OECD
        28-day repeated-dose toxicity test (OECD TG 407).</ArticleTitle><Pagination><StartPage>675</StartPage><EndPage>683</EndPage><MedlinePgn>675-683</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.envres.2019.03.004</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0013-9351(19)30133-1</ELocationID><Abstract><AbstractText>Citrate
        esters are considered functional alternatives to phthalate plasticizers, but
        their toxicity remains poorly understood. The toxicity of citrate esters,
        including triethyl 2-acetylcitrate (ATEC) and trihexyl O-acetylcitrate (ATHC),
        were examined together with that of bis (2-ethylhexyl) phthalate (DEHP) using
        the Organization for Economic Co-operation and Development Test Guideline
        407 (OECD TG407). Following 28-day oral administration, no significant differences
        in body weight or the weight of the brain, pituitary, heart, epididymis, seminal
        vesicles, or coagulating gland were found between the vehicle control and
        DEHP, ATEC or ATHC groups. In the 400&#x202f;mg/kg&#x202f;day DEHP group,
        liver, adrenal, thymus, spleen, kidney, testis, and prostate weights were
        significantly increased. In the 400&#x202f;mg/kg&#x202f;day ATHC group, kidney,
        adrenal, thymus, testis and prostate weights were significantly increased.
        In the 400&#x202f;mg/kg&#x202f;day ATEC group, kidney, adrenal and testis
        weights were significantly increased. Hepatocyte size was significantly increased
        in the 400&#x202f;mg/kg&#x202f;day DEHP group, suggestive of hepatotoxicity,
        but was not increased in the ATEC or ATHC groups. There were no significant
        differences in white blood cell, red blood cell or platelet counts, hemoglobin
        concentrations, hematocrit, mean corpuscular volume, fasting glucose, insulin,
        or testosterone concentrations between the vehicle control and DEHP, ATEC
        and ATHC groups. In the ATHC 400&#x202f;mg/kg&#x202f;day group, T3 was decreased
        while T4 was increased, suggestive of disruption of thyroid function. The
        results of the OECD TG407 subacute repeated dosing toxicity test indicate
        ATEC is less toxic compared to ATHC or DEHP and could be recommended as an
        alternative to phthalate plasticizers.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department
        of Life Science and Institute for Natural Sciences, Hanyang University, 222,
        Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Park</LastName><ForeName>Seung Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department
        of Life Science and Institute for Natural Sciences, Hanyang University, 222,
        Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Yoon</LastName><ForeName>Kyung Noh</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department
        of Life Science and Institute for Natural Sciences, Hanyang University, 222,
        Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Park</LastName><ForeName>Sun Jung</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department
        of Life Science and Institute for Natural Sciences, Hanyang University, 222,
        Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gye</LastName><ForeName>Myung Chan</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department
        of Life Science and Institute for Natural Sciences, Hanyang University, 222,
        Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea. Electronic address:
        mcgye@hanyang.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Environ
        Res</MedlineTA><NlmUniqueID>0147621</NlmUniqueID><ISSNLinking>0013-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002951">Citrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004952">Esters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002951" MajorTopicYN="N">Citrates</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="Y">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004952" MajorTopicYN="N">Esters</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066150" MajorTopicYN="N">Organisation for Economic Co-Operation and Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="Y">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018675" MajorTopicYN="N">Toxicity Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Citrate esters</Keyword><Keyword
        MajorTopicYN="N">Mouse</Keyword><Keyword MajorTopicYN="N">Phthalates</Keyword><Keyword
        MajorTopicYN="N">Plasticizer</Keyword><Keyword MajorTopicYN="N">TG407</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2018</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">30878739</ArticleId><ArticleId IdType="doi">10.1016/j.envres.2019.03.004</ArticleId><ArticleId
        IdType="pii">S0013-9351(19)30133-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2311188</PMID><DateCompleted><Year>1990</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>1990</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Long-term
        effects of hypolipidemic peroxisome proliferator administration on hepatic
        hydrogen peroxide metabolism in rats.</ArticleTitle><Pagination><StartPage>445</StartPage><EndPage>450</EndPage><MedlinePgn>445-50</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of prolonged dietary administration of peroxisome proliferators, such
        as clofibrate, bezafibrate and di(2-ethylhexyl)phthalate (DEHP), on hepatic
        hydrogen peroxide (H2O2) level and on hepatic activities of the enzymes relating
        to H2O2 metabolism were examined. Male rats were treated for 79 weeks with
        the above three peroxisome proliferators. The activities of the peroxisomal
        beta-oxidation and catalase were increased 8- to 20-fold and 2- to 3-fold,
        respectively, after 2 or 4 weeks of treatment with these peroxisome proliferators.
        However at 79 weeks the peroxisomal beta-oxidation activity was 3-8 times
        that of control. The level of catalase activity was kept at approximately
        2-fold even after prolonged treatment of peroxisome proliferators. Although
        the activities of glutathione peroxidase (GSH-Px) and glutathione S-transferase
        (GST) were decreased 50-60% at 4-12 weeks by the treatment with peroxisome
        proliferators, from 20 to 79 weeks those activities approached control levels
        in the case of clofibrate and bezafibrate but not DEHP-fed rats; GSH-Px and
        GST activities were kept at approximately 40% those of control. However hepatic
        capacities of H2O2-degrading enzymes, catalase and GSH-Px, apparently exceeded
        the H2O2-generating levels obtained on the basis of peroxisomal beta-oxidation
        activities in the livers of control and treated rats throughout the experimental
        period. The hepatic H2O2 levels increased only slightly but this increase
        did not correspond to changes in peroxisomal beta-oxidation. Our results suggest
        that a large part of H2O2 produced by peroxisomal beta-oxidation could be
        rapidly scavenged by catalase and GSH-Px in the liver of rats treated with
        peroxisome proliferators.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Tamura</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Clinical Biochemistry, Tokyo College of Pharmacy, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Iida</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Watanabe</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Suga</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000960">Hypolipidemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008054">Lipid Peroxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance
        UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber><NameOfSubstance
        UI="D005978">Glutathione</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000960" MajorTopicYN="N">Hypolipidemic Agents</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008054" MajorTopicYN="N">Lipid Peroxides</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2311188</ArticleId><ArticleId IdType="doi">10.1093/carcin/11.3.445</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11719701</PMID><DateCompleted><Year>2002</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>64</Volume><Issue>2</Issue><PubDate><Year>2001</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Reversibility and persistence
        of di-2-ethylhexyl phthalate (DEHP)- and phenobarbital-induced hepatocellular
        changes in rodents.</ArticleTitle><Pagination><StartPage>192</StartPage><EndPage>199</EndPage><MedlinePgn>192-9</MedlinePgn></Pagination><Abstract><AbstractText>The
        tumor promotion stage of chemical carcinogenesis has been shown to exhibit
        a persistence of cellular effects during treatment and the reversibility of
        these changes upon cessation of treatment. Inhibition of gap-junctional intercellular
        communication and increased replicative DNA synthesis appear to be important
        in this process. The present study assessed the persistence and reversibility
        of gap-junctional intercellular communication inhibition, peroxisomal proliferation,
        and replicative DNA synthesis in livers from male F344 rats and B6C3F1 mice.
        Dietary administration of 20,000 mg/kg DEHP to male rats for 2 weeks decreased
        intercellular communication (67% of control) and enhanced replicative DNA
        synthesis (4.8-fold over control). Elevation of the relative liver weight
        and the induction of peroxisomal beta oxidation were also observed following
        treatment with 20,000 mg/Kg DEHP for 2 weeks. Following DEHP administration
        at a dose of 6000 mg/kg for 18 months, inhibition of gap-junctional intercellular
        communication persisted, and the relative liver weight and induction of peroxisomal
        beta oxidation remained elevated in both rats and male B6C3F1 mice. Treatment
        of rats and mice with phenobarbital for 18 months (500-mg/kg diet) also produced
        an increase in relative liver weight and a decrease in cell-to-cell communication.
        In recovery studies in which DEHP was administered to male F344 rats for 2
        weeks and then withdrawn, the relative liver weight, rate of peroxisomal beta
        oxidation, increase in replicative DNA synthesis, and inhibition of gap-junctional
        intercellular communication returned to control values within 2 to 4 weeks
        after DEHP treatment ceased. Recovery studies with phenobarbital produced
        similar results. The primary active metabolite of DEHP, mono-2-ethylhexyl
        phthalate (MEHP), was detected in the livers of animals treated with DEHP
        for greater than 2 weeks. However, it could not be detected after removal
        of DEHP from the diet for 2 weeks. This study demonstrated that inhibition
        of gap-junctional intercellular communication, along with indicators of peroxisomal
        proliferation, including increased relative liver weight and enhanced peroxisomal
        beta oxidation, persist while DEHP treatment continues but reverses when treatment
        is stopped. Studies with phenobarbital produced a similar pattern of response.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Isenberg</LastName><ForeName>J
        S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division
        of Toxicology, Department of Pharmacology and Toxicology, Indiana University
        School of Medicine, 635 Barnhill Drive, MS-1021, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kamendulis</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Author><Author
        ValidYN="Y"><LastName>Ackley</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Author><Author
        ValidYN="Y"><LastName>Smith</LastName><ForeName>J H</ForeName><Initials>JH</Initials></Author><Author
        ValidYN="Y"><LastName>Pugh</LastName><ForeName>G</ForeName><Initials>G</Initials><Suffix>Jr</Suffix></Author><Author
        ValidYN="Y"><LastName>Lington</LastName><ForeName>A W</ForeName><Initials>AW</Initials></Author><Author
        ValidYN="Y"><LastName>McKee</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Author><Author
        ValidYN="Y"><LastName>Klaunig</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>6O7F7IX66E</RegistryNumber><NameOfSubstance
        UI="C032279">phthalic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections
        RefType="CommentIn"><RefSource>Toxicol Sci. 2001 Dec;64(2):147-8</RefSource><PMID
        Version="1">11719695</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017629" MajorTopicYN="N">Gap Junctions</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>11</Month><Day>24</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>4</Month><Day>2</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>11</Month><Day>24</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11719701</ArticleId><ArticleId IdType="doi">10.1093/toxsci/64.2.192</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2097173</PMID><DateCompleted><Year>1991</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>29</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0232-1513</ISSN><JournalIssue
        CitedMedium="Print"><Volume>40</Volume><Issue>3</Issue><PubDate><Year>1990</Year></PubDate></JournalIssue><Title>Experimental
        pathology</Title><ISOAbbreviation>Exp Pathol</ISOAbbreviation></Journal><ArticleTitle>Renal
        tubular cell or hepatocyte hyperplasia is not associated with tumor promotion
        by di(2-ethylhexyl)phthalate in B6C3F1 mice after transplacental initiation
        with N-nitrosoethylurea.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>138</EndPage><MedlinePgn>125-38</MedlinePgn></Pagination><Abstract><AbstractText>B6C3F1
        mice of both sexes that had been exposed transplacentally on day 18 of gestation
        to 0.5 mmole N-nitrosoethylurea (NEU) were fed either normal diets or diets
        containing di(2-ethylhexyl)phthalate (DEHP) at 6,000 ppm beginning at 6 wk
        of age and continuing to 78 wk of age. At 52 and 78 wk of age, 6-26 mice from
        each group received a single injection of 5-bromo-2''-deoxyuridine (Brdu)
        at 200 mg/kg i.p. and were sacrificed 1 h later for determination of the levels
        of renal and hepatic DNA synthesis by the Brdu immunohistochemical technique.
        No differences occurred in incidences of gross or microscopic renal tubular
        cell tumors between the NEU (males 15%, females 21%) and NEU-DEHP groups (males
        10%, females 15%) at 78 wk. The labelling index (LI) of renal cortical tubular
        cells was significantly increased at 78 wk (22.3 +/- 3.7/mm2 for males, 21.8
        +/- 1.2 for females) in mice given NEU and DEHP as compared with NEU alone
        (9.7 +/- 1.0 for males, 6.9 +/- 0.7 for females). The number and sizes of
        focal hepatocellular proliferative lesions (FHPL), including hyperplastic
        foci, hepatocellular adenomas and carcinomas, were quantified by image analysis
        and stereology. DEHP significantly enhanced the mean volume and volume % of
        FHPL, including liver tumors, but not numbers of FHPL/liver. Hepatocyte LI
        was also not affected, at least as detected by the technique used, while FHPL
        had significantly increased LI (14.5-48.3) as compared with normal hepatocytes
        (0.5-2.4). This study provides some evidence that enhanced chronic cell replication
        in the kidney may not always be associated with renal carcinogenesis of tumor
        promotion, while tumor promotion in liver may be a consequence of increased
        DNA synthesis in initiated or focus cells rather than in nonproliferative
        parenchymal hepatocytes, which may not be target cells of some tumor promoters.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Tumor
        Pathology and Pathogenesis Section, National Cancer Institute, Frederick,
        Maryland 21701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konishi</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Diwan</LastName><ForeName>B A</ForeName><Initials>BA</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>N01-CO-74102</GrantID><Acronym>CO</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01-CO-74103</GrantID><Acronym>CO</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Exp
        Pathol</MedlineTA><NlmUniqueID>8108218</NlmUniqueID><ISSNLinking>0232-1513</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>G34N38R2N1</RegistryNumber><NameOfSubstance
        UI="D001973">Bromodeoxyuridine</NameOfSubstance></Chemical><Chemical><RegistryNumber>P8M1T4190R</RegistryNumber><NameOfSubstance
        UI="D005038">Ethylnitrosourea</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001973" MajorTopicYN="N">Bromodeoxyuridine</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="Y">Diethylhexyl Phthalate</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005038" MajorTopicYN="Y">Ethylnitrosourea</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007684" MajorTopicYN="N">Kidney Tubules</DescriptorName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008431" MajorTopicYN="Y">Maternal-Fetal Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2097173</ArticleId><ArticleId IdType="doi">10.1016/s0232-1513(11)80335-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3303447</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0748-2337</ISSN><JournalIssue
        CitedMedium="Print"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and industrial health</Title><ISOAbbreviation>Toxicol Ind Health</ISOAbbreviation></Journal><ArticleTitle>In
        vivo studies on the mechanism of di(2-ethylhexyl)phthalate carcinogenesis.</ArticleTitle><Pagination><StartPage>151</StartPage><EndPage>163</EndPage><MedlinePgn>151-63</MedlinePgn></Pagination><Abstract><AbstractText>In
        a study sponsored by the National Toxicology Program, di(2-ethylhexyl)phthalate
        (DEHP) fed in the diet at 1.2% significantly increased the incidence of female
        rats with hepatocellular carcinomas. Extensive evaluation of DEHP for carcinogenicity
        has yielded negative results. The present investigations were designed to
        elucidate the mechanism of DEHP hepatocarcinogenesis under the conditions
        of the original bioassay. Short-term studies designed to evaluate the promoting
        capability of DEHP, when administered after initiation, were negative when
        livers of female Fischer-344 rats were evaluated using multiple histochemical
        stains to identify foci of cellular alteration. Two different protocols were
        used to evaluate the initiating potential of DEHP in the liver using histochemically
        defined foci as the endpoint. In both experiments the results were negative.
        Chronic exposure to DEHP at 1.2% in the diet for 2 years resulted in elevation
        of hepatic peroxisomal enzymes while DNA replication, an indication of cell
        proliferation, was not affected in hepatocytes. The number of foci was not
        elevated in the DEHP group compared to the controls, even though a low incidence
        of rats with liver tumors occurred in the treated group. The results of this
        series, as well as other published results, suggest that DEHP and other peroxisomal
        proliferating chemicals have unique effects on the development of hepatic
        neoplasms. The absence of altered foci after chronic administration or in
        initiation-promotion protocols distinguishes DEHP and perhaps other peroxisomal
        proliferating chemicals from both classic liver carcinogens and promoters.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author
        ValidYN="Y"><LastName>Garvey</LastName><ForeName>L K</ForeName><Initials>LK</Initials></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        Ind Health</MedlineTA><NlmUniqueID>8602702</NlmUniqueID><ISSNLinking>0748-2337</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>35</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3303447</ArticleId><ArticleId IdType="doi">10.1177/074823378700300211</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3303446</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0748-2337</ISSN><JournalIssue
        CitedMedium="Print"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and industrial health</Title><ISOAbbreviation>Toxicol Ind Health</ISOAbbreviation></Journal><ArticleTitle>The
        potential role of chemically induced hyperplasia in the carcinogenic activity
        of the hypolipidemic carcinogens.</ArticleTitle><Pagination><StartPage>129</StartPage><EndPage>149</EndPage><MedlinePgn>129-49</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)phthalate
        (DEHP) is a widely used plasticizing agent resulting in substantial human
        exposure and environmental contamination. In a chronic bioassay, high doses
        of DEHP induced hepatocellular carcinomas in female Fischer-344 rats and male
        and female B6C3F1 mice. Thus, there is considerable concern as to the species
        specificity, mechanism of action, and human risk assessment of DEHP. DEHP
        belongs to a class of agents described as hypolipidemic hepatocarcinogens.
        These chemicals share the ability to induce hepatic peroxisomal proliferation
        and range from very weak to very potent hepatocarcinogens. Unlike most identified
        carcinogens, the hypolipidemic carcinogens lack DNA reactivity in sensitive
        cell culture systems such as the Ames test. It has been proposed that active
        oxygen radicals, produced as a result of peroxisomal proliferation, induce
        DNA damage. While this is an attractive hypothesis, no genotoxic activity
        has been observed in hepatocytes with peroxisomal proliferation in treated
        animals. Another biological activity shared by this class of compounds is
        their ability to stimulate liver growth or hyperplasia. This additive hyperplasia
        results from direct mitogenic stimulation rather than regenerative growth
        following liver toxicity. This hyperplasia can be dramatic, with liver to
        body weight ratios from treated animals reaching two to three times normal.
        The degree of induced hyperplasia correlates well with the carcinogenic potency
        of these agents, whereas genotoxicity does not correlate at all. Increased
        cellular growth may result in spontaneous mutational events or promotional
        effects. While some feedback mechanism eventually inhibits liver growth, it
        is possible that key genes related to the regulation of cellular growth and
        cancer remain stimulated during continued administration of the chemical.
        Thus, determination of hyperplastic activity represents an attractive first-step
        approach to the short-term detection and study of the mode of action of nongenotoxic
        carcinogens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Butterworth</LastName><ForeName>B
        E</ForeName><Initials>BE</Initials></Author><Author ValidYN="Y"><LastName>Loury</LastName><ForeName>D
        J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Smith-Oliver</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        Ind Health</MedlineTA><NlmUniqueID>8602702</NlmUniqueID><ISSNLinking>0748-2337</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000960">Hypolipidemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009153">Mutagens</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000145"
        MajorTopicYN="N">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000960" MajorTopicYN="N">Hypolipidemic Agents</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009153" MajorTopicYN="N">Mutagens</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>102</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3303446</ArticleId><ArticleId IdType="doi">10.1177/074823378700300210</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3303445</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0748-2337</ISSN><JournalIssue
        CitedMedium="Print"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and industrial health</Title><ISOAbbreviation>Toxicol Ind Health</ISOAbbreviation></Journal><ArticleTitle>Mechanisms
        of rodent liver carcinogenesis.</ArticleTitle><Pagination><StartPage>119</StartPage><EndPage>128</EndPage><MedlinePgn>119-28</MedlinePgn></Pagination><Abstract><AbstractText>Stimulation
        of DNA synthesis by peroxisome proliferators, including DEHP, should be viewed
        differently from the stimulation of DNA synthesis by xenobiotic chemicals
        which stimulate restorative hyperplasia after hepatic necrosis induced by
        the toxicity of the chemical. The emerging picture of the control mechanisms
        for hepatocyte proliferation suggests that rather few and distinct factors
        are involved. The stimulation of DNA synthesis by peroxisome proliferators
        should be examined in the context of the effects of these factors. Comparisons
        with other xenobiotics show that induction of DNA synthesis at rates comparable
        to those of peroxisome proliferators is not sufficient to explain the rates
        of carcinogenicity associated with peroxisome proliferators. These considerations
        lead to the conclusion that although DNA synthesis enhances the incidence
        of neoplasia, it should not be viewed as a complete carcinogen, nor should
        it be considered as resulting in initiation at rates that can explain the
        carcinogenic potency of compounds such as peroxisome proliferators.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Michalopoulos</LastName><ForeName>G
        K</ForeName><Initials>GK</Initials></Author><Author ValidYN="Y"><LastName>Eckl</LastName><ForeName>P
        M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Cruise</LastName><ForeName>J
        L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Novicki</LastName><ForeName>D
        L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Jirtle</LastName><ForeName>R
        L</ForeName><Initials>RL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        Ind Health</MedlineTA><NlmUniqueID>8602702</NlmUniqueID><ISSNLinking>0748-2337</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>27</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3303445</ArticleId><ArticleId IdType="doi">10.1177/074823378700300209</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2863135</PMID><DateCompleted><Year>1985</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0091-6765</ISSN><JournalIssue
        CitedMedium="Print"><Volume>60</Volume><PubDate><Year>1985</Year><Month>May</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Concentration-dependent
        inhibition of development of GGT positive foci in rat liver by the environmental
        contaminant di(2-ethylhexyl) phthalate.</ArticleTitle><Pagination><StartPage>381</StartPage><EndPage>385</EndPage><MedlinePgn>381-5</MedlinePgn></Pagination><Abstract><AbstractText>The
        ability of di(2-ethylhexyl) phthalate (DEHP), a widely used plasticizer and
        environmental contaminant, to suppress development of putative preneoplastic
        lesions in rat liver was evaluated. gamma-Glutamyl transpeptidase-positive
        (GGT+) foci were initiated in the livers of Sprague-Dawley male rats with
        a single dose of diethylnitrosamine (DEN) following partial hepatectomy. Promotion
        of foci was commenced by feeding a choline-deficient diet (CD). A group of
        control rats was fed a choline-supplemented diet (CS). The ability of DEHP
        to suppress the emergence of GGT+ foci was evaluated by feeding additional
        groups of rats the CD diet containing either 0.1%, 0.5%, 1.0% or 2.0% DEHP.
        The CD diet promoted the number of GGT+ foci above levels in control livers.
        Inclusion of the plasticizer to the levels of 0.5%, 1.0% and 2.0% in the CD
        diet effectively inhibited the appearance of the foci. However, DEHP was unable
        to inhibit the promoting effect of the CD diet at a concentration of 0.1%.
        DEHP''s ability to block development of GGT+ foci correlated with its ability
        to increase liver weight and to induce carnitine acetyltransferase (EC 2.3.1.7),
        a marker of peroxisome proliferation.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>DeAngelo</LastName><ForeName>A
        B</ForeName><Initials>AB</Initials></Author><Author ValidYN="Y"><LastName>Queral</LastName><ForeName>A
        E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Garrett</LastName><ForeName>C
        T</ForeName><Initials>CT</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>1-RO1-CA-31324</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002796" MajorTopicYN="N">Choline Deficiency</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2863135</ArticleId><ArticleId IdType="pmc">PMC1568574</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.8560381</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am
        J Pathol. 1977 Sep;88(3):595-618</Citation><ArticleIdList><ArticleId IdType="pubmed">18937</ArticleId></ArticleIdList></Reference><Reference><Citation>Res
        Commun Chem Pathol Pharmacol. 1974 Nov;9(3):501-10</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4445568</ArticleId></ArticleIdList></Reference><Reference><Citation>AMA
        Arch Ind Hyg Occup Med. 1953 Sep;8(3):219-26</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13079323</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1983 Aug;4(8):1021-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6872148</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:99-101</Citation><ArticleIdList><ArticleId IdType="pubmed">6754365</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Pathol. 1984 Feb;114(2):287-300</Citation><ArticleIdList><ArticleId IdType="pubmed">6696045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fed
        Proc. 1984 Jan;43(1):126-30</Citation><ArticleIdList><ArticleId IdType="pubmed">6690332</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1979 Oct;76(10):5056-60</Citation><ArticleIdList><ArticleId
        IdType="pubmed">291922</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1978 Feb 2;271(5644):456-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24178</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Lett. 1983 Sep;20(2):199-205</Citation><ArticleIdList><ArticleId IdType="pubmed">6667460</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1978 Aug;45(2):497-504</Citation><ArticleIdList><ArticleId
        IdType="pubmed">705785</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1983 Apr;50:163-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6135607</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1973 Jun;4:3-26</Citation><ArticleIdList><ArticleId IdType="pubmed">4578674</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1978 Apr;38(4):1092-8</Citation><ArticleIdList><ArticleId IdType="pubmed">76508</ArticleId></ArticleIdList></Reference><Reference><Citation>Br
        J Cancer. 1978 Oct;38(4):537-43</Citation><ArticleIdList><ArticleId IdType="pubmed">728341</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1983;4(5):595-603</Citation><ArticleIdList><ArticleId IdType="pubmed">6850991</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1980 May 6;605(2):191-215</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6249365</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Lett. 1984 Jul;23(3):323-30</Citation><ArticleIdList><ArticleId IdType="pubmed">6146399</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Histochem Cytochem. 1969 Aug;17(8):517-26</Citation><ArticleIdList><ArticleId
        IdType="pubmed">5816239</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:35-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6754363</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1981 Jun;41(6):2556-62</Citation><ArticleIdList><ArticleId IdType="pubmed">6165465</ArticleId></ArticleIdList></Reference><Reference><Citation>AMA
        Arch Ind Health. 1956 Mar;13(3):259-64</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13291905</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv
        Cancer Res. 1953;1:451-501</Citation><ArticleIdList><ArticleId IdType="pubmed">13057710</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1965 May;240:2188-92</Citation><ArticleIdList><ArticleId IdType="pubmed">14299645</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:41-50</Citation><ArticleIdList><ArticleId IdType="pubmed">7140695</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10357793</PMID><DateCompleted><Year>1999</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>1999</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Hepatic
        hyperplasia and cancer in rats: alterations in copper metabolism.</ArticleTitle><Pagination><StartPage>1091</StartPage><EndPage>1096</EndPage><MedlinePgn>1091-6</MedlinePgn></Pagination><Abstract><AbstractText>We
        previously demonstrated that rats exposed to the peroxisome proliferator (PP)
        diethylhexylphthalate (DEHP) had reduced serum ceruloplasmin (CP) oxidase
        activity, which suggests tissue copper deposition. Copper is highly toxic
        in excess, and results in cellular damage and hepatocellular carcinomas (HCC).
        This study addresses changes in expression of copper-related genes and metal
        accumulation in hyperplastic liver and tumors induced by PP. Male rats were
        fed diets containing DEHP or clofibrate (CLF) for 3-60 days (hyperplasia)
        and 4-chloro-6-(2,3 xylidino)-2-pyrimidinyl-thio(N-beta-hydroxyethyl) acetamide
        for 10 months (HCC). During hyperplasia, an immediate and progressive decrease
        in serum CP activity was observed (P &lt; 0.05), as were reductions in mRNA
        levels for both CP and Wilson''s disease gene (WD gene, a P-type ATPase) (P
        &lt; 0.05). Tumor-bearing rats had lower serum CP activity (P &lt; 0.05),
        and CP and WD gene mRNA levels were reduced in tumors (P &lt; 0.05), and in
        liver surrounding tumors (SL) (P &lt; 0.05). Metallothionein mRNA showed no
        consistent changes during hyperplasia. Tumors showed a 2.5-fold induction
        of metallothionein mRNA (P &lt; 0.05), and a 1.2-fold increase in SL. Temporal
        increases in liver copper content occurred during hyperplasia, with increases
        of 2-fold (DEHP) and 3.3-fold (CLF) at 60 days (P &lt; 0.05). Copper content
        was 2.2-fold higher in tumors (P &lt; 0.05) and 1.7-fold higher in SL; iron
        did not increase and zinc decreased temporally. Thus, copper accumulation
        and changes in copper-related gene expression may be contributing factors
        in liver neoplasia in PP-treated rats. Loss of CP results in decreased free
        radical scavenger capacity and thus may enhance oxidative damage induced by
        PPs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eagon</LastName><ForeName>P
        K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>VA Medical
        Center, Pittsburgh, PA 15240, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Teepe</LastName><ForeName>A G</ForeName><Initials>AG</Initials></Author><Author
        ValidYN="Y"><LastName>Elm</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author
        ValidYN="Y"><LastName>Tadic</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author><Author
        ValidYN="Y"><LastName>Epley</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author
        ValidYN="Y"><LastName>Beiler</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author><Author
        ValidYN="Y"><LastName>Shinozuka</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Rao</LastName><ForeName>K N</ForeName><Initials>KN</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA53453</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance
        UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>9038-94-2</RegistryNumber><NameOfSubstance
        UI="D008668">Metallothionein</NameOfSubstance></Chemical><Chemical><RegistryNumber>969LVT6GJ2</RegistryNumber><NameOfSubstance
        UI="C016908">pirinixil</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.16.3.1</RegistryNumber><NameOfSubstance UI="D002570">Ceruloplasmin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002570" MajorTopicYN="N">Ceruloplasmin</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003300" MajorTopicYN="N">Copper</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008668" MajorTopicYN="N">Metallothionein</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10357793</ArticleId><ArticleId IdType="doi">10.1093/carcin/20.6.1091</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28267557</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0295</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>86</Volume><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Regulatory
        toxicology and pharmacology : RTP</Title><ISOAbbreviation>Regul Toxicol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Investigation
        of the mechanism of triclosan induced mouse liver tumors.</ArticleTitle><Pagination><StartPage>137</StartPage><EndPage>147</EndPage><MedlinePgn>137-147</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.yrtph.2017.03.001</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0273-2300(17)30059-4</ELocationID><Abstract><AbstractText>Chronic
        dietary exposure to Triclosan (TCS) produced increased incidence of liver
        tumors in mice. The mechanism for liver tumor induction has been attributed
        to activation of either peroxisome proliferator activated receptor &#x3b1;
        (PPAR&#x3b1;) or constitutive androstane receptor (CAR). To further define
        the mechanism of TCS induced liver tumors, male CD-1 and C57BL/6 mice were
        treated with TCS at 0, 10, 100 and 200&#xa0;mg/kg diet/day for 14 or 28 days.
        In addition, a recovery group and positive control groups for CAR or PPAR&#x3b1;
        activation with either phenobarbital or diethylhexyl-phthalate were included
        in the 14-day study. TCS induced a dose-dependent increase in relative liver
        weight and centrilobular hypertrophy in both strains of mice. Hepatocyte DNA
        synthesis (BrdU labeling) was also increased in a dose-related pattern. In
        comparison with previous studies, TCS induced a significant increase in CAR/PXR
        (Cyp2b10, Cyp3a11) and PPAR&#x3b1; (Cyp4a10) responsive genes in both CD-1
        and C57BL/6 mice. The corresponding enzyme activity for CAR (7-pentoxyresorufin-O-dealkylase)
        and PPAR&#x3b1; (peroxisomal Acyl-CoA oxidase) were also significantly increased
        in a similar fashion. Oxidative stress related genes Gpx1 and Aox1 were increased
        in the C57BL/6 but not in CD-1 mice. The increases in gene expression and
        enzyme activities returned to control levels after 14-day recovery. The present
        results demonstrate that both CAR and PPAR&#x3b1; activation are involved
        in the TCS induced mouse liver tumor.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zemin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory
        of Investigative Toxicology and Pathology, Department of Environmental Health,
        Indiana University, Bloomington, IN 47408, United States. Electronic address:
        zemwang@indiana.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xilin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Laboratory
        of Investigative Toxicology and Pathology, Department of Environmental Health,
        Indiana University, Bloomington, IN 47408, United States. Electronic address:
        lixil@indiana.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaunig</LastName><ForeName>James
        E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Laboratory
        of Investigative Toxicology and Pathology, Department of Environmental Health,
        Indiana University, Bloomington, IN 47408, United States. Electronic address:
        jklauni@indiana.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Regul
        Toxicol Pharmacol</MedlineTA><NlmUniqueID>8214983</NlmUniqueID><ISSNLinking>0273-2300</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000090702">Constitutive Androstane Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>4NM5039Y5X</RegistryNumber><NameOfSubstance
        UI="D014260">Triclosan</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.-</RegistryNumber><NameOfSubstance UI="C107176">peroxisomal acyl-CoA
        oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.3.3.6</RegistryNumber><NameOfSubstance
        UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000090702" MajorTopicYN="N">Constitutive Androstane Receptor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="N">PPAR alpha</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014260" MajorTopicYN="N">Triclosan</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Constitutive androstane receptor</Keyword><Keyword
        MajorTopicYN="N">Mechanism of action</Keyword><Keyword MajorTopicYN="N">Non-genotoxic
        carcinogens</Keyword><Keyword MajorTopicYN="N">Peroxisome proliferator-activated
        receptor alpha</Keyword><Keyword MajorTopicYN="N">Rodent liver</Keyword><Keyword
        MajorTopicYN="N">Triclosan</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2016</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2017</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2017</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">28267557</ArticleId><ArticleId IdType="doi">10.1016/j.yrtph.2017.03.001</ArticleId><ArticleId
        IdType="pii">S0273-2300(17)30059-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">20358181</PMID><DateCompleted><Year>2011</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0738</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>85</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>26-Week
        carcinogenicity study of di-isodecyl phthalate by dietary administration to
        CB6F1-rasH2 transgenic mice.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>66</EndPage><MedlinePgn>59-66</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1007/s00204-010-0536-6</ELocationID><Abstract><AbstractText>This
        study examined the carcinogenic potential of di-isodecyl phthalate (DIDP)
        in rasH2 mice. DIDP was administered to 15 rasH2 mice/gender/group at dietary
        levels of 0, 0.1, 0.33, or 1% and 15 wild-type mice/gender/group at dietary
        levels of 0 and 1% for 26 weeks. Non-neoplastic changes were observed in the
        liver (parenchymal inflammation, fatty changes, diffuse hepatocyte hypertrophy
        with eosinophilic granules and focal necrosis) and kidneys (tubular basophilia
        and tubular hyperplasia) after administration of DIDP in the rasH2 and wild-type
        mice. In the neoplastic lesions, there were a higher number of hepatocellular
        adenomas in the male rasH2 mice receiving 1% DIDP, compared with the findings
        in the liver of control rasH2 mice or wild-type mice. The incidence of hepatocellular
        adenomas in the 0.1, 0.33, and 1% DIDP exposed rasH2 mice was 7% (1/15), 7%
        (1/15), and 33% (5/15), respectively. This study adds a set of results for
        an additional test chemical for the performance of the rasH2 short-term transgenic
        model to the existing database of 3 compounds (WY-14643, DEHP, and clofibrate)
        tested in the ILSI/HESI ACT project.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Wan-Seob</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Centre
        for Inflammation Research, The Queen''s Medical Research Institute, The University
        of Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Jayoung</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Choi</LastName><ForeName>Mina</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Park</LastName><ForeName>Sue Nie</ForeName><Initials>SN</Initials></Author><Author
        ValidYN="Y"><LastName>Han</LastName><ForeName>Beom Seok</ForeName><Initials>BS</Initials></Author><Author
        ValidYN="Y"><LastName>Son</LastName><ForeName>Woo-Chan</ForeName><Initials>WC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2010</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>684-93-5</RegistryNumber><NameOfSubstance
        UI="D008770">Methylnitrosourea</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>WF93T741QI</RegistryNumber><NameOfSubstance
        UI="C042080">diisodecyl phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D018248" MajorTopicYN="N">Adenoma, Liver Cell</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011905" MajorTopicYN="N">Genes, ras</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008770" MajorTopicYN="N">Methylnitrosourea</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2009</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2010</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2011</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20358181</ArticleId><ArticleId IdType="doi">10.1007/s00204-010-0536-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8998951</PMID><DateCompleted><Year>1997</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0272-0590</ISSN><JournalIssue
        CitedMedium="Print"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>1996</Year><Month>May</Month></PubDate></JournalIssue><Title>Fundamental
        and applied toxicology : official journal of the Society of Toxicology</Title><ISOAbbreviation>Fundam
        Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>Oncogenicity testing
        of 2-ethylhexanol in Fischer 344 rats and B6C3F1 mice.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>41</EndPage><MedlinePgn>29-41</MedlinePgn></Pagination><Abstract><AbstractText>2-Ethylhexanol
        (2EH) is a weak nongenotoxic hepatic peroxisome proliferator in the rat. It
        is a high-volume chemical intermediate in the preparation of the plasticizers
        bis-(2-ethylhexyl) adipate (DEHA), bis-(2-ethylhexyl) phthalate (DEHP), and
        tris-(2-ethylhexyl) phosphate (TEHP), which are weak hepatocellular tumorigens
        in female mice. In consequence, the oncogenic potential of 2EH was evaluated
        in male (M) and female (F) rats and mice (50 animals/sex/group). Oral gavage
        doses of 2EH in 0.005% aqueous Cremophor EL (polyoxyl-35 castor oil) were
        given five times a week to rats: 0 (water), 0 (vehicle), 50, 150, and 500
        mg/kg for 24 months, and to mice: 0 (water), 0 (vehicle), 50, 200, and 750
        mg/kg for 18 months. Statistical comparisons of data were made between vehicle
        controls and treatment groups. There were no differences of biological significance
        between data from vehicle and water control groups. In rats, there were no
        dose-related changes at 50 mg/kg. There was reduced body weight gain at 150
        mg/kg (M, 16; F, 12%) and 500 mg/kg (M, 33; F, 31%) and an increased incidence
        of lethargy and unkemptness. There were dose-related increases in relative
        liver, stomach, brain, kidney, and testis weights at sacrifice. Female rat
        mortality was markedly increased at 500 mg/kg. There was marked aspiration-induced
        bronchopneumonia in rats at 500 mg/kg; hematologic, gross, and microscopic
        changes, including tumors, were otherwise comparable among all rat groups.
        In mice at 50 and 200 mg/kg there were no dose-related changes and essentially
        no time-dependent or time-independent adverse trends in liver tumor incidence
        at the 5% significance level. At 750 mg/kg mouse body weight gain was reduced
        (M, 26; F, 24%), and mortality increased (M and F, 30%) versus vehicle controls.
        At 750 mg/kg there was a slight increase in nonneoplastic focal hyperplasia
        in the forestomach of mice (M 5/50, F 4/50) versus vehicle controls (M 1/50,
        F 1/50). There were increases in mouse relative liver (F, 21%) and stomach
        (M, 13%; F, 19%) weights at 750 mg/kg. There was a 12% incidence of hepatic
        basophilic foci and an 18% incidence of hepatocellular carcinomas in male
        mice at 750 mg/kg, not statistically significant compared with either control
        by Fisher''s exact test. There was a 12% incidence of hepatic basophilic foci
        and a 10% incidence of hepatocellular carcinomas in female mice at 750 mg/kg,
        statistically significant (p &lt; 0.05) compared with vehicle but not with
        water controls by Fisher''s exact test. There were no metastases. Time-dependent
        and -independent statistical analyses showed an adverse trend in the incidence
        of hepatocellular carcinomas in male and female mice, correlated with toxicity
        (expressed as mortality) at 750 mg/kg. The time-adjusted incidence of hepatocellular
        carcinomas in male mice (18.8%) was within the historical normal range at
        the testing facility (0-22%), but that in females (13.1%) lay outside the
        normal range (0-2%). Under the conditions of these studies 2EH was not oncogenic
        in rats, but there were weak adverse trends in hepatocellular carcinoma incidence
        in mice at high dose levels which may have been associated with toxicity.
        The major effects of chronic dosing were mortality in female rats at 500 mg/kg
        and in male and female mice at 750 mg/kg, accompanied by reductions in body
        weight gain in rats at 150 and 500 mg/kg and in mice at 750 mg/kg. Direct
        comparison of any tumorogenic effects of 2EH given alone to female mice with
        those due to 2EH formed in vivo from DEHA, DEHP, or TEHP is limited by the
        high mortality caused by 2ER in female mice at equivalent doses of 2EH. While
        2EH may be a contributing factor in the hepatocellular carcinogenesis in female
        mice associated with the chronic administration of DEHA and DEHP, it is unlikely
        to be the entire proximate carcinogen.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Astill</LastName><ForeName>B
        D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Toxicology
        Research Task Group, Chemical Manufacturers Association, Washington, DC 20037,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gingell</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Hellwig</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Hodgson</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Kuettler</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Mellert</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>Murphy</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author
        ValidYN="Y"><LastName>Sielken</LastName><ForeName>R L</ForeName><Initials>RL</Initials><Suffix>Jr</Suffix></Author><Author
        ValidYN="Y"><LastName>Tyler</LastName><ForeName>T R</ForeName><Initials>TR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Fundam Appl Toxicol</MedlineTA><NlmUniqueID>8200838</NlmUniqueID><ISSNLinking>0272-0590</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014677">Pharmaceutical Vehicles</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007441" MajorTopicYN="N">Intubation, Gastrointestinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014677" MajorTopicYN="N">Pharmaceutical Vehicles</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8998951</ArticleId><ArticleId IdType="doi">10.1006/faat.1996.0073</ArticleId><ArticleId
        IdType="pii">S0272059096900731</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3383337</PMID><DateCompleted><Year>1988</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>1988</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Failure
        of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis
        in rat hepatocytes following in vivo treatment.</ArticleTitle><Pagination><StartPage>1179</StartPage><EndPage>1183</EndPage><MedlinePgn>1179-83</MedlinePgn></Pagination><Abstract><AbstractText>Peroxisome
        proliferator hepatocarcinogens lack genotoxic activity in numerous in vitro
        assays using non-target cells which do not respond with peroxisome proliferation.
        Therefore, the effect of in vivo treatment with WY-14,643 on DNA repair was
        quantitated in rat hepatocytes, the target cell for carcinogenesis. Palmitoyl
        CoA oxidase and carnitine acetyltransferase activities in isolated hepatocytes
        were elevated by WY-14,643 (50 mg/kg/day by gavage for up to 5 consecutive
        days) and by WY-14,643 (0.1%) or di(2-ethyl-hexyl)phthalate (DEHP) (1.2%)
        feeding (for up to 28 days), indicating peroxisome proliferation had occurred.
        DNA repair as unscheduled DNA synthesis (UDS) was measured autoradiographically
        as net nuclear grains following thymidine incorporation in primary hepatocyte
        cultures. Treatment of rats with WY-14,643 (gavage or feeding) or DEHP (feeding)
        did not induce UDS. Addition of 2-acetylaminofluorene to replicate cultures
        demonstrated that WY-14,643 or DEHP treatment did not prevent repair response.
        Additional cultures were treated with H2O2 (0.8 mM H2O2 3x at 1-h intervals)
        to evaluate the ability of UDS to detect any repair which may be induced by
        peroxisomal metabolism. H2O2 did not induce UDS at this concentration, nor
        did it prevent 2-acetylaminofluorene-induced repair. UDS was, however, observed
        in a separate experiment using a higher concentration of H2O2. In summary,
        a highly carcinogenic peroxisome proliferator did not induce UDS in the target
        cell for carcinogenesis in spite of peroxisome proliferation following in
        vivo treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, NC 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Smith-Oliver</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Butterworth</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 07945</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9M98QLJ2DL</RegistryNumber><NameOfSubstance
        UI="D015073">2-Acetylaminofluorene</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance
        UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.-</RegistryNumber><NameOfSubstance UI="C028427">palmitoyl CoA oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015073" MajorTopicYN="N">2-Acetylaminofluorene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3383337</ArticleId><ArticleId IdType="doi">10.1093/carcin/9.7.1179</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="Publisher" Owner="NLM"><PMID Version="1">12209194</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1521-4621</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>30</Volume><PubDate><Year>1995</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Toxicity
        report series</Title><ISOAbbreviation>Toxic Rep Ser</ISOAbbreviation></Journal><ArticleTitle>NTP
        technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2)
        Administered in Feed to F344/N Rats and B6C3F1 Mice.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>G5</EndPage><MedlinePgn>1-G5</MedlinePgn></Pagination><Abstract><AbstractText>Dibutyl
        phthalate is a phthalate ester with extensive use in industry in such products
        as plastic (PVC) piping, various varnishes and lacquers, safety glass, nail
        polishes, paper coatings, dental materials, pharmaceuticals, and plastic food
        wrap. Concomitant with this extensive worldwide use is the high potential
        for human exposure to dibutyl phthalate in the workplace and the home environment
        through direct sources as well as indirectly, through contamination of water,
        air, and foodstuffs. Because existing toxicity information was considered
        inadequate, the effects of exposure to dibutyl phthalate were examined in
        male and female F344/N rats and B6C3F1 mice in 13-week feed studies. Furthermore,
        due to concern over the potential for pervasive exposure of humans to dibutyl
        phthalate, additional perinatal studies examined rats and mice exposed as
        pups in utero, for the 4 weeks of lactation, and for an additional 4 weeks
        postweaning. Additional studies examined the effects on rats of combining
        perinatal and adult subchronic exposure. Due to the recognized biologic activity
        of this and other phthalates, hepatic peroxisome proliferation during the
        in utero and lactational phases and testicular toxicity during the perinatal
        period were also examined. Finally, reproductive assessment by continuous
        breeding (including crossover mating trials and offspring assessment) and
        genetic toxicity studies were also conducted. In the maximum perinatal exposure
        (MPE) determination study in rats, dibutyl phthalate was administered in the
        diet to dams during gestation and lactation, and to the pups postweaning for
        four additional weeks, at concentrations of 0, 1,250, 2,500, 5,000, 7,500,
        10,000, and 20,000 ppm. Decreased weight gains were noted in dams exposed
        to 20,000 ppm during gestation and to dams exposed to 10,000 ppm during lactation.
        The gestation index (number of live pups per breeding female) was significantly
        lower in the 20,000 ppm group than in the controls, and pup mortality in this
        group was marked (100% by Day 1 of lactation); however, survival was 89% or
        greater in all other treatment groups. The mean body weight of pups in the
        10,000 ppm group at Day 28 of lactation was approximately 90% of the mean
        weight of control pups. Pups were weaned onto diets containing dibutyl phthalate
        at the same concentrations fed to dams. After an additional 4 weeks of dietary
        administration, final mean body weights of pups in the 10,000 ppm groups were
        92% of the control value for males and 95% of the control value for females.
        Hepatomegaly (increased relative liver weight) was observed in males in all
        exposed groups and in females receiving 2,500 ppm or greater. No gross lesions
        were observed at necropsy. Moderate hypospermia of the epididymis was diagnosed
        in all male rats in the 7,500 and 10,000 ppm groups; mild hypospermia of the
        epididymis was diagnosed in 2 of 10 males in the 5,000 ppm group. No degeneration
        of the germinal epithelium was detected in the testis of these rats. Thus,
        although toxicologically important, the epididymal hypospermia was not considered
        to be life threatening, and 10,000 ppm was recommended as the MPE concentration
        for male and female rats. In the subsequent subchronic toxicity study of dibutyl
        phthalate with perinatal exposure, dams were administered diets containing
        0 or the MPE concentration (10,000 ppm) during gestation and lactation, and
        weaned pups were administered the same diets as their dams received for an
        additional 4 weeks, until the beginning of the 13-week exposure phase. Male
        and female rats then received diets containing dibutyl phthalate at concentrations
        of 0, 2,500, 5,000, 10,000, 20,000, and 40,000 ppm for 13 weeks. No mortality
        or toxicity was observed in dams during the perinatal phase of the study;
        however, before pups were culled at 4 days postpartum, the percentage of live
        pups per litter was 86% to 93% that of the controls. Through weaning, litter
        weights of exposed pups ranged from 89% to 92% of the control values. Ten
        control and ten exposed pups per sex were examined at the time of trol and
        ten exposed pups per sex were examined at the time of weaning; hepatomegaly
        and markedly increased peroxisomal enzyme activities (approximately 9-fold
        greater than the control values) were observed in exposed pups. Body weights
        of the perinatally exposed pups remained lower than those of the controls
        throughout the 4-week period before the 13-week adult exposures began. During
        the 13-week adult exposure phase, the final mean body weight of males in the
        MPE: 0 ppm control group (MPE rats, returned to the base diet for 13 weeks),
        was 95&amp;percnt; that of the controls. The body weight gain of females in
        the MPE:0 ppm group was greater than that of the unexposed controls, and the
        final body weights of these two groups were similar. Body weight gains of
        rats treated with dibutyl phthalate as adults decreased with increasing exposure
        concentration; for rats that received the MPE concentration followed by 40,000
        ppm for 13 weeks, final body weights were 51&amp;percnt; of the control value
        for males and 74&amp;percnt; of the control value for females. Hepatomegaly
        apparently regressed in rats in the MPE:0 ppm groups but was observed in male
        rats receiving 5,000 ppm or greater and in females receiving 2,500 ppm or
        greater. In males that received 20,000 ppm as adults, testis and epididymal
        weights were less than in the controls; males in the 40,000 ppm group also
        had a lower testis weight than the controls. Results of hematologic analyses
        conducted at the end of the 13-week exposure period suggested a mild anemia
        in male rats administered 10,000 ppm or greater as adults and female rats
        administered 40,000 ppm as adults. Hypocholesterolemia and hypotriglyceridemia
        were observed in male and female rats at the higher exposure concentrations.
        Hypotriglyceridemia was detected in females receiving 20,000 or 40,000 ppm
        and in males receiving 10,000 ppm or greater. Elevations in alkaline phosphatase
        activities and bile acid concentrations in male and female rats receiving
        20,000 or 40,000 ppm as adults were indicative of cholestasis. Microscopic
        examination revealed hepatocellular cytoplasmic alteration, consistent with
        glycogen depletion, in male and female rats receiving a concentration of 10,000
        ppm or greater. In the liver of rats receiving 40,000 ppm, small, fine, eosinophilic
        granules were also observed in the cytoplasm of hepatocytes. Ultrastructural
        examination suggested the presence of increased numbers of peroxisomes. Lipofuscin
        accumulation was detected in rats that received 10,000 ppm or greater. Consistent
        with the regression of the hepatomegaly in rats in the MPE:0 and MPE:2,500
        ppm groups, peroxisomal enzyme activity was not elevated in these groups.
        Marked elevations of peroxisomal enzyme activity were detected, however, in
        males receiving 5,000 ppm or greater and in females receiving 10,000 ppm or
        greater; at the 40,000 ppm concentration, the highest concentration tested,
        enzyme activities were approximately 20 fold greater than the control values.
        Histopathologic examination of the testes revealed degeneration of the germinal
        epithelium, a mild to moderate focal lesion in rats in the 10,000 and 20,000
        ppm groups and a marked, diffuse lesion in all males receiving 40,000 ppm;
        at 40,000 ppm, an almost complete loss of the germinal epithelium resulted.
        Testicular zinc concentrations were lower in the 40,000 ppm group than in
        the controls, a finding consistent with the marked loss of germinal epithelium
        at this exposure concentration. Spermatogenesis was evaluated in rats in the
        0, 2,500, 10,000, and 20,000 ppm groups; rats administered 20,000 ppm had
        fewer spermatid heads per testis than the unexposed controls, and epididymal
        spermatozoal concentration was less than that in the MPE:0 ppm group. For
        comparison with the perinatal subchronic study, a standard 13-week evaluation
        of the toxicity of dibutyl phthalate in male and female rats was also conducted.
        In this study, rats received dibutyl phthalate at the same dietary concentrations
        used in the 13-week exposure phase of the study with perinatal exposure: 0,
        2,500, 5,000, 10,000, 20,000, and 40,000 ppm. No deaths occurred in the standard
        study. Markedly reduced final mean body weights were observed in males and
        females in the 40,000 ppm groups (45&amp;percnt; and 73&amp;percnt; of control
        body weights, respectively); final mean body weights of males receiving 10,000
        ppm or greater and females receiving 20,000 ppm or greater were lower than
        those of the controls. Hepatomegaly was observed in males that received 5,000
        ppm or greater and in females that received 10,000 ppm or greater. Testis
        and epididymal weights of males in the 20,000 and 40,000 ppm groups were lower
        than those of the controls. A minimal anemia was detected in male rats receiving
        5,000 ppm or greater. Hypocholesterolemia was observed in male and female
        rats receiving 20,000 or 40,000 ppm, and hypotriglyceridemia was detected
        in males in all exposed groups and in females receiving 10,000 ppm or greater.
        Elevations in alkaline phosphatase activity and bile acid concentration in
        male and female rats were considered indicative of cholestasis. Morphologic
        evaluation again confirmed the toxicity of dibutyl phthalate to the liver
        and testes of rats. Microscopic examination of the liver revealed hepatocellular
        cytoplasmic alterations, consistent with glycogen depletion, in male and female
        rats receiving 10,000 ppm or greater. In the liver of rats in the 40,000 ppm
        groups, small, fine, eosinophilic granules were also observed in the cytoplasm
        of hepatocytes. Ultrastructural examination suggested the presence of increased
        numbers of peroxisomes, and peroxisomal enzyme activity was elevated in the
        livers of male and female rats administered 5,000 ppm or greater; the enzyme
        activities in the 40,000 ppm groups were approximately 13-fold greater than
        the control value for males and 32-fold greater than the control value for
        females. Lipofuscin accumulation was detected in rats receiving 10,000 ppm
        or greater. Histopathologic examination of the testes revealed degeneration
        of the germinal epithelium, a mild to marked focal lesion in the 10,000 and
        20,000 ppm groups and a marked, diffuse lesion in all males in the 40,000
        ppm group; at 40,000 ppm, an almost complete loss of the germinal epithelium
        resulted. Testicular zinc concentrations were lower in the 20,000 and 40,000
        ppm groups than in the controls. Serum testosterone values were also lower
        at these concentrations than in the controls. Spermatogenesis was evaluated
        in males in the 0, 2,500, 10,000, and 20,000 ppm groups; at 20,000 ppm, spermatid
        heads per testis and per gram testis, epididymal spermatozoal motility, and
        the number of epididymal spermatozoa per gram epididymis were lower than in
        the controls. All of these findings are consistent with the marked loss of
        germinal epithelium at these exposure concentrations. In the continuous breeding
        study, Sprague-Dawley rats received 0, 1,000, 5,000, or 10,000 ppm dibutyl
        phthalate in feed. Mean body weights of exposed dams at delivery and during
        lactation generally decreased with increasing exposure concentration. The
        mean pup weight at birth in the 10,000 ppm group was significantly lower than
        the control pup weight. The average number of live pups per litter in all
        exposed groups was lower than in the controls. Crossover mating trials in
        the F(0) generation revealed no effects on the fertility of male or female
        rats receiving 10,000 ppm. In contrast to the F(0) rats, mating, pregnancy,
        and fertility indices of F(1) rats were lower in the 10,000 ppm group than
        in the controls. Germinal epithelial degeneration of the testes and absence
        or under development of the epididymides were noted in F(1) males in the 10,000
        ppm group. Interstitial cell hyperplasia was noted in 7 of 10 males in the
        10,000 ppm group. These effects document the male and female reproductive
        toxicity of dibutyl phthalate in F(1) rats receiving 10,000 ppm and do not
        exclude the possibility of developmental toxicity to F2 offspring. In the
        MPE determination study in mice, dams received 0, 1,250, 2,500, 5,000, 7,500,
        10,000, or 20,000 ppm dibutyl phthalate in feed during gestation and lactation;
        pups were weaned onto the same diets as the dams received and were exposed
        for an additional 4 weeks. The gestation period was longer in dams that received
        2,500 ppm or greater than in the controls, and gestational body weight gain
        depressions were noted in dams receiving 7,500 ppm or greater. Only 5 of 20
        females in the 10,000 ppm group delivered live pups, and none of the 20 females
        receiving 20,000 ppm delivered live pups. Only one pup in the 10,000 ppm group
        survived past Lactation Day 1; the number of live pups per litter in the 7,500
        ppm group also remained low throughout lactation. No deaths of either male
        or female pups occurred after weaning. Initial (postweaning) and final body
        weights of male pups receiving 2,500 ppm or greater were significantly less
        than those of the control group. The mean body weights of exposed female pups
        were similar to the control body weight at weaning and remained similar throughout
        the 4 weeks postweaning. Hepatomegaly was present in male mice in all exposed
        groups, and the absolute liver weight of males administered 7,500 ppm was
        greater than that of the controls; although a similar change was apparent
        in females, no statistical differences between the liver weights of exposed
        and control females were detected. No treatment-related gross lesions were
        identified at necropsy, and no histopathologic lesions definitively associated
        with treatment were observed in male or female mice in the 7,500 ppm groups.
        The one surviving male pup in the 10,000 ppm group had cytoplasmic alteration
        in the liver, consistent with peroxisome proliferation. Developmental toxicity
        and fetal and pup mortality were suggested at concentrations as low as 7,500
        ppm. No subchronic toxicity study with prior MPE exposure was conducted with
        mice, although an MPE concentration of 5,000 ppm was suggested by the data.
        In a standard 13-week toxicity study, mice received 0, 1,250, 2,500, 5,000,
        10,000, or 20,000 ppm dibutyl phthalate in feed. No deaths occurred during
        this study. Mean body weights and weight gains of male and female mice decreased
        with increasing exposure concentration, and the decreases were significant
        for males and females that received 5,000 ppm or greater. Relative liver weights
        were greater in males and females receiving 5,000 ppm or greater than in the
        controls. A minimal anemia was suggested in female mice in the 20,000 ppm
        group. Although no gross lesions were observed at necropsy, microscopic examination
        revealed hepatocellular cytoplasmic alterations, consistent with glycogen
        depletion, in male mice receiving 10,000 or 20,000 ppm and female mice receiving
        20,000 ppm. Small, fine, eosinophilic granules, consistent with peroxisome
        proliferation, were also observed in the cytoplasm of hepatocytes in males
        and females in the 20,000 ppm groups. Lipofuscin accumulation in the liver
        was detected in mice receiving 10,000 ppm or greater. In a continuous breeding
        study using Swiss (CD-1&amp;reg;) mice, animals received 0, 300, 3,000, or
        10,000 ppm dibutyl phthalate in feed. The fertility index, average number
        of litters per breeding pair, and average number of live pups per litter in
        the 10,000 ppm group were lower than in the controls. Crossover mating trials
        of mice receiving 10,000 ppm revealed effects on dams in the F(0) generation,
        with a lower fertility index, number of live pups per litter, and pup weight
        than in the controls. Liver weights were greater in males and females, and
        the uterine weight was less in exposed dams than in the controls. No other
        changes were observed at necropsy or on histopathologic examination. These
        data document the female reproductive toxicity of dibutyl phthalate in F(0)
        mice. Dibutyl phthalate was not mutagenic in Salmonella typhimurium strain
        TA98, TA100, TA1535, or TA1537 with or without exogenous metabolic activation
        but did induce mutations in L5178Y mouse lymphoma cells treated without metabolic
        activation. In peripheral blood samples obtained from male and female mice
        at the end of the 13-week study, frequencies of micronucleated normochromatic
        erythrocytes were similar between exposed and control mice. Together, the
        studies in rodents suggest that young rodents (in utero and perinatal) respond
        in a manner qualitatively similar to that of adult rats and mice. Dibutyl
        phthalate induced toxic effects in rodents as pups in utero and during the
        lactational phases of development and also affected young adults, as evidenced
        by fetotoxicity and lethality, body weight gain decrements, increased liver
        weights, hepatic peroxisome proliferation, testicular toxicity, and female
        reproductive toxicity. Dibutyl phthalate was lethal to rat fetuses and rat
        and mouse neonates at dietary concentrations that were not toxic to dams.
        Otherwise, there was no teratogenic or morphologic evidence that rodent young
        were uniquely sensitive to the effects of short-term dibutyl phthalate treatment.
        Synonyms: 1,2-Benzenedicarboxylic acid dibutyl ester; benzene-o-dicarboxylic
        acid di-n-butyl ester; o-benzenedicarboxylic acid dibutyl ester; butyl phthalate;
        n-butyl phthalate; DBP; dibutyl 1,2-benzene dicarboxylate; dibutylphthalate;
        di-n-butylphthalate; di(n-butyl) phthalate; dibutyl-o-phthalate; phthalic
        acid dibutyl ester. Trade Names: Celluflex DBP; Elaol; Ergoplast FDB; Ersoplast
        FDA; Genoplast B; Hexaplas M/B; Palatinol C; Polycizer DBP; PX 104; RC Plasticizer
        DBP; Staflex DBP; Uniflex DBP; Unimoll DB; Witcizer 300; Witicizer 300. (NOTE:
        These studies were supported in part by funds from the Comprehensive Environmental
        Response, Compensation, and Liability Act trust fund (Superfund) by an interagency
        agreement with the Agency for Toxic Substances and Disease Registry, U.S.
        Public Health Service.)</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Marsman</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxic Rep Ser</MedlineTA><NlmUniqueID>101122696</NlmUniqueID><ISSNLinking>1521-4621</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1995</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>9</Month><Day>5</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1995</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12209194</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">23625783</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-2280</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>54</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Environmental
        and molecular mutagenesis</Title><ISOAbbreviation>Environ Mol Mutagen</ISOAbbreviation></Journal><ArticleTitle>Diethylhexyl
        phthalate exposure impairs follicular development and affects oocyte maturation
        in the mouse.</ArticleTitle><Pagination><StartPage>354</StartPage><EndPage>361</EndPage><MedlinePgn>354-61</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1002/em.21776</ELocationID><Abstract><AbstractText>Diethylhexyl
        phthalate (DEHP) is an estrogen-like compound widely used as a commercial
        plasticizer and present in medical devices, tubing, food containers and packaging.
        It is considered an endocrine disruptor and studies on experimental animals
        showed that exposure to DEHP can alter the function of several organs including
        liver, kidneys, lungs and reproductive system, particularly the developing
        testes of prenatal and neonatal males. Exposure to DEHP has been proposed
        as a potential human health hazard. This study assessed the effects of DEHP
        on folliculogenesis and oocyte maturation using the mouse as the experimental
        model. Newborn female mice were hypodermically injected with DEHP at doses
        of 20 and 40 &#x3bc;g/kg per body weight following different exposure regimens
        during the weaning period. We found that DEHP altered both folliculogenesis
        and oocyte development. In particular, DEHP exposure significantly decreased
        the number of the primordial follicles at pubertal and adult age by possibly
        accelerating the rate of follicle recruitment dynamics, reduced and/or delayed
        the level of imprinted gene methylation in the oocytes and increased metaphase
        II spindle abnormalities in oocytes matured in vitro. Furthermore, the weight
        of pups and litter size of mothers exposed to DEHP were significantly lower
        than controls. Finally, the number of primordial follicles appeared significantly
        reduced also in the F1 offspring at the adult age. These results show that
        DEHP may have a number of adverse effects on oogenesis, especially when exposure
        occurs during early postnatal age, arising concerns about the exposure of
        human female infants and children to this compound.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2013 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xi-Feng</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>Key
        Laboratory of Animal Reproduction and Germplasm Enhancement in Universities
        of Shandong, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lian-Jun</ForeName><Initials>LJ</Initials></Author><Author
        ValidYN="Y"><LastName>Li</LastName><ForeName>Lan</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Feng</LastName><ForeName>Yan-Ni</ForeName><Initials>YN</Initials></Author><Author
        ValidYN="Y"><LastName>Chen</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Ma</LastName><ForeName>Jin-Mei</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Huynh</LastName><ForeName>Evanna</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Shi</LastName><ForeName>Qing-Hua</ForeName><Initials>QH</Initials></Author><Author
        ValidYN="Y"><LastName>De Felici</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Shen</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2013</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Mol Mutagen</MedlineTA><NlmUniqueID>8800109</NlmUniqueID><ISSNLinking>0893-6692</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D052244">Endocrine Disruptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D052244" MajorTopicYN="N">Endocrine Disruptors</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018613" MajorTopicYN="N">Microscopy, Confocal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009865" MajorTopicYN="N">Oocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009866" MajorTopicYN="N">Oogenesis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008941" MajorTopicYN="N">Spindle Apparatus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2012</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2013</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2013</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">23625783</ArticleId><ArticleId IdType="doi">10.1002/em.21776</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8540215</PMID><DateCompleted><Year>1996</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0145-6296</ISSN><JournalIssue
        CitedMedium="Print"><Volume>37</Volume><Issue>4</Issue><PubDate><Year>1995</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Veterinary
        and human toxicology</Title><ISOAbbreviation>Vet Hum Toxicol</ISOAbbreviation></Journal><ArticleTitle>Testicular
        toxicity of Di(2-ethylhexyl)phthalate in developing rats.</ArticleTitle><Pagination><StartPage>310</StartPage><EndPage>313</EndPage><MedlinePgn>310-3</MedlinePgn></Pagination><Abstract><AbstractText>To
        understand the factors involved in the enhanced testicular toxicity of di(2-ethylhexyl)phthalate
        (DEHP) in developing animals, po doses of 50, 100, 250 or 500 mg DEHP/kg were
        administered to 25-d-old albino rats for 30 consecutive days. Activities of
        testicular and hepatic cytochrome P-450 enzymes were determined. A dose-dependent
        increase in the activities of lactate dehydrogenase and gamma-glutamyl transpeptidase
        and a decrease in sorbitol dehydrogenase was observed in the testes. The activity
        of beta-glucuronidase increased at dosages of 250 and 500 mg/kg, while acid
        phosphatase decreased. Testes had marked destructive changes in the advanced
        germ cell layers at dosages of 250 and 500 mg/kg, which supports biochemical
        studies indicating that DEHP interacts with the maturation process of the
        testes. The dose-dependent decrease in hepatic cytochrome P-450 levels and
        the activities of ethylmorphine N-demethylase and aniline hydroxylase suggest
        that impaired metabolism of DEHP could lead to higher amounts of the diester
        or its metabolites reaching the testes; this may result in enhanced vulnerability
        of the testes to DEHP in developing animals.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Parmar</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Industrial
        Toxicology Research Centre, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Srivastava</LastName><ForeName>S P</ForeName><Initials>SP</Initials></Author><Author
        ValidYN="Y"><LastName>Singh</LastName><ForeName>G B</ForeName><Initials>GB</Initials></Author><Author
        ValidYN="Y"><LastName>Seth</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Vet Hum Toxicol</MedlineTA><NlmUniqueID>7704194</NlmUniqueID><ISSNLinking>0145-6296</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.14</RegistryNumber><NameOfSubstance UI="D007064">L-Iditol 2-Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.27</RegistryNumber><NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.5.3.-</RegistryNumber><NameOfSubstance UI="D005037">Ethylmorphine-N-Demethylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.2.1.31</RegistryNumber><NameOfSubstance UI="D005966">Glucuronidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005037" MajorTopicYN="N">Ethylmorphine-N-Demethylase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005854" MajorTopicYN="N">Germ Cells</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005966" MajorTopicYN="N">Glucuronidase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007064" MajorTopicYN="N">L-Iditol 2-Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012671" MajorTopicYN="N">Seminiferous Tubules</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013091" MajorTopicYN="N">Spermatogenesis</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1995</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1995</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1995</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8540215</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10485824</PMID><DateCompleted><Year>1999</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0192-6233</ISSN><JournalIssue
        CitedMedium="Print"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>1999</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Toxicologic
        pathology</Title><ISOAbbreviation>Toxicol Pathol</ISOAbbreviation></Journal><ArticleTitle>Quantitative
        analysis of the lobular distribution of S-phase in rat liver following dietary
        administration of di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>436</StartPage><EndPage>440</EndPage><MedlinePgn>436-40</MedlinePgn></Pagination><Abstract><AbstractText>A
        simple image-analysis method is described, whereby the distribution of hepatocytes
        that have entered S-phase, as distinguished by the incorporation of bromodeoxyuridine,
        can be related to the position of the central and portal veins of the hepatic
        lobule. Hepatocyte S-phase was induced in the livers of male and female F344
        rats by administration of di(2-ethylhexyl)phthalate (DEHP) in the diet for
        7 days at 2 dose levels, and these livers were used to develop the procedure.
        The distributions of the S-phase between control and DEHP-treated livers were
        compared using statistical techniques. The results showed notable differences
        in the distribution of S-phase between male and female rats as well as limited
        dose-related effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Soames</LastName><ForeName>A R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Zeneca
        Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, United
        Kingdom. Tony.Soames@ctl.zeneca.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cliffe</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Pate</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author
        ValidYN="Y"><LastName>Foster</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Pathol</MedlineTA><NlmUniqueID>7905907</NlmUniqueID><ISSNLinking>0192-6233</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>G34N38R2N1</RegistryNumber><NameOfSubstance
        UI="D001973">Bromodeoxyuridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001973" MajorTopicYN="N">Bromodeoxyuridine</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002149" MajorTopicYN="N">Energy Intake</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016196" MajorTopicYN="Y">S Phase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10485824</ArticleId><ArticleId IdType="doi">10.1177/019262339902700407</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">22936646</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-7278</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Environmental
        toxicology</Title><ISOAbbreviation>Environ Toxicol</ISOAbbreviation></Journal><ArticleTitle>Induction
        of oxidative stress and histological changes in liver by subacute doses of
        butyl cyclohexyl phthalate.</ArticleTitle><Pagination><StartPage>345</StartPage><EndPage>353</EndPage><MedlinePgn>345-53</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1002/tox.21813</ELocationID><Abstract><AbstractText>Phthalates
        are esters of phthalic acid and are mainly used as plasticizers in a wide
        variety of products and applications. There is no information on butyl cyclohexyl
        phthalate (BCP) toxicity. This study was performed to evaluate the histopathological
        effects and to determine oxidative stress inducing potential in liver by subacute
        exposure of BCP. The animals of the treatment groups were orally administered
        100, 200, and 400 mg/kg/day BCP for 5 consecutive days per week during 28
        days. As a result, no significant changes were observed in body weight gains,
        and absolute and relative liver weights of liver of BCP treated mice, when
        compared with control group. Although the degree of lipid peroxidation in
        the liver tissue of all BCP exposure groups were significantly higher than
        those of the control (p &lt; 0.01), SOD and CAT activities in liver tissue
        of mice of 200 and 400 mg/kg exposure groups were significantly lower than
        those of the controls (p &lt; 0.01). Moreover, BCP caused dose-dependent histological
        changes in the liver of mice such as congestions in vena centralis, an enlargement
        of the sinusoids, degeneration in hepatocytes, vacuole formations and presence
        of lipid droplets in hepatocytes, eosinophilic cytoplasm. While iNOS immunoreactivity
        was increased in all treatment groups, Type IV collagen and Connexin 43 immunoreactivities
        were decreased in all treatment groups compared with the control group. Significant
        decrease was observed in the number of TUNEL-positive liver cells of BCP treated
        mice. These results suggested that BCP exposure induces oxidative stress in
        liver and exposure of BCP during long time period could lead to hepatocarcinogenesis.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2012 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Yava&#x15f;o&#x11f;lu</LastName><ForeName>N
        &#xdc;lk&#xfc; Karabay</ForeName><Initials>N&#xdc;</Initials><AffiliationInfo><Affiliation>Department
        of Biology, Faculty of Science, Ege University, 35100 Bornova, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>K&#xf6;ksal</LastName><ForeName>Cinel</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Da&#x11f;deviren</LastName><ForeName>Melih</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Aktu&#x11f;</LastName><ForeName>H&#xfc;seyin</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Yava&#x15f;o&#x11f;lu</LastName><ForeName>Altu&#x11f;</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Toxicol</MedlineTA><NlmUniqueID>100885357</NlmUniqueID><ISSNLinking>1520-4081</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D024141">Collagen Type IV</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018031">Connexin 43</NameOfSubstance></Chemical><Chemical><RegistryNumber>2286E5R2KE</RegistryNumber><NameOfSubstance
        UI="D003993">Dibutyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.13.39</RegistryNumber><NameOfSubstance UI="D052247">Nitric Oxide Synthase
        Type II</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance
        UI="C496317">Nos2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D024141" MajorTopicYN="N">Collagen Type IV</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018031" MajorTopicYN="N">Connexin 43</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003993" MajorTopicYN="N">Dibutyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D059551" MajorTopicYN="N">Toxicity Tests, Subacute</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">antioxidant enzymes</Keyword><Keyword
        MajorTopicYN="N">butyl cyclohexyl phthalate</Keyword><Keyword MajorTopicYN="N">hepatotoxicity</Keyword><Keyword
        MajorTopicYN="N">immunohistochemistry</Keyword><Keyword MajorTopicYN="N">lipid
        peroxidations</Keyword><Keyword MajorTopicYN="N">liver</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2011</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2012</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2012</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">22936646</ArticleId><ArticleId IdType="doi">10.1002/tox.21813</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2877511</PMID><DateCompleted><Year>1986</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>1986</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Di-n-octyl
        phthalate (DOP), a relatively ineffective peroxisome inducing straight chain
        isomer of the environmental contaminant di(2-ethylhexyl)phthalate (DEHP),
        enhances the development of putative preneoplastic lesions in rat liver.</ArticleTitle><Pagination><StartPage>279</StartPage><EndPage>288</EndPage><MedlinePgn>279-88</MedlinePgn></Pagination><Abstract><AbstractText>Di-n-octyl
        phthalate (DOP) is the straight chain isomer of di(2-ethylhexyl) phthalate
        (DEHP) which is a widely used plasticizer and an environmental contaminant.
        DEHP is a strong inducer of peroxisome proliferation in rat liver. This is
        significant since other compounds which are strong inducers of peroxisome
        proliferation have been reported to be weak carcinogens (Reddy, J.K. and Lalwani,
        N.D., CRC Crit. Rev. Toxicol., 12 (1983) 1). In contrast to DEHP, DOP causes
        little or no induction of liver peroxisomes (Mann, A.H. et al., Toxicol. Appl.
        Pharmacol., 77 (1985) 116, and Gray, T.J.B. et al., Toxicology, 28 (1983)
        167). In the current study the ability of 1% DOP to promote the development
        of putative preneoplastic lesions was evaluated. The effect of feeding 0.5%
        DEHP as well as equimolar amounts of its 2 major metabolites, mono(2-ethylhexyl)phthalate
        (MEHP) and 2-ethylhexanol (2-EH) were also investigated. GGT+ foci were initiated
        in the livers of Sprague--Dawley male rats with a single dose of diethylnitrosamine
        (DEN) following partial hepatectomy. The control group of rats was fed a semipurified
        diet (Co) for 10 weeks while the experimental groups received the semipurified
        diet containing the respective compounds. Induction of peroxisome proliferation
        was monitored by carnitine acetyltransferase (CAT) levels. DOP treatment resulted
        in a 6-fold increase in the number of GGT+ foci (20.8 +/- 4.0 vs. 3.5 +/-
        1.3; P less than 0.05). This was accompanied by no change in liver weight
        and only a slight increase in CAT activity when compared with control animals.
        In contrast to DOP, 2-EH produced essentially no effect with regard to number
        of foci, peroxisome proliferation or liver weight. DEHP and MEHP induced significant
        peroxisome proliferation and hepatomegaly but the number of foci were significantly
        lower than in 2-EH-treated rats. The mechanism for the promoting ability of
        DOP is not clear but would not appear to be related to peroxisome proliferation.
        Because of the close similarity of chemical structure and metabolism between
        DOP and DEHP, it is possible that studies to define the mechanism of DOP induced
        promotion might also serve to further clarify the mechanism of DEHP induced
        carcinogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>DeAngelo</LastName><ForeName>A B</ForeName><Initials>AB</Initials></Author><Author
        ValidYN="Y"><LastName>Garrett</LastName><ForeName>C T</ForeName><Initials>CT</Initials></Author><Author
        ValidYN="Y"><LastName>Manolukas</LastName><ForeName>L A</ForeName><Initials>LA</Initials></Author><Author
        ValidYN="Y"><LastName>Yario</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>1-R01-CA-31324</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>8X3RJ0527W</RegistryNumber><NameOfSubstance
        UI="C010715">di-n-octyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2877511</ArticleId><ArticleId IdType="doi">10.1016/0300-483x(86)90182-4</ArticleId><ArticleId
        IdType="pii">0300-483X(86)90182-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32471116</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>18</Day></DateRevised><Article
        PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>17</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>International
        journal of environmental research and public health</Title><ISOAbbreviation>Int
        J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Long-Term
        Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism
        in Hepatic Stellate Cells and Exacerbates Liver Librosis.</ArticleTitle><ELocationID
        EIdType="pii" ValidYN="Y">3802</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph17113802</ELocationID><Abstract><AbstractText>Phthalates
        are often added to plastic products to increase their flexibility. Di-(2-ethylhexyl)
        phthalate (DEHP) is one of the most common plasticizers. Previously, a major
        incident involving phthalate-contaminated foodstuffs occurred, where phthalates
        were deliberately added to foodstuffs as a substitute for emulsifiers, resulting
        in a threat to public health. DEHP exposure can cause liver damage and further
        lead to cancer; however, the effects of long-term exposure to low-dose DEHP
        on hepatic stellate cells (HSCs) and on liver fibrosis are still unclear.
        In this study, we showed that chronic exposure to low-dose DEHP results in
        an accumulation of cholesterol in HSCs by disturbing the cholesterol metabolism
        and enhancing endogenous cholesterol synthesis. In addition, long-term exposure
        to low-dose DEHP reduces the sensitivity of HSCs to platelet-derived growth
        factor BB (PDGF-BB)-induced proliferation by blocking the MAPK pathway. Dysfunction
        of mitochondrial respiration and induction of caspase 3/PARP-dependent apoptosis
        were observed in HSCs following chronic, low-dose exposure. The carbon tetrachloride
        (CCl<sub>4</sub>)-induced liver fibrosis mouse model showed that long-term
        administration of DEHP significantly promoted liver damage, inflammatory infiltration,
        cholesterol accumulation, and deposition of hepatic collagen. In conclusion,
        long-term exposure to low-dose DEHP may perturb the cholesterol metabolism
        in HSCs and accelerate liver damage and fibrosis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chun-Ya</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>School
        of Medical Laboratory Science and Biotechnology, College of Medical Science
        and Technology, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Suk</LastName><ForeName>Fat-Moon</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Division
        of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei
        Medical University, Taipei 116, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical
        University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Twu</LastName><ForeName>Yuh-Ching</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department
        of Biotechnology and Laboratory Science in Medicine, School of Biomedical
        Science and Engineering, National Yang-Ming University, Taipei 112, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Liao</LastName><ForeName>Yi-Jen</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>School
        of Medical Laboratory Science and Biotechnology, College of Medical Science
        and Technology, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int
        J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="Y">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D055166" MajorTopicYN="N">Hepatic Stellate Cells</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">cholesterol metabolism</Keyword><Keyword
        MajorTopicYN="N">di-(2-ethylhexyl) phthalate long-term low-dose exposure</Keyword><Keyword
        MajorTopicYN="N">hepatic stellate cells</Keyword><Keyword MajorTopicYN="N">liver
        fibrosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict
        of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2020</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">32471116</ArticleId><ArticleId IdType="pmc">PMC7312183</ArticleId><ArticleId
        IdType="doi">10.3390/ijerph17113802</ArticleId><ArticleId IdType="pii">ijerph17113802</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Halden
        R.U. Plastics and health risks. Annu. Rev. Public Health. 2010;31:179&#x2013;194.
        doi: 10.1146/annurev.publhealth.012809.103714.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1146/annurev.publhealth.012809.103714</ArticleId><ArticleId
        IdType="pubmed">20070188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee
        K.-I., Chiang C.-W., Lin H.-C., Zhao J.-F., Li C.-T., Shyue S.-K., Lee T.-S.
        Maternal exposure to di-(2-ethylhexyl) phthalate exposure deregulates blood
        pressure, adiposity, cholesterol metabolism and social interaction in mouse
        offspring. Arch. Toxicol. 2015;90:1211&#x2013;1224. doi: 10.1007/s00204-015-1539-0.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1007/s00204-015-1539-0</ArticleId><ArticleId IdType="pubmed">25995009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao
        J.F., Hsiao S.H., Hsu M.H., Pao K.C., Kou Y.R., Shyue S.K., Lee T.S. Di-(2-ethylhexyl)
        phthalate accelerates atherosclerosis in apolipoprotein E-deficient mice.
        Arch. Toxicol. 2016;90:181&#x2013;190. doi: 10.1007/s00204-014-1377-5.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1007/s00204-014-1377-5</ArticleId><ArticleId IdType="pubmed">25270622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen
        H., Zhang W., Rui B.B., Yang S.M., Xu W.P., Wei W. Di(2-ethylhexyl) phthalate
        exacerbates non-alcoholic fatty liver in rats and its potential mechanisms.
        Environ Toxicol. Pharmacol. 2016;42:38&#x2013;44. doi: 10.1016/j.etap.2015.12.016.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.etap.2015.12.016</ArticleId><ArticleId IdType="pubmed">26773359</ArticleId></ArticleIdList></Reference><Reference><Citation>Tickner
        J.A., Schettler T., Guidotti T., McCally M., Rossi M. Health risks posed by
        use of Di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: A critical
        review. Am. J. Ind. Med. 2001;39:100&#x2013;111. doi: 10.1002/1097-0274(200101)39:1&lt;100::AID-AJIM10&gt;3.0.CO;2-Q.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1002/1097-0274(200101)39:1&lt;100::AID-AJIM10&gt;3.0.CO;2-Q</ArticleId><ArticleId
        IdType="pubmed">11148020</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang
        J.W., Lee C.C., Pan W.H., Chou W.C., Huang H.B., Chiang H.C., Huang P.C. Estimated
        Daily Intake and Cumulative Risk Assessment of Phthalates in the General Taiwanese
        after the 2011 DEHP Food Scandal. Sci. Rep. 2017:7. doi: 10.1038/srep45009.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1038/srep45009</ArticleId><ArticleId IdType="pmc">PMC5361203</ArticleId><ArticleId
        IdType="pubmed">28327585</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang
        Y.Z., Zuo Y.Z., Du Z.H., Xia J., Zhang C., Wang H., Li X.N., Li J.L. Di (2-ethylhexyl)
        phthalate (DEHP)-induced hepatotoxicity in quails (Coturnix japonica) via
        triggering nuclear xenobiotic receptors and modulating cytochrome P450 systems.
        Food Chem. Toxicol. 2018;120:287&#x2013;293. doi: 10.1016/j.fct.2018.07.019.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.fct.2018.07.019</ArticleId><ArticleId IdType="pubmed">30017959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanioka
        N., Isobe T., Kinashi Y., Tanaka-Kagawa T., Jinno H. Hepatic and intestinal
        glucuronidation of mono(2-ethylhexyl) phthalate, an active metabolite of di(2-ethylhexyl)
        phthalate, in humans, dogs, rats, and mice: An in vitro analysis using microsomal
        fractions. Arch. Toxicol. 2016;90:1651&#x2013;1657. doi: 10.1007/s00204-015-1619-1.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1007/s00204-015-1619-1</ArticleId><ArticleId IdType="pubmed">26514348</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch
        H.M., Bolt H.M., Angerer J. Di(2-ethylhexyl)phthalate (DEHP) metabolites in
        human urine and serum after a single oral dose of deuterium-labelled DEHP.
        Arch. Toxicol. 2004;78:123&#x2013;130. doi: 10.1007/s00204-004-0642-4.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1007/s00204-004-0642-4</ArticleId><ArticleId IdType="pubmed">14576974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang
        O., Kim H.L., Weon J.I., Seo Y.R. Endocrine-disrupting Chemicals: Review of
        Toxicological Mechanisms Using Molecular Pathway Analysis. J. Cancer Prev.
        2015;20:12&#x2013;24. doi: 10.15430/JCP.2015.20.1.12.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.15430/JCP.2015.20.1.12</ArticleId><ArticleId IdType="pmc">PMC4384711</ArticleId><ArticleId
        IdType="pubmed">25853100</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittassek
        M., Koch H.M., Angerer J., Bruning T. Assessing exposure to phthalates&#x2013;the
        human biomonitoring approach. Mol. Nutr. Food Res. 2011;55:7&#x2013;31. doi:
        10.1002/mnfr.201000121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201000121</ArticleId><ArticleId
        IdType="pubmed">20564479</ArticleId></ArticleIdList></Reference><Reference><Citation>Doull
        J., Cattley R., Elcombe C., Lake B.G., Swenberg J., Wilkinson C., Williams
        G., van Gemert M. A cancer risk assessment of di(2-ethylhexyl)phthalate: Application
        of the new U.S. EPA Risk Assessment Guidelines. Regul. Toxicol. Pharmacol.
        1999;29:327&#x2013;357. doi: 10.1006/rtph.1999.1296.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1006/rtph.1999.1296</ArticleId><ArticleId IdType="pubmed">10388618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha
        M., Wei L., Guan X., Li L., Liu C. p53-dependent apoptosis contributes to
        di-(2-ethylhexyl) phthalate-induced hepatotoxicity. Environ. Pollut. 2016;208:416&#x2013;425.
        doi: 10.1016/j.envpol.2015.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envpol.2015.10.009</ArticleId><ArticleId
        IdType="pubmed">26549752</ArticleId></ArticleIdList></Reference><Reference><Citation>Praveena
        S.M., Teh S.W., Rajendran R.K., Kannan N., Lin C.C., Abdullah R., Kumar S.
        Recent updates on phthalate exposure and human health: A special focus on
        liver toxicity and stem cell regeneration. Environ. Sci. Pollut. Res. Int.
        2018;25:11333&#x2013;11342. doi: 10.1007/s11356-018-1652-8.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1007/s11356-018-1652-8</ArticleId><ArticleId IdType="pubmed">29546515</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulds
        C.E., Trevino L.S., York B., Walker C.L. Endocrine-disrupting chemicals and
        fatty liver disease. Nat. Rev. Endocrinol. 2017;13:445&#x2013;457. doi: 10.1038/nrendo.2017.42.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1038/nrendo.2017.42</ArticleId><ArticleId IdType="pmc">PMC5657429</ArticleId><ArticleId
        IdType="pubmed">28524171</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaitantzi
        H., Hakenberg P., Theobald J., Heinlein H., Cai C., Loff S., Wolfl S., Ebert
        M.P., Breitkopf-Heinlein K., Subotic U. Di (2-Ethylhexyl) Phthalate and Its
        Role in Developing Cholestasis: An In Vitro Study on Different Liver Cell
        Types. J. Pediatr. Gastroenterol. Nutr. 2018;66:28&#x2013;35. doi: 10.1097/MPG.0000000000001813.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1097/MPG.0000000000001813</ArticleId><ArticleId IdType="pubmed">29095348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushman
        M.E., Kraft A.D., Guyton K.Z., Chiu W.A., Makris S.L., Rusyn I. A systematic
        approach for identifying and presenting mechanistic evidence in human health
        assessments. Regul. Toxicol. Pharmacol. 2013;67:266&#x2013;277. doi: 10.1016/j.yrtph.2013.08.005.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.yrtph.2013.08.005</ArticleId><ArticleId IdType="pmc">PMC3818152</ArticleId><ArticleId
        IdType="pubmed">23959061</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I., Kadiiska M.B., Dikalova A., Kono H., Yin M., Tsuchiya K., Mason R.P.,
        Peters J.M., Gonzalez F.J., Segal B.H., et al. Phthalates rapidly increase
        production of reactive oxygen species in vivo: Role of Kupffer cells. Mol.
        Pharmacol. 2001;59:744&#x2013;750. doi: 10.1124/mol.59.4.744.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1124/mol.59.4.744</ArticleId><ArticleId IdType="pubmed">11259618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh
        J., Das J., Manna P., Sil P.C. Hepatotoxicity of di-(2-ethylhexyl)phthalate
        is attributed to calcium aggravation, ROS-mediated mitochondrial depolarization,
        and ERK/NF-kappaB pathway activation. Free Radic. Biol. Med. 2010;49:1779&#x2013;1791.
        doi: 10.1016/j.freeradbiomed.2010.09.011.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.freeradbiomed.2010.09.011</ArticleId><ArticleId IdType="pubmed">20854900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei
        N., Feng X., Xie Z., Zhang Y., Feng Y. Long-term di (2-ethylhexyl)-phthalate
        exposure promotes proliferation and survival of HepG2 cells via activation
        of NFkappaB. Toxicol. In Vitro. 2017;42:86&#x2013;92. doi: 10.1016/j.tiv.2017.04.015.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.tiv.2017.04.015</ArticleId><ArticleId IdType="pubmed">28412506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bataller
        R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005;115:209&#x2013;218.
        doi: 10.1172/JCI24282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI24282</ArticleId><ArticleId
        IdType="pmc">PMC546435</ArticleId><ArticleId IdType="pubmed">15690074</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman
        S.L. Liver fibrosis&#x2013;from bench to bedside. J. Hepatol. 2003;38:38&#x2013;53.
        doi: 10.1016/S0168-8278(02)00429-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-8278(02)00429-4</ArticleId><ArticleId
        IdType="pubmed">12591185</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuppan
        D., Afdhal N.H. Liver cirrhosis. Lancet. 2008;371:838&#x2013;851. doi: 10.1016/S0140-6736(08)60383-9.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/S0140-6736(08)60383-9</ArticleId><ArticleId IdType="pmc">PMC2271178</ArticleId><ArticleId
        IdType="pubmed">18328931</ArticleId></ArticleIdList></Reference><Reference><Citation>Iredale
        J.P. Models of liver fibrosis: Exploring the dynamic nature of inflammation
        and repair in a solid organ. J. Clin. Invest. 2007;117:539&#x2013;548. doi:
        10.1172/JCI30542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI30542</ArticleId><ArticleId
        IdType="pmc">PMC1804370</ArticleId><ArticleId IdType="pubmed">17332881</ArticleId></ArticleIdList></Reference><Reference><Citation>Twu
        Y.C., Lee T.S., Lin Y.L., Hsu S.M., Wang Y.H., Liao C.Y., Wang C.K., Liang
        Y.C., Liao Y.J. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells
        Activation by Regulating Free Cholesterol Accumulation. Int. J. Mol. Sci.
        2016;17:1122. doi: 10.3390/ijms17071122.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.3390/ijms17071122</ArticleId><ArticleId IdType="pmc">PMC4964497</ArticleId><ArticleId
        IdType="pubmed">27420058</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkham-Kamphorst
        E., Weiskirchen R. The PDGF system and its antagonists in liver fibrosis.
        Cytokine Growth Factor Rev. 2016;28:53&#x2013;61. doi: 10.1016/j.cytogfr.2015.10.002.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.cytogfr.2015.10.002</ArticleId><ArticleId IdType="pubmed">26547628</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogliati
        S., Enriquez J.A., Scorrano L. Mitochondrial Cristae: Where Beauty Meets Functionality.
        Trends Biochem. Sci. 2016;41:261&#x2013;273. doi: 10.1016/j.tibs.2016.01.001.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.tibs.2016.01.001</ArticleId><ArticleId IdType="pubmed">26857402</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason
        E.F., Rathmell J.C. Cell metabolism: An essential link between cell growth
        and apoptosis. Biochim. Biophys. Acta. 2011;1813:645&#x2013;654. doi: 10.1016/j.bbamcr.2010.08.011.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.bbamcr.2010.08.011</ArticleId><ArticleId IdType="pmc">PMC3010257</ArticleId><ArticleId
        IdType="pubmed">20816705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo
        D., Wang Y.T., Wu M.C. Hepatoprotective effect of silymarin on di(2-ethylhexyl)phthalate
        (DEHP) induced injury in liver FL83B cells. Environ. Toxicol. Pharmacol. 2014;38:112&#x2013;118.
        doi: 10.1016/j.etap.2014.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.etap.2014.05.005</ArticleId><ArticleId
        IdType="pubmed">24934613</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Gea
        V., Friedman S.L. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 2011;6:425&#x2013;456.
        doi: 10.1146/annurev-pathol-011110-130246.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1146/annurev-pathol-011110-130246</ArticleId><ArticleId IdType="pubmed">21073339</ArticleId></ArticleIdList></Reference><Reference><Citation>Schettler
        T. Human exposure to phthalates via consumer products. Int. J. Androl. 2006;29:134&#x2013;139.
        doi: 10.1111/j.1365-2605.2005.00567.x.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1111/j.1365-2605.2005.00567.x</ArticleId><ArticleId IdType="pubmed">16466533</ArticleId></ArticleIdList></Reference><Reference><Citation>Reagan-Shaw
        S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited.
        FASEB J. 2008;22:659&#x2013;661. doi: 10.1096/fj.07-9574LSF.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1096/fj.07-9574LSF</ArticleId><ArticleId IdType="pubmed">17942826</ArticleId></ArticleIdList></Reference><Reference><Citation>Li
        J.H., Ko Y.C. Plasticizer incident and its health effects in Taiwan. Kaohsiung
        J. Med. Sci. 2012;28:17&#x2013;21. doi: 10.1016/j.kjms.2012.05.005.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.kjms.2012.05.005</ArticleId><ArticleId IdType="pubmed">22871596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu
        M.T., Wu C.F., Wu J.R., Chen B.H., Chen E.K., Chao M.C., Liu C.K., Ho C.K.
        The public health threat of phthalate-tainted foodstuffs in Taiwan: The policies
        the government implemented and the lessons we learned. Environ. Int. 2012;44:75&#x2013;79.
        doi: 10.1016/j.envint.2012.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2012.01.014</ArticleId><ArticleId
        IdType="pubmed">22361240</ArticleId></ArticleIdList></Reference><Reference><Citation>Mettang
        T., Thomas S., Kiefer T., Fischer F.P., Kuhlmann U., Wodarz R., Rettenmeier
        A.W. Uraemic pruritus and exposure to di(2-ethylhexyl) phthalate (DEHP) in
        haemodialysis patients. Nephrol. Dial. Transplant. 1996;11:2439&#x2013;2443.
        doi: 10.1093/oxfordjournals.ndt.a027211.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1093/oxfordjournals.ndt.a027211</ArticleId><ArticleId IdType="pubmed">9017619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao
        Z.B., Ji K., Shen X.Y., Zhang W.W., Wang R., Xu W.P., Wei W. Di(2-ethylhexyl)
        phthalate promotes hepatic fibrosis by regulation of oxidative stress and
        inflammation responses in rats. Environ. Toxicol. Pharmacol. 2019;68:109&#x2013;119.
        doi: 10.1016/j.etap.2019.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.etap.2019.03.008</ArticleId><ArticleId
        IdType="pubmed">30884453</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigamonti
        E., Helin L., Lestavel S., Mutka A.L., Lepore M., Fontaine C., Bouhlel M.A.,
        Bultel S., Fruchart J.C., Ikonen E., et al. Liver X receptor activation controls
        intracellular cholesterol trafficking and esterification in human macrophages.
        Circ. Res. 2005;97:682&#x2013;689. doi: 10.1161/01.RES.0000184678.43488.9f.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1161/01.RES.0000184678.43488.9f</ArticleId><ArticleId IdType="pubmed">16141411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou
        G.N., Morrow O.B., Connole M.L., Lee S.P. Association between dietary nutrient
        composition and the incidence of cirrhosis or liver cancer in the United States
        population. Hepatology. 2009;50:175&#x2013;184. doi: 10.1002/hep.22941.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1002/hep.22941</ArticleId><ArticleId IdType="pubmed">19441103</ArticleId></ArticleIdList></Reference><Reference><Citation>Teratani
        T., Tomita K., Suzuki T., Oshikawa T., Yokoyama H., Shimamura K., Tominaga
        S., Hiroi S., Irie R., Okada Y., et al. A high-cholesterol diet exacerbates
        liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate
        cells. Gastroenterology. 2012;142:152&#x2013;164. doi: 10.1053/j.gastro.2011.09.049.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1053/j.gastro.2011.09.049</ArticleId><ArticleId IdType="pubmed">21995947</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomita
        K., Teratani T., Suzuki T., Shimizu M., Sato H., Narimatsu K., Okada Y., Kurihara
        C., Irie R., Yokoyama H., et al. Free cholesterol accumulation in hepatic
        stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis
        in mice. Hepatology. 2014;59:154&#x2013;169. doi: 10.1002/hep.26604.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1002/hep.26604</ArticleId><ArticleId IdType="pubmed">23832448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonen
        E. Mechanisms for cellular cholesterol transport: Defects and human disease.
        Physiol. Rev. 2006;86:1237&#x2013;1261. doi: 10.1152/physrev.00022.2005.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1152/physrev.00022.2005</ArticleId><ArticleId IdType="pubmed">17015489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou
        G.N. The Role of Cholesterol in the Pathogenesis of NASH. Trends Endocrinol.
        Metab. 2016;27:84&#x2013;95. doi: 10.1016/j.tem.2015.11.008.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.tem.2015.11.008</ArticleId><ArticleId IdType="pubmed">26703097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonen
        E. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol.
        Cell Biol. 2008;9:125&#x2013;138. doi: 10.1038/nrm2336.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1038/nrm2336</ArticleId><ArticleId IdType="pubmed">18216769</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullinger
        C.R., Eng C., Salen G., Shefer S., Batta A.K., Erickson S.K., Verhagen A.,
        Rivera C.R., Mulvihill S.J., Malloy M.J., et al. Human cholesterol 7alpha-hydroxylase
        (CYP7A1) deficiency has a hypercholesterolemic phenotype. J. Clin. Invest.
        2002;110:109&#x2013;117. doi: 10.1172/JCI0215387.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1172/JCI0215387</ArticleId><ArticleId IdType="pmc">PMC151029</ArticleId><ArticleId
        IdType="pubmed">12093894</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu
        X., Xiong S.L., Yi G.H. ABCA1, ABCG1, and SR-BI: Transit of HDL-associated
        sphingosine-1-phosphate. Clin. Chim. Acta. 2012;413:384&#x2013;390. doi: 10.1016/j.cca.2011.11.002.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1016/j.cca.2011.11.002</ArticleId><ArticleId IdType="pubmed">22115863</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang
        Y., Li F., Patterson A.D., Wang Y., Krausz K.W., Neale G., Thomas S., Nachagari
        D., Vogel P., Vore M., et al. Abcb11 deficiency induces cholestasis coupled
        to impaired beta-fatty acid oxidation in mice. J. Biol. Chem. 2012;287:24784&#x2013;24794.
        doi: 10.1074/jbc.M111.329318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.329318</ArticleId><ArticleId
        IdType="pmc">PMC3397905</ArticleId><ArticleId IdType="pubmed">22619174</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelissen
        I.C., Harris M., Rye K.A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan
        M., Kritharides L., Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol
        export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 2006;26:534&#x2013;540.
        doi: 10.1161/01.ATV.0000200082.58536.e1.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1161/01.ATV.0000200082.58536.e1</ArticleId><ArticleId IdType="pubmed">16357317</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8761421</PMID><DateCompleted><Year>1996</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>12</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>17</Volume><Issue>8</Issue><PubDate><Year>1996</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Hepatocyte
        expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras
        following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate
        (DHEP).</ArticleTitle><Pagination><StartPage>1647</StartPage><EndPage>1655</EndPage><MedlinePgn>1647-55</MedlinePgn></Pagination><Abstract><AbstractText>Phthalate
        esters such as di(2-ethylhexyl)phthalate (DEHP) either promote or inhibit
        rat liver tumorigenesis depending on the carcinogenesis protocol. In this
        study, we examined the expression of two histochemical markers, the tumor
        associated isozyme of aldehyde dehydrogenase (ALDH-3) and the oncoprotein
        p21 Ras, in the livers of male F344 rats. The rats were initiated with DEN
        and further treated with either DEHP (a known inhibitor of hepatocarcinogenesis),
        phenobarbital (PB, a known promoter of hepatocarcinogenesis), or a combination
        of DEHP and PB. The studies were designed to examine the expression of these
        markers in both normal appearing liver and hepatic hyperplastic and neoplastic
        lesions and to correlate the early expression of the markers at 26 weeks in
        the normal appearing liver to later tumor incidence at 52 weeks. The expression
        of each marker was detected by immunohistochemical methods on formalin-fixed
        paraffin embedded sections of normal appearing liver or liver lesions. We
        found that ALDH-3 and p21 expression were significantly enhanced in rats receiving
        PB after DEN initiation at 26 weeks and that the incidence of hepatocellular
        carcinomas was likewise increased compared to control or DEN only treated
        animals. DEN initiation followed by a combination of PB and either 0.1 or
        0.5% DEHP significantly reduced ALDH-3 but not p21 Ras expression at 26 weeks
        compared to DEN plus PB only. These treatment regimens also reduced the incidence
        of hepatocellular carcinomas at 52 weeks. DEN followed by any of the three
        doses of DEHP without PB resulted in ALDH-3 expression similar to DEN alone.
        However, p21 Ras expression was significantly increased after these treatments.
        For all treatment groups, both the early (26 weeks) expression of p21 Ras
        and ALDH-3 correlated with hepatocellular carcinoma incidence at 52 weeks.
        However, the correlation between hepatocellular carcinoma and ALDH-3 expression
        was better than p21 Ras or the other markers we have studied. We concluded
        that ALDH-3 expression is significantly downregulated after DEHP treatment,
        and that expression of the isozyme correlated with later hepatocarcinoma incidence
        and may indicate a significant relationship between ALDH-3 expression and
        hepatocarcinogenesis during DEHP treatment.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Richmond</LastName><ForeName>R
        E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Northern
        Kentucky University, Department of Biological Sciences, Highland Heights,
        KY 41099, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>J
        H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>H
        W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>F
        B</ForeName><Initials>FB</Initials></Author><Author ValidYN="Y"><LastName>Deangelo</LastName><ForeName>A
        B</ForeName><Initials>AB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IQ78TTX1A</RegistryNumber><NameOfSubstance
        UI="D004052">Diethylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.2.1.3</RegistryNumber><NameOfSubstance UI="D000444">Aldehyde Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.6.5.2</RegistryNumber><NameOfSubstance UI="D016283">Proto-Oncogene Proteins
        p21(ras)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000444" MajorTopicYN="N">Aldehyde Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004052" MajorTopicYN="N">Diethylnitrosamine</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006529" MajorTopicYN="N">Hepatomegaly</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016283" MajorTopicYN="N">Proto-Oncogene Proteins p21(ras)</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1996</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8761421</ArticleId><ArticleId IdType="doi">10.1093/carcin/17.8.1647</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8104013</PMID><DateCompleted><Year>1993</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0960-3271</ISSN><JournalIssue
        CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>1993</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Human
        &amp; experimental toxicology</Title><ISOAbbreviation>Hum Exp Toxicol</ISOAbbreviation></Journal><ArticleTitle>Interactive
        potential of omega-3 fatty acids with clofibrate or DEHP on hepatic peroxisome
        proliferation in male Wistar rats.</ArticleTitle><Pagination><StartPage>337</StartPage><EndPage>340</EndPage><MedlinePgn>337-40</MedlinePgn></Pagination><Abstract><AbstractText>The
        interactive potential of three known peroxisome proliferators, omega-3 fatty
        acids, clofibrate and di(2-ethylhexylphthalate (DEHP), was evaluated in male
        weanling Wistar rats for the effect on peroxisomal beta-oxidation. Omega-3
        fatty acids were supplied by menhaden oil which was fed in six regimens: low
        fat (5% w/w), low fat and clofibrate (0.3% w/w) or DEHP (0.25% w/w), high
        fat (20% w/w), high fat and clofibrate or DEHP in the aforementioned concentrations.
        Induction of peroxisomal beta-oxidation was measured by changes in liver-to-body
        weight ratio, fatty acyl-CoA oxidase (FAO) activity, and peroxisomal bifunctional
        enzyme (PBE) quantity. Analysis of transformed data indicated a less than
        additive response in FAO activity with no deviation from additivity seen with
        liver-to-body ratios and PBE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Wysynski</LastName><ForeName>A M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Environmental
        Health Sciences Program, School of Public Health, University of Massachusetts,
        Amherst 01003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldwin</LastName><ForeName>L
        A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Leonard</LastName><ForeName>D
        A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>E
        J</ForeName><Initials>EJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum
        Exp Toxicol</MedlineTA><NlmUniqueID>9004560</NlmUniqueID><ISSNLinking>0960-3271</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004041">Dietary Fats</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015525">Fatty Acids, Omega-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009097">Multienzyme Complexes</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.-</RegistryNumber><NameOfSubstance UI="D015094">3-Hydroxyacyl CoA Dehydrogenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        4.2.1.17</RegistryNumber><NameOfSubstance UI="D004746">Enoyl-CoA Hydratase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        4.2.1.17</RegistryNumber><NameOfSubstance UI="D063994">Peroxisomal Bifunctional
        Enzyme</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.-</RegistryNumber><NameOfSubstance
        UI="D007535">Isomerases</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015094" MajorTopicYN="N">3-Hydroxyacyl CoA Dehydrogenases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004041" MajorTopicYN="N">Dietary Fats</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004746" MajorTopicYN="N">Enoyl-CoA Hydratase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015525" MajorTopicYN="N">Fatty Acids, Omega-3</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007535" MajorTopicYN="N">Isomerases</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009097" MajorTopicYN="N">Multienzyme Complexes</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D063994" MajorTopicYN="N">Peroxisomal Bifunctional Enzyme</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1993</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1993</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1993</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8104013</ArticleId><ArticleId IdType="doi">10.1177/096032719301200413</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11950162</PMID><DateCompleted><Year>2002</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0192-6233</ISSN><JournalIssue
        CitedMedium="Print"><Volume>30</Volume><Issue>2</Issue><PubDate><Year>2002</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Toxicologic
        pathology</Title><ISOAbbreviation>Toxicol Pathol</ISOAbbreviation></Journal><ArticleTitle>Assessment
        of carcinogenicity of di(2-ethylhexyl)phthalate in a short-term assay using
        Xpa-/- and Xpa-/-/p53+/- mice.</ArticleTitle><Pagination><StartPage>188</StartPage><EndPage>199</EndPage><MedlinePgn>188-99</MedlinePgn></Pagination><Abstract><AbstractText>The
        potential of Xpa-/- and Xpa-/-/p53+/- mice for short-term carcinogenicity
        assays was evaluated with di(2-ethylhexyl)phthalate (DEHP). Groups of 15 male
        and female Xpa-/- mice, received diets containing 0, 1, 500, 3,000, or 6,000
        ppm DEHP, and wild-type (WT) and Xpa-/-p53+/-mice 0 or 6,000 ppm DEHP for
        39 weeks. Xpa-/-, Xpa-/-/p53+/-, and WT males, fed 2,500 ppm p-cresidine,
        served as a positive control. In all models, the survival was not altered
        by DEHP. Increased incidences of nonneoplastic lesions were recorded in testes
        and kidneys with no apparent difference between the models. The only liver
        tumors in all models were adenomas in males with no statistically significantly
        increased incidence. For p-cresidine. the survival was decreased (p &lt; 0.05)
        only in transgenic models. Statistically significantly increased incidences
        of nonneoplastic lesions were recorded in the liver, urinary bladder, and
        nasal cavity in all models, and in kidneys in transgenic models. The only
        tumors with statistically significantly increased incidence were liver adenomas
        in transgenic models (XPA: I vs 7: ''XPA/p53'': 0 vs 12; WT: 0 vs 5, p = 0.053)
        and urinary bladder carcinomas in XPA/p53 model (0 vs 7). The negative carcinogenic
        response to DEHP and the positive response to p-cresidine support the expected
        sensitivity to genotoxic carcinogens in these transgenic models.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Mortensen</LastName><ForeName>Alicja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Danish
        Veterinary and Food Administration, Institute of Food Safety and Toxicology,
        S&#xf8;borg. alm@fdir.dk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertram</LastName><ForeName>Margareta</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Aarup</LastName><ForeName>Vibeke</ForeName><Initials>V</Initials></Author><Author
        ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Ilona K</ForeName><Initials>IK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Pathol</MedlineTA><NlmUniqueID>7905907</NlmUniqueID><ISSNLinking>0192-6233</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D051760">Xeroderma Pigmentosum Group A Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C497315">Xpa protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004326" MajorTopicYN="N">Drinking</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051760" MajorTopicYN="N">Xeroderma Pigmentosum Group A Protein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>4</Month><Day>26</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11950162</ArticleId><ArticleId IdType="doi">10.1080/019262302753559524</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3919955</PMID><DateCompleted><Year>1985</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>11</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>1985</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Tumor-promoting
        effects of di(2-ethylhexyl)phthalate in JB6 mouse epidermal cells and mouse
        skin.</ArticleTitle><Pagination><StartPage>343</StartPage><EndPage>347</EndPage><MedlinePgn>343-7</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)phthalate
        (DEHP), a confirmed promoter of hepatocellular carcinogenesis in mice, was
        studied for tumor-promoting activity on the skin of SENCAR mice in vivo and
        on JB6 mouse epidermal cells in vitro. DEHP enhanced transformation to anchorage-independent
        growth of promotable JB6 clonal lines, C141, C121, and R219. DEHP induced
        colony formation in concentrations from 500 p.p.m. to 20 000 p.p.m./ml culture
        medium with maximum induction occurring at 10 000 p.p.m./ml. DEHP was inactive
        as a complete promoter of skin carcinogenesis initiated by 7,12-dimethylbenz[a]anthracene
        (DMBA) in SENCAR mice. Like the plant-derived natural product mezerein, however,
        DEHP significantly enhanced skin carcinogenesis in SENCAR mice when initiation
        by DMBA was followed by short term applications (2x/week, 2 weeks) of 12-O-tetradecanoylphorbol-13-acetate
        prior to application of DEHP. A random sample of the tumors observed was processed
        and examined histologically. Most neoplasms were papillomas; a few were squamous
        cell carcinomas. The kinds of tumors seen were identical with those reported
        in two-stage carcinogenesis experiments in SENCAR mice in which phorbol ester
        tumor promoters have been employed. Thus, DEHP promotes transformation in
        JB6 mouse epidermal cells and acts as a second-stage promoter in mouse skin
        carcinogenesis. DEHP therefore has promoting capability for at least two distinct
        kinds of epithelium in mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Diwan</LastName><ForeName>B A</ForeName><Initials>BA</Initials></Author><Author
        ValidYN="Y"><LastName>Ward</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Rice</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Colburn</LastName><ForeName>N H</ForeName><Initials>NH</Initials></Author><Author
        ValidYN="Y"><LastName>Spangler</LastName><ForeName>E F</ForeName><Initials>EF</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>N01-CO-23910</GrantID><Acronym>CO</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01-CP-15744</GrantID><Acronym>CP</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>57-97-6</RegistryNumber><NameOfSubstance
        UI="D015127">9,10-Dimethyl-1,2-benzanthracene</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>NI40JAQ945</RegistryNumber><NameOfSubstance
        UI="D013755">Tetradecanoylphorbol Acetate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015127" MajorTopicYN="N">9,10-Dimethyl-1,2-benzanthracene</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004817" MajorTopicYN="N">Epidermis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013755" MajorTopicYN="N">Tetradecanoylphorbol Acetate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3919955</ArticleId><ArticleId IdType="doi">10.1093/carcin/6.3.343</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6872148</PMID><DateCompleted><Year>1983</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>11</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>4</Volume><Issue>8</Issue><PubDate><Year>1983</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Dissimilar
        patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular
        neoplasia initiated by diethylnitrosamine in B6C3F1 mice.</ArticleTitle><Pagination><StartPage>1021</StartPage><EndPage>1029</EndPage><MedlinePgn>1021-9</MedlinePgn></Pagination><Abstract><AbstractText>Potentially
        preneoplastic hepatocellular hyperplastic foci and hepatocellular neoplasms
        were studied in weanling male B6C3F1 mice that received a single i.p. injection
        (80 mg/kg) of diethylnitrosamine (DEN) at 4 weeks of age, followed by oral
        administration of phenobarbital (PB) or di(2-ethylhexyl)-phthalate (DEHP)
        that began 2 weeks after DEN injection and continued for up to 6 months. PB
        was administered in drinking water at 500 p.p.m. and DEHP in the feed at 3000,
        6000 or 12 000 p.p.m. Groups of mice were sacrificed at 2, 4 and 6 months
        after DEN exposure; formalin-fixed liver samples were evaluated histologically.
        Hepatocellular neoplasms and foci of hyperplasia were quantified with the
        aid of an image analysis computer. Few foci were seen at 2, 4 or 6 months
        in mice exposed to DEN, PB or DEHP alone, while numerous foci and neoplasms
        were seen in mice given DEHP or PB after DEN. Area-perimeter measurements
        for each hepatocellular focus or neoplasm transection revealed that foci and
        neoplasms in PB-exposed mice increased both in size (area and volume) and
        in number throughout the study. In DEHP-exposed mice the pattern of response
        was different in that the numbers of foci did not increase between 4 and 6
        months, but the foci increased in mean diameter and volume throughout the
        experiment. Foci and tumors appeared earlier in mice given higher dietary
        levels of DEHP than in those given lower doses. By the end of the study the
        number of foci per unit volume of liver was similar in mice given any dose
        of DEHP, but their volume was dose-related. Hepatocellular foci and neoplasms
        in PB-exposed mice were composed predominantly of eosinophilic hepatocytes,
        while in DEHP-exposed mice, basophilic foci and neoplasms predominated; the
        latter were more malignant in appearance than neoplasms in PB-exposed mice.
        At 6 months, the neoplasms in high dose DEHP-exposed mice were significantly
        larger than those in PB exposed mice. Histochemistry, however, revealed similarities
        between lesions in mice exposed to PB or DEHP. PB given continuously for 6
        months revealed no initiating activity of DEHP given once by gavage and followed
        by PB in drinking water. Both morphology and biology of hepatocellular foci
        and neoplasms, which develop in mice after a single exposure to a carcinogen
        with initiating activity, thus depend, in part, on the subsequent promoting
        agent. More than one process of tumor promotion, as characterized by a specific
        sequence of morphologic and biochemical changes, is possible for the mouse
        hepatocyte.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>J
        M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>J
        M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Creasia</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Lynch</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Riggs</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>N01-CO-23910</GrantID><Acronym>CO</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01-CO-23912</GrantID><Acronym>CO</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01-CO-75380</GrantID><Acronym>CO</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009602">Nitrosamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IQ78TTX1A</RegistryNumber><NameOfSubstance
        UI="D004052">Diethylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000236" MajorTopicYN="N">Adenoma</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="Y">Carcinogens</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004052" MajorTopicYN="N">Diethylnitrosamine</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004357" MajorTopicYN="N">Drug Synergism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009602" MajorTopicYN="N">Nitrosamines</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1983</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1983</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1983</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6872148</ArticleId><ArticleId IdType="doi">10.1093/carcin/4.8.1021</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9547862</PMID><DateCompleted><Year>1998</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0192-6233</ISSN><JournalIssue
        CitedMedium="Print"><Volume>26</Volume><Issue>2</Issue><PubDate><Year>1998</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Toxicologic
        pathology</Title><ISOAbbreviation>Toxicol Pathol</ISOAbbreviation></Journal><ArticleTitle>Receptor
        and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate
        (DEHP) in peroxisome proliferator-activated receptor alpha-null mice.</ArticleTitle><Pagination><StartPage>240</StartPage><EndPage>246</EndPage><MedlinePgn>240-6</MedlinePgn></Pagination><Abstract><AbstractText>The
        peroxisome proliferator-activated receptor alpha (PPAR alpha) is the mediator
        of the biological effects of peroxisome proliferators through control of gene
        transcription. To determine if the toxic effects of di(2-ethylhexyl)phthalate
        (DEHP) are mediated by PPAR alpha, we examined its effect in PPAR alpha-null
        mice. Male Sv/129 mice, PPAR alpha-null (-/-) or wild-type (+/+) were fed
        ad libitum either a control diet or one containing 12,000 ppm DEHP for up
        to 24 wk. Significant body weight loss and high mortality was observed in
        (+/+) mice fed DEHP. By 16 wk, all DEHP-fed (+/+) mice had died of cystic
        renal tubular disease. In contrast, the (-/-) mice fed DEHP had no changes
        in body weight until later in the study nor increased mortality. Histologically,
        (+/+) mice fed DEHP had typical toxic lesions in liver, kidney, and testis
        while (-/-) mice fed DEHP had no toxic liver lesions but did show evidence
        of toxicity in kidney and testis after 4-8 wk of feeding, which progressed
        into moderate lesions by 24 wk. Analysis of hepatic and renal mRNAs showed
        a typical pleiotropic response in gene expression in the DEHP-fed (+/+) mice
        that was absent in the DEHP-fed (-/-) mice. These results provide evidence
        that PPAR alpha mediates the subacute-chronic toxicity of DEHP in liver, kidney,
        and testis. However, because (-/-) mice did develop toxic lesions in kidney
        and testis, DEHP can also act through PPAR alpha-independent pathways in mediating
        renal and testicular toxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Ward</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Veterinary
        and Tumor Pathology Section, Office of Laboratory Animal Resources, Frederick,
        Maryland 21702-1201, USA. ward@mail.ncifcrf.gov</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Perella</LastName><ForeName>C M</ForeName><Initials>CM</Initials></Author><Author
        ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>F J</ForeName><Initials>FJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013487">Research Support, U.S.
        Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Pathol</MedlineTA><NlmUniqueID>7905907</NlmUniqueID><ISSNLinking>0192-6233</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1998</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1998</Year><Month>4</Month><Day>21</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1998</Year><Month>4</Month><Day>21</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9547862</ArticleId><ArticleId IdType="doi">10.1177/019262339802600208</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">29474903</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>03</Month><Day>28</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3169</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>288</Volume><PubDate><Year>2018</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Hexamoll<sup>&#xae;</sup>
        DINCH: Lack of in vivo evidence for obesogenic properties.</ArticleTitle><Pagination><StartPage>99</StartPage><EndPage>110</EndPage><MedlinePgn>99-110</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.toxlet.2018.02.008</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0378-4274(18)30046-8</ELocationID><Abstract><AbstractText>Hexamoll<sup>&#xae;</sup>
        DINCH is an important alternative to phthalate plasticizers. Although regulatory
        reviews have not identified any potential hazards even in sensitive populations,
        an in vitro study by Campioli et al. (2015) suggested Hexamoll<sup>&#xae;</sup>
        DINCH might alter fat storage in adipocytes resulting in obesity. To evaluate
        this hypothesis, data from studies with Hexamoll<sup>&#xae;</sup> DINCH were
        reviewed for evidence of deposition in fat, changes in body weight, or changes
        in serum chemistry reflecting altered metabolic status. Body weights of F1
        and F2 pups in a two-generation study did not differ from controls even at
        1000&#x202f;mg Hexamoll<sup>&#xae;</sup> DINCH/kg body weight. Mean relative
        liver weights from the 1000 and 300&#x202f;mg/kg bw groups were increased,
        but without histopathologic changes. Triglyceride and cholesterol levels in
        serum were not affected. In addition, subchronic and chronic studies in rats
        did not give evidence of an obesogenic effect. Radioactivity from 20 or 1000&#x202f;mg/kg
        bw <sup>14</sup>C-labelled Hexamoll<sup>&#xae;</sup> DINCH dosed orally remained
        2-3 times longer in adipose tissue than in well-perfused tissues; however,
        levels were 20-500% below other tissues at 1 and 8&#x202f;h post dosing. Radioactivity
        concentrations in organs and tissues excluding the GI tract declined rapidly
        and continuously, and decreased in parallel to the concentration in plasma
        during the following 20&#x202f;h. Both, initial and terminal half-lives of
        radioactivity concentration do not indicate a potential for accumulation.
        Furthermore, a metabolomic comparison of Hexamoll<sup>&#xae;</sup> DINCH with
        DEHP and other phthalates shows complete separation of the metabolomic profile
        of these two chemical classes, meaning that their effects on the body and
        the body''s reaction to the substance are different. Hence, comprehensive
        in vivo data do not show any evidence of Hexamoll<sup>&#xae;</sup> DINCH altering
        fat metabolism or having obesogenic properties.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Langsch</LastName><ForeName>Angelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>BASF
        SE, 67056 Ludwigshafen, Germany. Electronic address: angelika.langsch@basf.com.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>David</LastName><ForeName>Raymond M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>BASF
        Corporation, Florham Park, NJ 07932, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Schneider</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BASF
        SE, 67056 Ludwigshafen, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sperber</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BASF
        SE, 67056 Ludwigshafen, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Haake</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Metanomics
        GmbH, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamp</LastName><ForeName>Hennicke</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>BASF
        SE, 67056 Ludwigshafen, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Leibold</LastName><ForeName>Edgar</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>BASF
        SE, 67056 Ludwigshafen, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ravenzwaay</LastName><ForeName>Bennard van</ForeName><Initials>BV</Initials><AffiliationInfo><Affiliation>BASF
        SE, 67056 Ludwigshafen, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Otter</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>BASF
        SE, 67056 Ludwigshafen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D003509">Cyclohexanecarboxylic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D003998">Dicarboxylic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C558012">diisononyl 1,2-cyclohexanedicarboxylic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D050154" MajorTopicYN="N">Adiposity</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003509" MajorTopicYN="N">Cyclohexanecarboxylic Acids</DescriptorName><QualifierName
        UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003998" MajorTopicYN="N">Dicarboxylic Acids</DescriptorName><QualifierName
        UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006207" MajorTopicYN="N">Half-Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="N">Prenatal Exposure Delayed Effects</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">2-generation study</Keyword><Keyword
        MajorTopicYN="N">DEHP</Keyword><Keyword MajorTopicYN="N">Hexamoll(&#xae;)
        DINCH</Keyword><Keyword MajorTopicYN="N">Metabolome</Keyword><Keyword MajorTopicYN="N">Obesogen</Keyword><Keyword
        MajorTopicYN="N">Toxicokinetics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2017</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2018</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">29474903</ArticleId><ArticleId IdType="doi">10.1016/j.toxlet.2018.02.008</ArticleId><ArticleId
        IdType="pii">S0378-4274(18)30046-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1600604</PMID><DateCompleted><Year>1992</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>1992</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Contrasting
        hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover
        for the hepatocarcinogens Wy-14,643 and clofibric acid.</ArticleTitle><Pagination><StartPage>1011</StartPage><EndPage>1017</EndPage><MedlinePgn>1011-7</MedlinePgn></Pagination><Abstract><AbstractText>Earlier
        studies indicated that the hepatocarcinogenic activity of two peroxisome proliferators
        (PP) Wy-14,643 and di(2-ethylhexyl)phthalate (DEHP) correlated to the degree
        of lipofuscin accumulation and sustained cell replication rather than the
        level of peroxisome induction. This study extends the comparison of peroxisome
        proliferation, lipofuscin accumulation and cell replication responses in rats
        fed (i) clofibric acid at 5000 p.p.m. (CA), a regimen of moderate hepatocarcinogenicity;
        (ii) Wy-14,643 at 50 p.p.m. (WYLD), a dose of unknown hepatocarcinogenicity;
        and (iii) Wy-14,643 at 1000 p.p.m. (WYHD), as the highly hepatocarcinogenic
        regimen. Adult male F344 rats were fed the experimental diets for 1, 2, 5,
        11 or 22 weeks. Relative liver weights (% of body weight) were increased in
        rats fed CA (1.6- to 1.7-fold), WYHD or WYLD (2.0- to 2.7-fold), compared
        to controls (approximately 3%) at all time points. All rats fed CA, WYHD or
        WYLD had similar hepatic peroxisome proliferation at all time points with
        large elevations in peroxisomal enzyme activities and number, size and mean
        volume of peroxisomes. In contrast, hepatocytic lipofuscin accumulation differed
        between treatments, with a decreasing order of accumulation observed in WYHD
        greater than WYLD approximately equal to CA greater than controls. Replicative
        DNA synthesis (as assessed by nuclear labeling index, LI) in nonlesion hepatocytes
        was markedly elevated at 1 week by both WYHD and WYLD (45- and 40-fold over
        controls respectively) while CA induced a 10-fold response over controls (control
        LI less than or equal to 1%). From week 2 to week 22 the hepatocytic LI was
        sustained in WYHD and WYLD rats (8- and 4-fold over controls respectively)
        but not in CA-rats, as compared to controls. In contrast to the cell replication
        response, apoptosis was elevated only in WYHD at 22 weeks. Collectively, this
        study supports the conclusion that neither hepatomegaly nor peroxisome proliferation
        are accurate predictors of carcinogenic activity for PP. Further, these results
        suggest that if lipofuscin accumulation or sustained cell turnover are indicators
        of PP-induced carcinogenesis, then WYLD should be at least as carcinogenic
        as CA. The moderate carcinogenic activity of CA also suggests that additional
        factor(s) may be necessary besides lipofuscin accumulation and sustained cell
        replication to determine the ultimate carcinogenic activity of PP.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Marsman</LastName><ForeName>D
        S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, NC 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Goldsworthy</LastName><ForeName>T L</ForeName><Initials>TL</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004273">DNA, Neoplasm</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008062">Lipofuscin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004273" MajorTopicYN="N">DNA, Neoplasm</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008062" MajorTopicYN="N">Lipofuscin</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1600604</ArticleId><ArticleId IdType="doi">10.1093/carcin/13.6.1011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1625184</PMID><DateCompleted><Year>1992</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0731-8898</ISSN><JournalIssue
        CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>1992</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Journal
        of environmental pathology, toxicology and oncology : official organ of the
        International Society for Environmental Toxicology and Cancer</Title><ISOAbbreviation>J
        Environ Pathol Toxicol Oncol</ISOAbbreviation></Journal><ArticleTitle>Hepatomegaly
        is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators.</ArticleTitle><Pagination><StartPage>145</StartPage><EndPage>149</EndPage><MedlinePgn>145-9</MedlinePgn></Pagination><Abstract><AbstractText>The
        relationship between hepatomegaly and the hepatocarcinogenesis associated
        with by peroxisome proliferators was examined. (1) Male F-344 rats were maintained
        on diets containing clofibrate, ciprofibrate, nafenopin, gemfibrozil, Wy-14,
        643, di(2-ethylhexyl)phthalate (DEHP), or di(2-ethylhexyl)adipate (DEHA) at
        carcinogenic doses for 1 week. A close correlation between relative liver
        weights and hepatocarcinogenicity was observed (r = 0.910). (2) Administration
        of perfluorooctanoic acid (PFOA), perfluorodecanoic acid (PFDA), simfibrate,
        or DL-040, for which hepatocarcinogenicity is not known, resulted in hepatomegaly
        in all treated groups, this being especially marked in the PFOA case. Therefore,
        PFOA may have strong hepatocarcinogenic potential. (3) Administration of the
        antioxidants butylated hydroxyanisole (BHA) or vitamin E (VE) did not affect
        the hepatomegaly induced by DEHP. These results suggest that the hepatomegaly
        may be an early biomarker for prediction of the potential hepatocarcinogenicity
        of peroxisome proliferators. However, this requires further clarification
        in terms of its relation to the oxidative stress thought to be involved in
        peroxisome proliferator-induced hepatocarcinogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division
        of Toxicology, National Institute of Hygienic Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sai</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Umemura</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Kurokawa</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Environ Pathol Toxicol Oncol</MedlineTA><NlmUniqueID>8501420</NlmUniqueID><ISSNLinking>0731-8898</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-18-4</RegistryNumber><NameOfSubstance
        UI="D014810">Vitamin E</NameOfSubstance></Chemical><Chemical><RegistryNumber>25013-16-5</RegistryNumber><NameOfSubstance
        UI="D002083">Butylated Hydroxyanisole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002083" MajorTopicYN="N">Butylated Hydroxyanisole</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006529" MajorTopicYN="N">Hepatomegaly</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014810" MajorTopicYN="N">Vitamin E</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1625184</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6716514</PMID><DateCompleted><Year>1984</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0098-4108</ISSN><JournalIssue
        CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>1984</Year></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health</Title><ISOAbbreviation>J Toxicol Environ
        Health</ISOAbbreviation></Journal><ArticleTitle>Effect of di(2-ethylhexyl)
        phthalate on DNA repair and lipid peroxidation in rat hepatocytes and on metabolic
        cooperation in Chinese hamster V-79 cells.</ArticleTitle><Pagination><StartPage>99</StartPage><EndPage>116</EndPage><MedlinePgn>99-116</MedlinePgn></Pagination><Abstract><AbstractText>Experiments
        were conducted to test the hypothesis that the hepatocarcinogenicity of di(2-ethylhexyl)
        phthalate (DEHP) is due to its ability to produce DNA damage, either directly
        or as a result of the proliferation of peroxisomes and accompanying increased
        production of H2O2 and other DNA--damaging oxygen radicals induced by sustained
        exposure to the plasticizer. DNA repair, as assessed by the autoradiographic
        measurement of unscheduled DNA synthesis (UDS), was not observed in primary
        rat hepatocytes exposed in vitro to 10(-5)-10(-2) M DEHP or in vivo by a single
        gavage dose of 5 g DEHP/kg body weight administered 2, 15, or 24 h prior to
        the isolation of hepatocytes. Thus, DEHP does not appear to directly produce
        repairable DNA damage in rat hepatocytes. Sustained feeding of DEHP at a dietary
        concentration of 2% led to a marked proliferation of peroxisomes in the liver
        after 4 wk. Additional administration of a single gavage dose of 5 g DEHP/kg
        body weight to animals fed the 2% diet for 4 or 8 wk, as well as to 4-wk-fed
        animals that were also pretreated with 3-amino-1,2,4-triazole to inhibit endogenous
        catalase activity, did not induce any detectable DNA repair in hepatocytes
        isolated 15 h following the single gavage dose of DEHP. Lipid peroxidation
        measured in the 9000 X g supernatant of livers from animals treated with a
        single dose of 5 g DEHP/kg body weight or the 2% DEHP diet for 6 wk plus a
        single dose of 5 g/kg body weight did not differ from controls. These findings
        suggest that DEHP does not elicit DNA damage or lipid peroxidation in liver
        consequent to the proliferation of peroxisomes resulting from prolonged administration.
        In addition, at noncytotoxic concentrations DEHP failed to produce a positive
        response in the Chinese hamster V-79 metabolic cooperation assay for tumor
        promoters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kornbrust</LastName><ForeName>D
        J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Barfknecht</LastName><ForeName>T
        R</ForeName><Initials>TR</Initials></Author><Author ValidYN="Y"><LastName>Ingram</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Shelburne</LastName><ForeName>J D</ForeName><Initials>JD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Toxicol Environ Health</MedlineTA><NlmUniqueID>7513622</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008054">Lipid Peroxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>9M98QLJ2DL</RegistryNumber><NameOfSubstance
        UI="D015073">2-Acetylaminofluorene</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber><NameOfSubstance
        UI="D005978">Glutathione</NameOfSubstance></Chemical><Chemical><RegistryNumber>ZF80H5GXUF</RegistryNumber><NameOfSubstance
        UI="D000640">Amitrole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015073" MajorTopicYN="N">2-Acetylaminofluorene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000640" MajorTopicYN="N">Amitrole</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008054" MajorTopicYN="N">Lipid Peroxides</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6716514</ArticleId><ArticleId IdType="doi">10.1080/15287398409530484</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2859109</PMID><DateCompleted><Year>1985</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0008-5472</ISSN><JournalIssue
        CitedMedium="Print"><Volume>45</Volume><Issue>6</Issue><PubDate><Year>1985</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cancer
        research</Title><ISOAbbreviation>Cancer Res</ISOAbbreviation></Journal><ArticleTitle>Phosphorylation
        of specific rat plasma membrane proteins during promotion of gamma-glutamyl
        transpeptidase-positive hepatic foci and inhibition by di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>2654</StartPage><EndPage>2660</EndPage><MedlinePgn>2654-60</MedlinePgn></Pagination><Abstract><AbstractText>The
        protein kinase activity of isolated plasma membranes from the livers of rats
        treated with three promoting regimens was examined using both exogenous proteins
        and endogenous plasma membrane proteins as substrates. Male rats first received
        either an initiating dose (30 mg/kg) of the hepatocarcinogen diethylnitrosamine
        or the 0.9% NaCl solution vehicle by i.p. injection at 18 h following partial
        hepatectomy. Ten days later, the three promoting regimens were begun. These
        consisted of 10 weeks of treatment with either (a) a choline-deficient (CD)
        diet, (b) a choline-supplemented (CS) diet containing 0.06% phenobarbital
        (PHB) (CS plus PHB), or (c) a CD diet containing 0.06% PHB (CD plus PHB).
        In addition, two other groups of rats received either (a) a CS diet containing
        2% di(2-ethylhexyl)phthalate (DEHP) (CS plus DEHP) or (b) a CD diet containing
        2% DEHP (CD plus DEHP). DEHP is a widely used plasticizer and environmental
        contaminant which we have shown previously inhibits the development of putative
        preneoplastic gamma-glutamyl transpeptidase (GGT) positive foci in rat liver.
        Total liver plasma membrane protein kinase activity using both protamine sulfate
        and histone was cyclic adenosine 3'':5''-monophosphate independent and did
        not appear to be a marker of promotion. Its activity was increased by both
        DEHP which suppresses the development of GGT positive foci and a CD diet which
        promotes the appearance of GGT positive foci. The CD, CS plus PHB, and CD
        plus PHB dietary regimens, which promote the appearance of GGT positive foci,
        induced the phosphorylation of a Mr 40,000 plasma membrane protein in vitro
        by endogenous protein kinases. Plasma membranes from DEHP-treated rats did
        not demonstrate phosphorylation of this Mr 40,000 protein. DEHP dietary treatment
        also blocked the ability of epidermal growth factor to enhance the phosphorylation
        of its Mr 175,000 receptor protein in isolated liver plasma membranes. These
        results suggest that the phosphorylation of a Mr 40,000 plasma membrane protein
        may be important to the early promotional phase of liver carcinogenesis, and
        that one mechanism by which DEHP inhibits the emergence of GGT positive foci
        may be by blocking the response of initiated cells to stimulation by epidermal
        growth factor.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>DeAngelo</LastName><ForeName>A B</ForeName><Initials>AB</Initials></Author><Author
        ValidYN="Y"><LastName>Garrett</LastName><ForeName>C T</ForeName><Initials>CT</Initials></Author><Author
        ValidYN="Y"><LastName>Queral</LastName><ForeName>A E</ForeName><Initials>AE</Initials></Author><Author
        ValidYN="Y"><LastName>Irwin</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>1-RO1-CA-31324</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Cancer Res</MedlineTA><NlmUniqueID>2984705R</NlmUniqueID><ISSNLinking>0008-5472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C000717332">Phb protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000091402">Prohibitins</NameOfSubstance></Chemical><Chemical><RegistryNumber>4R7X1O2820</RegistryNumber><NameOfSubstance
        UI="D002713">Chlorine</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.-</RegistryNumber><NameOfSubstance UI="D011494">Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002713" MajorTopicYN="N">Chlorine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000091402" MajorTopicYN="N">Prohibitins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011494" MajorTopicYN="N">Protein Kinases</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2859109</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3378278</PMID><DateCompleted><Year>1988</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>24</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0009-2797</ISSN><JournalIssue
        CitedMedium="Print"><Volume>65</Volume><Issue>3</Issue><PubDate><Year>1988</Year></PubDate></JournalIssue><Title>Chemico-biological
        interactions</Title><ISOAbbreviation>Chem Biol Interact</ISOAbbreviation></Journal><ArticleTitle>Modulation
        of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in F344 rats by di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>205</StartPage><EndPage>222</EndPage><MedlinePgn>205-22</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of cotreatment with a hyperlipidemic chemical, 2,3,7,8-tetrachlorodibenzo-p-dioxin
        (TCDD), and a hypolipidemic agent, di(2-ethylhexyl)-phthalate (DEHP), on lipid
        metabolism and toxicologic responses were studied in F344 rats. Treatment
        with TCDD alone (160 micrograms/kg) caused an increase in serum triglycerides
        and cholesterol while treatment with DEHP alone (2 g/kg/day) caused a decrease
        in triglycerides and cholesterol versus untreated controls. When administered
        before or after TCDD, DEHP caused a decrease in TCDD-induced hyperlipidemia.
        This change was attributed to enhanced hepatic peroxisomal beta-oxidation
        and decreased hepatic lipid synthesis resulting from treatment with DEHP.
        TCDD treatment produced a fatty liver, as determined by gravimetric analysis
        of extracted lipid and microscopic examination of liver sections which revealed
        extensive cytoplasmic vacuolization that stained positive with Oil Red 0,
        but did not induce peroxisomal beta-oxidation. Thus, an increase in hepatic
        or serum lipid levels is not sufficient for induction of peroxisome proliferation.
        Neither TCDD nor DEHP treatment affected mitochondrial beta-oxidation. Pretreatment
        of rats with DEHP, followed by daily exposure to this hypolipidemic agent
        after treatment with TCDD, had a partial protective effect against TCDD-induced
        fatty liver, body weight loss and mortality. Microscopic examination of liver
        sections confirmed the suppression of TCDD-induced fatty liver by pretreatment
        with DEHP. When DEHP treatment was initiated after the TCDD dose, there was
        less protection against the above parameters of TCDD toxicity. This study
        demonstrates that TCDD-induced fatty liver, hyperlipidemia and mortality can
        be antagonized by treatment with a hypolipidemic agent such as DEHP.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Tomaszewski</LastName><ForeName>K
        E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>National
        Toxicology Program, National Institute of Environmental Health Sciences, Research
        Triangle Park, NC 27709.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>C
        A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Melnick</LastName><ForeName>R
        L</ForeName><Initials>RL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Chem
        Biol Interact</MedlineTA><NlmUniqueID>0227276</NlmUniqueID><ISSNLinking>0009-2797</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004147">Dioxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000072317">Polychlorinated Dibenzodioxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004147" MajorTopicYN="N">Dioxins</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005234" MajorTopicYN="N">Fatty Liver</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007928" MajorTopicYN="N">Lethal Dose 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000072317" MajorTopicYN="N">Polychlorinated Dibenzodioxins</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014617" MajorTopicYN="N">Vacuoles</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3378278</ArticleId><ArticleId IdType="doi">10.1016/0009-2797(88)90107-x</ArticleId><ArticleId
        IdType="pii">0009-2797(88)90107-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">20854900</PMID><DateCompleted><Year>2011</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4596</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>49</Volume><Issue>11</Issue><PubDate><Year>2010</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Free
        radical biology &amp; medicine</Title><ISOAbbreviation>Free Radic Biol Med</ISOAbbreviation></Journal><ArticleTitle>Hepatotoxicity
        of di-(2-ethylhexyl)phthalate is attributed to calcium aggravation, ROS-mediated
        mitochondrial depolarization, and ERK/NF-&#x3ba;B pathway activation.</ArticleTitle><Pagination><StartPage>1779</StartPage><EndPage>1791</EndPage><MedlinePgn>1779-91</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2010.09.011</ELocationID><Abstract><AbstractText>Di-(2-ethylhexyl)phthalate
        (DEHP) is a widely used plasticizer found in a variety of polyvinyl chloride
        medical products. Although DEHP-induced cytotoxicity and apoptosis are well
        studied in various cell types, the precise mechanisms are not well understood
        so far. This study, aimed at going beyond the toxicology approach, focuses
        on the molecular mechanisms through which DEHP causes hepatotoxicity. We show
        that DEHP induces apoptotic cell death in a dose-dependent manner, as proven
        by an increase in annexin V-positively stained cells, DAPI/PI staining, and
        immunofluorescence studies. The DEHP-induced decrease in cell viability was
        significantly inhibited by adding catalase (CAT), but CAT treatment did not
        suppress the DEHP-stimulated calcium flux in the hepatocytes, whereas BAPTA-AM
        significantly reduced the DEHP-stimulated DCF intensity. These results demonstrate
        that DEHP increases the intracellular calcium level, which mediates the generation
        of H(2)O(2) in hepatocytes. Investigating cell-signaling mechanisms, we found
        that DEHP induced apoptotic cell death by mitochondrial-dependent caspase-3
        activation and PARP cleavage. These changes due to DEHP exposure were associated
        with increased IKK and NF-&#x3ba;B phosphorylation. Preexposure of hepatocytes
        to an IKK inhibitor (PS-1145) prevented DEHP-induced caspase-3 and PARP cleavage.
        DEHP also markedly increased the activity of ERK1/2 MAPK. Pretreatment with
        the ERK inhibitor PD98059 attenuated NF-&#x3ba;B and IKK phosphorylation,
        indicating that ERK MAPK is mainly involved in DEHP-induced NF-&#x3ba;B activation.
        These results, for the first time, reveal that DEHP induces apoptosis in hepatocytes
        via the activation of the ERK/NF-&#x3ba;B signaling pathway, in which calcium
        ions and hydrogen peroxide act as the pivotal mediators of the apoptotic signaling.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2010 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Jyotirmoy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division
        of Molecular Medicine, Bose Institute, Kolkata, India.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Das</LastName><ForeName>Joydeep</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Manna</LastName><ForeName>Prasenjit</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Sil</LastName><ForeName>Parames C</ForeName><Initials>PC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2010</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Free Radic Biol Med</MedlineTA><NlmUniqueID>8709159</NlmUniqueID><ISSNLinking>0891-5849</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.24</RegistryNumber><NameOfSubstance UI="D048049">Extracellular Signal-Regulated
        MAP Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance
        UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D048049" MajorTopicYN="N">Extracellular Signal-Regulated MAP Kinases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2010</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2010</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2010</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2011</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20854900</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2010.09.011</ArticleId><ArticleId
        IdType="pii">S0891-5849(10)00543-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8352887</PMID><DateCompleted><Year>1993</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>23</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0899-1987</ISSN><JournalIssue
        CitedMedium="Print"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>1993</Year></PubDate></JournalIssue><Title>Molecular
        carcinogenesis</Title><ISOAbbreviation>Mol Carcinog</ISOAbbreviation></Journal><ArticleTitle>Activation
        of immediate-early gene expression by peroxisome proliferators in vitro.</ArticleTitle><Pagination><StartPage>20</StartPage><EndPage>27</EndPage><MedlinePgn>20-7</MedlinePgn></Pagination><Abstract><AbstractText>The
        hepatocarcinogenicity of peroxisome proliferators (PPs) in rodents has been
        attributed both to oxidative DNA damage resulting from excessive leakage of
        peroxisomal H2O2 and to increased hepatocellular replication that may be independent
        of peroxisome proliferation. Because of the growing association between tumor
        promotion and alterations in growth-regulatory signal transduction pathways,
        we investigated whether PPs can modulate these pathways in a mouse liver epithelial
        cell line, BNL-CL.2. We tested two PPs that differ markedly in rodent tumorigenicity
        for their ability to activate immediate-early proto-oncogene expression. 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic
        acid (Wy-14643), a highly tumorigenic PP, was an exceptionally strong inducer
        of c-fos expression. Wy-14643 was also stronger than DEHP in stimulating c-jun
        expression, whereas both PPs were fairly strong inducers of jun-B and jun-D.
        The induction of fos and jun expression by Wy-14643 was specifically inhibited
        by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperizine
        dihydrochloride (H-7). DEHP-induced gene expression was strongly inhibited
        by H-7, but was also partially inhibited by an inhibitor of protein kinase
        A. The activation of fos and jun gene expression by PPs was independent of
        peroxisome proliferation since it was an immediately-early response not requiring
        protein synthesis and since the cell lines used in this study do not undergo
        peroxisome proliferation. Our r results raise the possibility that the carcinogenicity
        of PPs may be due, in part, to epigenetic modulation of growth-regulatory
        signal transduction pathways.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Ledwith</LastName><ForeName>B J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department
        of Genetic and Cellular Toxicology, Merck Research Laboratories, West Point,
        Pennsylvania 19486.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manam</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Troilo</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Joslyn</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Author><Author
        ValidYN="Y"><LastName>Galloway</LastName><ForeName>S M</ForeName><Initials>SM</Initials></Author><Author
        ValidYN="Y"><LastName>Nichols</LastName><ForeName>W W</ForeName><Initials>WW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Mol Carcinog</MedlineTA><NlmUniqueID>8811105</NlmUniqueID><ISSNLinking>0899-1987</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D016475" MajorTopicYN="N">3T3 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016762" MajorTopicYN="N">Genes, fos</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016758" MajorTopicYN="N">Genes, jun</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013268" MajorTopicYN="N">Stimulation, Chemical</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1993</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1993</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1993</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8352887</ArticleId><ArticleId IdType="doi">10.1002/mc.2940080107</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11341945</PMID><DateCompleted><Year>2001</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-3002</ISSN><JournalIssue
        CitedMedium="Print"><Volume>1544</Volume><Issue>1-2</Issue><PubDate><Year>2001</Year><Month>Jan</Month><Day>12</Day></PubDate></JournalIssue><Title>Biochimica
        et biophysica acta</Title><ISOAbbreviation>Biochim Biophys Acta</ISOAbbreviation></Journal><ArticleTitle>Differential
        induction of peroxisomal populations in subcellular fractions of rat liver.</ArticleTitle><Pagination><StartPage>358</StartPage><EndPage>369</EndPage><MedlinePgn>358-69</MedlinePgn></Pagination><Abstract><AbstractText>In
        rat liver, peroxisome proliferators induce profound changes in the number
        and protein composition of peroxisomes, which upon subcellular fractionation
        is reflected in heterogeneity in sedimentation properties of peroxisome populations.
        In this study we have investigated the time course of induction of the peroxisomal
        proteins catalase, acyl-CoA oxidase (ACO) and the 70 kDa peroxisomal membrane
        protein (PMP70) in different subcellular fractions. Rats were fed a di(2-ethylhexyl)phthalate
        (DEHP) containing diet for 8 days and livers were removed at different time-points,
        fractionated by differential centrifugation into nuclear, heavy and light
        mitochondrial, microsomal and soluble fractions, and organelle marker enzymes
        were measured. Catalase was enriched mainly in the light mitochondrial and
        soluble fractions, while ACO was enriched in the nuclear fraction (about 30%)
        and in the soluble fraction. PMP70 was found in all fractions except the soluble
        fraction. DEHP treatment induced ACO, catalase and PMP70 activity and immunoreactive
        protein, but the time course and extent of induction was markedly different
        in the various subcellular fractions. All three proteins were induced more
        rapidly in the nuclear fraction than in the light mitochondrial or microsomal
        fractions, with catalase and PMP70 being maximally induced in the nuclear
        fraction already at 2 days of treatment. Refeeding a normal diet quickly normalized
        most parameters. These results suggest that induction of a heavy peroxisomal
        compartment is an early event and that induction of ''small peroxisomes'',
        containing PMP70 and ACO, is a late event. These data are compatible with
        a model where peroxisomes initially proliferate by growth of a heavy, possibly
        reticular-like, structure rather than formation of peroxisomes by division
        of pre-existing organelles into small peroxisomes that subsequently grow.
        The various peroxisome populations that can be separated by subcellular fractionation
        may represent peroxisomes at different stages of biogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilcke</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The
        Wenner-Gren Institute, Stockholm University, Sweden. mona.wilcke@eu.pnu.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alexson</LastName><ForeName>S E</ForeName><Initials>SE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biochim
        Biophys Acta</MedlineTA><NlmUniqueID>0217513</NlmUniqueID><ISSNLinking>0006-3002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018528">ATP-Binding Cassette Transporters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C489272">Abcd3 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D018528" MajorTopicYN="Y">ATP-Binding Cassette Transporters</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013347" MajorTopicYN="N">Subcellular Fractions</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000648"
        MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>5</Month><Day>9</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>6</Month><Day>2</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>5</Month><Day>9</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11341945</ArticleId><ArticleId IdType="doi">10.1016/s0167-4838(00)00250-8</ArticleId><ArticleId
        IdType="pii">S0167-4838(00)00250-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">548985</PMID><DateCompleted><Year>1980</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0071-2736</ISSN><JournalIssue
        CitedMedium="Print"><Volume>16</Volume><PubDate><Year>1979</Year></PubDate></JournalIssue><Title>Proceedings
        of the European Dialysis and Transplant Association. European Dialysis and
        Transplant Association</Title><ISOAbbreviation>Proc Eur Dial Transplant Assoc</ISOAbbreviation></Journal><ArticleTitle>Influence
        of the plasticiser di-2-ethylhexyl-phthalate on drug metabolising enzymes
        in the liver of uraemic rats.</ArticleTitle><Pagination><StartPage>232</StartPage><EndPage>237</EndPage><MedlinePgn>232-7</MedlinePgn></Pagination><Abstract><AbstractText>After
        bilateral or subtotal nephrectomy male rats were given intraperitoneal injections
        of the plasticiser di-2-ethylhexylphthalate (DEHP) at differing time intervals
        in doses that do not affect the liver of normal rats. 200mg DEHP/100g body
        weight had no influence on the parameters measured. After administering 7
        x 200mg/100g body weight for 14 days, liver weight and in vitro activity of
        the mixed function oxidation system increased significantly. In addition,
        the hexobarbital sleeping time decreased, indicating a stimulation of the
        activity of drug metabolising enzymes in vivo. Similar results were obtained
        after the administration of 56 x 50mg DEHP/100g body weight for 19 weeks.
        It is concluded that uraemic rats are more susceptible to inducing effects,
        but that the DEHP toxicity is of little importance.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Leber</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author
        ValidYN="Y"><LastName>Uviss</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Prenter</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Proc
        Eur Dial Transplant Assoc</MedlineTA><NlmUniqueID>0355210</NlmUniqueID><ISSNLinking>0071-2736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>AL8Z8K3P6S</RegistryNumber><NameOfSubstance
        UI="D006591">Hexobarbital</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.-</RegistryNumber><NameOfSubstance UI="D004950">Esterases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004950" MajorTopicYN="N">Esterases</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006591" MajorTopicYN="N">Hexobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014511" MajorTopicYN="N">Uremia</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1979</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1979</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1979</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">548985</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2260097</PMID><DateCompleted><Year>1991</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>106</Volume><Issue>3</Issue><PubDate><Year>1990</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Toxicological
        studies on a benzofuran derivative. III. Comparison of peroxisome proliferation
        in rat and human hepatocytes in primary culture.</ArticleTitle><Pagination><StartPage>509</StartPage><EndPage>517</EndPage><MedlinePgn>509-17</MedlinePgn></Pagination><Abstract><AbstractText>Primary
        cultures of rat and human hepatocytes were used in our in vitro studies for
        investigating species differences in the response to a peroxisome proliferating
        benzofuran derivative, benzbromarone. Cyanide-insensitive palmitoyl coenzyme
        A oxidation (a marker of peroxisome fatty acid beta-oxidation) and electron
        microscopy were used to assess peroxisome proliferation. Hepatocytes were
        cultured essentially as described by Mitchell et al. (1984, Arch. Toxicol.
        55, 239-246); clofibric acid and mono(2-ethylhexyl) phthalate (MEHP) were
        used as reference compounds, as they are well known to cause peroxisome proliferation
        in rat hepatocytes in primary culture. The benzofuran derivative, tested at
        drug concentrations ranging from 2.37 to 59.20 microM in rat hepatocyte primary
        cultures, induced, after 96 hr, a dose-related increase of the peroxisomal
        beta-oxidase activity correlated with an increased number of peroxisomes;
        this increase was much less marked than that obtained with clofibric acid
        or MEHP. By contrast, using the same range of concentrations, human hepatocytes
        in primary culture treated with benzbromarone revealed no enhancement of enzymatic
        activity and no concomitant statistically significant increase in the number
        of peroxisomes; the same observations were reported with clofibric acid and
        MEHP. These results demonstrate clearly that species differences in sensitivity
        to peroxisome proliferation with the benzofuran derivative do exist.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Bichet</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sanofi
        Recherche, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cahard</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Fabre</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Remandet</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Gouy</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Cano</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4POG0RL69O</RegistryNumber><NameOfSubstance
        UI="D001553">Benzbromarone</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.-</RegistryNumber><NameOfSubstance UI="C028427">palmitoyl CoA oxidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001553" MajorTopicYN="N">Benzbromarone</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2260097</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(90)90345-u</ArticleId><ArticleId
        IdType="pii">0041-008X(90)90345-U</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6147206</PMID><DateCompleted><Year>1984</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>11</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>5</Volume><Issue>9</Issue><PubDate><Year>1984</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Accelerated
        regression of carcinogen-induced preneoplastic hepatocyte foci by peroxisome
        proliferators, BR931, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio (N-B-hydroxyethyl)acetamide,
        and di-(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>1193</StartPage><EndPage>1198</EndPage><MedlinePgn>1193-8</MedlinePgn></Pagination><Abstract><AbstractText>Enzyme
        altered preneoplastic hepatocyte foci were induced in male Sprague Dawley
        rats by a single injection of diethylnitrosamine (DEN) followed by dietary
        promotion of a choline-deficient (CD) diet for 4 weeks or by feeding a diet
        containing 0.02% 2-acetylaminofluorene for 4 weeks. BR931, a hypolipidemic
        agent, administered to rats bearing preneoplastic foci caused a rapid regression
        of the foci within 4-6 weeks. Di(2-ethylhexyl)phthalate (DEHP), a plasticiser,
        exerted the similar effect when tested on rats bearing preneoplastic foci
        induced by DEN + CD diet. Since BR931 and DEHP have been shown to be carcinogenic
        after long term feeding, the results suggest that the short-term effects of
        the class of agents known as hypolipidemic peroxisome proliferators are different
        from the chronic effects. Alternatively, the precursor lesions of hepatocellular
        carcinomas induced by hypolipidemic, peroxisome proliferators may differ from
        enzyme altered hepatocytic foci.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Perera</LastName><ForeName>M I</ForeName><Initials>MI</Initials></Author><Author
        ValidYN="Y"><LastName>Shinozuka</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 26556</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000960">Hypolipidemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IQ78TTX1A</RegistryNumber><NameOfSubstance
        UI="D004052">Diethylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>969LVT6GJ2</RegistryNumber><NameOfSubstance
        UI="C016908">pirinixil</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002796" MajorTopicYN="N">Choline Deficiency</DescriptorName><QualifierName
        UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004052" MajorTopicYN="N">Diethylnitrosamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000960" MajorTopicYN="N">Hypolipidemic Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6147206</ArticleId><ArticleId IdType="doi">10.1093/carcin/5.9.1193</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">21856391</PMID><DateCompleted><Year>2011</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3169</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>206</Volume><Issue>3</Issue><PubDate><Year>2011</Year><Month>Oct</Month><Day>30</Day></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Activation
        of Trim17 by PPAR&#x3b3; is involved in di(2-ethylhexyl) phthalate (DEHP)-induced
        apoptosis on Neuro-2a cells.</ArticleTitle><Pagination><StartPage>245</StartPage><EndPage>251</EndPage><MedlinePgn>245-51</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.toxlet.2011.08.002</ELocationID><Abstract><AbstractText>Di-(2-ethylhexyl)
        phthalate (DEHP) is widely used as a plasticizer in plastics. Its reproductive
        toxicity and teratogenic effects are well known. DEHP can cause liver damage
        and peroxisome proliferation, as well as carcinogenesis. Animal study has
        shown that DEHP causes neurodegeneration in rat brain. Prenatal exposure to
        DEHP disrupts brain development and decreases brain weight in rats. But its
        mechanism of action in the brain is not clear. This study used a neuroblastoma
        cell line, Neuro-2a cells, to investigate the toxic effect of DEHP. The results
        revealed that DEHP inhibits cell proliferation, activate caspase-3, induce
        apoptosis in a dose and time dependent manner, and activate expression of
        the PPAR&#x3b3; and Trim17 protein. Administration of the PPAR&#x3b3; agonist
        (troglitazone) enhanced DEHP-induced Trim17 protein expression and this enhancement
        could be reversed by the PPAR&#x3b3; antagonist (GW9662). These results suggest
        that DEHP activates the Trim17 protein via PPAR&#x3b3; leading to cleavage
        pro-caspase-3 and apoptosis. This finding may account for the central nervous
        system toxicity of DEHP and implies DEHP can impair fetal brain development.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2011 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chuang-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department
        of Physiology, College of Medicine, Kaohsiung Medical University, Kaohsiung
        807, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tsan-Ju</ForeName><Initials>TJ</Initials></Author><Author
        ValidYN="Y"><LastName>Chen</LastName><ForeName>Shun-Sheng</ForeName><Initials>SS</Initials></Author><Author
        ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Pei-Chun</ForeName><Initials>PC</Initials></Author><Author
        ValidYN="Y"><LastName>Yang</LastName><ForeName>Rei-Cheng</ForeName><Initials>RC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2011</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047495">PPAR gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000070584">Tripartite Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.27</RegistryNumber><NameOfSubstance UI="C485451">Trim17 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.4.22.-</RegistryNumber><NameOfSubstance UI="D053181">Caspase 8</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D053181" MajorTopicYN="N">Caspase 8</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D047495" MajorTopicYN="N">PPAR gamma</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000070584" MajorTopicYN="N">Tripartite Motif Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2011</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2011</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2011</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2011</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2011</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2011</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">21856391</ArticleId><ArticleId IdType="doi">10.1016/j.toxlet.2011.08.002</ArticleId><ArticleId
        IdType="pii">S0378-4274(11)01476-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10388618</PMID><DateCompleted><Year>1999</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0273-2300</ISSN><JournalIssue
        CitedMedium="Print"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>1999</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Regulatory
        toxicology and pharmacology : RTP</Title><ISOAbbreviation>Regul Toxicol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>A
        cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new
        U.S. EPA Risk Assessment Guidelines.</ArticleTitle><Pagination><StartPage>327</StartPage><EndPage>357</EndPage><MedlinePgn>327-57</MedlinePgn></Pagination><Abstract><AbstractText>The
        current United States Environmental Protection Agency (EPA) classification
        of di(2-ethylhexyl)phthalate (DEHP) as a B2 "probable human" carcinogen is
        based on outdated information. New toxicology data and a considerable amount
        of new mechanistic evidence were used to reconsider the cancer classification
        of DEHP under EPA''s proposed new cancer risk assessment guidelines. The total
        weight-of-evidence clearly indicates that DEHP is not genotoxic. In vivo administration
        of DEHP to rats and mice results in peroxisome proliferation in the liver,
        and there is strong evidence and scientific consensus that, in rodents, peroxisome
        proliferation is directly associated with the onset of liver cancer. Peroxisome
        proliferation is a transcription-mediated process that involves activation
        by the peroxisome proliferator of a nuclear receptor in rodent liver called
        the peroxisome proliferator-activated receptor (PPARalpha). The critical role
        of PPARalpha in peroxisomal proliferation and carcinogenicity in mice is clearly
        established by the lack of either response in mice genetically modified to
        remove the PPARalpha. Several mechanisms have been proposed to explain how,
        in rodents, peroxisome proliferation can lead to the formation of hepatocellular
        tumors. The general consensus of scientific opinion is that PPARalpha-induced
        mitogenesis and cell proliferation are probably the major mechanisms responsible
        for peroxisome proliferator-induced hepatocarcinogenesis in rodents. Oxidative
        stress appears to play a significant role in this increased cell proliferation.
        It triggers the release of TNFalpha by Kupffer cells, which in turn acts as
        a potent mitogen in hepatocytes. Rats and mice are uniquely responsive to
        the morphological, biochemical, and chronic carcinogenic effects of peroxisome
        proliferators, while guinea pigs, dogs, nonhuman primates, and humans are
        essentially nonresponsive or refractory; Syrian hamsters exhibit intermediate
        responsiveness. These differences are explained, in part, by marked interspecies
        variations in the expression of PPARalpha, with levels of expression in humans
        being only 1-10% of the levels found in rat and mouse liver. Recent studies
        of DEHP clearly indicate a nonlinear dose-response curve that strongly suggests
        the existence of a dose threshold below which tumors in rodents are not induced.
        Thus, the hepatocarcinogenic effects of DEHP in rodents result directly from
        the receptor-mediated, threshold-based mechanism of peroxisome proliferation,
        a well-understood process associated uniquely with rodents. Since humans are
        quite refractory to peroxisomal proliferation, even following exposure to
        potent proliferators such as hypolipidemic drugs, it is concluded that the
        hepatocarcinogenic response of rodents to DEHP is not relevant to human cancer
        risk at any anticipated exposure level. DEHP should be classified an unlikely
        human carcinogen with a margin of exposure (MOE) approach to risk assessment.
        The most appropriate and conservative point of reference for assessing MOEs
        should be 20 mg/kg/day, which is the mouse NOEL for peroxisome proliferation
        and increased liver weight. Exposure of the general human population to DEHP
        is approximately 30 microg/kg body wt/day, the major source being from residues
        in food. Higher exposures occur occupationally [up to about 700 microg/kg
        body wt/day (mainly by inhalation) based on current workplace standards] and
        through use of certain medical devices [e.g., up to 457 microg/kg body wt/day
        for hemodialysis patients (intravenous)], although these have little relevance
        because the routes of exposure bypass critical activation enzymes in the gastrointestinal
        tract.</AbstractText><CopyrightInformation>Copyright 1999 Academic Press.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Doull</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University
        of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Elcombe</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Lake</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Swenberg</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Williams</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>van Gemert</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Regul
        Toxicol Pharmacol</MedlineTA><NlmUniqueID>8214983</NlmUniqueID><ISSNLinking>0273-2300</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000145"
        MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000145"
        MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017408" MajorTopicYN="N">Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014484" MajorTopicYN="N">United States Environmental Protection Agency</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>155</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>7</Month><Day>2</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>7</Month><Day>2</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10388618</ArticleId><ArticleId IdType="doi">10.1006/rtph.1999.1296</ArticleId><ArticleId
        IdType="pii">S0273-2300(99)91296-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8887448</PMID><DateCompleted><Year>1997</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>23</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>140</Volume><Issue>2</Issue><PubDate><Year>1996</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Potent
        peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat
        liver.</ArticleTitle><Pagination><StartPage>322</StartPage><EndPage>327</EndPage><MedlinePgn>322-7</MedlinePgn></Pagination><Abstract><AbstractText>It
        is unknown whether peroxisome proliferators decrease hepatic fatty acid oxidation
        via uncoupling of respiration or if they inhibit extramitochondrial fatty
        acyl CoA synthesis. Therefore, the purpose of this study was to examine both
        processes simultaneously using the isolated perfused liver, a whole cell preparation
        where enzymes and biochemical processes can be monitored continuously under
        nearly physiological conditions. Accordingly, ketone body formation (beta-hydroxybutyrate
        + acetoacetate) from lipid metabolism and oxygen uptake, which is increased
        by uncoupling agents, were monitored at the same time. 2-Bromooctanoate, a
        known inhibitor of acyl CoA synthetase, decreased ketone body formation in
        a dose-dependent manner without altering cellular respiration (half-maximal
        inhibition, approximately 25 microM) and concomitantly increased protein kinase
        C nearly fourfold also in a dose-dependent fashion. Ketogenesis was also blocked
        maximally 50-66% with mono(ethylhexyl)phthalate, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio
        acetic acid (WY-14,643), and nafenopin, potent peroxisome proliferators and
        tumor promoters. These compounds also increased protein kinase C three- to
        fourfold without altering oxygen uptake significantly. Thus, lipid metabolism
        appears to be the prime target of potent peroxisome proliferators most likely
        on actions via acyl CoA synthetase rather than oxidative phosphorylation.
        In contrast, weak peroxisome proliferators and tumor promoters, di(ethylhexyl)phthalate
        and 2-ethylhexanol, did not affect ketogenesis, oxygen consumption, or protein
        kinase C at similar concentrations. Additionally, octanoate increased ketone
        body formation in the presence of nafenopin. Because octanoate is metabolized
        by mitochondrial acyl CoA synthetase independent of carnitine acyltransferase,
        these results indicate that nafenopin does not inhibit mitochondrial beta-oxidation.
        Taken together, it is concluded that potent peroxisome proliferators preferentially
        block ketogenesis without altering cellular respiration in the liver. This
        phenomenona, which occurs due to inhibition of acyl CoA synthetase, leads
        to an elevation of free fatty acids that stimulates protein kinase C and promotes
        cell proliferation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Bojes</LastName><ForeName>H K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department
        of Pharmacology and Curriculum in Toxicology, University of North Carolina
        at Chapel Hill, 27599-7365, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Thurman</LastName><ForeName>R G</ForeName><Initials>RG</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>ES-04325</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002210">Caprylates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000960">Hypolipidemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>OBL58JN025</RegistryNumber><NameOfSubstance
        UI="C031492">octanoic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002210" MajorTopicYN="N">Caprylates</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000960" MajorTopicYN="N">Hypolipidemic Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010085" MajorTopicYN="N">Oxidative Phosphorylation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8887448</ArticleId><ArticleId IdType="doi">10.1006/taap.1996.0227</ArticleId><ArticleId
        IdType="pii">S0041-008X(96)90227-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2857115</PMID><DateCompleted><Year>1985</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>1985</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Lack
        of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen
        di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>141</StartPage><EndPage>144</EndPage><MedlinePgn>141-4</MedlinePgn></Pagination><Abstract><AbstractText>The
        hepatocarcinogenicity of di(2-ethylhexyl)phthalate (DEHP) was demonstrated
        in a recent bioassay in both rats and mice. Due to the negative genotoxicity
        of DEHP in both in vivo and in vitro assays, it was hypothesized that the
        positive carcinogenic response of DEHP may have been due to a promotional
        effect of DEHP on spontaneous foci. However, when DEHP was used in the promotion
        phase of a rat hepatic initiation-promotion system, no promotional activity
        could be demonstrated after either 3 or 6 months of feeding DEHP at a dietary
        concentration of 1.2%. No neoplasms or nodules were identified. In addition,
        DEHP did not increase the number of foci or the mean volume of the foci when
        foci were identified by six different histologic stains.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author
        ValidYN="Y"><LastName>Garvey</LastName><ForeName>L K</ForeName><Initials>LK</Initials></Author><Author
        ValidYN="Y"><LastName>Hamm</LastName><ForeName>T E</ForeName><Initials>TE</Initials><Suffix>Jr</Suffix></Author><Author
        ValidYN="Y"><LastName>Swenberg</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IQ78TTX1A</RegistryNumber><NameOfSubstance
        UI="D004052">Diethylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004052" MajorTopicYN="N">Diethylnitrosamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2857115</ArticleId><ArticleId IdType="doi">10.1093/carcin/6.1.141</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3554467</PMID><DateCompleted><Year>1987</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0192-6233</ISSN><JournalIssue
        CitedMedium="Print"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>1987</Year></PubDate></JournalIssue><Title>Toxicologic
        pathology</Title><ISOAbbreviation>Toxicol Pathol</ISOAbbreviation></Journal><ArticleTitle>Free
        radical injury and liver tumor promotion.</ArticleTitle><Pagination><StartPage>51</StartPage><EndPage>59</EndPage><MedlinePgn>51-9</MedlinePgn></Pagination><Abstract><AbstractText>One
        of the underlying mechanisms of tumor promotion both in the skin and liver
        involves free radical mediated injury to informational macromolecules of target
        cells. A choline-deficient (CD) diet, which is an efficient liver tumor promoter,
        induces peroxidative damage of liver cell membrane lipids. By modifying components
        of a CD diet, we have shown that the efficacy of the promotion is correlated
        with the extent of lipid peroxidation. The substitution of fats in a CD diet
        with predominantly polyunsaturated fat and the addition of methapyrilene to
        a CD diet enhances membrane lipid peroxidation and the promoting effects.
        An antioxidant (BHT) and hypolipidemic peroxisome proliferators (BR931 and
        DEHP) suppress both of these effects. Contrary to these findings, phenobarbital
        did not induce membrane lipid peroxidation, and its addition to a CD diet
        inhibited the diet-induced lipid peroxidation, though such a combination exerted
        a stronger promoting action. Thus, a CD diet and phenobarbital exert their
        promoting actions through different mechanisms. The consequence of membrane
        lipid peroxidation in the liver cells induced by a CD diet may be multiple.
        Our recent study of surface membrane insulin receptors of liver cells of rats
        fed a CD diet showed a decrease in number and an enhanced binding affinity
        leading to altered responsiveness of liver cells to insulin mediated glycogen
        synthesis. It is suggested that CD diet-induced lipid peroxidation leads to
        functional alterations of membrane receptors involved in cell growth control
        and may thereby exert its promoting action.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>M
        I</ForeName><Initials>MI</Initials></Author><Author ValidYN="Y"><LastName>Betschart</LastName><ForeName>J
        M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Virji</LastName><ForeName>M
        A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Katyal</LastName><ForeName>S
        L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Shinozuka</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>AM27306</GrantID><Acronym>AM</Acronym><Agency>NIADDK
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA26556</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA40062</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Pathol</MedlineTA><NlmUniqueID>7905907</NlmUniqueID><ISSNLinking>0192-6233</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005609">Free Radicals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008054">Lipid Peroxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008563">Membrane Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.10.1</RegistryNumber><NameOfSubstance UI="D011972">Receptor, Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002796" MajorTopicYN="N">Choline Deficiency</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003043" MajorTopicYN="N">Cocarcinogenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005609" MajorTopicYN="N">Free Radicals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008054" MajorTopicYN="N">Lipid Peroxides</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008563" MajorTopicYN="N">Membrane Lipids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011972" MajorTopicYN="N">Receptor, Insulin</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>47</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3554467</ArticleId><ArticleId IdType="doi">10.1177/019262338701500106</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2125992</PMID><DateCompleted><Year>1991</Year><Month>03</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0910-5050</ISSN><JournalIssue
        CitedMedium="Print"><Volume>81</Volume><Issue>12</Issue><PubDate><Year>1990</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Japanese
        journal of cancer research : Gann</Title><ISOAbbreviation>Jpn J Cancer Res</ISOAbbreviation></Journal><ArticleTitle>Promoting
        effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate,
        on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.</ArticleTitle><Pagination><StartPage>1232</StartPage><EndPage>1238</EndPage><MedlinePgn>1232-8</MedlinePgn></Pagination><Abstract><AbstractText>The
        modifying potential of clofibrate and di(2-ethylhexyl)phthalate (DEHP) on
        second stage, N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-initiated urinary
        bladder carcinogenesis was investigated in male F344 rats, using a uracil-accelerated
        transitional cell proliferation model. Six-week-old animals received 0.05%
        BBN in their drinking water for 4 weeks and then clofibrate (1.0, 0.5, and
        0.25%) and DEHP (1.2, 0.6, and 0.3%) were given during experimental weeks
        5-8 and weeks 12-20. Uracil was administered during weeks 9-11 at a dietary
        level of 3.0%. Control rats were treated with BBN and uracil without peroxisome
        proliferator. Surviving animals were killed at the end of week 20 of the experiment,
        when the densities of putative preneoplastic, papillary or nodular (PN) hyperplasias
        (numbers per 10 cm of basement membrane) were significantly increased in all
        clofibrate-treated, but not the DEHP groups. The incidences of PN hyperplasia
        were similar in both treated animals and controls. In a second experiment,
        rats fed diets containing 1.0% clofibrate or 1.2% DEHP were assessed for levels
        of DNA synthesis in urinary bladder epithelium by 5-bromo-2-deoxyuridine immunohistochemistry.
        Numbers of labeled nuclei remained within normal levels, and no proliferative
        changes were evident. Thus, the present experiments indicated that while clofibrate,
        but not DEHP, exerts weak enhancing effects on BBN-initiated urinary bladder
        carcinogenesis in rats this is not associated with increased levels of DNA
        synthesis in the affected epithelium.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>First
        Department of Pathology, Nagoya City University Medical School.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tamano</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Ogiso</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Asakawa</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Fukushima</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Jpn
        J Cancer Res</MedlineTA><NlmUniqueID>8509412</NlmUniqueID><ISSNLinking>0910-5050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004273">DNA, Neoplasm</NameOfSubstance></Chemical><Chemical><RegistryNumber>3817-11-6</RegistryNumber><NameOfSubstance
        UI="D002085">Butylhydroxybutylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>56HH86ZVCT</RegistryNumber><NameOfSubstance
        UI="D014498">Uracil</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002085" MajorTopicYN="Y">Butylhydroxybutylnitrosamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="Y">Carcinogens</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004273" MajorTopicYN="N">DNA, Neoplasm</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014498" MajorTopicYN="N">Uracil</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2125992</ArticleId><ArticleId IdType="pmc">PMC5918008</ArticleId><ArticleId
        IdType="doi">10.1111/j.1349-7006.1990.tb02684.x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>)
        Reddy , J. K. and Lalwani , N. D.Carcinogenesis by hepatic peroxisome proliferators:
        evaluation of the risk of hypolipidemic drugs and industrial plasticizers
        to humans . CRC Crit. Rev. Toxicol. , 12 , 1 &#x2013; 58 ( 1983. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6360536</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Rao , M. S. and Reddy , J. K.Peroxisome proliferation and hepatocarcinogenesis
        . Carcinogenesis , 8 , 631 &#x2013; 636 ( 1987. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3555880</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Mochizuki , Y. , Furukawa , K. and Sawada , N.Effects of various concentrations
        of ethyl&#x2010;&#x3b1;&#x2010;p&#x2010;chlorophenoxy&#x2010;isobutylate (clofibrate)
        on diethylnitrosamine&#x2010;induced hepatic tumorigenesis in the rat . Carcinogenesis
        , 3 , 1027 &#x2013; 1029 ( 1982. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">7139857</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Mochizuki , Y. , Furukawa , K. and Sawada , N.Effects of simultaneous administration
        of clofibrate with diethyl&#x2010;nitrosamine on hepatic tumorigenesis in
        the rat . Cancer Lett. , 19 , 99 &#x2013; 105 ( 1983. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6850573</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Numoto , S. , Furukawa , K. , Furuya , K. and Williams , G. M.Effects of the
        hepatocarcinogenic peroxisome&#x2010;proliferating hypolipidemic agents clofibrate
        and nafe&#x2010;nopin on the rat liver cell membrane enzymes &#x3b3;&#x2010;glutamyl&#x2010;transpeptidase
        and alkaline phosphatase and on the early stages of liver carcinogenesis .
        Carcinogenesis , 5 , 1603 &#x2013; 1611 ( 1984. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6149819</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Popp , J. A. , Garvey , L. K. , Hamm , T. E. , Jr. and Swenberg , J. A.Lack
        of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen
        di(2&#x2010;ethylhexyl)phthalate . Carcinogenesis , 6 , 141 &#x2013; 144 (
        1985. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">2857115</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Ward , J. M. , Rice , J. M. , Creasia , D. , Lynch , P. and Riggs , C.Dissimilar
        patterns of promotion by di(2&#x2010;ethylhexyl)phthalate and phenobarbital
        of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice
        . Carcinogenesis , 4 , 1021 &#x2013; 1029 ( 1983. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6872148</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Ward , J. M. , Diwan , B. A. , Ohshima , M. , Hu , H. , Schuller , H. M. and
        Rice , J. M.Tumor initiating and promoting activities of di(2&#x2010;ethylhexyl)phthalate
        in vivo and in vitro . Environ. Health Perspect. , 65 , 279 &#x2013; 291 (
        1986. ).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1474721</ArticleId><ArticleId
        IdType="pubmed">3709454</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Williams , G. M. , Maruyama , H. and Tanaka , T.Lack of rapid initiating,
        promoting or sequential syncarcinogenic effects of di(2&#x2010;ethylhexyl)phthalate
        in rat liver carcinogenesis . Carcinogenesis , 8 , 875 &#x2013; 880 ( 1987.
        ).</Citation><ArticleIdList><ArticleId IdType="pubmed">3594721</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Cattley , R. C. , Conway , J. G. and Popp , J. A.Association of persistent
        peroxisome proliferation and oxidative injury with hepatocarcinogenicity in
        female F&#x2010;344 rats fed di(2&#x2010;ethylhexyl)phthalate for 2 years
        . Cancer Lett. , 38 , 15 &#x2013; 22 ( 1987. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3690505</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Conway , J. G. , Tomaszewski , K. E. , Olson , M. J. , Cattley , R. C. , Marsman
        , D. S. and Popp , J. A.Relationship of oxidative damage to the hepatocarcinogenicity
        of the peroxisome proliferators di(2&#x2010;ethylhexyl)phthalate and Wy&#x2010;14,643
        . Carcinogenesis , 10 , 513 &#x2013; 519 ( 1989. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2924396</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Fahl , W. E. , Lalwani , N. D. , Watanabe , T. , Goel , S. K. and Reddy ,
        J. K.DNA damage related to increased hydrogen peroxide generation by hypolipidemic
        drug&#x2010;induced liver peroxisomes . Proc. Natl. Acad. Sci. USA , 81 ,
        7827 &#x2013; 7830 ( 1984. ).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC392245</ArticleId><ArticleId
        IdType="pubmed">6096860</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Kasai , H. , Okada , Y. , Nishimura , S. , Rao , M. S. and Reddy , J. K.Formation
        of 8&#x2010;hydroxydeoxyguanidine in liver DNA of rats following long&#x2010;term
        exposure to a peroxisome proliferator . Cancer Res. , 49 , 2603 &#x2013; 2605
        ( 1989. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">2713844</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Ward , J. M. , Hagiwara , A. , Anderson , L. M. , Lindsey , K. and Diwan ,
        B. A.The chronic hepatic or renal toxicity of di(2&#x2010;ethylhexyl)phthalate,
        acetaminophen, sodium barbital, and phenobarbital in male B6C3F1 mice: auto&#x2010;radiographic,
        immunohistochemical, and biochemical evidence for levels of DNA synthesis
        not associated with carcinogenesis or tumor promotion . Toxcol. Appl. Pharmacol.
        , 96 , 494 &#x2013; 506 ( 1988. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">3206528</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Marsman , D. S. , Cattley , R. C. , Conway , J. G. and Popp , J. A.Relationship
        of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity
        of the peroxisome proliferators di(2&#x2010;ethylhexyl)phthalate and [4&#x2010;chloro&#x2010;6&#x2010;
        (2,3&#x2010;xylidino) &#x2010;2&#x2010;pyrimidinylthio] acetic acid (Wy&#x2010;14,643)
        in rats . Cancer Res. , 48 , 6739 &#x2013; 6744 ( 1988. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3180084</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans
        , Suppl. 7 . &#x201c; Overall Evaluations of Carcinogenicity: An Updating
        of IARC Monographs Volumes 1 to 42 ,&#x201d; pp. 171 &#x2013; 172 ( 1987.
        ). IARC; , Lyon .</Citation><ArticleIdList><ArticleId IdType="pubmed">3482203</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Fukushima , S. , Hagiwara , A. , Imaida , K. , Shirai , T. , Suzuki , M. and
        Ito , N.Use of a multi&#x2010;organ carcinogenesis model for detection of
        modifying factors . Proc. Jpn. Cancer Assoc., 47th Annu. Meet. , 90 , ( 1988.
        ) ( in Japanese ).</Citation></Reference><Reference><Citation>) Diwan , B.
        A. , Ward , J. M. , Rice , J. M. , Colburn , N. H. and Spangler , E. F.Tumor&#x2010;promoting
        effects of di(2&#x2010;ethylhexyl)phthalate in JB6 mouse epidermal cells and
        mouse skin . Carcinogenesis , 6 , 343 &#x2013; 347 ( 1985. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3919955</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Kurokawa , Y. , Takamura , N. , Matsushima , Y. , Imazawa , T. and Hayashi
        , Y.Promoting effect of peroxisome proliferators in two&#x2010;stage rat renal
        tumorigenesis . Cancer Lett. , 43 , 145 &#x2013; 149 ( 1988. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3203323</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Masui , T. , Shirai , T. , Takahashi , S. , Mutai , M. and Fukushima , S.Summation
        effect of uracil on the two&#x2010;stage and multistage models of urinary
        bladder carcinogenesis in F344 rats initiated by N&#x2010;butyl&#x2010;N&#x2010;(4&#x2010;hydroxybutyl)nitro&#x2010;samine
        . Carcinogenesis , 9 , 1981 &#x2013; 1985 ( 1988. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3180336</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Fukushima , S. , Murasaki , G. , Hirose , M. , Nakanishi , K. , Hasegawa ,
        R. and Ito , N.Histopathological analysis of preneoplastic changes during
        N&#x2010;butyl&#x2010;N&#x2010;(4&#x2010;hydroxybutyl)&#x2010;nitrosamine&#x2010;induced
        urinary bladder carcinogenesis in rats . Acta Pathol. Jpn. , 32 , 243 &#x2013;
        250 ( 1982. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">7090816</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Fukushima , S. and Cohen , S. M.Saccharin&#x2010;induced hyperplasia of the
        rat urinary bladder . Cancer Res. , 40 , 734 &#x2013; 736 ( 1980. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7471092</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Shibata , M&#x2010;A. , Yamada , M. , Tanaka , H. , Kagawa , M. and Fukushima
        , S.Changes in urine composition, bladder epithelial morphology and DNA synthesis
        in male F344 rats in response to ingestion of bladder tumor promoters . Toxicol.
        Appl. Pharmacol. , 99 , 37 &#x2013; 49 ( 1989. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2727999</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Hagiwara , A. , Diwan , B. A. and Ward , J. M.Barbital sodium, a tumor promoter
        for kidney tubules, urinary bladder and liver of the F344 rat, induces persistent
        increases in level of DNA synthesis in renal tubules but not in urinary bladder
        epithelium or hepatocytes . Fundam. Appl. Toxicol. , 13 , 332 &#x2013; 340
        ( 1989. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">2792600</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Fukushima , S. , Hagiwara , A. , Ogiso , T. , Shibata , M. and Ito , N.Promoting
        effects of various chemicals in rat urinary bladder carcinogenesis initiated
        by N&#x2010;nitroso&#x2010;N&#x2010;butyl(4&#x2010;hydroxybutyl)amine . Food
        Chem. Toxicol. , 21 , 59 &#x2013; 68 ( 1983. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6681793</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Kurata , Y. , Asamoto , M. , Hagiwara , A. , Masui , T. and Fukushima , S.Promoting
        effects of various agents in rat urinary bladder carcinogenesis initiated
        by N&#x2010;butyl&#x2010;N&#x2010;(4&#x2010;hydroxybutyl) nitrosamine . Cancer
        Lett. , 32 , 125 &#x2013; 135 ( 1986. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3756839</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Fukushima , S. and Ito , N.Promotion of urinary bladder carcinogenesis in
        experimental animals . Exp. Pathol. , 36 , 1 &#x2013; 15 ( 1989. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2659378</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Shirai , T. , Ikawa , E. , Fukushima , S. , Masui , T. and Ito , N.Uracil&#x2010;induced
        urolithiasis and the development of reversible papillomatosis in the urinary
        bladder of F344 rats . Cancer Res. , 46 , 2062 &#x2013; 2067 ( 1986. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3948181</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Shirai , T. , Tagawa , Y. , Fukushima , S. , Imaida , K. and Ito , N.Strong
        promoting activity of reversible uracil&#x2010;induced urolithiasis on urinary
        bladder carcinogenesis in rats initiated with N&#x2010;butyl&#x2010;N&#x2010;(4&#x2010;hydroxybutyl)nitrosamine
        . Cancer Res. , 47 , 6726 &#x2013; 6730 ( 1987. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3677102</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Sakata , T. , Masui , T. , St. John , M. and Cohen , S. M.Uracil&#x2010;induced
        calculi and proliferative lesions of the mouse urinary bladder . Carcinogenesis
        , 9 , 1271 &#x2013; 1276 ( 1988. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">3383344</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Shirai , T. , Fukushima , S. , Tagawa , Y. , Okumura , M. and Ito , N.Cell
        proliferation induced by uracil&#x2010;calculi and subsequent development
        of reversible papillomatosis in rat urinary bladder . Cancer Res. , 49 , 373
        &#x2013; 383 ( 1989. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">2910456</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1336490</PMID><DateCompleted><Year>1993</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0910-5050</ISSN><JournalIssue
        CitedMedium="Print"><Volume>83</Volume><Issue>11</Issue><PubDate><Year>1992</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Japanese
        journal of cancer research : Gann</Title><ISOAbbreviation>Jpn J Cancer Res</ISOAbbreviation></Journal><ArticleTitle>Effects
        of modifying agents on conformity of enzyme phenotype and proliferative potential
        in focal preneoplastic and neoplastic liver cell lesions in rats.</ArticleTitle><Pagination><StartPage>1154</StartPage><EndPage>1165</EndPage><MedlinePgn>1154-65</MedlinePgn></Pagination><Abstract><AbstractText>Development
        of preneoplastic lesions in the rat liver under the influence of various modifiers
        was investigated with particular attention to changes in simultaneous expression
        of altered enzyme phenotype within the lesions (conformity) and proliferation
        potential. Degree of conformity of marker enzymes such as glutathione S-transferase
        placental form (GST-P), glucose-6-phosphate dehydrogenase (G6PD), glucose-6-phosphatase,
        adenosine triphosphatase and gamma-glutamyltranspeptidase was compared with
        levels of 5-bromo-2-deoxyuridine labeling. After initiation with diethylnitrosamine,
        rats were administered the hepatopromoter sodium phenobarbital (PB, 0.05%),
        the antioxidant ethoxyquin (EQ, 0.5%), or a peroxisome proliferator, clofibrate
        (CF, 1.0%) or di(2-ethylhexyl)-phthalate (0.3%) and killed at week 16 or 32.
        The PB promoting regimen was clearly associated with increase in the numbers
        of high conformity class lesions simultaneously expressing three to five enzymes,
        and elevated proliferation potential. The inhibitor, EQ, in contrast, brought
        about a time-dependent decrease in conformity so that only 1 or 2 alterations
        were most commonly observed at week 32. Lesion populations in the peroxisome
        proliferator- and especially CF-treated cases were characterized by obvious
        dissociation between degree of conformity and proliferative status. Such treatment-dependent
        differences were not always correlated with the size of the lesion. The results
        thus suggested that the conformity and proliferation potential of preneoplastic
        lesions are dependent on modification treatment. Overall, GST-P was found
        to be the most reliable marker, although G6PD was less influenced in the peroxisome
        proliferator cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Tsuda</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>First
        Department of Pathology, Nagoya City University Medical School.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ozaki</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Uwagawa</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Hakoi</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Aoki</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Kato</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Sato</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Ito</LastName><ForeName>N</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Jpn
        J Cancer Res</MedlineTA><NlmUniqueID>8509412</NlmUniqueID><ISSNLinking>0910-5050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IQ78TTX1A</RegistryNumber><NameOfSubstance
        UI="D004052">Diethylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9T1410R4OR</RegistryNumber><NameOfSubstance
        UI="D005015">Ethoxyquin</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.49</RegistryNumber><NameOfSubstance UI="D005954">Glucosephosphate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.5.1.18</RegistryNumber><NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.3.9</RegistryNumber><NameOfSubstance UI="D005952">Glucose-6-Phosphatase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.6.1.-</RegistryNumber><NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance></Chemical><Chemical><RegistryNumber>G34N38R2N1</RegistryNumber><NameOfSubstance
        UI="D001973">Bromodeoxyuridine</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001973" MajorTopicYN="N">Bromodeoxyuridine</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004052" MajorTopicYN="N">Diethylnitrosamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005015" MajorTopicYN="N">Ethoxyquin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005952" MajorTopicYN="N">Glucose-6-Phosphatase</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005954" MajorTopicYN="N">Glucosephosphate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1336490</ArticleId><ArticleId IdType="pmc">PMC5918708</ArticleId><ArticleId
        IdType="doi">10.1111/j.1349-7006.1992.tb02739.x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>)
        Kier , L. W. , Brunsick , D. J. , Auletta , A. E. , Von Halle , E. S. , Brown
        , M. M. , Simon , V. F. , Dunkel , V. , McCann , J. , Morlelmans , K. , Prival
        , M. , Rao , T. K. and Ray , V.The Salmonella typhimurium/mammalian microsomal
        assay. A Report of the U.S. Environmental Protection Agency Gene&#x2010;Tox
        Program . Mutat. Res. , 168 , 69 &#x2013; 240 ( 1980. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3528831</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Ito , N. , Tsuda , H. , Tatematsu , M. , Imaida , K. , Kagawa , M. , Nakamura
        , A. , Yamaguchi , S. and Mutai , M.Development and application of an in vivo
        medium&#x2010;term bio&#x2010;assay system for the screening of hepatocarcinogens
        and inhibiting agents of hepatocarcinogenesis . In &#x201c; Chemical Carcinogenesis
        ,&#x201d; ed. Feo F. , Pani P. , Columbano A. and Garcea R. , pp. 425 &#x2013;
        432 ( 1988. ). Plenum Publishing Co. , New York .</Citation></Reference><Reference><Citation>)
        Ito , N. , Tsuda , H. , Tatematsu , M. , Inoue , T. , Tagawa , Y. , Aoki ,
        T. , Uwagawa , S. , Kagawa , M. , Ogiso , T. , Masui , T. , Imaida , K. ,
        Fukushima , S. and Asamoto , M.Enhancing effects of various hepatocarcinogens
        on induction of preneoplastic glutathione S&#x2010;transferase placental form
        positive foci in rats &#x2013; an approach for a new medium&#x2010;term bioassay
        system . Carcinogenesis , 9 , 387 &#x2013; 394 ( 1988. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3345580</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Tsuda , H. , Hasegawa , R. , Imaida , K. , Masui , T. , Moore , M. A. and
        Ito , N.Modifying potential of thirty&#x2010;one chemicals on the short&#x2010;term
        development of &#x3b3;&#x2010;glutamyl transpeptidase&#x2010;positive foci
        in diethylnitrosamine&#x2010;initiated rat liver . Gann , 75 , 876 &#x2013;
        883 ( 1984. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">6150874</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Satoh , K. , Kitahara , A. , Soma , Y. , Hatayama , I. and Sato , K.Purification,
        induction and distribution of placental glutathione transferase: a new marker
        enzyme for preneoplastic cells in the rat chemical carcinogenesis . Proc.
        Natl. Acad. Sci. USA , 82 , 3964 &#x2013; 3968 ( 1985. ).</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC397914</ArticleId><ArticleId IdType="pubmed">3923485</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Sato , K.Glutathione transferase as markers of pre&#x2010;neoplasia and neoplasia
        . Adv. Cancer Res. , 52 , 205 &#x2013; 255 ( 1989. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2662713</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Tatematsu , M. , Mera , Y. , Ito , N. , Satoh , K. and Sato , K.Relative merits
        of immunohistochemical demonstration of placental, A, B and C forms of glutathione
        S&#x2010;transferase as markers of altered foci during liver carcinogenesis
        . Carcinogenesis , 6 , 1621 &#x2013; 1626 ( 1985. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2865013</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Tatematsu , M. , Mera , Y. , Inoue , T. , Satoh , K. , Sato , K. and Ito ,
        N.Stable phenotypic expression of glutathione S&#x2010;transferase placental
        type and unstable phenotypic expression of 7&#x2010;glutamyltransferase in
        rat liver preneoplastic and neoplastic lesions . Carcinogenesis , 9 , 215
        &#x2013; 220 ( 1988. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">2892592</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Ogiso , T. , Tatematsu , M. , Tamano , S. , Tsuda , H. and Ito , N.Comparative
        effects of carcinogens on the induction of placental glutathione S&#x2010;transferase&#x2010;positive
        liver nodules in a short&#x2010;term assay and of hepatocellular carcinomas
        in a long&#x2010;term assay . Toxicol. Pathol. , 13 , 257 &#x2013; 265 ( 1985.
        ).</Citation><ArticleIdList><ArticleId IdType="pubmed">3834582</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Tatematsu , M. , Aoki , T. , Kagawa , M. , Mera , Y. and Ito , N.Reciprocal
        relationship between development of glutathione S&#x2010;transferase positive
        liver foci and proliferation of surrounding hepatocytes in rats . Carcinogenesis
        , 9 , 221 &#x2013; 226 ( 1988. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">3338104</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Pitot , H. C. , Barsness , L. , Gold worthy , T. and Kitagawa , T.Biochemical
        characterization of stages of hepatocarcinogenesis after a single dose of
        diethylnitrosamine . Nature. 271 , 456 &#x2013; 458 ( 1978. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">24178</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Rao , M. S. , Tatematsu , M. , Subbarao , V. , Ito , N. and Reddy , J. K.Analysis
        of peroxisome proliferator&#x2010;induced preneoplastic and neoplastic lesions
        of rat liver for placental form of glutathione S&#x2010;transferase and 7&#x2010;glutamyltrans&#x2010;peptidase
        . Cancer Res. , 46 , 5287 &#x2013; 5290 ( 1986. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2875789</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Hendrich , S. , Campbell , H. A. and Pitot , H. C.Quantitative stereological
        evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis
        in the rat . Carcinogenesis , 8 , 1245 &#x2013; 1250 ( 1987. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2887301</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Moore , M. A. , Weber , E. and Bannasch , P.Modulating influence of dehydroepiandrosterone
        administration on the morphology and enzyme phenotype of dimethylaminoazo&#x2010;benzene&#x2010;induced
        hepatocellular foci and nodules . Virch. Arch. B. Cell. Pathol , 55 , 337
        &#x2013; 343 ( 1988. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">2904189</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Weber , E. , Moore , M. A. and Bannasch , P.Enzyme histochemical and morphological
        phenotype of amphophilic foci and amphophilic/tigroid cell neoplastic nodules
        in rat liver after combined treatment with dehydroepiandrosterone and N&#x2010;nitrosomorpholine
        . Carcinogenesis , 9 , 1049 &#x2013; 1054 ( 1988. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2967125</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Hacker , H. J. , Moore , M. A.Mayer , D. and Bannasch , P.Correlative histochemistry
        of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic
        lesions in rat liver . Carcinogenesis , 3 , 1265 &#x2013; 1272 ( 1982. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6295653</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Vesselinovitch , S. D. , Hacker , H. J. and Bannasch , P.Histochemical characterization
        of focal hepatic lesions induced by single diethylnitrosamine treatment in
        infant mice . Cancer Res. , 45 , 2274 &#x2013; 2280 ( 1985. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2859111</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Perera , M. I. R. and Shinozuka , H.Accelerated regression of carcinogen&#x2010;induced
        preneoplastic hepatocyte foci by peroxisome proliferators, Br931,4&#x2010;chloro&#x2010;6&#x2010;(2,3&#x2010;xylidino)&#x2010;2&#x2010;pyrimidinylthio(N&#x2010;&#x3b2;&#x2010;hydroxyethyl)acetamine,
        and di(2&#x2010;ethylhexyl)phthalate . Carcinogenesis , 5 , 1193 &#x2013;
        1198 ( 1984. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">6147206</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Morstyn , G. , Hsu , S.&#x2010;M. , Kinsella , T. , Gratzner , H. , Russo
        , A. and Mitchell , J. B.Bromodeoxyuridine in tumors and chromosomes detected
        with a monoclonal antibody . J. Clin. Invest , 72 , 1844 &#x2013; 1850 ( 1983.
        ).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC370474</ArticleId><ArticleId
        IdType="pubmed">6355188</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Lanier , T. L. , Berger , E. K. and Eacho , P. I.Comparison of 5&#x2010;bromo&#x2010;2&#x2010;deoxyuridine
        and [3H]thymidine for studies of hepatocellular proliferation in rodents .
        Carcinogenesis , 10 , 1341 &#x2013; 1343 ( 1989. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2736724</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Meijer , A. E. F. H. and de Vries , G. P.Semipermeable membranes for improving
        the histochemical demonstration of enzyme activities in tissue sections. IV.
        Glucose&#x2010;6&#x2010;phosphate dehydrogenase and 6&#x2010;phosphogluconate
        dehydrogenase . Histochemistry , 40 , 349 &#x2013; 359 ( 1974. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4139151</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Lojda , Z. , Gossrau , R. and Schiebler , T. H. &#x201c; Enzyme Histochemical
        Methods &#x201d; ( 1976. ). Springer Verlag; , Berlin&#x2010;Heidelberg, New
        York .</Citation></Reference><Reference><Citation>) Hsu , S. M. , Raine ,
        L. and Farger , H.Use of avidin&#x2010;biotin&#x2010;peroxidase complex (ABC)
        in immunoperoxidase techniques: a procedure . J. Histochem. Cytochem. , 29
        , 577 &#x2013; 580 ( 1981. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">6166661</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Farber , E.Pre&#x2010;cancerous steps in carcinogenesis. Their physiological
        adaptive nature . Biochim. Biophys. Acta , 738 , 171 &#x2013; 180 ( 1985.
        ).</Citation><ArticleIdList><ArticleId IdType="pubmed">6394048</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Farber , E. , Parker , S. and Gruenstein , M.The resistance of putative premalignant
        liver cell populations, hyper&#x2010;plastic nodules, to the acute cytotoxic
        effects of some carcinogens . Cancer Res. , 36 , 3879 &#x2013; 3887 ( 1976.
        ).</Citation><ArticleIdList><ArticleId IdType="pubmed">975037</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Tsuda , H. , Asamoto , M. , Ogiso , T. , Inoue , T. , Ito , N. and Nagao ,
        M.Dose&#x2010;dependent induction of liver and thyroid neoplastic lesions
        by short&#x2010;term administration of 2&#x2010;amino&#x2010;3&#x2010;methylimidazo[4,5&#x2010;f]quinoline
        combined with partial hepatectomy followed by phenobarbital or low dose 3&#x2032;&#x2010;methyl&#x2010;4&#x2010;dimethylaminoazobenzene
        promotion . Jpn. J. Cancer Res. , 79 , 691 &#x2013; 697 ( 1988. ).</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC5917579</ArticleId><ArticleId IdType="pubmed">3137195</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Tsuda , H. , Moore , M. A. , Asamoto , M. , Inoue , T. , Fukushima , S. ,
        Ito , N. , Satoh , K. , Amelizad , Z. and Oesch , F.Immunohistochemically
        demonstrated altered expression of cytochrome P&#x2010;450 molecular forms
        and epoxide hydrolase in N&#x2010;ethylhydroxyethylnitrosamine&#x2010;induced
        rat kidney and liver lesions . Carcinogenesis , 8 , 711 &#x2013; 718 ( 1987.
        ).</Citation><ArticleIdList><ArticleId IdType="pubmed">3581429</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Bannasch , P. , Hacker , H. J. , Klimek , F. and Mayer , D.Hepatocellular
        glycogenesis and related pattern of enzymatic changes during hepatocarcinogenesis
        . Adv. Enzyme Regul , 22 , 97 &#x2013; 121 ( 1984. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6591771</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Pitot , H. C. , Glauert , H. P. and Hanigan , M.The significance of selected
        biochemical markers in the characterization of putative initiated cell populations
        in rodent liver . Cancer Lett , 29 , 1 &#x2013; 14 ( 1985. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2866027</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Pugh , T. and Goldfarb , S.Quantitative histochemical and autoradiographic
        studies of hepatocarcinogenesis in rats fed 2&#x2010;acetylaminofluorene .
        Cancer Res. , 38 , 4450 &#x2013; 4457 ( 1978. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">31235</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Moore , M. A. , Hacker , H. J. , Kunz , H. W. and Bannasch , P.Enhancement
        of NNM&#x2010;induced carcinogenesis in the rat liver by phenobarbital: a
        combined morphological and enzyme histochemical approach . Carcinogenesis
        , 4 , 473 &#x2013; 479 ( 1983. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">6132686</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Xu , Y.&#x2010;H. , Maronpot , R. and Pitot , H. C.Quantitative stereologic
        study of the effects of varying the time between initiation and promotion
        on four histochemical markers in rat liver during hepatocarcinogenesis . Carcinogenesis
        , 11 , 267 &#x2013; 282 ( 1990. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">1967985</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Rebes , H. M. , Buecher , Th. , Hartmann , A. , Linke , J. and Duenwald ,
        H.Clonal growth of carcinogen&#x2010;induced enzyme deficient preneoplastic
        populations in mouse liver . Cancer Res. , 42 , 3220 &#x2013; 3227 ( 1982.
        ).</Citation><ArticleIdList><ArticleId IdType="pubmed">7093961</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Kunz , H. W. , Buchmann , A. , Schwartz , M. , Kuhlmann , W. D. , and Oesch
        , F.Expression and inducibility of drug&#x2010;metabolizing enzymes in preneoplastic
        and neoplastic lesions of rat liver during nitrosamine&#x2013;induced hepatocarcinogenesis
        . Arch. Toxicol. , 60 , 198 &#x2013; 203 ( 1987. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2956937</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Rabes , H. M.Development and growth of early preneoplastic lesions induced
        in the liver by chemical carcinogens . J. Cancer Res. Clin. Oncol. , 106 ,
        85 &#x2013; 92 ( 1983. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">6630286</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Ito , N. , Moore , M. A. and Bannasch , P.Modification of the development
        of N&#x2010;nitrosomorpholine&#x2010;induced hepatic lesions by 2&#x2010;acetylaminofluorene,
        phenobarbital and 4,4&#x2032;&#x2010;diaminodiphenylmethane: a sequential
        histological and histochemical analysis . Carcinogenesis , 5 , 335 &#x2013;
        342 ( 1984. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">6705139</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Kitagawa , T. , Watanabe , R. and Sugano , H.Induction of 7&#x2010;glutamyl
        transpeptidase activity by dietary phenobarbital in &#x201c;spontaneous&#x201d;
        hepatic tumors of C3H mice . Gann , 71 , 536 &#x2013; 542 ( 1980. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6107258</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Tsuda , H. , Sakata , T. , Masui , T. , Imaida , K. and Ito , N.Modifying
        effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction
        of neoplastic lesions in rat liver and kidney initiated with N&#x2010;ethyl&#x2010;N&#x2010;hydroxyethylnitrosamine
        . Carcinogenesis , 5 , 525 &#x2013; 531 ( 1984. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6142774</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Tsuda , H. , Uwagawa , S. , Aoki , T. , Fukushima , S. , Imaida , K. , Ito
        , N. , Nakamura , A. and Oesch , F.Analysis of the effects of modifying agents
        on six different phenotypes in preneoplastic foci in the liver in medium&#x2010;term
        bioassay model in rats . In &#x201c; Chemical Carcinogenesis ,&#x201d; ed.
        Feo F. , Pani P. , Columbano A. and Garcea R. , pp. 399 &#x2013; 405 ( 1988.
        ). Plenum Publishing Co. , New York .</Citation></Reference><Reference><Citation>)
        Rao , S.M. , Usuda , N. , Subbarao , V. and Reddy , J. K.Absence of 7&#x2010;glutamyl
        transpeptidase activity in neoplastic lesions induced in the liver of male
        F344 rats by di(2&#x2010;ethylhexyl) phthalate, a peroxisome proliferator
        . Carcinogenesis , 8 , 1347 &#x2013; 1350 ( 1987. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2887302</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Kraupp&#x2010;Grasl , B. , Huber , W. , Putz , B. , Gerbracht , U. and Schulte&#x2010;Herman
        , R.Tumor promotion by the peroxisome proliferator nafenopin involving a specific
        subtype of altered foci in rat liver . Cancer Res. , 50 , 3701 &#x2013; 3708
        ( 1990. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">1971196</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Moore , M. A. , Nakamura , T. and Ito , N.Immunohistochemically demonstrated
        glucose&#x2010; 6 &#x2010;phosphate dehydrogenase, gamma&#x2010;glutamyltranspeptidase,
        ornithine decarboxylase and glutathione 5&#x2010;transferase enzymes: absence
        of direct correlation with cell proliferation in rat liver putative preneoplastic
        lesions . Carcinogenesis , 7 , 1419 &#x2013; 1424 ( 1986. ).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2874898</ArticleId></ArticleIdList></Reference><Reference><Citation>)
        Ward , J. M. , Tsuda , H. , Tatematsu , M. , Hagiwara , A. and Ito , N.Hepatotoxicity
        of agents that enhance formation of focal hepatocellular proliferative lesions
        (putative preneoplastic foci) in a rapid rat liver assay . Fund. Appl. Toxicol
        , 12 , 163 &#x2013; 171 ( 1989. ).</Citation><ArticleIdList><ArticleId IdType="pubmed">2925015</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10536109</PMID><DateCompleted><Year>1999</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0273-2300</ISSN><JournalIssue
        CitedMedium="Print"><Volume>30</Volume><Issue>2 Pt 1</Issue><PubDate><Year>1999</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Regulatory
        toxicology and pharmacology : RTP</Title><ISOAbbreviation>Regul Toxicol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The
        potential health effects of phthalate esters in children''s toys: a review
        and risk assessment.</ArticleTitle><Pagination><StartPage>140</StartPage><EndPage>155</EndPage><MedlinePgn>140-55</MedlinePgn></Pagination><Abstract><AbstractText>Diisononyl
        phthalate (DINP) is one of several dialkyl phthalate esters that are widely
        used as plasticizers to impart softness and flexibility to normally rigid
        polyvinyl chloride (PVC) products. During the past 2 years, concern has been
        voiced by public interest groups and regulatory agencies in Europe, Canada,
        and the United States regarding the potential adverse health effects of DINP
        migrating from children''s toys during mouthing activities. Concern has focused
        on potential chronic effects on the kidney and liver. In chronic high-dose
        studies with rodents, DINP causes a dose-related decrease in body weight,
        an increase in liver weight, and changes in liver cell histopathology (hypertrophy).
        To a lesser extent, the rodent kidney is also a target for prolonged high-level
        exposures of DINP. Prolonged high-level exposure of rodents to DINP leads
        to an increased incidence of liver tumors (adenomas and carcinomas). The chronic
        cancer and noncancer effects of DINP on rodent liver are consistent with its
        known action as a peroxisome proliferator. Peroxisome proliferation is a threshold-based
        effect that is reversible on cessation of exposure to proliferators such as
        DINP. Because rodents are uniquely responsive and humans and nonhuman primates
        are particularly nonresponsive to peroxisome proliferators, rodents are very
        poor animal models for use in human risk assessment of adverse effects mediated
        through peroxisome proliferation. Because DINP exerts its effects on rodent
        liver through a known threshold-based mechanism of little, if any, relevance
        to humans, a highly conservative risk assessment can be conducted using a
        NOAEL uncertainty factor approach. Chronic rodent no-observed-effect levels
        (NOELs) based on end points such as increased liver weight and changes in
        liver pathology that are early indicators of peroxisome proliferation but
        should not be considered adverse range from about 100 to 400 mg/kg/day. Application
        of a 100-fold uncertainty factor yields acceptable daily intakes (ADIs) ranging
        from 1 to 4 mg/kg/day. Estimates of DINP migration from soft PVC materials
        have been obtained from a variety of in vitro methods (simulated saliva and
        controlled agitation) as well as in vivo methods (controlled chewing) that
        more closely resemble child chewing and mouthing activities. Recent estimates
        by the Consumer Product Safety Commission (CPSC) suggest that maximum exposures
        occur in infants 3-12 months of age. The geometric mean (50th percentile)
        exposure is 5.7 microg/kg/day and the 95th percentile is 94.3 microg/kg/day.
        These exposure values are 17,500-70,000 and 1100-4200 times, respectively,
        lower than the chronic rodent NOAEL for DINP and 175-700 and 11-42 times lower
        than the corresponding ADI of 1-4 mg/kg/day. It is concluded, with a high
        degree of confidence, that the use of DINP in soft PVC toys and other children''s
        products does not present a significant risk to children. The scientific evidence
        supports the continued use of DINP as a plasticizer in children''s products.</AbstractText><CopyrightInformation>Copyright
        1999 Academic Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>C F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Jellinek,
        Schwartz &amp; Connolly, Inc., 1525 Wilson Boulevard, Suite 600, Arlington,
        Virginia 22209, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamb</LastName><ForeName>J
        C</ForeName><Initials>JC</Initials><Suffix>4th</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Regul
        Toxicol Pharmacol</MedlineTA><NlmUniqueID>8214983</NlmUniqueID><ISSNLinking>0273-2300</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>4010KIX4CK</RegistryNumber><NameOfSubstance
        UI="C012125">diisononyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005106" MajorTopicYN="N">Exploratory Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010988" MajorTopicYN="Y">Play and Playthings</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>75</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>10</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>10</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10536109</ArticleId><ArticleId IdType="doi">10.1006/rtph.1999.1338</ArticleId><ArticleId
        IdType="pii">S0273-2300(99)91338-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1469623</PMID><DateCompleted><Year>1993</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0022-3565</ISSN><JournalIssue
        CitedMedium="Print"><Volume>263</Volume><Issue>3</Issue><PubDate><Year>1992</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The
        Journal of pharmacology and experimental therapeutics</Title><ISOAbbreviation>J
        Pharmacol Exp Ther</ISOAbbreviation></Journal><ArticleTitle>Induction of peroxisomal
        enzyme activities by di-(2-ethylhexyl) phthalate in thyroidectomized rats
        with parathyroid replants.</ArticleTitle><Pagination><StartPage>1105</StartPage><EndPage>1110</EndPage><MedlinePgn>1105-10</MedlinePgn></Pagination><Abstract><AbstractText>Previous
        studies suggest that thyroid hormones are involved in the mechanism of peroxisome
        proliferation. However, those studies utilized either surgically thyroidectomized
        animals, which are also parathyroidectomized, without calcium supplementation,
        or animals pretreated with antithyroid drugs, which are known to produce metabolic
        as well as morphometric changes in the liver. Therefore, these animal models
        confound conclusions drawn in previous studies. The purpose of the present
        study was to investigate the role of thyroid hormones in peroxisomal proliferation
        by the phthalate ester plasticizer, di-(2-ethylhexyl)phthalate (DEHP) in thyroidectomized
        rats with parathyroid replants. Using this model, it was found that DEHP-induced
        hepatomegaly was partially dependent on thyroid hormones. DEHP produced a
        thyromimetic effect, inducing the activity of malic enzyme and carnitine acetyltransferase
        in the absence of thyroid hormones. Additionally, DEHP-induced activities
        of catalase were shown to be dependent on thyroid hormones, whereas the thyroid
        status of the animal had no effect on DEHP-induced activities of the peroxisomal
        beta-oxidizing enzymes. These data further confirm that endocrine factors
        play variable roles in the process of induction of various peroxisomal enzymes
        caused by peroxisome proliferators.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Badr</LastName><ForeName>M Z</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Division
        of Pharmacology, University of Missouri-Kansas City.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>ES-04778</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Pharmacol Exp Ther</MedlineTA><NlmUniqueID>0376362</NlmUniqueID><ISSNLinking>0022-3565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013963">Thyroid Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.37</RegistryNumber><NameOfSubstance UI="D008291">Malate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance
        UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006529" MajorTopicYN="N">Hepatomegaly</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008291" MajorTopicYN="N">Malate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010280" MajorTopicYN="N">Parathyroid Glands</DescriptorName><QualifierName
        UI="Q000637" MajorTopicYN="N">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013963" MajorTopicYN="N">Thyroid Hormones</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013965" MajorTopicYN="N">Thyroidectomy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1469623</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">7915705</PMID><DateCompleted><Year>1994</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>08</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0020-7136</ISSN><JournalIssue
        CitedMedium="Print"><Volume>58</Volume><Issue>5</Issue><PubDate><Year>1994</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>International
        journal of cancer</Title><ISOAbbreviation>Int J Cancer</ISOAbbreviation></Journal><ArticleTitle>Di(2-ethylhexyl)phthalate-induced
        changes in liver estrogen metabolism and hyperplasia.</ArticleTitle><Pagination><StartPage>736</StartPage><EndPage>743</EndPage><MedlinePgn>736-43</MedlinePgn></Pagination><Abstract><AbstractText>Exposure
        to a common phthalate, di(2-ethylhexyl)phthalate (DEHP), is associated with
        liver hyperplasia prior to the development of hepatocellular carcinoma in
        rodents. The exact mechanism of liver hyperplasia as well as tumorigenesis
        by this agent is not known. Since other lines of evidence point to estrogens
        as mediators of liver hyperplastic changes, we investigated whether DEHP exposure
        might alter hepatic estrogen metabolism and induce hyperplasia. Male Fischer
        344 rats were fed either control or 1.2% DEHP-containing diets and sacrificed
        after 4, 8 and 16 weeks of exposure; activities of several sex hormone-responsive
        markers were measured. Rats fed DEHP had significantly increased serum estradiol
        levels, but hepatic activity of both cytosolic and nuclear estrogen receptor
        (ER) was significantly reduced. The serum content of ceruloplasmin, an estrogen-responsive
        protein synthesized by the liver, was also reduced, perhaps as a consequence
        of loss of ER activity. The rise in serum estradiol in DEHP-treated rats may
        be explained by the observation that these rats showed significant losses
        in hepatic activity of both a major male estrogen-metabolizing enzyme, estrogen
        2-hydroxylase, and a male-specific estrogen-sequestering protein. In contrast
        to reductions in these activities, the expression of proliferating cell nuclear
        antigen and mRNAs for both ER and fos increased significantly as a result
        of exposure to DEHP. Our results suggest that changes in estrogen metabolism,
        receptor activity and activation of genes for cell proliferation are among
        the earliest metabolic alterations induced by DEHP. These changes together
        with the induced hyperplasia could play a crucial role in hepatocellular carcinoma
        development as a result of continuous exposure to DEHP.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Eagon</LastName><ForeName>P K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Veterans
        Affairs Medical Center, Pittsburgh, PA 15240.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chandar</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Epley</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author
        ValidYN="Y"><LastName>Elm</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author
        ValidYN="Y"><LastName>Brady</LastName><ForeName>E P</ForeName><Initials>EP</Initials></Author><Author
        ValidYN="Y"><LastName>Rao</LastName><ForeName>K N</ForeName><Initials>KN</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>NIAAA AA08914</GrantID><Acronym>AA</Acronym><Agency>NIAAA
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Int J Cancer</MedlineTA><NlmUniqueID>0042124</NlmUniqueID><ISSNLinking>0020-7136</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004967">Estrogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018809">Proliferating Cell Nuclear Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011960">Receptors, Estrogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance
        UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>4TI98Z838E</RegistryNumber><NameOfSubstance
        UI="D004958">Estradiol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><GeneSymbolList><GeneSymbol>fos</GeneSymbol><GeneSymbol>myc</GeneSymbol><GeneSymbol>ras</GeneSymbol></GeneSymbolList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004958" MajorTopicYN="N">Estradiol</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004967" MajorTopicYN="N">Estrogens</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016762" MajorTopicYN="N">Genes, fos</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016259" MajorTopicYN="N">Genes, myc</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011905" MajorTopicYN="N">Genes, ras</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018809" MajorTopicYN="N">Proliferating Cell Nuclear Antigen</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1994</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1994</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1994</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7915705</ArticleId><ArticleId IdType="doi">10.1002/ijc.2910580519</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8020155</PMID><DateCompleted><Year>1994</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>12</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>15</Volume><Issue>6</Issue><PubDate><Year>1994</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Inhibition
        by catechol and di(2-ethylhexyl)phthalate of pancreatic carcinogenesis after
        initiation with N-nitrosobis(2-hydroxypropyl)amine in Syrian hamsters.</ArticleTitle><Pagination><StartPage>1193</StartPage><EndPage>1196</EndPage><MedlinePgn>1193-6</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of dietary administration of catechol (CC), paramethylcatechol (PMC)
        and di(2-ethylhexyl)phthalate (DEHP) were compared with that of butylated
        hydroxyanisole (BHA) in Syrian hamsters initiated with N-nitrosobis(2-hydroxypropyl)amine
        (BHP). Development of pancreatic atypical hyperplasias and adenocarcinomas
        in terms of combined multiplicity was significantly reduced by CC and DEHP.
        A similar slight but non-significant tendency was observed for BHA, while
        PMC was without effect. No statistically significant reduction of liver or
        gall bladder lesions was observed. The results thus suggest that both antioxidant
        and peroxisome proliferator categories of agents can inhibit pancreatic carcinogenesis
        in hamsters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maruyama</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Oncological Pathology, Nara Medical College, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Amanuma</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Tsutsumi</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Tsujiuchi</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Horiguchi</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Denda</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Konishi</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002396">Catechols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009602">Nitrosamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>4J072HB2ND</RegistryNumber><NameOfSubstance
        UI="C012457">diisopropanolnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>LF3AJ089DQ</RegistryNumber><NameOfSubstance
        UI="C034221">catechol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002396" MajorTopicYN="N">Catechols</DescriptorName><QualifierName UI="Q000627"
        MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005704" MajorTopicYN="N">Gallbladder</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009602" MajorTopicYN="N">Nitrosamines</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517"
        MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1994</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1994</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1994</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8020155</ArticleId><ArticleId IdType="doi">10.1093/carcin/15.6.1193</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38056127</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>16</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2414</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>269</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Ecotoxicology
        and environmental safety</Title><ISOAbbreviation>Ecotoxicol Environ Saf</ISOAbbreviation></Journal><ArticleTitle>Prenatal
        exposure to low-dose di-(2-ethylhexyl) phthalate (DEHP) induces potentially
        hepatic lipid accumulation and fibrotic changes in rat offspring.</ArticleTitle><Pagination><StartPage>115776</StartPage><MedlinePgn>115776</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.ecoenv.2023.115776</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0147-6513(23)01280-0</ELocationID><Abstract><AbstractText>Di(2-ethylhexyl)
        phthalate (DEHP) is a plasticizer that is widely used to enhance the flexibility
        and durability of various products. As an endocrine disruptor, DEHP can interfere
        with normal hormonal functions, posing substantial health risks to organisms.
        Given the critical role of the liver in DEHP metabolism, we investigated potential
        liver damage in offspring induced by prenatal exposure to low doses of DEHP
        in Sprague Dawley rats. Pregnant rats were divided into three groups and administered
        20 or 200&#xa0;&#x3bc;g/kg/day of DEHP or corn oil vehicle control via oral
        gavage from gestation days 0-20. Male rat offspring were euthanized on postnatal
        day 84, and blood and liver specimens were collected for analysis. We observed
        fibrotic changes in the livers of the exposed groups, accompanied by the proliferation
        and activation of hepatic stellate cells and upregulated expression of TGF-B
        and collagen 1A1. Additionally, an inflammatory response, characterized by
        increased macrophage infiltration and elevated levels of pro-inflammatory
        cytokines, was evident. Third, hepatic and serum triglyceride and serum cholesterol
        were notably increased, along with upregulated expression of lipid metabolism-related
        proteins, such as sterol regulatory element-binding protein-1c, acetyl-CoA
        carboxylase, fatty acid synthase, and diacylglycerol O-acyltransferase 1,
        particularly in the low-dose group. These results suggest that prenatal exposure
        to DEHP can disrupt lipid metabolism, resulting in hepatic lipid accumulation
        in the offspring. This exposure may also induce an inflammatory response that
        contributes to the development of liver fibrosis. Thus, even at relatively
        low doses, such exposure can precipitate latent liver damage in offspring.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Hung-Yuan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department
        of Safety, Health and Environmental Engineering, National Kaohsiung University
        of Science and Technology, Kaohsiung 81157, Taiwan; School of Chinese Medicine
        for Post Baccalaureate, I-Shou University, Kaohsiung 824, Taiwan; Department
        of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lai</LastName><ForeName>Ching-Shu</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department
        of Seafood Science, National Kaohsiung University of Science and Technology,
        Kaohsiung 81157, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kuo-Hsin</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department
        of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan;
        School of Medicine, College of Medicine, I-Shou University, Kaohsiung 824,
        Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiang</LastName><ForeName>Yu-Wei</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department
        of Medical Research, Taipei Veterans General Hospital, Taipei 112, Taiwan;
        Department of Biology and Anatomy, National Defense Medical Center, Taipei
        11490, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chia-Chi</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>School
        of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung 824,
        Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung
        824, Taiwan; Department of Physical Therapy, I-Shou University, Kaohsiung
        824, Taiwan; Department of Emergency Medicine, E-Da Hospital, I-Shou University,
        Kaohsiung 824, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Ping-Chi</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department
        of Safety, Health and Environmental Engineering, National Kaohsiung University
        of Science and Technology, Kaohsiung 81157, Taiwan; Department of Public Health,
        Kaohsiung Medical University, Kaohsiung, 807, Taiwan; Department of Medical
        Research, China Medical University Hospital, China Medical University, Taichung
        404, Taiwan. Electronic address: pchsu@nkust.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ecotoxicol
        Environ Saf</MedlineTA><NlmUniqueID>7805381</NlmUniqueID><ISSNLinking>0147-6513</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>6O7F7IX66E</RegistryNumber><NameOfSubstance
        UI="C032279">phthalic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="Y">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="Y">Prenatal Exposure Delayed Effects</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008055" MajorTopicYN="N">Lipids</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="Y">Phthalic Acids</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Di-(2-ethylhexyl) phthalate</Keyword><Keyword
        MajorTopicYN="N">Hepatic fibrosis</Keyword><Keyword MajorTopicYN="N">Hepatic
        stellate cell</Keyword><Keyword MajorTopicYN="N">Liver</Keyword><Keyword MajorTopicYN="N">Multigeneration</Keyword><Keyword
        MajorTopicYN="N">Steatosis</Keyword></KeywordList><CoiStatement>Declaration
        of Competing Interest The authors declare that they have no known competing
        financial interests or personal relationships that could have appeared to
        influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2023</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>6</Day><Hour>18</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">38056127</ArticleId><ArticleId IdType="doi">10.1016/j.ecoenv.2023.115776</ArticleId><ArticleId
        IdType="pii">S0147-6513(23)01280-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">25789634</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-7600</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal
        of medicinal food</Title><ISOAbbreviation>J Med Food</ISOAbbreviation></Journal><ArticleTitle>Epigallocatechin-3-O-Gallate
        Protects Against Hepatic Damage and Testicular Toxicity in Male Mice Exposed
        to Di-(2-Ethylhexyl) Phthalate.</ArticleTitle><Pagination><StartPage>753</StartPage><EndPage>761</EndPage><MedlinePgn>753-61</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1089/jmf.2014.3247</ELocationID><Abstract><AbstractText>The
        aim of this study was to examine the effects of epigallocatechin-3-O-gallate
        (EGCG) on hepatic damage and testicular toxicity in male mice exposed to daily
        oral administration of di-(2-ethylhexyl) phthalate (DEHP). A mouse model was
        used to assess the effects of daily intraperitoneal EGCG injection on hepatic
        and testicular damage. Histological and mitochondrial membrane potential results
        revealed that EGCG treatment significantly arrested the progression of hepatic
        damage. EGCG treatment resulted in significant suppression of liver injury
        (i.e., reduced activities of alanine aminotransferase [ALT] and aspartate
        aminotransferase [AST]). The development of DEHP-induced hepatic and testicular
        damage altered the testosterone concentration in mouse serum, which could
        affect the reproductive ability of male mice. Moreover, EGCG treatment markedly
        attenuated testes lesions, sperm deformity, and spermatogenic cell apoptosis.
        At the molecular level, hepatic CYP3A4 expression was substantially reduced
        by EGCG treatment in mice exposed to DEHP compounds, whereas testicular aromatase
        expression was increased significantly in testes. Thus, these results demonstrate
        that EGCG administration may protect against liver damage and reproductive
        toxicity in males exposed to DEHP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Ge</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1
        College of Life Sciences, China Jiliang University , Hangzhou, China .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2
        Zhejiang Provincial Key Laboratory of Biometrology and Inspection &amp; Quarantine,
        China Jiliang University , Hangzhou, China .</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Han</LastName><ForeName>Baoyu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>2
        Zhejiang Provincial Key Laboratory of Biometrology and Inspection &amp; Quarantine,
        China Jiliang University , Hangzhou, China .</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hu</LastName><ForeName>Huajun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>1
        College of Life Sciences, China Jiliang University , Hangzhou, China .</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1
        College of Life Sciences, China Jiliang University , Hangzhou, China .</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1
        College of Life Sciences, China Jiliang University , Hangzhou, China .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Med Food</MedlineTA><NlmUniqueID>9812512</NlmUniqueID><ISSNLinking>1096-620X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004952">Esters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance
        UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>8R1V1STN48</RegistryNumber><NameOfSubstance
        UI="D002392">Catechin</NameOfSubstance></Chemical><Chemical><RegistryNumber>BQM438CTEL</RegistryNumber><NameOfSubstance
        UI="C045651">epigallocatechin gallate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D001141">Aromatase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D051544">Cytochrome P-450 CYP3A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001141" MajorTopicYN="N">Aromatase</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002392" MajorTopicYN="N">Catechin</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention
        &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051544"
        MajorTopicYN="N">Cytochrome P-450 CYP3A</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004952" MajorTopicYN="N">Esters</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007274" MajorTopicYN="N">Injections, Intraperitoneal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013094" MajorTopicYN="N">Spermatozoa</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013733" MajorTopicYN="N">Testicular Diseases</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517"
        MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">di-(2-ethylhexyl) phthalate (DEHP)</Keyword><Keyword
        MajorTopicYN="N">epigallocatechin-3-O-gallate (EGCG)</Keyword><Keyword MajorTopicYN="N">hepatic
        damage</Keyword><Keyword MajorTopicYN="N">testicular toxicity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">25789634</ArticleId><ArticleId IdType="doi">10.1089/jmf.2014.3247</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12505296</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>181-182</Volume><PubDate><Year>2002</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Development
        and implementation of the IPCS conceptual framework for evaluating mode of
        action of chemical carcinogens.</ArticleTitle><Pagination><StartPage>121</StartPage><EndPage>125</EndPage><MedlinePgn>121-5</MedlinePgn></Pagination><Abstract><AbstractText>The
        framework developed by the International Programme on Chemical Safety (IPCS)
        for assessing the mode of action of tumour induction of chemicals in experimental
        animals has been illustrated with d-limonene, sodium saccharin, di(2-ethylhexyl)phthalate
        (DEHP) and sulfamethazine as examples. d-Limonene causes renal tumours only
        in male rats through a response associated with alpha(2u)-globulin. Sodium
        saccharin induces urinary bladder tumours only in male rats through formation
        of a urinary precipitate causing erosion of the bladder surface and extensive
        regenerative hyperplasia. DEHP causes liver tumours in rats and mice through
        activation of the receptor PPAR alpha leading to peroxisome proliferation
        and hepatocellular proliferation. Sulfamethazine induces thyroid follicular
        cell tumours in rats and mice through a mechanism involving altered thyroid
        hormone homeostasis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Dybing</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division
        of Environmental Medicine, Norwegian Institute of Public Health, PO Box 4404
        Nydalen, 0403 Oslo, Norway. erik.dybing@fhi.no</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D053138">Cyclohexenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013729">Terpenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>48U51W007F</RegistryNumber><NameOfSubstance
        UI="D013418">Sulfamethazine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9MC3I34447</RegistryNumber><NameOfSubstance
        UI="D000077222">Limonene</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FST467XS7D</RegistryNumber><NameOfSubstance
        UI="D012439">Saccharin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D053138" MajorTopicYN="N">Cyclohexenes</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000077222" MajorTopicYN="N">Limonene</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012439" MajorTopicYN="N">Saccharin</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013418" MajorTopicYN="N">Sulfamethazine</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013729" MajorTopicYN="N">Terpenes</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>4</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>31</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>1</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>31</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12505296</ArticleId><ArticleId IdType="doi">10.1016/s0300-483x(02)00266-4</ArticleId><ArticleId
        IdType="pii">S0300483X02002664</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6710484</PMID><DateCompleted><Year>1984</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>72</Volume><Issue>1</Issue><PubDate><Year>1984</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Comparative
        studies on di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation
        in the rat and hamster.</ArticleTitle><Pagination><StartPage>46</StartPage><EndPage>60</EndPage><MedlinePgn>46-60</MedlinePgn></Pagination><Abstract><AbstractText>Young
        male Sprague-Dawley rats and Syrian hamsters were treated with 25-1000 mg/kg/day
        di-(2-ethylhexyl) phthalate (DEHP) orally for 14 days. Liver enlargement was
        observed in both species, the magnitude being greater in the rat than in the
        hamster. In the rat there was a marked dose-dependent induction of the peroxisomal
        marker cyanide-insensitive palmitoyl-CoA oxidation and also of carnitine acetyltransferase.
        Little effect was observed on the mitochondrial markers carnitine palmitoyltransferase
        and succinate dehydrogenase. Whereas in the rat, increased peroxisomal enzyme
        activities were observed after treatment with 100 and 250 mg/kg/day DEHP,
        much less effect was observed in the hamster even after 1000 mg/kg/day DEHP.
        Parallel morphological investigations demonstrated a greater increase in hepatic
        peroxisome numbers in the rat than in the hamster. 14C-labeled DEHP was found
        to be more rapidly hydrolyzed by rat than hamster hepatic and small intestinal
        mucosal cell preparations and differences were also observed in the absorption
        and excretion of oral doses of [14C]DEHP. Studies with mono-(2-ethylhexyl)
        phthalate (MEHP), a primary metabolite of DEHP, and a hypolipidemic drug clofibrate
        also resulted in a greater increase in hepatic peroxisomal enzymes in the
        rat compared to the hamster. The results demonstrate that while DEHP, MEHP,
        and clofibrate induced hepatic peroxisome proliferation in both species, there
        was a marked species difference in response. Comparative long-term studies
        in these species may thus help to clarify the role of peroxisome proliferation
        in the hepatocarcinogenicity of DEHP.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Gray</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Author><Author
        ValidYN="Y"><LastName>Foster</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Stubberfield</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6710484</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(84)90248-5</ArticleId><ArticleId
        IdType="pii">0041-008X(84)90248-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15901911</PMID><DateCompleted><Year>2005</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>86</Volume><Issue>2</Issue><PubDate><Year>2005</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Gene ontology mapping as an unbiased
        method for identifying molecular pathways and processes affected by toxicant
        exposure: application to acute effects caused by the rodent non-genotoxic
        carcinogen diethylhexylphthalate.</ArticleTitle><Pagination><StartPage>453</StartPage><EndPage>469</EndPage><MedlinePgn>453-69</MedlinePgn></Pagination><Abstract><AbstractText>Toxicogenomics
        has the potential to reveal the molecular pathways and cellular processes
        that mediate the adverse responses to a toxicant. However, the initial output
        of a toxicogenomic experiment often consists of large lists of genes whose
        expression is altered after toxicant exposure. To interpret gene expression
        changes in the context of underlying biological pathways and processes, new
        bioinformatics methods must be developed. We have used global gene expression
        profiling combined with an evaluation of Gene Ontology (GO) and pathway mapping
        tools as unbiased methods for identifying the molecular pathways and processes
        affected upon toxicant exposure. We chose to use the acute effects caused
        by the non-genotoxic carcinogen and peroxisome proliferator (PP) diethylhexylphthalate
        (DEHP) in the mouse liver as a model system. Consistent with what is known
        about the mode of action of DEHP, our GO analysis of transcript profiling
        data revealed a striking overrepresentation of genes associated with the peroxisomal
        cellular component, together with genes involved in carboxylic acid and lipid
        metabolism. Furthermore we reveal gene expression changes associated with
        additional biological functions, including complement activation, hemostasis,
        the endoplasmic reticulum overload response, and circadian rhythm. Together,
        these data reveal potential new pathways of PP action and shed new light on
        the mechanisms by which non-genotoxic carcinogens control hepatocyte hypertrophy
        and proliferation. We demonstrate that GO mapping can identify, in an unbiased
        manner, both known and novel DEHP-induced molecular changes in the mouse liver
        and is therefore a powerful approach for elucidating modes of toxicity based
        on toxicogenomic data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Currie</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Syngenta
        Central Toxicology Laboratory, Alderley Park, Cheshire SK10 4TJ, United Kingdom.
        richard.currie@syngenta.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bombail</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Author><Author
        ValidYN="Y"><LastName>Oliver</LastName><ForeName>Jason D</ForeName><Initials>JD</Initials></Author><Author
        ValidYN="Y"><LastName>Moore</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author
        ValidYN="Y"><LastName>Lim</LastName><ForeName>Fei Ling</ForeName><Initials>FL</Initials></Author><Author
        ValidYN="Y"><LastName>Gwilliam</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Author><Author
        ValidYN="Y"><LastName>Kimber</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author><Author
        ValidYN="Y"><LastName>Chipman</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Moggs</LastName><ForeName>Jonathan G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Orphanides</LastName><ForeName>George</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2005</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D043922" MajorTopicYN="N">Toxicogenetics</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2005</Year><Month>5</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2005</Year><Month>10</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2005</Year><Month>5</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15901911</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfi207</ArticleId><ArticleId
        IdType="pii">kfi207</ArticleId></ArticleIdList></PubmedData></PubmedArticle>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2404574</PMID><DateCompleted><Year>1990</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>30</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0008-5472</ISSN><JournalIssue
        CitedMedium="Print"><Volume>50</Volume><Issue>3</Issue><PubDate><Year>1990</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Cancer
        research</Title><ISOAbbreviation>Cancer Res</ISOAbbreviation></Journal><ArticleTitle>Peroxisome
        proliferator-induced alterations in the expression and modification of rat
        hepatocyte plasma membrane proteins.</ArticleTitle><Pagination><StartPage>669</StartPage><EndPage>676</EndPage><MedlinePgn>669-76</MedlinePgn></Pagination><Abstract><AbstractText>Rats
        were fed the peroxisome proliferator ciprofibrate (0.025%), and the effects
        on the expression, modification, and localization of seven domain-specific
        integral proteins of the rat hepatocyte plasma membrane were assessed using
        a combination of immunoblotting, -precipitation, and -fluorescence. Ciprofibrate
        caused the down-regulation of five of the plasma membrane proteins (the epidermal
        growth factor receptor, the asialoglycoprotein receptor, HA 321, HA 4, and
        dipeptidylpeptidase IV) and induced the expression of a more basic, lower-Mr
        isoform of the basolateral plasma membrane protein CE 9. Pulse labeling, chemical
        deglycosylation, and 125I-wheat germ lectin blotting suggested that the ciprofibrate-induced
        isoform of CE 9 differed in the posttranslational modification of its oligosaccharides
        and contained more sialic acid. These changes in hepatocyte surface differentiation
        were first observed between Days 1 and 5 on the ciprofibrate-containing diet,
        coincident with other aspects of the pleiotropic response of the hepatocyte
        to peroxisome proliferators, e.g., the induction of the Mr 78,000 peroxisome
        proliferation-associated protein. The effects were reversed within 2-3 weeks
        upon removal of ciprofibrate. The three other peroxisome proliferators tested,
        di(2-ethylhexyl)phthalate, clofibrate, and Wy-14,643, were found to exert
        most of these same effects on the expression and modification of the hepatocyte
        plasma membrane proteins, but the compounds differed in relative potency.
        The ciprofibrate-induced decreases in the concentrations of the epidermal
        growth factor receptor, the asialoglycoprotein receptor, HA 321, and HA 4
        were similar to the selective down-regulation of these proteins observed transiently
        during the period of hepatocyte proliferation following two-thirds hepatectomy.
        Other compounds frequently used in studies of liver enzyme induction and carcinogenesis,
        the antioxidants ethoxyquin and butylated hydroxyanisole and the liver tumor
        promoter phenobarbital, were not as effective as ciprofibrate or two-thirds
        hepatectomy at causing the down-regulation of these proteins. The induction
        of the lower-Mr isoform of the basolateral plasma membrane protein CE 9 was
        not observed following two-thirds hepatectomy or upon the feeding of the antioxidants
        or phenobarbital but was specific to the feeding of the peroxisome proliferators.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Bartles</LastName><ForeName>J
        R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department
        of Cell Molecular, Northwestern University Medical School, Chicago, Illinois
        60611.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khuon</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Lin</LastName><ForeName>X H</ForeName><Initials>XH</Initials></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>L Q</ForeName><Initials>LQ</Initials></Author><Author
        ValidYN="Y"><LastName>Reddy</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author
        ValidYN="Y"><LastName>Rao</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author
        ValidYN="Y"><LastName>Isoye</LastName><ForeName>S T</ForeName><Initials>ST</Initials></Author><Author
        ValidYN="Y"><LastName>Nehme</LastName><ForeName>C L</ForeName><Initials>CL</Initials></Author><Author
        ValidYN="Y"><LastName>Fayos</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA36130</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37
        GM23750</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>RR05370</GrantID><Acronym>RR</Acronym><Agency>NCRR
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Cancer Res</MedlineTA><NlmUniqueID>2984705R</NlmUniqueID><ISSNLinking>0008-5472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D037263">Asialoglycoprotein Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D058607">Fibric Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012795">Sialoglycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.10.1</RegistryNumber><NameOfSubstance UI="D066246">ErbB Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>F8252JGO9S</RegistryNumber><NameOfSubstance
        UI="C019304">ciprofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D037263" MajorTopicYN="N">Asialoglycoprotein Receptor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000031"
        MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066246" MajorTopicYN="N">ErbB Receptors</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D058607" MajorTopicYN="N">Fibric Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007526" MajorTopicYN="N">Isoelectric Point</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012795" MajorTopicYN="N">Sialoglycoproteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2404574</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10581215</PMID><DateCompleted><Year>2000</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>24</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>161</Volume><Issue>2</Issue><PubDate><Year>1999</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>trans-Activation
        of PPARalpha and PPARgamma by structurally diverse environmental chemicals.</ArticleTitle><Pagination><StartPage>209</StartPage><EndPage>218</EndPage><MedlinePgn>209-18</MedlinePgn></Pagination><Abstract><AbstractText>A
        large number of industrial chemicals and environmental pollutants, including
        trichloroethylene (TCE), di(2-ethylhexyl)phthalate (DEHP), perfluorooctanoic
        acid (PFOA), and various phenoxyacetic acid herbicides, are nongenotoxic rodent
        hepatocarcinogens whose human health risk is uncertain. Rodent model studies
        have identified the receptor involved in the hepatotoxic and hepatocarcinogenic
        actions of these chemicals as peroxisome proliferator-activated receptor alpha
        (PPARalpha), a nuclear receptor that is highly expressed in liver. Humans
        exhibit a weak response to these peroxisome proliferator chemicals, which
        in part results from the relatively low level of PPARalpha expression in human
        liver. Cell transfection studies were carried out to investigate the interactions
        of peroxisome proliferator chemicals with PPARalpha, cloned from human and
        mouse, and with PPARgamma, a PPAR isoform that is highly expressed in multiple
        human tissues and is an important regulator of physiological processes such
        as adipogenesis and hematopoiesis. With three environmental chemicals, TCE,
        perchloroethylene, and DEHP, PPARalpha was found to be activated by metabolites,
        but not by the parent chemical. A decreased sensitivity of human PPARalpha
        compared to mouse PPARalpha to trans-activation was observed with some (Wy-14,
        643, PFOA), but not other, peroxisome proliferators (TCE metabolites, trichloroacetate
        and dichloroacetate; and DEHP metabolites, mono[2-ethylhexyl]phthalate and
        2-ethylhexanoic acid). Investigation of human and mouse PPARgamma revealed
        the transcriptional activity of this receptor to be stimulated by mono(2-ethylhexyl)phthalate,
        a DEHP metabolite that induces developmental and reproductive organ toxicities
        in rodents. This finding suggests that PPARgamma, which is highly expressed
        in human adipose tissue, where many lipophilic foreign chemicals tend to accumulate,
        as well as in colon, heart, liver, testis, spleen, and hematopoietic cells,
        may be a heretofore unrecognized target in human cells for a subset of industrial
        and environmental chemicals of the peroxisome proliferator class.</AbstractText><CopyrightInformation>Copyright
        1999 Academic Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Maloney</LastName><ForeName>E K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Division
        of Cell and Molecular Biology, Boston University, Boston, Massachusetts, 02215,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waxman</LastName><ForeName>D
        J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>ES07381</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013486">Research Support, U.S.
        Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006540">Herbicides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>2577AQ9262</RegistryNumber><NameOfSubstance
        UI="D015084">2,4-Dichlorophenoxyacetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>290YE8AR51</RegistryNumber><NameOfSubstance
        UI="D014241">Trichloroethylene</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>D888C394VO</RegistryNumber><NameOfSubstance
        UI="D008456">2-Methyl-4-chlorophenoxyacetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>TJ904HH8SN</RegistryNumber><NameOfSubstance
        UI="D013750">Tetrachloroethylene</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015084" MajorTopicYN="N">2,4-Dichlorophenoxyacetic Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008456" MajorTopicYN="N">2-Methyl-4-chlorophenoxyacetic Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006540" MajorTopicYN="N">Herbicides</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013750" MajorTopicYN="N">Tetrachloroethylene</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014241" MajorTopicYN="N">Trichloroethylene</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>12</Month><Day>3</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>12</Month><Day>3</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10581215</ArticleId><ArticleId IdType="doi">10.1006/taap.1999.8809</ArticleId><ArticleId
        IdType="pii">S0041-008X(99)98809-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9398495</PMID><DateCompleted><Year>1998</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0272-0590</ISSN><JournalIssue
        CitedMedium="Print"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>1997</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Fundamental
        and applied toxicology : official journal of the Society of Toxicology</Title><ISOAbbreviation>Fundam
        Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>Expression of the immediate-early
        genes, c-fos, c-jun, and c-myc: a comparison in rats of nongenotoxic hepatocarcinogens
        with noncarcinogenic liver mitogens.</ArticleTitle><Pagination><StartPage>129</StartPage><EndPage>137</EndPage><MedlinePgn>129-37</MedlinePgn></Pagination><Abstract><AbstractText>The
        involvement of the immediate-early (IE) genes c-fos, c-jun, and c-myc in regenerative
        liver hyperplasia is accepted, but their involvement in direct hyperplasia
        is uncertain. We have examined the hypothesis that the ability to induce IE
        genes may reflect the hepatocarcinogenic potential of a chemical. The ability
        of 1,4-dichlorobenzene (DCB) (300 mg/kg) (a noncarcinogenic rat liver mitogen),
        diethylhexyl phthalate (DEHP) (950 mg/kg), and chlorendic acid (120 mg/kg)
        (both nongenotoxic hepatocarcinogens) to induce c-fos, c-jun, and c-myc expression
        in rat liver was determined by Northern blot analysis and by in situ hybridization.
        Results were correlated to hepatic labeling index (LI) as determined by incorporation
        of BrdU in each of three lobes for each of three male F344 rats per group.
        Carbon tetrachloride (CCl4) (2 ml/kg) was used as a positive control. Increased
        LI was preceded by elevated expression of all three IE genes after CCl4, but
        also after DCB and DEHP, although induction by these was less marked. In all
        cases, there was considerable interanimal variation within groups, but little
        interlobe variation. Interestingly, there was a good correlation (r2 &gt;
        or = 0.85) between c-myc expression and LI, but not between LI and c-fos or
        c-jun. Despite the disparate carcinogenic potential of DEHP and DCB, both
        chemicals induced similar patterns of IE gene expression, suggesting that
        this cannot distinguish hepatocarcinogenic liver mitogens from noncarcinogenic
        liver mitogens. These data assist in the evaluation of IE gene expression
        both as a marker of direct versus regenerative hyperplasia and as an indicator
        of the hepatocarcinogenic potential of liver mitogens.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hasmall</LastName><ForeName>S
        C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Zeneca Central
        Toxicology Laboratory, Macclesfield, Cheshire, United Kingdom.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Pyrah</LastName><ForeName>I T</ForeName><Initials>IT</Initials></Author><Author
        ValidYN="Y"><LastName>Soames</LastName><ForeName>A R</ForeName><Initials>AR</Initials></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Fundam Appl Toxicol</MedlineTA><NlmUniqueID>8200838</NlmUniqueID><ISSNLinking>0272-0590</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008934">Mitogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016760">Proto-Oncogene Proteins c-fos</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016755">Proto-Oncogene Proteins c-jun</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016271">Proto-Oncogene Proteins c-myc</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015152" MajorTopicYN="N">Blotting, Northern</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017781" MajorTopicYN="N">Genes, Immediate-Early</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017403" MajorTopicYN="N">In Situ Hybridization</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008934" MajorTopicYN="N">Mitogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016760" MajorTopicYN="N">Proto-Oncogene Proteins c-fos</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016755" MajorTopicYN="N">Proto-Oncogene Proteins c-jun</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016271" MajorTopicYN="N">Proto-Oncogene Proteins c-myc</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1997</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1997</Year><Month>12</Month><Day>17</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1997</Year><Month>12</Month><Day>17</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9398495</ArticleId><ArticleId IdType="doi">10.1006/faat.1997.2371</ArticleId><ArticleId
        IdType="pii">S027205909792371X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1516773</PMID><DateCompleted><Year>1992</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>07</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0272-0590</ISSN><JournalIssue
        CitedMedium="Print"><Volume>19</Volume><Issue>2</Issue><PubDate><Year>1992</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Fundamental
        and applied toxicology : official journal of the Society of Toxicology</Title><ISOAbbreviation>Fundam
        Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>The developmental toxicity
        of 2-ethylhexanol applied dermally to pregnant Fischer 344 rats.</ArticleTitle><Pagination><StartPage>176</StartPage><EndPage>185</EndPage><MedlinePgn>176-85</MedlinePgn></Pagination><Abstract><AbstractText>Undiluted
        2-ethylhexanol (2-EH) was administered by occluded dermal application for
        6 hr per day on Gestation Days 6 through 15 to pregnant Fischer 344 rats,
        in range-finding (R) and main (M) studies. The dermal route is considered
        to be the most relevant for human exposure. Treatment levels were (R) 0.0,
        0.5, 1.0, 2.0, and 3.0 ml/kg/day (equivalent to 0, 420, 840, 1680, and 2520
        mg/kg/day) and (M) 0.0, 0.3, 1.0, and 3.0 ml/kg/day (equivalent to 0, 252,
        840, and 2520 mg/kg/day). Controls (0.0 ml/kg/day, sham controls) received
        deionized water at 3.0 ml/kg/day. Dermal-positive control groups received
        undiluted 2-methoxyethanol (2-ME) at (R) 0.5 and 1.5 ml/kg/day and (M) 1.0
        ml/kg/day as a reference compound in a similar regimen. An oral reference
        compound, valproic acid, was administered by gavage in the range-finding study
        on Gestation Days 6 through 15 at 400 mg/kg/day. The range-finding study employed
        an untreated (naive) control group. Numbers of plug-positive females per group
        were (R) 8 and (M) 25. Maternal weight gain was reduced for 2-EH at 1680 (R)
        and 2520 (R and M studies) mg/kg/day. Exfoliation and encrustation were seen
        at the application site in both studies at 840, 1680, and 2520 mg/kg. Maternal
        liver, kidney, thymus, spleen, adrenal, and uterine weights, and gestational
        and fetal parameters were unaffected by treatment with 2-EH. There were no
        treatment-related increases in the incidence of individual or pooled external,
        visceral, and skeletal malformations or variations following the application
        of 2-EH. The NOAELs for the maternal toxicity of 2-EH were 252 mg/kg/day based
        on skin irritation and 840 mg/kg/day based on systemic toxicity. The developmental
        toxicity NOAEL was at least 2520 mg/kg/day, with no teratogenicity. Administration
        of 2-ME at 840 mg/kg/day resulted in reduced maternal weight gain and food
        consumption, increased postimplantation loss, reduced numbers of live fetuses
        per litter, and reduced fetal body weights per litter. The incidence of fetal
        malformations and variations was increased. Oral administration of VPA produced
        maternal toxicity, developmental toxicity, and teratogenicity. The Fischer
        344 rat is thus susceptible to known rodent teratogens by both the dermal
        and oral routes. It is concluded that 2-EH is not developmentally toxic by
        the dermal route in the Fischer 344 rat at and below treatment levels which
        produce maternal toxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Tyl</LastName><ForeName>R W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Bushy
        Run Research Center, Export, Pennsylvania 15632.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Fisher</LastName><ForeName>L C</ForeName><Initials>LC</Initials></Author><Author
        ValidYN="Y"><LastName>Kubena</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author
        ValidYN="Y"><LastName>Vrbanic</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author
        ValidYN="Y"><LastName>Gingell</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Hodgson</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Murphy</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author
        ValidYN="Y"><LastName>Tyler</LastName><ForeName>T R</ForeName><Initials>TR</Initials></Author><Author
        ValidYN="Y"><LastName>Astill</LastName><ForeName>B D</ForeName><Initials>BD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Fundam Appl Toxicol</MedlineTA><NlmUniqueID>8200838</NlmUniqueID><ISSNLinking>0272-0590</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005026">Ethylene Glycols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013723">Teratogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>614OI1Z5WI</RegistryNumber><NameOfSubstance
        UI="D014635">Valproic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EK1L6XWI56</RegistryNumber><NameOfSubstance
        UI="C005219">methyl cellosolve</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000279" MajorTopicYN="N">Administration, Cutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000013" MajorTopicYN="N">Congenital Abnormalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005026" MajorTopicYN="N">Ethylene Glycols</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013723" MajorTopicYN="N">Teratogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014635" MajorTopicYN="N">Valproic Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1516773</ArticleId><ArticleId IdType="doi">10.1016/0272-0590(92)90149-c</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">14630134</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>01</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0278-6915</ISSN><JournalIssue
        CitedMedium="Print"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Comparison of oxidative stress
        and changes of xenobiotic metabolizing enzymes induced by phthalates in rats.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>114</EndPage><MedlinePgn>107-14</MedlinePgn></Pagination><Abstract><AbstractText>Phthalates
        are widely used as a plasticizer and cause a peroxisome proliferation. Peroxisome
        proliferators (PPs), such as di-2-ethylhexyl phthalate (DEHP) and clofibrate
        (CF) are known to have a hepatocarcinogenic potential in rodents. It has been
        proposed that these PPs may cause hepatocellular cancer by an oxidative damage-mediated
        mechanism(s). The primary purpose of this study is to find whether there is
        a difference between the oxidative damage by hepatocarcinogenic PPs (DEHP
        and CF) and the oxidative damage by weak PPs [di-n-butyl phthalate (DBP) and
        n-butylbenzyl phthalate (BBP)]. The second purpose is to investigate if phthalates
        can affect the phase I/phase II enzymes, and if the effect of PPs on metabolizing
        enzymes correlates with peroxisome proliferation or not. After rats were treated
        with PPs (DEHP, DBP and BBP; 50, 200, 1000 mg/kg, CF; 100 mg/kg, p.o., for
        14 days), the activities of metabolizing enzymes and peroxisomal enzymes were
        investigated, and the oxidative damage was measured using 8-hydroxydeoxyguanosine
        (8-OHdG) in the DNA and malonedialdehyde (MDA) in the livers. These four PPs
        significantly increased the relative liver weights, palmitoyl-CoA oxidation
        and activity of carnitine acetyltransferase. DEHP was found to be the most
        potent PP among three phthalates. A dramatic and dose-dependent increase in
        hepatic MDA levels was observed in CF (100 mg/kg), DEHP (&gt;or=50 mg/kg),
        DBP and BBP (&gt;or=200 mg/kg) groups. However, the 8-OHdG in hepatic DNA
        was increased only in DEHP (1000 mg/kg) and CF groups. Activities of cytochrome
        p4501A1, 1A2, 3A4, UDP-glucuronosyl transferase and glutathione S-transferase
        were decreased overall by PPs, but there is no correlation between the inhibitory
        effect on metabolizing enzymes and the peroxisome proliferation. These results
        indicate that 8-OHdG positively correlates with carcinogenic potential of
        PPs, but other factors as well as peroxisomal H(2)O(2) could be involved in
        the generation of 8-OHdG and the carcinogenesis of PPs. The present findings
        also demonstrate that the effect of PPs on xenobiotic metabolizing enzymes
        may be independent of the peroxisome proliferation and the oxidative stress.
        Thus it is possible that the PPs affect the hepatic toxification/detoxification
        capacity even in humans.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Seo</LastName><ForeName>Kyung Won</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Toxicology
        Department, National Institute of Toxicological Research, Korea Food and Drug
        Administration, 5 Nokbundong, Eunpyunggu, Seoul 122-704, South Korea. kwseo@kfda.gov.kr</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyu Bong</ForeName><Initials>KB</Initials></Author><Author
        ValidYN="Y"><LastName>Kim</LastName><ForeName>Yun Jung</ForeName><Initials>YJ</Initials></Author><Author
        ValidYN="Y"><LastName>Choi</LastName><ForeName>Ju Young</ForeName><Initials>JY</Initials></Author><Author
        ValidYN="Y"><LastName>Lee</LastName><ForeName>Kyung Tae</ForeName><Initials>KT</Initials></Author><Author
        ValidYN="Y"><LastName>Choi</LastName><ForeName>Kwang Sik</ForeName><Initials>KS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000960">Hypolipidemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015262">Xenobiotics</NameOfSubstance></Chemical><Chemical><RegistryNumber>4Y8F71G49Q</RegistryNumber><NameOfSubstance
        UI="D008315">Malondialdehyde</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003600" MajorTopicYN="N">Cytosol</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation
        &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000960" MajorTopicYN="N">Hypolipidemic Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008315" MajorTopicYN="N">Malondialdehyde</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015262" MajorTopicYN="N">Xenobiotics</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">14630134</ArticleId><ArticleId IdType="doi">10.1016/j.fct.2003.08.010</ArticleId><ArticleId
        IdType="pii">S027869150300245X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1473784</PMID><DateCompleted><Year>1993</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0278-6915</ISSN><JournalIssue
        CitedMedium="Print"><Volume>30</Volume><Issue>11</Issue><PubDate><Year>1992</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Di-(2-ethylhexyl) phthalate:
        a short-term repeated inhalation toxicity study including fertility assessment.</ArticleTitle><Pagination><StartPage>915</StartPage><EndPage>919</EndPage><MedlinePgn>915-9</MedlinePgn></Pagination><Abstract><AbstractText>In
        a study of the 28-day inhalation toxicity of di-(2-ethylhexyl) phthalate (DEHP)
        aerosols, 9-wk-old Wistar rats, 27 males (mean weight 226 g) and 17 females
        (mean weight 155 g) per group, were exposed in head-nose inhalation systems
        to DEHP aerosols of respirable particle size (mass median aerodynamic diameter
        &lt; or = 1.2 microns) or air (controls). Exposure for 6 hr per day, 5 days
        per wk for 4 wk to target concentrations of 0, 0.01, 0.05 and 1.0 mg/litre
        gave estimated doses of 230, 11 and 2.3 mg/kg/day for the males, and 360,
        18 and 3.6 mg/kg/day for females, on the assumption of 100% deposition and
        absorption. Clinical investigation and blood chemistry parameters did not
        reveal any treatment-related effects. At the end of exposure a statistically
        significant (16%) increase in relative lung weights, accompanied by increased
        foam-cell proliferation and thickening of the alveolar septi, was found in
        the males of the highest dose group. Absolute liver weights were significantly
        (8.75%) increased in females and relative liver weights were increased in
        both sexes in the highest dose group, but there were no corresponding histological
        effects. All these effects were reversed during the 8-wk post-exposure period.
        No testicular toxicity was observed histologically and no impact on mating
        performance and male fertility was detected after two matings of treated males
        with untreated females, 2 and 6 wk after the end of exposure. Electron microscopic
        examination of liver samples from two male and two female rats per group at
        the end of exposure and after the 8-wk post-exposure period did not reveal
        clear substructural changes that could be attributed to exposure or to peroxisome
        proliferation. The no-observed-effect level for all exposure-related findings
        was 0.05 mg/litre under the conditions used.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Klimisch</LastName><ForeName>H
        J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department
        of Toxicology, BASF Aktiensellschaft, Ludwigshafen, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gamer</LastName><ForeName>A O</ForeName><Initials>AO</Initials></Author><Author
        ValidYN="Y"><LastName>Hellwig</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Kaufmann</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>J&#xe4;ckh</LastName><ForeName>R</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000336">Aerosols</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.6.1.1</RegistryNumber><NameOfSubstance UI="D001219">Aspartate Aminotransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.6.1.2</RegistryNumber><NameOfSubstance UI="D000410">Alanine Transaminase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.3.1</RegistryNumber><NameOfSubstance UI="D000469">Alkaline Phosphatase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000336" MajorTopicYN="N">Aerosols</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000410" MajorTopicYN="N">Alanine Transaminase</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000469" MajorTopicYN="N">Alkaline Phosphatase</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001219" MajorTopicYN="N">Aspartate Aminotransferases</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005298" MajorTopicYN="N">Fertility</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1473784</ArticleId><ArticleId IdType="doi">10.1016/0278-6915(92)90175-k</ArticleId><ArticleId
        IdType="pii">0278-6915(92)90175-K</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6182138</PMID><DateCompleted><Year>1982</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>11</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0021-924X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>92</Volume><Issue>2</Issue><PubDate><Year>1982</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal
        of biochemistry</Title><ISOAbbreviation>J Biochem</ISOAbbreviation></Journal><ArticleTitle>Biosynthesis
        of enzymes of peroxisomal beta-oxidation.</ArticleTitle><Pagination><StartPage>319</StartPage><EndPage>326</EndPage><MedlinePgn>319-26</MedlinePgn></Pagination><Abstract><AbstractText>Male
        Wistar rats were fed a diet with or without di(2-ethylhexyl)phthalate (DEHP),
        a peroxisome proliferator, for 2 weeks. The increases in the individual enzymes
        of the hepatic peroxisomal beta-oxidation system after administration of DEHP
        were 31- to 33-fold. It was found by in vivo experiments using L-[4,5-3H]leucine
        and the immunoprecipitation technique that the rates of synthesis of the enzymes
        were 16- to 20-fold higher and those of degradation were 1.7- to 1.9-fold
        lower in the DEHP group. The translation rates of these enzymes in vitro with
        liver RNA in the reticulocyte-lysate system were 12- to 14-fold higher in
        the DEHP group. Short-term kinetic labeling experiments on acyl-CoA oxidase
        consisting of three subunits were conducted in vivo to explore the biogenesis
        of peroxisomes. The label was found in the biggest subunit of the enzyme in
        the supernatant fraction shortly after the label injection, but was distributed
        to the smaller subunits later. The labeling in the smaller subunits in the
        peroxisomal fraction was greater than that of the supernatant. The distribution
        of the label among the subunits in these subcellular fractions was the same
        as that of the protein amounts 1 day after the label injection. This paper
        reports that the increase in the quantities of peroxisomal enzymes upon administration
        of DEHP is mainly due to the increase in their synthesis rates caused by the
        increase in amounts of mRNA coding for these enzymes.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Furuta</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Miyazawa</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Biochem</MedlineTA><NlmUniqueID>0376600</NlmUniqueID><ISSNLinking>0021-924X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance
        UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>GMW67QNF9C</RegistryNumber><NameOfSubstance
        UI="D007930">Leucine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007930" MajorTopicYN="N">Leucine</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009940" MajorTopicYN="N">Organoids</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013347" MajorTopicYN="N">Subcellular Fractions</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1982</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1982</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1982</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6182138</ArticleId><ArticleId IdType="doi">10.1093/oxfordjournals.jbchem.a133937</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10478855</PMID><DateCompleted><Year>1999</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>50</Volume><Issue>2</Issue><PubDate><Year>1999</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Chronic peroxisome proliferation
        and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate
        and the effects of recovery.</ArticleTitle><Pagination><StartPage>195</StartPage><EndPage>205</EndPage><MedlinePgn>195-205</MedlinePgn></Pagination><Abstract><AbstractText>This
        study compared the levels of cell proliferation and peroxisome proliferation
        in rodent liver with tumor incidence, to provide more information on the relationship
        between these events following chronic exposure. Fischer 344 rats were treated
        with 0, 100, 500, 2500, or 12,500 ppm DEHP, and B6C3F1 mice were treated with
        0, 100, 500, 1500, or 6000 ppm DEHP in the diet for up to 104 weeks. Additional
        groups of rats and mice received the highest concentration for 78 weeks and
        then the control diet for an additional 26 weeks (recovery groups). Animals
        were terminated at weeks 79 and 105 for histopathologic examination. Elevated
        palmitoyl CoA oxidation activity and higher liver-to-body weight ratios were
        observed for the 2500- and 12,500-ppm groups of rats, and for the 500-, 1500-,
        and 6000-ppm groups of mice at Week 105. No increase in palmitoyl CoA oxidation
        activity was evident in the recovery group, and relative liver weights were
        near control levels following recovery. No hepatic cell proliferation was
        detected at Weeks 79 or 105 in either species although preliminary data indicated
        that cell proliferation did occur within the first 13 weeks of exposure. A
        significantly higher incidence of hepatocellular tumors was only observed
        for the 2500- and 12,500-ppm group and its recovery group of rats, and for
        the 500-, 1500-, and 6000-ppm groups and the recovery group of mice. The tumor
        incidences were reduced for the recovery groups compared with the groups fed
        DEHP continuously for 104 weeks. The data indicate that high levels of peroxisome
        proliferation and hepatomegaly are associated with DEHP hepatocarcinogenesis
        in rodent liver, and that the tumorigenic process may be arrested by cessation
        of DEHP treatment, suggesting that extended treatment with DEHP acts to promote
        tumor growth.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>David</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Eastman
        Kodak Company, Rochester, New York 14652-6272, USA. davidtox@kodak.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Moore</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author><Author
        ValidYN="Y"><LastName>Cifone</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author
        ValidYN="Y"><LastName>Finney</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>1763-10-6</RegistryNumber><NameOfSubstance
        UI="D010171">Palmitoyl Coenzyme A</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006529" MajorTopicYN="N">Hepatomegaly</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010171" MajorTopicYN="N">Palmitoyl Coenzyme A</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018901" MajorTopicYN="N">Peroxisomal Disorders</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>9</Month><Day>9</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>9</Month><Day>9</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10478855</ArticleId><ArticleId IdType="doi">10.1093/toxsci/50.2.195</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">99598</PMID><DateCompleted><Year>1978</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0098-6577</ISSN><JournalIssue
        CitedMedium="Print"><Issue>8</Issue><PubDate><Year>1978</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Kidney
        international. Supplement</Title><ISOAbbreviation>Kidney Int Suppl</ISOAbbreviation></Journal><ArticleTitle>Enzyme
        induction in the uremic liver.</ArticleTitle><Pagination><StartPage>S43</StartPage><EndPage>S48</EndPage><MedlinePgn>S43-8</MedlinePgn></Pagination><Abstract><AbstractText>Forty-five
        days after subtotal nephrectomy or sham-operation of male rats, microsomal
        enzymes were investigated in vitro. The activities (per milligram) of microsomal
        protein of two esterases and of two glucuronyltransferases were normal in
        the uremic rats. The mixed-function oxidation system had lower activities
        per milligram of protein than that in sham-operated controls. Due to a decrease
        of the microsomal protein content of the uremic liver, the activities of these
        enzymes were decreased when calculated for the whole liver. In contrast, the
        glucoronidation of phenolphthalein remained normal when related to the whole
        liver, due to an increased activity per mg of protein. Treatment with the
        plasticizer di-(2-ethylhexyl)-phthalate caused a significant increase of the
        liver wet weight, the microsomal protein content, and the activity per mg
        of protein for the demethylation of aminopyrine in subtotally nephrectomized
        rats but was without influence on the liver of sham-operated controls. It
        is concluded that uremia itself does not induce liver microsomal enzymes.
        The microsomal enzymes, however, remain inducible by foreign compounds even
        under uremic conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Leber</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author
        ValidYN="Y"><LastName>Gleumes</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Sch&#xfc;tterle</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Kidney Int Suppl</MedlineTA><NlmUniqueID>7508622</NlmUniqueID><ISSNLinking>0098-6577</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D006899">Mixed Function Oxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.4.1.17</RegistryNumber><NameOfSubstance UI="D014453">Glucuronosyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.-</RegistryNumber><NameOfSubstance UI="D004950">Esterases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004950" MajorTopicYN="N">Esterases</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014453" MajorTopicYN="N">Glucuronosyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006899" MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009392" MajorTopicYN="N">Nephrectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014511" MajorTopicYN="N">Uremia</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1978</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1978</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1978</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">99598</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9367824</PMID><DateCompleted><Year>1997</Year><Month>12</Month><Day>12</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-291X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>239</Volume><Issue>3</Issue><PubDate><Year>1997</Year><Month>Oct</Month><Day>29</Day></PubDate></JournalIssue><Title>Biochemical
        and biophysical research communications</Title><ISOAbbreviation>Biochem Biophys
        Res Commun</ISOAbbreviation></Journal><ArticleTitle>Suppression of cytochrome
        P450 Cyp2f2 mRNA levels in mice by the peroxisome proliferator diethylhexylphthalate.</ArticleTitle><Pagination><StartPage>660</StartPage><EndPage>665</EndPage><MedlinePgn>660-5</MedlinePgn></Pagination><Abstract><AbstractText>Exposure
        to peroxisome proliferators, which are extensively used, causes a number of
        pleiotrophic effects. Prolonged exposure to the peroxisome proliferator, DEHP,
        causes hepatic hyperplasia and liver tumors in rats and mice. This exposure
        can also induce a number of enzymes. To identify additional genes that are
        regulated by DEHP, mRNA differential display was used. One of the genes affected
        is cytochrome 450 Cyp2f2, a naphthalene hydroxylase. Using northern analysis,
        RNase protection assay, and RT-PCR, we show that the Cyp2f2 mRNA levels are
        decreased in mouse liver following DEHP treatment. A smaller Cyp2f2 mRNA transcript
        was also detected in kidney and these transcript levels were also suppressed
        but to a lesser extent than that in the liver. The response to DEHP in mouse
        liver is both dose and time dependent.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department
        of Entomology, University of California, Riverside 92521, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lu</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Gill</LastName><ForeName>S S</ForeName><Initials>SS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Biochem Biophys Res Commun</MedlineTA><NlmUniqueID>0372516</NlmUniqueID><ISSNLinking>0006-291X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004794" MajorTopicYN="N">Enzyme Repression</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1997</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1997</Year><Month>11</Month><Day>21</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1997</Year><Month>11</Month><Day>21</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9367824</ArticleId><ArticleId IdType="doi">10.1006/bbrc.1997.7529</ArticleId><ArticleId
        IdType="pii">S0006-291X(97)97529-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3966235</PMID><DateCompleted><Year>1985</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>77</Volume><Issue>1</Issue><PubDate><Year>1985</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Comparison
        of the short-term effects of di(2-ethylhexyl) phthalate, di(n-hexyl) phthalate,
        and di(n-octyl) phthalate in rats.</ArticleTitle><Pagination><StartPage>116</StartPage><EndPage>132</EndPage><MedlinePgn>116-32</MedlinePgn></Pagination><Abstract><AbstractText>This
        study compares changes in the livers of rats treated with di(2-ethylhexyl)
        phthalate (DEHP) and its straight-chain analogs di(n-hexyl) phthalate (DnHP)
        and di(n-octyl phthalate (DnOP). Groups of rats were fed diets containing
        20,000 ppm of one of these compounds. Subgroups were killed after 3, 10, and
        21 days, and the livers were examined by histological, cytological, and biochemical
        methods. The results show considerable differences between the effects of
        the branched-chain phthalate ester DEHP and its straight-chain analogs. The
        major effects on the liver following administration of diets containing DEHP
        were midzonal and periportal accumulation of small droplets of lipid, hepatomegaly
        accompanied by an initial burst of mitosis, proliferation of hepatic peroxisomes
        and of smooth endoplasmic reticulum accompanied by induction of peroxisomal
        fatty acid oxidation, damage to the peroxisomal membranes as evidenced by
        increased leakage of catalase to the cytosol, and centrilobular loss of glycogen
        and falls in glucose-6-phosphatase activity and in low-molecular-weight reducing
        agents. In contrast, diets containing DnHP or DnOP induced accumulation of
        large droplets of fat around central veins leading, by 10 days, to mild centrilobular
        necrosis and a very slight induction of one peroxisomal enzyme and an increase
        in liver weight, but no significant changes in any other parameters which
        were affected by DEHP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Mann</LastName><ForeName>A H</ForeName><Initials>AH</Initials></Author><Author
        ValidYN="Y"><LastName>Price</LastName><ForeName>S C</ForeName><Initials>SC</Initials></Author><Author
        ValidYN="Y"><LastName>Mitchell</LastName><ForeName>F E</ForeName><Initials>FE</Initials></Author><Author
        ValidYN="Y"><LastName>Grasso</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Hinton</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Author><Author
        ValidYN="Y"><LastName>Bridges</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>42MAH1QFG5</RegistryNumber><NameOfSubstance
        UI="C027387">di-n-hexyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>8X3RJ0527W</RegistryNumber><NameOfSubstance
        UI="C010715">di-n-octyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3966235</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(85)90273-x</ArticleId><ArticleId
        IdType="pii">0041-008X(85)90273-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10650916</PMID><DateCompleted><Year>2000</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>05</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0340-5761</ISSN><JournalIssue
        CitedMedium="Print"><Volume>73</Volume><Issue>8-9</Issue><PubDate><Year>1999</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Suppression
        of apoptosis and induction of DNA synthesis in vitro by the phthalate plasticizers
        monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP): a comparison
        of rat and human hepatocytes in vitro.</ArticleTitle><Pagination><StartPage>451</StartPage><EndPage>456</EndPage><MedlinePgn>451-6</MedlinePgn></Pagination><Abstract><AbstractText>Diethylhexylphthalate
        (DEHP) and diisononylphthalate (DINP) are plasticizers with many important
        commercial, industrial and medical applications. However, both DEHP and DINP
        are rodent peroxisome proliferators (PPs), a class of compounds that cause
        rodent liver tumours associated with peroxisome proliferation, induction of
        hepatic DNA synthesis and the suppression of apoptosis. Despite these effects
        in the rodent, humans appear to be nonresponsive to the adverse effects of
        PPs. Previously, we have shown that the fibrate hypolipidaemic peroxisome
        proliferator, nafenopin, induced DNA synthesis and suppressed apoptosis in
        rat but not in human hepatocytes. In this work, we have examined species differences
        in the response of rat and human hepatocytes to DEHP and DINP in vitro. In
        rat hepatocytes in vitro, both DINP and MEHP (a principle metabolite of DEHP
        and the proximal peroxisome proliferator) caused a concentration-dependent
        induction of DNA synthesis and suppression of both spontaneous and transforming
        growth factor beta1 (TGFbeta1)-induced apoptosis. Similarly, both MEHP and
        DINP caused a concentration-dependent induction of peroxisomal beta-oxidation
        although the response to DINP was less robust. In contrast to the pleiotropic
        response noted in rat hepatocytes, neither DINP nor MEHP caused an induction
        of beta-oxidation, stimulation of DNA synthesis and suppression of apoptosis
        in human hepatocytes cultured from three separate donors. These data provide
        evidence for species differences in the hepatic response to the phthalates
        DEHP and DINP, confirming that human hepatocytes appear to be refractory to
        the hepatocarcinogenic effects of PPs first noted in rodents.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hasmall</LastName><ForeName>S
        C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Cancer Biology
        Group, AstraZeneca Central Toxicology Laboratory, Alderley Park, Macclesfield,
        Cheshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>N
        H</ForeName><Initials>NH</Initials></Author><Author ValidYN="Y"><LastName>Macdonald</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>West</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Chevalier</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Cosulich</LastName><ForeName>S C</ForeName><Initials>SC</Initials></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>4010KIX4CK</RegistryNumber><NameOfSubstance
        UI="C012125">diisononyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>1</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2000</Year><Month>3</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>1</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10650916</ArticleId><ArticleId IdType="doi">10.1007/s002040050634</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3617066</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0748-2337</ISSN><JournalIssue
        CitedMedium="Print"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and industrial health</Title><ISOAbbreviation>Toxicol Ind Health</ISOAbbreviation></Journal><ArticleTitle>Structure-activity
        relationships for induction of peroxisomal enzyme activities by phthalate
        monoesters in primary rat hepatocyte cultures.</ArticleTitle><Pagination><StartPage>165</StartPage><EndPage>183</EndPage><MedlinePgn>165-83</MedlinePgn></Pagination><Abstract><AbstractText>Rat
        hepatocytes were cultured for 70 hours with a series of four isomeric octyl
        and five isomeric hexyl phthalate monoesters, and their effects on peroxisomal
        fatty acid beta-oxidation (palmitoyl-CoA oxidation) and carnitine acetyltransferase
        activities determined. All nine monoesters produced dose-related increases
        in enzyme activities and marked quantitative compound potency differences
        were observed. Generally octyl isomers were more potent than hexyl isomers
        and 2- and 3-ethyl substituted isomers were more potent than their straight
        chain and 1-ethyl substituted analogs. For example, mono(2-ethylhexyl)phthalate
        was more potent than mono(1-ethylhexyl)phthalate, and this was also observed
        after oral administration of the two isomers to rats for seven days. The cell
        culture data for induction of palmitoyl-CoA oxidation were used to generate
        quantitative structure-activity relationships. Relatively poor correlations
        were observed between biological activity and simple hydrophobic parameters,
        but a good correlation was obtained when compound electronic structural parameters,
        obtained by molecular orbital calculations, were employed. These studies demonstrate
        relationships between biological activity and chemical structure for a series
        of phthalate monoesters and indicate the potential usefulness of primary rat
        hepatocyte cultures to screen compounds for peroxisome proliferation.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Gray</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Author><Author
        ValidYN="Y"><LastName>Lewis</LastName><ForeName>D F</ForeName><Initials>DF</Initials></Author><Author
        ValidYN="Y"><LastName>Beamand</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author
        ValidYN="Y"><LastName>Hodder</LastName><ForeName>K D</ForeName><Initials>KD</Initials></Author><Author
        ValidYN="Y"><LastName>Purchase</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        Ind Health</MedlineTA><NlmUniqueID>8602702</NlmUniqueID><ISSNLinking>0748-2337</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>1763-10-6</RegistryNumber><NameOfSubstance
        UI="D010171">Palmitoyl Coenzyme A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010171" MajorTopicYN="N">Palmitoyl Coenzyme A</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3617066</ArticleId><ArticleId IdType="doi">10.1177/074823378700300212</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3617068</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0748-2337</ISSN><JournalIssue
        CitedMedium="Print"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and industrial health</Title><ISOAbbreviation>Toxicol Ind Health</ISOAbbreviation></Journal><ArticleTitle>The
        use of multivariate analysis to compare peroxisome induction data on phthalate
        esters in rats.</ArticleTitle><Pagination><StartPage>25</StartPage><EndPage>48</EndPage><MedlinePgn>25-48</MedlinePgn></Pagination><Abstract><AbstractText>This
        paper contains statistical evaluations of the effect of 9 different plasticizers
        on rat hepatic peroxisome proliferation. There were 9 21-day feeding studies
        with one plasticizer in each study. The plasticizers are: di(2-ethylhexyl)phthalate
        (DEHP), butyl benzyl phthalate (BBP), 711 phthalate (711P), di(n-butyl)phthalate
        (DBP), di(undecyl)phthalate (DUP), di(isodecyl)phthalate (DIDP), di(isononyl)phthalate
        (DINP), 610 phthalate (610P), and di(ethylhexyl)adipate (DEHA). For each plasticizer,
        several dosage (as % of diet) groups, plus a negative control group (0%) and
        a reference control group (1.2% DEHP) were included. There were 5 males and
        5 females, approximately 5 weeks old, per group per plasticizer, for a total
        of 470 animals. For each animal, body weight and food intake were measured
        prior to treatment and twice a week during the treatment period. Animals were
        necropsied at the end of the 21-day treatment period. Selected organs and
        blood samples of each animal were collected for measuring hepatic enzymes,
        proteins, fat stains, organ weights and serum fats. The endpoints included
        electron microscopy examination of liver peroxisome proliferation and liver
        histological abnormalities. The statistical evaluation utilized a multivariate
        approach that condensed a complex phenomenon into certain meaningful and simple
        endpoints for quantitative comparisons. The dose of each plasticizer that
        would protect 99% and 99.9% of rats against peroxisome proliferation (xx%
        statistically predicted dose, or xx% SPD) was estimated. Marked differences
        were seen in the ability of the 9 test compounds to cause hepatic peroxisome
        proliferation in rats. The graphic ranking of overall potency is, in order
        from most potent to least potent: DEHP, DIDP, DINP, DBP, DEHA, DUP, BBP, 711P
        and 610P. The ranking in terms of 99.9% SPD is: DEHP, DINP, DIDP, DBP, 610P,
        DUP, DBP, 711P and DEHA. It was also found that the histological findings
        of reduced basophilia or increased eosinophilia were highly correlated with
        peroxisome proliferation (r = 0.94). The other histological findings were
        incidental observations for specific plasticizers.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>L I</ForeName><Initials>LI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        Ind Health</MedlineTA><NlmUniqueID>8602702</NlmUniqueID><ISSNLinking>0748-2337</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001491" MajorTopicYN="N">Basophils</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004804" MajorTopicYN="N">Eosinophils</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3617068</ArticleId><ArticleId IdType="doi">10.1177/074823378700300204</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10889518</PMID><DateCompleted><Year>2000</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0960-3271</ISSN><JournalIssue
        CitedMedium="Print"><Volume>19</Volume><Issue>3</Issue><PubDate><Year>2000</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Human
        &amp; experimental toxicology</Title><ISOAbbreviation>Hum Exp Toxicol</ISOAbbreviation></Journal><ArticleTitle>Peroxisome
        proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell
        lines.</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>202</EndPage><MedlinePgn>193-202</MedlinePgn></Pagination><Abstract><AbstractText>We
        examined the effects of various peroxisome proliferators (PPs) such as the
        hypolipidaemic agents clofibric acid (CLO), bezafibrate (BEZA), ciprofibrate
        (CIPRO) and nafenopin (NAFE) and the plasticizer di-(2-ethylhexyl)phthalate
        (DEHP) on peroxisomal enzyme activities, apoptosis and DNA synthesis in rat
        FaO and human HepG2 hepatoma cell lines. Both growing and confluent cultures
        were treated with PPs (250 microM) for 48 or 72 h. In accordance with our
        previous observations in PP-treated primary hepatocyte cultures of rat and
        human origin, the various PPs increased peroxisomal enzyme activities in rat
        FaO cells but not in human HepG2 cells. PPs strongly induced apoptosis in
        FaO cells. They did not affect TGFbeta-induced apoptosis, with the exception
        of DEHP and NAFE, respectively blocking and increasing induced apoptosis in
        confluent cultures. Moreover, PPs produced a minor, but significant, decrease
        in DNA synthesis in FaO cells. PPs also decreased DNA synthesis in growing
        HepG2 cells, and CLO, CIPRO and NAFE induced apoptosis in confluent HepG2
        cultures. This is in opposition with the effects of PPs on primary hepatocyte
        cultures, i.e. inhibition of both spontaneous and TGFbeta-induced apoptosis
        and increases in DNA synthesis in rat hepatocytes, and unchanged mitosis-apoptosis
        balance in human hepatocytes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Goll</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratoire
        de Biologie Cellulaire, Facult&#xe9; de M&#xe9;decine et de Pharmacie, Besan&#xe7;on,
        France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viollon-Abadie</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Nicod</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Richert</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum
        Exp Toxicol</MedlineTA><NlmUniqueID>9004560</NlmUniqueID><ISSNLinking>0960-3271</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016211">Transforming Growth Factor alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018197" MajorTopicYN="N">Hepatoblastoma</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016211" MajorTopicYN="N">Transforming Growth Factor alpha</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>7</Month><Day>13</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2000</Year><Month>10</Month><Day>21</Day><Hour>11</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>7</Month><Day>13</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10889518</ArticleId><ArticleId IdType="doi">10.1191/096032700678827753</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3617071</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0748-2337</ISSN><JournalIssue
        CitedMedium="Print"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and industrial health</Title><ISOAbbreviation>Toxicol Ind Health</ISOAbbreviation></Journal><ArticleTitle>Peroxisome
        induction studies on seven phthalate esters.</ArticleTitle><Pagination><StartPage>7</StartPage><EndPage>24</EndPage><MedlinePgn>7-24</MedlinePgn></Pagination><Abstract><AbstractText>Seven
        phthalate esters, representing a variety of chain lengths and degrees of branching
        in the alcohol moiety, were tested for their ability to produce peroxisome
        proliferation in the Fischer 344 rat. Di(2-ethylhexyl)adipate (DEHA) was tested
        using the same protocol and di(2-ethylhexyl)phthalate (DEHP) was run with
        each study as an internal control. Each ester was administered in the feed
        for a period of 21 days at levels of 2.5%, 1.2% and either 0.6% or 0.3%. DEHP
        and DEHA were also fed at levels of 0.1% and 0.01%. The animals were sacrificed
        and samples of liver were prepared for both light and electron microscopy.
        Serum samples were assayed for both triglyceride and cholesterol. The remaining
        portion of the liver was homogenized and assayed for cyanide-insensitive palmitoyl-CoA
        oxidation, lauric acid 11-hydroxylase and lauric acid 12-hydroxylase. The
        results show that there is approximately a ten-fold difference between the
        weakest and strongest esters in terms of their potency to induce changes in
        relative liver weight and in several of the biochemical parameters. In general,
        the longer chain esters were more potent than the shorter chain ones, and
        branched chain esters seemed more potent than straight. Several statistical
        analyses of the dataset have been performed and all render similar conclusions.
        The results of one of these evaluations are presented elsewhere in this volume
        (Lin, 1987).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>E
        D</ForeName><Initials>ED</Initials></Author><Author ValidYN="Y"><LastName>Astill</LastName><ForeName>B
        D</ForeName><Initials>BD</Initials></Author><Author ValidYN="Y"><LastName>Moran</LastName><ForeName>E
        J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>B
        F</ForeName><Initials>BF</Initials></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>T
        J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>B
        G</ForeName><Initials>BG</Initials></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>J
        G</ForeName><Initials>JG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        Ind Health</MedlineTA><NlmUniqueID>8602702</NlmUniqueID><ISSNLinking>0748-2337</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>1763-10-6</RegistryNumber><NameOfSubstance
        UI="D010171">Palmitoyl Coenzyme A</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010171" MajorTopicYN="N">Palmitoyl Coenzyme A</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3617071</ArticleId><ArticleId IdType="doi">10.1177/074823378700300203</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3617070</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0748-2337</ISSN><JournalIssue
        CitedMedium="Print"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and industrial health</Title><ISOAbbreviation>Toxicol Ind Health</ISOAbbreviation></Journal><ArticleTitle>Peroxisome
        induction studies on di(2-ethylhexyl)terephthalate.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>78</EndPage><MedlinePgn>63-78</MedlinePgn></Pagination><Abstract><AbstractText>Groups
        of five male and five female rats were fed diets containing from 0% to 2.5%
        di(2-ethylhexyl)terephthalate (DEHT) or 1.2% di(2-ethylhexyl)phthalate (DEHP)
        for 21 days. Feed consumption and body weight gains were collected and, at
        study termination, animals were examined for alterations in body weight, differences
        in serum lipids, changes in the activities of certain enzymes associated with
        fat metabolism, and proliferation of hepatic peroxisomes. Feed consumption
        and weight gain were greatly decreased in DEHT-fed animals only at 2.5%. No
        biologically significant alterations in absolute liver weight occurred with
        DEHT. Relative liver weights were increased at 2.5% in both sexes and at 1.0%
        and 1.2% in females. The alterations were due wholly to decreased terminal
        body weights. Serum triglyceride and cholesterol levels were not found useful
        in interpreting the effects of DEHT. Cyanide-insensitive palmitoyl CoA oxidation
        and lauric acid 11- and 12-hydroxylation were increased in animals consuming
        2.5%, but no lower levels of DEHT. Induction of hepatic peroxisomes did not
        occur at 1.2% DEHT. Interpretation of minimal peroxisomal effects with 2.5%
        DEHT was confounded by reduced feed consumption. Slight decreases in weight
        gain occurred in males consuming the 1.2% DEHP diet, but differences were
        minor relative to effects observed at 2.5% DEHT. Results with DEHP contrasted
        with those obtained with DEHT. Absolute and relative liver weights, activities
        of enzymes of lipid metabolism, and peroxisome content were all significantly
        increased at 1.2% DEHP. Reduction of feed intake was implicated in the effects
        observed at 2.5% DEHT, since the amount of DEHT consumed by 2.5% animals was
        only 1.4 times as much as by 1.2% animals. A possible explanation for the
        observed differences between DEHP and DEHT was related to the results of a
        metabolic fate study on DEHT. Metabolism of DEHT by the rat appears to occur
        via rapid hydrolysis of both ester linkages to give two moles of 2-ethylhexanol
        and one mole of terephthalic acid. Although 2-ethylhexanol has been shown
        to induce peroxisome proliferation, it appears to be less active in this respect
        than the monoester of DEHP. The relatively smaller amounts of monoester produced
        during the metabolism of DEHT may explain the differences seen in these experiments.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Topping</LastName><ForeName>D
        C</ForeName><Initials>DC</Initials></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>G
        P</ForeName><Initials>GP</Initials></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>J
        G</ForeName><Initials>JG</Initials></Author><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>B
        G</ForeName><Initials>BG</Initials></Author><Author ValidYN="Y"><LastName>O''Donoghue</LastName><ForeName>J
        L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Lockhart</LastName><ForeName>H
        B</ForeName><Initials>HB</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        Ind Health</MedlineTA><NlmUniqueID>8602702</NlmUniqueID><ISSNLinking>0748-2337</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>1763-10-6</RegistryNumber><NameOfSubstance
        UI="D010171">Palmitoyl Coenzyme A</NameOfSubstance></Chemical><Chemical><RegistryNumber>4VS908W98L</RegistryNumber><NameOfSubstance
        UI="C053316">di-(2-ethylhexyl) terephthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D006899">Mixed Function Oxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.15.3</RegistryNumber><NameOfSubstance UI="D042926">Cytochrome P-450 CYP4A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D042926" MajorTopicYN="N">Cytochrome P-450 CYP4A</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006899" MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010171" MajorTopicYN="N">Palmitoyl Coenzyme A</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3617070</ArticleId><ArticleId IdType="doi">10.1177/074823378700300206</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3815733</PMID><DateCompleted><Year>1987</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>11</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>8</Volume><Issue>3</Issue><PubDate><Year>1987</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>A
        cytological comparison between regeneration, hyperplasia and early neoplasia
        in the rat liver.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>399</EndPage><MedlinePgn>391-9</MedlinePgn></Pagination><Abstract><AbstractText>Regeneration,
        hyperplasia and neoplasia are three different responses to injury in the rat
        liver. These phenomena were induced in rat liver and the parameters of ploidy,
        nuclearity and DNA synthesis were examined. Analysis of hepatocytes from animals
        undergoing liver regeneration following two-thirds partial hepatectomy revealed
        that there is an increase in the cycling of diploid hepatocytes and a large
        increase in the frequency of binucleated tetraploid cells undergoing DNA synthesis
        and amitotic cytokinesis to mononucleated tetraploid cells. This results in
        an overall increase in the ratio of tetraploid:diploid cells but no change
        in the proportion of binucleated cells. The liver appears, temporarily, to
        undergo an increased rate of maturation. In both hyperplasia inducted by oral
        administration of 25 mg/kg methylclofenapate or diethylhexylphthalate (1 g/kg
        for 4 weeks) and neoplasia induced by the hepatocarcinogens 3''-methyl-4-dimethylaminoazobenzene
        (3''M), 6-p-dimethylaminophenylazobenzthiazole (6BT), 5-phenylazoindazole
        (5I), diethylnitrosamine (DEN) and thioacetamide (TA) the binucleated cell
        is sensitive to the action of the chemicals, although its response is different.
        Both types of carcinogen induce a reduction in the frequency of binucleated
        cells but the mononucleated diploid cells produced by cytokinesis without
        a preceding S phase as a result of the action of genotoxic carcinogens appear
        to be incapable of polyploidization and give rise to a liver with a permanently
        depressed tetraploid:diploid hepatocyte ratio. The nongenotoxic carcinogens
        methylclofenapate and DEHP cause an initial hyperplastic response due to the
        rapid conversion of binucleated cells to mononucleated tetraploids by amitotic
        cytokinesis following S phase. Over a longer period of exposure there is an
        increase in the tetraploid:diploid ratio due to the continued conversion of
        newly formed binucleates to tetraploid mononucleates.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Styles</LastName><ForeName>J
        A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Elcombe</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006498" MajorTopicYN="N">Hepatectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName
        UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008115" MajorTopicYN="Y">Liver Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3815733</ArticleId><ArticleId IdType="doi">10.1093/carcin/8.3.391</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15664438</PMID><DateCompleted><Year>2005</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>208</Volume><Issue>1</Issue><PubDate><Year>2005</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Evaluation
        of anti-androgenic activity of di-(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>115</StartPage><EndPage>121</EndPage><MedlinePgn>115-21</MedlinePgn></Pagination><Abstract><AbstractText>DEHP
        is a widely used platiciser in the manufacture of PVC-based materials. It
        is known to disrupt the reproductive tract development in male rats. We have
        performed the Hershberger assay with DEHP on an immature castrated rat model
        to check if DEHP antagonise the testosterone propionate androgenic effect
        on the accessory sex organs development. DEHP significantly decreased the
        BC/LA muscles, the prostate, and the seminal vesicles relative weights from
        100, 200, and 400 mg/kg bw/day, respectively. DEHP increased the liver relative
        weight from 100 mg/kg bw/day. A study was also performed on MDA-MB453 cell
        line stably transfected with pMMTVneo-Luc with DEHP and its major metabolites
        (MEHP and metabolites VI and IX) to identify anti-androgenic activity. Neither
        DEHP nor MEHP antagonised DHT activity in the MDA-MB453 transfected cells.
        In contrast, metabolites VI and IX were anti-androgenic in vitro. DEHP appeared
        not to be a 5alpha-reductase inhibitor and acted in an independent mechanism
        from the testicular production in the young rat.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Stroheker</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UMR
        1234 Toxicologie Alimentaire, University of Burgundy/INRA, 1 Esplanade Erasme,
        21000 Dijon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabaton</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Nourdin</LastName><ForeName>Gorian</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>R&#xe9;gnier</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials></Author><Author
        ValidYN="Y"><LastName>Lhuguenot</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>Chagnon</LastName><ForeName>Marie-Christine</ForeName><Initials>MC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000726">Androgen Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C479069">mono(2-ethyl-5-hydroxyhexyl) phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>08J2K08A3Y</RegistryNumber><NameOfSubstance
        UI="D013196">Dihydrotestosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>40321-98-0</RegistryNumber><NameOfSubstance
        UI="C080276">mono(2-ethyl-5-oxohexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.13.12.-</RegistryNumber><NameOfSubstance UI="D008156">Luciferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI93Z9138A</RegistryNumber><NameOfSubstance
        UI="D043343">Testosterone Propionate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000726" MajorTopicYN="N">Androgen Antagonists</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013196" MajorTopicYN="N">Dihydrotestosterone</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004357" MajorTopicYN="N">Drug Synergism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005837" MajorTopicYN="N">Genitalia, Male</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName><QualifierName UI="Q000037"
        MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009919" MajorTopicYN="N">Orchiectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D043343" MajorTopicYN="N">Testosterone Propionate</DescriptorName><QualifierName
        UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2004</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2004</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2004</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2005</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2005</Year><Month>3</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2005</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15664438</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2004.11.013</ArticleId><ArticleId
        IdType="pii">S0300-483X(04)00613-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11560248</PMID><DateCompleted><Year>2002</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0192-6233</ISSN><JournalIssue
        CitedMedium="Print"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2001</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Toxicologic
        pathology</Title><ISOAbbreviation>Toxicol Pathol</ISOAbbreviation></Journal><ArticleTitle>Reversibility
        of the chronic effects of di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>430</StartPage><EndPage>439</EndPage><MedlinePgn>430-9</MedlinePgn></Pagination><Abstract><AbstractText>Fischer-344
        rats treated with 12,500 ppm (728 and 879 mg/kg/d for male and females, respectively)
        and B6C3F1 mice treated with 6,000 ppm (1,227 and 1,408 mg/kg/d, respectively)
        di(2-ethylhexyl)phthalate (DEHP) in the diet for 78 weeks were allowed to
        recover for an additional 26 weeks on control diet. Blood was analyzed at
        weeks 78 and 104 from 10 animals per sex per group; animals were sacrificed
        at weeks 79 and 105 for histopathologic examination. The results are compared
        with data from animals continuously exposed to these dietary levels for 104
        weeks (10, 11). Body weights and food consumption were measured monthly. BUN,
        albumin, and globulin that were significantly different for rats exposed to
        DEHP throughout 104 weeks, were comparable to controls for the recovery group.
        Reversibility of chronic effects on erythrocyte count, hemoglobin, and hematocrit
        values was apparent only for female rats. Chronic exposure demonstrated effects
        on liver, kidney, and testes weights. All organ weight effects except for
        testes for the Recovery group of rats, and all organ weight effects for mice,
        were reversible. Pigmentation of Kupffer cells and renal tubules present in
        chronically treated rats were not observed for the Recovery group. Lesions
        in the testes and pituitary gland were not reversible in rats. This may be
        a reflection of the senescence of the hypothalamic-gonad axis in rats. Cessation
        of exposure for mice resulted in amelioration of effects in the kidneys, liver,
        and testes. The extent of reversibility suggests that many chronic effects
        may be associated with a metabolic phenomenon such as peroxisome proliferation,
        which also reverted to control levels after 26 weeks of recovery.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>David</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Health
        and Environment Laboratories, Eastman Kodak Company, Rochester, New York 14652,
        USA. raymond.david@kodak.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Moore</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author><Author
        ValidYN="Y"><LastName>Finney</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Pathol</MedlineTA><NlmUniqueID>7905907</NlmUniqueID><ISSNLinking>0192-6233</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012709">Serum Albumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012712">Serum Globulins</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001806" MajorTopicYN="N">Blood Urea Nitrogen</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007674" MajorTopicYN="N">Kidney Diseases</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008107" MajorTopicYN="N">Liver Diseases</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010900" MajorTopicYN="N">Pituitary Diseases</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012709" MajorTopicYN="N">Serum Albumin</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012712" MajorTopicYN="N">Serum Globulins</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013733" MajorTopicYN="N">Testicular Diseases</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>9</Month><Day>19</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>3</Month><Day>30</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>9</Month><Day>19</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11560248</ArticleId><ArticleId IdType="doi">10.1080/01926230152500040</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3617093</PMID><DateCompleted><Year>1987</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue
        CitedMedium="Print"><Volume>37</Volume><Issue>3</Issue><PubDate><Year>1987</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Acyl
        CoA oxidase is the most suitable marker for hepatic peroxisomal changes caused
        by treatment of F344 rats with di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>203</StartPage><EndPage>212</EndPage><MedlinePgn>203-12</MedlinePgn></Pagination><Abstract><AbstractText>Hepatic
        peroxisomal changes, caused by treating male Fischer 344 rats with di(2-ethylhexyl)phthalate,
        were examined by measuring activities of enzymes involved in peroxisomal beta-oxidation,
        catalase and levels of the 80,000 Da peroxisome proliferation-associated polypeptide.
        Acyl CoA oxidase activity was increased 2.5-fold after 1 day, and 8-fold after
        14 days. Enoyl CoA hydratase activity increased 2-fold after 2 days and 6-fold
        after 14 days. There were no significant increases in hydroxyacyl CoA dehydrogenase
        or catalase activities after 3 days of treatment. Thus acyl CoA oxidase activity
        was the most sensitive marker of early peroxisomal changes. The apparent no-observable-effect
        level for this change was 0.06 g/kg/day.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Tomaszewski</LastName><ForeName>K
        E</ForeName><Initials>KE</Initials></Author><Author ValidYN="Y"><LastName>Derks</LastName><ForeName>M
        C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Melnick</LastName><ForeName>R
        L</ForeName><Initials>RL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.-</RegistryNumber><NameOfSubstance UI="D015094">3-Hydroxyacyl CoA Dehydrogenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        4.2.1.17</RegistryNumber><NameOfSubstance UI="D004746">Enoyl-CoA Hydratase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015094" MajorTopicYN="N">3-Hydroxyacyl CoA Dehydrogenases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004746" MajorTopicYN="N">Enoyl-CoA Hydratase</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3617093</ArticleId><ArticleId IdType="doi">10.1016/0378-4274(87)90133-0</ArticleId><ArticleId
        IdType="pii">0378-4274(87)90133-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">7115078</PMID><DateCompleted><Year>1982</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0340-5761</ISSN><JournalIssue
        CitedMedium="Print"><Volume>50</Volume><Issue>1</Issue><PubDate><Year>1982</Year><Month>May</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Phthalate
        esters I: Effects on cytochrome P-450 mediated metabolism in rat liver and
        lung, serum enzymatic activities and serum protein levels.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><Abstract><AbstractText>Dimethylphthalate
        (DMP), dibutylphthalate (DBP) and di(2-ethylhexyl)phthalate (DEHP) were given
        i.p. (3.8 mM/kg) to Sprague Dawley rats for 5 days. DBP increased significantly
        the liver concentration of cytochrome P-450, but decreased the lung concentration
        by about 40%. DBP decreased the lung concentration of cytochrome b5 and NADPH-cytochrome-c-reductase
        activity by about 30%. Only minor effects were seen after treatment with DMP
        and DEHP. The direction of B(a)P metabolism was changed and the formation
        of 2- and 3-hexanol metabolites were increased in liver microsomes after DBP
        treatment. All phthalate esters decreased the lung metabolism of B(a)P. The
        cytochrome P-450 enzyme system in the lung was ten times more effective than
        that in the liver as far as metabolism of n-hexane was concerned. Only minor
        effects were observed in serum enzyme activities, but a significant decrease
        in the serum level of albumin was observed after treatment with DBP. No relationship
        was found between the carbon chain length of the investigated chemicals and
        effects on microsomal enzymatic activities.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Walseth</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author
        ValidYN="Y"><LastName>Toftg&#xe5;rd</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Nilsen</LastName><ForeName>O G</ForeName><Initials>OG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004798">Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>08X7F5UDJM</RegistryNumber><NameOfSubstance
        UI="C024629">dimethyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>2286E5R2KE</RegistryNumber><NameOfSubstance
        UI="D003993">Dibutyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003993" MajorTopicYN="N">Dibutyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004798" MajorTopicYN="N">Enzymes</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1982</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1982</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1982</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7115078</ArticleId><ArticleId IdType="doi">10.1007/BF00569231</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature.
        1970 Aug 15;227(5259):680-5</Citation><ArticleIdList><ArticleId IdType="pubmed">5432063</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1977 May;40(2):355-64</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17933</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1962 Feb;237:587-95</Citation><ArticleIdList><ArticleId IdType="pubmed">14007123</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1979 Apr;48(2):337-42</Citation><ArticleIdList><ArticleId
        IdType="pubmed">473183</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1964 Jul;239:2370-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14209971</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1977 Jan 24;496(1):115-35</Citation><ArticleIdList><ArticleId
        IdType="pubmed">402160</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Toxicol. 1978;13(2):257-68</Citation><ArticleIdList><ArticleId IdType="pubmed">367696</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1973 Jan;3:95-102</Citation><ArticleIdList><ArticleId IdType="pubmed">4735799</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1949 Feb;177(2):751-66</Citation><ArticleIdList><ArticleId IdType="pubmed">18110453</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal
        Biochem. 1978 Jun 1;86(2):725-32</Citation><ArticleIdList><ArticleId IdType="pubmed">655426</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1978 Nov;11(3):271-5</Citation><ArticleIdList><ArticleId IdType="pubmed">734683</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta
        Pharmacol Toxicol (Copenh). 1981 May;48(5):369-76</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7336952</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta
        Pharmacol Toxicol (Copenh). 1980 May;46(5):353-61</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7376887</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1973 Jun 21;306(3):380-90</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4726865</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1977 Feb;39(2):239-48</Citation><ArticleIdList><ArticleId
        IdType="pubmed">403636</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Chem. 1978 Jan;24(1):80-6</Citation><ArticleIdList><ArticleId IdType="pubmed">618669</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1975 May;32(2):355-67</Citation><ArticleIdList><ArticleId
        IdType="pubmed">168667</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1951 Nov;193(1):265-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14907713</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry.
        1971 Nov;10(23):4228-32</Citation><ArticleIdList><ArticleId IdType="pubmed">5166642</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Int Pharmacodyn Ther. 1978 Oct;235(2):187-95</Citation><ArticleIdList><ArticleId
        IdType="pubmed">736698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1972 Aug 18;238(5364):411-3</Citation><ArticleIdList><ArticleId IdType="pubmed">4626399</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull
        Environ Contam Toxicol. 1974 Dec;12(6):721-5</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4457184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">26252616</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2015</Year><Month>09</Month><Day>12</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1528-7394</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>78</Volume><Issue>16</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health. Part A</Title><ISOAbbreviation>J Toxicol
        Environ Health A</ISOAbbreviation></Journal><ArticleTitle>Comparative Cytotoxicity
        and Sperm Motility Using a Computer-Aided Sperm Analysis System (CASA) for
        Isomers of Phthalic Acid, a Common Final Metabolite of Phthalates.</ArticleTitle><Pagination><StartPage>1038</StartPage><EndPage>1050</EndPage><MedlinePgn>1038-50</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1080/15287394.2015.1067503</ELocationID><Abstract><AbstractText>The
        general population is exposed to phthalates through consumer products, diet,
        and medical devices. Phthalic acid (PA) is a common final metabolite of phthalates,
        and its isomers include isophthalic acid (IPA), terephthalic acid (TPA), and
        phthalaldehyde (o-phthalic acid, OPA). The purpose of this study was to investigate
        whether PA and PA isomers exert reproductive toxicity, including altered sperm
        movement. In vitro cell viability assays were comparatively performed using
        Sertoli and liver cell lines. In animal experiments, PA or PA isomers (10,
        100, or 1000 mg/kg) were administered orally to Sprague-Dawley (SD) rats,
        and semen samples were analyzed by computer-aided sperm analysis (CASA). PA
        treatment produced a significant effect on curvilinear velocity (VCL), straight-line
        velocity (VSL), mean velocity or average path velocity (VAP), amplitude of
        lateral head displacement (ALH), and frequency of head displacement or beat
        cross-frequency (BCF), whereas IPA, TPA, and OPA induced no marked effects.
        In vitro cell viability assays showed that mouse normal testis cells (TM4)
        and human testis cancer cells (NTERA 2 cl. D1) were more sensitive to PA and
        OPA than mouse liver normal cells (NCTC clone 1469) and human fetal liver
        cells (FL 62891). Our study suggests that PA and PA isomers specifically produced
        significant in vitro and in vivo reproductive toxicity, particularly sperm
        toxicity and testis cell cytotoxicity. Of the isomers examined, PA appeared
        to be the most toxic and may serve as a surrogate biomarker for reproductive
        toxicity following mixed exposure to phthalates.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwack</LastName><ForeName>Seung
        Jun</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>a Department
        of Biochemistry and Health Science , College of Natural Sciences, Changwon
        National University , Changwon , Gyeongnam , South Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lee</LastName><ForeName>Byung-Mu</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>b
        Division of Toxicology , College of Pharmacy, Sungkyunkwan University , Suwon
        , Gyeonggi-Do , Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Toxicol Environ Health A</MedlineTA><NlmUniqueID>100960995</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>121-91-5</RegistryNumber><NameOfSubstance
        UI="C059768">isophthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>643-79-8</RegistryNumber><NameOfSubstance
        UI="D009764">o-Phthalaldehyde</NameOfSubstance></Chemical><Chemical><RegistryNumber>6O7F7IX66E</RegistryNumber><NameOfSubstance
        UI="C032279">phthalic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>6S7NKZ40BQ</RegistryNumber><NameOfSubstance
        UI="C011363">terephthalic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004822" MajorTopicYN="N">Epididymis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013081" MajorTopicYN="N">Sperm Motility</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009764" MajorTopicYN="N">o-Phthalaldehyde</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">26252616</ArticleId><ArticleId IdType="doi">10.1080/15287394.2015.1067503</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3583306</PMID><DateCompleted><Year>1987</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0301-1208</ISSN><JournalIssue
        CitedMedium="Print"><Volume>23</Volume><Issue>5</Issue><PubDate><Year>1986</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Indian
        journal of biochemistry &amp; biophysics</Title><ISOAbbreviation>Indian J
        Biochem Biophys</ISOAbbreviation></Journal><ArticleTitle>A comparative study
        of the effects of administration of diethylhexyl phthalate on hepatic mitochondria
        of the rat and the mouse.</ArticleTitle><Pagination><StartPage>270</StartPage><EndPage>273</EndPage><MedlinePgn>270-3</MedlinePgn></Pagination><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Kurup</LastName><ForeName>C K</ForeName><Initials>CK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian
        J Biochem Biophys</MedlineTA><NlmUniqueID>0310774</NlmUniqueID><ISSNLinking>0301-1208</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008930" MajorTopicYN="N">Mitochondria, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3583306</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11091278</PMID><DateCompleted><Year>2000</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0009-9104</ISSN><JournalIssue
        CitedMedium="Print"><Volume>122</Volume><Issue>2</Issue><PubDate><Year>2000</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Clinical
        and experimental immunology</Title><ISOAbbreviation>Clin Exp Immunol</ISOAbbreviation></Journal><ArticleTitle>Effects
        of peroxisome proliferators on the thymus and spleen of mice.</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>226</EndPage><MedlinePgn>219-26</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of peroxisome proliferators on the immune system of male C57B1/6 mice
        have been investigated. Significant atrophy of the thymus and spleen was observed
        in animals treated with potent peroxisome proliferators (e.g. perfluorooctanoic
        acid (PFOA), di(2-ethylhexyl)phthalate (DEHP), Wy-14643 and nafenopin), whereas
        the effects of a moderate peroxisome proliferator (i.e. acetylsalicylic acid
        (ASA)) were relatively weak. The time course of thymic and splenic atrophy
        caused by PFOA was found to resemble the time course of the increase in liver
        weight and of peroxisome proliferation. Analysis of the numbers and phenotypes
        of thymocytes and splenocytes from PFOA-treated mice revealed the following:
        (i) the numbers of thymocytes and splenocytes were decreased &gt; 90% and
        about 50%, respectively, by PFOA treatment; (ii) although all populations
        of thymocytes were decreased, the immature CD4+CD8+ population was decreased
        most dramatically; (iii) the numbers of both T and B cells in the spleen were
        decreased by PFOA treatment. Analysis of the cell cycle of thymocytes indicated
        that the thymic atrophy caused by PFOA in mice results, at least in part,
        from inhibition of thymocyte proliferation. Interestingly, in vitro exposure
        to PFOA for up to 24 h did not produce analogous effects in either thymocytes
        or splenocytes. Thus, the thymic and splenic atrophy caused by PFOA appears
        to involve an indirect pathway.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Yang</LastName><ForeName>Q</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Stockholm University, Sweden. Qian@tuborg.biokemi.su.se</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Xie</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Depierre</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin
        Exp Immunol</MedlineTA><NlmUniqueID>0057202</NlmUniqueID><ISSNLinking>0009-9104</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002210">Caprylates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005466">Fluorocarbons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>947VD76D3L</RegistryNumber><NameOfSubstance
        UI="C023036">perfluorooctanoic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance
        UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276"
        MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002210" MajorTopicYN="N">Caprylates</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005466" MajorTopicYN="N">Fluorocarbons</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276"
        MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013950" MajorTopicYN="N">Thymus Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000276"
        MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>11</Month><Day>25</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>11</Month><Day>25</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11091278</ArticleId><ArticleId IdType="pmc">PMC1905771</ArticleId><ArticleId
        IdType="doi">10.1046/j.1365-2249.2000.01367.x</ArticleId><ArticleId IdType="pii">cei1367</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gonzalez
        FJ, Peters JM, Cattley RC. Mechanism of action of the nongenotoxic peroxisome
        proliferators: role of the peroxisome proliferator-activator receptor alpha.
        J Natl Cancer Inst. 1998;90:1702&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9827524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, DeLuca J, Elcombe C, et al. Do peroxisome proliferating compounds pose
        a hepatocarcinogenic hazard to humans? Regul Toxicol Pharmacol. 1998;27:47&#x2013;60.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9618323</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman
        L, Fruchart JC, Auwerx J. An update on the mechanisms of action of the peroxisome
        proliferator-activated receptors (PPARs) and their roles in inflammation and
        cancer. Cell Mol Life Sci. 1999;55:932&#x2013;43.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10412372</ArticleId></ArticleIdList></Reference><Reference><Citation>Luster
        MI, Rosenthal GJ. Chemical agents and the immune response. Environ Health
        Perspect. 1993;100:219&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1519592</ArticleId><ArticleId
        IdType="pubmed">8354170</ArticleId></ArticleIdList></Reference><Reference><Citation>Voccia
        I, Blakley B, Brousseau P, Fournier M. Immunotoxicity of pesticides: a review.
        Toxicol Ind Health. 1999;15:119&#x2013;32.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10188195</ArticleId></ArticleIdList></Reference><Reference><Citation>Descotes
        J. An introduction to immunotoxicology. 1. London: Taylor &amp; Francis Ltd;
        1999.</Citation></Reference><Reference><Citation>Dogra RK, Khanna S, Nagale
        SL, et al. Effect of dioctyl phthalate on immune system of rat. Indian J Exp
        Biol. 1985;23:315&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">4077130</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris
        MW, Uraih LC, Birnbaum LS. Acute toxicity of perfluorodecanoic acid in C57BL/6
        mice differs from 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol.
        1989;13:723&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">2620793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson
        DL, Frazier DE, Ericson JE, et al. The effects of perfluorodecanoic acid (PFDA)
        on humoral, cellular, and innate immunity in Fischer 344 rats. Immunopharmacol
        Immunotoxicol. 1992;14:925&#x2013;38.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1294628</ArticleId></ArticleIdList></Reference><Reference><Citation>Van
        Loveren H, Steerenberg PA, Vos JG. Early detection of immunotoxicity: from
        animal studies to human biomonitoring. Toxicol Lett. 1995;77:73&#x2013;80.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7618171</ArticleId></ArticleIdList></Reference><Reference><Citation>Karol
        MH. Target organs and systems: methodologies to assess immune system function.
        Environ Health Perspect. 1998;106(Suppl. 2):533&#x2013;40.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1533401</ArticleId><ArticleId IdType="pubmed">9599701</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoletti
        I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring
        thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol
        Methods. 1991;139:271&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1710634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapira
        L, Takashiba S, Kalmar JR, et al. Rapid fluorometric quantification of monocyte
        attachment in tissue culture wells. J Immunol Methods. 1993;165:93&#x2013;98.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8409472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda
        T, Aiba K, Fukuda K, Tanaka M. The induction of peroxisome proliferation in
        rat liver by perfluorinated fatty acids, metabolically inert derivatives of
        fatty acids. J Biochem (Tokyo) 1985;98:475&#x2013;82.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4066651</ArticleId></ArticleIdList></Reference><Reference><Citation>DePierre
        JW, Sohlenius AK, Eriksson AM, et al. Responses of epoxide hydrolases, glutathione
        S-transferase, DT-diaphorase and catalase in mouse liver to treatment with
        peroxisome proliferators. In: Moody DE, editor. Peroxisome proliferators:
        unique inducers of drug-metabolizing enzymes. Boca Raton, Florida: CRC Press
        Inc; 1994. pp. 123&#x2013;36.</Citation></Reference><Reference><Citation>Ward
        JM, Peters JM, Perella CM, Gonzalez FJ. Receptor and nonreceptor-mediated
        organ-specific toxicity of di(2-ethylhexyl) phthalate (DEHP) in peroxisome
        proliferator-activated receptor alpha-null mice. Toxicol Pathol. 1998;26:240&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9547862</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden
        Heuvel JP, Kuslikis BI, Van Rafelghem MJ, Peterson RE. Disposition of perfluorodecanoic
        acid in male and female rats. Toxicol Appl Pharmacol. 1991;107:450&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2000633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohlenius
        AK, Lundgren B, DePierre JW. Perfluorooctanoic acid has persistent effects
        on peroxisome proliferation and related parameters in mouse liver. J Biochem
        Toxicol. 1992;7:205&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">1293309</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabalina
        IG, Panaretakis T, DePierre JW. Effects of the rodent peroxisome proliferator
        and hepatocarcinogen perfluorooctanoic acid on the cell cycle and apoptosis
        in human hepatoma HepG2 cells. Carcinogenesis. 1999 in press.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10590214</ArticleId></ArticleIdList></Reference><Reference><Citation>Janeway
        CA, Travers P, Walport M, Capra JD. Immunobiology: the immune system in health
        and disease. 4. New York: Garland Publishing; 1999.</Citation></Reference><Reference><Citation>Schuurman
        HJ, Van Loveren H, Rozing J, Vos JG. Chemicals trophic for the thymus: risk
        for immunodeficiency and autoimmunity. Int J Immunopharmacol. 1992;14:369&#x2013;75.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1618591</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenlee
        WF, Dold KM, Irons RD, Osborne R. Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin
        (TCDD) on thymic epithelium. Toxicol Appl Pharmacol. 1985;79:112&#x2013;20.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2996175</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaylock
        BL, Holladay SD, Comment CE, et al. Exposure to tetrachlorodibenzo-p-dioxin
        (TCDD) alters fetal thymocyte maturation. Toxicol Appl Pharmacol. 1992;112:207&#x2013;13.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1531708</ArticleId></ArticleIdList></Reference><Reference><Citation>Comment
        CE, Blaylock BL, Germolec DR, et al. Thymocyte injury after in vitro chemical
        exposure: potential mechanisms for thymic atrophy. J Pharmacol Exp Ther. 1992;262:1267&#x2013;73.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1527729</ArticleId></ArticleIdList></Reference><Reference><Citation>McConkey
        DJ, Jondal M, Orrenius S. The regulation of apoptosis in thymocytes. Biochem
        Soc Trans. 1994;22:606&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">7821647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruett
        SB, Ensley DK, Crittenden PL. The role of chemical-induced stress responses
        in immunosuppression: a review of quantitative associations and cause-effect
        relationships between chemical-induced stress responses and immunosuppression.
        J Toxicol Environ Health. 1993;39:163&#x2013;92.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8501763</ArticleId></ArticleIdList></Reference><Reference><Citation>Devchand
        PR, Keller H, Peters JM, et al. The PPARalpha-leukotriene B4 pathway to inflammation
        control. Nature. 1996;384:39&#x2013;43.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8900274</ArticleId></ArticleIdList></Reference><Reference><Citation>Braissant
        O, Foufelle F, Scotto C, et al. Differential expression of peroxisome proliferator-activated
        receptors (PPARs): tissue distribution of PPAR-alpha-beta, and -gamma in the
        adult rat. Endocrinology. 1996;137:354&#x2013;66.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8536636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricote
        M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor
        gamma is a negative regulator of macrophage activation. Nature. 1998;391:79&#x2013;82.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9422508</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang
        C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory
        cytokines. Nature. 1998;391:82&#x2013;86.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9422509</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">33166671</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>11</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6351</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>146</Volume><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Disturbance of di-(2-ethylhexyl)
        phthalate in hepatic lipid metabolism in rats fed with high fat diet.</ArticleTitle><Pagination><StartPage>111848</StartPage><MedlinePgn>111848</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.fct.2020.111848</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0278-6915(20)30738-9</ELocationID><Abstract><AbstractText>Di-(2-ethylhexyl)
        phthalate (DEHP), which is widely used as an industrial plasticizer, may cause
        liver damage. Concomitantly, bad dietary habits can exacerbate the liver burden.
        In this study, high-fat diet (HFD)-fed rats were treated with DEHP (10, 100,
        or 300&#xa0;mg/kg bw) for 5 weeks, and a biochemical method was adopted to
        detect serum lipid contents. Key metabolic genes and pathological changes
        were assessed by different methods (RT-PCR, Western Bloting, ELISA and HE
        staining). The rats which were exposed to DEHP at a dose of 10&#xa0;mg/kg
        bw exhibited dyslipidemia and increased transcription of SREBP-1 and its target
        FAS, thereby prompting de novo lipogenesis, but they did not become obese.
        Instead, DEHP at a dose of 300&#xa0;mg/kg bw elevated the levels of AMPK phosphorylation
        and the mRNA levels of PPAR-&#x3b1;, PGC-1&#x3b1;, CPT-1 and lipin-1 in the
        liver, which led to fatty acid oxidation. Additionally, DEHP at the highest
        dose increased the TNF-&#x3b1; mRNA expression in the liver. Based on these
        findings, we conclude that excess fatty acid oxidation might increase the
        inflammatory response. No toxic effects on hepatic function were observed.
        These findings suggest that different doses of DEHP have the potential to
        disturb hepatic metabolic imbalance in HFD-fed rats.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuexia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute
        of Environmental Science, Shanxi University, Taiyuan, 030006, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ge</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute
        of Environmental Science, Shanxi University, Taiyuan, 030006, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhenhua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute
        of Environmental Science, Shanxi University, Taiyuan, 030006, China. Electronic
        address: yzh429@sxu.edu.cn.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Li</LastName><ForeName>Zhongping</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute
        of Environmental Science, Shanxi University, Taiyuan, 030006, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gong</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute
        of Environmental Science, Shanxi University, Taiyuan, 030006, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Quanxi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute
        of Environmental Science, Shanxi University, Taiyuan, 030006, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dong</LastName><ForeName>Wenjuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute
        of Environmental Science, Shanxi University, Taiyuan, 030006, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dong</LastName><ForeName>Chuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute
        of Environmental Science, Shanxi University, Taiyuan, 030006, China. Electronic
        address: dongch958@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D059305" MajorTopicYN="N">Diet, High-Fat</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Fatty acid oxidation</Keyword><Keyword
        MajorTopicYN="N">High-fat diet</Keyword><Keyword MajorTopicYN="N">Lipogenesis</Keyword><Keyword
        MajorTopicYN="N">Liver</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2019</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>9</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">33166671</ArticleId><ArticleId IdType="doi">10.1016/j.fct.2020.111848</ArticleId><ArticleId
        IdType="pii">S0278-6915(20)30738-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">23899473</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3177</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>27</Volume><Issue>7</Issue><PubDate><Year>2013</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Toxicology
        in vitro : an international journal published in association with BIBRA</Title><ISOAbbreviation>Toxicol
        In Vitro</ISOAbbreviation></Journal><ArticleTitle>Evidence for triclosan-induced
        activation of human and rodent xenobiotic nuclear receptors.</ArticleTitle><Pagination><StartPage>2049</StartPage><EndPage>2060</EndPage><MedlinePgn>2049-60</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.tiv.2013.07.008</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0887-2333(13)00186-0</ELocationID><Abstract><AbstractText>The
        bacteriostat triclosan (2,4,4''-trichloro-2''-hydroxydiphenylether) (TCS)
        decreases rat serum thyroxine via putative nuclear receptor (NR) interaction(s)
        and subsequent transcriptional up-regulation of hepatic catabolism and clearance.
        However, due to the evolutionary divergence of the constitutive androstane
        and pregnane-X receptors (CAR, PXR), TCS-mediated downstream effects may be
        species-dependent. To test the hypothesis that TCS activates xenobiotic NRs
        across species, cell-based NR reporter assays were employed to assess potential
        activation of rat, mouse, and human PXR, and rat, mouse, and three splice
        variants of human CAR. TCS activated hPXR, acted as an inverse agonist of
        hCAR1, and as a weak agonist of hCAR3. TCS failed to activate rPXR in full-length
        receptor reporter assays, and instead acted as a modest inverse agonist of
        rCAR. Consistent with the rat data, TCS also failed to activate mPXR and was
        a modest inverse agonist of mCAR. These data suggest that TCS may interact
        with multiple NRs, including hPXR, hCAR1, hCAR3, and rCAR in order to potentially
        affect hepatic catabolism. Overall these data support the conclusion that
        TCS may interact with NRs to regulate hepatic catabolism and downstream thyroid
        hormone homeostasis in both rat and human models, though perhaps by divergent
        mechanisms.</AbstractText><CopyrightInformation>Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Katie
        B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>University
        of North Carolina at Chapel Hill, Curriculum in Toxicology, CB 7270, Chapel
        Hill, NC 27599, United States; Integrated Systems Toxicology Division, National
        Health and Environmental Effects Research Laboratory, United States.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Thompson</LastName><ForeName>Jerry T</ForeName><Initials>JT</Initials></Author><Author
        ValidYN="Y"><LastName>Simmons</LastName><ForeName>Steven O</ForeName><Initials>SO</Initials></Author><Author
        ValidYN="Y"><LastName>Vanden Heuvel</LastName><ForeName>John P</ForeName><Initials>JP</Initials></Author><Author
        ValidYN="Y"><LastName>Crofton</LastName><ForeName>Kevin M</ForeName><Initials>KM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        In Vitro</MedlineTA><NlmUniqueID>8712158</NlmUniqueID><ISSNLinking>0887-2333</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000891">Anti-Infective Agents, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000090702">Constitutive Androstane Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000077297">Pregnane X Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011987">Receptors, Steroid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>4NM5039Y5X</RegistryNumber><NameOfSubstance
        UI="D014260">Triclosan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000891" MajorTopicYN="N">Anti-Infective Agents, Local</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000090702" MajorTopicYN="N">Constitutive Androstane Receptor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D054314" MajorTopicYN="N">Drug Inverse Agonism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000077297" MajorTopicYN="N">Pregnane X Receptor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="Y">agonists</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011987" MajorTopicYN="N">Receptors, Steroid</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="Y">agonists</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014260" MajorTopicYN="N">Triclosan</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">1,4-bis[2-(3,5-dichloropyridyloxy)]benzene</Keyword><Keyword
        MajorTopicYN="N">6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)
        oxime</Keyword><Keyword MajorTopicYN="N">AOP</Keyword><Keyword MajorTopicYN="N">CITCO</Keyword><Keyword
        MajorTopicYN="N">CTZ</Keyword><Keyword MajorTopicYN="N">CYP</Keyword><Keyword
        MajorTopicYN="N">Constitutive androstane receptor</Keyword><Keyword MajorTopicYN="N">DEHP</Keyword><Keyword
        MajorTopicYN="N">DPX2</Keyword><Keyword MajorTopicYN="N">EC50</Keyword><Keyword
        MajorTopicYN="N">Hepatic catabolism</Keyword><Keyword MajorTopicYN="N">LBD</Keyword><Keyword
        MajorTopicYN="N">MIE</Keyword><Keyword MajorTopicYN="N">PB</Keyword><Keyword
        MajorTopicYN="N">Pregnane-X receptor</Keyword><Keyword MajorTopicYN="N">RPXR</Keyword><Keyword
        MajorTopicYN="N">T4</Keyword><Keyword MajorTopicYN="N">TCPOBOP</Keyword><Keyword
        MajorTopicYN="N">TCS</Keyword><Keyword MajorTopicYN="N">Thyroid disruption</Keyword><Keyword
        MajorTopicYN="N">Triclosan</Keyword><Keyword MajorTopicYN="N">adverse outcome
        pathway</Keyword><Keyword MajorTopicYN="N">cDNA</Keyword><Keyword MajorTopicYN="N">clotrimazole</Keyword><Keyword
        MajorTopicYN="N">complementary DNA</Keyword><Keyword MajorTopicYN="N">cytochrome
        P450</Keyword><Keyword MajorTopicYN="N">di-(2-ethylhexyl)phthalate</Keyword><Keyword
        MajorTopicYN="N">hCAR</Keyword><Keyword MajorTopicYN="N">hPXR</Keyword><Keyword
        MajorTopicYN="N">half-maximal effect concentration</Keyword><Keyword MajorTopicYN="N">human
        PXR</Keyword><Keyword MajorTopicYN="N">human constitutive androstane receptor</Keyword><Keyword
        MajorTopicYN="N">ligand binding domain</Keyword><Keyword MajorTopicYN="N">mCAR</Keyword><Keyword
        MajorTopicYN="N">mPXR</Keyword><Keyword MajorTopicYN="N">molecular-initiating
        event</Keyword><Keyword MajorTopicYN="N">mouse PXR</Keyword><Keyword MajorTopicYN="N">mouse
        constitutive androstane receptor</Keyword><Keyword MajorTopicYN="N">name of
        the hPXR model, commercial product of Puracyp, Inc</Keyword><Keyword MajorTopicYN="N">name
        of the rPXR model, commercial product of Puracyp, Inc</Keyword><Keyword MajorTopicYN="N">phenobarbital</Keyword><Keyword
        MajorTopicYN="N">rCAR</Keyword><Keyword MajorTopicYN="N">rPXR</Keyword><Keyword
        MajorTopicYN="N">rat PXR</Keyword><Keyword MajorTopicYN="N">rat constitutive
        androstane receptor</Keyword><Keyword MajorTopicYN="N">thyroxine</Keyword><Keyword
        MajorTopicYN="N">triclosan</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2013</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2013</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2013</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">23899473</ArticleId><ArticleId IdType="doi">10.1016/j.tiv.2013.07.008</ArticleId><ArticleId
        IdType="pii">S0887-2333(13)00186-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">25270622</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0738</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>90</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Di-(2-ethylhexyl)
        phthalate accelerates atherosclerosis in apolipoprotein E-deficient mice.</ArticleTitle><Pagination><StartPage>181</StartPage><EndPage>190</EndPage><MedlinePgn>181-90</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1007/s00204-014-1377-5</ELocationID><Abstract><AbstractText>Di-(2-ethylhexyl)
        phthalate (DEHP) is associated with atherosclerosis-related cardiovascular
        disease complications, but we lack direct evidence of its unfavorable effect
        on atherogenesis. In this study, we aimed to clarify in vivo and in vitro
        the contribution of DEHP to the development of atherosclerosis and its underlying
        mechanisms. Apolipoprotein E-deficient (apoE(-/-)) mice chronically treated
        with DEHP for 4 weeks showed exacerbated hyperlipidemia, systemic inflammation,
        and atherosclerosis. In addition, DEHP promoted low-density lipoprotein (LDL)
        oxidation, which led to inflammation in endothelial cells as evidenced by
        increased protein expression of pro-inflammatory mediators. Furthermore, chronic
        DEHP treatment increased hepatic cholesterol accumulation by downregulating
        the protein expression of key regulators in cholesterol clearance including
        LDL receptor, cholesterol 7&#x3b1;-hydrolase, ATP-binding cassette transporter
        G5 and G8, and liver X receptor &#x3b1;. Moreover, the adiposity and inflammation
        of white adipose tissues were promoted in DEHP-treated apoE(-/-) mice. In
        conclusion, DEHP may disturb cholesterol homeostasis and deregulate the inflammatory
        response, thus leading to accelerated atherosclerosis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jin-Feng</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department
        of Physiology, School of Medicine, National Yang-Ming University, Taipei,
        11221, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Sheng-Huang</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, Ren-Ai Taipei City Hospital, Taipei, 10629, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hsu</LastName><ForeName>Ming-Hua</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Nuclear
        Science and Technology Development Center, National Tsing Hua University,
        Hsinchu, 30013, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pao</LastName><ForeName>Kuan-Chuan</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Nuclear
        Science and Technology Development Center, National Tsing Hua University,
        Hsinchu, 30013, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kou</LastName><ForeName>Yu
        Ru</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Department
        of Physiology, School of Medicine, National Yang-Ming University, Taipei,
        11221, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shyue</LastName><ForeName>Song-Kun</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Cardiovascular
        Division, Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529,
        Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Tzong-Shyuan</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department
        of Physiology, School of Medicine, National Yang-Ming University, Taipei,
        11221, Taiwan. tslee@ym.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008077">Lipoproteins, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C099252">oxidized low density lipoprotein</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D052436" MajorTopicYN="N">Adipose Tissue, White</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D050154" MajorTopicYN="N">Adiposity</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName
        UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D050197" MajorTopicYN="N">Atherosclerosis</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139"
        MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008077" MajorTopicYN="N">Lipoproteins, LDL</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Atherosclerosis</Keyword><Keyword
        MajorTopicYN="N">Cholesterol metabolism</Keyword><Keyword MajorTopicYN="N">DEHP</Keyword><Keyword
        MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2014</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">25270622</ArticleId><ArticleId IdType="doi">10.1007/s00204-014-1377-5</ArticleId><ArticleId
        IdType="pii">10.1007/s00204-014-1377-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10502499</PMID><DateCompleted><Year>1999</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>160</Volume><Issue>1</Issue><PubDate><Year>1999</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Comparison
        of the effects of various peroxisome proliferators on peroxisomal enzyme activities,
        DNA synthesis, and apoptosis in rat and human hepatocyte cultures.</ArticleTitle><Pagination><StartPage>21</StartPage><EndPage>32</EndPage><MedlinePgn>21-32</MedlinePgn></Pagination><Abstract><AbstractText>Peroxisome
        proliferators (PPs) are a class of rodent nongenotoxic hepatocarcinogens that
        cause hepatocyte peroxisome proliferation, increased DNA synthesis, and decreased
        spontaneous apoptosis. We examined the effects of various PPs such as the
        hypolipidemic agents clofibric acid (CLO), bezafibrate (BEZA), ciprofibrate
        (CIPRO), and nafenopin (NAFE) and the plasticizer di-(2-ethylhexyl)phthalate
        (DEHP) on the various parameters in vitro in rat and human hepatocyte cultures.
        In rat hepatocyte cultures, after 72 h of treatment with the various PPs at
        100-500 microM, a compound-dependent increase in acyl CoA oxidase (ACO) and
        carnitine acetyl transferase (CAT) activities, markers of peroxisome proliferation,
        was observed with the following potencies: CIPRO = NAFE &gt; BEZA &gt; CLO
        &gt; DEHP. A minor (120-150%), but significant, no concentration-dependent
        increase in DNA synthesis and a marked, no compound-dependent and, with the
        exception of NAFE, no concentration-dependent 60-80% decrease in spontaneous
        apoptosis was observed with all tested compounds (50-250 microM) after 48
        h of treatment. Inhibition of spontaneous apoptosis in PP-treated versus control
        rat hepatocyte cultures was also observed morphologically. Furthermore, PPs
        inhibited transforming growth factor beta (TGFbeta)-induced apoptosis but
        not tumor necrosis factor alpha (TNFalpha)/alpha Amanitine (alphaAma)-induced
        apoptosis in rat hepatocyte cultures. In human hepatocyte cultures, the various
        PPs at 50-500 microM did not affect peroxisomal enzyme activities, DNA synthesis,
        or spontaneous and induced (TGFbeta or TNFalpha/alphaAma) apoptosis. The compound-dependent
        peroxisome proliferation but no compound-dependent disruption of the mitogenic/apoptotic
        balance elicited by PPs in primary rat hepatocyte cultures supports the hypothesis
        that oxidative stress is directly linked to the hepatocarcinogenic potential
        of a given PP in rodents and that disruption of the mitogenic/apoptotic balance
        contributes to the development of PP-induced hepatocarcinogenesis. In addition,
        the absence of effects of all PPs on both peroxisome proliferation-associated
        parameters and mitogenic/apoptotic balance supports the hypothesis that human
        liver cells are refractory to PP-induced hepatocarcinogenesis.</AbstractText><CopyrightInformation>Copyright
        1999 Academic Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Goll</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratoire
        de Biologie Cellulaire, Facult&#xe9; de M&#xe9;decine et de Pharmacie, 4 Place
        Saint-Jacques, Besan&#xe7;on, 25030, France.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alexandre</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Viollon-Abadie</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Nicod</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Jaeck</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Richert</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>9</Month><Day>30</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>9</Month><Day>30</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10502499</ArticleId><ArticleId IdType="doi">10.1006/taap.1999.8737</ArticleId><ArticleId
        IdType="pii">S0041-008X(99)98737-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12215663</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>69</Volume><Issue>1</Issue><PubDate><Year>2002</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Evaluation of a 15-day screening
        assay using intact male rats for identifying antiandrogens.</ArticleTitle><Pagination><StartPage>92</StartPage><EndPage>108</EndPage><MedlinePgn>92-108</MedlinePgn></Pagination><Abstract><AbstractText>An
        in vivo screening assay using intact adult male rats has been evaluated for
        its ability to detect six antiandrogenic compounds via oral administration.
        The test compounds included cyproterone acetate (CPA), flutamide (FLUT), p,p''-DDE
        (DDE), di-n-butyl phthalate (DBP), linuron (LIN), and vinclozolin (VCZ). Two
        of the test compounds (DDE and FLUT) have been previously evaluated in the
        15-day intact male assay with compound administration via intraperitoneal
        injection (ip). For the current studies, male rats were dosed for 15 days
        via oral gavage and euthanized on the morning of test day 15. The endpoints
        evaluated included final body and organ weights (liver, thyroid gland, testes,
        epididymides, prostate, seminal vesicles with fluid, accessory sex gland unit
        [ASG]), serum hormone concentrations (testosterone [T], estradiol [E2], dihydrotestosterone
        [DHT], luteinizing hormone [LH], follicle stimulating hormone [FSH], prolactin
        [PRL], T(3), T(4), and thyroid stimulating hormone[TSH]), and histopathology
        of the testis, epididymis, and thyroid gland; positive results for each endpoint
        are described below. In addition, an evaluation of immune system endpoints
        (humoral immune function, spleen and thymus weights, and spleen cell number)
        was conducted on a subset of animals dosed with either DDE or FLUT. All six
        endocrine-active compounds (EACs) increased relative liver weight. FLUT and
        VCZ caused the typical pattern for an androgen receptor (AR) antagonist, although
        not all endpoints were statistically significant for VCZ: decreased ASG weights,
        hormonal alterations (increased T, DHT, LH, and FSH), and induced Leydig cell
        hypertrophy and/or hyperplasia. CPA caused effects consistent with its mixed
        AR antagonist/progesterone receptor agonist activity: it decreased ASG weights,
        caused hormonal alterations (increased T and E2; decreased FSH), and caused
        spermatid retention. DBP, a compound with antiandrogen-like activity via a
        nonreceptor mediated mechanism, caused hormonal alterations (decreased T,
        DHT, and E2; increased LH, FSH, and PRL) and induced general testicular degeneration.
        LIN, a weak AR antagonist, decreased ASG weights, caused hormonal alterations
        (decreased T, DHT, and LH; increased E2), and caused spermatid retention.
        Unlike the other AR antagonists evaluated, DDE, a weak AR antagonist, did
        not alter reproductive parameters. All six antiandrogens caused some effects
        on thyroid parameters, although only CPA, DDE, and VCZ caused results consistent
        with a potential thyroid-modulator. FLUT and DDE did not alter the primary
        humoral immune response to SRBC, spleen or thymus weights, or spleen cell
        number. In the current study, 5 of the six test substances were identified
        as endocrine-active substances consistent with their known/proposed mechanism(s)
        of action. The effects that were observed in the current study via oral (gavage)
        compound administration were similar to the responses that were observed by
        the ip route in previous studies for DDE and FLUT. This report, in addition
        to the &gt; 20 compounds that have already been examined using the 15-day
        intact male assay, supports this assay as a viable screening assay for detecting
        EACs, and also illustrates that the ability to identify EACs using the intact
        male assay will be equivalent regardless of the route of compound administration.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>O''Connor</LastName><ForeName>John
        C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>DuPont Haskell
        Laboratory for Health and Environmental Sciences, P.O. Box 50, Newark, Delaware
        19714, USA. john.c.oconnor@usa.dupont.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Frame</LastName><ForeName>Steven R</ForeName><Initials>SR</Initials></Author><Author
        ValidYN="Y"><LastName>Ladics</LastName><ForeName>Gregory S</ForeName><Initials>GS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000726">Androgen Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010080">Oxazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>01XP1SU59O</RegistryNumber><NameOfSubstance
        UI="D008044">Linuron</NameOfSubstance></Chemical><Chemical><RegistryNumber>4KM2BN5JHF</RegistryNumber><NameOfSubstance
        UI="D017373">Cyproterone Acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>4M7FS82U08</RegistryNumber><NameOfSubstance
        UI="D003633">Dichlorodiphenyl Dichloroethylene</NameOfSubstance></Chemical><Chemical><RegistryNumber>76W6J0943E</RegistryNumber><NameOfSubstance
        UI="D005485">Flutamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>JJ258EZN1I</RegistryNumber><NameOfSubstance
        UI="C025643">vinclozolin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000726" MajorTopicYN="N">Androgen Antagonists</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000728" MajorTopicYN="N">Androgens</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017373" MajorTopicYN="N">Cyproterone Acetate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003633" MajorTopicYN="N">Dichlorodiphenyl Dichloroethylene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005485" MajorTopicYN="N">Flutamide</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007107" MajorTopicYN="N">Immune System</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008044" MajorTopicYN="N">Linuron</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010080" MajorTopicYN="N">Oxazoles</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>9</Month><Day>7</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>28</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>9</Month><Day>7</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12215663</ArticleId><ArticleId IdType="doi">10.1093/toxsci/69.1.92</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9146736</PMID><DateCompleted><Year>1997</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>31</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0278-6915</ISSN><JournalIssue
        CitedMedium="Print"><Volume>35</Volume><Issue>2</Issue><PubDate><Year>1997</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Subchronic oral toxicity
        of di-n-octyl phthalate and di(2-Ethylhexyl) phthalate in the rat.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>239</EndPage><MedlinePgn>225-39</MedlinePgn></Pagination><Abstract><AbstractText>The
        subchronic oral toxicity of di(2-ethylhexyl) phthalate (DEHP) and di-n-octyl
        phthalate (DNOP) was studied. Groups of 10 male and 10 female Sprague-Dawley
        rats were administered DEHP in the diet at 0, 5, 50, 500 or 5000 ppm for 13
        wk. In a separate study, groups of 10 male and 10 female Sprague-Dawley rats
        were given DNOP (5, 50, 500 and 5000 ppm) in the diet while control groups
        received basal diet containing 4% corn oil and positive control groups were
        fed a diet containing 5000 ppm DEHP. Growth rate and food consumption were
        not affected by treatment with either compound. Hepatomegaly was observed
        in the highest dose groups of both sexes administered DEHP but not in the
        DNOP-treated animals. At the highest dose, DNOP caused threefold (females)
        and 12-fold (males) increases in liver ethoxyresorufin-O-deethylase activity
        while DEHP did not. Mild changes in serum biochemistries were mostly confined
        to rats in the highest dose group of DEHP, and included increased serum albumin
        and albumin/globulin ratio in both sexes and decreased cholesterol in female
        rats. Mild vacuolations in the Sertoli cells were observed in male rats exposed
        to 500 ppm DEHP. At 5000 ppm DEHP, there was mild to moderate seminiferous
        tubule atrophy and Sertoli cell vacuolation in males, and rats of both sexes
        showed hepatic peroxisome proliferation. Both DEHP and DNOP at 5000 ppm caused
        mild histological changes in the thyroid consisting of reduced follicle size
        and colloid density, and the liver consisting of endothelial nuclear prominence,
        nuclear hyperchromicity and anisokaryosis. There was accentuation of zonation
        of the hepatic lobules and increased perivenous cytoplasmic vacuolation in
        DNOP-treated rats. Trace quantities (3-5 ppm) of DEHP and DNOP were detected
        in the liver, and 15-31 ppm were found in adipose tissue of the highest dose
        groups. The no observed-effect-level was judged to be 50 ppm in the diet or
        3.7 mg/kg body weight/day for DEHP, and 500 ppm or 36.8 mg/kg body weight/day
        for DNOP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Poon</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Environmental
        Health Directorate and Food Directorate, Health Protection Branch, Ottawa,
        Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lecavalier</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Mueller</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Valli</LastName><ForeName>V E</ForeName><Initials>VE</Initials></Author><Author
        ValidYN="Y"><LastName>Procter</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Chu</LastName><ForeName>I</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1997</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1997</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1997</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9146736</ArticleId><ArticleId IdType="doi">10.1016/s0278-6915(96)00064-6</ArticleId><ArticleId
        IdType="pii">S0278691596000646</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">22588786</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-9924</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>120</Volume><Issue>8</Issue><PubDate><Year>2012</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Effects
        of di(2-ethylhexyl) phthalate (DEHP) on female fertility and adipogenesis
        in C3H/N mice.</ArticleTitle><Pagination><StartPage>1123</StartPage><EndPage>1129</EndPage><MedlinePgn>1123-9</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1289/ehp.1104016</ELocationID><Abstract><AbstractText
        Label="BACKGROUND" NlmCategory="BACKGROUND">Di(2-ethylhexyl) phthalate (DEHP)
        and its metabolites are known to affect lipid metabolism and adipogenesis,
        mainly by activation of peroxisome proliferator-activated receptors (PPARs).
        Exposure to DEHP has been linked with testicular impairment and male subfertility.
        However, the effects of DEHP on female reproductive health and metabolism
        have not been studied in detail.</AbstractText><AbstractText Label="OBJECTIVE"
        NlmCategory="OBJECTIVE">We examined the effects of dietary DEHP exposure on
        metabolism and fertility in female mice.</AbstractText><AbstractText Label="METHODS"
        NlmCategory="METHODS">In two independent approaches, female C3H/N mice were
        exposed to DEHP (0.05, 5, or 500 mg/kg of body weight per day) via their diet
        for 8 weeks, and we recorded food intake, weight gain, and litter size. After
        exposure, liver, visceral fat, and plasma from F0 females (study I) and F0
        dams and their F1 offspring (study II) were analyzed by quantitative real-time
        polymerase chain reaction and enzyme-linked immunosorbent assay.</AbstractText><AbstractText
        Label="RESULTS" NlmCategory="RESULTS">In study I, DEHP-exposed F0 females
        (all dose groups) had a significant increase in body weight, food intake,
        and visceral adipose tissue compared with controls. In the 500-mg DEHP group,
        PPAR&#x3b1; and PPAR&#x3b3; transcripts were significantly changed in liver
        tissue. In the same group, PPAR&#x3b3; mRNA was significantly reduced in liver
        but not in fat tissue. In addition, leptin and FABP4 (fatty acid binding protein
        4) mRNA were increased in adipose tissue, whereas adiponectin was decreased.
        In study II, we detected a 100% abortion rate in F0 dams in the 500-mg group.
        F1 offspring exposed in utero and during lactation had an increase in visceral
        fat tissue and body weight.</AbstractText><AbstractText Label="CONCLUSION"
        NlmCategory="CONCLUSIONS">Fertility was impaired in mice exposed to high doses
        of DEHP, and body weight and visceral fat deposits were increased in mice
        exposed to environmentally relevant doses. Although F1 mice were exposed to
        DEHP only in utero and during lactation, we observed metabolic changes in
        the offspring of diet-exposed females.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Juliane-Susanne</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department
        of Anatomy and Cell Biology, Martin Luther University Faculty of Medicine,
        Halle (Saale), Germany. juliane-susanne.schmidt@medizin.uni-halle.de</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Schaedlich</LastName><ForeName>Kristina</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Fiandanese</LastName><ForeName>Nadia</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Pocar</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Fischer</LastName><ForeName>Bernd</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2012</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D017931">DNA Primers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047492">Peroxisome Proliferator-Activated Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections
        RefType="CommentIn"><RefSource>Environ Health Perspect. 2012 Aug;120(8):a320</RefSource><PMID
        Version="1">22854284</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D050156" MajorTopicYN="N">Adipogenesis</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005247" MajorTopicYN="N">Feeding Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005298" MajorTopicYN="N">Fertility</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D047492" MajorTopicYN="N">Peroxisome Proliferator-Activated Receptors</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The
        authors declare they have no actual or potential competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2011</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2012</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">22588786</ArticleId><ArticleId IdType="pmc">PMC3440070</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.1104016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adibi
        JJ, Perera FP, Jedrychowski W, Camann DE, Barr D, Jacek R, et al. Prenatal
        exposures to phthalates among women in New York City and Krakow, Poland. Environ
        Health Perspect. 2003;111:1719&#x2013;1722.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1241713</ArticleId><ArticleId IdType="pubmed">14594621</ArticleId></ArticleIdList></Reference><Reference><Citation>Adibi
        JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, et al. Characterization
        of phthalate exposure among pregnant women assessed by repeat air and urine
        samples. Environ Health Perspect. 2008;116:467&#x2013;473.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2291011</ArticleId><ArticleId IdType="pubmed">18414628</ArticleId></ArticleIdList></Reference><Reference><Citation>Campfield
        LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence
        for a peripheral signal linking adiposity and central neural networks. Science.
        1995;269(5223):546&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">7624778</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr
        MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome:
        importance of type 2 diabetes and familial combined hyperlipidemia in coronary
        artery disease risk. J Clin Endocrinol Metab. 2004;89(6):2601&#x2013;2607.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15181030</ArticleId></ArticleIdList></Reference><Reference><Citation>Chomczynski
        P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform
        extraction. Anal Biochem. 1987;162(1):156&#x2013;159.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2440339</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis
        BJ, Maronpot RR, Heindel JJ. Di-(2-ethylhexyl) phthalate suppresses estradiol
        and ovulation in cycling rats. Toxicol Appl Pharmacol. 1994;128(2):216&#x2013;223.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7940536</ArticleId></ArticleIdList></Reference><Reference><Citation>European
        Union. Directive 2005/84/EC of the European Parliament and of the Council.
        2005.  Available:  http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2005:344:0040:0043:en:PDF
        [accessed 24 June 2012]</Citation></Reference><Reference><Citation>European
        Union. European Union Risk Assessment Report. Bis(2-ethylhexyl)phthalate (DEHP).
        2008.  Available:  http://www.dehp-facts.com/upload/documents/webpage/DEHP%20RA%20report%20full.pdf
        [accessed 24 June 2012]</Citation></Reference><Reference><Citation>Feige JN,
        Gelman L, Rossi D, Zoete V, M&#xe9;tivier R, Tudor C, et al. The endocrine
        disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated
        receptor &#x3b3; modulator that promotes adipogenesis. J Biol Chem. 2007;282(26):19152&#x2013;19166.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17468099</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E, et al. The pollutant
        diethylhexyl phthalate regulates hepatic energy metabolism via species-specific
        PPAR&#x3b1;-dependent mechanisms. Environ Health Perspect. 2010;118:234&#x2013;241.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2831923</ArticleId><ArticleId IdType="pubmed">20123618</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler
        PA, Bellingham M, Sinclair KD, Evans NP, Pocar P, Fischer B, et al. Impact
        of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol
        Cell Endocrinol. 2012;355(2):231&#x2013;239.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">22061620</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederich
        RC, Hamann A, Anderson S, L&#xf6;llmann B, Lowell BB, Flier JS. Leptin levels
        reflect body lipid content in mice: evidence for diet-induced resistance to
        leptin action. Nat Med. 1995;12:1311&#x2013;1314.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7489415</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen
        H, Skakkeb&#xe6;k NE, Andersson AM. Metabolism of phthalates in humans. Mol
        Nutr Food Res. 2007;51:899&#x2013;911.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17604388</ArticleId></ArticleIdList></Reference><Reference><Citation>Grande
        SW, Andrade AJM, Talsness CE, Grote K, Chahoud I. A dose-response study following
        in utero and lactational exposure to di(2 ethylhexyl)phthalate: effects on
        female rat reproductive development. Toxicol Sci. 2006;91(1):247&#x2013;254.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16476687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xfc;n
        F, Blumberg B. Endocrine disrupters as obesogens. Mol Cell Endocrinol. 2009;304(1&#x2013;2):19&#x2013;29.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2713042</ArticleId><ArticleId IdType="pubmed">19433244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatch
        EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M, et al. 2008Association
        of urinary phthalate metabolite concentrations with body mass index and waist
        circumference: a cross-sectional study of NHANES data, 1999&#x2013;2002. Environ
        Health 727 doi:10.1186/1476-069X-7-27[Online 3 June 2008]</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1186/1476-069X-7-27</ArticleId><ArticleId IdType="pmc">PMC2440739</ArticleId><ArticleId
        IdType="pubmed">18522739</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser
        R, Calafat AM. Phthalates and human health. Occup Environ Med. 2005;2(11):806&#x2013;818.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1740925</ArticleId><ArticleId IdType="pubmed">16234408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser
        R, Meeker JD, Singh NP, Silva MJ, Ryan L, Duty S, et al. DNA damage in human
        sperm is related to urinary levels of phthalate monoester and oxidative metabolites.
        Hum Reprod. 2007;22(3):688&#x2013;695.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17090632</ArticleId></ArticleIdList></Reference><Reference><Citation>Heindel
        JJ, vom Saal FS. Role of nutrition and environmental endocrine disrupting
        chemicals during the perinatal period on the aetiology of obesity. Mol Cell
        Endocrinol. 2009;304(1&#x2013;2):90&#x2013;96.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19433253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadowaki
        T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. Adiponectin and adiponectin
        receptors in insulin resistance, diabetes and metabolic syndrom. J Clin Invest.
        2006;116:1784&#x2013;1792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1483172</ArticleId><ArticleId
        IdType="pubmed">16823476</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavlock
        R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, et al. NTP
        Center for the Evaluation of Risks to Human Reproduction: phthalates expert
        panel report on the reproductive and developmental toxicity of di(2-ethylhexyl)
        phthalate. Reprod Toxicol. 2002;16:529&#x2013;653.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12406494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluwe
        WM, McConnell EE, Huff JE, Haseman JK, Douglas JF, Hartwell WV. Carcinogenicity
        testing of phthalate esters and related compounds by the National Toxicology
        Program and the National Cancer Institute. Environ Health Perspect. 1982;45:129&#x2013;133.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1569006</ArticleId><ArticleId IdType="pubmed">7140685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb
        JC, IV, Chapin RE, Teague J, Lawton AD, Reel JR. Reproductive effects of four
        phthalic acid esters in the mouse. Toxicol Appl Pharmacol. 1987;88(2):255&#x2013;269.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3564043</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapinskas
        PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, et al. Role
        of PPAR&#x3b1; in mediating the effects of phthalates and metabolites in the
        liver. Toxicology. 2005;207(1):149&#x2013;163.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15590130</ArticleId></ArticleIdList></Reference><Reference><Citation>Latini
        G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, et al. In utero
        exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ
        Health Perspect. 2003;111:1783&#x2013;1785.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1241724</ArticleId><ArticleId IdType="pubmed">14594632</ArticleId></ArticleIdList></Reference><Reference><Citation>Latini
        G, Gallo F, Iughetti L. Toxic environment and obesity pandemia: is there a
        relationship? Ital J Pediatr. 2010;36:38.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2823765</ArticleId><ArticleId IdType="pubmed">20205780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin
        Y, Wei J, Li Y, Chen J, Zhou Z, Song L, et al. 2011Developmental Exposure
        to Di(2-ethylhexyl) Phthalate Impairs Endocrine Pancreas and Leads to Long-term
        Adverse Effects on Glucose Homeostasis in the Rat. Am J Physiol Endocrinol
        Metab 301E527&#x2013;E538. doi:10.1152/ajpendo.00233.2011[Online 14 June 2011]</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1152/ajpendo.00233.2011</ArticleId><ArticleId IdType="pubmed">21673306</ArticleId></ArticleIdList></Reference><Reference><Citation>Main
        KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, et al.
        Human breast milk contamination with phthalates and alterations of endogenous
        reproductive hormones in infants three months of age. Environ Health Perspect.
        2005;114:270&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1367843</ArticleId><ArticleId
        IdType="pubmed">16451866</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        D. NTP Technical Report on the Toxicity Studies of Dibutyl Phthalate (CAS
        No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Toxicity
        Report Series. 1995:30. Research Triangle Park, NC:National Toxicology Program.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12209194</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore
        RW, Rudy TA, Lin TM, Ko K, Peterson RE. Abnormalities of sexual development
        in male rats with in utero and lactational exposure to the antiandrogenic
        plasticizer di(2-ethylhexyl) phthalate. Environ Health Perspect. 2001;109:229&#x2013;237.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1240240</ArticleId><ArticleId IdType="pubmed">11333183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogden
        CL, Yanovski SZ, Carroll MD, Flegal KM.2007The epidemiology of obesity. Gastroenterology
        132: 2087&#x2013;2102.</Citation><ArticleIdList><ArticleId IdType="pubmed">17498505</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant
        N, Shukla M, Kumar Patel D, Shukla Y, Mathur N, Kumar Gupta Y, et al. Correlation
        of phthalate exposures with semen quality. Toxicol and Appl Pharmacol. 2008;231(1):112&#x2013;116.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18513777</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquali
        R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence
        to adult age. Ann NY Acad Sci. 2006;1092:158&#x2013;174.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17308142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargis
        RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors
        promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor
        activation. Obesity (Silver Spring) 2009;18(7):1283&#x2013;1288.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3957336</ArticleId><ArticleId IdType="pubmed">19927138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe
        RM. Pathways of endocrine disruption during male sexual differentiation and
        masculinization. Best Pract Res Clin Endocrinol Metab. 2006;20(1):91&#x2013;110.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16522522</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahlhut
        RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary
        phthalate metabolites are associated with increased waist circumference and
        insulin resistance in adult U.S. males. Environ Health Perspect. 2007;115:876&#x2013;882.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1892109</ArticleId><ArticleId IdType="pubmed">17589594</ArticleId></ArticleIdList></Reference><Reference><Citation>Swan
        SH. Environmental phthalate exposure in relation to reproductive outcomes
        and other health endpoints in humans. Environ Res. 2008;108(2):177&#x2013;184.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2775531</ArticleId><ArticleId IdType="pubmed">18949837</ArticleId></ArticleIdList></Reference><Reference><Citation>Takai
        R, Hayashi S, Kiyokawa J, Iwata Y, Matsuo S, Suzuki M, et al. Collaborative
        work on evaluation of ovarian toxicity. 10) Two- or four-week repeated dose
        studies and fertility study of di-(2-ethylhexyl) phthalate (DEHP) in female
        rats. J Toxicologycal Science. 2009;34(suppl 1: ):SP111&#x2013;SP119.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19265277</ArticleId></ArticleIdList></Reference><Reference><Citation>Terra
        X, Quintero Y, Auguet T, Porras JA, Hern&#xe1;ndez M, Sabench F, et al. FABP
        4 is associated with inflammatory markers and metabolic syndrome in morbidly
        obese women. Eur J Endocrinol. 2011;164(4):539&#x2013;547.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21257725</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo
        ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to
        biomarker of the metabolic syndrome. J Intern Med. 2005;257:167&#x2013;175.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15656875</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittassek
        M, Angerer J, Kolossa-Gehring M, Sch&#xe4;fer SD, Klockenbusch W, Dobler L,
        et al. Fetal exposure to phthalates&#x2014;a pilot study. Int J Hyg Environ
        Health. 2009;212(5):492&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">19423389</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO
        (World Health Organization) Part I: The problem of overweight and obesity.
        In: Obesity: Preventing and Managing the Global Epidemic. Technical Report
        Series 894. Geneva:WHO, 5&#x2013;37. 2000.  Available:  http://whqlibdoc.who.int/trs/WHO_TRS_894_(part1).pdf
        [accessed 21 June 2012]</Citation></Reference><Reference><Citation>WHO (World
        Health Organization) Chemical Fact Sheets: Di(2-ethylhexyl)phthalate. 2003.  Available:  http://www.who.int/water_sanitation_health/dwq/chemicals/di2ethylhexylphthalatesum.pdf
        [accessed 24 June 2012]</Citation></Reference><Reference><Citation>WHO (World
        Health Organization) Obesity: Facts and Figures. 2012.  Available:  http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/obesity
        [accessed 1 May 2012]</Citation></Reference><Reference><Citation>Xu A, Wang
        Y, Xu JY, Stejskal D, Tam S, Zhang J, et al. Adipocyte fatty acid-binding
        protein is a plasma biomarker closely associated with obesity and metabolic
        syndrome. Clin Chem. 2006;52(3):405&#x2013;413.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16423904</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2781555</PMID><DateCompleted><Year>1989</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>100</Volume><Issue>2</Issue><PubDate><Year>1989</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Induction
        of hepatic metallothionein in male B6C3F1 mice exposed to hepatic tumor promoters:
        effects of phenobarbital, acetaminophen, sodium barbital, and di(2-ethylhexyl)
        phthalate.</ArticleTitle><Pagination><StartPage>217</StartPage><EndPage>226</EndPage><MedlinePgn>217-26</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of various compounds known to be hepatic tumor promoters and toxins
        in the male B6C3F1 mouse liver, including di(2-ethylhexyl)phthalate (DEHP),
        acetaminophen (ACT), barbital (BB), and phenobarbital (PB) on hepatic metallothionein
        (MT) concentrations were assessed after chronic exposure. From 6 weeks of
        age, male mice were maintained on diets containing DEHP at 12,000 or 6000
        ppm, ACT at 10,000 or 5000 ppm, BB at 1,000 ppm, or drinking water with PB
        at 500 ppm for up to 24 weeks. MT was measured in hepatic cytosol at 0, 2,
        8, and 24 weeks of exposure. DEHP proved a very effective inducer, producing
        elevations of MT as high as 11-fold. The increases in hepatic MT with DEHP
        were both dose- and time-related. ACT was likewise effective in producing
        hepatic MT elevations (maximum 6.7-fold) in a dose- and time-related fashion.
        BB and PB, however, had no effect on hepatic MT levels at any time point.
        While DEHP, BB, and PB treatments produced hepatomegaly, histopathological
        analysis at 24 weeks revealed that in both DEHP- and ACT-treated livers hepatocellular
        proliferation was prominent while livers exposed to BB or PB showed predominantly
        hepatocellular hypertrophy. Gel-filtration of DEHP-treated liver cytosol revealed
        that zinc was associated with the MT peak. This peak also bound cadmium in
        vitro and could be extracted by heat treatment and selective acetone precipitation,
        both typical characteristics of MT. Further confirmation of the presence of
        MT after DEHP treatment was obtained by sodium dodecyl sulfate-polyacrylamide
        gel electrophoresis (10 to 20% acrylamide). Results indicate that some, but
        not all, tumor promoters can induce target organ MT and that such an induction
        appears associated with those promoters inducing persistent cellular hyperplasia
        but not those inducing cellular hypertrophy.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Waalkes</LastName><ForeName>M
        P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Division
        of Cancer Etiology, National Cancer Institute, Frederick, Maryland 21701-1013.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ward</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>00BH33GNGH</RegistryNumber><NameOfSubstance
        UI="D002104">Cadmium</NameOfSubstance></Chemical><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance
        UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>5WZ53ENE2P</RegistryNumber><NameOfSubstance
        UI="D001462">Barbital</NameOfSubstance></Chemical><Chemical><RegistryNumber>9038-94-2</RegistryNumber><NameOfSubstance
        UI="D008668">Metallothionein</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance
        UI="D015032">Zinc</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001462" MajorTopicYN="N">Barbital</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002104" MajorTopicYN="N">Cadmium</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002850" MajorTopicYN="N">Chromatography, Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003600" MajorTopicYN="N">Cytosol</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008668" MajorTopicYN="N">Metallothionein</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1989</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1989</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1989</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2781555</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(89)90308-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1458550</PMID><DateCompleted><Year>1993</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>24</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0009-2797</ISSN><JournalIssue
        CitedMedium="Print"><Volume>85</Volume><Issue>1</Issue><PubDate><Year>1992</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>Chemico-biological
        interactions</Title><ISOAbbreviation>Chem Biol Interact</ISOAbbreviation></Journal><ArticleTitle>The
        involvement of selenium in peroxisome proliferation caused by dietary administration
        of clofibrate to rats.</ArticleTitle><Pagination><StartPage>49</StartPage><EndPage>67</EndPage><MedlinePgn>49-67</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of dietary treatment with clofibrate (0.5% w/w for 10 days) on the
        livers of selenium-deficient male rats were examined. The peroxisome proliferation
        (as determined by electron microscopy) in the livers of selenium-deficient
        animals was much less pronounced than in the case of selenium-adequate rats
        and no increase in peroxisomal fatty acid beta-oxidation (assayed both as
        antimycin-insensitive palmitoyl-CoA oxidation and lauroyl-CoA oxidase activity)
        was observed in the deficient animals. On the other hand, in selenium-deficient
        rats clofibrate caused increases in the specific activity of microsomal lauric
        acid omega- and omega-1-hydroxylation and an apparent change in mitochondrial
        size, seen as a redistribution of mitochondria from the 600 x g(av) pellet
        to the 10,000 x g(av) pellet, which were approximately 50% as great as the
        corresponding effects on control animals. Obviously, then, these three different
        effects of clofibrate are not strictly coupled and may involve at least partially
        distinct underlying mechanisms. Initial experiments demonstrated that peroxisome
        proliferation could be obtained by exposing primary hepatocyte cultures derived
        from selenium-deficient rats to clofibric acid (an in vivo hydrolysis product
        of clofibrate which is the proximate peroxisome proliferator), nafenopin or
        mono(2-ethylhexyl)phthalate. This finding suggests that selenium deficiency
        does not have a direct influence on the basic process(es) underlying peroxisome
        proliferation, but rather has indirect effects, influencing, for example,
        the pharmacokinetics of clofibrate and/or hormonal factors.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Olsson</LastName><ForeName>U</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department
        of Genetic and Cellular Toxicology, Wallenberg Laboratory, Stockholm University,
        Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garberg</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Lundgren</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Andersson</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Hultenby</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Bergstrand</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Eriksson</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author
        ValidYN="Y"><LastName>H&#xf6;gberg</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>DePierre</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Chem
        Biol Interact</MedlineTA><NlmUniqueID>0227276</NlmUniqueID><ISSNLinking>0009-2797</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC
        1.11.1.9</RegistryNumber><NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.5.1.18</RegistryNumber><NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>H6241UJ22B</RegistryNumber><NameOfSubstance
        UI="D012643">Selenium</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005979" MajorTopicYN="N">Glutathione Peroxidase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008930" MajorTopicYN="N">Mitochondria, Liver</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012643" MajorTopicYN="N">Selenium</DescriptorName><QualifierName UI="Q000172"
        MajorTopicYN="Y">deficiency</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>11</Month><Day>30</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>11</Month><Day>30</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1458550</ArticleId><ArticleId IdType="doi">10.1016/0009-2797(92)90052-m</ArticleId><ArticleId
        IdType="pii">0009-2797(92)90052-M</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9013627</PMID><DateCompleted><Year>1997</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue
        CitedMedium="Print"><Volume>272</Volume><Issue>6</Issue><PubDate><Year>1997</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>The
        Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Induction
        of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol
        12,13-myristate-type tumor promoters in immortalized mouse liver cells.</ArticleTitle><Pagination><StartPage>3707</StartPage><EndPage>3714</EndPage><MedlinePgn>3707-14</MedlinePgn></Pagination><Abstract><AbstractText>Increased
        expression of cyclooxygenase-2 (COX-2), the rate-limiting enzyme in prostaglandin
        synthesis, has been associated with growth regulation and carcinogenesis in
        several systems. COX-2 is known to be induced by cytokines and the skin tumor
        promoter 12-tetradecanoylphorbol-13-myristate (TPA). In the present study,
        we investigated the effects of several non-TPA-type tumor promoters on COX-2
        expression in immortalized mouse liver cells. Specifically, we tested peroxisome
        proliferators (PPs), which are rodent liver tumor promoters that cause gross
        alterations in cellular lipid metabolism, the rodent liver tumor promoter
        phenobarbital, and the skin tumor promoters okadaic acid and thapsigargin.
        The PPs Wy-14643, mono-ethylhexyl phthalate, clofibrate, ciprofibrate ethyl
        ester, and eicosatetraynoic acid each caused large increases in COX-2 mRNA
        and protein, with maximal expression seen approximately 10 h after treatment
        of quiescent cells. COX-2 expression was also induced by thapsigargin, okadaic
        acid, and calcium ionophore A23187, but not by phenobarbital or the steroid
        PP dehydroepiandrosterone sulfate. Induction of COX-2 expression generally
        resulted in increased synthesis of prostaglandin E2 (PGE2). However, the PPs
        caused little or no increase in PGE2 levels, and they inhibited serum-induced
        PGE2 synthesis. Unlike non-steroidal anti-inflammatory drugs, the PPs do not
        directly inhibit cyclooxygenase enzyme activity in vitro. Thus, PPs regulate
        prostaglandin metabolism via both positive (COX-2 induction) and inhibitory
        mechanisms. In summary, the strong induction of COX-2 expression by PPs, thapsigargin,
        and okadaic acid suggests a possible role for COX-2 in the growth regulatory
        activity of these non-TPA-type tumor promoters.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Ledwith</LastName><ForeName>B
        J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department
        of Genetic and Cellular Toxicology, Merck Research Laboratories, West Point,
        Pennsylvania 19486, USA. brian_ledwith@merck.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Pauley</LastName><ForeName>C J</ForeName><Initials>CJ</Initials></Author><Author
        ValidYN="Y"><LastName>Wagner</LastName><ForeName>L K</ForeName><Initials>LK</Initials></Author><Author
        ValidYN="Y"><LastName>Rokos</LastName><ForeName>C L</ForeName><Initials>CL</Initials></Author><Author
        ValidYN="Y"><LastName>Alberts</LastName><ForeName>D W</ForeName><Initials>DW</Initials></Author><Author
        ValidYN="Y"><LastName>Manam</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>1191-85-1</RegistryNumber><NameOfSubstance
        UI="D015117">5,8,11,14-Eicosatetraynoic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.99.1</RegistryNumber><NameOfSubstance UI="D051545">Cyclooxygenase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.99.1</RegistryNumber><NameOfSubstance UI="D011451">Prostaglandin-Endoperoxide
        Synthases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance
        UI="C496512">Ptgs1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>K7Q1JQR04M</RegistryNumber><NameOfSubstance
        UI="D015232">Dinoprostone</NameOfSubstance></Chemical><Chemical><RegistryNumber>NI40JAQ945</RegistryNumber><NameOfSubstance
        UI="D013755">Tetradecanoylphorbol Acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>XXE1CET956</RegistryNumber><NameOfSubstance
        UI="D007213">Indomethacin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015117" MajorTopicYN="N">5,8,11,14-Eicosatetraynoic Acid</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051545" MajorTopicYN="N">Cyclooxygenase 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015232" MajorTopicYN="N">Dinoprostone</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007213" MajorTopicYN="N">Indomethacin</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011451" MajorTopicYN="N">Prostaglandin-Endoperoxide Synthases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013755" MajorTopicYN="N">Tetradecanoylphorbol Acetate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1997</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1997</Year><Month>2</Month><Day>7</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1997</Year><Month>2</Month><Day>7</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9013627</ArticleId><ArticleId IdType="doi">10.1074/jbc.272.6.3707</ArticleId><ArticleId
        IdType="pii">S0021-9258(19)78438-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12668284</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0304-3835</ISSN><JournalIssue
        CitedMedium="Print"><Volume>192</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>31</Day></PubDate></JournalIssue><Title>Cancer
        letters</Title><ISOAbbreviation>Cancer Lett</ISOAbbreviation></Journal><ArticleTitle>Overexpression
        of the peroxisome proliferator activated receptor alpha or the human c-Ha-ras
        transgene is not involved in tumorigenesis induced by di(2-ethylhexyl)phthalate
        in rasH2 mice.</ArticleTitle><Pagination><StartPage>199</StartPage><EndPage>203</EndPage><MedlinePgn>199-203</MedlinePgn></Pagination><Abstract><AbstractText>The
        mRNA profiles for peroxisome proliferator activated receptor (PPAR) alpha
        and human c-Ha-ras genes were determined by real-time semi-quantitative polymerase
        chain reaction analysis of hepatocellular adenomas induced by di(2-ethylhexyl)phthalate
        (DEHP) in transgenic mice carrying a human prototype c-Ha-ras gene (rasH2
        mice). The mRNA levels were essentially equal in hepatocellular adenomas and
        adjacent non-neoplastic hepatocytes, in spite of a remarkable elevation in
        the cell proliferation index in tumors determined by anti-Ki-67 immunohistochemistry.
        From the results, it is concluded that overexpression of PPARalpha or the
        transgene is not associated with the liver tumorigenesis induced by DEHP in
        rasH2 mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toyosawa</LastName><ForeName>Kaoru</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Drug
        Research Division, Dainippon Pharmaceutical Co., Ltd., 33-94 Enoki, Suita,
        564-0053, Osaka, Japan. kaoru-toyozawa@dianippon-pharm.co.jp</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Okugawa</LastName><ForeName>Kenji</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Teranishi</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kohji</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Nobuo</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Cancer
        Lett</MedlineTA><NlmUniqueID>7600053</NlmUniqueID><ISSNLinking>0304-3835</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D018248" MajorTopicYN="N">Adenoma, Liver Cell</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011905" MajorTopicYN="N">Genes, ras</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12668284</ArticleId><ArticleId IdType="doi">10.1016/s0304-3835(02)00714-0</ArticleId><ArticleId
        IdType="pii">S0304383502007140</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3206528</PMID><DateCompleted><Year>1989</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>96</Volume><Issue>3</Issue><PubDate><Year>1988</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The
        chronic hepatic or renal toxicity of di(2-ethylhexyl) phthalate, acetaminophen,
        sodium barbital, and phenobarbital in male B6C3F1 mice: autoradiographic,
        immunohistochemical, and biochemical evidence for levels of DNA synthesis
        not associated with carcinogenesis or tumor promotion.</ArticleTitle><Pagination><StartPage>494</StartPage><EndPage>506</EndPage><MedlinePgn>494-506</MedlinePgn></Pagination><Abstract><AbstractText>Male
        B6C3F1 mice, 6 weeks of age, were fed diets or water containing di(2-ethylhexyl)
        phthalate (DEHP) at 12,000 or 6000 ppm, acetaminophen (ACT) at 10,000 or 5000
        ppm, sodium barbital (BBS) at 1000 ppm, or phenobarbital (PB) at 500 ppm for
        40 weeks. Groups of six mice were terminated at 2, 8, 24, and 40 weeks for
        evaluation of liver and kidney weights, histopathology, and thymidine kinase
        (TK) activity in liver and kidney and levels of DNA synthesis, measured by
        tritiated thymidine [( 3H]T) autoradiography or bromodeoxyuridine (BrdU) immunohistochemistry.
        Liver weights, as percentage of body weight, were significantly elevated at
        most time intervals for mice exposed to all chemicals at each dose. The hepatocyte
        labeling indices (LI) with [3H]T autoradiography or BrdU immunocytochemistry
        were significantly elevated in mice fed DEHP at 12,000 ppm at 24 and 40 weeks
        or BBS and ACT at 2 weeks. LI were not elevated in mice fed PB. Hepatic TK
        activity was significantly elevated in mice fed DEHP, BBS, or ACT at Weeks
        2 and 8. Histopathologic hepatic lesions were associated with these elevations,
        while hepatic lesions were not associated with changes in TK activity in PB-treated
        mice. In contrast, only DEHP and BBS induced toxic renal lesions. Persistent
        or transient elevation of the renal LI and TK activity accompanied renal toxicity.
        Thus, the hepatic toxin DEHP induced chronic renal hyperplasia without evidence
        of renal carcinogenicity or tumor promotion in previous studies at the doses
        used. ACT, a hepatotoxin, produced transient chronic hepatic hyperplasia without
        evidence of carcinogenicity in B6C3F1 mice in earlier studies at the same
        doses used. Thus, persistent or transient hepatic or renal hyperplasia was
        associated with carcinogenic or tumor promoting activity of these chemicals
        in some cases but not in others.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Ward</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division
        of Cancer Etiology, National Cancer Institute, Frederick, Maryland 21701-1013.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Anderson</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Author><Author
        ValidYN="Y"><LastName>Lindsey</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Diwan</LastName><ForeName>B A</ForeName><Initials>BA</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>N01-C0-74102</GrantID><Agency>PHS HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>N01-C0-74103</GrantID><Agency>PHS
        HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001463">Barbiturates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance
        UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>5WZ53ENE2P</RegistryNumber><NameOfSubstance
        UI="D001462">Barbital</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.1.21</RegistryNumber><NameOfSubstance UI="D013937">Thymidine Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001345" MajorTopicYN="N">Autoradiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001462" MajorTopicYN="N">Barbital</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001463" MajorTopicYN="N">Barbiturates</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013937" MajorTopicYN="N">Thymidine Kinase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3206528</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(88)90009-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6488454</PMID><DateCompleted><Year>1984</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>11</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>5</Volume><Issue>10</Issue><PubDate><Year>1984</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Lack
        of genotoxic activity of di(2-ethylhexyl)phthalate (DEHP) in rat and human
        hepatocytes.</ArticleTitle><Pagination><StartPage>1329</StartPage><EndPage>1335</EndPage><MedlinePgn>1329-35</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)phthalate
        (DEHP) is a widely used plasticizer which has been reported to induce a statistically
        significant increase in the incidence of hepatocellular carcinomas in female
        Fischer-344 rats (8/50) when administered in the diet at 12 000 p.p.m. for
        two years. Numerous studies with cells in culture have failed to show any
        genotoxic activity associated with DEHP. Because DEHP induces multiple changes
        in the liver, such as peroxisomal proliferation, it was possible that these
        alterations could result in genotoxic effects in the treated whole animal
        that would not be seen in cells in culture. Accordingly, the ability of DEHP
        to induce DNA damage or repair was examined in rat hepatocytes in vivo and
        in vitro and in human hepatocytes in vitro. Unscheduled DNA synthesis was
        measured by incorporation of [3H]thymidine into primary hepatocyte cultures
        immediately isolated from treated animals or hepatocyte cultures incubated
        directly with DEHP. DNA damage was measured by alkaline elution of cellular
        DNA from the same cultures. In vivo-in vitro treatment regimens were: (i)
        female rats, 12 000 p.p.m. DEHP in the diet for 30 days; (ii) female rats,
        12 000 p.p.m. in the diet for 30 days, followed by 500 mg/kg DEHP by gavage
        2 h before sacrifice; (iii) male rats, 500 mg/kg DEHP by gavage 2, 12, 24,
        or 48 h before sacrifice; and (iv) male rats, 150 mg/kg/day by gavage for
        14 days. In vitro conditions were 0.1, 1.0 and 10.0 mM DEHP in the cultures
        for 18 h. Primary cultures of human hepatocytes were prepared from freshly
        discarded surgical material and exposed to the same concentration of DEHP.
        Concentrations up to 0.5 mM mono(2-ethylhexyl)phthalate, a principal metabolite
        of DEHP, were also examined in the human hepatocyte assay. No chemically induced
        DNA damage or repair was observed in vivo or in vitro in rat or human hepatocytes
        under any of the conditions employed. However, an increase in the percentage
        of cells in S-phase in the animals given DEHP was observed. These data indicate
        that DEHP does not exhibit direct genotoxic activity in the animals even with
        a treatment regimen which eventually produced tumors in a long term bioassay,
        and that both rat and human hepatocytes are similar in their lack of a genotoxic
        response to DEHP exposure in culture.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Butterworth</LastName><ForeName>B
        E</ForeName><Initials>BE</Initials></Author><Author ValidYN="Y"><LastName>Bermudez</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Smith-Oliver</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Earle</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Martin</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author
        ValidYN="Y"><LastName>Strom</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Jirtle</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Michalopoulos</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009153">Mutagens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009153" MajorTopicYN="Y">Mutagens</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6488454</ArticleId><ArticleId IdType="doi">10.1093/carcin/5.10.1329</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2635147</PMID><DateCompleted><Year>1990</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0019-5189</ISSN><JournalIssue
        CitedMedium="Print"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>1989</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Indian
        journal of experimental biology</Title><ISOAbbreviation>Indian J Exp Biol</ISOAbbreviation></Journal><ArticleTitle>Biochemical
        alterations in rat fetal liver following in utero exposure to di(2-ethylhexyl)phthalate
        (DEHP).</ArticleTitle><Pagination><StartPage>885</StartPage><EndPage>888</EndPage><MedlinePgn>885-8</MedlinePgn></Pagination><Abstract><AbstractText>Oral
        administration of DEHP, 1000 mg/kg body weight, to rats daily from 6 to 15
        day of gestation resulted in retardation of fetal growth and increase in fetal
        liver weight which contained significant quantities of DEHP. The activities
        of mitochondrial succinate dehydrogenase, malate dehydrogenase, cytochrome
        c oxidase and adenosine triphosphatase were decreased in fetal liver. The
        data indicate that exposure of mothers to DEHP during pregnancy could adversely
        affect the fetal livers by interfering with bioenergetics of the cell.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Srivastava</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Awasthi</LastName><ForeName>V K</ForeName><Initials>VK</Initials></Author><Author
        ValidYN="Y"><LastName>Srivastava</LastName><ForeName>S P</ForeName><Initials>SP</Initials></Author><Author
        ValidYN="Y"><LastName>Seth</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian
        J Exp Biol</MedlineTA><NlmUniqueID>0233411</NlmUniqueID><ISSNLinking>0019-5189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005333" MajorTopicYN="N">Fetus</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008431" MajorTopicYN="Y">Maternal-Fetal Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1989</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1989</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1989</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2635147</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2804110</PMID><DateCompleted><Year>1989</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-3002</ISSN><JournalIssue
        CitedMedium="Print"><Volume>985</Volume><Issue>3</Issue><PubDate><Year>1989</Year><Month>Nov</Month><Day>03</Day></PubDate></JournalIssue><Title>Biochimica
        et biophysica acta</Title><ISOAbbreviation>Biochim Biophys Acta</ISOAbbreviation></Journal><ArticleTitle>Protective
        effect of the plasticizer di(2-ethylhexyl) phthalate against damage of the
        mitochondrial membrane induced by calcium: possible participation of the adenine
        nucleotide translocator.</ArticleTitle><Pagination><StartPage>286</StartPage><EndPage>292</EndPage><MedlinePgn>286-92</MedlinePgn></Pagination><Abstract><AbstractText>The
        effect of di(2-ethylhexyl) phthalate (DEHP) on the response of isolated rat
        liver mitochondria to Ca2+ was investigated. DEHP was found to inhibit more
        than 60% of the auto-accelerating release of respiration induced by 100 microM
        Ca2+, being maximally inhibitory at 40 microM. Prior addition of DEHP also
        partially inhibited Ca2+-induced swelling of the mitochondrial matrix. However,
        DEHP did not change the net rate of Ca2+ uptake measured by the steady-state
        infusion method. DEHP also reduced the rate of adenine nucleotide exchange
        across the mitochondrial membrane. Another alkyl phthalate and alkyl citrates
        had similar effects on Ca2+-induced membrane damage, but their potencies depended
        on the lengths of their alkyl chains. These results suggest that the effects
        of DEHP and other alkyl esters on mitochondrial functions are mainly based
        on their actions on membrane lipids surrounding adenine nucleotide translocator
        (AdNT), resulting in alteration of the interaction between these phospholipids
        and AdNT, and consequent modification of the state of the protein.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Kora</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Technical
        R&amp;D Division, Terumo Corporation, Fuji, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sado</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Koike</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Terada</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biochim
        Biophys Acta</MedlineTA><NlmUniqueID>0217513</NlmUniqueID><ISSNLinking>0006-3002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000227">Adenine Nucleotides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance
        UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000227" MajorTopicYN="N">Adenine Nucleotides</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008564" MajorTopicYN="N">Membrane Potentials</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008930" MajorTopicYN="N">Mitochondria, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1989</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1989</Year><Month>11</Month><Day>3</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1989</Year><Month>11</Month><Day>3</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2804110</ArticleId><ArticleId IdType="doi">10.1016/0005-2736(89)90414-8</ArticleId><ArticleId
        IdType="pii">0005-2736(89)90414-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">25683344</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1349-7006</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>106</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>Cancer
        science</Title><ISOAbbreviation>Cancer Sci</ISOAbbreviation></Journal><ArticleTitle>Validation
        study of the combined repeated-dose toxicity and genotoxicity assay using
        gpt delta rats.</ArticleTitle><Pagination><StartPage>529</StartPage><EndPage>541</EndPage><MedlinePgn>529-41</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1111/cas.12634</ELocationID><Abstract><AbstractText>Transgenic
        rodents carrying reporter genes to detect organ-specific in vivo genetic alterations
        are useful for risk assessment of genotoxicity that causes cancer. Thus, the
        Organization for Economic Co-operation and Development has established the
        guideline for genotoxicity tests using transgenic animals, which may be combined
        with repeated-dose toxicity studies. Here, we provide evidence to support
        equivalence of gpt delta and wild type (WT) rats in terms of toxicological
        responses to a genotoxic hepatocarcinogen, N-nitrosodiethylamine (DEN), and
        a non-genotoxic hepatocarcinogen, di(2-ethylhexyl)phthalate (DEHP). gpt delta
        rats treated with DEHP showed similar increases in liver and kidney weights,
        serum albumin, albumin/globulin ratios, and incidence of diffuse hepatocyte
        hypertrophy compared to WT F344 and Sprague-Dawley (SD) rats. DEN-treated
        gpt delta rats showed equivalent increases in the number and area of precancerous
        GST-P-positive foci in the liver compared to WT rats. The livers of DEN-treated
        gpt delta rats also showed increased frequencies of gpt and Spi(-) mutations;
        such changes were not observed in DEHP-treated gpt delta rats. These results
        indicated that gpt delta rats (both F344 and SD backgrounds) showed comparable
        DEHP-induced toxicity and DEN-induced genotoxicity to those observed in WT
        rats. With regard to the administration period, the general toxicity of 1.2%
        DEHP was evident throughout the experimental period, and the genotoxicity
        of 10 p.p.m. DEN could be detected after 2 weeks of administration and further
        increased at 4 weeks. These results suggested that combined assays using gpt
        delta rats could detect both general toxicity and genotoxicity by the canonical
        4-week administration protocol. Therefore, this assay using gpt delta rats
        would be applicable for risk assessment including early detection of genotoxic
        carcinogens and ultimately serve to reduce cancer risks in humans from environmental
        chemicals.</AbstractText><CopyrightInformation>&#xa9; 2015 The Authors. Cancer
        Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer
        Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Akagi</LastName><ForeName>Jun-Ichi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division
        of Pathology, National Institute of Health Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Toyoda</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division
        of Pathology, National Institute of Health Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cho</LastName><ForeName>Young-Man</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Division
        of Pathology, National Institute of Health Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mizuta</LastName><ForeName>Yasuko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division
        of Pathology, National Institute of Health Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nohmi</LastName><ForeName>Takehiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Biological
        Safety Research Center, National Institute of Health Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        for Innovative Drug Discovery and Development, National Institute of Biomedical
        Innovation, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nishikawa</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biological
        Safety Research Center, National Institute of Health Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Kumiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division
        of Pathology, National Institute of Health Sciences, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D023361">Validation
        Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cancer
        Sci</MedlineTA><NlmUniqueID>101168776</NlmUniqueID><ISSNLinking>1347-9032</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IQ78TTX1A</RegistryNumber><NameOfSubstance
        UI="D004052">Diethylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004052" MajorTopicYN="N">Diethylnitrosamine</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009152" MajorTopicYN="N">Mutagenicity Tests</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D055647" MajorTopicYN="Y">Rats, Transgenic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Genotoxicity</Keyword><Keyword MajorTopicYN="N">gpt
        delta</Keyword><Keyword MajorTopicYN="N">mutation</Keyword><Keyword MajorTopicYN="N">reduction
        of animal use</Keyword><Keyword MajorTopicYN="N">repeated-dose toxicity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2014</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2015</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">25683344</ArticleId><ArticleId IdType="pmc">PMC4452153</ArticleId><ArticleId
        IdType="doi">10.1111/cas.12634</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>OECD.
        OECD Guideline for Testing of Chemicals No. 488: Transgenic Rodent Somatic
        and Germ Cell Gene Mutation Assays. OECD: Paris; 2013.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">30057023</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi
        H, Kondo H, Masumura K, Shindo Y, Nohmi T. Novel transgenic rat for in&#xa0;vivo
        genotoxicity assays using 6-thioguanine and Spi&#x2212; selection. Environ
        Mol Mutagen. 2003;41:253&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12717780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nohmi
        T, Katoh M, Suzuki H, et al. A new transgenic mouse mutagenesis test system
        using Spi&#x2212; and 6-thioguanine selections. Environ Mol Mutagen. 1996;28:465&#x2013;70.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8991079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatematsu
        M, Tsuda H, Shirai T, Masui T, Ito N. Placental glutathione S-transferase
        (GST-P) as a new marker for hepatocarcinogenesis: in&#xa0;vivo short-term
        screening for hepatocarcinogens. Toxicol Pathol. 1987;15:60&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2883719</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC.
        IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some N-nitroso
        compounds. IARC: Lyon; 1977.</Citation></Reference><Reference><Citation>Kluwe
        WM, McConnell EE, Huff JE, Haseman JK, Douglas JF, Hartwell WV. Carcinogenicity
        testing of phthalate esters and related compounds by the National Toxicology
        Program and the National Cancer Institute. Environ Health Perspect. 1982;45:129&#x2013;33.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1569006</ArticleId><ArticleId IdType="pubmed">7140685</ArticleId></ArticleIdList></Reference><Reference><Citation>NTP
        (National Toxicology Program) Carcinogenesis Bioassay of Di(2-ethylhexyl)phthalate
        (CAS No. 117-81-7) in F344 Rats and B6C3F1 Mice (Feed Study) Research Triangle
        Park, NC: NTP; 1982. . US Department of Health and Human Services, NTP publication
        No. 217.</Citation><ArticleIdList><ArticleId IdType="pubmed">12778218</ArticleId></ArticleIdList></Reference><Reference><Citation>NTP
        (National Toxicology Program) Update on the Reproductive and Developmental
        Toxicity of DEHP. Research Triangle Park, NC: NTP; 2006. . US Department of
        Health and Human Services, NTP publication No. 06-4476.</Citation></Reference><Reference><Citation>Kanki
        K, Nishikawa A, Masumura K, et al. In vivo mutational analysis of liver DNA
        in gpt delta transgenic rats treated with the hepatocarcinogens N-nitrosopyrrolidine,
        2-amino-3-methylimidazo[4,5-f]quinoline, and di(2-ethylhexyl)phthalate. Mol
        Carcinog. 2005;42:9&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">15486947</ArticleId></ArticleIdList></Reference><Reference><Citation>Nohmi
        T, Suzuki T, Masumura K. Recent advances in the protocols of transgenic mouse
        mutation assays. Mutat Res. 2000;455:191&#x2013;215.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11113476</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Tatematsu M, Subbarao V, Ito N, Reddy JK. Analysis of peroxisome proliferator-induced
        preneoplastic and neoplastic lesions of rat liver for placental form of glutathione
        S-transferase and gamma-glutamyltranspeptidase. Cancer Res. 1986;46:5287&#x2013;90.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2875789</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC.
        IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Industrial
        Chemicals. IARC: Lyon; 2000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5098133</ArticleId><ArticleId
        IdType="pubmed">11236796</ArticleId></ArticleIdList></Reference><Reference><Citation>Akingbemi
        BT, Youker RT, Sottas CM, et al. Modulation of rat Leydig cell steroidogenic
        function by di(2-ethylhexyl)phthalate. Biol Reprod. 2001;65:1252&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11566751</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon
        R, Lecavalier P, Mueller R, Valli VE. Subchronic oral toxicity of di-n-octyl
        phthalate and di (2-ethylhexyl) phthalate in the rat. Chem Toxicol. 1997;35:225&#x2013;39.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9146736</ArticleId></ArticleIdList></Reference><Reference><Citation>Swenberg
        JA, Hoel DG, Magee PN. Mechanistic and statistical insight into the large
        carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine.
        Cancer Res. 1991;51:6409&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">1933905</ArticleId></ArticleIdList></Reference><Reference><Citation>Rumsby
        PC, Barrass NC, Phillimore HE, Evans JG. Analysis of the Ha-ras oncogene in
        C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine
        or phenobarbitone. Carcinogenesis. 1991;12:2331&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1747936</ArticleId></ArticleIdList></Reference><Reference><Citation>You
        M, Wang Y, Lineen AM, Stoner GD, Anderson MW. Mutagenesis of the K-ras protooncogene
        in mouse lung tumors induced by N-ethyl-N-nitrosourea or N-nitrosodiethylamine.
        Carcinogenesis. 1992;13:1583&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1394843</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen
        B, Liu L, Castonguay A, Maronpot RR, Anderson MW, You M. Dose-dependent ras
        mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
        induced mouse lung tumors. Carcinogenesis. 1993;14:1603&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8353844</ArticleId></ArticleIdList></Reference><Reference><Citation>Boerrigter
        ME. Mutagenicity of the peroxisome proliferators clofibrate, Wyeth 14,643
        and di-2-ethylhexyl phthalate in the lacZ plasmid-based transgenic mouse mutation
        assay. J Carcinog. 2004;3:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC420255</ArticleId><ArticleId
        IdType="pubmed">15128457</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldwell
        JC. DEHP: genotoxicity and potential carcinogenic mechanisms-a review. Mutat
        Res. 1012;751:82&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">22484601</ArticleId></ArticleIdList></Reference><Reference><Citation>OECD.
        OECD Guideline for Testing of Chemicals No. 407: Repeated Dose 28-Day Oral
        Toxicity Study in Rodents. OECD: Paris; 2008.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3594641</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0009-2797</ISSN><JournalIssue
        CitedMedium="Print"><Volume>62</Volume><Issue>2</Issue><PubDate><Year>1987</Year></PubDate></JournalIssue><Title>Chemico-biological
        interactions</Title><ISOAbbreviation>Chem Biol Interact</ISOAbbreviation></Journal><ArticleTitle>Changes
        in hepatic dolichol and dolichyl monophosphate caused by treatment of rats
        with inducers of the endoplasmic reticulum and peroxisomes and during ontogeny.</ArticleTitle><Pagination><StartPage>191</StartPage><EndPage>208</EndPage><MedlinePgn>191-208</MedlinePgn></Pagination><Abstract><AbstractText>Rats
        were treated with various inducers of the endoplasmic reticulum and peroxisomes
        and the properties and distributions of dolichol and dolichyl phosphate analyzed.
        The treatment of rats with carcinogenic agents 2-acetylaminofluorene, N-nitrosodiethylamine
        and 3-methylcholanthrene and with the compounds such as phenobarbital, terpentine,
        cholestyramine and di(2-ethylhexyl)phthalate have all caused changes in the
        microsomal or lysosomal contents of dolichol to various extents, but only
        the latter group influenced dolichyl-P concentration. Shortly after birth,
        the hepatic content of dolichyl-P reaches the adult level, whereas the level
        of the free alcohol is low at birth but increases continuously thereafter.
        Incorporation of [3H]mevalonate into dolichol was also dependent on factors
        other than de novo synthesis, e.g., the pool size. Rates of glycosylation
        reactions dependent on dolichyl-P exhibit considerable changes but are independent
        of the existing levels of lipid intermediate. GDP-mannosyl transferase activity
        increases greatly with birth, but the enzyme activity returns to the adult
        level within a day after birth. These results demonstrate that structural
        and functional modifications induced with drugs can greatly influence the
        content and distribution of dolichol which are independent of the existing
        levels of dolichyl-P.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Edlund</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Ericsson</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Dallner</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Chem
        Biol Interact</MedlineTA><NlmUniqueID>0227276</NlmUniqueID><ISSNLinking>0009-2797</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004048">Diethylamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004224">Diterpenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004288">Dolichol Phosphates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004286">Dolichols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011106">Polyisoprenyl Phosphates</NameOfSubstance></Chemical><Chemical><RegistryNumber>11041-12-6</RegistryNumber><NameOfSubstance
        UI="D002792">Cholestyramine Resin</NameOfSubstance></Chemical><Chemical><RegistryNumber>56-49-5</RegistryNumber><NameOfSubstance
        UI="D008748">Methylcholanthrene</NameOfSubstance></Chemical><Chemical><RegistryNumber>6O7F7IX66E</RegistryNumber><NameOfSubstance
        UI="C032279">phthalic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>9M98QLJ2DL</RegistryNumber><NameOfSubstance
        UI="D015073">2-Acetylaminofluorene</NameOfSubstance></Chemical><Chemical><RegistryNumber>D7TJ0C6RJO</RegistryNumber><NameOfSubstance
        UI="C031406">N-nitrodiethylamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.6.99.3</RegistryNumber><NameOfSubstance UI="D009245">NADH Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.4.1.-</RegistryNumber><NameOfSubstance UI="D006602">Hexosyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>XJ6RUH0O4G</RegistryNumber><NameOfSubstance
        UI="D014425">Turpentine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015073" MajorTopicYN="N">2-Acetylaminofluorene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002451" MajorTopicYN="N">Cell Compartmentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002792" MajorTopicYN="N">Cholestyramine Resin</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004048" MajorTopicYN="N">Diethylamines</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004224" MajorTopicYN="N">Diterpenes</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004288" MajorTopicYN="N">Dolichol Phosphates</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004286" MajorTopicYN="N">Dolichols</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006602" MajorTopicYN="N">Hexosyltransferases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000254"
        MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008115" MajorTopicYN="N">Liver Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008748" MajorTopicYN="N">Methylcholanthrene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009245" MajorTopicYN="N">NADH Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011106" MajorTopicYN="N">Polyisoprenyl Phosphates</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014425" MajorTopicYN="N">Turpentine</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3594641</ArticleId><ArticleId IdType="doi">10.1016/0009-2797(87)90090-1</ArticleId><ArticleId
        IdType="pii">0009-2797(87)90090-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">26519955</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0929</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>149</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Dose and Effect Thresholds for
        Early Key Events in a PPAR&#x3b1;-Mediated Mode of Action.</ArticleTitle><Pagination><StartPage>312</StartPage><EndPage>325</EndPage><MedlinePgn>312-25</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1093/toxsci/kfv236</ELocationID><Abstract><AbstractText>Current
        strategies for predicting adverse health outcomes of environmental chemicals
        are centered on early key events in toxicity pathways. However, quantitative
        relationships between early molecular changes in a given pathway and later
        health effects are often poorly defined. The goal of this study was to evaluate
        short-term key event indicators using qualitative and quantitative methods
        in an established pathway of mouse liver tumorigenesis mediated by peroxisome
        proliferator-activated receptor alpha (PPAR&#x3b1;). Male B6C3F1 mice were
        exposed for 7 days to di (2-ethylhexyl) phthalate (DEHP), di-n-octyl phthalate
        (DNOP), and n-butyl benzyl phthalate (BBP), which vary in PPAR&#x3b1; activity
        and liver tumorigenicity. Each phthalate increased expression of select PPAR&#x3b1;
        target genes at 7 days, while only DEHP significantly increased liver cell
        proliferation labeling index (LI). Transcriptional benchmark dose (BMDT) estimates
        for dose-related genomic markers stratified phthalates according to hypothetical
        tumorigenic potencies, unlike BMDs for non-genomic endpoints (relative liver
        weights or proliferation). The 7-day BMDT values for Acot1 as a surrogate
        measure for PPAR&#x3b1; activation were 29, 370, and 676&#x2009;mg/kg/day
        for DEHP, DNOP, and BBP, respectively, distinguishing DEHP (liver tumor BMD
        of 35&#x2009;mg/kg/day) from non-tumorigenic DNOP and BBP. Effect thresholds
        were generated using linear regression of DEHP effects at 7 days and 2-year
        tumor incidence values to anchor early response molecular indicators and a
        later phenotypic outcome. Thresholds varied widely by marker, from 2-fold
        (Pdk4 and proliferation LI) to 30-fold (Acot1) induction to reach hypothetical
        tumorigenic expression levels. These findings highlight key issues in defining
        thresholds for biological adversity based on molecular changes.</AbstractText><CopyrightInformation>Published
        by Oxford University Press on behalf of the Society of Toxicology 2015. This
        work is written by US Government employees and is in the public domain in
        the US.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Lake</LastName><ForeName>April D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>*Curriculum
        in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27599;
        Oak Ridge Institute for Science and Education (ORISE) participant at the National
        Health and Environmental Effects Research Laboratory (NHEERL), Office of Research
        and Development (ORD), U.S. Environmental Protection Agency (U.S. EPA), Research
        Triangle Park, North Carolina 27711; Integrated Systems Toxicology Division,
        NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wood</LastName><ForeName>Charles E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhat</LastName><ForeName>Virunya
        S</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>NSF International,
        Ann Arbor, Michigan 48105;</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chorley</LastName><ForeName>Brian N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carswell</LastName><ForeName>Gleta
        K</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sey</LastName><ForeName>Yusupha
        M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenyon</LastName><ForeName>Elaina
        M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padnos</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Tanya
        M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tennant</LastName><ForeName>Alan
        H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Judith
        E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Toxicology
        Assessment Division, NHEERL, ORD; and.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>George</LastName><ForeName>Barbara Jane</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Office
        of the Associate Director for Health, NHEERL, ORD, U.S. EPA, Research Triangle
        Park, North Carolina 27711.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ross</LastName><ForeName>David G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Michael
        F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corton</LastName><ForeName>J
        Christopher</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Jane
        Ellen</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McQueen</LastName><ForeName>Charlene
        A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hester</LastName><ForeName>Susan
        D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park,
        North Carolina 27711; hester.susan@epa.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YPC4PJX59M</RegistryNumber><NameOfSubstance
        UI="C027561">butylbenzyl phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019985" MajorTopicYN="N">Benchmarking</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="N">PPAR alpha</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse outcome pathway</Keyword><Keyword
        MajorTopicYN="N">benchmark dose</Keyword><Keyword MajorTopicYN="N">liver carcinogenesis</Keyword><Keyword
        MajorTopicYN="N">mode of action</Keyword><Keyword MajorTopicYN="N">peroxisome
        proliferator-activated receptor-alpha</Keyword><Keyword MajorTopicYN="N">phthalate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">26519955</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfv236</ArticleId><ArticleId
        IdType="pii">kfv236</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">20654484</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0887-2333</ISSN><JournalIssue
        CitedMedium="Print"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>1999</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Toxicology
        in vitro : an international journal published in association with BIBRA</Title><ISOAbbreviation>Toxicol
        In Vitro</ISOAbbreviation></Journal><ArticleTitle>An in vitro model for peroxisome
        proliferation utilizing primary hepatocytes in sandwich culture.</ArticleTitle><Pagination><StartPage>265</StartPage><EndPage>273</EndPage><MedlinePgn>265-73</MedlinePgn></Pagination><Abstract><AbstractText>Peroxisome
        proliferators comprise a group of structurally diverse chemicals which share
        as a common biologic effect the induction of peroxisomal fatty acid degrading
        enzymes. Concomitantly, the number and size of peroxisomes within hepatocytes
        increases. Following chronic administration some peroxisome proliferators
        act as non-genotoxic hepatocarcinogens in susceptible species such as rodents.
        To establish an in vitro model for the toxicological investigation of peroxisome
        proliferation, primary hepatocytes of rats, dogs and humans were cultivated
        in an organotypic cell culture model (sandwich model). By employing a panel
        of diverse compounds in this model a graded response was observed in the induction
        of carnitine acetyl transferase (CAT), the activity of which was determined
        as an endpoint. The following results were obtained in the order of decreasing
        inducing potential for rat hepatocytes: FOE 3798&gt;nafenopin&gt;fenofibrate
        (&lt;clofibrate&gt;ciprofibrate&gt;bezafibrate DEHP approximately ETYA&gt;DEHA.
        Induction of CAT activity was generally higher than reported in earlier cell
        culture systems, probably reflecting the effect of the extracellular matrix
        provided by the collagen gel sandwich. In parallel, transcription of the rat
        CYP4A1 gene was induced by a similar order of magnitude as measured by TaqMan
        RT-PCR. In accordance with literature data, human and dog hepatocytes did
        not display such a strong and graded response but rather were not susceptible
        to this effect. In addition, (3)H-thymidine incorporation data demonstrated
        that nafenopin was able to induce DNA synthesis in rat hepatocytes whereas
        it did not in human hepatocytes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Hildebrand</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Bayer
        AG, Toxikologie, D-42096 Wuppertal, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Schmidt</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author
        ValidYN="Y"><LastName>Kempka</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Jacob</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Ahr</LastName><ForeName>H J</ForeName><Initials>HJ</Initials></Author><Author
        ValidYN="Y"><LastName>Ebener</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Goretzki</LastName><ForeName>P E</ForeName><Initials>PE</Initials></Author><Author
        ValidYN="Y"><LastName>Bader</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol
        In Vitro</MedlineTA><NlmUniqueID>8712158</NlmUniqueID><ISSNLinking>0887-2333</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="accepted"><Year>1998</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20654484</ArticleId><ArticleId IdType="doi">10.1016/s0887-2333(98)00078-2</ArticleId><ArticleId
        IdType="pii">S0887-2333(98)00078-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3354005</PMID><DateCompleted><Year>1988</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue
        CitedMedium="Print"><Volume>40</Volume><Issue>3</Issue><PubDate><Year>1988</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Effect
        of di(2-ethylhexyl)phthalate (DEHP) on hepatic mixed function oxidases in
        different animal species.</ArticleTitle><Pagination><StartPage>209</StartPage><EndPage>217</EndPage><MedlinePgn>209-17</MedlinePgn></Pagination><Abstract><AbstractText>Administration
        of 2000 mg/kg of di(2-ethylhexyl)phthalate (DEHP) for a period of 7 or 15
        days in rats, mice, guinea pigs and rabbits produced a differential effect
        as judged by alterations in body weight gain, liver weight and activities
        of mixed function oxidases. DEHP exposure for 7 days caused an increase in
        the activity of aniline hydroxylase, arylhydrocarbon hydroxylase and ethylmorphine
        N-demethylase in rats, mice and guinea pigs, but a decrease in that of rabbits.
        However, exposure for 15 days produced a smaller degree of increase in the
        activity of these enzymes in rats and mice and even produced a decrease in
        the activity of these enzymes in guinea pigs. This differential response of
        DEHP in various animal species suggests a species difference in the toxicity
        of the plasticizer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Parmar</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Industrial
        Toxicology Research Centre, Mahatma Gandhi Marg, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Srivastava</LastName><ForeName>S P</ForeName><Initials>SP</Initials></Author><Author
        ValidYN="Y"><LastName>Seth</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D006899">Mixed Function Oxygenases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006899" MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011817" MajorTopicYN="N">Rabbits</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3354005</ArticleId><ArticleId IdType="doi">10.1016/0378-4274(88)90043-4</ArticleId><ArticleId
        IdType="pii">0378-4274(88)90043-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">16326050</PMID><DateCompleted><Year>2006</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>22</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue
        CitedMedium="Print"><Volume>163</Volume><Issue>3</Issue><PubDate><Year>2006</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Mono(2-ethylhexyl)phthalate
        and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors
        alpha and gamma in breast.</ArticleTitle><Pagination><StartPage>224</StartPage><EndPage>234</EndPage><MedlinePgn>224-34</MedlinePgn></Pagination><Abstract><AbstractText>The
        phthalates di(2-ethylhexyl)phthalate (DEHP) and di-n-butyl phthalate (DBP)
        are environmental contaminants with significant human exposures. Both compounds
        are known reproductive toxins in rodents and DEHP also induces rodent hepatocarcinogenesis
        in a process believed to be mediated via the peroxisome proliferator-activated
        receptor alpha (PPARalpha). DEHP and DBP are metabolised to their respective
        monoesters, mono-(2-ethylhexyl)phthalate (MEHP) and mono-n-butyl phthalate
        (MBP), which are the active metabolites. MEHP also activates another member
        of the PPAR subfamily, PPARgamma. The effects of PPARalpha and PPARgamma activation
        in human breast cells appears to be opposing; PPARalpha activators in breast
        cells cause an increase in proliferation, while PPARgamma activation in breast
        cells is associated with differentiation and an inhibition of cell proliferation.
        Further to this the activation of the PPARs is cell and ligand specific, suggesting
        the importance of examining the effect of MEHP and MBP on the activation of
        PPARalpha, PPARbeta and PPARgamma in human breast. We used the common model
        of human breast cancer MCF-7 and examined the ability of MEHP and MBP to activate
        human PPARs in this system. The ability of MBP and MEHP to block PPAR responses
        was also assessed. We found that both human PPARalpha and PPARgamma were activated
        by MEHP whereas MEHP could not activate PPARbeta. MBP was unable to activate
        any PPAR isoforms in this breast model, despite being a weak peroxisome proliferator
        in liver, although MBP was an antagonist for both PPARgamma and PPARbeta.
        Our results suggest that the toxicological consequences of MEHP in the breast
        could be complex given the opposing effects of PPARalpha and PPARgamma in
        human breast cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Venkata</LastName><ForeName>Nagaraj Gopisetty</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>School
        of Pharmacy, University of Queensland, Steele Building 03, St. Lucia, Qld.
        4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Jodie
        A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Cabot</LastName><ForeName>Peter
        J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Monteith</LastName><ForeName>Greg R</ForeName><Initials>GR</Initials></Author><Author
        ValidYN="Y"><LastName>Roberts-Thomson</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2005</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002087">Butyrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C453899">GW 7647</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047495">PPAR gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D048068">PPAR-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010671">Phenylurea Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013844">Thiazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D045162">Thiazolidinediones</NameOfSubstance></Chemical><Chemical><RegistryNumber>4PZK9FJC4Z</RegistryNumber><NameOfSubstance
        UI="C479979">(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic
        acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>U8QXS1WU8G</RegistryNumber><NameOfSubstance
        UI="C039671">ciglitazone</NameOfSubstance></Chemical><Chemical><RegistryNumber>ZI46LWZ45G</RegistryNumber><NameOfSubstance
        UI="C028577">monobutyl phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002087" MajorTopicYN="N">Butyrates</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="N">PPAR alpha</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047495" MajorTopicYN="N">PPAR gamma</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D048068" MajorTopicYN="N">PPAR-beta</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010671" MajorTopicYN="N">Phenylurea Compounds</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013844" MajorTopicYN="N">Thiazoles</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D045162" MajorTopicYN="N">Thiazolidinediones</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2005</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2005</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2005</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2005</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2006</Year><Month>5</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2005</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">16326050</ArticleId><ArticleId IdType="doi">10.1016/j.toxlet.2005.11.001</ArticleId><ArticleId
        IdType="pii">S0378-4274(05)00370-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2867621</PMID><DateCompleted><Year>1986</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>81</Volume><Issue>3 Pt 1</Issue><PubDate><Year>1985</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Time
        and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl)
        phthalate.</ArticleTitle><Pagination><StartPage>371</StartPage><EndPage>392</EndPage><MedlinePgn>371-92</MedlinePgn></Pagination><Abstract><AbstractText>Groups
        of male and groups of female Wistar albino rats were administered diets containing
        sufficient di(2-ethylhexyl) phthalate (DEHP) to ensure intakes of either 1000,
        200, or 50 mg/kg/day. Four rats from each experimental group and six control
        rats of the same sex were killed 3, 7, 14, and 28 days and 9 months after
        commencement of treatment. At all time points the major abdominal organs were
        removed and subjected to histological examination. A more extensive necropsy
        was performed on those rats killed after 9 months of treatment. At all time
        points the livers of the rats were subjected to extensive histologic, electron
        microscopic, and biochemical examination. Changes could be grouped according
        to their time course. Two early and transient alterations were noticed. First,
        there were morphologic changes in the bile canaliculi of male rats treated
        with 1000 mg/kg/day of DEHP. Second, there was a burst of mitosis immediately
        after the start of administration of the compound. The time course of this
        mitotic burst varied; the increase in mitosis was greatest at 3 days in rats
        treated with 1000 mg/kg/day of DEHP and was smaller but more prolonged in
        rats treated with 200 or 50 mg/kg/day. Other changes, namely, a midzonal to
        periportal accumulation of fat, induction of peroxisomal enzymes, and induction
        of the P-450 isoenzyme also developed rapidly but were sustained throughout
        the study. The maximal change was usually attained within 7 days of commencement
        of treatment. More slowly developing changes were hypertrophy of the hepatocytes,
        centrilobular loss of glycogen, and a fall in glucose-6-phosphatase activity.
        Here maximal changes were not attained until 28 days after commencement of
        treatment. These three effects were clearly observed in rats treated with
        200 or 1000 mg/kg/day of DEHP but were only marginally altered in rats treated
        with 50 mg/kg/day. Finally accumulation of lipid-loaded lysosomes assessed
        by light and electron microscopy and by assay of beta-galactosidase activity
        was only apparent in rats treated with DEHP for 9 months with 200 or 1000
        mg/kg/day of DEHP. Changes in female rats were qualitatively similar to those
        observed in male rats. The alterations were, however, less pronounced than
        in male rats treated with an equal dose of DEHP and the degree of liver enlargement
        was much less because, although the initial hyperplasia was clearly apparent,
        there was a much smaller degree of hypertrophy.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>F
        E</ForeName><Initials>FE</Initials></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>S
        C</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Hinton</LastName><ForeName>R
        H</ForeName><Initials>RH</Initials></Author><Author ValidYN="Y"><LastName>Grasso</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Bridges</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.-</RegistryNumber><NameOfSubstance UI="D005993">Glycerolphosphate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.2.2</RegistryNumber><NameOfSubstance UI="D010170">Palmitoyl-CoA Hydrolase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005993" MajorTopicYN="N">Glycerolphosphate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006529" MajorTopicYN="N">Hepatomegaly</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010170" MajorTopicYN="N">Palmitoyl-CoA Hydrolase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2867621</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(85)90409-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3770794</PMID><DateCompleted><Year>1986</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0301-1208</ISSN><JournalIssue
        CitedMedium="Print"><Volume>23</Volume><Issue>2</Issue><PubDate><Year>1986</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Indian
        journal of biochemistry &amp; biophysics</Title><ISOAbbreviation>Indian J
        Biochem Biophys</ISOAbbreviation></Journal><ArticleTitle>Are the hypocholesterolaemic
        action and metabolic effects of diethylhexyl phthalate mediated by thyroxine?</ArticleTitle><Pagination><StartPage>76</StartPage><EndPage>79</EndPage><MedlinePgn>76-9</MedlinePgn></Pagination><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Kurup</LastName><ForeName>C K</ForeName><Initials>CK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian
        J Biochem Biophys</MedlineTA><NlmUniqueID>0310774</NlmUniqueID><ISSNLinking>0301-1208</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>721M9407IY</RegistryNumber><NameOfSubstance
        UI="D011441">Propylthiouracil</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q51BO43MG4</RegistryNumber><NameOfSubstance
        UI="D013974">Thyroxine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="Y">anatomy &amp; histology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008930" MajorTopicYN="N">Mitochondria, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011441" MajorTopicYN="N">Propylthiouracil</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013965" MajorTopicYN="N">Thyroidectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013974" MajorTopicYN="N">Thyroxine</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3770794</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10547627</PMID><DateCompleted><Year>2000</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0260-437X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>19</Volume><Issue>6</Issue><PubDate><Year>1999</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Journal
        of applied toxicology : JAT</Title><ISOAbbreviation>J Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>Phase
        III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds
        with and without an exogenous metabolic activation system.</ArticleTitle><Pagination><StartPage>447</StartPage><EndPage>472</EndPage><MedlinePgn>447-72</MedlinePgn></Pagination><Abstract><AbstractText>FETAX
        (Frog Embryo Teratogenesis Assay-Xenopus) is a 96-h whole-embryo developmental
        toxicity screening assay that can be used in ecotoxicology and in detecting
        mammalian developmental toxicants when an in vitro metabolic activation system
        is employed. A standardized American Society for Testing and Materials (ASTM)
        guide for the conduct of FETAX has been published, along with a companion
        atlas that helps in embryo staging and in identifying malformations. As part
        of the ASTM process, an interlaboratory validation study was undertaken to
        evaluate the repeatability and reliability of FETAX and to evaluate the potential
        teratogenic hazard of 12 compounds. Three different laboratories participated
        in the study. All three participating laboratories had extensive experience
        with the assay. FETAX intralaboratory and interlaboratory variability, as
        judged by coefficients of variation, were very low. Potential teratogenic
        hazard was evaluated using two major criteria from FETAX experiments employing
        metabolic activation systems (MAS). These were the teratogenic index TI (TI
        = 96-h lc(50)/96-h ec(50) (malformation)) and the minimum concentration that
        inhibits growth (MCIG). A compound was considered teratogenic by this criterion
        when the MCIG was significantly different from controls at concentrations
        below the 30% level of the MAS 96-h lc(50). Based on the results of this and
        other studies, a decision table was constructed in order to evaluate additional
        studies. Severity of malformations caused, especially near the MAS 96-h ec(50)
        (malformation), were also evaluated. Four compounds were non-teratogenic but
        two compounds were clearly teratogenic. The remaining six compounds were ranked
        as equivocal teratogens. The results were discussed in light of the difficulty
        of producing an adequate decision table. FETAX proved to yield repeatable
        and reliable data as long as care was taken during range-finding and technicians
        were adequately trained. The MAS was essential in using FETAX to predict developmental
        hazard in mammals, and still requires further development.</AbstractText><CopyrightInformation>Copyright
        1999 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Bantle</LastName><ForeName>J
        A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department
        of Zoology, Oklahoma State University, Stillwater, OK 74078, USA. bantle@ohio.edu</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Finch</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author><Author
        ValidYN="Y"><LastName>Fort</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Author><Author
        ValidYN="Y"><LastName>Stover</LastName><ForeName>E L</ForeName><Initials>EL</Initials></Author><Author
        ValidYN="Y"><LastName>Hull</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Kumsher-King</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Gaudet-Hull</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Appl Toxicol</MedlineTA><NlmUniqueID>8109495</NlmUniqueID><ISSNLinking>0260-437X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000085">Acetates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018053">Arsenites</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001888">Boric Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001959">Bromates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D062845">Chloroacetates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005026">Ethylene Glycols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006842">Hydrocarbons, Brominated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007461">Iodoacetates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D017670">Sodium Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013723">Teratogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>11097-69-1</RegistryNumber><NameOfSubstance
        UI="D020111">Chlorodiphenyl (54% Chlorine)</NameOfSubstance></Chemical><Chemical><RegistryNumber>20R035KLCI</RegistryNumber><NameOfSubstance
        UI="D020106">Acrylamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>32YXG88KK0</RegistryNumber><NameOfSubstance
        UI="C053484">triglyme</NameOfSubstance></Chemical><Chemical><RegistryNumber>3WJQ0SDW1A</RegistryNumber><NameOfSubstance
        UI="D011092">Polyethylene Glycols</NameOfSubstance></Chemical><Chemical><RegistryNumber>5V2JDO056X</RegistryNumber><NameOfSubstance
        UI="D014238">Trichloroacetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>61BR964293</RegistryNumber><NameOfSubstance
        UI="C013484">diethylene glycol</NameOfSubstance></Chemical><Chemical><RegistryNumber>6O7F7IX66E</RegistryNumber><NameOfSubstance
        UI="C032279">phthalic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>71KTL99QJX</RegistryNumber><NameOfSubstance
        UI="C017766">tribromoacetic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9LSH52S3LQ</RegistryNumber><NameOfSubstance
        UI="D003999">Dichloroacetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>FC72KVT52F</RegistryNumber><NameOfSubstance
        UI="D019855">Ethylene Glycol</NameOfSubstance></Chemical><Chemical><RegistryNumber>R57ZHV85D4</RegistryNumber><NameOfSubstance
        UI="C032688">boric acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>U54JK6453O</RegistryNumber><NameOfSubstance
        UI="C060553">sodium bromate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000085" MajorTopicYN="N">Acetates</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020106" MajorTopicYN="N">Acrylamide</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018053" MajorTopicYN="N">Arsenites</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001681" MajorTopicYN="N">Biological Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001711" MajorTopicYN="N">Biotransformation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001888" MajorTopicYN="N">Boric Acids</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001959" MajorTopicYN="N">Bromates</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D062845" MajorTopicYN="N">Chloroacetates</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020111" MajorTopicYN="N">Chlorodiphenyl (54% Chlorine)</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003999" MajorTopicYN="N">Dichloroacetic Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004622" MajorTopicYN="N">Embryo, Mammalian</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004625" MajorTopicYN="Y">Embryo, Nonmammalian</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019855" MajorTopicYN="N">Ethylene Glycol</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005026" MajorTopicYN="N">Ethylene Glycols</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006842" MajorTopicYN="N">Hydrocarbons, Brominated</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007461" MajorTopicYN="N">Iodoacetates</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011092" MajorTopicYN="N">Polyethylene Glycols</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017670" MajorTopicYN="N">Sodium Compounds</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013723" MajorTopicYN="N">Teratogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014238" MajorTopicYN="N">Trichloroacetic Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014981" MajorTopicYN="N">Xenopus</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>11</Month><Day>5</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>11</Month><Day>5</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10547627</ArticleId><ArticleId IdType="doi">10.1002/(sici)1099-1263(199911/12)19:6&lt;447::aid-jat601&gt;3.0.co;2-4</ArticleId><ArticleId
        IdType="pii">10.1002/(SICI)1099-1263(199911/12)19:6&lt;447::AID-JAT601&gt;3.0.CO;2-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10839475</PMID><DateCompleted><Year>2000</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0340-5761</ISSN><JournalIssue
        CitedMedium="Print"><Volume>74</Volume><Issue>2</Issue><PubDate><Year>2000</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Species
        differences in response to diethylhexylphthalate: suppression of apoptosis,
        induction of DNA synthesis and peroxisome proliferator activated receptor
        alpha-mediated gene expression.</ArticleTitle><Pagination><StartPage>85</StartPage><EndPage>91</EndPage><MedlinePgn>85-91</MedlinePgn></Pagination><Abstract><AbstractText>Diethylhexylphthalate
        (DEHP) is a phthalate plasticizer that belongs to the peroxisome proliferator
        (PP) class of rodent nongenotoxic hepatocarcinogens. Previously, we have shown
        that MEHP (a principal metabolite of DEHP and the proximal PP) induced DNA
        synthesis and suppressed apoptosis in rat but not in human hepatocytes in
        vitro. Here, we present further studies of species differences in response
        to DEHP. In rats, 4 days of exposure to DEHP (950 mg/kg per day by gavage)
        induced peroxisomal beta-oxidation, DNA synthesis and suppressed apoptosis.
        In contrast, there was no response of guinea pig liver to DEHP. In rat hepatocytes
        in vitro, MEHP (250, 500 and 750 microM) induced peroxisomal beta-oxidation,
        DNA synthesis and suppressed apoptosis. In contrast to the pleiotropic response
        noted in rat hepatocytes, there was no response of human hepatocytes to 250,
        500 or 750 microM MEHP. PPs activate the peroxisome proliferator activated
        receptor alpha (PPARalpha) that binds to DNA at peroxisome proliferator response
        elements (PPREs) within the promoters of PP-responsive genes such as rat acyl
        CoA oxidase (ACO). However, the human ACO gene promoter differs at three bases
        within the PPRE from the rat ACO promoter and appears refractory to PPs. To
        address species differences in response to DEHP at the molecular level, we
        used promoter-reporter gene assays to compare the ability of MEHP to induce
        gene expression from the rat or the human ACO promoter. MEHP gave a concentration-dependent
        increase in reporter gene expression from the rat ACO gene promoter with either
        mouse or human PPARalpha. In contrast, the human ACO promoter was unable to
        drive MEHP-induced gene transcription irrespective of the species origin of
        PPARalpha. These data provide further weight of evidence at the cellular and
        molecular levels for a lack of risk to human health from the phthalate DEHP.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hasmall</LastName><ForeName>S
        C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Cancer Biology
        Group, Zeneca Central Toxicology Laboratory, Macclesfield, Cheshire, United
        Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>N
        H</ForeName><Initials>NH</Initials></Author><Author ValidYN="Y"><LastName>Macdonald</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Soames</LastName><ForeName>A R</ForeName><Initials>AR</Initials></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>62229-50-9</RegistryNumber><NameOfSubstance
        UI="D004815">Epidermal Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.2.1.23</RegistryNumber><NameOfSubstance UI="D001616">beta-Galactosidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D016475" MajorTopicYN="N">3T3 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004261"
        MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004815" MajorTopicYN="N">Epidermal Growth Factor</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020287" MajorTopicYN="N">In Situ Nick-End Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001616" MajorTopicYN="N">beta-Galactosidase</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2000</Year><Month>8</Month><Day>19</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10839475</ArticleId><ArticleId IdType="doi">10.1007/s002040050657</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9274804</PMID><DateCompleted><Year>1997</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>122</Volume><Issue>1-2</Issue><PubDate><Year>1997</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Peroxisome
        proliferators increase the formation of BPDE-DNA adducts in isolated rat hepatocytes.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>91</EndPage><MedlinePgn>81-91</MedlinePgn></Pagination><Abstract><AbstractText>Peroxisome
        proliferators are known to modulate the activity of xenobiotic-metabolising
        enzymes, including glutathione S-transferase (GST) and cytochrome P-450 (CYP).
        In this study the effect of peroxisome proliferators silvex and di(2-ethylhexyl)phthalate
        (DEHP) on the formation of (+)-anti-benzo(a)pyrene -7,8-dihydrodiol-9,10-epoxide
        (BPDE)-DNA adducts from a proximate mutagen and carcinogen (-)-transbenzo(a)pyrene-7,8-dihydrodiol
        (BPDD) has been investigated. Rat CYP1A1 metabolises BPDD to mutagenic BPDE,
        which may form DNA adducts or, alternatively, be detoxified by hydrolysis
        or glutathione conjugation. In this experiment the formation of BPDE-DNA adducts
        was significantly increased in hepatocytes isolated from all silvex treated
        rats and two out of four DEHP treated rats (14 day treatment). The activity
        of CYP1A1 was increased whereas GST was reduced by the peroxisome proliferator
        silvex. These changes were more significant than those induced by DEHP. We
        have hypothesised that the formation of BPDE-DNA adducts was primarily due
        to the increased BPDD activation to BPDE versus reduced detoxication of BPDE.
        Other hepatic changes induced by the peroxisome proliferators, e.g. peroxisome
        proliferation per se and increased mitotic activity of the liver could have
        an effect on the outcome of BPDD exposure.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Voskoboinik</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Key
        Centre for Applied and Nutritional Toxicology, RMIT-University, Melbourne,
        Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ooi</LastName><ForeName>S
        G</ForeName><Initials>SG</Initials></Author><Author ValidYN="Y"><LastName>Drew</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Ahokas</LastName><ForeName>J T</ForeName><Initials>JT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018736">DNA Adducts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004101">Dihydroxydihydrobenzopyrenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006540">Herbicides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007210">Indoleacetic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C043931">benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>55097-80-8</RegistryNumber><NameOfSubstance
        UI="D015123">7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>9Q963S4YMX</RegistryNumber><NameOfSubstance
        UI="D015085">2,4,5-Trichlorophenoxyacetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>D2HZL58IS3</RegistryNumber><NameOfSubstance
        UI="C009264">fenoprop</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015085" MajorTopicYN="N">2,4,5-Trichlorophenoxyacetic Acid</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015123" MajorTopicYN="N">7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide</DescriptorName><QualifierName
        UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018736" MajorTopicYN="N">DNA Adducts</DescriptorName><QualifierName UI="Q000138"
        MajorTopicYN="Y">chemical synthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004101" MajorTopicYN="N">Dihydroxydihydrobenzopyrenes</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006540" MajorTopicYN="N">Herbicides</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007210" MajorTopicYN="N">Indoleacetic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1997</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1997</Year><Month>9</Month><Day>26</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1997</Year><Month>9</Month><Day>26</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9274804</ArticleId><ArticleId IdType="doi">10.1016/s0300-483x(97)00083-8</ArticleId><ArticleId
        IdType="pii">S0300-483X(97)00083-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9465269</PMID><DateCompleted><Year>1998</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>148</Volume><Issue>1</Issue><PubDate><Year>1998</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>A
        glucose-regulated protein, GRP58, is down-regulated in C57B6 mouse liver after
        diethylhexyl phthalate exposure.</ArticleTitle><Pagination><StartPage>101</StartPage><EndPage>108</EndPage><MedlinePgn>101-8</MedlinePgn></Pagination><Abstract><AbstractText>Diethylhexyl
        phthalate (DEHP) is a widely used plasticizer that induces peroxisome proliferation
        in rodents. Prolonged exposure to DEHP results in a variety of toxic effects,
        the most significant of which appears to be an increased incidence of liver
        cancer and male reproductive toxicity in rodents. Accompanying these toxic
        effects is the induction of a number of genes within the liver, particularly
        those genes involved in peroxisomal fatty acid beta-oxidation and members
        of the cytochrome P450 family, CYP4A. In order to explore which additional
        genes may be altered by DEHP exposure, mRNA differential display was performed
        using total liver RNA from male C57B6 mice that were treated with either O
        or 2% DEHP in their diet for 7 days. In doing so, a number of partial cDNAs
        representing messages that are potentially differentially expressed have been
        isolated. One of these cDNAs was found to be similar to the previously cloned
        gene, GRP58. Analysis by RNase protection assay and North hybridization have
        shown that the transcript for GRP58 is down-regulated in the liver after DEHP
        exposure. Analysis of dose-response exposures to DEHP by reverse transcription
        (RT)-PCR confirm these results and also shows that GRP58 is not altered in
        kidney or testis. Immunoblot analysis using GRP58-specific antibodies also
        shows a decrease in GRP58 protein levels in DEHP-treated mice. Moreover, exposure
        of mice to another peroxisome proliferator, clofibrate, results in a slight
        down-regulation of GRP58 at the highest dose, 0.5%. Thus, it appears as if
        DEHP and clofibrate can use different pathways to affect gene expression.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Muhlenkamp</LastName><ForeName>C
        R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department
        of Entomology, University of California, Riverside 92521, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gill</LastName><ForeName>S S</ForeName><Initials>SS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D017931">DNA Primers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006360">Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        5.-</RegistryNumber><NameOfSubstance UI="D007535">Isomerases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        5.3.4.1</RegistryNumber><NameOfSubstance UI="C513195">Pdia3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        5.3.4.1</RegistryNumber><NameOfSubstance UI="D019704">Protein Disulfide-Isomerases</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015536" MajorTopicYN="Y">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006360" MajorTopicYN="N">Heat-Shock Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007535" MajorTopicYN="N">Isomerases</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019704" MajorTopicYN="N">Protein Disulfide-Isomerases</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1998</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1998</Year><Month>2</Month><Day>18</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1998</Year><Month>2</Month><Day>18</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9465269</ArticleId><ArticleId IdType="doi">10.1006/taap.1997.8323</ArticleId><ArticleId
        IdType="pii">S0041-008X(97)98323-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3798454</PMID><DateCompleted><Year>1987</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>87</Volume><Issue>1</Issue><PubDate><Year>1987</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Hepatic
        peroxisome proliferation and hypolipidemic effects of di(2-ethylhexyl)phthalate
        in neonatal and adult rats.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>90</EndPage><MedlinePgn>81-90</MedlinePgn></Pagination><Abstract><AbstractText>To
        determine the relative sensitivity of suckling rats as compared to adults
        to the effects of di(2-ethylhexyl) phthalate (DEHP), five daily oral doses
        of 0, 10, 100, 1000, or 2000 mg DEHP/kg body weight were given to male Sprague-Dawley
        rats beginning at 6, 14, 16, 21, 42, and 86 days of age. Twenty-four hours
        after the last dose, rats were sacrificed and plasma cholesterol and triglyceride
        levels and the activities of the hepatic peroxisomal enzymes, palmitoyl CoA
        oxidase and carnitine acetyltransferase, were determined. Suckling rats (1-3
        weeks of age) suffered severe growth retardation at doses of 1000 mg/kg and
        death at 2000 mg/kg while older rats only showed decreased weight gain at
        2000 mg/kg. Of particular interest was the lethality at doses of 1000 mg/kg
        at 14 days of age but not at 16 days or at other ages. Increases in relative
        liver weight and hepatic peroxisomal enzyme activities were similar in all
        age groups except the 14-day old group in which the increases were greater.
        Relative kidney weight was increased in 21-, 42-, and 86-day-old rats at the
        highest doses but not in younger rats. Hypolipidemia was observed only in
        21-, 42-, and 86-day-old rats at doses of 1000 and 2000 mg/kg, while elevated
        plasma cholesterol levels were observed in 6- and 14-day-old rats at the 1000
        mg/kg dose, possibly due to the dietary differences between suckling and weaned
        rats. The results suggest that neonatal and suckling rats are more sensitive
        to the lethal and growth retardation effects of DEHP than are adult rats,
        but the hepatic peroxisome proliferation is similar at all ages with the exception
        of a greater increase at 14 days of age.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Dostal</LastName><ForeName>L
        A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>W
        L</ForeName><Initials>WL</Initials></Author><Author ValidYN="Y"><LastName>Schwetz</LastName><ForeName>B
        A</ForeName><Initials>BA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3798454</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(87)90086-x</ArticleId><ArticleId
        IdType="pii">0041-008X(87)90086-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8817083</PMID><DateCompleted><Year>1996</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1040-8444</ISSN><JournalIssue
        CitedMedium="Print"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>1996</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Critical
        reviews in toxicology</Title><ISOAbbreviation>Crit Rev Toxicol</ISOAbbreviation></Journal><ArticleTitle>Hepatocarcinogenic
        potential of di(2-ethylhexyl)phthalate in rodents and its implications on
        human risk.</ArticleTitle><Pagination><StartPage>365</StartPage><EndPage>481</EndPage><MedlinePgn>365-481</MedlinePgn></Pagination><Abstract><AbstractText>The
        plasticizer di(2-ethylhexyl) phthalate (DEHP), to which humans are extensively
        exposed, was found to be hepatocarcinogenic in rats and mice. DEHP is potentially
        set free from objects made of synthetic materials (e.g., those used in medicine).
        Chronically, the greatest amounts are transferred to persons undergoing hemodialysis
        (up to 3.1 mg/kg b.w. per day) who would thus be considered the individuals
        most endangered by tumorigenesis. Although toxicokinetics seem to play a certain
        unclear role in the course of DEHP-related toxicity, toxicodynamic factors
        appear more decisive. DEHP is a representative of "peroxisome proliferators"
        (PP), a distinct group of substances that, in rodents, do not only induce
        peroxisomes but also specific enzymes in other organelles, organ growth, and
        DNA synthesis. The cluster of the characteristic effects of PP is generally,
        although perhaps not quite appropriately summarized as "peroxisome proliferation,"
        and is strongest in the liver. The lowest observed effect level (LOEL) and
        the no observed effect level (NOEL) of peroxisome proliferation in the rat,
        as determined by the induction of specific enzymes (peroxisomal beta-oxidation,
        carnitine-acetyl-transferase, cytochrome P-452), DNA synthesis, and hepatomegaly,
        may be assumed as 50 and 25 mg/kg b.w. per day, respectively. DEHP and other
        carcinogenic PP are neither genotoxic nor tumor initiators, but they appear
        to be tumor promoters, also implicating a threshold level for the carcinogenic
        effect. Although a causal relationship between a particular effect of peroxisome
        proliferation and hepatocarcinogenesis is as yet unknown, peroxisome proliferation
        as a whole phenomenon appears to be associated with the potential of tumor
        induction, as shown by comparison of the relative strength of individual PP
        and by comparison of species and organ specificities. Likewise, LOEL and NOEL
        of rodent carcinogenesis, that is, 300 and 50 to 100 mg/kg b.w. per day, respectively,
        are above but not too far from the corresponding values for the investigated
        parameters of peroxisome proliferation. Thus, with respect to dose alone,
        worst-case exposure in hemodialysis patients is at least 16-fold below the
        LOEL of any characterized PP-specific effect of DEHP and approximately 100-fold
        below that of DEHP-related tumorigenesis. Also, primates are less responsive
        to PP than rats with respect to the investigated biochemical and morphological
        parameters. If this lower primate responsiveness is extrapolated to estimate
        carcinogenicity in humans, we might thus arrive at an even larger safety margin
        than when based on exposure alone. Doses of PP hypolipidemics that had clearly
        induced several indicators of peroxisome proliferation in rats did not cause
        any clear-cut enhancements in the peroxisomes of patients, even though most
        of these hypolipidemics were considerably stronger PP than DEHP. Thus, an
        actual threat to humans by DEHP seems rather unlikely. Accordingly, hepatocarcinogenesis
        was neither enhanced in workers exposed to DEHP nor in patients treated with
        hypolipidemics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Huber</LastName><ForeName>W W</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Institut
        f&#xfc;r Tumorbiologie und Krebsforschung, University of Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Grasl-Kraupp</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Schulte-Hermann</LastName><ForeName>R</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit
        Rev Toxicol</MedlineTA><NlmUniqueID>8914275</NlmUniqueID><ISSNLinking>1040-8444</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000493"
        MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D019055" MajorTopicYN="N">No-Observed-Adverse-Effect Level</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>483</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8817083</ArticleId><ArticleId IdType="doi">10.3109/10408449609048302</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">7873979</PMID><DateCompleted><Year>1995</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0145-5680</ISSN><JournalIssue
        CitedMedium="Print"><Volume>40</Volume><Issue>8</Issue><PubDate><Year>1994</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cellular
        and molecular biology (Noisy-le-Grand, France)</Title><ISOAbbreviation>Cell
        Mol Biol (Noisy-le-grand)</ISOAbbreviation></Journal><ArticleTitle>Effects
        of Di-(2-ethylhexyl)phthalate on peroxisomes of liver, kidney and brain of
        lactating rats and their pups.</ArticleTitle><Pagination><StartPage>1063</StartPage><EndPage>1076</EndPage><MedlinePgn>1063-76</MedlinePgn></Pagination><Abstract><AbstractText>Di-(2-ethylhexyl)phthalate
        administered to adult lactating rats, from delivery to weaning, induces modifications
        of the peroxisomal enzymatic pattern in the liver, kidney and brain of both
        dams and pups. These modifications are age- and organ-dependent. Biochemical
        analysis shows that: 1) catalase specific activity is two-fold increased in
        the liver of both adult and newborn animals, in the kidney of newborns and
        in the brain of adults. 2)D-amino acid oxidase doubles in all newborn organs
        and in adult brain; it increases, although to a lesser extent, also in adult
        kidney, while it is half-reduced in adult liver. 3) Dihydroxyacetone phosphate
        acyl transferase only doubles in newborn liver, remaining fairly unchanged
        in all the other tested tissues. 4) Palmitoyl-CoA oxidase is greatly induced
        in the liver of both dams and litters, doubled in the kidneys and slightly
        increased or not at all in the brain of pups and mothers, respectively. The
        effect of the drug on enzyme activities is reversible, with different time
        courses depending on the considered enzyme and organ. Western blottings confirm
        the biochemical data. Electron microscopy shows proliferated peroxisomes in
        the liver and kidney of treated animals but not in the brain, where high catalase-like
        immunoreactivity is observed in the cytosol of neurons. Taken together, our
        data demonstrate that the response of peroxisomal enzymes to DEHP treatment
        is age- as well as tissue-dependent and specific for each enzyme studied.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Cimini</LastName><ForeName>A
        M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Dept. of
        Basic and Applied Biology, University of L''Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sulli</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Stefanini</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Serafini</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Moreno</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Rossi</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Giorgi</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Ceru</LastName><ForeName>M P</ForeName><Initials>MP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Cell
        Mol Biol (Noisy-le-grand)</MedlineTA><NlmUniqueID>9216789</NlmUniqueID><ISSNLinking>0145-5680</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.-</RegistryNumber><NameOfSubstance UI="D000217">Acyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.42</RegistryNumber><NameOfSubstance UI="C020051">glycerone-phosphate
        O-acyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000217" MajorTopicYN="N">Acyltransferases</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000833" MajorTopicYN="N">Animals, Suckling</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007774" MajorTopicYN="N">Lactation</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013534" MajorTopicYN="N">Survival</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1994</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1994</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1994</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7873979</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15364543</PMID><DateCompleted><Year>2004</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>199</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Simultaneous,
        bidirectional inhibitory crosstalk between PPAR and STAT5b.</ArticleTitle><Pagination><StartPage>275</StartPage><EndPage>284</EndPage><MedlinePgn>275-84</MedlinePgn></Pagination><Abstract><AbstractText>The
        transcription factors peroxisome proliferator-activated receptor (PPAR) and
        signal transducer and activator of transcription 5 (STAT5) activate genes
        involved in fatty acid metabolism (PPARalpha) and adipogenesis (PPARgamma)
        and mediate hormonal responses important for body growth, liver gene expression,
        and mammary gland development (STAT5a and STAT5b). These seemingly disparate
        pathways are subject to mutually inhibitory crosstalk, with growth hormone
        (GH)-activated STAT5 able to inhibit PPAR-regulated gene transcription by
        approximately 80%, and conversely, ligand-activated PPAR able to inhibit STAT5-regulated
        transcription to a similar degree. Given the co-expression of PPAR and STAT5
        in multiple tissues, we investigated whether one of the factors dominates
        the inhibitory crosstalk. A PPAR-responsive Renilla luciferase reporter was
        constructed and used to monitor PPAR transcriptional activity in COS-1 cells
        co-transfected with a STAT5 firefly luciferase reporter. In cells co-stimulated
        with GH and a PPAR agonist, STAT5b inhibited expression of the PPAR-regulated
        Renilla luciferase reporter, whereas PPARalpha and PPARgamma inhibited transcription
        of the STAT5b-regulated firefly luciferase reporter. The extent of the inhibitory
        crosstalk was dependent on the relative levels of expression of each transcription
        factor and on the relative concentrations of GH and PPAR agonist. Dose-response
        studies revealed that STAT5b was inhibited at an approximately 7-fold lower
        concentration of the PPARgamma ligand troglitazone than was required for activation
        of PPARgamma, indicating that only a portion of cellular PPARgamma is needed
        for STAT5b inhibition. Similarly, mono-(2-ethylhexyl)phthalate (MEHP), a reproductive
        toxicant and primary metabolite of the environmental chemical di-(2-ethylhexyl)phthalate
        (DEHP), inhibited STAT5b transcriptional activity with an EC50 value of 1.1
        microM, corresponding to an approximately 10-fold lower concentration than
        required for activation of PPARgamma-dependent transcription. We conclude
        that the cross-inhibition between PPAR and STAT5 proceeds in a simultaneous,
        bidirectional manner. Exposure to phthalates and other environmental chemical
        activators of PPARs may thus lead to alteration of hormone-induced, STAT5-regulated
        gene expression in tissues such as liver, fat and breast, where both transcription
        factors are expressed. Conversely, STAT5-activating hormones and cytokines
        may modulate the responsiveness of PPARs to their foreign chemical ligands.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Shipley</LastName><ForeName>Jonathan
        M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division
        of Cell and Molecular Biology, Department of Biology, Boston University, MA
        02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waxman</LastName><ForeName>David
        J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>5 P42 ES07381</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002839">Chromans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008894">Milk Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D050799">STAT5 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C494093">Stat5a protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C494094">Stat5a protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C494096">Stat5b protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C494097">Stat5b protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D045162">Thiazolidinediones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.13.12.-</RegistryNumber><NameOfSubstance UI="D008156">Luciferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>I66ZZ0ZN0E</RegistryNumber><NameOfSubstance
        UI="D000077288">Troglitazone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002839" MajorTopicYN="N">Chromans</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001517" MajorTopicYN="N">Coleoptera</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008894" MajorTopicYN="N">Milk Proteins</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020239" MajorTopicYN="N">Receptor Cross-Talk</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D050799" MajorTopicYN="N">STAT5 Transcription Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D045162" MajorTopicYN="N">Thiazolidinediones</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000077288" MajorTopicYN="N">Troglitazone</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2003</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2003</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2004</Year><Month>9</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2004</Year><Month>11</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2004</Year><Month>9</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15364543</ArticleId><ArticleId IdType="doi">10.1016/j.taap.2003.12.020</ArticleId><ArticleId
        IdType="pii">S0041008X04000547</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10728921</PMID><DateCompleted><Year>2000</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>05</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0901-9928</ISSN><JournalIssue
        CitedMedium="Print"><Volume>86</Volume><Issue>2</Issue><PubDate><Year>2000</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pharmacology
        &amp; toxicology</Title><ISOAbbreviation>Pharmacol Toxicol</ISOAbbreviation></Journal><ArticleTitle>Toxicity
        study of di(2-ethylhexyl)phthalate (DEHP) in combination with acetone in rats.</ArticleTitle><Pagination><StartPage>92</StartPage><EndPage>100</EndPage><MedlinePgn>92-100</MedlinePgn></Pagination><Abstract><AbstractText>In
        two separate studies with exposure duration 9 weeks or 4 weeks, male Wistar
        rats were dosed with di(2-ethylhexyl)phthalate (DEHP) by gavage and exposed
        to drinking water with or without acetone (0.5% wt/v in the 9-week study,
        1.0% wt/v in the 4-week study). In the 9-week study the doses of DEHP were
        0, 125, 250, 500 or 1000 mg/kg b.wt. In the 4-week study the doses of DEHP
        were increased to 1000, 5000 and 10,000 mg/kg b.wt. In the 9-week study, the
        relative liver weight was increased in the rats exposed to 500 and 1000 mg/kg
        b.wt. No interaction of DEHP and acetone was observed in any of the measured
        parameters. In the 4-week study DEHP, at the highest dose level, resulted
        in severe general toxicity. The group exposed to DEHP in combination with
        acetone was more affected. Male fertility was decreased. Body weight was decreased,
        and the relative weight of the liver, kidney, heart, brain and adrenals increased.
        The relative weight of the testes decreased in the 5000 and 10,000 mg/kg b.wt.
        groups. The weight of seminal vesicles and epididymals decreased at 10,000
        mg/kg b.wt. In animals exposed to 5000 and 10,000 mg DEHP/kg b.wt. a severe
        atrophy of the seminiferous tubules and a slight diffuse Leydig''s cell hyperplasia
        was observed. The cellular debris and conglomerates of desquamated cells found
        in the lumen of the seminiferous tubules were immunostained positive for vimentin.
        This indicates that Sertoli cell cytoplasm is included in the conglomerates
        an interesting finding not previously described. No specific interaction of
        DEHP and acetone was observed in any of the measured parameters.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Dalgaard</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute
        of Food Safety and Toxicology, Danish Veterinary and Food Administration,
        S&#xf8;borg. MAC@VFD.dk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostergaard</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Lam</LastName><ForeName>H R</ForeName><Initials>HR</Initials></Author><Author
        ValidYN="Y"><LastName>Hansen</LastName><ForeName>E V</ForeName><Initials>EV</Initials></Author><Author
        ValidYN="Y"><LastName>Ladefoged</LastName><ForeName>O</ForeName><Initials>O</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pharmacol
        Toxicol</MedlineTA><NlmUniqueID>8702180</NlmUniqueID><ISSNLinking>0901-9928</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014746">Vimentin</NameOfSubstance></Chemical><Chemical><RegistryNumber>1364PS73AF</RegistryNumber><NameOfSubstance
        UI="D000096">Acetone</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000096" MajorTopicYN="N">Acetone</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004326" MajorTopicYN="N">Drinking</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005298" MajorTopicYN="N">Fertility</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012708" MajorTopicYN="N">Sertoli Cells</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018675" MajorTopicYN="N">Toxicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014746" MajorTopicYN="N">Vimentin</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2000</Year><Month>3</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>3</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10728921</ArticleId><ArticleId IdType="doi">10.1034/j.1600-0773.2000.d01-17.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1423834</PMID><DateCompleted><Year>1992</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>1992</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Peroxisome
        proliferation and resistance to hydrogen peroxide in rat hepatocytes: is development
        of resistance an adaptation to cytotoxicity?</ArticleTitle><Pagination><StartPage>1751</StartPage><EndPage>1758</EndPage><MedlinePgn>1751-8</MedlinePgn></Pagination><Abstract><AbstractText>In
        this work the resistance of peroxisome-proliferated hepatocytes to hydrogen
        peroxide (H2O2) has been studied. The question has been raised as to whether
        this resistance is a response to cytotoxicity. In an initial series of experiments,
        hepatocytes were isolated from rats that had been treated with nafenopin (NAF-hepatocytes).
        Isolated cells were exposed to a H2O2-generating system or to H2O2 in pulses.
        The ability to attach to collagen was used as a toxicological endpoint. Loss
        of attachment was found to be correlated to glutathione (GSH) depletion, and
        NAF-hepatocytes were more resistant to GSH depletion and to loss of attachment
        induced by H2O2 than were control hepatocytes. NAF-hepatocytes were not resistant
        to hydroquinone or to adriamycin. It was also indicated that this resistance
        was related to an altered metabolism of H2O2, less dependent on GSH. In a
        second series of experiments, hepatocytes from altered hepatic foci-bearing
        rats, treated with nafenopin or di(2-ethylhexyl)phthalate (DEHP), were used.
        This model was used in an attempt to monitor the development of resistance
        in different subpopulations of hepatocytes. It was found that the majority
        of hepatocytes developed resistance towards H2O2, and that, for example, foci
        marker-positive hepatocytes were as resistant as marker-negative cells. In
        control experiments with this model, it was found that marker-positive cells
        were more resistant towards diethyl maleate (DEM) or phorone than were marker-negative
        cells. In addition to demonstrating the validity of the model, these control
        experiments indicate an increased steady-state level of H2O2 in cells from
        peroxisome proliferator-treated rats. Other control experiments suggested
        that a low GSH-peroxidase activity protected from, rather than aggravated,
        the effect of peroxisome proliferation on marker-negative and GSH-depleted
        cells. It is concluded that H2O2 metabolism may affect the function of collagen
        receptors, but that a shift in H2O2 metabolism, so that it becomes less dependent
        on GSH, conferred resistance to this effect. The apparent non-focal induction
        of resistance to peroxisome proliferators, as opposed to the focal induction
        of resistance induced by most liver carcinogens, may explain the lack of development
        of gamma-glutamyltranspeptidase-positive foci in peroxisome proliferator-treated
        rats.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garberg</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National
        Institute of Occupational Health, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Stenius</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author
        ValidYN="Y"><LastName>Nilsson</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>H&#xf6;gberg</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-34-5</RegistryNumber><NameOfSubstance
        UI="D003094">Collagen</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance
        UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.5.1.18</RegistryNumber><NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000222" MajorTopicYN="N">Adaptation, Physiological</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003094" MajorTopicYN="N">Collagen</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010920" MajorTopicYN="N">Placenta</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013347" MajorTopicYN="N">Subcellular Fractions</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1423834</ArticleId><ArticleId IdType="doi">10.1093/carcin/13.10.1751</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">734683</PMID><DateCompleted><Year>1979</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>1978</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Effect
        of Di-(2-ethylhexyl) phthalate (DEHP) on chemical constituents and enzymatic
        activity of rat liver.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>275</EndPage><MedlinePgn>271-5</MedlinePgn></Pagination><Abstract><AbstractText>Effect
        of Di(2-ethylhexyl) phthalate (DEHP), was investigated on chemical constituents
        and activity of certain enzymes of rat liver. A significant increase in liver
        weight; total and relative to body weight; decrease in total, free and esterified
        cholesterol; and no change in dry weight, moisture; RNA, DNA, total lipids,
        phospholipids, pyruvic acid and lactic acid contents was observed in liver
        of DEHP-treated rats as compared to controls. Activity of 3 mitochondrial
        enzymes, malic dehydrogenase, cytochrome-c-oxidase and diaphorase were significantly
        decreased while that of NADH-cytochrome c reductase, RNAase and DNAase remained
        unaltered upon treatment. The results suggest that DEHP exerts its hepatotoxic
        effects by interfering with bioenergetics of the cell.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Srivastava</LastName><ForeName>S
        P</ForeName><Initials>SP</Initials></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>D
        K</ForeName><Initials>DK</Initials></Author><Author ValidYN="Y"><LastName>Mushtaq</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Seth</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1978</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1978</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1978</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">734683</ArticleId><ArticleId IdType="doi">10.1016/s0300-483x(78)91639-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3594721</PMID><DateCompleted><Year>1987</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>8</Volume><Issue>7</Issue><PubDate><Year>1987</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Lack
        of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate
        in rat liver carcinogenesis.</ArticleTitle><Pagination><StartPage>875</StartPage><EndPage>880</EndPage><MedlinePgn>875-80</MedlinePgn></Pagination><Abstract><AbstractText>The
        effect of prolonged dietary administration of the peroxisome proliferating
        plasticizer di(2-ethylhexyl)phthalate (DEHP) was studied on liver carcinogenesis
        initiated by N-2-fluorenylacetamide (FAA) and compared with that of the neoplasm-promoter
        phenobarbital (PB). Also, DEHP was studied as an initiator by giving it in
        place of FAA before PB. Male rats were fed FAA for 7 weeks to induce hepatocellular
        altered foci, and were subsequently given no chemical, 12,000 p.p.m. DEHP
        or 500 p.p.m. PB for 24 weeks in the diet. In the rats fed DEHP, substantial
        hepatomegaly and peroxisome proliferation were induced. No evidence of induction
        of hepatocellular altered foci or hepatic neoplasms was found either when
        DEHP was given alone for 24 weeks or for 7 weeks followed by PB. Also, DEHP
        fed for 24 weeks had no promoting effect on liver altered foci that were induced
        by FAA and produced little or no enhancement of the occurrence of FAA-induced
        liver neoplasms. In contrast, PB exerted a marked enhancing effect on foci
        and substantially increased the incidence and multiplicity of liver neoplasms.
        Thus, the findings demonstrate that DEHP did not have either a rapid initiating
        activity, a significant sequential syncarcinogenic activity, or a promoting
        effect on liver carcinogenesis under conditions in which numerous agents with
        such activities have been identified.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>G
        M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Maruyama</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Tanaka</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA-39545</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IQ78TTX1A</RegistryNumber><NameOfSubstance
        UI="D004052">Diethylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9M98QLJ2DL</RegistryNumber><NameOfSubstance
        UI="D015073">2-Acetylaminofluorene</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015073" MajorTopicYN="N">2-Acetylaminofluorene</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003043" MajorTopicYN="Y">Cocarcinogenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004052" MajorTopicYN="N">Diethylnitrosamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3594721</ArticleId><ArticleId IdType="doi">10.1093/carcin/8.7.875</ArticleId></ArticleIdList></PubmedData></PubmedArticle>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8838637</PMID><DateCompleted><Year>1996</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0272-0590</ISSN><JournalIssue
        CitedMedium="Print"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>1996</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Fundamental
        and applied toxicology : official journal of the Society of Toxicology</Title><ISOAbbreviation>Fundam
        Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>Prechronic toxicity
        studies on 2-ethylhexanol in F334 rats and B6C3F1 mice.</ArticleTitle><Pagination><StartPage>31</StartPage><EndPage>39</EndPage><MedlinePgn>31-9</MedlinePgn></Pagination><Abstract><AbstractText>Data
        on the subchronic toxicity of 2-ethylhexanol (2EH) were required to establish
        the dose vehicle and dose levels for oncogenicity studies. In preliminary
        studies 2EH was given subacutely (11 days) to male and female Fischer 344
        rats and B6C3F1 mice as an aqueous emulsion by oral gavage (0, 100, 330, 1000,
        and 1500 mg/kg/day). Clinical observations were made, body weights, food consumption,
        clinical chemistries, hematologies, and selected organ weights were measured,
        and gross and micropathologies were performed. Target organs were the central
        nervous system, liver, forestomach, spleen, thymus, and kidney in rats and
        the central nervous system, liver, and forestomach in mice. 2EH was then administered
        by oral gavage to male and female F344 rats and B6C3F1 mice as an aqueous
        emulsion (0, 25, 125, 250, and 500 mg/kg/day) for 13 weeks. At 500 mg/kg/day
        in the rat there was reduced body weight gain (6% male, 7% female), increased
        relative liver (29% male, 15% female), kidney (16% male, 6% female), stomach
        (11% male, 16% female), and testes (6%) weights, and moderate gross and microscopic
        changes in the liver and forestomach. There were no behavioral effects or
        effects on the spleen or thymus. A no-effect level for target organ effects
        in the rat was 125 mg of 2EH/kg/day. At 500 mg of 2EH/kg/day in the mouse
        the only effects were increased relative stomach weights in males (13%) and
        a low incidence of gross and microscopic findings in the forestomach (male
        and female) and liver (female). A no-effect level for target organ effects
        in the mouse was 125 mg of 2EH/kg/day. 2EH was a peroxisome proliferator in
        the rat but not in the mouse at subchronic dose levels of 500 mg/kg/day. Dose
        levels in oncogenicity studies were set at 50 mg/kg/day for the absence of
        treatment-related effects in rats and mice, and 500 and 750 mg/kg/day, respectively,
        in rats and mice as high doses producing minimal toxicity without altering
        the life span.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Astill</LastName><ForeName>B D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Toxicology
        Research Task Group, Chemical Manufacturers Association, Washington, DC 20037,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deckardt</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Gembardt</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Gingell</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Hodgson</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Mellert</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>Murphy</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author
        ValidYN="Y"><LastName>Tyler</LastName><ForeName>T R</ForeName><Initials>TR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Fundam Appl Toxicol</MedlineTA><NlmUniqueID>8200838</NlmUniqueID><ISSNLinking>0272-0590</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>1763-10-6</RegistryNumber><NameOfSubstance
        UI="D010171">Palmitoyl Coenzyme A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.6.1.-</RegistryNumber><NameOfSubstance UI="D000637">Transaminases</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002624" MajorTopicYN="N">Chemistry, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010171" MajorTopicYN="N">Palmitoyl Coenzyme A</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018675" MajorTopicYN="N">Toxicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000637" MajorTopicYN="N">Transaminases</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1996</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8838637</ArticleId><ArticleId IdType="doi">10.1006/faat.1996.0003</ArticleId><ArticleId
        IdType="pii">S0272059096900032</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10828276</PMID><DateCompleted><Year>2000</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>55</Volume><Issue>2</Issue><PubDate><Year>2000</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Chronic toxicity of di(2-ethylhexyl)phthalate
        in rats.</ArticleTitle><Pagination><StartPage>433</StartPage><EndPage>443</EndPage><MedlinePgn>433-43</MedlinePgn></Pagination><Abstract><AbstractText>Fischer
        344 rats were treated with 0, 100, 500, 2500, or 12,500 ppm di(2-ethylhexyl)phthalate
        (DEHP) in the diet for up to 104 weeks. Blood and urine were analyzed at weeks
        26, 52, 78, and 104 from 10 animals per sex per group. Survival was slightly
        but not statistically reduced for rats receiving 12,500 ppm DEHP. Body weights
        and food consumption were significantly reduced for rats receiving the highest
        dose level of DEHP and occasionally for the male 2500-ppm group. BUN and albumin
        were significantly higher and globulin lower at nearly every sampling interval
        for the 12,500-ppm group compared with the controls. There was an increase
        in the mean activities of AST and ALT at 104 weeks, but no statistically significant
        differences were seen. Erythrocyte count, hemoglobin, and hematocrit values
        for the 12,500-ppm group were significantly lower than controls at nearly
        every sampling interval. No other differences in hematology were seen. No
        toxicologically significant changes were observed in urinalysis. At termination,
        relative lung weights for the 2500- and 12,500-ppm male groups of rats were
        significantly higher than for the controls. Absolute and relative liver and
        kidney weights for the 2500- and 12,500-ppm male rats, and liver weights for
        12,500-ppm female rats were higher compared with the controls. Absolute and
        relative testes weights for the 12, 500-ppm male rats were lower compared
        with the controls. All organs were examined for histopathology. The incidence
        of hepatocellular lesions has been reported separately and correlated with
        the induction of peroxisomal enzyme activity (David et al., 1999). A dose
        level of 500 ppm was the NOEL for peroxisome proliferation. Bilateral aspermatogenesis
        in the testes, castration cells in the pituitary gland, spongiosis hepatis,
        and pancreatic acinar cell adenoma were observed for 12,500-ppm male rats.
        Aspermatogenesis and spongiosis hepatis were observed for 2500-ppm male rats,
        and aspermatogenesis was seen at 500 ppm. DEHP exposure exacerbated age-,
        species- or strain-related lesions such as mineralization of the renal papilla
        and chronic progressive nephropathy in male rats. Kupffer cell pigmentation
        and renal tubule pigmentation were seen in male and female 12,500-ppm rats.
        The increased incidence of spongiosis hepatis correlated with increased palmitoyl
        CoA oxidase activity, but the incidence of pancreatic acinar cell adenoma
        was increased only at the highest dose level of 12,500 ppm. These lesions,
        although typical of those seen with other peroxisome proliferators, may respond
        differently depending on the potency of the peroxisome proliferator. A dose
        level of 500 ppm (28.9-36.1 mg/kg/day) was considered to be the NOAEL.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>David</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Health
        and Environment Laboratories, Eastman Kodak Company, Rochester, New York 14652-6272,
        USA. raymond.david@kodak.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Moore</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author><Author
        ValidYN="Y"><LastName>Finney</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012709">Serum Albumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012712">Serum Globulins</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000236" MajorTopicYN="N">Adenoma</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001806" MajorTopicYN="N">Blood Urea Nitrogen</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004906" MajorTopicYN="N">Erythrocyte Count</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006400" MajorTopicYN="N">Hematocrit</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012709" MajorTopicYN="N">Serum Albumin</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012712" MajorTopicYN="N">Serum Globulins</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018675" MajorTopicYN="N">Toxicity Tests</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2000</Year><Month>7</Month><Day>15</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10828276</ArticleId><ArticleId IdType="doi">10.1093/toxsci/55.2.433</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15838709</PMID><DateCompleted><Year>2005</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0340-5761</ISSN><JournalIssue
        CitedMedium="Print"><Volume>79</Volume><Issue>4</Issue><PubDate><Year>2005</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Tryptophan-NAD+
        pathway metabolites as putative biomarkers and predictors of peroxisome proliferation.</ArticleTitle><Pagination><StartPage>208</StartPage><EndPage>223</EndPage><MedlinePgn>208-23</MedlinePgn></Pagination><Abstract><AbstractText>The
        present study was designed to provide further information about the relevance
        of raised urinary levels of N-methylnicotinamide (NMN), and/or its metabolites
        N-methyl-4-pyridone-3-carboxamide (4PY) and N-methyl-2-pyridone-3-carboxamide
        (2PY), to peroxisome proliferation by dosing rats with known peroxisome proliferator-activated
        receptor alpha (PPARalpha) ligands [fenofibrate, diethylhexylphthalate (DEHP)
        and long-chain fatty acids (LCFA)] and other compounds believed to modulate
        lipid metabolism via PPARalpha-independent mechanisms (simvastatin, hydrazine
        and chlorpromazine). Urinary NMN was correlated with standard markers of peroxisome
        proliferation and serum lipid parameters with the aim of establishing whether
        urinary NMN could be used as a biomarker for peroxisome proliferation in the
        rat. Data from this study were also used to validate a previously constructed
        multivariate statistical model of peroxisome proliferation (PP) in the rat.
        The predictive model, based on 1H nuclear magnetic resonance (NMR) spectroscopy
        of urine, uses spectral patterns of NMN, 4PY and other endogenous metabolites
        to predict hepatocellular peroxisome count. Each treatment induced pharmacological
        (serum lipid) effects characteristic of their class, but only fenofibrate,
        DEHP and simvastatin increased peroxisome number and raised urinary NMN, 2PY
        and 4PY, with simvastatin having only a transient effect on the latter. These
        compounds also reduced mRNA expression for aminocarboxymuconate-semialdehyde
        decarboxylase (ACMSDase, EC 4.1.1.45), the enzyme believed to be involved
        in modulating the flux of tryptophan through this pathway, with decreasing
        order of potency, fenofibrate (-10.39-fold) &gt;DEHP (-3.09-fold) &gt;simvastatin
        (-1.84-fold). Of the other treatments, only LCFA influenced mRNA expression
        of ACMSDase (-3.62-fold reduction) and quinolinate phosphoribosyltransferase
        (QAPRTase, EC 2.4.2.19) (-2.42-fold) without any change in urinary NMN excretion.
        Although there were no correlations between urinary NMN concentration and
        serum lipid parameters, NMN did correlate with peroxisome count (r2=0.63)
        and acyl-CoA oxidase activity (r2=0.61). These correlations were biased by
        the large response to fenofibrate compared to the other treatments; nevertheless
        the data do indicate a relationship between the tryptophan-NAD+ pathway and
        PPARalpha-dependent pathways, making this metabolite a potentially useful
        biomarker to detect PP. In order to strengthen the observed link between the
        metabolites associated with the tryptophan-NAD+ pathway and more accurately
        predict PP, other urinary metabolites were included in a predictive statistical
        model. This statistical model was found to predict the observed PP in 26/27
        instances using a pre-determined threshold of 2-fold mean control peroxisome
        count. The model also predicted a time-dependent increase in peroxisome count
        for the fenofibrate group, which is important when considering the use of
        such modelling to predict the onset and progression of PP prior to its observation
        in samples taken at autopsy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Delaney</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Safety
        Assessment, GlaxoSmithKline, Park Road, Ware, Herts, SG12 0DP, UK.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hodson</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials></Author><Author
        ValidYN="Y"><LastName>Thakkar</LastName><ForeName>Hansa</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Connor</LastName><ForeName>Susan C</ForeName><Initials>SC</Initials></Author><Author
        ValidYN="Y"><LastName>Sweatman</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials></Author><Author
        ValidYN="Y"><LastName>Kenny</LastName><ForeName>Steve P</ForeName><Initials>SP</Initials></Author><Author
        ValidYN="Y"><LastName>McGill</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials></Author><Author
        ValidYN="Y"><LastName>Holder</LastName><ForeName>Julie C</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>Hutton</LastName><ForeName>Kathryn A</ForeName><Initials>KA</Initials></Author><Author
        ValidYN="Y"><LastName>Haselden</LastName><ForeName>John N</ForeName><Initials>JN</Initials></Author><Author
        ValidYN="Y"><LastName>Waterfield</LastName><ForeName>Catherine J</ForeName><Initials>CJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2004</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000960">Hypolipidemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008074">Lipoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0U46U6E8UK</RegistryNumber><NameOfSubstance
        UI="D009243">NAD</NameOfSubstance></Chemical><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance
        UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.4.2.-</RegistryNumber><NameOfSubstance UI="D010430">Pentosyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.4.2.19</RegistryNumber><NameOfSubstance UI="C021863">nicotinate-nucleotide
        diphosphorylase (carboxylating)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        4.1.1.-</RegistryNumber><NameOfSubstance UI="D002262">Carboxy-Lyases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        4.1.1.45</RegistryNumber><NameOfSubstance UI="C024396">aminocarboxymuconate-semialdehyde
        decarboxylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002262" MajorTopicYN="N">Carboxy-Lyases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000648"
        MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000960" MajorTopicYN="N">Hypolipidemic Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008074" MajorTopicYN="N">Lipoproteins</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008111" MajorTopicYN="N">Liver Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013058" MajorTopicYN="N">Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D046529" MajorTopicYN="N">Microscopy, Electron, Transmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009243" MajorTopicYN="N">NAD</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010430" MajorTopicYN="N">Pentosyltransferases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000648"
        MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2004</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2004</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2005</Year><Month>4</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2005</Year><Month>9</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2005</Year><Month>4</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15838709</ArticleId><ArticleId IdType="doi">10.1007/s00204-004-0625-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9207284</PMID><DateCompleted><Year>1997</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>07</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0016-5085</ISSN><JournalIssue
        CitedMedium="Print"><Volume>113</Volume><Issue>1</Issue><PubDate><Year>1997</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Gastroenterology</Title><ISOAbbreviation>Gastroenterology</ISOAbbreviation></Journal><ArticleTitle>Hepatic
        hyperplasia and cancer in rats: metabolic alterations associated with cell
        growth.</ArticleTitle><Pagination><StartPage>238</StartPage><EndPage>248</EndPage><MedlinePgn>238-48</MedlinePgn></Pagination><Abstract><AbstractText
        Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">We showed previously
        that the peroxisome proliferators di(2-ethylhexyl)phthalate (DEHP), clofibrate,
        and 4-chloro-6-(2,3 xylidino)-2-pyrimidinylthio (N-beta-hydroxyl)acetamide
        (BR931) alter hepatic sex steroid metabolism and receptor expression during
        induction of hepatic hyperplasia and hepatocellular carcinoma (HCC) in rats.
        The aim of this study was to identify metabolic changes associated with cell
        growth during hyperplasia and HCC.</AbstractText><AbstractText Label="METHODS"
        NlmCategory="METHODS">Hepatic hyperplasia was induced in male rats by a diet
        containing DEHP and clofibrate for 3-60 days. HCC was induced by feeding a
        diet containing BR931, a more potent hepatocarcinogen, for 10 months.</AbstractText><AbstractText
        Label="RESULTS" NlmCategory="RESULTS">Cholesterol biosynthesis was depressed
        in hyperplastic livers but increased in HCC. Glucose-6-phosphate dehydrogenase
        (G6PD) activity was inhibited in hyperplastic liver as well as in HCC, whereas
        malic enzyme activity increased severalfold. Protein and messenger RNA (mRNA)
        levels for both G6PD and malic enzyme increased in hyperplastic livers and
        HCC. mRNA levels for 3-hydroxy-3-methylglutaryl-coenzyme A reductase decreased
        in hyperplasia and increased in HCC, whereas low-density lipoprotein receptor
        mRNA increased in hyperplasia and decreased in HCC.</AbstractText><AbstractText
        Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Neoplastic cells acquire a growth
        advantage by their capacity to synthesize cholesterol and obtain reduced nicotinamide
        adenine dinucleotide phosphate by the malic enzyme pathway when G6PD activity
        is inhibited by peroxisome proliferators.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>K N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, University of Pittsburgh Medical Center, Pennsylvania 15213-2582,
        USA. rao@med.pitt.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elm</LastName><ForeName>M
        S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>R
        H</ForeName><Initials>RH</Initials></Author><Author ValidYN="Y"><LastName>Chandar</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Brady</LastName><ForeName>E P</ForeName><Initials>EP</Initials></Author><Author
        ValidYN="Y"><LastName>Rao</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Shinozuka</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Eagon</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>AA08914</GrantID><Acronym>AA</Acronym><Agency>NIAAA
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA53453</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Gastroenterology</MedlineTA><NlmUniqueID>0374630</NlmUniqueID><ISSNLinking>0016-5085</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011973">Receptors, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>53-59-8</RegistryNumber><NameOfSubstance
        UI="D009249">NADP</NameOfSubstance></Chemical><Chemical><RegistryNumber>969LVT6GJ2</RegistryNumber><NameOfSubstance
        UI="C016908">pirinixil</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.-</RegistryNumber><NameOfSubstance UI="D006903">Hydroxymethylglutaryl
        CoA Reductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.1.37</RegistryNumber><NameOfSubstance
        UI="D008291">Malate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.49</RegistryNumber><NameOfSubstance UI="D005954">Glucosephosphate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005954" MajorTopicYN="N">Glucosephosphate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006903" MajorTopicYN="N">Hydroxymethylglutaryl CoA Reductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008291" MajorTopicYN="N">Malate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009249" MajorTopicYN="N">NADP</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010427" MajorTopicYN="N">Pentose Phosphate Pathway</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011973" MajorTopicYN="N">Receptors, LDL</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1997</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1997</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1997</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9207284</ArticleId><ArticleId IdType="doi">10.1016/s0016-5085(97)70101-x</ArticleId><ArticleId
        IdType="pii">S0016508597003338</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15297022</PMID><DateCompleted><Year>2004</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>201</Volume><Issue>1-3</Issue><PubDate><Year>2004</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Phthalate
        treatment does not influence levels of IgE or Th2 cytokines in B6C3F1 mice.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>85</EndPage><MedlinePgn>77-85</MedlinePgn></Pagination><Abstract><AbstractText>Bronchial
        asthma is mediated, in part, by the immunoregulatory cytokines interleukins
        4 and 13 (IL-4 and IL-13). These cytokines stimulate IgE synthesis that in
        turn is associated with airway hyper-responsiveness. Compounds that stimulate
        IgE synthesis and elicit bronchial reactivity are generally considered to
        be respiratory sensitizers. Recently, it has been hypothesized that exposure
        to phthalates may contribute to childhood asthma. To address this question,
        di-(2-ethylhexyl) phthalate (DEHP) was tested using a protocol adapted from
        work by Dearman that involves topical application (and challenge) of test
        substances to mice followed by measurements of total serum IgE. In addition,
        auricular lymph nodes were harvested for measurement of IL-4 and IL-13 proteins
        and their corresponding messenger RNAs. Because skin absorption of high molecular
        weight phthalates is limited, liver weight increase, a measure of peroxisomal
        proliferation, was monitored to assure that internal dosing had been achieved.
        ELISA and RNAse protection assays demonstrated that DEHP treatment did not
        significantly affect IgE, IL-4, or IL-13 levels. Similarly, IL-4 and IL-13
        mRNA levels were not elevated. In contrast, all of these were significantly
        elevated by trimellitic anhydride (TMA), a respiratory sensitizer used as
        the positive control in this assay. Liver weights were significantly elevated
        by DEHP, providing evidence of sufficient percutaneous absorption to induce
        physiological responses. To extend these observations, three other commercial
        phthalate ester plasticizers, di-isononyl phthalate (DINP), di-isohexyl phthalate
        (DIHP), and butyl benzyl phthalate (BBP), were assessed using the same protocol.
        As above, ELISA and RNAse protection assays showed that IgE, IL-4, and IL-13
        proteins, and IL-4 and IL-13 mRNAs in the phthalate-treated animals were all
        at levels similar to that of control values. The positive control, TMA, produced
        large, statistically significant increases in all parameters, demonstrating
        responsiveness of the assay. Another control, dinitrochlorobenzene (DNCB),
        a contact sensitizer, also responded as expected, producing smaller but statistically
        significant increases in IgE and in mRNA for IL-4 and IL-13 but not in the
        levels of these cytokines. In summary, treatment with DEHP, DINP, DIHP, and
        BBP did not result in significant elevations in total serum IgE, IL-4, or
        IL-13. As such it is unlikely that these substances would produce antibody-mediated
        respiratory allergy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Butala</LastName><ForeName>John H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Toxicology
        Consultants, Gibsonia, PA, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>David</LastName><ForeName>Raymond M</ForeName><Initials>RM</Initials></Author><Author
        ValidYN="Y"><LastName>Gans</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>McKee</LastName><ForeName>Richard H</ForeName><Initials>RH</Initials></Author><Author
        ValidYN="Y"><LastName>Guo</LastName><ForeName>Tai L</ForeName><Initials>TL</Initials></Author><Author
        ValidYN="Y"><LastName>Peachee</LastName><ForeName>Vanessa L</ForeName><Initials>VL</Initials></Author><Author
        ValidYN="Y"><LastName>White</LastName><ForeName>Kimber L</ForeName><Initials>KL</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018793">Interleukin-13</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>207137-56-2</RegistryNumber><NameOfSubstance
        UI="D015847">Interleukin-4</NameOfSubstance></Chemical><Chemical><RegistryNumber>37341-29-0</RegistryNumber><NameOfSubstance
        UI="D007073">Immunoglobulin E</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007073" MajorTopicYN="N">Immunoglobulin E</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018793" MajorTopicYN="N">Interleukin-13</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015847" MajorTopicYN="N">Interleukin-4</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2004</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2004</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2004</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2004</Year><Month>8</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2004</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2004</Year><Month>8</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15297022</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2004.04.004</ArticleId><ArticleId
        IdType="pii">S0300483X04002367</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9538047</PMID><DateCompleted><Year>1998</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>1998</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Subchronic toxicity of Di(2-ethylhexyl)phthalate
        in common marmosets: lack of hepatic peroxisome proliferation, testicular
        atrophy, or pancreatic acinar cell hyperplasia.</ArticleTitle><Pagination><StartPage>49</StartPage><EndPage>56</EndPage><MedlinePgn>49-56</MedlinePgn></Pagination><Abstract><AbstractText>To
        evaluate the toxicological effect, di(2-ethylhexyl)phthalate (DEHP) was administered
        orally at 100, 500, and 2500 mg/kg to four male and four female marmosets
        in each group for 13 weeks. Its potentials of hepatic peroxisome proliferation,
        testicular atrophy, and pancreatic acinar cell hyperplasia were evaluated
        more closely. Clofibrate, which potently causes peroxisome proliferation in
        rodents, was administered in like manner at 250 mg/kg as a reference drug.
        DEHP induced significant suppression of weight gain in males at 2500 mg/kg.
        However, the increase in liver mass and hypertrophy of hepatocytes were not
        detected in organ weight measurements or histopathological examination. The
        number of peroxisomes, volume density, peroxisome morphology, and peroxisomal
        enzyme activities were not different from those in the control group, though
        the males treated with 500 and 2500 mg/kg DEHP showed 1.3- and 1.4-fold increases
        in mean peroxisome volume, respectively. In contrast, clofibrate induced 2.2
        (in male)- and 1.9-fold (in female) increases in hepatic cyanide-insensitive
        acyl CoA oxidation system activity, 1. 2 (in male)- and 1.7-fold (in female)
        increases in hepatic carnitine-dependent acetyltransferase activity, and 1.8
        (in male)- and 3.0-fold (in female) increases of carnitine-dependent palmitoyltransferase
        activity. Cytochrome P-450 contents tended to increase in all males and females
        administered 500 and 2500 mg/kg of DEHP and clofibrate associated with the
        increase in hepatic microsomal protein content, suggesting a relationship
        with the treatment. The atrophic change in the testis or proliferative change
        in the pancreatic acinar cells seen in rodents were not seen histopathologically;
        also, no changes were observed in testes weight, testicular zinc level, blood
        levels of testosterone and estradiol, pancreas weight, and blood levels of
        cholecystokinin. Finally, no changes considered to be due to the administration
        of DEHP were noted in blood chemical examination or pathological examination
        of other organs.</AbstractText><CopyrightInformation>Copyright 1998 Academic
        Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Kurata</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Mitsubishi
        Chemical Safety Institute Ltd., 14 Sunayama, Hasaki-machi, Kashima-gun, Ibaraki-ken,
        314-02, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kidachi</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author
        ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Toyota</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Tsuchitani</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Katoh</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002144" MajorTopicYN="N">Callithrix</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018675" MajorTopicYN="N">Toxicity Tests</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1998</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1998</Year><Month>5</Month><Day>30</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1998</Year><Month>5</Month><Day>30</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9538047</ArticleId><ArticleId IdType="doi">10.1006/toxs.1997.2414</ArticleId><ArticleId
        IdType="pii">S1096-6080(97)92414-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35810816</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>29</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0953</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>214</Volume><Issue>Pt 2</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Environmental
        research</Title><ISOAbbreviation>Environ Res</ISOAbbreviation></Journal><ArticleTitle>Transcriptome-metabolome-wide
        association study (TMWAS) in rats revealed a potential carcinogenic effect
        of DEHP in thyroid associated with eicosanoids.</ArticleTitle><Pagination><StartPage>113805</StartPage><MedlinePgn>113805</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.envres.2022.113805</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0013-9351(22)01132-X</ELocationID><Abstract><AbstractText>The
        incidence of thyroid cancer (TC) has increased considerably in the last few
        decades. Environmental factors, including plasticizers, are recognized as
        potential risks leading to thyroid cancer in humans. In this study, we used
        a transcriptome-metabolome-wide association study to find the unidentified
        carcinogenic mechanism of di-2-ethylhexyl phthalate (DEHP) in thyroid and
        biomarkers for non-invasive diagnosis. Rats were treated with different doses
        of DEHP (0, 0.3, 3, 30, 150&#xa0;mg DEHP/kg bw/day) for 13 weeks. Then, the
        thyroids were processed for Ki67 staining and RNA-seq. Also, 17-h urine samples
        were collected for high-resolution metabolomics analysis. After a high dose
        of DEHP exposure, the terminal body weights and the thyroid and parathyroid
        glands weights were not altered. However, the liver weights and numbers of
        Ki67-positive cells were increased. Further, multivariate statistical analysis
        revealed that metabolic shifts were considerably altered above 30&#xa0;mg
        DEHP/kg bw/day. In RNA-seq analysis, some cancer-related genes were altered,
        including 18 upregulated and 9 downregulated transcripts. These cancer transcripts
        and whole metabolome data were integrated to uncover thyroid cancer-related
        metabolic pathways, which revealed that cancer-related transcripts had a network
        structure linked to eicosanoids such as leukotriene D4 and prostaglandin.
        In brief, our study demonstrated that DEHP can induce thyroid hyperplasia
        through the eicosanoid-associated pathway, providing further insight into
        the mechanism of DEHP-associated thyroid cancer.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Kwan</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>College
        of Pharmacy, Korea University, Sejong, 30019, Republic of Korea; Korea Basic
        Science Institute, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Omics
        Research Center, Sejong, 30019, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hwang</LastName><ForeName>Seungwoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Korean
        Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology,
        Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cho</LastName><ForeName>Seongha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College
        of Pharmacy, Korea University, Sejong, 30019, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Yu</LastName><ForeName>Wook-Joon</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Developmental
        and Reproductive Toxicology Research Group, Korea Institute of Toxicology,
        Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jeong</LastName><ForeName>Ji-Seong</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Developmental
        and Reproductive Toxicology Research Group, Korea Institute of Toxicology,
        Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Park</LastName><ForeName>Il-Hyun</ForeName><Initials>IH</Initials><AffiliationInfo><Affiliation>GENECAST
        Co., Seoul, 05838, South Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lee</LastName><ForeName>Byung-Chul</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>GENECAST
        Co., Seoul, 05838, South Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jee</LastName><ForeName>Sun Ha</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department
        of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate
        School of Public Health, Yonsei University, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lim</LastName><ForeName>Kyung-Min</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>College
        of Pharmacy, Ewha Womans University, Seoul, 03760, South Korea. Electronic
        address: kmlim@ewha.ac.kr.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Park</LastName><ForeName>Youngja H</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>College
        of Pharmacy, Korea University, Sejong, 30019, Republic of Korea; Omics Research
        Center, Sejong, 30019, Republic of Korea. Electronic address: yjhwang@korea.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Environ
        Res</MedlineTA><NlmUniqueID>0147621</NlmUniqueID><ISSNLinking>0013-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015777">Eicosanoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D019394">Ki-67 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="Y">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015777" MajorTopicYN="N">Eicosanoids</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019394" MajorTopicYN="N">Ki-67 Antigen</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013964" MajorTopicYN="Y">Thyroid Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Di-2-ethylhexyl phthalate</Keyword><Keyword
        MajorTopicYN="N">Eicosanoids</Keyword><Keyword MajorTopicYN="N">Metabolomics</Keyword><Keyword
        MajorTopicYN="N">Thyroid cancer</Keyword><Keyword MajorTopicYN="N">Transcriptomics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2021</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>10</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">35810816</ArticleId><ArticleId IdType="doi">10.1016/j.envres.2022.113805</ArticleId><ArticleId
        IdType="pii">S0013-9351(22)01132-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11099649</PMID><DateCompleted><Year>2001</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>58</Volume><Issue>2</Issue><PubDate><Year>2000</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Chronic toxicity of di(2-ethylhexyl)phthalate
        in mice.</ArticleTitle><Pagination><StartPage>377</StartPage><EndPage>385</EndPage><MedlinePgn>377-85</MedlinePgn></Pagination><Abstract><AbstractText>B6C3F1
        mice were treated with 0, 100, 500, 1500, or 6000 ppm di(2-ethylhexyl)phthalate
        (DEHP) in the diet for up to 104 weeks. Blood and urine were analyzed at Weeks
        26, 52, 78, and 104 from 10 animals per sex per group. Body weights and food
        consumption were measured weekly for the first 16 weeks, then monthly thereafter.
        Survival was reduced for mice receiving 6000 ppm DEHP. Overall weight gains
        were significantly lower for the 6000-ppm male group, but there was no difference
        among female groups. Food consumption was not affected by exposure. No biologically
        significant changes in clinical chemistry, hematology, or urinalysis were
        observed. After 104 weeks of exposure, kidney weights for the 500- and 1500-ppm
        male, and 6000-ppm male/female groups were significantly lower than for the
        controls. Significantly higher liver weight was seen for the 500-, 1500-,
        and 6000-ppm male groups and the 6000-ppm female group of mice. Testis weights
        for the 500-, 1500-, and 6000-ppm males were significantly lower than for
        the controls. Uterine weights for the 6000-ppm group were significantly lower
        than for the controls. All organs were examined for histopathology. The incidence
        of hepatocellular lesions has been reported separately (R. M. David et al.,
        1999. Toxicol. Sci. 50, 195-205). Tumors were observed at &gt; or = 500-ppm
        dosages, where peroxisome proliferation was significantly increased. A NOEL
        for both tumors and peroxisome proliferation was 100 ppm. In the study presented
        here, bilateral hypospermia in the testes of male mice, hepatocyte pigmentation
        and cytoplasmic eosinophilia in the liver, and chronic progressive nephropathy
        of male and female mice were observed at 6000 ppm. Hypospermia and chronic
        progressive nephropathy were also observed at 1500 ppm, where peroxisome proliferation
        was 2.7-6.8-fold higher than controls. Many lesions observed in rats were
        not seen in mice. A dose level of 500 ppm (98.5-116.8 mg/kg/day) was identified
        as a no-observed-adverse-effect level (NOAEL) for noncarcinogenic effects.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>David</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Health
        and Environment Laboratories, Eastman Kodak Company, 1100 Ridgeway Ave., Rochester,
        New York 14652-6272, USA. raymond.david@kodak.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Moore</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author><Author
        ValidYN="Y"><LastName>Finney</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>12</Month><Day>2</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>12</Month><Day>2</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11099649</ArticleId><ArticleId IdType="doi">10.1093/toxsci/58.2.377</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">21616130</PMID><DateCompleted><Year>2011</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2012</Year><Month>11</Month><Day>15</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3169</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>205</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Systemic
        toxicity of di-2-ethylhexyl terephthalate (DEHT) in rodents following four
        weeks of intravenous exposure.</ArticleTitle><Pagination><StartPage>8</StartPage><EndPage>14</EndPage><MedlinePgn>8-14</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.toxlet.2011.04.020</ELocationID><Abstract><AbstractText
        Label="BACKGROUND" NlmCategory="BACKGROUND">Di-2-ethylhexyl-terephtalate (DEHT)
        is a general purpose plasticizer and a structural isomer to di-2-ethylhexyl
        phthalate (DEHP) being known for its toxicity. Despite the fact that DEHT
        is used in quite a number of synthetics for medical device production including
        equipment for intravenous administration, toxicity of DEHT has not been assessed
        after/during intravenous exposure. Hence we report here the results of a toxicity
        study in male and female rats with continuous intravenous infusion of DEHT
        over 4 weeks.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The
        study was done according to OECD guidelines under GLP conditions. The dose
        was infused per day to male and female rats over a period of 4 weeks with
        saline (control), middle chain triglycerides (vehicle) as well as with 38.2,
        114.5 or 381.6mg DEHT/kg. Each group (n=6) was closely monitored regarding
        survival, body weight development, food and water consumption. Moreover blood
        and urine samples were taken and a standardized necropsy as wall as a histological
        analysis was performed after the investigation period.</AbstractText><AbstractText
        Label="RESULTS" NlmCategory="RESULTS">DEHT had no effect on survival, body
        weight development, food and water consumption in the whole dose range investigated.
        There were no indications as to hematotoxicity or immunotoxicity. Clinical
        chemistry and histopathology indicated no exposure related effect on hepatic,
        thyroidal and reproductive functions or organs.</AbstractText><AbstractText
        Label="CONCLUSION" NlmCategory="CONCLUSIONS">DEHT administered via intravenous
        infusion was tolerated systemically and locally without adverse effects up
        to and including 381.6mg/kg/day (NOAEL=381.6mg/kg&#xd7;day). In particular,
        there were no effects on reproductive tissues/organs, kidneys, liver hepatocytes
        and peroxisomes, which are known targets of DEHP-toxicity.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2011 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Wirnitzer</LastName><ForeName>U</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Bayer
        Schering Pharma AG, GDD-GED Toxicology, 42096 Wuppertal, Germany. uta.wirnitzer@bayer.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rickenbacher</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author
        ValidYN="Y"><LastName>Katerkamp</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Schachtrupp</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2011</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>4VS908W98L</RegistryNumber><NameOfSubstance
        UI="C053316">di-(2-ethylhexyl) terephthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001774" MajorTopicYN="N">Blood Chemical Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000648"
        MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008401" MajorTopicYN="N">Gas Chromatography-Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019055" MajorTopicYN="N">No-Observed-Adverse-Effect Level</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013534" MajorTopicYN="N">Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016482" MajorTopicYN="N">Urinalysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2011</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2011</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2011</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2011</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2011</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2011</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">21616130</ArticleId><ArticleId IdType="doi">10.1016/j.toxlet.2011.04.020</ArticleId><ArticleId
        IdType="pii">S0378-4274(11)00184-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3564043</PMID><DateCompleted><Year>1987</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>88</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Reproductive
        effects of four phthalic acid esters in the mouse.</ArticleTitle><Pagination><StartPage>255</StartPage><EndPage>269</EndPage><MedlinePgn>255-69</MedlinePgn></Pagination><Abstract><AbstractText>These
        studies compared the reproductive toxicity of four phthalates by a continuous
        breeding protocol. Mice were given diets with diethyl phthalate (DEP) (0.0,
        0.25, 1.25, or 2.5%), di-n-butyl phthalate (DBP) (0.0, 0.03, 0.3, or 1.0%),
        di-n-hexyl phthalate (DHP) (0.0, 0.3, 0.6, or 1.2%), or di(2-ethylhexyl) phthalate
        (DEHP) (0.0, 0.01, 0.1, or 0.3%). Both male and female CD-1 mice were dosed
        for 7 days prior to and during a 98-day cohabitation period. Reproductive
        function was evaluated during the cohabitation period by measuring the numbers
        of litters per pair and of live pups per litter, pup weight, and offspring
        survival. There was no apparent effect on reproductive function in the animals
        exposed to DEP, despite significant effects on body weight gain and liver
        weight. DBP exposure resulted in a reduction in the numbers of litters per
        pair and of live pups per litter and in the proportion of pups born alive
        at the 1.0% amount, but not at lower dose levels. A crossover mating trial
        demonstrated that female mice, but not males, were affected by DBP, as shown
        by significant decreases in the percentage of fertile pairs, the number of
        live pups per litter, the proportion of pups born alive, and live pup weight.
        DHP in the diet resulted in dose-related adverse effects on the numbers of
        litters per pair and of live pups per litter and proportion of pups born alive
        at 0.3, 0.6, and 1.2% DHP in the diet. A crossover mating study demonstrated
        that both sexes were affected. DEHP (at 0.1 and 0.3%) caused dose-dependent
        decreases in fertility and in the number and the proportion of pups born alive.
        A crossover mating trial showed that both sexes were affected by exposure
        to DEHP. These data demonstrate the ability of the continuous breeding protocol
        to discriminate the qualitative and quantitative reproductive effects of the
        more and less active congeners as well as the large differences in reproductive
        toxicity attributable to subtle changes in the alkyl substitution of phthalate
        esters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamb</LastName><ForeName>J
        C</ForeName><Initials>JC</Initials><Suffix>4th</Suffix></Author><Author ValidYN="Y"><LastName>Chapin</LastName><ForeName>R
        E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Teague</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Lawton</LastName><ForeName>A D</ForeName><Initials>AD</Initials></Author><Author
        ValidYN="Y"><LastName>Reel</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>N01-ES-25014</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01-ES95615</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N0I-ES-15733</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013487">Research Support, U.S.
        Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>2286E5R2KE</RegistryNumber><NameOfSubstance
        UI="D003993">Dibutyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>42MAH1QFG5</RegistryNumber><NameOfSubstance
        UI="C027387">di-n-hexyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>UF064M00AF</RegistryNumber><NameOfSubstance
        UI="C007379">diethyl phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003993" MajorTopicYN="N">Dibutyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3564043</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(87)90011-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3709451</PMID><DateCompleted><Year>1986</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0091-6765</ISSN><JournalIssue
        CitedMedium="Print"><Volume>65</Volume><PubDate><Year>1986</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Studies
        on the genetic effects of phthalic acid esters on cells in culture.</ArticleTitle><Pagination><StartPage>263</StartPage><EndPage>266</EndPage><MedlinePgn>263-6</MedlinePgn></Pagination><Abstract><AbstractText>Mono(2-ethylhexyl)
        phthalate (MEHP) induced chromosome aberrations in cells of two culture lines,
        one derived from Chinese hamster ovary cells (CHO) and the other from rat
        liver cells (RL4). In CHO cells, the clastogenicity of MEHP was unaffected
        by the presence of an exogenous metabolic activation system (S-9 mix). 2-Ethylhexanol,
        o-phthalic acid, and phthalic anhydride were without effect. Cytochemical
        methods and assays for carnitine acetyltransferase and KCN-insensitive palmitoyl
        CoA oxidation were employed to determine whether chromosome damage was associated
        with peroxisome proliferation. No evidence of an increase in peroxisome numbers
        or of induction of marker enzymes was found in CHO cells treated with MEHP
        for up to 72 hr. Clofibric acid and BR931 were also ineffective. Observations
        on changes in CHO cell structure and permeability, and on the haemolytic effects
        of phthalate monoesters, suggest that the cytotoxicity of MEHP may be due
        primarily to its action on cell membranes. Since chromosome damage was observed
        only at cytotoxic concentrations, it is suggested that damage to lysosomal
        membranes and the release of endonucleases may be responsible for the observed
        clastogenicity of MEHP in vitro.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Phillips</LastName><ForeName>B J</ForeName><Initials>BJ</Initials></Author><Author
        ValidYN="Y"><LastName>Anderson</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002463" MajorTopicYN="N">Cell Membrane Permeability</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002869" MajorTopicYN="N">Chromosome Aberrations</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002875" MajorTopicYN="N">Chromosomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006461" MajorTopicYN="N">Hemolysis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010053" MajorTopicYN="N">Ovary</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3709451</ArticleId><ArticleId IdType="pmc">PMC1474679</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.8665263</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature.
        1965 Sep 11;207(5002):1170-3</Citation><ArticleIdList><ArticleId IdType="pubmed">5882717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1970 Aug 15;227(5259):707-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4914590</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Chromatogr. 1973 Feb 28;76(2):321-30</Citation><ArticleIdList><ArticleId IdType="pubmed">4689606</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1975 Dec;31(6):347-64</Citation><ArticleIdList><ArticleId IdType="pubmed">768755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1977 Oct;45(1):91-101</Citation><ArticleIdList><ArticleId IdType="pubmed">917038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1979 Oct;64(5):329-37</Citation><ArticleIdList><ArticleId IdType="pubmed">117353</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp
        Cell Res. 1965 Apr;38:144-52</Citation><ArticleIdList><ArticleId IdType="pubmed">14277325</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:119-25</Citation><ArticleIdList><ArticleId IdType="pubmed">6814903</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:35-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6754363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1982 Oct-Nov;102(3):297-304</Citation><ArticleIdList><ArticleId IdType="pubmed">6890626</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1983 Jan;67(1):15-25</Citation><ArticleIdList><ArticleId IdType="pubmed">6845354</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1984 May;126(3):265-71</Citation><ArticleIdList><ArticleId IdType="pubmed">6325900</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1974 Jul;29(1):35-46</Citation><ArticleIdList><ArticleId IdType="pubmed">4283679</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:115-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7140683</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">16476687</PMID><DateCompleted><Year>2006</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>91</Volume><Issue>1</Issue><PubDate><Year>2006</Year><Month>May</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>A dose-response study following
        in utero and lactational exposure to di(2-ethylhexyl)phthalate: effects on
        female rat reproductive development.</ArticleTitle><Pagination><StartPage>247</StartPage><EndPage>254</EndPage><MedlinePgn>247-54</MedlinePgn></Pagination><Abstract><AbstractText>Phthalates,
        a class of chemicals used as plasticizers, are economically important due
        to several industrial applications. Di(2-ethylhexyl)phthalate (DEHP) is the
        most commonly used phthalate plasticizer, and it has been described as a potent
        antiandrogen in males. We performed an extensive dose-response study following
        developmental exposure to DEHP and evaluated the effects on female reproductive
        development. Two wide ranges of doses that included dose levels relevant for
        human exposure as well as high doses typically used in toxicological studies
        were tested. Female Wistar rats were treated daily with DEHP and peanut oil
        (vehicle control) by gavage from gestation day 6 to lactation day 22. The
        low doses were 0.015, 0.045, 0.135, 0.405, and 1.215 mg DEHP/kg body weight
        (bw)/day, and the high doses were 5, 15, 45, 135, and 405 mg DEHP/kg bw/day.
        At the dose levels tested, no signs of maternal toxicity were observed. A
        significant delay in the age at vaginal opening (approximately 2 days) at
        15 mg DEHP/kg bw/day and above, as well as a trend for a delay in the age
        at first estrus at 135 and 405 mg DEHP/kg bw/day (approximately 2 days), was
        observed. Liver enlargement (characteristic of phthalate exposure in rats)
        was limited to the 135- and 405-mg DEHP/kg bw/day doses. Anogenital distance
        and nipple development were unaffected. Based on the results of delayed pubertal
        onset, the no observed adverse effect level for female reproductive development
        may be set at 5 mg DEHP/kg bw/day.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Grande</LastName><ForeName>Simone Wichert</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department
        of Toxicology, Institute of Clinical Pharmacology and Toxicology, Campus Benjamin
        Franklin, Charit&#xe9; University Medical School Berlin, 14195 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Andrade</LastName><ForeName>Anderson J M</ForeName><Initials>AJ</Initials></Author><Author
        ValidYN="Y"><LastName>Talsness</LastName><ForeName>Chris E</ForeName><Initials>CE</Initials></Author><Author
        ValidYN="Y"><LastName>Grote</LastName><ForeName>Konstanze</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Chahoud</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2006</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004971" MajorTopicYN="N">Estrus</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007774" MajorTopicYN="Y">Lactation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018811" MajorTopicYN="Y">Maternal Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014621" MajorTopicYN="N">Vagina</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2006</Year><Month>2</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2006</Year><Month>6</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2006</Year><Month>2</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">16476687</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfj128</ArticleId><ArticleId
        IdType="pii">kfj128</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">996879</PMID><DateCompleted><Year>1977</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>1976</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Studies
        on the effects of orally administered Di-(2-ethylhexyl) phthalate in the ferret.</ArticleTitle><Pagination><StartPage>341</StartPage><EndPage>356</EndPage><MedlinePgn>341-56</MedlinePgn></Pagination><Abstract><AbstractText>A
        target-organ study of the effects of the phthalate ester di-(2-ethylhexyl)
        phthalate (DEHP) has been conducted in mature male albino ferrets. DEHP treatment
        caused a loss of body weight when administered as a 1% (w/w) diet for 14 months.
        Additionally marked liver enlargement with associated morphological and biochemical
        changes was observed. These changes consisted of liver cell enlargement, lysosomal
        changes, dilatation of the endoplasmic reticulum and the depression of a number
        of marker enzyme activities. The only other tissue observed to be affected
        by DEHP treatment was the testes where histological evidence of tissue damage
        was observed in some animals. Studies on the metabolism of [14C]DEHP in the
        ferret indicated that the diester was metabolised to derivatives of mono-(2-ethylhexyl)
        phthalate which were excreted in the urine both unconjugated and as glucuronides.
        The results obtained have been compared with previous studies in the rat and
        it is concluded that DEHP is hepatotoxic in both species.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Brantom</LastName><ForeName>P G</ForeName><Initials>PG</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author><Author
        ValidYN="Y"><LastName>Butterworth</LastName><ForeName>K R</ForeName><Initials>KR</Initials></Author><Author
        ValidYN="Y"><LastName>Grasso</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002335" MajorTopicYN="Y">Carnivora</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005289" MajorTopicYN="Y">Ferrets</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1976</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1976</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1976</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">996879</ArticleId><ArticleId IdType="doi">10.1016/0300-483x(76)90038-x</ArticleId><ArticleId
        IdType="pii">0300-483X(76)90038-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3709458</PMID><DateCompleted><Year>1986</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0091-6765</ISSN><JournalIssue
        CitedMedium="Print"><Volume>65</Volume><PubDate><Year>1986</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Chemical
        industry voluntary test program for phthalate esters: health effects studies.</ArticleTitle><Pagination><StartPage>329</StartPage><EndPage>336</EndPage><MedlinePgn>329-36</MedlinePgn></Pagination><Abstract><AbstractText>The
        Chemical Manufacturers'' Association voluntary test program on phthalate esters
        is described, and the results of certain key aspects of the program are presented.
        Representative phthalate esters were chosen for genotoxicity testing and peroxisome
        proliferation screening, and di-2-ethylhexyl phthalate (DEHP) and its initial
        metabolic products were tested in the genotoxicity battery. A comparative
        metabolism study was performed with DEHP in the mouse, rat, and cynomologus
        monkey, together with a study of the metabolism of DEHP in the rodent at several
        dose levels, and after prolonged feeding. A standard test for peroxisome proliferation
        in the rat, employing 21 days of feeding and several end points is described,
        based on DEHP as a reference compound. DEHP is shown to be nongenotoxic in
        the test battery, and its initial major metabolites are also nongenotoxic.
        A nonlinear dose response with respect to the beta-oxidation of DEHP in the
        rodent is demonstrated. Quantitative differences exist between the mouse and
        rat, and the cynomologus monkey with respect to the beta-oxidation of DEHP,
        beta-oxidation being a much less used pathway in the monkey. The significance
        of these results in interpreting the hepatocellular carcinogenesis of DEHP
        in the Fischer 344 rat is discussed.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Astill</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Barber</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Lington</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Moran</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Mulholland</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Robinson</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Scheider</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002617" MajorTopicYN="N">Chemical Industry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009152" MajorTopicYN="N">Mutagenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3709458</ArticleId><ArticleId IdType="pmc">PMC1474691</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.8665329</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J
        Chromatogr. 1973 Feb 28;76(2):321-30</Citation><ArticleIdList><ArticleId IdType="pubmed">4689606</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1976 Jun;73(6):2043-6</Citation><ArticleIdList><ArticleId
        IdType="pubmed">180535</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1978 Aug;45(2):497-504</Citation><ArticleIdList><ArticleId
        IdType="pubmed">705785</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1980 Jan 24;283(5745):397-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6766207</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1985 Aug;80(1):11-22</Citation><ArticleIdList><ArticleId IdType="pubmed">4024100</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:99-101</Citation><ArticleIdList><ArticleId IdType="pubmed">6754365</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1982 Oct-Nov;102(3):297-304</Citation><ArticleIdList><ArticleId IdType="pubmed">6890626</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Mutagen. 1983;5(2):227-31</Citation><ArticleIdList><ArticleId IdType="pubmed">6861726</ArticleId></ArticleIdList></Reference><Reference><Citation>Xenobiotica.
        1984 Mar;14(3):269-76</Citation><ArticleIdList><ArticleId IdType="pubmed">6711016</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:19-25</Citation><ArticleIdList><ArticleId IdType="pubmed">7140694</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3709461</PMID><DateCompleted><Year>1986</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0091-6765</ISSN><JournalIssue
        CitedMedium="Print"><Volume>65</Volume><PubDate><Year>1986</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Effects
        of di(2-ethylhexyl) phthalate on the gonadal pathophysiology, sperm morphology,
        and reproductive performance of male rats.</ArticleTitle><Pagination><StartPage>343</StartPage><EndPage>350</EndPage><MedlinePgn>343-50</MedlinePgn></Pagination><Abstract><AbstractText>Dietary
        exposure of adult male F344 rats to 0, 320, 1250, 5000, or 20,000 ppm DEHP
        for 60 consecutive days resulted in a dose-dependent reduction in total body,
        testis, epididymis, and prostate weights at 5000 and 20,000 ppm. Degenerative
        changes were observed in testis, along with decreased testicular zinc content,
        reduced epididymal sperm density and motility, and increased occurrence of
        abnormal sperm at 20,000 ppm. There was a trend towards reduced testosterone
        and increased luteinizing hormone and follicle stimulating hormone in serum
        at 5000 and 20,000 ppm. The mean percentage of fertile animals was unchanged
        and reduction in fertility parameters, although not marked in severity, were
        correlated with gonadal effects. Average litter size was reduced at 20,000
        ppm, but initial pup weights and growth were unaffected. There were no grossly
        observed abnormalities in the offspring and the rate of neonatal deaths was
        similar in control and DEHP treated groups. Characteristic toxicity manifestations
        of DEHP included dose-dependent enlargement of liver and reduced sperm triglycerides
        and cholesterol. Additionally, serum albumin and total proteins were dose
        dependently increased upon treatment with DEHP. Cessation of exposure to DEHP
        initiated partial to complete recovery from toxicity in most cases. The magnitude
        of recovery were variable with that of the gonads being slower than other
        systems. These data suggest a lack of reproductive dysfunction in F344 male
        rats at DEHP doses below 20,000 ppm which produced measurable testicular degeneration
        and afflicted epididymal sperm morphology under the present experimental conditions.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>D
        K</ForeName><Initials>DK</Initials></Author><Author ValidYN="Y"><LastName>Eustis</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Lamb</LastName><ForeName>J C</ForeName><Initials>JC</Initials><Suffix>4th</Suffix></Author><Author
        ValidYN="Y"><LastName>Reel</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Kluwe</LastName><ForeName>W M</ForeName><Initials>WM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004822" MajorTopicYN="N">Epididymis</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008098" MajorTopicYN="N">Litter Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012726" MajorTopicYN="N">Sexual Behavior, Animal</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013076" MajorTopicYN="N">Sperm Count</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013081" MajorTopicYN="N">Sperm Motility</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013091" MajorTopicYN="N">Spermatogenesis</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013094" MajorTopicYN="N">Spermatozoa</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3709461</ArticleId><ArticleId IdType="pmc">PMC1474682</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.8665343</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin
        Chem. 1974 Apr;20(4):470-5</Citation><ArticleIdList><ArticleId IdType="pubmed">4818200</ArticleId></ArticleIdList></Reference><Reference><Citation>Can
        J Biochem Physiol. 1958 Jun;36(6):557-69</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13536888</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1975 Nov;72(11):4425-9</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1060122</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Physiol. 1976 Jun;230(6):1730-2</Citation><ArticleIdList><ArticleId IdType="pubmed">779495</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1977 Sep;41(3):609-18</Citation><ArticleIdList><ArticleId
        IdType="pubmed">918990</ArticleId></ArticleIdList></Reference><Reference><Citation>Food
        Cosmet Toxicol. 1977 Oct;15(5):389-99</Citation><ArticleIdList><ArticleId
        IdType="pubmed">598790</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Chem. 1979 Feb;25(2):273-8</Citation><ArticleIdList><ArticleId IdType="pubmed">759021</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Toxicol. 1978;13(1):89-139</Citation><ArticleIdList><ArticleId IdType="pubmed">367693</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1979 Feb;64(1):27-35</Citation><ArticleIdList><ArticleId IdType="pubmed">440324</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1980 Mar 30;53(1):35-41</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7385236</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Toxicol Suppl. 1980;4:452-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6776936</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1980;15(3):197-202</Citation><ArticleIdList><ArticleId IdType="pubmed">7466832</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1982 Mar 30;63(1):120-32</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7071867</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:115-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7140683</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:19-25</Citation><ArticleIdList><ArticleId IdType="pubmed">7140694</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:41-50</Citation><ArticleIdList><ArticleId IdType="pubmed">7140695</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:77-84</Citation><ArticleIdList><ArticleId IdType="pubmed">6754364</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Pathol. 1983 Mar;139(3):309-21</Citation><ArticleIdList><ArticleId IdType="pubmed">6834175</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1983 Aug;70(1):43-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6612737</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit
        Rev Toxicol. 1984;13(4):283-317</Citation><ArticleIdList><ArticleId IdType="pubmed">6386344</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1985 Jun 14;35(3):189-206</Citation><ArticleIdList><ArticleId IdType="pubmed">3925598</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1986 Mar;65:229-35</Citation><ArticleIdList><ArticleId IdType="pubmed">3709446</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Anat. 1956 Nov;99(3):507-16</Citation><ArticleIdList><ArticleId IdType="pubmed">13402729</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1974 Mar;2(1):51-65</Citation><ArticleIdList><ArticleId IdType="pubmed">4823738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3564055</PMID><DateCompleted><Year>1987</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>1987</Year><Month>May</Month></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Effect
        of prolonged administration of clofibric acid and di-(2-ethylhexyl)phthalate
        on hepatic enzyme activities and lipid peroxidation in the rat.</ArticleTitle><Pagination><StartPage>213</StartPage><EndPage>228</EndPage><MedlinePgn>213-28</MedlinePgn></Pagination><Abstract><AbstractText>Male
        Sprague-Dawley rats were fed diets containing either 0.5% clofibric acid (CA)
        or 2% di-(2-ethylhexyl)phthalate (DEHP) for 2 years. Both compounds produced
        liver enlargement which was accompanied by the formation of liver nodules.
        Hepatic peroxisomal and microsomal fatty acid oxidising enzyme activities
        were induced in both large nodules and host tissue (i.e. tissue remaining
        after removal of large nodules) preparations from CA and DEHP treated rats.
        In contrast, little change in catalase activity was observed and the activities
        of cytosolic GSH peroxidase and GSH S-transferases were markedly reduced.
        Increased lipid peroxidation was observed by measurement of conjugated dienes
        in host tissue homogenates from CA and DEHP treated rats. Microsomal NADPH-dependent
        lipid peroxidation was also stimulated. Histological examination revealed
        extensive lipofuscin deposition in non-nodular, but not in nodular, tissue
        sections from treated rats. These results demonstrate that prolonged peroxisome
        proliferation can result in lipid peroxidation and that certain enzymes which
        metabolise hydrogen peroxide and organic hydroperoxides are either little
        affected or markedly inhibited.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Lake</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Kozlen</LastName><ForeName>S L</ForeName><Initials>SL</Initials></Author><Author
        ValidYN="Y"><LastName>Evans</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Gray</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Author><Author
        ValidYN="Y"><LastName>Young</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008054">Lipid Peroxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000031"
        MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006529" MajorTopicYN="N">Hepatomegaly</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008054" MajorTopicYN="N">Lipid Peroxides</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3564055</ArticleId><ArticleId IdType="doi">10.1016/0300-483x(87)90151-x</ArticleId><ArticleId
        IdType="pii">0300-483X(87)90151-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12805656</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>74</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Activation of PPARalpha and PPARgamma
        by environmental phthalate monoesters.</ArticleTitle><Pagination><StartPage>297</StartPage><EndPage>308</EndPage><MedlinePgn>297-308</MedlinePgn></Pagination><Abstract><AbstractText>Phthalate
        esters are widely used as plasticizers in the manufacture of products made
        of polyvinyl chloride. Mono-(2-ethylhexyl)-phthalate (MEHP) induces rodent
        hepatocarcinogenesis by a mechanism that involves activation of the nuclear
        transcription factor peroxisome proliferator-activated receptor-alpha (PPARalpha).
        MEHP also activates PPAR-gamma (PPARgamma), which contributes to adipocyte
        differentiation and insulin sensitization. Human exposure to other phthalate
        monoesters, including metabolites of di-n-butyl phthalate and butyl benzyl
        phthalate, is substantially higher than that of MEHP, prompting this investigation
        of their potential for PPAR activation, assayed in COS cells and in PPAR-responsive
        liver (PPARalpha) and adipocyte (PPARgamma) cell lines. Monobenzyl phthalate
        (MBzP) and mono-sec-butyl phthalate (MBuP) both increased the COS cell transcriptional
        activity of mouse PPARalpha, with effective concentration for half-maximal
        response (EC50) values of 21 and 63 microM, respectively. MBzP also activated
        human PPARalpha (EC50=30 microM) and mouse and human PPARgamma (EC50=75-100
        microM). MEHP was a more potent PPAR activator than MBzP or MBuP, with mouse
        PPARalpha more sensitive to MEHP (EC50=0.6 microM) than human PPARalpha (EC50=3.2
        microM). MEHP activation of PPARgamma required somewhat higher concentrations,
        EC50=10.1 microM (mouse PPARgamma) and 6.2 microM (human PPARgamma). No significant
        PPAR activation was observed with the monomethyl, mono-n-butyl, dimethyl,
        or diethyl esters of phthalic acid. PPARalpha activation was verified in FAO
        rat liver cells stably transfected with PPARalpha, where expression of several
        endogenous PPARalpha target genes was induced by MBzP, MBuP, and MEHP. Similarly,
        activation of endogenous PPARgamma target genes was evidenced for all three
        phthalates by the stimulation of PPARgamma-dependent adipogenesis in the 3T3-L1
        cell differentiation model. These findings demonstrate the potential of environmental
        phthalate monoesters for activation of rodent and human PPARs and may help
        to elucidate the molecular basis for the adverse health effects proposed to
        be associated with human phthalate exposure.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hurst</LastName><ForeName>Christopher
        H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department
        of Biology, Division of Cell and Molecular Biology, Boston University, Boston,
        Massachusetts 02215, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Waxman</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>5 P42 ES07381</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32
        ES11105</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2003</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D041721" MajorTopicYN="N">3T3-L1 Cells</DescriptorName><QualifierName
        UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017667" MajorTopicYN="N">Adipocytes</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12805656</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfg145</ArticleId><ArticleId
        IdType="pii">kfg145</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11401753</PMID><DateCompleted><Year>2001</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0091-6765</ISSN><JournalIssue
        CitedMedium="Print"><Volume>109</Volume><Issue>5</Issue><PubDate><Year>2001</Year><Month>May</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Is
        peroxisome proliferation an obligatory precursor step in the carcinogenicity
        of di(2-ethylhexyl)phthalate (DEHP)?</ArticleTitle><Pagination><StartPage>437</StartPage><EndPage>442</EndPage><MedlinePgn>437-42</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)phthalate
        (DEHP), a peroxisome proliferator, has been listed by the International Agency
        for Research on Cancer (IARC) and by the National Toxicology Program as a
        possible or reasonably anticipated human carcinogen because it induces dose-related
        increases in liver tumors in both sexes of rats and mice. Recently, the suggestion
        has been advanced that DEHP should be considered unlikely to be a human carcinogen
        because it is claimed that the carcinogenic effects of this agent in rodents
        are due to peroxisome proliferation and that humans are nonresponsive to this
        process. An IARC working group recently downgraded DEHP to "not classifiable
        as to its carcinogenicity to humans" because they concluded that DEHP produces
        liver tumors in rats and mice by a mechanism involving peroxisome proliferation,
        which they considered to be not relevant to humans. The literature review
        presented in this commentary reveals that, although our knowledge of the mechanism
        of peroxisome proliferation has advanced greatly over the past 10 years, our
        understanding of the mechanism(s) of carcinogenicty of peroxisome proliferators
        remains incomplete. Most important is that published studies have not established
        peroxisome proliferation per se as an obligatory pathway in the carcinogenicity
        of DEHP. No epidemiologic studies have been reported on the potential carcinogenicity
        of DEHP, and cancer epidemiologic studies of hypolipidemic fibrate drugs (peroxisome
        proliferators) are inconclusive. Most of the pleiotropic effects of peroxisome
        proliferators are mediated by the peroxisome proliferator activated receptor
        (PPAR), a ligand-activated transcription factor that is expressed at lower
        levels in humans than in rats and mice. In spite of this species difference
        in PPAR expression, hypolipidemic fibrates have been shown to induce hypolipidemia
        in humans and to modulate gene expression (e.g., genes regulating lipid homeostasis)
        in human hepatocytes by PPAR activation. Thus, humans are responsive to agents
        that induce peroxisome proliferation in rats and mice. Because peroxisome
        proliferators can affect multiple signaling pathways by transcriptional activation
        of PPAR-regulated genes, it is likely that alterations in specific regulated
        pathways (e.g., suppression of apoptosis, protooncogene expression) are involved
        in tumor induction by peroxisome proliferators. In addition, because DEHP
        also induces biological effects that occur independently of peroxisome proliferation
        (e.g., morphologic cell transformation and decreased levels of gap junction
        intercellular communication), it is possible that some of these responses
        also contribute to the carcinogenicity of this chemical. Last, species differences
        in tissue expression of PPARs indicate that it may not be appropriate to expect
        exact site correspondence for potential PPAR-mediated effects induced by peroxisome
        proliferators in animals and humans. Because peroxisome proliferation has
        not been established as an obligatory step in the carcinogenicity of DEHP,
        the contention that DEHP poses no carcinogenic risk to humans because of species
        differences in peroxisome proliferation should be viewed as an unvalidated
        hypothesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Melnick</LastName><ForeName>R
        L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>National
        Institute of Environmental Health Sciences, Research Triangle Park, North
        Carolina 27709, USA. melnickr@niehs.nih.gov</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections
        RefType="CommentIn"><RefSource>Environ Health Perspect. 2001 Oct;109(10):A462-4</RefSource><PMID
        Version="1">11675276</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>6</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>8</Month><Day>24</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>6</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11401753</ArticleId><ArticleId IdType="pmc">PMC1240301</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.01109437</ArticleId><ArticleId IdType="pii">sc271_5_1835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carcinogenesis.
        1997 Aug;18(8):1453-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9276615</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochimie.
        1997 Feb-Mar;79(2-3):139-44</Citation><ArticleIdList><ArticleId IdType="pubmed">9209711</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1997 Nov;18(11):2029-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9395198</ArticleId></ArticleIdList></Reference><Reference><Citation>Teratology.
        1997 Nov;56(5):311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9451755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Pharmacol. 1998 Jan;53(1):14-22</Citation><ArticleIdList><ArticleId IdType="pubmed">9443928</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1998 Jan;19(1):43-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9472691</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit
        Rev Toxicol. 1998 Jan;28(1):1-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9493760</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Environ Contam Toxicol. 1998 Apr;34(3):306-10</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9504980</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Toxicol. 1998 Feb;72(3):169-77</Citation><ArticleIdList><ArticleId IdType="pubmed">9520140</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Pathol. 1998 Mar-Apr;26(2):240-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9547862</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        J. 1998 Jun 15;332 ( Pt 3):689-93</Citation><ArticleIdList><ArticleId IdType="pubmed">9620871</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1998 Jun;150(2):277-86</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9653058</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Toxicol. 1998 Dec;72(12):777-83</Citation><ArticleIdList><ArticleId IdType="pubmed">9950074</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1999 Mar;20(3):369-72</Citation><ArticleIdList><ArticleId IdType="pubmed">10190548</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol
        Ther. 1999 Apr;82(1):63-70</Citation><ArticleIdList><ArticleId IdType="pubmed">10341357</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinology.
        1999 Jul;140(7):2968-75</Citation><ArticleIdList><ArticleId IdType="pubmed">10385388</ArticleId></ArticleIdList></Reference><Reference><Citation>Regul
        Toxicol Pharmacol. 1999 Jun;29(3):327-57</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10388618</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1999 Oct 1;160(1):21-32</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10502499</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1996 Aug;17(8):1623-32</Citation><ArticleIdList><ArticleId IdType="pubmed">8761418</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit
        Rev Toxicol. 1996 Jun;26(4):365-481</Citation><ArticleIdList><ArticleId IdType="pubmed">8817083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1996 Dec 27;804:252-65</Citation><ArticleIdList><ArticleId IdType="pubmed">8993548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Cell Endocrinol. 1997 May 16;129(2):229-35</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9202406</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1997 Oct 24;272(43):27307-12</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9341179</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1999 Dec 1;161(2):209-18</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10581215</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Toxicol. 1999 Nov;73(8-9):451-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10650916</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Toxicol. 2000 Apr;74(2):85-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10839475</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1975 May;32(2):355-67</Citation><ArticleIdList><ArticleId
        IdType="pubmed">168667</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1980 Jan 24;283(5745):397-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6766207</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Toxicol Environ Health. 1982 Oct-Nov;10(4-5):797-815</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7161829</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1985 Jan;34(1):13-27</Citation><ArticleIdList><ArticleId IdType="pubmed">3969678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1988 Dec 1;48(23):6739-44</Citation><ArticleIdList><ArticleId IdType="pubmed">3180084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1990 Oct 18;347(6294):645-50</Citation><ArticleIdList><ArticleId IdType="pubmed">2129546</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1990 Dec;106(3):509-17</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2260097</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1990 Dec 31;173(3):855-61</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2268348</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1991 Mar;12(3):469-73</Citation><ArticleIdList><ArticleId IdType="pubmed">1849052</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB
        J. 1992 Jun;6(9):2698-706</Citation><ArticleIdList><ArticleId IdType="pubmed">1612294</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1992 Aug 27;358(6389):771-4</Citation><ArticleIdList><ArticleId IdType="pubmed">1324435</ArticleId></ArticleIdList></Reference><Reference><Citation>Fundam
        Appl Toxicol. 1992 Nov;19(4):590-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1426718</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1993 Jan;14(1):145-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8425263</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1993 Feb;14(2):251-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8435866</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1993 Apr;14(4):611-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8472324</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry.
        1993 Jun 1;32(21):5598-604</Citation><ArticleIdList><ArticleId IdType="pubmed">7684926</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Ind Health. 1993 May-Jun;9(3):415-38</Citation><ArticleIdList><ArticleId IdType="pubmed">8367884</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Steroid Biochem Mol Biol. 1994 Nov;51(3-4):157-66</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum
        Exp Toxicol. 1994 Nov;13 Suppl 2:S1-117</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7857698</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Clin Invest. 1995 Aug;96(2):741-50</Citation><ArticleIdList><ArticleId IdType="pubmed">7635967</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA.
        1996 Jan 3;275(1):55-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8531288</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1996 Jan 26;271(4):2147-55</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8567672</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1996 Jul 26;1302(2):93-109</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8695669</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">18403868</PMID><DateCompleted><Year>2008</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1348-9585</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>50</Volume><Issue>2</Issue><PubDate><Year>2008</Year></PubDate></JournalIssue><Title>Journal
        of occupational health</Title><ISOAbbreviation>J Occup Health</ISOAbbreviation></Journal><ArticleTitle>Different
        mechanisms of DEHP-induced hepatocellular adenoma tumorigenesis in wild-type
        and Ppar alpha-null mice.</ArticleTitle><Pagination><StartPage>169</StartPage><EndPage>180</EndPage><MedlinePgn>169-80</MedlinePgn></Pagination><Abstract><AbstractText>Di
        (2-ethylhexyl) phthalate (DEHP) exposure is thought to lead to hepatocellular
        hypertrophy and hyperplasia in rodents mediated via peroxisome proliferator-activated
        receptor alpha (PPAR alpha). A recent study revealed that long-term exposure
        to relatively low-dose DEHP (0.05%) caused liver tumors including hepatocellular
        carcinomas, hepatocellular adenomas, and chologiocellular carcinomas at a
        higher incidence in Ppar alpha-null mice (25.8%) than in wild-type mice (10.0%).
        Using tissues with hepatocellular adenoma, microarray (Affymetrix MOE430A)
        as well as, in part, real-time quantitative PCR analysis was conducted to
        elucidate the mechanisms of the adenoma formation resulting from DEHP exposure
        in both genotyped mice. The microarray profiles showed that the up- or down-regulated
        genes were quite different between hepatocellular adenoma tissues of wild-type
        and Ppar alpha-null mice exposed to DEHP. The gene expressions of apoptotic
        peptidase activating factor 1 (Apaf1) and DNA-damage-inducible 45 alpha (Gadd45a)
        were increased in the hepatocellular adenoma tissues of wild-type mice exposed
        to DEHP, whereas they were unchanged in corresponding tissues of Ppar alpha-null
        mice. On the other hand, the expressions of cyclin B2 and myeloid cell leukemia
        sequence 1 were increased only in the hepatocellular adenoma tissues of Ppar
        alpha-null mice. Taken together, DEHP may induce hepatocellular adenomas,
        in part, via suppression of G2/M arrest regulated by Gadd45a and caspase 3-dependent
        apoptosis in Ppar alpha-null mice, but these genes may not be involved in
        tumorigenesis in the wild-type mice. In contrast, the expression level of
        Met was notably increased in the liver adenoma tissue of wild-type mice, which
        may suggest the involvement of Met in DEHP-induced tumorigenesis in wild-type
        mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takashima</LastName><ForeName>Kayoko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department
        of Preventive Medicine, Shinshu University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ito</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials></Author><Author
        ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Tamie</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>Z01 BC005561</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z01
        BC005562</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>Z01 BC005708</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J
        Occup Health</MedlineTA><NlmUniqueID>9616320</NlmUniqueID><ISSNLinking>1341-9145</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C506593">Apaf1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D053477">Apoptotic Protease-Activating Factor 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C499072">Gadd45a protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D053477" MajorTopicYN="N">Apoptotic Protease-Activating Factor 1</DescriptorName><QualifierName
        UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName
        UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016195" MajorTopicYN="N">G2 Phase</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D046228" MajorTopicYN="N">Microarray Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName
        UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="N">PPAR alpha</DescriptorName><QualifierName UI="Q000172"
        MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2008</Year><Month>4</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2008</Year><Month>6</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2008</Year><Month>4</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">18403868</ArticleId><ArticleId IdType="mid">NIHMS1584371</ArticleId><ArticleId
        IdType="pmc">PMC7217336</ArticleId><ArticleId IdType="doi">10.1539/joh.l7105</ArticleId><ArticleId
        IdType="pii">JST.JSTAGE/joh/L7105</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huber
        WW, Grasl-Kraupp B and Schulte-Hermann R: Hepatocarcinogenic potential of
        di (2-Ethelhexyl) phthalate in rodents and its implications on human risk.
        Cnt Rev Toxicol 26, 365&#x2013;481 (1996)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8817083</ArticleId></ArticleIdList></Reference><Reference><Citation>International
        Agency for Research on Cancer (IARC). Some industrial chemicals IARC monographs
        on the Evaluation of Carcinogenic Risks to Humans 77. Lyon: IARC, 2000: 41&#x2013;148.</Citation></Reference><Reference><Citation>Corton
        JC, Anderson SP and Stauber A: Central role of peroxisome proliferator-activated
        receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol
        40, 491&#x2013;518 (2000)</Citation><ArticleIdList><ArticleId IdType="pubmed">10836145</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Cattley RC and Gonzalez FJ: Role of PPAR alpha in the mechanism of action
        of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis
        18, 2029&#x2013;2033 (1997)</Citation><ArticleIdList><ArticleId IdType="pubmed">9395198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashby
        J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, Tugwood JD, Kettle
        S and Purchase IF: Mechanistically-based human hazard assessment of peroxisome
        proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol 13, S1&#x2013;S117
        (1994)</Citation><ArticleIdList><ArticleId IdType="pubmed">7857698</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursch
        W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J and Schulte-Hermann
        R: Controlled death (apoptosis) of normal and putative preneoplastic cells
        in rat liver following withdrawal of tumor promoters. Carcinogenesis 5, 453&#x2013;458
        (1984)</Citation><ArticleIdList><ArticleId IdType="pubmed">6231134</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        DS, Goldsworthy TL and Popp JA: Contrasting hepatocytic peroxisome proliferation,
        lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643
        and clofibric acid. Carcinogenesis 13, 1011&#x2013;1017 (1992)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1600604</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Aoyama T, Cattley RC, Nobumitsu U, Hashimoto T and Gonzalez FJ: Role of
        peroxisome proliferator-activated receptor alpha in altered cell cycle regulation
        in mouse liver. Carcinogenesis 19, 1989&#x2013;1994 (1998)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9855014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayly
        AC, Roberts RA and Dive C: Suppression of liver cell apoptosis in vitro by
        the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin.
        J Cell Biol 125, 197&#x2013;203 (1994)</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2120009</ArticleId><ArticleId IdType="pubmed">8138571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill
        JH, James NH, Roberts RA and Dive C: The non-genotoxic hepatocarcinogen nafenopin
        suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and
        Fas. Carcinogenesis 19, 299&#x2013;304 (1998)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9498280</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah
        YM, Morimura K, Yang Q, Tanabe T, Takagi M and Gonzalez FJ: Peroxisome proliferator-activated
        receptor alpha regulates a microRNA-mediated signaling cascade responsible
        for hepatocellular proliferation. Mol Cell Biol 27, 4238&#x2013;4247 (2007)</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1900062</ArticleId><ArticleId IdType="pubmed">17438130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito
        Y, Yamanoshita O, Asaeda N, Tagawa Y, Lee CH, Aoyama T, Ichihara G, Furuhashi
        K, Kamijima M, Gonzalez FJ and Nakajima T: Di(2-ethylhexyl)phthalate induces
        hepatic tumorigenesis through a peroxisome proliferator-activated receptor
        alpha-independent pathway. J Occup Health 49, 172&#x2013;182 (2007)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17575397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee
        SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM,
        Westphal H and Gonzalez FJ: Targeted disruption of the alpha isoform of the
        peroxisome proliferator-activated receptor gene in mice results in abolishment
        of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15,
        3012&#x2013;3022 (1995)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230532</ArticleId><ArticleId
        IdType="pubmed">7539101</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb
        JC 4th, Chapin RE, Teague J, Lawton AD and Reel JR: Reproductive effects of
        four phthalic acid esters in the mouse. Toxicol Appl Pharmacol 88, 255&#x2013;269
        (1987)</Citation><ArticleIdList><ArticleId IdType="pubmed">3564043</ArticleId></ArticleIdList></Reference><Reference><Citation>Richert
        L, Lamboley C, Viollon-Abadie C, Grass P, Hartmann N, Laurent S, Heyd B, Mantion
        G, Chibout SD and Staedtler F: Effects of clofibric acid on mRNA expression
        profiles in primary cultures of rat, mouse and human hepatocytes. Toxicol
        Appl Pharmacol 191, 130&#x2013;146 (2003)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12946649</ArticleId></ArticleIdList></Reference><Reference><Citation>Arellano
        M and Moreno S: Regulation of CDK/cyclin complexes during the cell cycle.
        Int Biochem Cell Biol 29, 559&#x2013;573 (1997)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9363633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherr
        CJ: Mammalian G1 cyclins. Cell 73, 1059&#x2013;1065 (1993)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8513492</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesche-Soldato
        DE, Swan RZ, Chung CS and Ayala A: The apoptotic pathway as a therapeutic
        target in sepsis. Curr Drug Targets 8, 493&#x2013;500 (2007)</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1852483</ArticleId><ArticleId IdType="pubmed">17430119</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato
        J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ: Direct binding of cyclin
        D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the
        cyclin D-dependent kinase CDK4. Genes Dev 7, 331&#x2013;342 (1993)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8449399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lew
        DJ and Kornbluth S: Regulatory roles of cyclin dependent kinase phosphorylation
        in cell cycle control. Curr Opin Cell Biol 8, 795&#x2013;804 (1996)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8939679</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg
        AS and Weinberg RA: Functional inactivation of the retinoblastoma protein
        requires sequential modification by at least two distinct cyclin-cdk complexes.
        Mol Cell Biol 18, 753&#x2013;761 (1998)</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC108786</ArticleId><ArticleId IdType="pubmed">9447971</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon
        MJ, Glotzer M, Lee TH, Philippe M and Kirschner MW: Cyclin activation of p34cdc2.
        Cell 63, 1013&#x2013;1024 (1990)</Citation><ArticleIdList><ArticleId IdType="pubmed">2147872</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg
        RA: The retinoblastoma protein and cell cycle control. Cell 81, 323&#x2013;330
        (1995)</Citation><ArticleIdList><ArticleId IdType="pubmed">7736585</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda
        T, Hanna AN, Sim AB, Chua PP, Chong MT and Tron VA: GADD45 regulates G2/M
        arrest, DNA repair, and cell death in keratinocytes following ultraviolet
        exposure. J Invest Dermatol 119, 22&#x2013;26 (2002)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12164919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan
        Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC and Fornace AJ Jr:
        Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by
        the p53-regulated protein Gadd45. Oncogene 18, 2892&#x2013;2900 (1999)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10362260</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabelof
        DC, Raffoul JJ, Yanamadala S, Guo Z and Heydari AR: Induction of DNA polymerase
        beta-dependent base excision repair in response to oxidative stress in vivo.
        Carcinogenesis 23, 1419&#x2013;1425 (2002)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12189182</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastan
        MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein
        B and Fornace AJ Jr.: A mammalian cell cycle checkpoint pathway utilizing
        p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587&#x2013;597
        (1992)</Citation><ArticleIdList><ArticleId IdType="pubmed">1423616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossy-Wetzel
        E and Green DR: Apoptosis: checkpoint at the mitochondrial frontier. Mutat
        Res 434, 243&#x2013;251 (1999)</Citation><ArticleIdList><ArticleId IdType="pubmed">10486595</ArticleId></ArticleIdList></Reference><Reference><Citation>Budihardjo
        I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation
        during apoptosis. Annu Rev Cell Dev Biol 15, 269&#x2013;290 (1999)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10611963</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi
        F: Apaf1 and the apoptotic machinery. Cell Death Differ 6, 1087&#x2013;1098
        (1999)</Citation><ArticleIdList><ArticleId IdType="pubmed">10578178</ArticleId></ArticleIdList></Reference><Reference><Citation>Clohessy
        JG, Zhuang J, de Boer J, Gil-G&#xf3;mez G and Brady HJ: Mcl-1 interacts with
        truncated Bid and inhibits its induction of cytochrome c release and its role
        in receptor-mediated apoptosis. J Biol Chem 281, 5750&#x2013;5759 (2006)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16380381</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds
        JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A and Craig RW: Mcl-1, a
        member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression
        in Chinese hamster ovary cells. Cancer Res 54, 6348&#x2013;6352 (1994)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7987827</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou
        P, Qian L, Kozopas KM and Craig RW: Mcl-1, a Bcl-2 family member, delays the
        death of hematopoietic cells under a variety of apoptosis-inducing conditions.
        Blood 89, 630&#x2013;643 (1997)</Citation><ArticleIdList><ArticleId IdType="pubmed">9002967</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao
        S, Anderson SP, Swanson C, Bahnemann R, Voss KA, Stauber AJ and Corton JC:
        Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis
        in the mouse liver. Toxicol Sci 92, 368&#x2013;377 (2006)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16687391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattler
        M and Salgia R: c-Met and hepatocyte growth factor: potential as novel targets
        in cancer therapy. Curr Oncol Rep 9, 102&#x2013;108 (2007)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17288874</ArticleId></ArticleIdList></Reference><Reference><Citation>Frith
        CH and Wiley L: Spontaneous hepatocellular neoplasms and hepatic hemangiosarcomas
        in several strains of mice. Lab Anim Sci 32, 157&#x2013;162 (1982)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6281574</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura
        K, Kuramoto K, Shibasaki K, Shumiya S and Ohtsubo K: Age-related incidence
        of spontaneous tumors in SPF C57BL/6 and BDF1 mice. Jikken Dobutsu 41, 279&#x2013;285
        (1992) (in Japanese)</Citation><ArticleIdList><ArticleId IdType="pubmed">1324182</ArticleId></ArticleIdList></Reference><Reference><Citation>Howroyd
        P, Swanson C, Dunn C, Cattley RC and Corton JC: Decreased longevity and enhancement
        of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated
        receptor alpha (PPARalpha). Toxicol Pathol 32, 591&#x2013;599 (2004)</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15603543</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1979936</PMID><DateCompleted><Year>1991</Year><Month>02</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>1990</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Di(2-ethylhexyl)phthalate
        alters carbohydrate enzyme activities and foci incidence in rat liver.</ArticleTitle><Pagination><StartPage>2111</StartPage><EndPage>2115</EndPage><MedlinePgn>2111-5</MedlinePgn></Pagination><Abstract><AbstractText>The
        effect of di(2-ethylhexyl)phthalate (DEHP) on diethylnitrosamine (DEN)-initiated
        preneoplastic liver lesions with expression of gamma-glutamyltranspeptidase
        (GGTase) and loss of adenosine triphosphatase (ATPase) as well as alterations
        of hepatic carbohydrate metabolism in male and female Sprague-Dawley rats
        have been investigated. Two treatment schedules have been compared with respect
        to their sensitivity by the histochemical demonstration of preneoplastic islands
        and by the biochemical determination of alterations in enzyme activities of
        liver homogenates and of serum, the last indicating hepatotoxicity. For initiation,
        a single dose of DEN was given, followed by treatment with various doses of
        DEHP given three times weekly by gavage for 7 or 11 consecutive weeks. As
        histochemical enzyme markers, the expression of positive GGTase as well as
        the deficiency in ATPase were used for identification of liver foci. The weanling
        female rats (protocol A) were found to be more sensitive to the carcinogenic
        effect of DEN in view of foci incidence than the mature male rats which underwent
        partial hepatectomy prior to DEN application. The administration of 200 mg
        DEHP/kg body wt increased the incidence of ATPase-deficient foci in both male
        and female rats; however, concentrations of 1000 and 2000 mg DEHP/kg decreased
        the incidence of liver foci. The number of foci with expression of GGTase
        was only slightly increased in female rats following a DEHP concentration
        of 50 mg/kg, and 200 mg/kg body wt. DEHP alone did not induce preneoplastic
        lesions that could be identified by these two markers. Biochemical investigations
        indicate that DEHP alters the metabolic pattern in liver. An increase of the
        NADP-linked enzymes glucose-6-phosphate dehydrogenase (G6PDH), malic enzyme,
        extra-mitochondrial ICDH as well as an enhancement of NAD-dependent alpha-G3PDH
        and lactate dehydrogenase were found following DEHP administration. On the
        other hand the glycolytic enzymes pyruvate kinase (PK) and enolase as well
        as the gluconeogenetic enzyme fructose-1,6-bisphosphatase (FBPase) were significantly
        reduced. In protocol B (male rats) the reactions of PK, FBPase and malic enzyme
        were more altered after DEHP exposure than in protocol A, while the activity
        of G6PDH was more increased in protocol A. Most enzymes being involved in
        the carbohydrate metabolism are influenced by DEHP in a dose-dependent manner.
        There was no increase in serum FBPase activity in both male and female rats
        after DEHP treatment but a reduction of glutamate-oxalate-transaminase and
        glutamate-pyruvate-transaminase activities was observed.(ABSTRACT TRUNCATED
        AT 400 WORDS)</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Gerbracht</LastName><ForeName>U</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute
        of Veterinary Biochemistry, University of Geissen, FRG.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Einig</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Oesterle</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Deml</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Schlatterer</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Eigenbrodt</LastName><ForeName>E</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.-</RegistryNumber><NameOfSubstance UI="D005993">Glycerolphosphate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.27</RegistryNumber><NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.37</RegistryNumber><NameOfSubstance UI="D008291">Malate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.40</RegistryNumber><NameOfSubstance UI="C031917">malate dehydrogenase
        (oxaloacetate-decarboxylating) (NADP+)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.41</RegistryNumber><NameOfSubstance UI="D007521">Isocitrate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.49</RegistryNumber><NameOfSubstance UI="D005954">Glucosephosphate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.6.1.1</RegistryNumber><NameOfSubstance UI="D001219">Aspartate Aminotransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.6.1.2</RegistryNumber><NameOfSubstance UI="D000410">Alanine Transaminase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.3.1</RegistryNumber><NameOfSubstance UI="D000469">Alkaline Phosphatase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.3.11</RegistryNumber><NameOfSubstance UI="D006597">Fructose-Bisphosphatase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.6.1.-</RegistryNumber><NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000410" MajorTopicYN="N">Alanine Transaminase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000469" MajorTopicYN="N">Alkaline Phosphatase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001219" MajorTopicYN="N">Aspartate Aminotransferases</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D050260" MajorTopicYN="N">Carbohydrate Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006597" MajorTopicYN="N">Fructose-Bisphosphatase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005954" MajorTopicYN="N">Glucosephosphate Dehydrogenase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005993" MajorTopicYN="N">Glycerolphosphate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007521" MajorTopicYN="N">Isocitrate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008291" MajorTopicYN="N">Malate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1979936</ArticleId><ArticleId IdType="doi">10.1093/carcin/11.12.2111</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12802597</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0948-6143</ISSN><JournalIssue
        CitedMedium="Print"><Volume>120</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Histochemistry
        and cell biology</Title><ISOAbbreviation>Histochem Cell Biol</ISOAbbreviation></Journal><ArticleTitle>Effects
        of the plasticiser DEHP on lung of newborn rats: catalase immunocytochemistry
        and morphometric analysis.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>49</EndPage><MedlinePgn>41-9</MedlinePgn></Pagination><Abstract><AbstractText>Experimental
        administration of di-(2-ethylexyl)-phthalate (DEHP), a plasticiser employed
        in the fabrication of polyvinyl chloride (PVC), causes increases in lipid
        metabolising enzymes along with marked peroxisomal proliferation. The effects
        are found in several mammalian tissues, of which the rodent liver is the most
        responsive target. Leakage of DEHP from PVC devices is favoured by high temperature
        and contact with lipid-containing biological fluids. Since preterm babies
        are currently ventilated through endotracheal PVC tubes, it seemed worthwhile
        to investigate DEHP effects on immature mammalian lung. In this research,
        female rats were fed with DEHP in the last week of pregnancy and after delivery,
        and lungs were excised from 2-day-old pups. At this age, in fact, rat lung
        histological features closely resemble those found in 24- to 36-week-old human
        fetuses. In treated animals, morphometric analysis of histological parameters
        revealed a dramatic decrease in the number of parenchymal airspaces, together
        with significant increases in their mean size. Moreover, cytochemical detection
        of the peroxisomal marker catalase revealed an increase in the number of type
        II pneumocytes. Our findings closely resemble abnormal histological features
        observed in autoptic lung specimens from children affected with chronic lung
        diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Magliozzi</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Cellular and Developmental Biology, University La Sapienza, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nardacci</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Scarsella</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Di Carlo</LastName><ForeName>Valeria</ForeName><Initials>V</Initials></Author><Author
        ValidYN="Y"><LastName>Stefanini</LastName><ForeName>Stefania</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2003</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Histochem
        Cell Biol</MedlineTA><NlmUniqueID>9506663</NlmUniqueID><ISSNLinking>0948-6143</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000098"
        MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D021041" MajorTopicYN="N">Placental Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="accepted"><Year>2003</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12802597</ArticleId><ArticleId IdType="doi">10.1007/s00418-003-0543-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J
        Histochem Cytochem. 1971 Jun;19(6):339-48</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4104130</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol
        Neonate. 1999 Jun;76 Suppl 1:22-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10393390</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1987 Aug;73:251-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3665868</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Physiol. 1987 Dec;253(6 Pt 1):C835-45</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3425706</ArticleId></ArticleIdList></Reference><Reference><Citation>N
        Engl J Med. 1975 Feb 20;292(8):381-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1110722</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Chem. 1978 May;24(5):741-6</Citation><ArticleIdList><ArticleId IdType="pubmed">647906</ArticleId></ArticleIdList></Reference><Reference><Citation>Early
        Hum Dev. 1986 Feb;13(1):1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">3956418</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Pharm Sci. 1972 Jan;61(1):51-5</Citation><ArticleIdList><ArticleId IdType="pubmed">5058645</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol
        Neonate. 1997;71 Suppl 1:35-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9209748</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Respir Crit Care Med. 1999 Mar;159(3):945-58</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10051278</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Environ Contam Toxicol. 1985 Sep;14(5):605-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4051570</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:57-64</Citation><ArticleIdList><ArticleId IdType="pubmed">7140697</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics.
        1975 Jun;55(6):788-96</Citation><ArticleIdList><ArticleId IdType="pubmed">1094399</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Pathol. 1998 Sep-Oct;26(5):628-35</Citation><ArticleIdList><ArticleId IdType="pubmed">9789949</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta
        Paediatr. 1997 Dec;86(12):1277-82</Citation><ArticleIdList><ArticleId IdType="pubmed">9475300</ArticleId></ArticleIdList></Reference><Reference><Citation>Can
        Med Assoc J. 1970 Mar 28;102(6):595-601</Citation><ArticleIdList><ArticleId
        IdType="pubmed">5265797</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Lipid Res. 1998 Dec;39(12 ):2483-92</Citation><ArticleIdList><ArticleId IdType="pubmed">9831638</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1987 Jan;87(1):81-90</Citation><ArticleIdList><ArticleId IdType="pubmed">3798454</ArticleId></ArticleIdList></Reference><Reference><Citation>Food
        Chem Toxicol. 1992 Nov;30(11):915-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1473784</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinology.
        1997 Sep;138(9):3695-703</Citation><ArticleIdList><ArticleId IdType="pubmed">9275054</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        Rev Respir Dis. 1991 Feb;143(2):391-400</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1990959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell
        Mol Biol (Noisy-le-grand). 1994 Dec;40(8):1063-76</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7873979</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1986 Mar;65:249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">3709449</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Pharmacokinet. 1999 Jun;36(6):439-52</Citation><ArticleIdList><ArticleId IdType="pubmed">10427468</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Pediatr. 1988 Jan;147(1):41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3422189</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1994 Dec 30;205(3):1581-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7811239</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB
        J. 1992 Aug;6(11):2895-904</Citation><ArticleIdList><ArticleId IdType="pubmed">1644255</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biochem. 1978 May;83(5):1361-5</Citation><ArticleIdList><ArticleId IdType="pubmed">659402</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1990 Nov;89:189-93</Citation><ArticleIdList><ArticleId IdType="pubmed">2088746</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr
        Res. 1982 Nov;16(11):969-72</Citation><ArticleIdList><ArticleId IdType="pubmed">7155668</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Physiol. 1997 Mar;272(3 Pt 1):L433-41</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9124600</ArticleId></ArticleIdList></Reference><Reference><Citation>Teratology.
        1997 Nov;56(5):311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9451755</ArticleId></ArticleIdList></Reference><Reference><Citation>Transfusion.
        1985 Sep-Oct;25(5):424-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4049487</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics.
        1996 Jul;98(1):24-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8668407</ArticleId></ArticleIdList></Reference><Reference><Citation>Int
        J Pharm. 1999 Mar 25;180(1):113-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10089298</ArticleId></ArticleIdList></Reference><Reference><Citation>Early
        Hum Dev. 1998 Nov;53(1):81-94</Citation><ArticleIdList><ArticleId IdType="pubmed">10193929</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol
        Cell. 1995;85(2-3):167-76</Citation><ArticleIdList><ArticleId IdType="pubmed">8785518</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Histochem Cytochem. 1972 Mar;20(3):180-91</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4112911</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Physiol. 1997 Dec;273(6 Pt 1):L1249-57</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9435581</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull
        Environ Contam Toxicol. 1992 Apr;48(4):572-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1504503</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1984 Jan;72(1):46-60</Citation><ArticleIdList><ArticleId IdType="pubmed">6710484</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1990 Dec 4;1047(3):264-70</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2174704</ArticleId></ArticleIdList></Reference><Reference><Citation>Transfusion.
        1993 Jul;33(7):598-605</Citation><ArticleIdList><ArticleId IdType="pubmed">8333024</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1980;18(1):49-60</Citation><ArticleIdList><ArticleId IdType="pubmed">7210023</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta
        Paediatr. 1999 Oct;88(10):1174-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10565474</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1999 Dec 1;161(2):209-18</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10581215</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Ind Med. 2001 Jan;39(1):100-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11148020</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1975 Sep;33(3):514-25</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1188948</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochem
        Cell Biol. 2001 Apr;115(4):333-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11405062</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Physiol. 1997 Mar;272(3 Pt 1):L452-60</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9124602</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Pathol. 1998 Mar-Apr;26(2):240-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9547862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum
        Pathol. 1998 Jul;29(7):710-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9670828</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Hosp Pharm. 1993 Jul;50(7):1405-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8362871</ArticleId></ArticleIdList></Reference><Reference><Citation>N
        Engl J Med. 1972 Nov 30;287(22):1114-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">5082191</ArticleId></ArticleIdList></Reference><Reference><Citation>N
        Engl J Med. 1989 Jun 8;320(23):1563</Citation><ArticleIdList><ArticleId IdType="pubmed">2725593</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1995 Jan 20;1254(2):198-206</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7827125</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr
        Res. 1999 Dec;46(6):641-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10590017</ArticleId></ArticleIdList></Reference><Reference><Citation>Virchows
        Arch B Cell Pathol Incl Mol Pathol. 1988;54(4):232-40</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2895534</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol
        Neonate. 2000 Nov;78(4):269-76</Citation><ArticleIdList><ArticleId IdType="pubmed">11093005</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Biochem. 1989 Sep 1;184(1):69-78</Citation><ArticleIdList><ArticleId IdType="pubmed">2776771</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp
        Mol Pathol. 1988 Apr;48(2):262-71</Citation><ArticleIdList><ArticleId IdType="pubmed">3258252</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 2000 Feb 15;60(4):1129-38</Citation><ArticleIdList><ArticleId IdType="pubmed">10706135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6355494</PMID><DateCompleted><Year>1983</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0098-4108</ISSN><JournalIssue
        CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>1983</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health</Title><ISOAbbreviation>J Toxicol Environ
        Health</ISOAbbreviation></Journal><ArticleTitle>The carcinogenicity of di(2-ethylhexyl)
        phthalate (DEHP) in perspective.</ArticleTitle><Pagination><StartPage>159</StartPage><EndPage>169</EndPage><MedlinePgn>159-69</MedlinePgn></Pagination><Abstract><AbstractText>The
        commonly used plasticizer di(2-ethylhexyl) phthalate (DEHP) was recently tested
        for chronic toxic potential by incorporation into the diet of rats and mice
        for approximately 2 yr. Upon reviewing the test results, the sponsoring organization
        concluded that DEHP was carcinogenic to the rats and mice, as indicated by
        increased occurrences of liver tumors in the DEHP-exposed animals in comparison
        to controls. Another group has disagreed with this conclusion, however, citing
        perceived methodological deficiencies and improper interpretations in the
        study, and has also suggested that rodents may not be adequate models of human
        response to DEHP. This communication compares the conduct of the DEHP bioassay
        favorably with state-of-the-art procedures in animal carcinogenicity testing
        and documents approval of the study interpretations by several independent
        peer review groups. The carcinogenic potential of DEHP is placed in perspective
        by evaluating the evidence for DEHP-induced tumors in rodent species in light
        of dose response relationships, other biochemical and toxicological effects
        of DEHP, and its comparative metabolism and disposition in rodent and primate
        species. A composite analysis of the currently available information indicates
        that DEHP has been shown to be carcinogenic to rodents in a valid chronic
        test, indicating that it should be considered as a potential carcinogen in
        humans, as well. Further experimental inquiry will be required, however, to
        accurately assess the potential health risks posed to humans by exposure to
        small amounts of this plasticizer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Kluwe</LastName><ForeName>W M</ForeName><Initials>WM</Initials></Author><Author
        ValidYN="Y"><LastName>Haseman</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author
        ValidYN="Y"><LastName>Huff</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Toxicol Environ Health</MedlineTA><NlmUniqueID>7513622</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008452" MajorTopicYN="N">Maximum Allowable Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008722" MajorTopicYN="N">Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>35</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1983</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1983</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1983</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6355494</ArticleId><ArticleId IdType="doi">10.1080/15287398309530414</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11995694</PMID><DateCompleted><Year>2002</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1528-7394</ISSN><JournalIssue
        CitedMedium="Print"><Volume>65</Volume><Issue>8</Issue><PubDate><Year>2002</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health. Part A</Title><ISOAbbreviation>J Toxicol
        Environ Health A</ISOAbbreviation></Journal><ArticleTitle>Comparative effects
        of phthalate monoesters on gap junctional intercellular communication and
        peroxisome proliferation in rodent and primate hepatocytes.</ArticleTitle><Pagination><StartPage>569</StartPage><EndPage>588</EndPage><MedlinePgn>569-88</MedlinePgn></Pagination><Abstract><AbstractText>Several
        phthalate esters, compounds used as plasticizers in a variety of commercial
        products, have been shown to induce hepatic tumors in rodents. In this study,
        the comparative effects of phthalate monoesters on inhibition of gap junctional
        intercellular communication and induction of peroxisomal beta-oxidation were
        assessed in primary cultured hepatocytes from rats, mice, hamsters, cynomolgus
        monkeys, and humans. A human liver cell line was also utilized. Eight monoesters
        examined included mono-2-ethylhexyl phthalate (MEHP), mono-n-octyl phthalate
        (MNOP), mono-isononyl phthalate (MINP, 3 types, -1, -2, and -3), mono-isoheptyl
        phthalate (MIHP), mono-isodecyl phthalate (MIDP), and mono-(heptyl, nonyl,
        undecyl) phthalate (M711P). Gap junctional intercellular communication was
        measured 4 and 24 h after treatment by lucifer yellow dye coupling. Gap junctional
        intercellular communication was inhibited in rat and mouse hepatocytes by
        all eight monoesters in a concentration-dependent manner. In most cases, gap
        junctional intercellular communication was significantly reduced at the lowest
        concentrations tested (50 pM). Inhibition of gap junctional intercellular
        communication in rodent cells was substantially reversed within 24 h of monoester
        removal. In contrast, cell-to-cell communication was not inhibited in hamster,
        cynomolgus, or human hepatocytes or in a human liver cell line at any concentration
        examined. In rat hepatocytes, peroxisomal beta-oxidation was elevated after
        treatment with MEHP, MINP, MIHP, and MIDP but not MNOP or M711P, and with
        all but MIHP in mouse hepatocytes. The eight phthalates produced no marked
        change on peroxisomal beta-oxidation in hepatocytes from other species. These
        data provide additional evidence that the toxicological effects of phthalate
        esters are species specific.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Kamendulis</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department
        of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis
        46202-5120, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isenberg</LastName><ForeName>Jason
        S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Jacqueline
        H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Pugh</LastName><ForeName>George</ForeName><Initials>G</Initials><Suffix>Jr</Suffix></Author><Author
        ValidYN="Y"><LastName>Lington</LastName><ForeName>Arthur W</ForeName><Initials>AW</Initials></Author><Author
        ValidYN="Y"><LastName>Klaunig</LastName><ForeName>James E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Toxicol Environ Health A</MedlineTA><NlmUniqueID>100960995</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004952">Esters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>57716-89-9</RegistryNumber><NameOfSubstance
        UI="C020922">4-O-methyl-12-O-tetradecanoylphorbol 13-acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>NI40JAQ945</RegistryNumber><NameOfSubstance
        UI="D013755">Tetradecanoylphorbol Acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004952" MajorTopicYN="N">Esters</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017629" MajorTopicYN="N">Gap Junctions</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013755" MajorTopicYN="N">Tetradecanoylphorbol Acetate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>5</Month><Day>9</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>5</Month><Day>25</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>5</Month><Day>9</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11995694</ArticleId><ArticleId IdType="doi">10.1080/152873902317349736</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1632818</PMID><DateCompleted><Year>1992</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>23</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-2952</ISSN><JournalIssue
        CitedMedium="Print"><Volume>43</Volume><Issue>12</Issue><PubDate><Year>1992</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Biochemical
        pharmacology</Title><ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Microsomal
        lauric acid hydroxylase activities after treatment of rats with three classical
        cytochrome P450 inducers and peroxisome proliferating compounds.</ArticleTitle><Pagination><StartPage>2621</StartPage><EndPage>2629</EndPage><MedlinePgn>2621-9</MedlinePgn></Pagination><Abstract><AbstractText>In
        order to investigate a proposed relationship between induction of hepatic
        microsomal lauric acid hydroxylase activity and peroxisome proliferation in
        the liver, male Wistar rats were treated with peroxisome proliferating compounds,
        and the lauric acid hydroxylase activity, the immunochemical detectable levels
        of cytochrome P450 4A1 and the activities of peroxisomal enzymes were determined.
        In addition, the levels of cytochrome P450 4A1 and lauric acid hydroxylase
        activities were studied after treatment of rats with three cytochrome P450
        inducers. After treatment with aroclor-1254, phenobarbital or 3-methylcholanthrene
        total cytochrome P450 was 1.7-2.7 times induced. However, no induction of
        lauric acid omega-hydroxylase activities or P450 4A1 levels were found. After
        treatment of rats with di(2-ethylhexyl)phthalate (DEHP) a dose-dependent induction
        of lauric acid omega-hydroxylase activities, levels of cytochrome P450 4A1
        and peroxisomal fatty acid beta-oxidation was found. Even at a dose-level
        of 100 mg DEPH/kg body weight per day a significant induction of these activities
        was observed. The main metabolites of DEHP, mono(2-ethylhexyl)phthalate and
        2-ethyl-1-hexanol, also caused an induction of levels of P450 4A1, lauric
        acid omega-hydroxylase activities and the activity of peroxisomal palmitoyl-CoA
        oxidase. 2-Ethyl-1-hexanoic acid did not influence lauric acid omega-hydroxylase
        activities, but did induce levels of P450 4A1 and palmitoyl-CoA oxidase activities.
        Three other compounds (perfluoro-octanoic acid, valproate and nafenopin) induced
        both lauric acid omega-hydroxylase activity and peroxisomal palmitoyl-CoA
        oxidase activity. The plasticizer, di(2-ethylhexyl)adipate, did not induce
        levels of P450 4A1, lauric acid omega-hydroxylase activities or palmitoyl-CoA
        oxidase activities. With the compounds tested a close association between
        the induction of lauric acid omega-hydroxylase activities and peroxisomal
        palmitoyl-CoA oxidase activity was found. These data support the theory that
        peroxisome proliferating compounds do induce lauric acid omega-hydroxylase
        activities and that there might be a mechanistic inter-relationship between
        peroxisome proliferation and induction of lauric acid omega-hydroxylase activities.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Dirven</LastName><ForeName>H
        A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department
        of Toxicology, University of Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>van den Broek</LastName><ForeName>P H</ForeName><Initials>PH</Initials></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Noordhoek</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Jongeneelen</LastName><ForeName>F J</ForeName><Initials>FJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem
        Pharmacol</MedlineTA><NlmUniqueID>0101032</NlmUniqueID><ISSNLinking>0006-2952</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001140">Aroclors</NameOfSubstance></Chemical><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>11097-69-1</RegistryNumber><NameOfSubstance
        UI="D020111">Chlorodiphenyl (54% Chlorine)</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical><Chemical><RegistryNumber>56-49-5</RegistryNumber><NameOfSubstance
        UI="D008748">Methylcholanthrene</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D006899">Mixed Function Oxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.15.3</RegistryNumber><NameOfSubstance UI="D042926">Cytochrome P-450 CYP4A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.-</RegistryNumber><NameOfSubstance UI="C028427">palmitoyl CoA oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001140" MajorTopicYN="N">Aroclors</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020111" MajorTopicYN="N">Chlorodiphenyl (54% Chlorine)</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D042926" MajorTopicYN="N">Cytochrome P-450 CYP4A</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008748" MajorTopicYN="N">Methylcholanthrene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006899" MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1632818</ArticleId><ArticleId IdType="doi">10.1016/0006-2952(92)90151-8</ArticleId><ArticleId
        IdType="pii">0006-2952(92)90151-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3180084</PMID><DateCompleted><Year>1988</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0008-5472</ISSN><JournalIssue
        CitedMedium="Print"><Volume>48</Volume><Issue>23</Issue><PubDate><Year>1988</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Cancer
        research</Title><ISOAbbreviation>Cancer Res</ISOAbbreviation></Journal><ArticleTitle>Relationship
        of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity
        of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic
        acid (Wy-14,643) in rats.</ArticleTitle><Pagination><StartPage>6739</StartPage><EndPage>6744</EndPage><MedlinePgn>6739-44</MedlinePgn></Pagination><Abstract><AbstractText>The
        mechanism of hepatocarcinogenesis caused by peroxisome proliferators (PP)
        is poorly understood, making it difficult to predict the carcinogenicity of
        PP to rodents or other species. It has been suggested that the carcinogenic
        potential of individual PP in rodents is correlated with the degree of PP-induced
        hepatic peroxisome proliferation. To evaluate this possible correlation, di(2-ethylhexyl)phthalate
        (DEHP) at 1.2% and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid
        (Wy-14,643) at 0.1% were fed to male F-344 rats for up to 365 days and hepatocytic
        peroxisome proliferation and DNA replication were measured. All rats fed Wy-14,643
        for 365 days had numerous grossly visible nodules in comparison to none in
        the livers of DEHP-fed or control rats. Despite this difference in the induction
        of tumors, both DEHP and Wy-14,643 increased the peroxisomal volume density
        4- to 6-fold from 8 to 365 days of treatment. Peroxisomal beta-oxidation enzyme
        activities were increased 8-fold by both DEHP and Wy-14,643 after 18 days.
        At later time points (77 to 365 days), these enzyme activities were about
        25% higher in livers of Wy-14,643- than DEHP-fed rats. DEHP or Wy-14,643 increased
        absolute liver weights 50 to 75% above controls after 18 to 365 days of feeding.
        Labeling of hepatocyte nuclei with a single injection of tritiated thymidine
        revealed a rapid burst in replicative DNA synthesis in both DEHP and Wy-14,643-fed
        rats, with a return to control levels by 4 days. Additional rats were implanted
        with 7-day osmotic pumps containing tritiated thymidine. With this more extended
        method of labeling a 5- to 10-fold increase in replicative DNA synthesis was
        observed in rats receiving Wy-14,643 for 39 to 365 days as compared to DEHP-fed
        rats or controls. In conclusion, when performed under conditions similar to
        the tumorigenicity studies, the degree of peroxisome proliferation correlated
        poorly with the relative hepatocarcinogenicity of DEHP and Wy-14,643. However,
        a strong correlation was observed between the relative hepatocarcinogenicity
        of DEHP and Wy-14,643 and the ability to induce a persistent increase in replicative
        DNA synthesis. These data emphasize the possible importance of cell replication
        in the mechanism of PP-induced hepatocarcinogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Marsman</LastName><ForeName>D
        S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author
        ValidYN="Y"><LastName>Conway</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 07945</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Cancer Res</MedlineTA><NlmUniqueID>2984705R</NlmUniqueID><ISSNLinking>0008-5472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3180084</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">14727734</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1040-8444</ISSN><JournalIssue
        CitedMedium="Print"><Volume>33</Volume><Issue>6</Issue><PubDate><Year>2003</Year></PubDate></JournalIssue><Title>Critical
        reviews in toxicology</Title><ISOAbbreviation>Crit Rev Toxicol</ISOAbbreviation></Journal><ArticleTitle>PPARalpha
        agonist-induced rodent tumors: modes of action and human relevance.</ArticleTitle><Pagination><StartPage>655</StartPage><EndPage>780</EndPage><MedlinePgn>655-780</MedlinePgn></Pagination><Abstract><AbstractText>Widely
        varied chemicals--including certain herbicides, plasticizers, drugs, and natural
        products--induce peroxisome proliferation in rodent liver and other tissues.
        This phenomenon is characterized by increases in the volume density and fatty
        acid oxidation of these organelles, which contain hydrogen peroxide and fatty
        acid oxidation systems important in lipid metabolism. Research showing that
        some peroxisome proliferating chemicals are nongenotoxic animal carcinogens
        stimulated interest in developing mode of action (MOA) information to understand
        and explain the human relevance of animal tumors associated with these chemicals.
        Studies have demonstrated that a nuclear hormone receptor implicated in energy
        homeostasis, designated peroxisome proliferator-activated receptor alpha (PPARalpha),
        is an obligatory factor in peroxisome proliferation in rodent hepatocytes.
        This report provides an in-depth analysis of the state of the science on several
        topics critical to evaluating the relationship between the MOA for PPARalpha
        agonists and the human relevance of related animal tumors. Topics include
        a review of existing tumor bioassay data, data from animal and human sources
        relating to the MOA for PPARalpha agonists in several different tissues, and
        case studies on the potential human relevance of the animal MOA data. The
        summary of existing bioassay data discloses substantial species differences
        in response to peroxisome proliferators in vivo, with rodents more responsive
        than primates. Among the rat and mouse strains tested, both males and females
        develop tumors in response to exposure to a wide range of chemicals including
        DEHP and other phthalates, chlorinated paraffins, chlorinated solvents such
        as trichloroethylene and perchloroethylene, and certain pesticides and hypolipidemic
        pharmaceuticals. MOA data from three different rodent tissues--rat and mouse
        liver, rat pancreas, and rat testis--lead to several different postulated
        MOAs, some beginning with PPARalpha activation as a causal first step. For
        example, studies in rodent liver identified seven "key events," including
        three "causal events"--activation of PPARalpha, perturbation of cell proliferation
        and apoptosis, and selective clonal expansion--and a series of associative
        events involving peroxisome proliferation, hepatocyte oxidative stress, and
        Kupffer-cell-mediated events. Similar in-depth analysis for rat Leydig-cell
        tumors (LCTs) posits one MOA that begins with PPARalpha activation in the
        liver, but two possible pathways, one secondary to liver induction and the
        other direct inhibition of testicular testosterone biosynthesis. For this
        tumor, both proposed pathways involve changes in the metabolism and quantity
        of related hormones and hormone precursors. Key events in the postulated MOA
        for the third tumor type, pancreatic acinar-cell tumors (PACTs) in rats, also
        begin with PPARalpha activation in the liver, followed by changes in bile
        synthesis and composition. Using the new human relevance framework (HRF) (see
        companion article), case studies involving PPARalpha-related tumors in each
        of these three tissues produced a range of outcomes, depending partly on the
        quality and quantity of MOA data available from laboratory animals and related
        information from human data sources.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Klaunig</LastName><ForeName>James
        E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Indiana University
        School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Babich</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials></Author><Author
        ValidYN="Y"><LastName>Baetcke</LastName><ForeName>Karl P</ForeName><Initials>KP</Initials></Author><Author
        ValidYN="Y"><LastName>Cook</LastName><ForeName>Jon C</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>Corton</LastName><ForeName>J Chris</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>David</LastName><ForeName>Raymond M</ForeName><Initials>RM</Initials></Author><Author
        ValidYN="Y"><LastName>DeLuca</LastName><ForeName>John G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Lai</LastName><ForeName>David Y</ForeName><Initials>DY</Initials></Author><Author
        ValidYN="Y"><LastName>McKee</LastName><ForeName>Richard H</ForeName><Initials>RH</Initials></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>Ruth A</ForeName><Initials>RA</Initials></Author><Author
        ValidYN="Y"><LastName>Fenner-Crisp</LastName><ForeName>Penelope A</ForeName><Initials>PA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit
        Rev Toxicol</MedlineTA><NlmUniqueID>8914275</NlmUniqueID><ISSNLinking>1040-8444</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012097">Repressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001681" MajorTopicYN="N">Biological Assay</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002471" MajorTopicYN="Y">Cell Transformation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007984" MajorTopicYN="N">Leydig Cell Tumor</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011323" MajorTopicYN="N">Primates</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012097" MajorTopicYN="N">Repressor Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013736" MajorTopicYN="N">Testicular Neoplasms</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016335" MajorTopicYN="N">Zinc Fingers</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>562</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">14727734</ArticleId><ArticleId IdType="doi">10.1080/713608372</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1610294</PMID><DateCompleted><Year>1992</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>02</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0340-5761</ISSN><JournalIssue
        CitedMedium="Print"><Volume>66</Volume><Issue>5</Issue><PubDate><Year>1992</Year></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Peroxisome
        proliferation due to di (2-ethylhexyl) adipate, 2-ethylhexanol and 2-ethylhexanoic
        acid.</ArticleTitle><Pagination><StartPage>321</StartPage><EndPage>326</EndPage><MedlinePgn>321-6</MedlinePgn></Pagination><Abstract><AbstractText>The
        dose-response relationships for peroxisome proliferation due to Di (2-ethylhexyl)
        adipate (DEHA), 2-ethylhexanol (EH), 2-ethylhexanoic acid (EHA) have been
        investigated in rats and mice. Linear dose-response relationships were observed
        for induction of cyanide-insensitive palmitoyl CoA oxidation (PCO), used as
        a enzyme marker of peroxisome proliferation, by DEHA, EH and EHA in both species.
        Relative liver weights were also increased in a dose related manner. On a
        molar basis, DEHA was twice as potent as EH or EHA which were equipotent and
        PCO was stimulated to a greater extent in male mice than in rats or female
        mice. At doses above 8 mmol/kg/day, EH was toxic to rats (both sexes) and
        similarly EHA at 13.5 mmol/kg/day lead to the death of female rats. In a attempt
        to explain the species difference in carcinogenicity of DEHA previously reported,
        we also used Fischer 344 rats and B6C3F1 mice. DEHA administration (2.5 g/kg/day)
        to Fischer 344 rats and B6C3F1 mice lead to toxicity in female rats. Relative
        liver weights were increased in a dose related fashion by DEHA administration
        to both rats and mice, PCO but not catalase was markedly increased (up to
        15 fold in male rats). Light microscopy examination indicated some glycogen
        loss, a dose related hypertrophy and increased eosinophilia in both rats and
        mice. Electron microscopy confirmed peroxisome proliferation accompanied by
        a marked reduction of lipid in the centrilobular hepatocytes. These data suggest
        EHA to be the proximate peroxisome proliferator derived from DEHA.(ABSTRACT
        TRUNCATED AT 250 WORDS)</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Keith</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>D&#xe9;partement
        de Biochimie et Toxicologie Alimentaires, ENS.BANA, Dijon, France.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cornu</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author><Author
        ValidYN="Y"><LastName>Canning</LastName><ForeName>P M</ForeName><Initials>PM</Initials></Author><Author
        ValidYN="Y"><LastName>Foster</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Lhuguenot</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>Elcombe</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002208">Caproates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>01MU2J7VVZ</RegistryNumber><NameOfSubstance
        UI="C040668">2-ethylhexanoic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002208" MajorTopicYN="N">Caproates</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1610294</ArticleId><ArticleId IdType="doi">10.1007/BF01973626</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carcinogenesis.
        1986 May;7(5):795-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3009047</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1984 May;73(3):373-87</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6719458</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:99-101</Citation><ArticleIdList><ArticleId IdType="pubmed">6754365</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1981;22(3):223-33</Citation><ArticleIdList><ArticleId IdType="pubmed">7340012</ArticleId></ArticleIdList></Reference><Reference><Citation>Natl
        Toxicol Program Tech Rep Ser. 1982 Mar;212:1-121</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12778223</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1988 Dec 1;48(23):6739-44</Citation><ArticleIdList><ArticleId IdType="pubmed">3180084</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1978 Aug;45(2):497-504</Citation><ArticleIdList><ArticleId
        IdType="pubmed">705785</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit
        Rev Toxicol. 1983;12(1):1-58</Citation><ArticleIdList><ArticleId IdType="pubmed">6360536</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1979 Jun 13;88(3):1030-6</Citation><ArticleIdList><ArticleId
        IdType="pubmed">465070</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:111-4</Citation><ArticleIdList><ArticleId IdType="pubmed">6754360</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1988 Sep;9(9):1647-55</Citation><ArticleIdList><ArticleId IdType="pubmed">3409467</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1952 Mar;195(1):133-40</Citation><ArticleIdList><ArticleId IdType="pubmed">14938361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1980 Jan 24;283(5745):397-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6766207</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1985 Mar 15;34(3):247-59</Citation><ArticleIdList><ArticleId IdType="pubmed">3883574</ArticleId></ArticleIdList></Reference><Reference><Citation>Xenobiotica.
        1975 Oct;5(10):625-36</Citation><ArticleIdList><ArticleId IdType="pubmed">1189459</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Pharmacol. 1992 May 28;43(10):2129-34</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1599500</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1951 Nov;193(1):265-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14907713</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1985 Aug;80(1):23-32</Citation><ArticleIdList><ArticleId IdType="pubmed">4024105</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">27040317</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>20</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1708</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>61</Volume><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Reproductive
        toxicology (Elmsford, N.Y.)</Title><ISOAbbreviation>Reprod Toxicol</ISOAbbreviation></Journal><ArticleTitle>Repeated
        exposures of the male Sprague Dawley rat reproductive tract to environmental
        toxicants: Do earlier exposures to di-(2-ethylhexyl)phthalate (DEHP) alter
        the effects of later exposures?</ArticleTitle><Pagination><StartPage>136</StartPage><EndPage>141</EndPage><MedlinePgn>136-41</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.reprotox.2016.03.046</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0890-6238(16)30047-8</ELocationID><Abstract><AbstractText>Although
        exposures to environmental toxicants occur throughout life, little attention
        has been paid to the possible effects of exposures early in life on later
        exposure effects. We asked whether DEHP administered in utero (GD14-parturition)
        affects how male rats respond to later exposures. Neither in utero nor juvenile
        (PND21-35) exposures to 100mg/kg/day DEHP affected testis weight or histology
        as assessed on PND35. However, after in utero DEHP, subsequent juvenile exposure
        resulted in significantly reduced testis weight and altered testicular histology.
        Both in utero and juvenile exposures resulted in significant reductions in
        serum testosterone, but there was no effect of earlier on later exposure.
        Whether or not there had been in utero DEHP exposure, juvenile DEHP exposure
        had no effect on body, kidney or liver weights. These observations indicate
        that in utero exposure can, but will not necessarily, alter later exposure
        effects, with outcomes dependent upon endpoints measured and dose.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Traore</LastName><ForeName>Kassim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department
        of Chemistry, Elizabeth City State University, Elizabeth City, NC 27909, United
        States. Electronic address: ktraore@campbell.edu.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Martinez-Arguelles</LastName><ForeName>Daniel B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Research
        Institute of the McGill University, Health Centre and Departments of Medicine,
        Biochemistry, Pharmacology &amp; Therapeutics, McGill University, Montreal,
        Quebec H3G 1A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadopoulos</LastName><ForeName>Vassilios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research
        Institute of the McGill University, Health Centre and Departments of Medicine,
        Biochemistry, Pharmacology &amp; Therapeutics, McGill University, Montreal,
        Quebec H3G 1A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Haolin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public
        Health, Baltimore, MD 21205, United States.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zirkin</LastName><ForeName>Barry R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public
        Health, Baltimore, MD 21205, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>R01 AG021092</GrantID><Acronym>AG</Acronym><Agency>NIA
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>SC2
        GM099578</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>R37 AG021092</GrantID><Acronym>AG</Acronym><Agency>NIA
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MOP-111131</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research
        Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Reprod Toxicol</MedlineTA><NlmUniqueID>8803591</NlmUniqueID><ISSNLinking>0890-6238</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D052244">Endocrine Disruptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance
        UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D052244" MajorTopicYN="N">Endocrine Disruptors</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="Y">Prenatal Exposure Delayed Effects</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Di-(2-ethylhexyl)phthalate (DEHP)</Keyword><Keyword
        MajorTopicYN="N">Endocrine disruptors</Keyword><Keyword MajorTopicYN="N">Environmental
        toxicants</Keyword><Keyword MajorTopicYN="N">Leydig cells</Keyword><Keyword
        MajorTopicYN="N">Testosterone</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2015</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2016</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">27040317</ArticleId><ArticleId IdType="doi">10.1016/j.reprotox.2016.03.046</ArticleId><ArticleId
        IdType="pii">S0890-6238(16)30047-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15588926</PMID><DateCompleted><Year>2005</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>206</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Lifelong
        exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes
        of Sprague-Dawley rats.</ArticleTitle><Pagination><StartPage>359</StartPage><EndPage>371</EndPage><MedlinePgn>359-71</MedlinePgn></Pagination><Abstract><AbstractText>The
        plasticizer di-(2-ethylhexyl)-phthalate (DEHP) is the most important phthalate
        with respect to its production, use and occurrence in the environment. In
        standard carcinogenicity experiments with F344 rats and B6C3F1 mice, DEHP
        has been shown to induce hepatocellular tumors. Moreover, DEHP is strongly
        suspected to be a developmental and reproductive toxicant. The present study
        aimed at determining the long-term toxic effects of lifetime exposure to low
        concentrations of DEHP in Sprague-Dawley rat strain. Seven hundred and thirty
        male rats, stratified into four groups, received DEHP with the diet, resulting
        in dosages of 300, 95, 30 and 0 mg/kg per day for up to 159 weeks and were
        only sacrificed when moribund. All organs of the dead and sacrificed animals
        were histopathologically examined. Significantly increased tumor incidences
        after exposure to 300 mg/kg per day DEHP (P = 0.04 for testes and 0.05 for
        liver) and a significant dose-related trend (P(Trend) = 0.02 for testes and
        0.03 for liver) were detected in both organs liver and testes. Time to tumor
        analysis revealed that DEHP-induced testicular tumors developed earlier in
        lifetime than hepatocellular neoplasias, and their multiplicity increased
        with time. In addition, animals exposed to the highest DEHP dose showed a
        significantly increased rate of testicular tubular atrophy (P &lt; 0.01).
        In conclusion, this study shows for the first time that the rat testes are
        a target organ of DEHP carcinogenicity in Sprague-Dawley rats upon lifetime
        exposure. This new finding indicates the importance of evaluating the effects
        of lifetime exposure in assessing the potential human health risks of DEHP.
        In addition, the carcinogenicity should be evaluated in rat strains with low
        spontaneous tumor incidence in the organs known as target of DEHP toxicity.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit
        of Toxicology and Chemotherapy, Deutsches Krebsforschungszentrum Heidelberg,
        Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zerban</LastName><ForeName>Heide</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Bannasch</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Berger</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006651" MajorTopicYN="N">Histocytochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007984" MajorTopicYN="N">Leydig Cell Tumor</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013047" MajorTopicYN="N">Specific Pathogen-Free Organisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013736" MajorTopicYN="N">Testicular Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2004</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2004</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2004</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2004</Year><Month>12</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2005</Year><Month>2</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2004</Year><Month>12</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15588926</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2004.07.016</ArticleId><ArticleId
        IdType="pii">S0300-483X(04)00419-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11246142</PMID><DateCompleted><Year>2001</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>160</Volume><Issue>1-3</Issue><PubDate><Year>2001</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Weight-of-evidence
        versus strength-of-evidence in toxicologic hazard identification: Di(2-ethylhexyl)phthalate
        (DEHP).</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>226</EndPage><MedlinePgn>219-26</MedlinePgn></Pagination><Abstract><AbstractText>Toxicokinetic
        and mode of action data for DEHP reduce the concern for its potential carcinogenic
        hazard to human health. Chronic, high dose ingestion of DEHP and related peroxisome
        proliferators (PP) by mice and rats precipitate the following: activation
        of peroxisome proliferator activated receptor (PPARalpha) and its binding
        to peroxisome proliferator response elements (PPREs) within promoters of PP-responsive
        genes, peroxisome proliferation, increased microsomal fatty acid oxidation,
        increased hepatic hydrogen peroxide, hepatomegaly, hyperplasia and subsequent
        neoplasia. Neither peroxisome proliferation nor increased liver cancer occur
        in patients treated with pharmacologic doses of PP. Species differences in
        endogenous PPARalpha expression and differential activity of the peroxisome
        proliferator response element (PPRE) contribute to the failure of humans to
        respond in a manner qualitatively similar to that of rats or mice. Where it
        can be demonstrated that a mechanism for rodent tumor formation has no relevance
        for humans, then a substance which elicits a carcinogenic response in the
        test species via that mechanism should not be classified as anything other
        than an animal carcinogen. Systemic noncarcinogenic endpoints are available
        for definition of a DEHP reference dose. Considerable difficulty is encountered
        in the revision of promulgated regulations and in public risk communication
        when a material is no longer considered a carcinogenic hazard to humans.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Willhite</LastName><ForeName>C
        C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department
        of Toxic Substances Control, State of California, 700 Heinz Street, Suite
        200, Berkeley, CA 94710, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000145"
        MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011640" MajorTopicYN="N">Public Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName
        UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName><QualifierName
        UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014484" MajorTopicYN="N">United States Environmental Protection Agency</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>67</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>3</Month><Day>14</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>4</Month><Day>17</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>3</Month><Day>14</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11246142</ArticleId><ArticleId IdType="doi">10.1016/s0300-483x(00)00451-0</ArticleId><ArticleId
        IdType="pii">S0300483X00004510</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3574334</PMID><DateCompleted><Year>1987</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>02</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0027-5107</ISSN><JournalIssue
        CitedMedium="Print"><Volume>188</Volume><Issue>1</Issue><PubDate><Year>1987</Year><Month>May</Month></PubDate></JournalIssue><Title>Mutation
        research</Title><ISOAbbreviation>Mutat Res</ISOAbbreviation></Journal><ArticleTitle>Correlation
        of the carcinogenic potential of di(2-ethylhexyl)phthalate (DEHP) with induced
        hyperplasia rather than with genotoxic activity.</ArticleTitle><Pagination><StartPage>21</StartPage><EndPage>28</EndPage><MedlinePgn>21-8</MedlinePgn></Pagination><Abstract><AbstractText>It
        has been reported that in a long-term feeding study 12,000 ppm of di(2-ethylhexyl)phthalate
        (DEHP) in the diet produced hepatocellular carcinomas in male and female F-344
        rats while 6000 ppm DEHP produced the same tumor type in male and female B6C3F1
        mice. In terms of the actual numbers of animals with tumors DEHP produced
        a greater response in mice than rats. DEHP and its principal hydrolysis product,
        mono(2-ethylhexyl)phtalate (MEHP) produce multiple effects in the animal such
        as liver peroxisomal proliferation and hyperplasia. Accordingly, genotoxicity
        as DNA repair or unscheduled DNA synthesis (UDS) and cell replication as the
        percentage of cells undergoing scheduled DNA synthesis (SDS or S phase) were
        determined in mouse hepatocytes in vitro and in vivo in response to DEHP and
        MEHP. UDS and SDS were determined by autoradiographic quantitation of [3H]-thymidine
        incorporation in primary hepatocyte cultures treated directly or isolated
        from B6C3F1 male mice treated in vivo. No DNA repair was observed in mouse
        hepatocyte cultures treated with up to 1.0 mM DEHP or 0.5 mM MEHP. No DNA
        repair was observed in cultures from mice treated with up to 500 mg/kg DEHP
        12, 24 or 48 h previously or from animals treated up to 28 days with 6000
        ppm DEHP in the diet. At 24 h following treatment with 500 mg/kg DEHP, 3.1%
        of the hepatocytes were in S phase compared to control values of 0.2%. Administration
        of DEHP in the diet at 6000 ppm produced 9.2% of the cells in S phase at day
        7 with the value returning to control levels by day 14. On day 28 of the feeding
        study the liver to body weight ratios had almost doubled in the group treated
        with DEHP compared to controls. No increase in the liver-specific enzyme alanine
        aminotransferase was seen in the serum following treatment with 500 mg/kg
        DEHP, indicating that the hyperplasia was due to mitogenic stimulation rather
        than regenerative hyperplasia in response to cytotoxicity. Increases in the
        endpoints relating to hyperplasia in response to DEHP were greater in the
        mouse than those that have been reported in the rat. Thus, the carcinogenic
        response of DEHP correlates better with induced hyperplasia rather than with
        genotoxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Smith-Oliver</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Butterworth</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat
        Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.6.1.2</RegistryNumber><NameOfSubstance UI="D000410">Alanine Transaminase</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000410" MajorTopicYN="N">Alanine Transaminase</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D056486" MajorTopicYN="Y">Chemical and Drug Induced Liver Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008115" MajorTopicYN="N">Liver Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009152" MajorTopicYN="N">Mutagenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3574334</ArticleId><ArticleId IdType="doi">10.1016/0165-1218(87)90110-8</ArticleId><ArticleId
        IdType="pii">0165-1218(87)90110-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">24769090</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0333</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>278</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Fibroblast
        growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor
        (AhR).</ArticleTitle><Pagination><StartPage>65</StartPage><EndPage>71</EndPage><MedlinePgn>65-71</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.taap.2014.04.013</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0041-008X(14)00153-7</ELocationID><Abstract><AbstractText>The
        toxic effects of dioxins, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),
        mainly through activation of the aryl hydrocarbon receptor (AhR) are well
        documented. Fibroblast growth factor (Fgf) 21 plays critical roles in metabolic
        adaptation to fasting by increasing lipid oxidation and ketogenesis in the
        liver. The present study was performed to determine whether activation of
        the AhR induces Fgf21 expression. In mouse liver, TCDD increased Fgf21 mRNA
        in both dose- and time-dependent manners. In addition, TCDD markedly increased
        Fgf21 mRNA expression in cultured mouse and human hepatocytes. Moreover, TCDD
        increased mRNA (in liver) and protein levels (in both liver and serum) of
        Fgf21 in wild-type mice, but not in AhR-null mice. Chromatin immunoprecipitation
        assays showed that TCDD increased AhR protein binding to the Fgf21 promoter
        (-105/+1 base pair). Fgf21-null mice administered 200&#x3bc;g/kg of TCDD died
        within 20days, whereas wild-type mice receiving the same treatment were still
        alive at one month after administration. This indicates that TCDD-induced
        Fgf21 expression protects against TCDD toxicity. Diethylhexylphthalate (DEHP)
        pretreatment attenuated TCDD-induced Fgf21 expression in mouse liver and white
        adipose tissue, which may explain a previous report that DEHP pretreatment
        decreases TCDD-induced wasting. In conclusion, Fgf21 appears to be a target
        gene of AhR-signaling pathway in mouse and human liver.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2014 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Xingguo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department
        of Pharmaceutical Sciences, St. John''s University, 8000 Utopia Parkway, Queens,
        NY 11439, USA. Electronic address: chengx@stjohns.edu.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Vispute</LastName><ForeName>Saurabh G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department
        of Pharmaceutical Sciences, St. John''s University, 8000 Utopia Parkway, Queens,
        NY 11439, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard,
        Kansas City, KS 66160, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cheng</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lilly
        Research Laboratories, Division of Eli Lilly and Co., Indianapolis, IN 46285,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharitonenkov</LastName><ForeName>Alexei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lilly
        Research Laboratories, Division of Eli Lilly and Co., Indianapolis, IN 46285,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaassen</LastName><ForeName>Curtis
        D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department
        of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard,
        Kansas City, KS 66160, USA. Electronic address: curtisklaassenphd@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>R01 DK081461</GrantID><Acronym>DK</Acronym><Agency>NIDDK
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES019487</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01
        ES009649</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>R01 ES019487</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK081461</GrantID><Acronym>DK</Acronym><Agency>NIDDK
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES09649</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research
        Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C111235">AHR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C484722">Ahr protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D051792">Basic Helix-Loop-Helix Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000072317">Polychlorinated Dibenzodioxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018336">Receptors, Aryl Hydrocarbon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C414620">fibroblast growth factor 21</NameOfSubstance></Chemical><Chemical><RegistryNumber>62031-54-3</RegistryNumber><NameOfSubstance
        UI="D005346">Fibroblast Growth Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D052436" MajorTopicYN="N">Adipose Tissue, White</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051792" MajorTopicYN="N">Basic Helix-Loop-Helix Transcription Factors</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005346" MajorTopicYN="N">Fibroblast Growth Factors</DescriptorName><QualifierName
        UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000072317" MajorTopicYN="N">Polychlorinated Dibenzodioxins</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018336" MajorTopicYN="N">Receptors, Aryl Hydrocarbon</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">AhR</Keyword><Keyword MajorTopicYN="N">DEHP</Keyword><Keyword
        MajorTopicYN="N">Fgf21</Keyword><Keyword MajorTopicYN="N">Liver</Keyword><Keyword
        MajorTopicYN="N">TCDD</Keyword><Keyword MajorTopicYN="N">White adipose tissue</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2014</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2014</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">24769090</ArticleId><ArticleId IdType="mid">NIHMS594981</ArticleId><ArticleId
        IdType="pmc">PMC4090247</ArticleId><ArticleId IdType="doi">10.1016/j.taap.2014.04.013</ArticleId><ArticleId
        IdType="pii">S0041-008X(14)00153-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adams
        AC, Coskun T, Cheng CC, LSOF, Dubois SL, Kharitonenkov A. Fibroblast growth
        factor 21 is not required for the antidiabetic actions of the thiazoladinediones.
        Mol Metab. 2013;2:205&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3773835</ArticleId><ArticleId
        IdType="pubmed">24049735</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams
        AC, Kharitonenkov A. FGF21: The center of a transcriptional nexus in metabolic
        regulation. Curr Diabetes Rev. 2012;8:285&#x2013;293.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">22587513</ArticleId></ArticleIdList></Reference><Reference><Citation>Amakura
        Y, Tsutsumi T, Sasaki K, Nakamura M, Yoshida T, Maitani T. Influence of food
        polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in
        vitro bioassay. Phytochemistry. 2008;69:3117&#x2013;3130.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17869316</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar-Mohamed
        A, El-Kadi AO. Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity
        levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human
        HepG2 cells. Cancer Lett. 2009;275:93&#x2013;101.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19013013</ArticleId></ArticleIdList></Reference><Reference><Citation>Badman
        MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast
        growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic
        lipid metabolism in ketotic states. Cell Metab. 2007;5:426&#x2013;437.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17550778</ArticleId></ArticleIdList></Reference><Reference><Citation>Beenken
        A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nature
        reviews Drug discovery. 2009;8:235&#x2013;253.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3684054</ArticleId><ArticleId IdType="pubmed">19247306</ArticleId></ArticleIdList></Reference><Reference><Citation>Berglund
        ED, Li CY, Bina HA, Lynes SE, Michael MD, Shanafelt AB, Kharitonenkov A, Wasserman
        DH. Fibroblast growth factor 21 controls glycemia via regulation of hepatic
        glucose flux and insulin sensitivity. Endocrinology. 2009;150:4084&#x2013;4093.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2736088</ArticleId><ArticleId IdType="pubmed">19470704</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng
        X, Maher J, Dieter MZ, Klaassen CD. Regulation of mouse organic anion-transporting
        polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that
        activate distinct transcription factor pathways. Drug Metab Dispos. 2005;33:1276&#x2013;1282.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15919853</ArticleId></ArticleIdList></Reference><Reference><Citation>Croutch
        CR, Lebofsky M, Schramm KW, Terranova PF, Rozman KK. 2,3,7,8-Tetrachlorodibenzo-p-dioxin
        (TCDD) and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin (HxCDD) alter body weight
        by decreasing insulin-like growth factor I (IGF-I) signaling. Toxicol Sci.
        2005;85:560&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">15703265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding
        X, Lichti K, Kim I, Gonzalez FJ, Staudinger JL. Regulation of constitutive
        androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear
        factor alpha, and the coactivator peroxisome proliferator-activated receptor
        gamma coactivator-1alpha. J Biol Chem. 2006;281:26540&#x2013;26551.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2991045</ArticleId><ArticleId IdType="pubmed">16825189</ArticleId></ArticleIdList></Reference><Reference><Citation>Fon
        Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi
        M, Kuro-o M, Mangelsdorf DJ, Kliewer SA. Research resource: Comprehensive
        expression atlas of the fibroblast growth factor system in adult mouse. Mol
        Endocrinol. 2010;24:2050&#x2013;2064.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2954642</ArticleId><ArticleId IdType="pubmed">20667984</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried
        KW, Schneider CM, Schramm KW, Datta A, Chahbane N, Corsten C, Powell DR, Lenoir
        D, Kettrup A, Terranova P, Georg GI, Rozman KK. From dioxin to drug lead--the
        development of 2,3,7,8-tetrachlorophenothiazine. Chem Med Chem. 2007;2:890&#x2013;897.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17394264</ArticleId></ArticleIdList></Reference><Reference><Citation>Galman
        C, Lundasen T, Kharitonenkov A, Bina HA, Eriksson M, Hafstrom I, Dahlin M,
        Amark P, Angelin B, Rudling M. The circulating metabolic regulator FGF21 is
        induced by prolonged fasting and PPARalpha activation in man. Cell Metab.
        2008;8:169&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">18680716</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC.
        Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans. Vol.
        69. International Agency for Research on Cancer; 1997. IARC Monographs on
        the Evaluation of Carcinogenic Risks to Humans.</Citation></Reference><Reference><Citation>Inagaki
        T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi
        M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ,
        Kliewer SA. Endocrine regulation of the fasting response by PPARalpha-mediated
        induction of fibroblast growth factor 21. Cell Metab. 2007;5:415&#x2013;425.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17550777</ArticleId></ArticleIdList></Reference><Reference><Citation>Inagaki
        T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of
        growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab.
        2008;8:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2575072</ArticleId><ArticleId
        IdType="pubmed">18585098</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumiya
        Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K. FGF21 is an Akt-regulated
        myokine. FEBS Lett. 2008;582:3805&#x2013;3810.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2604129</ArticleId><ArticleId IdType="pubmed">18948104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharitonenkov
        A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE,
        Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski
        VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB. FGF-21 as a novel metabolic
        regulator. J Clin Invest. 2005;115:1627&#x2013;1635.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1088017</ArticleId><ArticleId IdType="pubmed">15902306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharitonenkov
        A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt
        AB, Etgen GJ. The metabolic state of diabetic monkeys is regulated by fibroblast
        growth factor-21. Endocrinology. 2007;148:774&#x2013;781.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17068132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kociba
        RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson
        LE, Park CN, Barnard SD, Hummel RA, Humiston CG. Results of a two-year chronic
        toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in
        rats. Toxicol Appl Pharmacol. 1978;46:279&#x2013;303.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">734660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshman
        MR, Ghosh P, Chirtel SJ. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin
        on intermediary metabolism in the rat. J Pharmacol Exp Ther. 1991;258:317&#x2013;319.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2072303</ArticleId></ArticleIdList></Reference><Reference><Citation>Loaiza-Perez
        AI, Kenney S, Boswell J, Hollingshead M, Alley MC, Hose C, Ciolino HP, Yeh
        GC, Trepel JB, Vistica DT, Sausville EA. Aryl hydrocarbon receptor activation
        of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast
        tumor cells. Mol Cancer Ther. 2004;3:715&#x2013;725.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15210858</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundasen
        T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE, Rudling M. PPARalpha
        is a key regulator of hepatic FGF21. Biochem Biophys Res Commun. 2007;360:437&#x2013;440.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17601491</ArticleId></ArticleIdList></Reference><Reference><Citation>McLane
        KE, Whitlock JP., Jr DNA sequence requirements for Ah receptor/Arnt recognition
        determined by in vitro transcription. Receptor. 1994;4:209&#x2013;222.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7894337</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyers
        JS, Shiyanova TL, Mehrbod F, Dunbar JD, Noblitt TW, Otto KA, Reifel-Miller
        A, Kharitonenkov A. Molecular determinants of FGF-21 activity-synergy and
        cross-talk with PPARgamma signaling. J Cell Physiol. 2007;210:1&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17063460</ArticleId></ArticleIdList></Reference><Reference><Citation>Muise
        ES, Azzolina B, Kuo DW, El-Sherbeini M, Tan Y, Yuan X, Mu J, Thompson JR,
        Berger JP, Wong KK. Adipose fibroblast growth factor 21 is up-regulated by
        peroxisome proliferator-activated receptor gamma and altered metabolic states.
        Mol Pharmacol. 2008;74:403&#x2013;412.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18467542</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura
        T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially
        expressed in the liver. Biochim Biophys Acta. 2000;1492:203&#x2013;206.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10858549</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrick
        JS, Klaassen CD. Importance of hepatic induction of constitutive androstane
        receptor and other transcription factors that regulate xenobiotic metabolism
        and transport. Drug Metab Dispos. 2007;35:1806&#x2013;1815.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17627975</ArticleId></ArticleIdList></Reference><Reference><Citation>Potthoff
        MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf
        DJ, Kliewer SA, Burgess SC. FGF21 induces PGC-1{alpha} and regulates carbohydrate
        and fatty acid metabolism during the adaptive starvation response. Proc Natl
        Acad Sci U S A. 2009;106:10853&#x2013;10858.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2705613</ArticleId><ArticleId IdType="pubmed">19541642</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt
        JV, Su GH, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine
        Ahr null allele: involvement of the Ah receptor in hepatic growth and development.
        Proc Natl Acad Sci U S A. 1996;93:6731&#x2013;6736.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC39095</ArticleId><ArticleId IdType="pubmed">8692887</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki
        M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi
        A, Oka S, Imamura T. betaKlotho is required for fibroblast growth factor (FGF)
        21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol Endocrinol. 2008;22:1006&#x2013;1014.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC5419549</ArticleId><ArticleId IdType="pubmed">18187602</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijet
        N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, Pohjanvirta R. Aryl hydrocarbon
        receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries.
        Mol Pharmacol. 2006;69:140&#x2013;153.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16214954</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaszewski
        KE, Montgomery CA, Melnick RL. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin
        toxicity in F344 rats by di(2-ethylhexyl)phthalate. Chem Biol Interact. 1988;65:205&#x2013;222.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3378278</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang
        H, Qiang L, Farmer SR. Identification of a domain within peroxisome proliferator-activated
        receptor gamma regulating expression of a group of genes containing fibroblast
        growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol
        Cell Biol. 2008;28:188&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2223282</ArticleId><ArticleId
        IdType="pubmed">17954559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Peters JM, Perella CM, Gonzalez FJ. Receptor and nonreceptor-mediated
        organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome
        proliferator-activated receptor alpha-null mice. Toxicol Pathol. 1998;26:240&#x2013;246.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9547862</ArticleId></ArticleIdList></Reference><Reference><Citation>Wente
        W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, Sandusky GE, Sewing S,
        Treinies I, Zitzer H, Gromada J. Fibroblast growth factor-21 improves pancreatic
        beta-cell function and survival by activation of extracellular signal-regulated
        kinase 1/2 and Akt signaling pathways. Diabetes. 2006;55:2470&#x2013;2478.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16936195</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock
        JP., Jr Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin
        action. Annu Rev Pharmacol Toxicol. 1990;30:251&#x2013;277.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2188570</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu
        J, Stanislaus S, Chinookoswong N, Lau YY, Hager T, Patel J, Ge H, Weiszmann
        J, Lu SC, Graham M, Busby J, Hecht R, Li YS, Li Y, Lindberg R, Veniant MM.
        Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant
        mouse models--association with liver and adipose tissue effects. Am J Physiol
        Endocrinol Metab. 2009;297:E1105&#x2013;1114.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19706786</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6143560</PMID><DateCompleted><Year>1984</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>23</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-2952</ISSN><JournalIssue
        CitedMedium="Print"><Volume>33</Volume><Issue>7</Issue><PubDate><Year>1984</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Biochemical
        pharmacology</Title><ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Induction
        of rat hepatic long-chain acyl-CoA hydrolases by various peroxisome proliferators.</ArticleTitle><Pagination><StartPage>1081</StartPage><EndPage>1085</EndPage><MedlinePgn>1081-5</MedlinePgn></Pagination><Abstract><AbstractText>Induction
        of cytosolic long-chain acyl-CoA hydrolases was investigated in rat liver
        after administration of various peroxisome proliferators and related compounds.
        Treatment of rats with di-(2-ethylhexyl)-phthalate, di-(2-ethylhexyl)-adipate
        or tiadenol induced hydrolases I and II, while acetylsalicylic acid induced
        only hydrolase II. Among the various phenoxyacetic acid derivatives and related
        compounds, 2,4,5-trichlorophenoxyacetic acid, 2-(4-chlorophenoxy)-2-methylacetic
        acid, 2-(2-chlorophenoxy)-2-methylpropionic acid and clofibric acid induced
        both hydrolases I and II, whereas 2, 4-dichlorophenoxyacetic acid induced
        only hydrolase II. All nine of the above-mentioned inducers also markedly
        increased the activity of peroxisomal beta-oxidation. Other compounds tested
        (2-chlorophenoxyacetic acid, 4-chlorophenoxyacetic acid, 4-chlorophenol, phenoxyacetic
        acid and phenoxy-2-methylacetic acid) were ineffective as inducers. These
        results suggest that inducers of acyl-CoA hydrolase II also enhance peroxisomal
        beta-oxidation activity, but do not necessarily induce acyl-CoA hydrolase
        I. The structure-inducing activity relationships of these compounds are discussed.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Katoh</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Nakajima</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Kawashima</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Kozuka</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Uchiyama</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem
        Pharmacol</MedlineTA><NlmUniqueID>0101032</NlmUniqueID><ISSNLinking>0006-2952</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005233">Fatty Alcohols</NameOfSubstance></Chemical><Chemical><RegistryNumber>22251270CX</RegistryNumber><NameOfSubstance
        UI="C004568">tiadenol</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.2.-</RegistryNumber><NameOfSubstance UI="D013869">Thiolester Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.2.2</RegistryNumber><NameOfSubstance UI="D010170">Palmitoyl-CoA Hydrolase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005233" MajorTopicYN="N">Fatty Alcohols</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010170" MajorTopicYN="N">Palmitoyl-CoA Hydrolase</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013869" MajorTopicYN="N">Thiolester Hydrolases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6143560</ArticleId><ArticleId IdType="doi">10.1016/0006-2952(84)90517-3</ArticleId><ArticleId
        IdType="pii">0006-2952(84)90517-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3934796</PMID><DateCompleted><Year>1986</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>37</Volume><Issue>3-4</Issue><PubDate><Year>1985</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Distribution
        and retention of some chlorinated hydrocarbons and a phthalate in the mouse
        brain during the pre-weaning period.</ArticleTitle><Pagination><StartPage>189</StartPage><EndPage>203</EndPage><MedlinePgn>189-203</MedlinePgn></Pagination><Abstract><AbstractText>In
        a quantitative retaining study and a whole-body autoradiographic study 5 14C-labelled
        compounds, bis-(4-chlorophenyl)trichloroethane (DDT), 2,2'',4,4'',5,5''-hexachlorobiphenyl
        (6-CB), hexachlorophene (HCP), polychlorohexadecane (PCHD) and diethylhexylphthalate
        (DEHP) were each administered to mice at the age of 3, 10 and 20 days. The
        mice were killed 24 h or 7 days after treatment and the amount of radioactivity
        in the whole brain was measured and its distribution studied. The retention
        of radioactivity was most pronounced in mice receiving DDT, PCHD, and 6-CB
        during the tenth day of life. Here the level of radioactivity 7 days after
        treatment was nearly as high as that observed after 24 h (ratio between 0.86
        and 0.74). In contrast, HCP showed a rapid elimination from the brain and
        was hardly retained at all in the 20-day-old mouse brain. The retention of
        DEHP in the brain was minimal. Some of the autoradiographic sections were
        also subjected to myelin staining. Large amounts of radioactivity were found
        in the myelinated areas of the brain after HCP and PCHD administration. DDT
        and 6-CB showed a more even distribution within the brain and were not particularly
        concentrated in the myelin. There was no obvious relationship between the
        lipophilicity of the parent compounds and their retention in the brain.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Eriksson</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Darnerud</LastName><ForeName>P O</ForeName><Initials>PO</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002250">Carbon Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>DFC2HB4I0K</RegistryNumber><NameOfSubstance
        UI="D011078">Polychlorinated Biphenyls</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001345" MajorTopicYN="N">Autoradiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002250" MajorTopicYN="N">Carbon Radioisotopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009186" MajorTopicYN="N">Myelin Sheath</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011078" MajorTopicYN="N">Polychlorinated Biphenyls</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3934796</ArticleId><ArticleId IdType="doi">10.1016/0300-483x(85)90082-4</ArticleId><ArticleId
        IdType="pii">0300-483X(85)90082-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15914576</PMID><DateCompleted><Year>2006</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-2267</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>Physiological
        genomics</Title><ISOAbbreviation>Physiol Genomics</ISOAbbreviation></Journal><ArticleTitle>Pooling
        samples within microarray studies: a comparative analysis of rat liver transcription
        response to prototypical toxicants.</ArticleTitle><Pagination><StartPage>346</StartPage><EndPage>355</EndPage><MedlinePgn>346-55</MedlinePgn></Pagination><Abstract><AbstractText>Combining
        or pooling individual samples when carrying out transcript profiling using
        microarrays is a fairly common means to reduce both the cost and complexity
        of data analysis. However, pooling does not allow for statistical comparison
        of changes between samples and can result in a loss of information. Because
        a rigorous comparison of the identified expression changes from the two approaches
        has not been reported, we compared the results for hepatic transcript profiles
        from pooled vs. individual samples. Hepatic transcript profiles from a single-dose
        time-course rat study in response to the prototypical toxicants clofibrate,
        diethylhexylphthalate, and valproic acid were evaluated. Approximately 50%
        more transcript expression changes were observed in the individual (statistical)
        analysis compared with the pooled analysis. While the majority of these changes
        were less than twofold in magnitude ( approximately 80%), a substantial number
        were greater than twofold (approximately 20%). Transcript changes unique to
        the individual analysis were confirmed by quantitative RT-PCR, while all the
        changes unique to the pooled analysis did not confirm. The individual analysis
        identified more hits per biological pathway than the pooled approach. Many
        of the transcripts identified by the individual analysis were novel findings
        and may contribute to a better understanding of molecular mechanisms of these
        compounds. Furthermore, having individual animal data provided the opportunity
        to correlate changes in transcript expression to phenotypes (i.e., histology)
        observed in toxicology studies. The two approaches were similar when clustering
        methods were used despite the large difference in the absolute number of transcripts
        changed. In summary, pooling reduced resource requirements substantially,
        but the individual approach enabled statistical analysis that identified more
        gene expression changes to evaluate mechanisms of toxicity. An individual
        animal approach becomes more valuable when the overall expression response
        is subtle and/or when associating expression data to variable phenotypic responses.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Jolly</LastName><ForeName>Robert
        A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Lilly Research
        Laboratories, Greenfield, Indiana 46140, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Keith M</ForeName><Initials>KM</Initials></Author><Author
        ValidYN="Y"><LastName>Wei</LastName><ForeName>Tao</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Gao</LastName><ForeName>Hong</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Chen</LastName><ForeName>Peining</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Huang</LastName><ForeName>Shuguang</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Colet</LastName><ForeName>Jean-Marie</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Ryan</LastName><ForeName>Timothy P</ForeName><Initials>TP</Initials></Author><Author
        ValidYN="Y"><LastName>Thomas</LastName><ForeName>Craig E</ForeName><Initials>CE</Initials></Author><Author
        ValidYN="Y"><LastName>Estrem</LastName><ForeName>Shawn T</ForeName><Initials>ST</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Physiol Genomics</MedlineTA><NlmUniqueID>9815683</NlmUniqueID><ISSNLinking>1094-8341</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008110">Liver Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>614OI1Z5WI</RegistryNumber><NameOfSubstance
        UI="D014635">Valproic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance
        UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008110" MajorTopicYN="N">Liver Extracts</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014635" MajorTopicYN="N">Valproic Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2005</Year><Month>5</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2006</Year><Month>6</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2005</Year><Month>5</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15914576</ArticleId><ArticleId IdType="doi">10.1152/physiolgenomics.00260.2004</ArticleId><ArticleId
        IdType="pii">00260.2004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">26188368</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4847</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>26</Volume><Issue>11</Issue><PubDate><Year>2015</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The
        Journal of nutritional biochemistry</Title><ISOAbbreviation>J Nutr Biochem</ISOAbbreviation></Journal><ArticleTitle>In
        utero growth restriction and catch-up adipogenesis after developmental di
        (2-ethylhexyl) phthalate exposure cause glucose intolerance in adult male
        rats following a high-fat dietary challenge.</ArticleTitle><Pagination><StartPage>1208</StartPage><EndPage>1220</EndPage><MedlinePgn>1208-20</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.jnutbio.2015.05.012</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0955-2863(15)00145-X</ELocationID><Abstract><AbstractText>Phthalates
        impact adipocyte morphology in vitro, but the sex-specific adipogenic signature
        immediately after perinatal di(2-ethylhexyl) phthalate (DEHP) exposure and
        adulthood physiology following a high-fat (HF) dietary challenge are unknown.
        In the current study, pregnant and lactating dams received DEHP (300 mg/kg
        body weight) or oil. At weaning [postnatal day (PND) 21], adipose tissue was
        sampled for real-time polymerase chain reaction. The remaining offspring consumed
        a control or HF diet. DEHP decreased % fat in males at birth from 13.9%&#xb1;0.2
        to 11.8%&#xb1;0.6 (mean&#xb1;S.E.M.), representing a 15.1% decrease in fat
        by DEHP, and these males caught up in adiposity to controls by PND21. Adult
        DEHP-exposed males had a 27.5% increase in fat (12.5%&#xb1;0.9% in controls
        vs. 15.9%&#xb1;1.5% in the DEHP group); adipocyte perimeter was increased
        as well, with fewer small/medium-sized adipocytes, and decreased cell number
        compared to oil controls. HF diet intake in DEHP-exposed males further increased
        male energy intake and body weight and led to glucose intolerance. In PND21
        males, DEHP increased the expression of adipogenic markers (Pparg1, Cebpa,
        Adipoq, Ppard, Fabp4, Fasn, Igf1), decreased Lep, and decreased markers of
        mesenchymal stem cell commitment to the adipogenic lineage (Bmp2, Bmp4, Stat1,
        Stat5a) compared to oil controls. These data suggest that DEHP may decrease
        the adipocyte pool at birth, which initially increases adaptive adipocyte
        maturation and lipid accumulation, but leads to adipose tissue dysfunction
        in adulthood, decreasing the capacity to adapt to a HF diet, and leading to
        systemic glucose intolerance.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Strakovsky</LastName><ForeName>Rita
        S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department
        of Food Science and Human Nutrition, University of Illinois, Urbana-Champaign,
        Urbana, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lezmi</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Pathobiology, University of Illinois, Urbana-Champaign, Urbana, Illinois.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shkoda</LastName><ForeName>Ielyzaveta</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department
        of Food Science and Human Nutrition, University of Illinois, Urbana-Champaign,
        Urbana, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaws</LastName><ForeName>Jodi
        A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department
        of Comparative Biosciences, University of Illinois, Urbana-Champaign, Urbana,
        Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helferich</LastName><ForeName>William
        G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Department
        of Food Science and Human Nutrition, University of Illinois, Urbana-Champaign,
        Urbana, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yuan-Xiang</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department
        of Food Science and Human Nutrition, University of Illinois, Urbana-Champaign,
        Urbana, Illinois; Division of Nutritional Sciences, University of Illinois,
        Urbana-Champaign, Urbana, Illinois. Electronic address: yxpan@illinois.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>T32ES007326</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32
        ES007326</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>R01 ES019178</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01
        ES022848</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>R01ES019178</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research
        Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Nutr Biochem</MedlineTA><NlmUniqueID>9010081</NlmUniqueID><ISSNLinking>0955-2863</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance
        UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D017667" MajorTopicYN="N">Adipocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D050156" MajorTopicYN="N">Adipogenesis</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001724" MajorTopicYN="N">Birth Weight</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D059305" MajorTopicYN="N">Diet, High-Fat</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018149" MajorTopicYN="Y">Glucose Intolerance</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="Y">Prenatal Exposure Delayed Effects</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Adipose</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword
        MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Phthalates</Keyword><Keyword
        MajorTopicYN="N">Pparg</Keyword><Keyword MajorTopicYN="N">Programming</Keyword></KeywordList><CoiStatement><b>Statement
        of Ethics:</b> The authors declare no financial conflict of interest. We certify
        that all applicable institutional and governmental regulations regarding the
        ethical use of animals were followed during this research (University of Illinois
        Institutional Animal Care and Use Committee approval #11191).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2014</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2015</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2015</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">26188368</ArticleId><ArticleId IdType="mid">NIHMS705112</ArticleId><ArticleId
        IdType="pmc">PMC4631689</ArticleId><ArticleId IdType="doi">10.1016/j.jnutbio.2015.05.012</ArticleId><ArticleId
        IdType="pii">S0955-2863(15)00145-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lind
        PM, Zethelius B, Lind L. Circulating levels of phthalate metabolites are associated
        with prevalent diabetes in the elderly. Diabetes Care. 2012;35:1519&#x2013;1524.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3379584</ArticleId><ArticleId IdType="pubmed">22498808</ArticleId></ArticleIdList></Reference><Reference><Citation>Heudorf
        U, Mersch-Sundermann V, Angerer J. Phthalates: toxicology and exposure. Int
        J Hyg Environ Health. 2007;210:623&#x2013;634.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17889607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye
        X, Pierik FH, Hauser R, Duty S, Angerer J, Park MM, et al. Urinary metabolite
        concentrations of organophosphorous pesticides, bisphenol A, and phthalates
        among pregnant women in Rotterdam, the Netherlands: the Generation R study.
        Environ Res. 2008;108:260&#x2013;267.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2628162</ArticleId><ArticleId IdType="pubmed">18774129</ArticleId></ArticleIdList></Reference><Reference><Citation>Adibi
        JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, et al. Characterization
        of phthalate exposure among pregnant women assessed by repeat air and urine
        samples. Environ Health Perspect. 2008;116:467&#x2013;473.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2291011</ArticleId><ArticleId IdType="pubmed">18414628</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen
        S, Boberg J, Axelstad M, Dalgaard M, Vinggaard AM, Metzdorff SB, et al. Low-dose
        perinatal exposure to di(2-ethylhexyl) phthalate induces anti-androgenic effects
        in male rats. Reprod Toxicol. 2010;30:313&#x2013;321.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20420898</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsee
        K, Woodruff TJ, Axelrad DA, Calafat AM, Swan SH. Estimated daily phthalate
        exposures in a population of mothers of male infants exhibiting reduced anogenital
        distance. Environ Health Perspect. 2006;114:805&#x2013;809.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1480516</ArticleId><ArticleId IdType="pubmed">16759976</ArticleId></ArticleIdList></Reference><Reference><Citation>James-Todd
        T, Stahlhut R, Meeker JD, Powell SG, Hauser R, Huang T, et al. Urinary Phthalate
        Metabolite Concentrations and Diabetes among Women in the National Health
        and Nutrition Examination Survey (NHANES) 2001&#x2013;2008. Environ Health
        Perspect. 2012;120:1307&#x2013;1313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3440117</ArticleId><ArticleId
        IdType="pubmed">22796563</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahlhut
        RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary
        phthalate metabolites are associated with increased waist circumference, insulin
        resistance in adult U.Smales. Environ Health Perspect. 2007;115:876&#x2013;882.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1892109</ArticleId><ArticleId IdType="pubmed">17589594</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E, et al. The pollutant
        diethylhexyl phthalate regulates hepatic energy metabolism via species-specific
        PPARalpha-dependent mechanisms. Environ Health Perspect. 2010;118:234&#x2013;241.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2831923</ArticleId><ArticleId IdType="pubmed">20123618</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinelli
        MI, Mocchiutti NO, Bernal CA. Dietary di(2-ethylhexyl)phthalate-impaired glucose
        metabolism in experimental animals. Hum Exp Toxicol. 2006;25:531&#x2013;538.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17017006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajesh
        P, Sathish S, Srinivasan C, Selvaraj J, Balasubramanian K. Exposure to diethyl
        hexyl phthalate (DEHP) to adult male rat is associated with insulin resistance
        in adipose tisssue: Protective role of antioxidant vitamins (C &amp; E) J
        Cell Biochem. 2012</Citation></Reference><Reference><Citation>Schmidt JS,
        Schaedlich K, Fiandanese N, Pocar P, Fischer B. Effects of Di(2-ethylhexyl)
        Phthalate (DEHP) on Female Fertility and Adipogenesis in C3H/N Mice. Environ
        Health Perspect. 2012;120:1123&#x2013;1129.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3440070</ArticleId><ArticleId IdType="pubmed">22588786</ArticleId></ArticleIdList></Reference><Reference><Citation>Unuvar
        T, Buyukgebiz A. Fetal and neonatal endocrine disruptors. J Clin Res Pediatr
        Endocrinol. 2012;4:51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3386773</ArticleId><ArticleId
        IdType="pubmed">22672860</ArticleId></ArticleIdList></Reference><Reference><Citation>Billon
        N, Monteiro MC, Dani C. Developmental origin of adipocytes: new insights into
        a pending question. Biology of the cell / under the auspices of the European
        Cell Biology Organization. 2008;100:563&#x2013;575.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18793119</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozak
        LP, Newman S, Chao PM, Mendoza T, Koza RA. The early nutritional environment
        of mice determines the capacity for adipose tissue expansion by modulating
        genes of caveolae structure. PLoS One. 2010;5:e11015.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2888576</ArticleId><ArticleId IdType="pubmed">20574519</ArticleId></ArticleIdList></Reference><Reference><Citation>Conceicao
        EP, Trevenzoli IH, Oliveira E, Franco JG, Carlos AS, Nascimento-Saba CC, et
        al. Higher white adipocyte area and lower leptin production in adult rats
        overfed during lactation. Horm Metab Res. 2011;43:513&#x2013;516.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21512961</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrighi
        Polidori G, Lomax MA, Docherty K. Palmitate enhances the differentiation of
        mouse embryonic stem cells towards white adipocyte lineages. Mol Cell Endocrinol.
        2012;361:40&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">22484460</ArticleId></ArticleIdList></Reference><Reference><Citation>Campioli
        E, Martinez-Arguelles DB, Papadopoulos V. In utero exposure to the endocrine
        disruptor di-(2-ethylhexyl) phthalate promotes local adipose and systemic
        inflammation in adult male offspring. Nutrition &amp; diabetes. 2014;4:e115.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4042311</ArticleId><ArticleId IdType="pubmed">24799162</ArticleId></ArticleIdList></Reference><Reference><Citation>Campioli
        E, Batarseh A, Li J, Papadopoulos V. The endocrine disruptor mono-(2-ethylhexyl)
        phthalate affects the differentiation of human liposarcoma cells (SW 872)
        PLoS One. 2011;6:e28750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3244402</ArticleId><ArticleId
        IdType="pubmed">22205965</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C, et al. The endocrine
        disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated
        receptor gamma modulator that promotes adipogenesis. J Biol Chem. 2007;282:19152&#x2013;19166.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17468099</ArticleId></ArticleIdList></Reference><Reference><Citation>Biemann
        R, Navarrete Santos A, Navarrete Santos A, Riemann D, Knelangen J, Bluher
        M, et al. Endocrine disrupting chemicals affect the adipogenic differentiation
        of mesenchymal stem cells in distinct ontogenetic windows. Biochem Biophys
        Res Commun. 2012;417:747&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pubmed">22197818</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker
        K, Seiwert M, Angerer J, Heger W, Koch HM, Nagorka R, et al. DEHP metabolites
        in urine of children and DEHP in house dust. International journal of hygiene
        and environmental health. 2004;207:409&#x2013;417.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15575555</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade
        AJ, Grande SW, Talsness CE, Gericke C, Grote K, Golombiewski A, et al. A dose
        response study following in utero and lactational exposure to di-(2-ethylhexyl)
        phthalate (DEHP): reproductive effects on adult male offspring rats. Toxicology.
        2006;228:85&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">16996189</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray
        LE, Jr, Ostby J, Furr J, Price M, Veeramachaneni DN, Parks L. Perinatal exposure
        to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual
        differentiation of the male rat. Toxicol Sci. 2000;58:350&#x2013;365.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11099647</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin
        GL, Ogden LG, Hill JO. Trends in carbohydrate, fat, and protein intakes and
        association with energy intake in normal-weight, overweight, and obese individuals:
        1971&#x2013;2006. Am J Clin Nutr. 2011;93:836&#x2013;843.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21310830</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra
        A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes
        in developing countries: role of dietary fats and oils. J Am Coll Nutr. 2010;29:289S&#x2013;301S.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20823489</ArticleId></ArticleIdList></Reference><Reference><Citation>Strakovsky
        RS, Lezmi S, Flaws JA, Schantz SL, Pan YX, Helferich WG. Genistein exposure
        during the early postnatal period favors the development of obesity in female,
        but not male rats. Toxicol Sci. 2014;138:161&#x2013;174.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3930366</ArticleId><ArticleId IdType="pubmed">24361872</ArticleId></ArticleIdList></Reference><Reference><Citation>Strakovsky
        RS, Pan Y-X. A Decrease in DKK1, a WNT Inhibitor, Contributes to Placental
        Lipid Accumulation in an Obesity-Prone Rat Model. Biol Reprod. 2011</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC6584127</ArticleId><ArticleId IdType="pubmed">22133691</ArticleId></ArticleIdList></Reference><Reference><Citation>Strakovsky
        RS, Zhang X, Zhou D, Pan YX. Gestational High Fat Diet Programs Hepatic Phosphoenolpyruvate
        Carboxykinase (Pck) Expression and Histone Modification in Neonatal Offspring
        Rats. J Physiol. 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3112549</ArticleId><ArticleId
        IdType="pubmed">21486814</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen
        H, Pan YX, Dudenhausen EE, Kilberg MS. Amino acid deprivation induces the
        transcription rate of the human asparagine synthetase gene through a timed
        program of expression and promoter binding of nutrient-responsive basic region/leucine
        zipper transcription factors as well as localized histone acetylation. J Biol
        Chem. 2004;279:50829&#x2013;50839.</Citation><ArticleIdList><ArticleId IdType="pubmed">15385533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipson
        KE, Baserga R. Transcriptional activity of the human thymidine kinase gene
        determined by a method using the polymerase chain reaction and an intron-specific
        probe. Proc Natl Acad Sci U S A. 1989;86:9774&#x2013;9777.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC298584</ArticleId><ArticleId IdType="pubmed">2481317</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammarstedt
        A, Graham TE, Kahn BB. Adipose tissue dysregulation and reduced insulin sensitivity
        in non-obese individuals with enlarged abdominal adipose cells. Diabetology
        &amp; metabolic syndrome. 2012;4:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3523053</ArticleId><ArticleId
        IdType="pubmed">22992414</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillen
        IC, Rattanatray L, Duffield JA, Morrison JL, MacLaughlin SM, Gentili S, et
        al. The early origins of later obesity: pathways and mechanisms. Adv Exp Med
        Biol. 2009;646:71&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">19536665</ArticleId></ArticleIdList></Reference><Reference><Citation>Casals-Casas
        C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption.
        Annu Rev Physiol. 2011;73:135&#x2013;162.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21054169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin
        Y, Wei J, Li Y, Chen J, Zhou Z, Song L, et al. Developmental exposure to di(2-ethylhexyl)
        phthalate impairs endocrine pancreas and leads to long-term adverse effects
        on glucose homeostasis in the rat. Am J Physiol Endocrinol Metab. 2011;301:E527&#x2013;E538.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21673306</ArticleId></ArticleIdList></Reference><Reference><Citation>Maranghi
        F, Lorenzetti S, Tassinari R, Moracci G, Tassinari V, Marcoccia D, et al.
        In utero exposure to di-(2-ethylhexyl) phthalate affects liver morphology
        and metabolism in post-natal CD-1 mice. Reprod Toxicol. 2010;29:427&#x2013;432.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20307648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gower
        BA, Munoz J, Desmond R, Hilario-Hailey T, Jiao X. Changes in intra-abdominal
        fat in early postmenopausal women: effects of hormone use. Obesity (Silver
        Spring) 2006;14:1046&#x2013;1055.</Citation><ArticleIdList><ArticleId IdType="pubmed">16861610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhl
        J, Hilding A, Ostenson CG, Grill V, Efendic S, Bavenholm P. Characterisation
        of subjects with early abnormalities of glucose tolerance in the Stockholm
        Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity.
        Diabetologia. 2005;48:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">15619073</ArticleId></ArticleIdList></Reference><Reference><Citation>Macotela
        Y, Boucher J, Tran TT, Kahn CR. Sex and depot differences in adipocyte insulin
        sensitivity and glucose metabolism. Diabetes. 2009;58:803&#x2013;812.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2661589</ArticleId><ArticleId IdType="pubmed">19136652</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubbins
        RE, Holcomb VB, Hong J, Nunez NP. Estrogen modulates abdominal adiposity and
        protects female mice from obesity and impaired glucose tolerance. Eur J Nutr.
        2012;51:861&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">22042005</ArticleId></ArticleIdList></Reference><Reference><Citation>Allan
        CA, McLachlan RI. Androgens and obesity. Current opinion in endocrinology,
        diabetes, and obesity. 2010;17:224&#x2013;232.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20418719</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh
        R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, et al. Testosterone
        inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation
        of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass
        canonical Wnt signaling to down-regulate adipogenic transcription factors.
        Endocrinology. 2006;147:141&#x2013;154.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4417624</ArticleId><ArticleId IdType="pubmed">16210377</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato
        T, Matsumoto T, Yamada T, Watanabe T, Kawano H, Kato S. Late onset of obesity
        in male androgen receptor-deficient (AR KO) mice. Biochem Biophys Res Commun.
        2003;300:167&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pubmed">12480537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarr
        O, Yang K, Regnault TR. In utero programming of later adiposity: the role
        of fetal growth restriction. Journal of pregnancy. 2012;2012:134758.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3518064</ArticleId><ArticleId IdType="pubmed">23251802</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison
        JL, Duffield JA, Muhlhausler BS, Gentili S, McMillen IC. Fetal growth restriction,
        catch-up growth and the early origins of insulin resistance and visceral obesity.
        Pediatr Nephrol. 2010;25:669&#x2013;677.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20033220</ArticleId></ArticleIdList></Reference><Reference><Citation>Claris
        O, Beltrand J, Levy-Marchal C. Consequences of intrauterine growth and early
        neonatal catch-up growth. Semin Perinatol. 2010;34:207&#x2013;210.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20494737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang
        Y, Lin L, Cao Y, Chen B, Zheng L, Ge RS. Phthalate levels and low birth weight:
        a nested case-control study of Chinese newborns. J Pediatr. 2009;155:500&#x2013;504.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19555962</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen
        SQ, Chen JN, Cai XH, Chen GR, Gao Y, Ge RS, et al. Perinatal exposure to di-(2-ethylhexyl)
        phthalate leads to restricted growth and delayed lung maturation in newborn
        rats. J Perinat Med. 2010;38:515&#x2013;521.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20629491</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang
        H, Song TJ, Li X, Hu L, He Q, Liu M, et al. BMP signaling pathway is required
        for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage.
        Proc Natl Acad Sci U S A. 2009;106:12670&#x2013;12675.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2722335</ArticleId><ArticleId IdType="pubmed">19620713</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung
        HS, Lee YJ, Kim YH, Paik S, Kim JW, Lee JW. Peroxisome proliferator-activated
        receptor gamma/signal transducers and activators of transcription 5A pathway
        plays a key factor in adipogenesis of human bone marrow-derived stromal cells
        and 3T3-L1 preadipocytes. Stem cells and development. 2012;21:465&#x2013;475.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3272248</ArticleId><ArticleId IdType="pubmed">21542777</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart
        WC, Morrison RF, Young SL, Stephens JM. Regulation of signal transducers and
        activators of transcription (STATs) by effectors of adipogenesis: coordinate
        regulation of STATs 1, 5A, and 5B with peroxisome proliferator-activated receptor-gamma
        and C/AAAT enhancer binding protein-alpha. Biochim Biophys Acta. 1999;1452:188&#x2013;196.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10559472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tontonoz
        P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation
        by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev.
        1995;5:571&#x2013;576.</Citation><ArticleIdList><ArticleId IdType="pubmed">8664544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane
        MD, Tang QQ, Jiang MS. Role of the CCAAT enhancer binding proteins (C/EBPs)
        in adipocyte differentiation. Biochem Biophys Res Commun. 1999;266:677&#x2013;683.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10603305</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid
        B, Rippmann JF, Tadayyon M, Hamilton BS. Inhibition of fatty acid synthase
        prevents preadipocyte differentiation. Biochem Biophys Res Commun. 2005;328:1073&#x2013;1082.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15707987</ArticleId></ArticleIdList></Reference><Reference><Citation>Samulin
        J, Berget I, Lien S, Sundvold H. Differential gene expression of fatty acid
        binding proteins during porcine adipogenesis. Comparative biochemistry and
        physiology Part B, Biochemistry &amp; molecular biology. 2008;151:147&#x2013;152.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18621139</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu
        A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively
        reduces the high molecular weight form of adiponectin by inhibiting its secretion
        from adipocytes. J Biol Chem. 2005;280:18073&#x2013;18080.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15760892</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizawa
        H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens
        decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.
        Diabetes. 2002;51:2734&#x2013;2741.</Citation><ArticleIdList><ArticleId IdType="pubmed">12196466</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanase
        T, Fan W, Kyoya K, Min L, Takayanagi R, Kato S, et al. Androgens and metabolic
        syndrome: lessons from androgen receptor knock out (ARKO) mice. J Steroid
        Biochem Mol Biol. 2008;109:254&#x2013;257.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18472261</ArticleId></ArticleIdList></Reference><Reference><Citation>Monickaraj
        F, Gokulakrishnan K, Prabu P, Sathishkumar C, Anjana RM, Rajkumar JS, et al.
        Convergence of adipocyte hypertrophy, telomere shortening and hypoadiponectinemia
        in obese subjects and in patients with type 2 diabetes. Clin Biochem. 2012</Citation><ArticleIdList><ArticleId
        IdType="pubmed">22827962</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman
        JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature.
        1998;395:763&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pubmed">9796811</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen
        XL, Hausman DB, Dean RG, Hausman GJ. Hormonal regulation of leptin mRNA expression
        and preadipocyte recruitment and differentiation in porcine primary cultures
        of S-V cells. Obesity research. 1998;6:164&#x2013;172.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9545024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollmer
        M, Buhrman JS, Zhang Y, Gemeinhart RA. Markers Are Shared Between Adipogenic
        and Osteogenic Differentiated Mesenchymal Stem Cells. Journal of developmental
        biology and tissue engineering. 2013;5:18&#x2013;25.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3765027</ArticleId><ArticleId IdType="pubmed">24013643</ArticleId></ArticleIdList></Reference><Reference><Citation>Melzner
        I, Scott V, Dorsch K, Fischer P, Wabitsch M, Bruderlein S, et al. Leptin gene
        expression in human preadipocytes is switched on by maturation-induced demethylation
        of distinct CpGs in its proximal promoter. J Biol Chem. 2002;277:45420&#x2013;45427.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12213831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang
        F, Mullican SE, DiSpirito JR, Peed LC, Lazar MA. Lipoatrophy and severe metabolic
        disturbance in mice with fat-specific deletion of PPARgamma. Proc Natl Acad
        Sci U S A. 2013;110:18656&#x2013;18661.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3831974</ArticleId><ArticleId IdType="pubmed">24167256</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonjes
        A, Stumvoll M. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated
        receptor gamma in diabetes risk. Curr Opin Clin Nutr Metab Care. 2007;10:410&#x2013;414.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17563457</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison
        RF, Farmer SR. Role of PPARgamma in regulating a cascade expression of cyclin-dependent
        kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J Biol
        Chem. 1999;274:17088&#x2013;17097.</Citation><ArticleIdList><ArticleId IdType="pubmed">10358062</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller
        E, Drori S, Aiyer A, Yie J, Sarraf P, Chen H, et al. Genetic analysis of adipogenesis
        through peroxisome proliferator-activated receptor gamma isoforms. J Biol
        Chem. 2002;277:41925&#x2013;41930.</Citation><ArticleIdList><ArticleId IdType="pubmed">12200443</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick
        RL. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity
        of di(2-ethylhexyl)phthalate (DEHP)? Environ Health Perspect. 2001;109:437&#x2013;442.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1240301</ArticleId><ArticleId IdType="pubmed">11401753</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney
        EK, Waxman DJ. trans-Activation of PPARalpha and PPARgamma by structurally
        diverse environmental chemicals. Toxicol Appl Pharmacol. 1999;161:209&#x2013;218.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10581215</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellero-Simatos
        S, Claus SP, Benelli C, Forest C, Letourneur F, Cagnard N, et al. Combined
        transcriptomic-(1)H NMR metabonomic study reveals that monoethylhexyl phthalate
        stimulates adipogenesis and glyceroneogenesis in human adipocytes. J Proteome
        Res. 2011;10:5493&#x2013;5502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3229183</ArticleId><ArticleId
        IdType="pubmed">22017230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8162897</PMID><DateCompleted><Year>1994</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>23</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0893-6692</ISSN><JournalIssue
        CitedMedium="Print"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>1994</Year></PubDate></JournalIssue><Title>Environmental
        and molecular mutagenesis</Title><ISOAbbreviation>Environ Mol Mutagen</ISOAbbreviation></Journal><ArticleTitle>Genetic
        toxicology testing of di(2-ethylhexyl) terephthalate.</ArticleTitle><Pagination><StartPage>228</StartPage><EndPage>233</EndPage><MedlinePgn>228-33</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)
        terephthalate (DEHT) is a commercially produced chemical (Kodaflex DOTP) that
        is used as a general purpose, low-volatility plasticizer for polyvinyl chloride
        and other polymeric materials. Less than 30 million kilograms of DEHT are
        produced annually. DEHT is isomeric with di(2-ethylhexyl) phthalate (DEHP),
        a nongenotoxic rodent carcinogen whose mode of action has been suggested to
        derive from its ability to produce hepatocellular proliferation and/or hepatic
        peroxisome proliferation. Thus it is important to know the behavior of DEHT
        in genotoxicity assays in order to compare it with that of DEHP and other
        phthalate ester plasticizers. It is known from previously published studies
        that rats fed DEHT in the diet at 2,000 mg/kg produce urine that is negative
        in the Ames Salmonella bacterial mutagenicity assay in the presence and absence
        of induced rat liver S-9 and in the presence and absence of beta-glucuronidase/aryl
        sulfatase. Reported here are the results of direct testing of DEHT in the
        Ames plate incorporation assay, the Chinese hamster ovary/hypoxanthine guanine
        phosphoribosyl transferase (CHO/HGPRT) in vitro mammalian cell mutagenicity
        assay, and an in vitro chromosome aberrations assay using CHO cells. The results
        for mono(ethylhexyl) terephthalate (MEHT), a metabolite of DEHT, in the Ames
        Salmonella bacterial mutagenicity assay are also presented. All test results
        for both DEHT and MEHT were found to be negative, and it is therefore concluded
        that DEHT, like its isomeric relative DEHP, is not genotoxic.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>E
        D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Corporate
        Health and Environment Laboratories, Eastman Kodak Company, Rochester, New
        York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Mol Mutagen</MedlineTA><NlmUniqueID>8800109</NlmUniqueID><ISSNLinking>0893-6692</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009153">Mutagens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>4VS908W98L</RegistryNumber><NameOfSubstance
        UI="C053316">di-(2-ethylhexyl) terephthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001711" MajorTopicYN="N">Biotransformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002869" MajorTopicYN="N">Chromosome Aberrations</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009152" MajorTopicYN="N">Mutagenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009153" MajorTopicYN="N">Mutagens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012486" MajorTopicYN="N">Salmonella typhimurium</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1994</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8162897</ArticleId><ArticleId IdType="doi">10.1002/em.2850230311</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11581012</PMID><DateCompleted><Year>2001</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>06</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0804-4643</ISSN><JournalIssue
        CitedMedium="Print"><Volume>145</Volume><Issue>4</Issue><PubDate><Year>2001</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European
        journal of endocrinology</Title><ISOAbbreviation>Eur J Endocrinol</ISOAbbreviation></Journal><ArticleTitle>Bisphenol-A,
        an environmental estrogen, activates the human orphan nuclear receptor, steroid
        and xenobiotic receptor-mediated transcription.</ArticleTitle><Pagination><StartPage>513</StartPage><EndPage>517</EndPage><MedlinePgn>513-7</MedlinePgn></Pagination><Abstract><AbstractText
        Label="BACKGROUND" NlmCategory="BACKGROUND">There is increasing concern about
        endocrine-disrupting chemicals (EDCs) which may produce adverse health effects
        in humans and other species. One such chemical, bisphenol-A (BPA), a monomer
        of polycarbonate plastics, is widely used in consumer products; it has been
        reported to contain estrogenic activity through binding to estrogen receptors.
        Cytochrome P450 mono-oxygenase 3A4 (CYP3A4) is one of the key enzymes for
        the metabolism of endogenous steroids and foreign chemicals in liver. The
        orphan nuclear receptor, steroid and xenobiotic receptor (SXR/PXR), has recently
        been isolated. A variety of known inducers of CYP3A4 bind to SXR/PXR, and
        stimulate transcription on xenobiotic-response elements (XREs) located in
        the promoter region of the CYP3A4 gene. Recent study has shown that EDCs,
        diethylhexylphthalate (DEHP) and nonylphenol, but not BPA, induce mouse SXR/PXR-mediated
        transcription. However, it is known that species differences in SXR alter
        CYP3A inducibility.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To
        test whether BPA stimulates human SXR/PXR-mediated transcription using reporter
        gene assays.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Transfection
        assays were performed with human SXR/PXR expression plasmid and a reporter
        plasmid containing the XREs in the CYP3A4 gene promoter in HepG2 cells. BPA-induced
        interaction of human SXR/PXR with steroid receptor coactivator-1 (SRC-1) was
        analyzed by mammalian two-hybrid assays.</AbstractText><AbstractText Label="RESULTS"
        NlmCategory="RESULTS">BPA, as well as DEHP, activated human SXR-mediated transcription
        on the XREs. In mammalian two-hybrid assays, BPA recruited SRC-1 to the ligand-binding
        domain of human SXR/PXR.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our
        observations have indicated that BPA may be a human-specific inducer of the
        CYP3A4 gene, and may influence the metabolism of endogenous steroids, drugs,
        and other xenobiotics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Takeshita</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division
        of Endocrinology and Metabolism, Toranomon Hospital, Okinaka Memorial Institute
        for Medical Research, Tokyo 105-8470, Japan. coactivator@mac.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Koibuchi</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Oka</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Taguchi</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Shishiba</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Ozawa</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur
        J Endocrinol</MedlineTA><NlmUniqueID>9423848</NlmUniqueID><ISSNLinking>0804-4643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001559">Benzhydryl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004968">Estrogens, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010636">Phenols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000077297">Pregnane X Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011987">Receptors, Steroid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D006899">Mixed Function Oxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="C104464">CYP3A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D051544">Cytochrome P-450 CYP3A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.55</RegistryNumber><NameOfSubstance UI="C510163">CYP3A4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.48</RegistryNumber><NameOfSubstance UI="D051548">Histone Acetyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.48</RegistryNumber><NameOfSubstance UI="C538859">NCOA1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.48</RegistryNumber><NameOfSubstance UI="C538861">Ncoa1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.48</RegistryNumber><NameOfSubstance UI="D056920">Nuclear Receptor Coactivator
        1</NameOfSubstance></Chemical><Chemical><RegistryNumber>MLT3645I99</RegistryNumber><NameOfSubstance
        UI="C006780">bisphenol A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D019677" MajorTopicYN="N">Artificial Gene Fusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001559" MajorTopicYN="N">Benzhydryl Compounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051544" MajorTopicYN="N">Cytochrome P-450 CYP3A</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004968" MajorTopicYN="N">Estrogens, Non-Steroidal</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051548" MajorTopicYN="N">Histone Acetyltransferases</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006899" MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D056920" MajorTopicYN="N">Nuclear Receptor Coactivator 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010636" MajorTopicYN="N">Phenols</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000077297" MajorTopicYN="N">Pregnane X Receptor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011987" MajorTopicYN="N">Receptors, Steroid</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>1</Month><Day>5</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11581012</ArticleId><ArticleId IdType="doi">10.1530/eje.0.1450513</ArticleId><ArticleId
        IdType="pii">1450513</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3621460</PMID><DateCompleted><Year>1987</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>1987</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Lack
        of DNA damage or lipid peroxidation measured in vivo in the rat liver following
        treatment with peroxisomal proliferators.</ArticleTitle><Pagination><StartPage>1213</StartPage><EndPage>1218</EndPage><MedlinePgn>1213-8</MedlinePgn></Pagination><Abstract><AbstractText>This
        study was undertaken to investigate the hypothesis linking peroxisome proliferation
        with the production of reactive oxygen species and subsequent DNA damage.
        Hepatic peroxisomal proliferation was induced in male Wistar-derived rats
        by the administration of clofibrate, methyl clofenapate, di(2-ethylhexyl)phthalate,
        or its metabolite mono (2-ethylhexyl)phthalate (MEHP) for periods of up to
        28 days. Genotoxicity was monitored using an alkaline elution technique to
        assay for DNA strandbreaks and cytotoxicity was monitored by measuring lipid
        peroxidation. Both parameters might be expected to be elevated if peroxisome
        proliferation is accompanied by an elevated level of oxygen free radicals
        within the cell. Enzyme measurements made on the livers of the treated rats
        showed that peroxisomal palmitoyl CoA oxidase activity was markedly increased
        over control whereas peroxisomal catalase activity was not. In addition, both
        the cytosolic glutathione peroxidase and superoxide dismutase activities were
        found to be lowered in the treated animals by up to 50 and 20% respectively.
        Despite such changes in enzyme activity, no evidence for increases in DNA
        strandbreaks or lipid peroxidation was obtained with any of the chemicals
        at any of the time points examined. DNA strandbreaks were also assayed on
        hepatocytes treated in culture with MEHP (0.5 mM) for 3 days and then exposed
        to inhibitors of DNA repair for 2 h immediately before assay. Again, no significant
        increase over controls was observed. Our data suggest that any increase in
        radical production in the livers of rats exposed to peroxisome proliferators
        is not large enough to give rise to a biologically significant degree of DNA
        damage and that the mechanism whereby such chemicals produce liver tumours
        in certain rodent species may be one other than simply DNA damage due to increased
        production of radical species.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Elliott</LastName><ForeName>B M</ForeName><Initials>BM</Initials></Author><Author
        ValidYN="Y"><LastName>Elcombe</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008054">Lipid Peroxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>21340-68-1</RegistryNumber><NameOfSubstance
        UI="D002992">Clofenapate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.9</RegistryNumber><NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002992" MajorTopicYN="N">Clofenapate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005979" MajorTopicYN="N">Glutathione Peroxidase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008054" MajorTopicYN="N">Lipid Peroxides</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3621460</ArticleId><ArticleId IdType="doi">10.1093/carcin/8.9.1213</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">30884453</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>11</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7077</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>68</Volume><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Environmental
        toxicology and pharmacology</Title><ISOAbbreviation>Environ Toxicol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Di(2-ethylhexyl)
        phthalate promotes hepatic fibrosis by regulation of oxidative stress and
        inflammation responses in rats.</ArticleTitle><Pagination><StartPage>109</StartPage><EndPage>119</EndPage><MedlinePgn>109-119</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.etap.2019.03.008</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S1382-6689(18)30308-9</ELocationID><Abstract><AbstractText>Di(2-ethylhexyl)
        phthalate (DEHP) is an environmental pollutant that is widely used in medical
        and consumer products. An epidemiological study has suggested that a large
        daily intake of DEHP from phthalate-contaminated food may be a risk factor
        for liver dysfunction. Long-term exposure to DEHP is associated with liver
        disease and exacerbates the progression of chronic liver injury. However,
        the effect of DEHP on hepatic fibrosis is rarely studied. In the present study,
        we sought to determine the effect of DEHP on carbon tetrachloride (CCl4)-induced
        liver fibrosis, and to further examine the molecular mechanisms. We found
        that DEHP exposure remarkably promoted liver inflammation, necrosis and fibrosis,
        and increased expression of the protein associated with liver inflammation
        and fibrogenesis, including &#x3b1;-SMA, COL-&#x2160;, COL-&#x2162;, TGF-&#x3b2;1,
        P-Smad2, P-Smad3, P-p38 and P-p65. The similar trend was observed in the LX-2
        cells. Furthermore, DEHP exposure induced oxidative stress and inflammatory
        cytokine production. Taken together, DEHP might play a fibrotic role in hepatic
        fibrosis rats and TGF-&#x3b2;1-stimulated LX-2 cells in vitro which was related
        to TGF-&#x3b2;1/Smad and p38MAPK/NF-&#x3ba;B signal pathway.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zong-Biao</ForeName><Initials>ZB</Initials><AffiliationInfo><Affiliation>Institute
        of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory
        and Immune Medicine of Education Ministry, Anhui Collaborative Innovation
        Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ji</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute
        of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory
        and Immune Medicine of Education Ministry, Anhui Collaborative Innovation
        Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shen</LastName><ForeName>Xin-Yue</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Institute
        of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory
        and Immune Medicine of Education Ministry, Anhui Collaborative Innovation
        Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wen-Wen</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Institute
        of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory
        and Immune Medicine of Education Ministry, Anhui Collaborative Innovation
        Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute
        of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory
        and Immune Medicine of Education Ministry, Anhui Collaborative Innovation
        Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Xu</LastName><ForeName>Wei-Ping</ForeName><Initials>WP</Initials><AffiliationInfo><Affiliation>Anhui
        Provincial Hospital, Hefei 230001, Anhui, China. Electronic address: xu_weiping666@163.com.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute
        of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory
        and Immune Medicine of Education Ministry, Anhui Collaborative Innovation
        Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.
        Electronic address: wwei@ahmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Environ
        Toxicol Pharmacol</MedlineTA><NlmUniqueID>9612020</NlmUniqueID><ISSNLinking>1382-6689</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D051785">Smad Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D053773">Transforming Growth Factor beta1</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.24</RegistryNumber><NameOfSubstance UI="D048051">p38 Mitogen-Activated
        Protein Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051785" MajorTopicYN="N">Smad Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D048051" MajorTopicYN="N">p38 Mitogen-Activated Protein Kinases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">DEHP</Keyword><Keyword MajorTopicYN="N">Hepatic
        fibrosis</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword
        MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">TGF-&#x3b2;1</Keyword><Keyword
        MajorTopicYN="N">p38MAPK</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2018</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">30884453</ArticleId><ArticleId IdType="doi">10.1016/j.etap.2019.03.008</ArticleId><ArticleId
        IdType="pii">S1382-6689(18)30308-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11940454</PMID><DateCompleted><Year>2002</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0091-6765</ISSN><JournalIssue
        CitedMedium="Print"><Volume>110</Volume><Issue>4</Issue><PubDate><Year>2002</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Prediction
        of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue
        changes in rodents following exposure to nine nongenotoxic NTP carcinogens.</ArticleTitle><Pagination><StartPage>363</StartPage><EndPage>375</EndPage><MedlinePgn>363-75</MedlinePgn></Pagination><Abstract><AbstractText>We
        studied nine presumed nongenotoxic rodent carcinogens, as defined by the U.S.
        National Toxicology Program (NTP), to determine their ability to induce acute
        or subacute biochemical and tissue changes that may act as useful predictors
        of nongenotoxic rodent carcinogenesis. The chemicals selected included six
        liver carcinogens (two of which are peroxisome proliferators), three thyroid
        gland carcinogens, and four kidney carcinogens. We administered the chemicals
        (diethylhexyl phthalate, cinnamyl anthranilate, chlorendic acid, 1,4-dichlorobenzene,
        monuron, ethylene thiourea, diethyl thiourea, trimethyl thiourea, and d-limonene
        to the same strains of mice and rats used in the original NTP bioassays (nine
        chemicals to rats and seven to mice). Selected tissues (liver, thyroid gland,
        and kidney) were collected from groups of animals at 7, 28, and 90 days for
        evaluation. Tissue changes selected for study were monitored for all of the
        test groups, irrespective of the specificity of the carcinogenic responses
        observed in those tissues. This allowed us to assess both the carcinogen specificity
        and the carcinogen sensitivity of the events being monitored. We studied relative
        weight, cell labeling indices, and pathologic changes such as hypertrophy
        in all tissues; a range of cytochrome P450 enzymes and palmitoyl coenzyme
        A oxidase in the liver; changes in the levels of plasma total triiodothyronine,
        total thyroxine, and thyroid-stimulating hormone (TSH) as markers of thyroid
        gland function; and hyaline droplet formation, tubular basophilia, and the
        formation of granular casts in the kidney. There were no single measurements
        that alerted specifically to the carcinogenicity of the agents to the rodent
        liver, thyroid gland, or kidney. However, in the majority of cases, the chemical
        induction of cancer in a tissue was preceded by a range of biochemical/morphologic
        changes, most of which were moderately specific for a carcinogenic outcome,
        and some of which were highly specific for it (e.g., increases in TSH in the
        thyroid gland and increases in relative liver weight in the mouse). The only
        measurements that failed to correlate usefully with carcinogenicity were the
        induction of liver enzymes (with the exception of the enzymes associated with
        peroxisome proliferation). Most of the useful markers were evident at the
        early times studied (7 days and 28 days), but no overall best time for the
        measurement of all markers was identified. The judicious choice of markers
        and evaluation times can aid the detection of potential nongenotoxic rodent
        carcinogens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elcombe</LastName><ForeName>Clifford
        R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Syngenta
        Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, United
        Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odum</LastName><ForeName>Jenny</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Foster</LastName><ForeName>John R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Stone</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Hasmall</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Soames</LastName><ForeName>Anthony R</ForeName><Initials>AR</Initials></Author><Author
        ValidYN="Y"><LastName>Kimber</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author><Author
        ValidYN="Y"><LastName>Ashby</LastName><ForeName>John</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001681" MajorTopicYN="N">Biological Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000009"
        MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002471" MajorTopicYN="Y">Cell Transformation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>4</Month><Day>10</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>5</Month><Day>15</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>4</Month><Day>10</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11940454</ArticleId><ArticleId IdType="pmc">PMC1240799</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.02110363</ArticleId><ArticleId IdType="pii">sc271_5_1835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J
        Biol Chem. 1951 Nov;193(1):265-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14907713</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1964 Jul;239:2370-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14209971</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Pathol. 1999 Nov-Dec;27(6):618-27</Citation><ArticleIdList><ArticleId IdType="pubmed">10588541</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1999;895:56-79</Citation><ArticleIdList><ArticleId IdType="pubmed">10676409</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Sci. 2000 Feb;53(2):213-23</Citation><ArticleIdList><ArticleId IdType="pubmed">10696769</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Pathol. 2001;29 Suppl:177-82</Citation><ArticleIdList><ArticleId IdType="pubmed">11695555</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1979 Jun 13;88(3):1030-6</Citation><ArticleIdList><ArticleId
        IdType="pubmed">465070</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC
        Sci Publ. 1980;(27):343-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7002781</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1986 Oct;41(2):161-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2429405</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1987 May;44(2):213-28</Citation><ArticleIdList><ArticleId IdType="pubmed">3564055</ArticleId></ArticleIdList></Reference><Reference><Citation>Food
        Chem Toxicol. 1987 May;25(5):345-53</Citation><ArticleIdList><ArticleId IdType="pubmed">3609973</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Ind Health. 1987 Jun;3(2):7-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3617071</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1987 Oct;74:229-35</Citation><ArticleIdList><ArticleId IdType="pubmed">3691430</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1988 Jan;92(1):103-12</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3341020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1988 Dec 1;48(23):6739-44</Citation><ArticleIdList><ArticleId IdType="pubmed">3180084</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1988 Nov;9(11):2045-52</Citation><ArticleIdList><ArticleId IdType="pubmed">3052903</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1989 Jun 15;99(2):216-28</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2734788</ArticleId></ArticleIdList></Reference><Reference><Citation>Fundam
        Appl Toxicol. 1989 May;12(4):629-97</Citation><ArticleIdList><ArticleId IdType="pubmed">2663577</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        J. 1989 Aug 15;262(1):151-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2818560</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1991 May;257(3):229-306</Citation><ArticleIdList><ArticleId IdType="pubmed">1707500</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Carcinog. 1991;4(6):420-40</Citation><ArticleIdList><ArticleId IdType="pubmed">1793481</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis.
        1992 Mar;13(3):409-15</Citation><ArticleIdList><ArticleId IdType="pubmed">1547531</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Pathol. 1998 Jul-Aug;26(4):474-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9715505</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1998 Nov 16;131(2-3):73-91</Citation><ArticleIdList><ArticleId IdType="pubmed">9928623</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Toxicol. 1998 Dec;72(12):784-90</Citation><ArticleIdList><ArticleId IdType="pubmed">9950075</ArticleId></ArticleIdList></Reference><Reference><Citation>Regul
        Toxicol Pharmacol. 1999 Feb;29(1):23-36</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10051416</ArticleId></ArticleIdList></Reference><Reference><Citation>Xenobiotica.
        1992 Jan;22(1):83-103</Citation><ArticleIdList><ArticleId IdType="pubmed">1615711</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1993 Mar;99:313-49</Citation><ArticleIdList><ArticleId IdType="pubmed">7686485</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Histochem Cytochem. 1994 Jul;42(7):939-44</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8014477</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum
        Exp Toxicol. 1994 Nov;13 Suppl 2:S1-117</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7857698</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1995 Oct;103(10):942-50</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8529591</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp
        Toxicol Pathol. 1996 Feb;48(2-3):169-74</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8672871</ArticleId></ArticleIdList></Reference><Reference><Citation>Regul
        Toxicol Pharmacol. 1996 Apr;23(2):117-27</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8661330</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1997 Feb;142(2):338-47</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9070357</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Comp Pathol. 1997 Feb;116(2):113-44</Citation><ArticleIdList><ArticleId IdType="pubmed">9131429</ArticleId></ArticleIdList></Reference><Reference><Citation>Fundam
        Appl Toxicol. 1997 Sep;39(1):60-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9325028</ArticleId></ArticleIdList></Reference><Reference><Citation>Fundam
        Appl Toxicol. 1997 Sep;39(1):67-75</Citation><ArticleIdList><ArticleId IdType="pubmed">9325029</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Pathol. 1998 Jan-Feb;26(1):104-12</Citation><ArticleIdList><ArticleId IdType="pubmed">9502392</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">17098345</PMID><DateCompleted><Year>2007</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>229</Volume><Issue>1-2</Issue><PubDate><Year>2007</Year><Month>Jan</Month><Day>05</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>A
        dose-response study following in utero and lactational exposure to di-(2-ethylhexyl)
        phthalate (DEHP): reproductive effects on adult female offspring rats.</ArticleTitle><Pagination><StartPage>114</StartPage><EndPage>122</EndPage><MedlinePgn>114-22</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)
        phthalate (DEHP) is used in numerous consumer products, mainly imparting flexibility
        and durability to polyvinyl chloride (PVC) based plastics. It is a known reproductive
        and developmental toxicant in male rodents. However, data regarding effects
        of DEHP on female reproductive health are particularly sparse. We performed
        an extensive dose-response study following developmental exposure to DEHP
        and evaluated the effects on adult female reproductive function. Two wide
        ranges of doses, low and high, were tested. Female Wistar rats were treated
        daily with DEHP and peanut oil (vehicle control) by gavage from gestation
        day 6 to lactation day 21. The low doses were: 0.015, 0.045, 0.135, 0.405
        and 1.215mgDEHP/kg/bw/day and the high doses were: 5, 15, 45, 135 and 405mg
        DEHP/kg/bw/day. At the doses tested, no effects on organ (liver, kidney, spleen,
        thymus, thyroid, ovary and uterus) or body weights were detected. Female offspring
        presented a normal pattern of estrous cyclicity with no hormonal alterations
        (serum estradiol and progesterone). A statistically significant increase in
        tertiary atretic follicles was observed at the highest dose (405mgDEHP/kg/day).
        Morphometric analysis indicated that uterus and vagina luminal epithelial
        cell height were unaffected by treatment. An increase in the number of ovarian
        atretic tertiary follicles was the only effect observed in adult female offspring
        exposed in utero and during lactation to DEHP.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Grande</LastName><ForeName>Simone
        W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Charit&#xe9;
        University Medical School Berlin, Campus Benjamin Franklin, Institute of Clinical
        Pharmacology and Toxicology, Department of Toxicology, Garystrasse 5, 14195
        Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Anderson
        J M</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Talsness</LastName><ForeName>Chris
        E</ForeName><Initials>CE</Initials></Author><Author ValidYN="Y"><LastName>Grote</LastName><ForeName>Konstanze</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Golombiewski</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Sterner-Kock</LastName><ForeName>Anja</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Chahoud</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2006</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004031" MajorTopicYN="N">Diestrus</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004971" MajorTopicYN="N">Estrus</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007441" MajorTopicYN="N">Intubation, Gastrointestinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007774" MajorTopicYN="N">Lactation</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018811" MajorTopicYN="N">Maternal Exposure</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008431" MajorTopicYN="N">Maternal-Fetal Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006080" MajorTopicYN="N">Ovarian Follicle</DescriptorName><QualifierName
        UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="N">Prenatal Exposure Delayed Effects</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014599" MajorTopicYN="N">Uterus</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014621" MajorTopicYN="N">Vagina</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2006</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2006</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2006</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2006</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2007</Year><Month>4</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2006</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">17098345</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2006.10.005</ArticleId><ArticleId
        IdType="pii">S0300-483X(06)00612-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">29197930</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>24</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0738</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>92</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>The
        PPAR&#x3b1;-dependent rodent liver tumor response is not relevant to humans:
        addressing misconceptions.</ArticleTitle><Pagination><StartPage>83</StartPage><EndPage>119</EndPage><MedlinePgn>83-119</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1007/s00204-017-2094-7</ELocationID><Abstract><AbstractText>A
        number of industrial chemicals and therapeutic agents cause liver tumors in
        rats and mice by activating the nuclear receptor peroxisome proliferator-activated
        receptor &#x3b1; (PPAR&#x3b1;). The molecular and cellular events by which
        PPAR&#x3b1; activators induce rodent hepatocarcinogenesis have been extensively
        studied elucidating a number of consistent mechanistic changes linked to the
        increased incidence of liver neoplasms. The weight of evidence relevant to
        the hypothesized mode of action (MOA) for PPAR&#x3b1; activator-induced rodent
        hepatocarcinogenesis is summarized here. Chemical-specific and mechanistic
        data support concordance of temporal and dose-response relationships for the
        key events associated with many PPAR&#x3b1; activators. The key events (KE)
        identified in the MOA are PPAR&#x3b1; activation (KE1), alteration in cell
        growth pathways (KE2), perturbation of hepatocyte growth and survival (KE3),
        and selective clonal expansion of preneoplastic foci cells (KE4), which leads
        to the apical event-increases in hepatocellular adenomas and carcinomas (KE5).
        In addition, a number of concurrent molecular and cellular events have been
        classified as modulating factors, because they potentially alter the ability
        of PPAR&#x3b1; activators to increase rodent liver cancer while not being
        key events themselves. These modulating factors include increases in oxidative
        stress and activation of NF-kB. PPAR&#x3b1; activators are unlikely to induce
        liver tumors in humans due to biological differences in the response of KEs
        downstream of PPAR&#x3b1; activation. This conclusion is based on minimal
        or no effects observed on cell growth pathways and hepatocellular proliferation
        in human primary hepatocytes and absence of alteration in growth pathways,
        hepatocyte proliferation, and tumors in the livers of species (hamsters, guinea
        pigs and cynomolgus monkeys) that are more appropriate human surrogates than
        mice and rats at overlapping dose levels. Despite this overwhelming body of
        evidence and almost universal acceptance of the PPAR&#x3b1; MOA and lack of
        human relevance, several reviews have selectively focused on specific studies
        that, as discussed, contradict the consensus opinion and suggest uncertainty.
        In the present review, we systematically address these most germane suggested
        weaknesses of the PPAR&#x3b1; MOA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Corton</LastName><ForeName>J Christopher</ForeName><Initials>JC</Initials><Identifier
        Source="ORCID">0000-0002-6197-2036</Identifier><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, National Health and Environmental Effects Research
        Laboratory, U.S. Environmental Protection Agency, 109 T.W. Alexander Dr, MD-B105-03,
        Research Triangle Park, NC, 27711, USA. corton.chris@epa.gov.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>The
        Department of Veterinary and Biomedical Sciences and Center for Molecular
        Toxicology and Carcinogenesis, The Pennsylvania State University, University
        Park, PA, 16803, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaunig</LastName><ForeName>James
        E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department
        of Environmental Health, Indiana University, Bloomington, IN, 47402, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>EPA999999</GrantID><Agency>Intramural EPA</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000073931" MajorTopicYN="N">Adverse Outcome Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="N">PPAR alpha</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012377" MajorTopicYN="Y">Rodentia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Human relevancy framework</Keyword><Keyword
        MajorTopicYN="N">Key events</Keyword><Keyword MajorTopicYN="N">Liver cancer</Keyword><Keyword
        MajorTopicYN="N">Mode of action</Keyword><Keyword MajorTopicYN="N">NF-kB</Keyword><Keyword
        MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Peroxisome
        proliferator-activated receptor &#x3b1; (PPAR&#x3b1;)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2017</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">29197930</ArticleId><ArticleId IdType="mid">NIHMS936806</ArticleId><ArticleId
        IdType="pmc">PMC6092738</ArticleId><ArticleId IdType="doi">10.1007/s00204-017-2094-7</ArticleId><ArticleId
        IdType="pii">10.1007/s00204-017-2094-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdellatif
        AG, Preat V, Vamecq J, Nilsson R, Roberfroid M. (1990). Peroxisome proliferation
        and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid,
        2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopindichlorophenoxyacetic
        acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin.
        Carcinogenesis 11(11): 1899&#x2013;1902.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2225320</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsarra
        IA, Brockmann WG, Cunningham ML, Badr MZ. (2006). Hepatocellular proliferation
        in response to agonists of peroxisome proliferator-activated receptor alpha:
        a role for Kupffer cells? J Carcinog 5: 26.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1684246</ArticleId><ArticleId IdType="pubmed">17129391</ArticleId></ArticleIdList></Reference><Reference><Citation>Amacher
        DE, Beck R, Schomaker SJ, Kenny CV. Hepatic microsomal enzyme induction, beta-oxidation,
        and cell proliferation following administration of clofibrate, gemfibrozil,
        or bezafibrate in the CD rat. Toxicol Appl Pharmacol. 1997. January;142(1):143&#x2013;50.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9007043</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson
        SP, Dunn C, Laughter A, Yoon L, Swanson C, Stulnig TM, Steffensen KR, Chandraratna
        RA, Gustafsson JA, Corton JC. (2004a). Overlapping transcriptional programs
        regulated by the nuclear receptors peroxisome proliferator-activated receptor
        alpha, retinoid X receptor, and liver X receptor in mouse liver. Mol Pharmacol
        66(6):1440&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">15371561</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson
        SP, Dunn CS, Cattley RC, Corton JC. (2001). Hepatocellular proliferation in
        response to a peroxisome proliferator does not require TNF&#x3b1;lpha signaling.
        Carcinogenesis 22: 1843&#x2013;1851.</Citation><ArticleIdList><ArticleId IdType="pubmed">11698348</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson
        SP, Howroyd P, Liu J, Qian X, Bahnemann R, Swanson C, Kwak MK, Kensler TW,
        Corton JC. (2004b). The transcriptional response to a peroxisome proliferator-activated
        receptor alpha agonist includes increased expression of proteome maintenance
        genes. J Biol Chem 279(50):52390&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15375163</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson
        SP, Yoon L, Richard EB, Dunn CS, Cattley RC, Corton JC. (2002). Delayed liver
        regeneration in peroxisome proliferator-activated receptor-alpha-null mice.
        Hepatology 36(3):544&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">12198646</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama
        T, . Peters J, Iritani N, Nakajima T, Furihata K, Hashimotot T, Gonzalez FJ.
        et al. (1998). Altered Constitutive Expression of Fatty Acid-metabolizing
        Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor &#x3b1;
        (PPAR&#x3b1;). J Biol Chem 273 (10) 5678&#x2013;5684.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9488698</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsura
        M, Cavin LG. (2005). Nuclear factor-kappaB and liver carcinogenesis. Cancer
        Lett 229(2):157&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">16125305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashby
        J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, Tugwood JD, Kettle
        S, Purchase IF. (1994). Mechanistically-based human hazard assessment of peroxisome
        proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol 13 Suppl 2: S1&#x2013;117.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7857698</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin
        EW, Okita JR, Okita RT, Larson JL, Bull RJ. (1995). Modification of lipoperoxidative
        effects of dichloroacetate and trichloroacetate is associated with peroxisome
        proliferation. Toxicology 97(1-3): 59&#x2013;69.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7716793</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrass
        NC, Price RJ, Lake BG, Orton TC. (1993). Comparison of the acute and chronic
        mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric
        acid in rat liver. Carcinogenesis 14(7): 1451&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8330363</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayly
        AC, Roberts RA, Dive C. (1994). Suppression of liver cell apoptosis in vitro
        by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin.
        J Cell Biol 125(1): 197&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120009</ArticleId><ArticleId
        IdType="pubmed">8138571</ArticleId></ArticleIdList></Reference><Reference><Citation>Becuwe
        P, Dau&#xe7;a M (2005). Comparison of cytotoxicity induced by hypolipidemic
        drugs via reactive oxygen species in human and rodent liver cells. Int J Mol
        Med 16(3):483&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">16077959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell
        AR, Savory R, Horley NJ, Choudhury AI, Dickins M, Gray TJ, Salter SM, Bell
        DR. (1998). Molecular basis of non-responsiveness to peroxisome proliferators:
        the guinea-pig PPAR&#x3b1; is functional and mediates peroxisome proliferator-induced
        hypolipidaemia. Biochem J 332 (Pt 3): 689&#x2013;93.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1219529</ArticleId><ArticleId IdType="pubmed">9620871</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell
        DR, Plant NJ, Rider CG, Na L, Brown S, Ateitalla I, Acharya SK, Davies MH,
        Elias E, Jenkins NA, et al. (1993). Species-specific induction of cytochrome
        P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs.
        Biochem J 294 ( Pt 1):173&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1134581</ArticleId><ArticleId
        IdType="pubmed">8363569</ArticleId></ArticleIdList></Reference><Reference><Citation>Benninghoff
        AD, Bisson WH, Koch DC, Ehresman DJ, Kolluri SK, Williams DE. Estrogen-like
        activity of perfluoroalkyl acids in vivo and interaction with human and rainbow
        trout estrogen receptors in vitro. Toxicol Sci. 2011. March;120(1):42&#x2013;58.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3044205</ArticleId><ArticleId IdType="pubmed">21163906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentley
        P, Calder I, Elcombe C, Grasso P, Stringer D, Wiegand HJ. (1993). Hepatic
        peroxisome proliferation in rodents and its significance for humans. Food
        Chem Toxicol 31:857&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">8258416</ArticleId></ArticleIdList></Reference><Reference><Citation>Biegel
        LB, Hurtt ME, Frame SR, O&#x2019;Connor JC, Cook JC. (2001). Mechanisms of
        extrahepatic tumor induction by peroxisome proliferators in male CD rats.
        Toxicol Sci 60(1): 44&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">11222872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bility
        MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM.
        (2004). Activation of mouse and human peroxisome proliferator-activated receptors
        (PPARs) by phthalate monoesters. Toxicol Sci 82(1): 170&#x2013;182.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15310864</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumcke
        S, Schwartzkopff W, Lobeck H, Edmondson NA, Prentice DE, Blane GF (1983).
        Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic
        patients. Atherosclerosis 46:105&#x2013;116.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6838687</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojes
        HK, Germolec DR, Simeonova P, Bruccolrei A, Schoonhoven R, Luster MI, Thurman
        RG. (1997). Antibodies to tumor necrosis factor alpha prevent increases in
        cell replication in liver due to the potent peroxisome proliferator WY14,643.
        Carcinogenesis 18:669&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">9111198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonovas
        S, Sitaras NM. Editorial: prophylactic treatment with antiviral agents to
        prevent infection and disease. Curr Med Chem. 2012;19(35):5923.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">22963559</ArticleId></ArticleIdList></Reference><Reference><Citation>Boobis
        AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J,
        Seed J, Vickers C. (2008). IPCS framework for analyzing the relevance of a
        noncancer mode of action for humans. Crit Rev Toxicol 38(2):87&#x2013;96.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18259981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull
        RJ, Orner GA, Cheng RS, Stillwell L, Stauber AJ, Sasser LB, Lingohr MK, Thrall
        BD. (2002). Contribution of dichloroacetate and trichloroacetate to liver
        tumor induction in mice by trichloroethylene. Toxicol Appl Pharmacol 182(1):
        55&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">12127263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull
        RJ, Sanchez IM, Nelson MA, Larson JL, Lansing AJ. (1990). Liver tumor induction
        in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63(3):
        341&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">2219130</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt
        S, Mellert W, Reinacher M, Bahnenmann R. (2001). Zonal evaluation of proliferation
        and apoptosis in mice reveals new mechanistic data for PB, WY 14,643 and CH.
        Toxicologist 60:286.</Citation></Reference><Reference><Citation>Bursch W,
        Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schulte-Hermann R.
        (1984). Controlled death (apoptosis) of normal and putative preneoplastic
        cells in rat liver following withdrawal of tumor promoters. Carcinogenesis
        5(4):453&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">6231134</ArticleId></ArticleIdList></Reference><Reference><Citation>Busser
        MT, Lutz WK. (1987). Stimulation of DNA synthesis in rat and mouse liver by
        various tumor promoters. Carcinogenesis 8(10): 1433&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2443263</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai
        Y, Appelkvist EL, DePierre JW. (1995). Hepatic oxidative stress and related
        defenses during treatment of mice with acetylsalicylic acid and other peroxisome
        proliferators. J Biochem Toxicol 10(2): 87&#x2013;94.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7562957</ArticleId></ArticleIdList></Reference><Reference><Citation>Caira
        F, Cl&#xe9;mencet MC, Cherkaoui-Malki M, Dieuaide-Noubhani M, Pacot C, Van
        Veldhoven PP, Latruffe N. (1998). Differential regulation by a peroxisome
        proliferator of the different multifunctional proteins in guinea pig: cDNA
        cloning of the guinea pig D-specific multifunctional protein 2. Biochem J
        330 (Pt 3):1361&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1219283</ArticleId><ArticleId
        IdType="pubmed">9494107</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldwell
        JC. DEHP: genotoxicity and potential carcinogenic mechanisms-a review. Mutat
        Res. 2012. Oct-Dec;751(2):82&#x2013;157.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">22484601</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee-Mason
        KG, Lee EY, Spear BT, Glauert HP. Role of the p50 subunit of NF-kappaB in
        vitamin E-induced changes in mice treated with the peroxisome proliferator,
        ciprofibrate. Food Chem Toxicol. 2008. June;46(6):2062&#x2013;73.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2600965</ArticleId><ArticleId IdType="pubmed">18336980</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee-Mason
        KG, Spear BT, Glauert HP. (2004). Effects of vitamin E on the NF-kappaB pathway
        in rats treated with the peroxisome proliferator, ciprofibrate. Toxicol Appl
        Pharmacol 199(1): 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15289085</ArticleId></ArticleIdList></Reference><Reference><Citation>Cariello
        NF, Romach EH, Colton HM, Ni H, Yoon L, Falls JG, Casey W, Creech D, Anderson
        SP, Benavides GR, Hoivik DJ, Brown R, Miller RT. (2005). Gene expression profiling
        of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. Toxicol
        Sci 88(1):250&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">16081524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, Conway JG, Popp JA. (1987). Association of persistent peroxisome proliferation
        and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate
        for 2 years. Cancer Lett 38(1-2): 15&#x2013;22.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3690505</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, DeLuca J, Elcombe C, Fenner-Crisp P, Lake BG, Marsman DS, Pastoor TA,
        Popp JA, Robinson DE, Schwetz B, Tugwood J, Wahli W. (1998). Do peroxisome
        proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul
        Toxicol Pharmacol 27: 47&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">9618323</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, Marsman DS, Popp JA. (1991). Age-related susceptibility to the carcinogenic
        effect of the peroxisome proliferatorWY14,643 in rat liver. Carcinogenesis
        12:469&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">1849052</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, Popp JA. (1989). Differences between the promoting activities of the peroxisome
        proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res 49(12):
        3246&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">2566380</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan
        E, Tan CS, Deurenberg-Yap M, Chia KS, Chew SK, Tai ES. (2006). The V227A polymorphism
        at the PPAR&#x391; locus is associated with serum lipid concentrations and
        modulates the association between dietary polyunsaturated fatty acid intake
        and serum high density lipoprotein concentrations in Chinese women. Atherosclerosis
        187(2):309&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">16288935</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang
        CK, Llanes S, Schumer W. Effect of dexamethasone on NF-kB activation, tumor
        necrosis factor formation, and glucose dyshomeostasis in septic rats. J Surg
        Res. 1997. October;72(2):141&#x2013;5.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9356235</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen
        C, Hennig GE, Whiteley HE, Corton JC, Manautou JE. Peroxisome proliferator-activated
        receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following
        clofibrate exposure. Toxicol Sci. 2000. October;57(2):338&#x2013;44.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11006363</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen
        H, Huang CY, Wilson MW, Lay LT, Robertson LW, Chow CK, Glauert HP. (1994).
        Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic
        acid on hepatic cell proliferation and toxicity in Sprague Dawley rats. Carcinogenesis
        15(12): 2847&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">8001245</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung
        C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ. (2004).
        Diminished hepatocellular proliferation in mice humanized for the nuclear
        receptor peroxisome proliferator-activated receptor alpha. Cancer Res 64(11):3849&#x2013;54.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15172993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinje
        E, Kentish P, Jarnot B, George M, Gibson G. (1994). Induction of the CYP4A
        subfamily by perfluorodecanoic acid: the rat and the guinea pig as susceptible
        and non-susceptible species. Toxicol Lett 71(1):69&#x2013;75.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8140591</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury
        AI, Chahal S, Bell AR, Tomlinson SR, Roberts RA, Salter AM, Bell DR. (2000).
        Species differences in peroxisome proliferation; mechanisms and relevance.
        Mutat Res 448(2):201&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725473</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury
        AI, Sims HM, Horley NJ, Roberts RA, Tomlinson SR, Salter AM, Bruce M, Shaw
        PN, Kendall D, Barrett DA, Bell DR. (2004). Molecular analysis of peroxisome
        proliferation in the hamster. Toxicol Appl Pharmacol 197(1):9&#x2013;18.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15126070</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen
        JG, Gonzales AJ, Cattley RC, Goldsworthy TL. (1998). Regulation of apoptosis
        in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens.
        Cell Growth Differ 9(9): 815&#x2013;25.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9751125</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen
        SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow
        DG, Seed J, Dellarco V, Fenner-Crisp P, Patton D. (2004). Evaluating the human
        relevance of chemically induced animal tumors. Toxicol Sci 78(2):181&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14737005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen
        SM, Meek ME, Klaunig JE, Patton DE, Fenner-Crisp PA. (2003). The Human Relevance
        of Information on Carcinogenic Modes of Action: Overview. Crit Rev Toxicol
        33(6):581&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">14727732</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee
        of Principal Investigators (1978). A cooperative trial in the primary prevention
        of ischemic heart disease using clofibrate. Br Heart J 40: 1069&#x2013;1118.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC483536</ArticleId><ArticleId IdType="pubmed">361054</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway
        JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, Popp JA. (1989). Relationship
        of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators
        di(2-ethylhexyl)phthalate and WY-14,643. Carcinogenesis 10(3): 513&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2924396</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornu-Chagnon
        MC, Dupont H, Edgar A. (1995). Fenofibrate: Metabolism and species differences
        for peroxisome proliferation in cultured hepatocytes. Fundam Appl Toxicol
        26:63&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">7657063</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton
        JC, Anderson SP, Stauber A. (2000). Central role of peroxisome proliferator-activated
        receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol
        40: 491&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">10836145</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton
        JC, Apte U, Anderson SP, Limaye P, Yoon L, Latendresse J, Dunn C, Everitt
        JI, Voss KA, Swanson C, Kimbrough C, Wong JS, Gill SS, Chandraratna RA, Kwak
        MK, Kensler TW, Stulnig TM, Steffensen KR, Gustafsson JA, Mehendale HM. (2004).
        Mimetics of caloric restriction include agonists of lipid-activated nuclear
        receptors. J Biol Chem 279(44):46204&#x2013;12.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15302862</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton
        JC, Lapinskas PJ. (2005). Peroxisome proliferator-activated receptors: mediators
        of phthalate ester-induced effects in the male reproductive tract? Toxicol
        Sci 83(1): 4&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">15496498</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton
        JC. (2008). Evaluation of the role of peroxisome proliferator-activated receptor
        alpha (PPAR&#x3b1; in mouse liver tumor induction by trichloroethylene and
        metabolites. Crit Rev Toxicol 38(10):857&#x2013;75.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18821149</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton
        JC. (2010). Mode of Action Analysis and Human Relevance of Liver Tumors Induced
        by PPAR&#x3b1; Activation In Cancer Risk Assessment: Chemical Carcinogenesis
        from Biology to Standards Quantification, Hsu Ching-Hung and Stedeford Todd
        (editors), John Wiley and Sons, Inc., Hoboken, New Jersey.</Citation></Reference><Reference><Citation>Cunningham
        ML, Collins BJ, Hejtmancik MR, Herbert RA, Travlos GS, Vallant MK, Stout MD.
        (2010). Effects of the PPAR&#x3b1; agonist and widely used antihyperlipidemic
        drug gemfibrozil on hepatic toxicity and lipid metabolism. PPAR Research pii:
        681963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952818</ArticleId><ArticleId
        IdType="pubmed">20953357</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham
        ML. Toxicity studies of WY-14,643 (CAS No. 50892-23-4) administered in feed
        to male Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters. Toxic Rep Ser.
        2007. October;(62):1&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">24743700</ArticleId></ArticleIdList></Reference><Reference><Citation>Currie
        RA, Bombail V, Oliver JD, Moore DJ, Lim FL, Gwilliam V, Kimber I, Chipman
        K, Moggs JG, Orphanides G. (2005). Gene ontology mapping as an unbiased method
        for identifying molecular pathways and processes affected by toxicant exposure:
        application to acute effects caused by the rodent non-genotoxic carcinogen
        diethylhexylphthalate. Toxicol Sci 86(2):453&#x2013;69.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15901911</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaja
        MJ. (2007). Cell signaling in oxidative stress-induced liver injury. Semin
        Liver Dis 27(4):378&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">17979074</ArticleId></ArticleIdList></Reference><Reference><Citation>Das
        KP, Wood CR, Lin MT, Starkov AA, Lau C, Wallace KB, Corton JC, Abbott BD.
        Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling
        lipid homeostasis. Toxicology. 2017. March 1;378:37&#x2013;52.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC5994610</ArticleId><ArticleId IdType="pubmed">28049043</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, Moore MR, Cifone MA, Finney DC, Guest D. (1999). Chronic peroxisome proliferation
        and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate
        and the effects of recovery. Toxicol Sci 50(2):195&#x2013;205.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10478855</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, Moore MR, Finney DC, Guest D. (2000a). Chronic toxicity of di(2-ethylhexyl)phthalate
        in mice. Toxicol Sci 58(2):377&#x2013;85.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11099649</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, Moore MR, Finney DC, Guest D. (2000b). Chronic toxicity of di(2-ethylhexyl)phthalate
        in rats. Toxicol Sci 55(2):433&#x2013;43.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10828276</ArticleId></ArticleIdList></Reference><Reference><Citation>De
        Bosscher K, Vanden Berghe W, Haegeman G. Cross-talk between nuclear receptors
        and nuclear factor kappaB. Oncogene. 2006. October 30;25(51):6868&#x2013;86.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17072333</ArticleId></ArticleIdList></Reference><Reference><Citation>de
        Duve C. (1996). The peroxisome in retrospect. Ann N Y Acad Sci 804:1&#x2013;10.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8993531</ArticleId></ArticleIdList></Reference><Reference><Citation>de
        la Iglesia FA, Lewis JE, Buchanan RA, Marcus EL, McMahon G. (1982). Light
        and electron microscopy of liver in hyperlipoproteinemic patients under long-term
        gemfibrozil treatment. Atherosclerosis 43:19&#x2013;37.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6807326</ArticleId></ArticleIdList></Reference><Reference><Citation>De
        Minicis S, Bataller R, Brenner DA. (2006). NADPH oxidase in the liver: defensive,
        offensive, or fibrogenic? Gastroenterology 131(1):272&#x2013;5.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16831609</ArticleId></ArticleIdList></Reference><Reference><Citation>DeAngelo
        AB, Daniel FB, McMillan L, Wernsing P, Savage RE Jr. (1989). Species and strain
        sensitivity to the induction of peroxisome proliferation by chloroacetic acids.
        Toxicol Appl Pharmacol 101(2): 285&#x2013;98.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2815084</ArticleId></ArticleIdList></Reference><Reference><Citation>DeAngelo
        AB, Daniel FB, Most BM, Olson GR. (1997). Failure of monochloroacetic acid
        and trichloroacetic acid administered in the drinking water to produce liver
        cancer in male F344/N rats. J Toxicol Environ Health 52(5): 425&#x2013;45.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9388534</ArticleId></ArticleIdList></Reference><Reference><Citation>Dees
        C, Travis C. (1994). Trichloroacetate stimulation of liver DNA synthesis in
        male and female mice. Toxicol Lett 70(3): 343&#x2013;55.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8284802</ArticleId></ArticleIdList></Reference><Reference><Citation>Dostalek
        M, Hardy KD, Milne GL, Morrow JD, Chen C, Gonzalez FJ, Gu J, Ding X, Johnson
        DA, Johnson JA, Martin MV, Guengerich FP. (2008). Development of oxidative
        stress by cytochrome P450 induction in rodents is selective for barbiturates
        and related to loss of pyridine nucleotide-dependent protective systems. J
        Biol Chem 283(25):17147&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2427356</ArticleId><ArticleId
        IdType="pubmed">18442974</ArticleId></ArticleIdList></Reference><Reference><Citation>Doull
        J, Cattley R, Elcombe C, Lake BG, Swenberg J, Wilkinson C, Williams G, van
        Gemert M. (1999). A cancer risk assessment of di(2-ethylhexyl)phthalate: Application
        of the new U.S. EPA Risk Assessment Guidelines. Regul Toxicol Pharmacol 29:327&#x2013;357.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10388618</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwivedi
        RS, Alvares K, Nemali MR, Subbarao V, Reddy MK, Usman MI, Rademaker AW, Reddy
        JK, Rao MS. (1989). Comparison of the peroxisome proliferator-induced pleiotropic
        response in the liver of nine strains of mice. Toxicol Pathol 17(1 Pt 1):
        16&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">2749133</ArticleId></ArticleIdList></Reference><Reference><Citation>Elcock
        FJ, Chipman JK, Roberts RA (1998). The rodent nongenotoxic hepatocarcinogen
        and peroxisome proliferator nafenopin inhibits intercellular communication
        in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis
        Archives of Toxicology 72(7): 439&#x2013;444.F</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9708883</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott
        BM, Elcombe CR. (1987). Lack of DNA damage or lipid peroxidation measured
        in vivo in the rat liver following treatment with peroxisomal proliferators.
        Carcinogenesis 8(9): 1213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">3621460</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher
        P, Wahli W. Peroxisome proliferator-activated receptors: insight into multiple
        cellular functions. Mutat Res. 2000. March 17;448(2):121&#x2013;38.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725467</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveillard
        A, Lasserre F, de Tayrac M, Polizzi A, Claus S, Canlet C, Mselli-Lakhal L,
        Gotardi G, Paris A, Guillou H, Martin PG, Pineau T. (2009b). Identification
        of potential mechanisms of toxicity after di-(2-ethylhexyl)-phthalate (DEHP)
        adult exposure in the liver using a systems biology approach. Toxicol Appl
        Pharmacol. 236(3):282&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">19245819</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveillard
        A, Mselli-Lakhal L, Mogha A, Lasserre F, Polizzi A, Pascussi JM, Guillou H,
        Martin PG, Pineau T. (2009a). Di-(2-ethylhexyl)-phthalate (DEHP) activates
        the constitutive androstane receptor (CAR): a novel signalling pathway sensitive
        to phthalates. Biochem Pharmacol. 77(11):1735&#x2013;46.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19428328</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan
        CY, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK. (1998). Steatohepatitis,
        spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal
        fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated
        receptor alpha natural ligand metabolism. J Biol Chem 273:15639&#x2013;15645.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9624157</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer
        JG, Glauert HP, Yin T, Sweeney-Reeves ML, Larmonier N, Black MC. (2002). Moderate
        iron overload enhances lipid peroxidation in livers of rats, but does not
        affect NF-kappaB activation induced by the peroxisome proliferator, WY-14,643.
        J Nutr 132(9): 2525&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221204</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald
        JE, Sanyer JL, Schardein JL, Lake RS, McGuire EJ, de la Iglesia FA. (1981).
        Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent
        gemfibrozil. J Natl Cancer Inst 67(5): 1105&#x2013;16.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7029098</ArticleId></ArticleIdList></Reference><Reference><Citation>Flavell
        DM, Pineda Torra I, Jamshidi Y, Evans D, Diamond JR, Elkeles RS, Bujac SR,
        Miller G, Talmud PJ, Staels B, Humphries SE. (2000). Variation in the PPAR&#x3b1;
        gene is associated with altered function in vitro and plasma lipid concentrations
        in Type II diabetic subjects. Diabetologia 43(5):673&#x2013;80.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10855543</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick
        MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi
        P, Koskinen P, Manninen V, et al. (1987). Helsinki Heart Study: primary-prevention
        trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment,
        changes in risk factors, and incidence of coronary heart disease. N Engl J
        Med 317(20): 1237&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">3313041</ArticleId></ArticleIdList></Reference><Reference><Citation>Gariot
        P, Barrat E, Drouin P, Genton P, Pointel JP, Foliguet B, Kolopp M, Debry G.
        (1987). Morphometric study of human hepatic cell modifications induced by
        fenofibrate. Metabolism 36:203&#x2013;210.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3821501</ArticleId></ArticleIdList></Reference><Reference><Citation>Gariot
        P, Barrat E, Mejean L, Pointel JP, Drouin P, Debry G. (1983). Fenofibrate
        and human liver. Lack of proliferation of peroxisomes. Arch Toxicol 53(2):151&#x2013;63.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6882216</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentry
        PR, Clewell HJ 3rd, Clewell R, Campbell J, Van Landingham C, Shipp AM. Challenges
        in the application of quantitative approaches in risk assessment: a case study
        with di-(2-ethylhexyl)phthalate. Crit Rev Toxicol. 2011. August;41 Suppl 2:1&#x2013;72.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21838516</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervois
        P, Torra IP, Chinetti G, Grotzinger T, Dubois G, Fruchart JC, Fruchart-Najib
        J, Leitersdorf E, Staels B. (1999). A truncated human peroxisome proliferator-activated
        receptor alpha splice variant with dominant negative activity. Mol Endocrinol
        13:1535&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pubmed">10478844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill
        JH, Brickell P, Dive C, Roberts RA. The rodent non-genotoxic hepatocarcinogen
        nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but
        also elevates CDK4, a cell cycle progression factor. Carcinogenesis. 1998.
        October;19(10):1743&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9806153</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill
        JH, Roberts RA, Dive C. (1998). The nongenotoxic hepatocarcinogen nafenopin
        suppresses rodent hepatocyte apoptosis induced by TGFb1, DNA damage and FAS.
        Carcinogenesis 19:299&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">9498280</ArticleId></ArticleIdList></Reference><Reference><Citation>Glauert
        HP, Beaty MM, Clark TD, Greenwell WS, Tatum V, Chen LC, Borges T, Clark TL,
        Srinivasan SR, Chow CK. (1990). Effect of dietary vitamin E on the development
        of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator
        ciprofibrate. J Cancer Res Clin Oncol 116(4): 351&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1975253</ArticleId></ArticleIdList></Reference><Reference><Citation>Glauert
        HP, Eyigor A, Tharappel JC, Cooper S, Lee EY, Spear BT. (2006). Inhibition
        of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in
        mice administered the peroxisome proliferator WY-14,643. Toxicol Sci 90(2):
        331&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16434500</ArticleId></ArticleIdList></Reference><Reference><Citation>Glauert
        HP, Srinivasan S, Tatum VL, Chen LC, Saxon DM, Lay LT, Borges T, Baker M,
        Chen LH, Robertson LW, et al. (1992). Effects of the peroxisome proliferators
        ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and
        lipid peroxidation in rats. Biochem Pharmacol 43(6): 1353&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1562286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloire
        G, Legrand-Poels S, Piette J. (2006). NF-kappaB activation by reactive oxygen
        species: fifteen years later. Biochem Pharmacol 72(11):1493&#x2013;505.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16723122</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel
        SK, Lalwani ND, Reddy JK. (1986). Peroxisome proliferation and lipid peroxidation
        in rat liver. Cancer Res 46(3): 1324&#x2013;30.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3943099</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold
        LS, Manley NB, Slone TH, Rohrbach L, Garfinkel GB. Supplement to the Carcinogenic
        Potency Database (CPDB): results of animal bioassays published in the general
        literature through 1997 and by the National Toxicology Program in 1997-1998.
        Toxicol Sci. 2005. June;85(2):747&#x2013;808.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15800034</ArticleId></ArticleIdList></Reference><Reference><Citation>Goll
        V, Alexandre E, Viollon-Abadie C, Nicod L, Jaeck D, Richert L. (1999). Comparison
        of the effects of various peroxisome proliferators on peroxisomal enzyme activities,
        DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxicol
        Appl Pharmacol 160:21&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">10502499</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlicher
        M, Widmark E, Li Q, Gustafsson JA. (1992). Fatty acids activate a chimera
        of the clofibric acid-activated receptor and the glucocorticoid receptor.
        Proc Natl Acad Sci U S A 89(10): 4653&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC49141</ArticleId><ArticleId IdType="pubmed">1316614</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasl-Kraupp
        B, Huber W, Just W, Gibson G, Schulte-Hermann R. (1993c). Enhancement of peroxisomal
        enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci
        of rat liver treated with the peroxisome proliferator nafenopin. Carcinogenesis
        14(5): 1007&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8099311</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasl-Kraupp
        B, Huber W, Timmermann-Trosiener I, Schulte-Hermann R. (1993a). Peroxisomal
        enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic
        liver foci of rats treated with a single dose of the peroxisome proliferator
        nafenopin. Carcinogenesis 14:2435&#x2013;2437.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8242878</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasl-Kraupp
        B, Ruttkay-Nedecky B, Mullauer L, Taper H, Huber W, Bursch W, Schulte-Hermann
        R. (1997). Inherent increase of apoptosis in liver tumors: Implications for
        carcinogenesis and tumor regression. Hepatology 25:906&#x2013;912.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9096596</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasl-Kraupp
        B, Waldhor T, Huber W, Schulte-Hermann R. (1993b). Glutathione S-transferase
        isoenzyme patterns in different subtypes of enzyme-altered rat liver foci
        treated with the peroxisome proliferator nafenopin or with phenobarbital.
        Carcinogenesis 14(11): 2407&#x2013;12.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8242872</ArticleId></ArticleIdList></Reference><Reference><Citation>Grivennikov
        SI, Karin M. Inflammatory cytokines in cancer: tumour necrosis factor and
        interleukin 6 take the stage. Ann Rheum Dis. 2011. March;70 Suppl 1:i104&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21339211</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo
        D, Sarkar J, Suino-Powell K, Xu Y, Matsumoto K, Jia Y, Yu S, Khare S, Haldar
        K, Rao MS, Foreman JE, Monga SP, Peters JM, Xu HE, Reddy JK. (2007). Induction
        of nuclear translocation of constitutive androstane receptor by peroxisome
        proliferator-activated receptor alpha synthetic ligands in mouse liver. J
        Biol Chem 282: 36766&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">17962186</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyton
        KZ, Chiu WA, Bateson TF, Jinot J, Scott CS, Brown RC, Caldwell JC. (2009).
        A reexamination of the PPAR-&#x3b1; activation mode of action as a basis for
        assessing human cancer risks of environmental contaminants. Environmental
        Health Perspectives 117(11):1664&#x2013;72.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2801168</ArticleId><ArticleId IdType="pubmed">20049115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagmann
        M, Georgiev O and Schaffner. (1997) The VP16 Paradox: Herpes Simplex Virus
        VP16 Contains a Long-Range Activation Domain but within the Natural Multiprotein
        Complex Activates Only from Promoter-Proximal Positions. Journal of Virology
        71 (8) 5952&#x2013;5962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191851</ArticleId><ArticleId
        IdType="pubmed">9223485</ArticleId></ArticleIdList></Reference><Reference><Citation>Handler
        JA, Seed CB, Bradford BU, Thurman RG. (1992). Induction of peroxisomes by
        treatment with perfluorooctanoate does not increase rates of H2O2 production
        in intact liver. Toxicol Lett 60(1): 61&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1539182</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanefeld
        M, Kemmer C, Kadner E. (1983). Relationship between morphological changes
        and lipid lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic
        mitochondria and peroxisomes in man. Atherosclerosis 46:239&#x2013;246.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6838704</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanefeld
        M, Kemmer C, Leonhardt W, Kunze KD, Jaross W, Haller H. (1980). Effects of
        p-chlorophenoxyisobutyric acid (CPIB) on the human liver. Atherosclerosis
        36(2):159&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">7406947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanselman
        JC, Vartanian MA, Koester BP, Gray SA, Essenburg AD, Rea TJ, Bisgaier CL,
        Pape ME. (2001). Expression of the mRNA encoding truncated PPAR alpha does
        not correlate with hepatic insensitivity to peroxisome proliferators. Mol
        Cell Biochem 217(1-2):91&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11269670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto
        T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ, Yeldandi AV, Rao
        MS, Reddy JK. (1999). Peroxisomal and mitochondrial fatty acid beta-oxidation
        in mice nullizygous for both peroxisome proliferator-activated receptor alpha
        and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver
        phenotype. J Biol Chem 274(27):19228&#x2013;36.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10383430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, Gonzalez FJ, Peters JM, Roberts RA. (2000a). Suppression
        of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPAR&#x3b1;
        and TNF&#x3b1;lpha. Mutat Res 448(2): 193&#x2013;200.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, Soames AR, Roberts RA. (2000b). Species differences
        in response to diethylhexylphthalate: suppression of apoptosis, induction
        of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated
        gene expression. Arch Toxicol 74(2): 85&#x2013;91.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10839475</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, West D, Chevalier S, Cosulich SC, Roberts RA. (1999).
        Suppression of apoptosis and induction of DNA synthesis in vitro by the phthalate
        plasticizers monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP):
        a comparison of rat and human hepatocytes in vitro. Arch Toxicol 73(8-9):
        451&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10650916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Soames AR, Roberts RA. (1998). The peroxisome proliferator nafenopin
        does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in
        human hepatocytes in vitro. Arch Toxicol 72(12):777&#x2013;83.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9950074</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, West DA, Olsen K, Roberts RA. (2000c). Role of hepatic non-parenchymal
        cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin
        in vitro. Carcinogenesis 21(12): 2159&#x2013;65.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11133804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi
        Y, Ito Y, Yamagishi N, Yanagiba Y, Tamada H, Wang D, Ramdhan DH, Naito H,
        Harada Y, Kamijima M, Gonzales FJ, Nakajima T. Hepatic peroxisome proliferator-activated
        receptor &#x3b1; may have an important role in the toxic effects of di(2-ethylhexyl)phthalate
        on offspring of mice. Toxicology. 2011. October 28;289(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21354252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays
        T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. (2005).
        Role of peroxisome proliferator-activated receptor-alpha (PPAR&#x3b1;) in
        bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 26(1):
        219&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">15447978</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkler
        F, Brinkmann J, Luch A. The role of oxidative stress in carcinogenesis induced
        by metals and xenobiotics. Cancers (Basel). 2010. April 8;2(2):376&#x2013;96.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3835083</ArticleId><ArticleId IdType="pubmed">24281075</ArticleId></ArticleIdList></Reference><Reference><Citation>Herren-Freund
        SL, Pereira MA, Khoury MD, Olson G. (1987). The carcinogenicity of trichloroethylene
        and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse
        liver. Toxicol Appl Pharmacol 90(2): 183&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3629594</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinton
        RH, Mitchell FE, Mann A, Chescoe D, Price SC, Nunn A, Grasso P, Bridges JW.
        (1986). Effects of phthalic acid esters on the liver and thyroid. Environ
        Health Perspect 70: 195&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1474287</ArticleId><ArticleId
        IdType="pubmed">3830106</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoivik
        DJ, Qualls CW Jr, Mirabile RC, Cariello NF, Kimbrough CL, Colton HM, Anderson
        SP, Santostefano MJ, Morgan RJ, Dahl RR, Brown AR, Zhao Z, Mudd PN Jr, Oliver
        WB Jr, Brown HR, Miller RT. (2004). Fibrates induce hepatic peroxisome and
        mitochondrial proliferation without overt evidence of cellular proliferation
        and oxidative stress in cynomolgus monkeys. Carcinogenesis 25(9):1757&#x2013;69.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15131011</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden
        P, Hasmall S, James N, West D, Brindle R, Gonzalez F, Peters J, Roberts R.
        (2000). Tumour necrosis factor a (TNF&#x3b1;): Role in suppression of apoptosis
        by peroxisome proliferators. Cell Mol Biol 46:29&#x2013;39.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10726969</ArticleId></ArticleIdList></Reference><Reference><Citation>Howroyd
        P, Swanson C, Dunn C, Cattley RC, Corton JC. (2004). Decreased longevity and
        enhancement of age-dependent lesions in mice lacking the nuclear receptor
        peroxisome proliferator-activated receptor alpha (PPAR&#x3b1;). Toxicol Pathol
        32(5): 591&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15603543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh
        LL, Shinozuka H, Weinstein IB. (1991). Changes in expression of cellular oncogenes
        and endogenous retrovirus-like sequences during hepatocarcinogenesis induced
        by a peroxisome proliferator. Br J Cancer 64(5):815&#x2013;20.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1977482</ArticleId><ArticleId IdType="pubmed">1931600</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber
        W, Kraupp-Grasl B, Esterbauer H, Schulte-Hermann R. (1991). Role of oxidative
        stress in age dependent hepatocarcinogenesis by the peroxisome proliferator
        nafenopin in the rat. Cancer Res 51(7): 1789&#x2013;92.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2004363</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber
        WW, Grasl-Kraupp B, Stekel H, Gschwentner C, Lang H, Schulte-Hermann R. (1997).
        Inhibition instead of enhancement of lipid peroxidation by pretreatment with
        the carcinogenic peroxisome proliferator nafenopin in rat liver exposed to
        a high single dose of corn oil. Arch Toxicol 71(9): 575&#x2013;81.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9285040</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttunen
        JK, Heinonen OP, Manninen V, Koskinen P, Hakulinen T, Teppo L, Manttari M,
        Frick MH. (1994). The Helsinki Heart Study: an 8.5-year safety and mortality
        follow-up. J Intern Med 235(1): 31&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8283157</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC.
        (1996). Some pharmaceutical drugs. IARC Monographs on the Evaluation of the
        Carcinogenic Risk of Chemicals to Humans. Lyon, France: IARC Press, 391&#x2013;426.</Citation></Reference><Reference><Citation>Isenberg
        JS, Kamendulis LM, Ackley DC, Smith JH, Pugh G Jr, Lington AW, McKee RH, Klaunig
        JE. (2001). Reversibility and persistence of di-2-ethylhexyl phthalate (DEHP)-
        and phenobarbital-induced hepatocellular changes in rodents. Toxicol Sci 64(2):
        192&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11719701</ArticleId></ArticleIdList></Reference><Reference><Citation>Isenberg
        JS, Kamendulis LM, Smith JH, Ackley DC, Pugh G Jr, Lington AW, Klaunig JE.
        (2000). Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular
        communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX)
        in rat, mouse, and hamster liver. Toxicol Sci 56(1): 73&#x2013;85.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10869455</ArticleId></ArticleIdList></Reference><Reference><Citation>Isenberg
        JS, Kolaja KL, Ayoubi SA, Watkins JB 3rd, Klaunig JE. (1997). Inhibition of
        WY 14,643-induced hepatic lesion growth in mice by rotenone. Carcinogenesis
        18:1511&#x2013;1519.</Citation><ArticleIdList><ArticleId IdType="pubmed">9276624</ArticleId></ArticleIdList></Reference><Reference><Citation>Issemann
        I, Green S. (1990). Activation of a member of the steroid hormone receptor
        superfamily by peroxisome proliferators. Nature 347(6294): 645&#x2013;50.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2129546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito
        Y, Nakamura T, Yanagiba Y, Ramdhan DH, Yamagishi N, Naito H, Kamijima M, Gonzalez
        FJ, Nakajima T. Plasticizers May Activate Human Hepatic Peroxisome Proliferator-Activated
        Receptor &#x3b1; Less Than That of a Mouse but May Activate Constitutive Androstane
        Receptor in Liver. PPAR Res. 2012;2012:201284.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3388330</ArticleId><ArticleId IdType="pubmed">22792086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito
        Y, Yamanoshita O, Asaeda N, Tagawa Y, Lee CH, Aoyama T, Ichihara G, Furuhashi
        K, Kamijima M, Gonzalez FJ, Nakajima T. (2007). Di(2-ethylhexyl)phthalate
        induces hepatic tumorigenesis through a peroxisome proliferator-activated
        receptor alpha-independent pathway. J Occup Health 49(3):172&#x2013;82.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17575397</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Gill JH, Brindle R, Woodyatt NJ, Macdonald N, Rolfe M, Hasmall SC, Tugwood
        JD, Holden PR, Roberts RA. (1998b). Peroxisome proliferator-activated receptor
        (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis.
        Toxicol Lett 102-103:91&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10022238</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Roberts RA. (1996). Species differences in response to peroxisome proliferators
        correlate in vitro with induction of DNA synthesis rather than suppression
        of apoptosis. Carcinogenesis 17(8): 1623&#x2013;32.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8761418</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Roberts RA. Species differences in response to peroxisome proliferators
        correlate in vitro with induction of DNA synthesis rather than suppression
        of apoptosis. Carcinogenesis. 1996. August;17(8):1623&#x2013;32.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8761418</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Soames AR, Roberts RA. (1998a). Suppression of hepatocyte apoptosis and
        induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphthalate
        (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB). Arch Toxicol
        72:784&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">9950075</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia
        Y, Qi C, Zhang Z, Hashimoto T, Rao MS, Huyghe S, Suzuki Y, Van Veldhoven PP,
        Baes M, Reddy JK. (2003). Overexpression of peroxisome proliferator-activated
        receptor-alpha (PPAR&#x3b1;)-regulated genes in liver in the absence of peroxisome
        proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase
        enzymes of peroxisomal beta-oxidation system. J Biol Chem 278(47):47232&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14500732</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolly
        RA, Goldstein KM, Wei T, Gao H, Chen P, Huang S, Colet JM, Ryan TP, Thomas
        CE, Estrem ST. Pooling samples within microarray studies: a comparative analysis
        of rat liver transcription response to prototypical toxicants. Physiol Genomics.
        2005. August 11;22(3):346&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">15914576</ArticleId></ArticleIdList></Reference><Reference><Citation>Judson
        RS, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Mortensen HM, Reif DM, Rotroff
        DM, Shah I, Richard AM, Dix DJ. In vitro screening of environmental chemicals
        for targeted testing prioritization: the ToxCast project. Environ Health Perspect.
        2010. April;118(4):485&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2854724</ArticleId><ArticleId
        IdType="pubmed">20368123</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien
        E, Boobis AR, Olin SS. (2009). The key events dose-response framework: A cross-disciplinary
        mode-of-action based approach to examining dose-response and thresholds. Crit
        Rev Food Sci Nutr 49 (8):682&#x2013;689.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2840877</ArticleId><ArticleId IdType="pubmed">19690994</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin
        M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature
        441(7092):431&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16724054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima
        Y, Suzuki S, Kozuka H, Sato M, Suzuki Y. (1994). Effects of prolonged administration
        of perfluorooctanoic acid on hepatic activities of enzymes which detoxify
        peroxide and xenobiotic in the rat. Toxicology 93(2-3): 85&#x2013;97.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7974521</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller
        H, Devchand PR, Perroud M, Wahli W. (1997). PPAR alpha structure-function
        relationships derived from species-specific differences in responsiveness
        to hypolipidemic agents. Biol Chem 378:651&#x2013;655.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9278144</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller
        H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W. (1993). Fatty acids and
        retinoids control lipid metabolism through activation of peroxisome proliferator-activated
        receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci 90(6):2160&#x2013;4.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC46045</ArticleId><ArticleId IdType="pubmed">8384714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten
        S. et al. (1999) Peroxisome proliferator&#x2013;activated receptor &#x3b1;
        mediates the adaptive response to fasting J Clin Inv 103 (11) 1489&#x2013;1498.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC408372</ArticleId><ArticleId IdType="pubmed">10359558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten
        S. Integrated physiology and systems biology of PPAR&#x3b1;. Mol Metab. 2014.
        March 6;3(4):354&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4060217</ArticleId><ArticleId
        IdType="pubmed">24944896</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshava
        N, Caldwell JC. Key issues in the role of peroxisome proliferator-activated
        receptor agonism and cell signaling in trichloroethylene toxicity. Environ
        Health Perspect. 2006. September;114(9):1464&#x2013;70.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1570084</ArticleId><ArticleId IdType="pubmed">16966106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler
        W, Numtip W, Grote K, Csan&#xe1;dy GA, Chahoud I, Filser JG. Blood burden
        of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl)
        phthalate in pregnant and nonpregnant rats and marmosets. Toxicol Appl Pharmacol.
        2004. March 1;195(2):142&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">14998681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim
        MY, Song KS, Park GH, Chang SH, Kim HW, Park JH, Jin H, Eu KJ, Cho HS, Kang
        G, Kim YC, Cho MH. (2004). B6C3F1 mice exposed to ozone with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
        and/or dibutyl phthalate showed toxicities through alterations of NF-kappaB,
        AP-1, Nrf2, and osteopontin. J Vet Sci 5(2): 131&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15192340</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY,
        McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA. (2003). PPAR&#x3b1; agonist-induced
        rodent tumors: modes of action and human relevance. Crit Rev Toxicol 33(6):655&#x2013;780.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14727734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluwe
        WM, Huff JE, Matthews HB, Irwin R, Haseman JK. (1985). Comparative Chronic
        Toxicities and Carcinogenic Potentials of 2-Ethylhexyl- Containing Compounds
        in Rats and Mice, Carcinogenesis 6(11):1577&#x2013;1583.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4053278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluwe
        WM, McConnell EE, Huff JE, Haseman JK, Douglas JF, Hartwell WV. (1982). Carcinogenicity
        Testing Of Phthalate Esters And Related Compounds Environ. Health Perspect.
        45:129&#x2013;133, 1982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569006</ArticleId><ArticleId
        IdType="pubmed">7140685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolaja
        KL, Stevenson DE, Walborg EF Jr., Klaunig JE (1996a). Dose Dependence of Phenobarbital
        Promotion of Preneoplastic Hepatic Lesions in F344 Rats and B6C3F1 Mice: Effects
        on DNA Synthesis and Apoptosis. Carcinogenesis, 17(5), 947&#x2013;954.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8640942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolaja
        KL, Stevenson DE, Walborg EF Jr., Klaunig JE (1996b). Reversibility of Promoter
        Induced Hepatic Focal Lesion Growth in Mice. Carcinogenesis, 17(7), 1403&#x2013;1409.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8706241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreamer
        BL, Staecker JL, Sawada N, Sattler GL, Hsia MT, Pitot HC. Use of a low-speed,
        iso-density percoll centrifugation method to increase the viability of isolated
        rat hepatocyte preparations. In Vitro Cell Dev Biol. 1986. April;22(4):201&#x2013;11.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2871008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacquemant
        C, Lepretre F, Pineda Torra I, Manraj M, Charpentier G, Ruiz J, Staels B,
        Froguel P. (2000). Mutation screening of the PPAR&#x3b1; gene in type 2 diabetes
        associated with coronary heart disease. Diabetes Metab 26(5):393&#x2013;401.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11119019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Evans JG, Cunninghame ME, Price RJ. (1993). Comparison of the hepatic
        effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication
        in the rat and Syrian hamster. Environ Health Perspect 101 Suppl 5: 241&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1519442</ArticleId><ArticleId IdType="pubmed">8013414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Evans JG, Gray TJ, K&#xf6;r&#xf6;si SA, North CJ. (1989b). Comparative
        studies on nafenopin-induced hepatic peroxisome proliferation in the rat,
        Syrian hamster, guinea pig, and marmoset. Toxicol Appl Pharmacol. 99(1):148&#x2013;60.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2499080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Gray TJ, K&#xf6;r&#xf6;si SA, Walters DG. (1989a). Nafenopin, a peroxisome
        proliferator, depletes hepatic vitamin E content and elevates plasma oxidised
        glutathione levels in rats. Toxicol Lett. 45(2-3):221&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2919403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Kozlen SL, Evans JG, Gray TJ, Young PJ, Gangolli SD. (1987). Effect of
        prolonged administration of clofibric acid and di-(2-ethylhexyl)phthalate
        on hepatic enzyme activities and lipid peroxidation in the rat. Toxicology
        44(2): 213&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">3564055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Rumsby PC, Price RJ, Cunninghame ME. (2000). Species differences in hepatic
        peroxisome proliferation, cell replication and transforming growth factor-beta1
        gene expression in the rat, Syrian hamster and guinea pig. Mutat Res. 448(2):213&#x2013;25.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725474</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapinskas
        PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, Corton JC.
        (2005). Role of PPAR&#x3b1;lpha in mediating the effects of phthalates and
        metabolites in the liver. Toxicology. 207(1):149&#x2013;63.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15590130</ArticleId></ArticleIdList></Reference><Reference><Citation>Laughter
        AR, Dunn CS, Swanson CL, Howroyd P, Cattley RC, Corton JC. (2004). Role of
        the peroxisome proliferator-activated receptor alpha (PPAR&#x3b1;) in responses
        to trichloroethylene and metabolites, trichloroacetate and dichloroacetate
        in mouse liver. Toxicology 203(1-3):83&#x2013;98.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15363585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence
        JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, Zhou G.
        (2001c). Differential gene regulation in human versus rodent hepatocytes by
        peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails
        to induce peroxisome proliferation-associated genes in human cells independently
        of the level of receptor expression. J Biol Chem 276(34): 31521&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11418601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence
        JW, Wollenberg GK, DeLuca JG. (2001b). Tumor necrosis factor alpha is not
        required for WY14,643-induced cell proliferation. Carcinogenesis 22(3): 381&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11238176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee
        J, Lim KT. Plant-originated glycoprotein (24 kDa) has an inhibitory effect
        on proliferation of BNL CL.2 cells in response to di(2-ethylhexyl)phthalate.
        Cell Biochem Funct. 2011. August;29(6):496&#x2013;505.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21721021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee
        SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM,
        Westphal H, Gonzalez FJ. (1995). Targeted disruption of the alpha isoform
        of the peroxisome proliferator-activated receptor gene in mice results in
        abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell
        Biol 15: 3012&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230532</ArticleId><ArticleId
        IdType="pubmed">7539101</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone
        TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated
        receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null
        mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S
        A. 1999. June 22;96(13):7473&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC22110</ArticleId><ArticleId IdType="pubmed">10377439</ArticleId></ArticleIdList></Reference><Reference><Citation>Li
        Y, Glauert HP, Spear BT. (2000a). Activation of nuclear factor-kappaB by the
        peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its
        inhibition by the antioxidants N-acetylcysteine and vitamin E. Biochem Pharmacol
        59(4): 427&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">10644051</ArticleId></ArticleIdList></Reference><Reference><Citation>Li
        Y, Tharappel JC, Cooper S, Glenn M, Glauert HP, Spear BT. (2000b). Expression
        of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates
        NF-kappaB. DNA Cell Biol 19(2): 113&#x2013;20.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10701777</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu
        MH, Li J, Shen P, Husna B, Tai ES, Yong EL. (2008). A natural polymorphism
        in peroxisome proliferator-activated receptor-alpha hinge region attenuates
        transcription due to defective release of nuclear receptor corepressor from
        chromatin. Mol Endocrinol 22(5):1078&#x2013;92.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC5419521</ArticleId><ArticleId IdType="pubmed">18292238</ArticleId></ArticleIdList></Reference><Reference><Citation>Luebker
        DJ, Hansen KJ, Bass NM, Butenhoff JL, Seacat AM. (2002). Interactions of fluorochemicals
        with rat liver fatty acid-binding protein. Toxicology 176(3):175&#x2013;85.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12093614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgren
        B, Meijer J, DePierre JW. Induction of cytosolic and microsomal epoxide hydrolases
        and proliferation of peroxisomes and mitochondria in mouse liver after dietary
        exposure to p-chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid and
        2,4,5-trichlorophenoxyacetic acid. Biochem Pharmacol. 1987. March 15;36(6):815&#x2013;21.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3032197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma
        X, Stoffregen DA, Wheelock GD, Rininger JA, Babish JG. Discordant hepatic
        expression of the cell division control enzyme p34cdc2 kinase, proliferating
        cell nuclear antigen, p53 tumor suppressor protein, and p21Waf1 cyclin-dependent
        kinase inhibitory protein after WY14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic
        acid) dosing to rats. Mol Pharmacol. 1997. January;51(1):69&#x2013;78.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9016348</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald
        N, Holden PR, Roberts RA. (1999). Addition of peroxisome proliferator-activated
        receptor alpha to guinea pig hepatocytes confers increased responsiveness
        to peroxisome proliferators. Cancer Res 59(19):4776&#x2013;80.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda
        S, Kamata H, Luo JL, Leffert H, Karin M. (2005). IKKbeta couples hepatocyte
        death to cytokine-driven compensatory proliferation that promotes chemical
        hepatocarcinogenesis. Cell 121(7):977&#x2013;90.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15989949</ArticleId></ArticleIdList></Reference><Reference><Citation>Makowska
        JM, Gibson GG, Bonner FW. (1992). Species differences in ciprofibrate induction
        of hepatic cytochrome P450 4A1 and peroxisome proliferation. J Biochem Toxicol
        7(3):183&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">1282571</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney
        EK, Waxman DJ. (1999). Trans-activation of PPAR&#x3b1; and PPAR&#x3b3;amma
        by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 161(2):
        209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">10581215</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        D. (1995). NTP Technical Report on the Toxicity Studies of Dibutyl Phthalate
        (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Toxic
        Rep Ser 30: 1&#x2013;G5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12209194</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        DS, Cattley RC, Conway JG, Popp JA. (1988). Relationship of hepatic peroxisome
        proliferation and replicative DNA synthesis to the hepatocarcinogenicity of
        the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic
        acid (WY-14,643) in rats. Cancer Res 48(23): 6739&#x2013;44.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3180084</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        DS, Goldsworthy TL, Popp JA. (1992). Contrasting hepatocytic peroxisome proliferation,
        lipofuscin accumulation and cell turnover for the hepatocarcinogens WY-14,643
        and clofibric acid. Carcinogenesis 13(6): 1011&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1600604</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        DS, Popp JA. (1994). Biological potential of basophilic hepatocellular foci
        and hepatic adenoma induced by the peroxisome proliferator, WY-14,643. Carcinogenesis
        15(1): 111&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7507413</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama
        H, Amanuma T, Tsutsumi M, Tsujiuchi T, Horiguchi K, Denda A, Konishi Y. (1994).
        Inhibition by catechol and di(2-ethylhexyl)phthalate of pancreatic carcinogenesis
        after initiation with N-nitrosobis(2-hydroxypropyl)amine in Syrian hamsters.
        Carcinogenesis. 15(6):1193&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8020155</ArticleId></ArticleIdList></Reference><Reference><Citation>Meek
        ME. (2008). Recent developments in frameworks to consider human relevance
        of hypothesized modes of action for tumours in animals. Environ Mol Mutagen
        49(2):110&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18213650</ArticleId></ArticleIdList></Reference><Reference><Citation>Menegazzi
        M, Carcereri-De Prati A, Suzuki H, Shinozuka H, Pibiri M, Piga R, Columbano
        A, Ledda-Columbano GM. (1997). Liver cell proliferation induced by nafenopin
        and cyproterone acetate is not associated with increases in activation of
        transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis
        factor alpha. Hepatology 25(3): 585&#x2013;92.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9049203</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer
        K, Lee JS, Dyck PA, Cao WQ, Rao MS, Thorgeirsson SS, Reddy JK. (2003). Molecular
        profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA
        oxidase deficient mice: comparison with liver tumors induced in wild-type
        mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis
        24(5):975&#x2013;84. Carcinogenesis 24(5):975-84.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12771043</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller
        RT, Shah RS, Cattley RC, Popp JA. The peroxisome proliferations WY-14,643
        and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific
        DNA synthesis in F344 rats. Toxicol Appl Pharmacol. 1996. June;138(2):317&#x2013;23.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8658533</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimura
        K, Cheung C, Ward JM, Reddy JK, Gonzalez FJ. (2006). Differential susceptibility
        of mice humanized for peroxisome proliferator-activated receptor alpha to
        WY-14,643-induced liver tumorigenesis. Carcinogenesis 27(5):1074&#x2013;80.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1447533</ArticleId><ArticleId IdType="pubmed">16377806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee
        R, Jow L, Noonan D, McDonnell DP. (1994). Human and rat peroxisome proliferator
        activated receptors (PPARs) demonstrate similar tissue distribution but different
        responsiveness to PPAR activators. J Steroid Biochem Molec Biol 51: 157&#x2013;166.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa
        T, Ramdhan DH, Tanaka N, Naito H, Tamada H, Ito Y, Li Y, Hayashi Y, Yamagishi
        N, Yanagiba Y, Aoyama T, Gonzalez FJ, Nakajima T. Modulation of ammonium perfluorooctanoate-induced
        hepatic damage by genetically different PPAR&#x3b1; in mice. Arch Toxicol.
        2012. January;86(1):63&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6594146</ArticleId><ArticleId
        IdType="pubmed">21499893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima
        T, Tanaka N, Li G, Hu R, Kamijo Y, Hara A, Aoyama T. Effect of bezafibrate
        on hepatic oxidative stress: comparison between conventional experimental
        doses and clinically-relevant doses in mice. Redox Rep. 2010;15(3):123&#x2013;30.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC7067332</ArticleId><ArticleId IdType="pubmed">20594415</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura
        T, Ito Y, Yanagiba Y, Ramdhan DH, Kono Y, Naito H, Hayashi Y, Li Y, Aoyama
        T, Gonzalez FJ, Nakajima T. Microgram-order ammonium perfluorooctanoate may
        activate mouse peroxisome proliferator-activated receptor alpha, but not human
        PPARalpha. Toxicology. 2009. November 9;265(1-2):27&#x2013;33.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2848383</ArticleId><ArticleId IdType="pubmed">19751795</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson
        MA, Sanchez IM, Bull RJ, Sylvester SR. Increased expression of c-myc and c-Ha-ras
        in dichloroacetate and trichloroacetate-induced liver tumors in B6C3F1 mice.
        Toxicology. 1990. October;64(1):47&#x2013;57.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2219132</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemali
        MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK. (1988).
        Comparison of constitutive and inducible levels of expression of peroxisomal
        beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.
        Cancer Res 48:5316&#x2013;5324.</Citation><ArticleIdList><ArticleId IdType="pubmed">2900680</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesfield
        SR, Clarke CJ, Hoivik DJ, Miller RT, Allen JS, Selinger K, Santostefano MJ.
        (2005b). Evaluation of the carcinogenic potential of clofibrate in the rasH2
        mouse. Int J Toxicol. 24(5):301&#x2013;11.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16257850</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesfield
        SR, Williams TC, Hoivik DJ, Miller RT, Allen JS, Selinger K, Rickert D, Santostefano
        MJ. (2005a). Evaluation of the carcinogenic potential of clofibrate in the
        neonatal mouse. Int J Toxicol. 24(5):341&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16257853</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls-Grzemski
        FA, Belling GB, Priestly BG, Calder IC, Burcham PC. (2000). Clofibrate pretreatment
        in mice confers resistance against hepatic lipid peroxidation. J Biochem Mol
        Toxicol 14(6): 335&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">11083087</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilakantan
        V, Spear BT, Glauert HP. (1998). Liver-specific catalase expression in transgenic
        mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome
        proliferator ciprofibrate. Carcinogenesis 19(4): 631&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9600348</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien
        ML, Cunningham ML, Spear BT, Glauert HP. (2001a). Effects of peroxisome proliferators
        on glutathione and glutathione-related enzymes in rats and hamsters. Toxicol
        Appl Pharmacol 171(1): 27&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">11181109</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien
        ML, Twaroski TP, Cunningham ML, Glauert HP, Spear BT. (2001b). Effects of
        peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in
        rats and hamsters. Toxicol Sci 60(2): 271&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11248139</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberhammer
        FA, Qin HM. (1995). Effect of three tumour promoters on the stability of hepatocytes
        cultures and apoptosis after transforming growth factor-beta1. Carcinogenesis
        16:1363&#x2013;1371.</Citation><ArticleIdList><ArticleId IdType="pubmed">7788856</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien
        ML, Spear BT, Glauert HP. Role of oxidative stress in peroxisome proliferator-mediated
        carcinogenesis. Crit Rev Toxicol. 2005. January;35(1):61&#x2013;88.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15742903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohmura
        T, Ledda-Columbano GM, Piga R, Columbano A, Glemba J, Katyal SL, Locker J,
        Shinozuka H. (1996). Hepatocyte proliferation induced by a single dose of
        a peroxisome proliferator. Am J Pathol 148(3): 815&#x2013;24.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1861716</ArticleId><ArticleId IdType="pubmed">8774136</ArticleId></ArticleIdList></Reference><Reference><Citation>Oreskes
        N, Conway EM. Defeating the merchants of doubt. (2010). Nature 465(7299):686&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20535183</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshida
        K, Vasani N, Jones C, Moore T, Hester S, Nesnow S, Auerbach S, Geter DR, Aleksunes
        LM, Thomas RS, Applegate D, Klaassen CD, Corton JC. Identification of chemical
        modulators of the constitutive activated receptor (CAR) in a gene expression
        compendium. Nucl Recept Signal. 2015. April 27;13:e002.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4422105</ArticleId><ArticleId IdType="pubmed">25949234</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacot
        C, Petit M, Rollin M, Behechti N, Moisant M, Deslex P, Althoff J, Lhuguenot
        JC, Latruffe N. (1996). Difference between guinea pig and rat in the liver
        peroxisomal response to equivalent plasmatic level of ciprofibrate. Arch Biochem
        Biophys 327(1):181&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8615689</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer
        CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF. (1998). Peroxisome proliferator
        activated receptor-alpha expression in human liver. Mol Pharmacol 53(1): 14&#x2013;22.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9443928</ArticleId></ArticleIdList></Reference><Reference><Citation>Parzefall
        W, Berger W, Kainzbauer E, Teufelhofer O, Schulte-Hermann R, Thurman RG. (2001).
        Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes.
        Carcinogenesis 22(3): 519&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11238195</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazienza
        V, Vinciguerra M, Mazzoccoli G. PPARs Signaling and Cancer in the Gastrointestinal
        System. PPAR Res. 2012;2012:560846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3458283</ArticleId><ArticleId
        IdType="pubmed">23028383</ArticleId></ArticleIdList></Reference><Reference><Citation>Permadi
        H, Lundgren B, Andersson K, Sundberg C, DePierre JW. (1993). Effects of perfluoro
        fatty acids on peroxisome proliferation and mitochondrial size in mouse liver:
        dose and time factors and effect of chain length. Xenobiotica 23(7): 761&#x2013;70.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8237058</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone
        CE, Shao L, Williams GM. (1998). Effect of rodent hepatocarcinogenic peroxisome
        proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured
        human and rat hepatocytes. Toxicol Appl Pharmacol 150: 277&#x2013;86.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9653058</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone
        CE, Williams GM. Rodent hepatocarcinogenic peroxisome proliferators induce
        proliferation of rat hepatocytes in primary mixed cultures with rat liver
        epithelial cells. Cancer Lett. 1998. January 16;123(1):27&#x2013;33.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9461014</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Aoyama T, Cattley RC, Nobumitsu U, Hashimoto T, Gonzalez FJ. (1998). Role
        of peroxisome proliferator-activated receptor alpha in altered cell cycle
        regulation in mouse liver. Carcinogenesis 19(11): 1989&#x2013;94.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9855014</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Cattley RC, Gonzalez FJ. (1997). Role of PPAR alpha in the mechanism of
        action of the nongenotoxic carcinogen and peroxisome proliferator WY-14,643.
        Carcinogenesis 18 (11): 2029&#x2013;33.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9395198</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Cheung C, Gonzalez FJ. (2005). Peroxisome proliferator-activated receptor-&#x3b1;
        and liver cancer: where do we stand? J Mol Med 83: 774&#x2013;785.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15976920</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Rusyn I, Rose ML, Gonzalez FJ, Thurman EG. (2000). Peroxisome proliferator-activated
        receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells:
        implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.
        Carcinogenesis 21(4): 823&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10753222</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant
        NJ, Horley NJ, Dickins M, Hasmall S, Elcombe CR, Bell DR. (1998). The coordinate
        regulation of DNA synthesis and suppression of apoptosis is differentially
        regulated by the liver growth agents, phenobarbital and methylclofenapate.
        Carcinogenesis 19(9): 1521&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9771920</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogribny
        IP, Tryndyak VP, Woods CG, Witt SE, Rusyn I. Epigenetic effects of the continuous
        exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent
        upon peroxisome proliferator activated receptor alpha. Mutat Res. 2007. December
        1;625(1-2):62&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2111058</ArticleId><ArticleId
        IdType="pubmed">17586532</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogribny
        IP. MicroRNA dysregulation during chemical carcinogenesis. Epigenomics. 2009.
        December;1(2):281&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">22122703</ArticleId></ArticleIdList></Reference><Reference><Citation>Polvani
        S, Tarocchi M, Tempesti S, Galli A. Nuclear receptors and pathogenesis of
        pancreatic cancer. World J Gastroenterol. 2014. September 14;20(34):12062&#x2013;81.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4161795</ArticleId><ArticleId IdType="pubmed">25232244</ArticleId></ArticleIdList></Reference><Reference><Citation>Price
        RJ, Evans JG, Lake BG. (1992). Comparison of the effects of nafenopin on hepatic
        peroxisome proliferation and replicative DNA synthesis in the rat and Syrian
        hamster. Food Chem Toxicol 30(11):937&#x2013;44.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1473786</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugh
        G Jr, Isenberg JS, Kamendulis LM, Ackley DC, Clare LJ, Brown R, Lignton AW,
        Smith JH, Klaunig JE. (2000). Effects of diisononyl phthalate, di-2-ethylhexyl
        phthalate, and clofibrate in cynomolgus monkeys. Toxicol Sci 56:181&#x2013;188.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10869467</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu
        A, Jiang C, Cai Y, Kim JH, Tanaka N, Ward JM, Shah YM, Gonzalez FJ. Role of
        Myc in hepatocellular proliferation and hepatocarcinogenesis. J Hepatol. 2014.
        February;60(2):331&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3909877</ArticleId><ArticleId
        IdType="pubmed">24096051</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu
        A, Shah YM, Matsubara T, Yang Q, Gonzalez FJ. (2010). PPAR&#x3b1;lpha-dependent
        activation of cell cycle control and DNA repair genes in hepatic nonparenchymal
        cells. Toxicol Sci 118(2):404&#x2013;10.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2984533</ArticleId><ArticleId IdType="pubmed">20813756</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu
        B, Halliwell B, Ong CN, Lee BL, Li QT. (2000). Caloric restriction prevents
        oxidative damage induced by the carcinogen clofibrate in mouse liver. FEBS
        Lett 473(1): 85&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10802065</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhshandehroo
        M, Hooiveld G, M&#xfc;ller M, Kersten S. (2009). Comparative analysis of gene
        regulation by the transcription factor PPAR&#x3b1; between mouse and human.
        PLoS One 4(8):e6796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2729378</ArticleId><ArticleId
        IdType="pubmed">19710929</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Dwivedi RS, Subbarao V, Reddy JK. (1988) Induction of peroxisome proliferation
        and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.
        Br J Cancer.;58(1):46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2246483</ArticleId><ArticleId
        IdType="pubmed">2901849</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Lalwani ND, Scarpelli DG, Reddy JK. (1982). The absence of gamma-glutamyl
        transpeptidase activity in putative preneoplastic lesions and in hepatocellular
        carcinomas induced in rats by the hypolipidemic peroxisome proliferator WY-14,643.
        Carcinogenesis 3(10): 1231&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">6129072</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Lalwani ND, Watanabe TK, Reddy JK. (1984). Inhibitory effect of antioxidants
        ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in
        rats fed ciprofibrate, a peroxisome proliferator. Cancer Res 44(3): 1072&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6692393</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Reddy JK. (1996). Hepatocarcinogenesis of peroxisome proliferators. Ann
        N Y Acad Sci 804:573&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">8993574</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Subbarao V. (1997a). The effect of deferoxamine on ciprofibrate-induced
        hepatocarcinogenesis in the rat. In Vivo 11(6): 495&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9509299</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Subbarao V. (1999). Inhibition of ciprofibrate-induced hepatocarcinogenesis
        in the rat by dimethylthiourea, a scavenger of hydroxyl radical. Oncol Rep
        6(6): 1285&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10523698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Subbarao V. Effect of dexamethasone on ciprofibrate-induced cell proliferation
        and peroxisome proliferation. Fundam Appl Toxicol. 1997b. January;35(1):78&#x2013;83.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9024675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Tatematsu M, Subbarao V, Ito N, Reddy JK. (1986). Analysis of peroxisome
        proliferator-induced preneoplastic and neoplastic lesions of rat liver for
        placental form of glutathione S-transferase and gamma-glutamyltranspeptidase.
        Cancer Res 46(10): 5287&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">2875789</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Thangada S, Subbarao V. (1991). Peroxisome proliferation in neoplastic
        nodules and hepatocellular carcinomas induced by ciprofibrate in the rat.
        Exp Pathol 41(1):44&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2022255</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao
        MS, Usuda N, Subbarao V, Reddy JK. (1987). Absence of gamma-glutamyl transpeptidase
        activity in neoplastic lesions induced in the liver of male F-344 rats by
        di-(2-ethylhexyl)phthalate, a peroxisome proliferator. Carcinogenesis 8(9):
        1347&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">2887302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray
        A, Prefontaine KE. Physical association and functional antagonism between
        the p65 subunit of transcription factor NF-kappa B and the glucocorticoid
        receptor. Proc Natl Acad Sci U S A. 1994. January 18;91(2):752&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC43027</ArticleId><ArticleId IdType="pubmed">8290595</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Lalwani ND, Reddy MK, Qureshi SA. (1982). Excessive accumulation of autofluorescent
        lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate
        and other hypolipidemic peroxisome proliferators. Cancer Res 42(1): 259&#x2013;66.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7053853</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Qureshi SA. (1979). Tumorigenicity of the hypolipidaemic peroxisome proliferator
        ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats. Br J Cancer 40(3):
        476&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2010046</ArticleId><ArticleId
        IdType="pubmed">508572</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Rao MS, Azarnoff DL, Sell S. (1979b). Mitogenic and carcinogenic effects
        of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic
        acid (WY-14, 643), in rat and mouse liver. Cancer Res.39(1):152&#x2013;61.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">83907</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Rao MS. (1977). Malignant tumors in rats fed nafenopin, a hepatic peroxisome
        proliferator. J Natl Cancer Inst 59(6): 1645&#x2013;50.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">200757</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Rao MS. (1989). Oxidative DNA damage caused by persistent peroxisome proliferation:
        Its role in hepatocarcinogenesis. Mutat Res 214:63&#x2013;68.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2671702</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren
        H, Aleksunes LM, Wood C, Vallanat B, George MH, Klaassen CD, Corton JC. (2010).
        Characterization of peroxisome proliferator-activated receptor alpha--independent
        effects of PPAR&#x3b1;lpha activators in the rodent liver: di-(2-ethylhexyl)
        phthalate also activates the constitutive-activated receptor. Toxicol Sci.
        113(1):45&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2794335</ArticleId><ArticleId
        IdType="pubmed">19850644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren
        H, Vallanat B, Nelson DM, Yeung LW, Guruge KS, Lam PK, Lehman-McKeeman LD,
        Corton JC. (2009). Evidence for the involvement of xenobiotic-responsive nuclear
        receptors in transcriptional effects upon perfluoroalkyl acid exposure in
        diverse species. Reprod Toxicol. 27(3-4):266&#x2013;77.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19162173</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigden
        M, Pelletier G, Poon R, Zhu J, Auray-Blais C, Gagnon R, Kubwabo C, Kosarac
        I, Lalonde K, Cakmak S, Xiao B, Leingartner K, Ku KL, Bose R, Jiao J. Assessment
        of urinary metabolite excretion after rat acute exposure to perfluorooctanoic
        acid and other peroxisomal proliferators. Arch Environ Contam Toxicol. 2015.
        January;68(1):148&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25015730</ArticleId></ArticleIdList></Reference><Reference><Citation>Rininger
        JA, Wheelock GD, Ma X, Babish JG. Discordant expression of the cyclin-dependent
        kinases and cyclins in rat liver following acute administration of the hepatocarcinogen
        [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY14,643). Biochem
        Pharmacol. 1996. December 13;52(11):1749&#x2013;55.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8986138</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA, James NH, Hasmall SC, Holden PR, Lambe K, Macdonald N, West D, Woodyatt
        NJ, Whitcome D. (2000). Apoptosis and proliferation in nongenotoxic carcinogenesis:
        species differences and role of PPAR&#x3b1;. Toxicol Lett 112-113:49&#x2013;57.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10720712</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA. (1999). Peroxisome proliferators: mechanisms of adverse effects in rodents
        and molecular basis for species differences. Arch Toxicol 73(8-9):413&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10650911</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfe
        M, James NH, Roberts RA. (1997). Tumour necrosis factor alpha (TNF-alpha)
        suppresses apoptosis and induces S-phase in rodent hepatocytes: A mediator
        of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis 18:2277&#x2013;2280.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9395232</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnolo
        DF, Zempleni J, Selmin OI. Nuclear receptors and epigenetic regulation: opportunities
        for nutritional targeting and disease prevention. Adv Nutr. 2014. July 14;5(4):373&#x2013;85.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4085186</ArticleId><ArticleId IdType="pubmed">25022987</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Cattley RC, Dunn C, Wong V, Li X, Thurman RG. (1999b). Dietary glycine
        prevents the development of liver tumors caused by the peroxisome proliferator
        WY-14,643. Carcinogenesis 20(11): 2075&#x2013;81.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10545408</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Germolec D, Arteel GE, Schoonhoven R, Thurman RG. (1997a). Dietary glycine
        prevents increases in hepatocyte proliferation caused by the peroxisome proliferator
        WY-14,643. Chem Res Toxicol 10(10):1198&#x2013;204.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9348444</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Germolec DR, Schoonhoven R, Thurman RG. (1997b). Kupffer cells are causally
        responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis
        18(8):1453&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9276615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Rivera CA, Bradford BU, Graves LM, Cattley RC, Schoonhoven R, Swenberg
        JA, Thurman RG. (1999a). Kupffer cell oxidant production is central to the
        mechanism of peroxisome proliferators. Carcinogenesis 20(1): 27&#x2013;33.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9934846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen
        MB, Abbott BD, Wolf DC, Corton JC, Wood CR, Schmid JE, Das KP, Zehr RD, Blair
        ET, Lau C. (2008a). Gene profiling in the livers of wild-type and PPAR&#x3b1;-null
        mice exposed to perfluorooctanoic acid. Toxicol Pathol 36(4):592&#x2013;607.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18467677</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen
        MB, Das KP, Wood CR, Wolf CJ, Abbott BD, Lau C. Evaluation of perfluoroalkyl
        acid activity using primary mouse and human hepatocytes. Toxicology. 2013.
        June 7;308:129&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">23567314</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen
        MB, Lee JS, Ren H, Vallanat B, Liu J, WaalKEs MP, Abbott BD, Lau C, Corton
        JC. (2008b). Toxicogenomic dissection of the perfluorooctanoic acid transcript
        profile in mouse liver: evidence for the involvement of nuclear receptors
        PPAR alpha and CAR. Toxicol Sci 103(1):46&#x2013;56.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18281256</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen
        MB, Schmid JR, Corton JC, Zehr RD, Das KP, Abbott BD, Lau C. (2010). Gene
        expression profiling in wild-type and PPAR&#x3b1;-null mice exposed to perfluorooctane
        sulfonate reveals PPAR&#x3b1;-independent effects. PPAR Research pii: 794739.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2948942</ArticleId><ArticleId IdType="pubmed">20936131</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen
        MB, Das Kaberi P., Rooney John, Abbott Barbara, Lau Christopher and Corton
        J. Christopher. PPAR&#x3b1;-independent transcriptional targets of perfluoroalkyl
        acids revealed by transcript profiling. Submitted to Toxicology.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC6129013</ArticleId><ArticleId IdType="pubmed">28558994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland
        IR. Metabolism of di-(2-ethylhexyl) phthalate by the contents of the alimentary
        tract of the rat. Food Cosmet Toxicol. 1974. June;12(3):293&#x2013;303.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4442812</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Kadiiska MB, Dikalova A, Kono H, Yin M, Tsuchiya K, Mason RP, Peters JM,
        Gonzalez FJ, Segal BH, Holland SM, Thurman RG. (2001). Phthalates rapidly
        increase production of reactive oxygen species in vivo: role of Kupffer cells.
        Mol Pharmacol 59(4): 744&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">11259618</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Peters JM, Cunningham ML. (2006). Modes of action and species-specific
        effects of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol 36(5):459&#x2013;79.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2614359</ArticleId><ArticleId IdType="pubmed">16954067</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Tsukamoto H, Thurman RG. (1998). WY-14 643 rapidly activates nuclear factor
        kappaB in Kupffer cells before hepatocytes. Carcinogenesis 19(7): 1217&#x2013;22.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9683180</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Yamashina S, Segal BH, Schoonhoven R, Holland SM, Cattley RC, Swenberg
        JA, Thurman RG. (2000). Oxidants from nicotinamide adenine dinucleotide phosphate
        oxidase are involved in triggering cell proliferation in the liver due to
        peroxisome proliferators. Cancer Res 60(17): 4798&#x2013;803.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10987289</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson
        LM, de Groot PJ, Hooiveld GJ, Koppen A, Kalkhoven E, M&#xfc;ller M, Kersten
        S. (2008). Effect of synthetic dietary triglycerides: a novel research paradigm
        for nutrigenomics. PLoS One 3(2):e1681.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2244803</ArticleId><ArticleId IdType="pubmed">18301758</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapone
        A, Peters JM, Sakai S, Tomita S, Papiha SS, Dai R, Friedman FK, Gonzalez FJ.
        (2000). The human peroxisome proliferator-activated receptor alpha gene: identification
        and functional characterization of two natural allelic variants. Pharmacogenetics
        10(4):321&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">10862523</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmezer
        P, Pool BL, Klein RG, Komitowski D, Schm&#xe4;hl D. (1988). Various short-term
        assays and two long-term studies with the plasticizer di(2-ethylhexyl)phthalate
        in the Syrian golden hamster. Carcinogenesis 9(1):37&#x2013;43.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3335045</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Hermann
        R, Ohde G, Schuppler J, Timmermann-Trosiener I. (1981). Enhanced proliferation
        of putative preneoplastic cells in rat liver following treatment with the
        tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and
        nafenopin. Cancer Res 41(6): 2556&#x2013;62.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6165465</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz
        JJ, Chakraborty T, Martin J, Zhou J and Olson EN (1992) The Basic Region of
        Myogenin Cooperates with Two Transcription Activation Domains To Induce Muscle-Specific
        Transcription. Mol Cell Biol 12 (1) 266&#x2013;275.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC364092</ArticleId><ArticleId IdType="pubmed">1309591</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo
        KW, Kim KB, Kim YJ, Choi JY, Lee KT, Choi KS. (2004). Comparison of oxidative
        stress and changes of xenobiotic metabolizing enzymes induced by phthalates
        in rats. Food Chem Toxicol 42(1): 107&#x2013;14.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14630134</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah
        YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez FJ. (2007). Peroxisome
        proliferator-activated receptor alpha regulates a microRNA-mediated signaling
        cascade responsible for hepatocellular proliferation. Mol Cell Biol 27(12):4238&#x2013;47.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1900062</ArticleId><ArticleId IdType="pubmed">17438130</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw
        D, Lee R, Roberts RA. (2002). Species differences in response to the phthalate
        plasticizer monoisononylphthalate (MINP) in vitro: a comparison of rat and
        human hepatocytes. Arch Toxicol 76(5-6):344&#x2013;50.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12107652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher
        T, Yi HF, McBride OW, Gonzalez FJ. (1993). cDNA cloning, chromosomal mapping,
        and functional characterization of the human peroxisome proliferator activated
        receptor. Biochemistry 32(21): 5598&#x2013;604.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7684926</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipley
        JM, Hurst CH, Tanaka SS, DeRoos FL, Butenhoff JL, Seacat AM, Waxman DJ. (2004).
        trans-activation of PPAR&#x3b1; and induction of PPAR&#x3b1; target genes
        by perfluorooctane-based chemicals. Toxicol Sci 80(1):151&#x2013;60.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15071170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipes
        NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ,
        Kavlock RJ, Knudsen TB. Profiling 976 ToxCast chemicals across 331 enzymatic
        and receptor signaling assays Chem Res Toxicol. 2013. June 17;26(6):878&#x2013;95.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3685188</ArticleId><ArticleId IdType="pubmed">23611293</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Oliver
        T, Butterworth BE. (1987). Correlation of the carcinogenic potential of di(2-ethylhexyl)phthalate
        (DEHP) with induced hyperplasia rather than with genotoxic activity. Mutat
        Res 188(1): 21&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">3574334</ArticleId></ArticleIdList></Reference><Reference><Citation>Soames
        AR, Cliffe S, Pate I, Foster JR. (1999). Quantitative analysis of the lobular
        distribution of S-phase in rat liver following dietary administration of di(2-ethylhexyl)phthalate.
        Toxicol Pathol 27(4): 436&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485824</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman
        MS, Cunningham ML, Morrow JD, Roberts LJ 2nd, Badr MZ. (1997). Evidence against
        peroxisome proliferation-induced hepatic oxidative damage. Biochem Pharmacol
        53(9): 1369&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">9214698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonich-Mullin
        C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley
        M, Knaap A, Kroese D, Mangelsdorf I, Meek ME, Rice JM, Younes M. (2001). IPCS
        conceptual framework for evaluating a mode of action for chemical carcinogenesis.
        Regul Toxicol Pharmacol 34 (2):146&#x2013;152.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11603957</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanko
        RT, Sekas G, Isaacson IA, Clarke MR, Billiar TR, Paul HS. (1995). Pyruvate
        inhibits clofibrate-induced hepatic peroxisomal proliferation and free radical
        production in rats. Metabolism 44(2): 166&#x2013;71.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7869911</ArticleId></ArticleIdList></Reference><Reference><Citation>Stauber
        AJ, Bull RJ. (1997). Differences in phenotype and cell replicative behavior
        of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA).
        Toxicol Appl Pharmacol 144(2): 235&#x2013;46.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9194407</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenland
        K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of
        perfluorooctanoic acid (PFOA). Environ Health Perspect. 2010. August;118(8):1100&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2920088</ArticleId><ArticleId IdType="pubmed">20423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Styles
        JA, Kelly MD, Pritchard NR, Elcombe CR. (1990). Acute hyperplasia and peroxisome
        proliferation induced by methylclofenapate: a species comparison and implications
        for liver carcinogenesis. Prog Clin Biol Res. 331:385&#x2013;93.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2315346</ArticleId></ArticleIdList></Reference><Reference><Citation>Svoboda
        DJ, Azarnoff DL. (1979). Tumors in male rats fed ethyl chlorophenoxyisobutyrate,
        a hypolipidemic drug. Cancer Res 39(9): 3419&#x2013;28.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">582575</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai
        ES, Demissie S, Cupples LA, Corella D, Wilson PW, Schaefer EJ, Ordovas JM.
        (2002). Association between the PPAR&#x391; L162V polymorphism and plasma
        lipid levels: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol.
        22(5):805&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12006394</ArticleId></ArticleIdList></Reference><Reference><Citation>Takacs
        ML, Abbott BD. (2007). Activation of mouse and human peroxisome proliferator-activated
        receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane
        sulfonate. Toxicol Sci 95(1): 108&#x2013;17.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17047030</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashima
        K, Ito Y, Gonzalez FJ, Nakajima T. (2008). Different mechanisms of DEHP-induced
        hepatocellular adenoma tumorigenesis in wild-type and PPAR alpha-null mice.
        J Occup Health. 50(2):169&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217336</ArticleId><ArticleId
        IdType="pubmed">18403868</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka
        K, Smith PF, Stromberg PC, Eydelloth RS, Herold EG, Grossman SJ, Frank JD,
        Hertzog PR, Soper KA, Keenan KP. (1992). Studies of early hepatocellular proliferation
        and peroxisomal proliferation in Sprague Dawley rats treated with tumorigenic
        doses of clofibrate. Toxicol Appl Pharmacol 116(1): 71&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1529455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka
        N, Moriya K, Kiyosawa K, Koike K, Aoyama T. (2008b). Hepatitis C virus core
        protein induces spontaneous and persistent activation of peroxisome proliferator-activated
        receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.
        Int J Cancer 122(1):124&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17764115</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka
        N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T (2008a). PPAR&#x3b1;
        activation is essential for HCV core protein-induced hepatic steatosis and
        hepatocellular carcinoma in mice. J Clin Invest. 118(2):683&#x2013;94.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2176192</ArticleId><ArticleId IdType="pubmed">18188449</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateno
        C, Yamamoto T, Utoh R, Yamasaki C, Ishida Y, Myoken Y, Oofusa K, Okada M,
        Tsutsui N, Yoshizato K. Chimeric mice with hepatocyte-humanized liver as an
        appropriate model to study human peroxisome proliferator-activated receptor-&#x3b1;.
        Toxicol Pathol. 2015. February;43(2):233&#x2013;48.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">25107573</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateno
        C, Yamamoto T, Utoh R, Yamasaki C, Ishida Y, Myoken Y, Oofusa K, Okada M,
        Tsutsui N, Yoshizato K. Chimeric mice with hepatocyte-humanized liver as an
        appropriate model to study human peroxisome proliferator-activated receptor-&#x3b1;.
        Toxicol Pathol. 2015. February;43(2):233&#x2013;48.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">25107573</ArticleId></ArticleIdList></Reference><Reference><Citation>Tharappel
        JC, Cunningham ML, Spear BT, Glauert HP (2001). Differential activation of
        hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators WY-14,643,
        gemfibrozil, and dibutyl phthalate. Toxicol Sci 62(1): 20&#x2013;7.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11399789</ArticleId></ArticleIdList></Reference><Reference><Citation>Tharappel
        JC, Nalca A, Owens AB, Ghabrial L, Konz EC, Glauert HP, Spear BT. (2003).
        Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB
        p50 subunit after treatment with the peroxisome proliferator ciprofibrate.
        Toxicol Sci 75(2): 300&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12883078</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas
        M, Bayha C, Klein K, M&#xfc;ller S, Weiss TS, Schwab M, Zanger UM. The truncated
        splice variant of peroxisome proliferator-activated receptor alpha, PPAR&#x3b1;-tr,
        autonomously regulates proliferative and pro-inflammatory genes. BMC Cancer.
        2015. June 30;15:488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4485637</ArticleId><ArticleId
        IdType="pubmed">26122096</ArticleId></ArticleIdList></Reference><Reference><Citation>Thottassery
        J, Winberg L, Youssef J, Cunningham ML, Badr M. (1992). Regulation of perfluorooctanoic
        acid--induced peroxisomal enzyme activities and hepatocellular growth by adrenal
        hormones. Hepatology 15(2): 316&#x2013;22.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1735536</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaszewski
        KE, Heindel SW, Jenkins WL, Melnick RL. (1990). Induction of peroxisomal acyl
        CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
        Toxicology 65(1-2): 49&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">2274969</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker
        MJ, Orton TC. (1995). Comparative Toxicology of Hypolipidaemic Fibrates. Taylor
        and Francis, Bristol, PA.</Citation></Reference><Reference><Citation>Tugwood
        JD, Aldridge TC, Lambe KG, Macdonald N, and Woodyatt NJ (1996). Peroxisome
        proliferator-activated receptors: Structures and function. Ann. NY Acad. Sci
        804:252&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">8993548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tugwood
        JD, Aldridge TC, Lambe KG, Macdonald N, Woodyatt NJ. (1996). Peroxisome proliferator-activated
        receptors: structures and function. Ann N Y Acad Sci. 804:252&#x2013;65.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8993548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tugwood
        JD, Holden PR, James NH, Prince RA, Roberts RA. (1998). A PPAR alpha cDNA
        cloned from guinea pig liver encodes a protein with similar properties to
        the mouse PPAR alpha: Implications for species differences in response to
        peroxisome proliferators. Arch. Toxicol 72:169&#x2013;177.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9520140</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S.
        Environmental Protection Agency. (2005) Guidelines for carcinogen risk assessment
        and supplemental guidance for assessing susceptibility from early-life exposure
        to carcinogens. Fed. Reg 70:66 , pp. 17765&#x2013;17817.</Citation></Reference><Reference><Citation>Urbanek-Olejnik
        K, Liszewska M, Winczura A, Kostka G. Changes of c-Myc and DNMT1 mRNA and
        protein levels in the rat livers induced by dibutyl phthalate treatment. Toxicol
        Ind Health. 2016. May;32(5):801&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">24311629</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdellatif
        AG, Preat V, Taper HS, Roberfroid M. (1991). The modulation of rat liver carcinogenesis
        by perfluorooctanoic acid, a peroxisome proliferator. Toxicol Appl Pharmacol
        111(3): 530&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">1684073</ArticleId></ArticleIdList></Reference><Reference><Citation>Valles
        EG, Laughter AR, Dunn CS, Cannelle S, Swanson CL, Cattley RC, Corton JC. (2003).
        Role of the peroxisome proliferator-activated receptor alpha in responses
        to diisononyl phthalate. Toxicology 191(2-3):211&#x2013;25.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12965124</ArticleId></ArticleIdList></Reference><Reference><Citation>Van
        Rafelghem MJ, Mattie DR, Bruner RH, Andersen ME. (1987). Pathological and
        hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid
        in the rat, hamster, mouse, and guinea pig. Fundam Appl Toxicol 9(3): 522&#x2013;40.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3692011</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden
        Heuvel JP, Thompson JT, Frame SR, Gillies PJ. (2006). Differential activation
        of nuclear receptors by perfluorinated fatty acid analogs and natural fatty
        acids: a comparison of human, mouse, and rat peroxisome proliferator-activated
        receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha.
        Toxicol Sci 92(2): 476&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">16731579</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada
        N, Marsman DS, Popp JA. (1992). Dose-related effects of the hepatocarcinogen,
        WY-14,643, on peroxisomes and cell replication. Fundam Appl Toxicol 18(1):
        149&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">1601204</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters
        MW, Bjork JA, Wallace KB. Perfluorooctanoic acid stimulated mitochondrial
        biogenesis and gene transcription in rats. Toxicology. 2009. October 1;264(1-2):10&#x2013;5.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19616056</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Hagiwara A, Anderson LM, Lindsey K, Diwan BA. (1988). The chronic hepatic
        or renal toxicity of di(2-ethylhexyl) phthalate, acetaminophen, sodium barbital,
        and phenobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical,
        and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis
        or tumor promotion. Toxicol Appl Pharmacol 96(3):494&#x2013;506.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3206528</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe
        T, Horie S, Yamada J, Isaji M, Nishigaki T, Naito J, Suga T. (1989). Species
        differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic
        peroxisome-associated enzymes. Biochem. Pharmacol 38:367&#x2013;371.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2914022</ArticleId></ArticleIdList></Reference><Reference><Citation>Weglarz
        TC, Sandgren EP. (2004). Cell cross-talk mediates PPAR&#x3b1; null hepatocyte
        proliferation after peroxisome proliferator exposure. Carcinogenesis 25(1):
        107&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">14514660</ArticleId></ArticleIdList></Reference><Reference><Citation>West
        D, James N, Holden P, Brindle R, Rolfe M, Roberts R. (1999). Role for tumour
        necrosis factor a (TNF&#x3b1;) receptor 1 (TNFR1) and interleukin 1 receptor
        (IL1R) in the suppression of apoptosis by peroxisome proliferators. Hepatology
        30:1417&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pubmed">10573520</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler
        MD, Smutney OM, Check JF, Rusyn I, Schulte-Hermann R, Thurman RG. (2003).
        Impaired Ras membrane association and activation in PPAR&#x3b1; knockout mice
        after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol. 284(2):G302&#x2013;12.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12388208</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams
        GM, Perrone C. (1995). Mechanism based risk assessment of peroxisome proliferating
        rodent hepatocarcinogens. In: Peroxisomes: Biology and Role in Toxicology
        and Disease, eds. Reddy JK, Suga T, and Mannaerts GP, Ann.NYAcad. Sci 804:554&#x2013;572.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8993573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf
        DC, Moore T, Abbott BD, Rosen MB, Das KP, Zehr RD, Lindstrom AB, Strynar MJ,
        Lau C. (2008). Comparative hepatic effects of perfluorooctanoic acid and WY
        14,643 in PPAR-alpha knockout and wild-type mice. Toxicol. Pathol 36(4):632&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18467680</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods
        CG, Burns AM, Bradford BU, Ross PK, Kosyk O, Swenberg JA, Cunningham ML, Rusyn
        I. (2007c). WY-14,643 induced cell proliferation and oxidative stress in mouse
        liver are independent of NADPH oxidase. Toxicol Sci. 98(2):366&#x2013;74.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17483499</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods
        CG, Burns AM, Maki A, Bradford BU, Cunningham ML, Connor HD, Kadiiska MB,
        Mason RP, Peters JM, Rusyn I. (2007b). Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone
        radical adducts in mouse liver by peroxisome proliferators is dependent upon
        peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase. Free
        Radic Biol Med 42(3): 335&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1829322</ArticleId><ArticleId
        IdType="pubmed">17210446</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods
        CG, Kosyk O, Bradford BU, Ross PK, Burns AM, Cunningham ML, Qu P, Ibrahim
        JG, Rusyn I. (2007a). Time course investigation of PPAR&#x3b1;- and Kupffer
        cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
        Toxicol Appl Pharmacol. 225(3):267&#x2013;77.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2153436</ArticleId><ArticleId IdType="pubmed">17950772</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao
        S, Anderson SP, Swanson C, Bahnemann R, Voss KA, Stauber AJ, Corton JC. (2006).
        Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis
        in the mouse liver. Toxicol Sci. 92(2):368&#x2013;77.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16687391</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa-Kobayashi
        K, Ishiguro H, Arinami T, Miyazaki R, Hamaguchi H. (2002). A Val227Ala polymorphism
        in the peroxisome proliferator activated receptor alpha (PPAR&#x3b1;) gene
        is associated with variations in serum lipid levels. J Med Genet. 39(3):189&#x2013;91.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1735067</ArticleId><ArticleId IdType="pubmed">11897821</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang
        Q, Ito S, Gonzalez FJ. (2007). Hepatocyte-restricted constitutive activation
        of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis. Carcinogenesis.
        28(6):1171&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1885989</ArticleId><ArticleId
        IdType="pubmed">17331954</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang
        Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ. (2008). The PPAR alpha-humanized
        mouse: a model to investigate species differences in liver toxicity mediated
        by PPAR alpha. Toxicol Sci. 101(1):132&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2197159</ArticleId><ArticleId IdType="pubmed">17690133</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeldandi
        AV, Milano M, Subbarao V, Reddy JK, Rao MS. (1989). Evaluation of liver cell
        proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett
        47(1-2): 21&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2636030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeldandi
        AV, Rao MS, Reddy JK. (2000). Hydrogen peroxide generation in peroxisome proliferator-induced
        oncogenesis. Mutat Res. 448(2):159&#x2013;77.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725470</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef
        JA, Bouziane M, Badr MZ. (2003). Age-dependent effects of nongenotoxic hepatocarcinogens
        on liver apoptosis in vivo. Mech Ageing Dev 124(3): 333&#x2013;40.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12663131</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8785518</PMID><DateCompleted><Year>1996</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>24</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0248-4900</ISSN><JournalIssue
        CitedMedium="Print"><Volume>85</Volume><Issue>2-3</Issue><PubDate><Year>1995</Year></PubDate></JournalIssue><Title>Biology
        of the cell</Title><ISOAbbreviation>Biol Cell</ISOAbbreviation></Journal><ArticleTitle>Morphometric
        analysis of liver and kidney peroxisomes in lactating rats and their pups
        after treatment with the peroxisomal proliferator di-(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>167</StartPage><EndPage>176</EndPage><MedlinePgn>167-76</MedlinePgn></Pagination><Abstract><AbstractText>Di-(2-ethylexyl)phthalate
        (DEHP) administered to adult lactating rats from delivery to weaning induces
        age- and organ-specific modifications of the peroxisomal morphometric parameters
        (VV, NA and D) in the liver and kidney of both rats and their pups. In both
        tissues, peroxisomal relative volume and catalase biochemical activity show
        a similar pattern during the development, as well as under DEHP treatment.
        Morphometric results suggest that two modalities of peroxisomal proliferation
        exist, involving: a) increases in both number and mean diameter of the organelles;
        b) a purely numerical increase of the organelles, accompanied by a remarkable
        decrement in their mean diameter. A peroxisomal population proliferated through
        the latter model appears unable to return to normal conditions, following
        treatment withdrawal. These two proliferation systems, the first implying
        a swelling and the latter a fragmentation of pre-existing peroxisomal profiles,
        are supposed to be tissue-specific in the adult animal. In particular, in
        the liver the ''swelling'' model appears more suitable to explain peroxisome
        proliferation, while the kidney this process would follow the ''fragmentation''
        model. Immature animals might instead show in both organs intermediate features
        of peroxisomal proliferation modalities.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Stefanini</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Cellular and Developmental Biology, University of Rome, La Sapienza, Italy.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Serafini</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Nardacci</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Vecchioli</LastName><ForeName>S F</ForeName><Initials>SF</Initials></Author><Author
        ValidYN="Y"><LastName>Moreno</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Sartori</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biol
        Cell</MedlineTA><NlmUniqueID>8108529</NlmUniqueID><ISSNLinking>0248-4900</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006133">Growth Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000833" MajorTopicYN="Y">Animals, Suckling</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006133" MajorTopicYN="N">Growth Substances</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007774" MajorTopicYN="Y">Lactation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1995</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1995</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1995</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8785518</ArticleId><ArticleId IdType="doi">10.1016/0248-4900(96)85277-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">22484601</PMID><DateCompleted><Year>2012</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-5107</ISSN><JournalIssue
        CitedMedium="Print"><Volume>751</Volume><Issue>2</Issue><PubDate><Year>2012</Year><Season>Oct-Dec</Season></PubDate></JournalIssue><Title>Mutation
        research</Title><ISOAbbreviation>Mutat Res</ISOAbbreviation></Journal><ArticleTitle>DEHP:
        genotoxicity and potential carcinogenic mechanisms-a review.</ArticleTitle><Pagination><StartPage>82</StartPage><EndPage>157</EndPage><MedlinePgn>82-157</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.mrrev.2012.03.001</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S1383-5742(12)00017-8</ELocationID><Abstract><AbstractText>Di(ethylhexyl)
        phthalate (DEHP) is a manufactured chemical commonly added to plastics: it
        is a ubiquitous environmental contaminant to which humans are exposed through
        multiple routes. DEHP is a rodent carcinogen with an extensive data base on
        genotoxicity and related effects spanning several decades. Although DEHP has
        been reported to be negative in most non-mammalian in vitro mutation assays,
        most studies were performed under conditions of concurrent cytotoxicity, precipitation,
        or irrelevant metabolic activation. However, a number of in vitro rodent tissue
        assays have reported DEHP to be positive for effects on chromosomes, spindle,
        and mitosis. A robust database shows that DEHP increases transformation and
        inhibits apoptosis in Syrian hamster embryo cells. In a transgenic mouse assay,
        in vivo DEHP exposure increased the mutation frequency only in the liver,
        which is the target organ for cancer. In vitro exposure of human cells or
        tissues to DEHP induced DNA damage; altered mitotic rate, apoptosis, and cell
        proliferation; increased proliferation, tumor mobility, and invasiveness of
        tumor cell lines; and activated a number of nuclear receptors. DEHP has been
        shown to be an agonist for CAR2, a novel constitutive androstane receptor
        occurring only in humans. Environmental exposures of humans to DEHP have been
        associated with DNA damage. After taking into account study context and relevant
        issues affecting interpretation, in vitro studies reported that a similar
        DEHP concentration range induced both mutagenic and non-mutagenic effects
        in human tissues and, using a much more limited rodent database, transformation
        of embryonic rodent tissues. The human and rodent data suggest that DEHP induces
        cancer through multiple molecular signals, including DNA damage. The analyses
        presented here may provide guidance for similar data sets used in structure-activity
        relationships, computational-toxicology extrapolations, and attempts to extrapolate
        in vitro results to predict in vivo effects for hazard characterization.</AbstractText><CopyrightInformation>Published
        by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Caldwell</LastName><ForeName>Jane C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>National
        Center for Environmental Assessment, Office of Research and Development, U.S.
        Environmental Protection Agency, 1200 Pennsylvania Avenue, NW, Mail Code:
        8623P, Washington, DC 20460, United States. Electronic address: Caldwell.jane@epa.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2012</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat
        Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002869" MajorTopicYN="N">Chromosome Aberrations</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2012</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2012</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2012</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2012</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2012</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2012</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">22484601</ArticleId><ArticleId IdType="doi">10.1016/j.mrrev.2012.03.001</ArticleId><ArticleId
        IdType="pii">S1383-5742(12)00017-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">28426879</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2180</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Acute
        exposure to DEHP metabolite, MEHP cause genotoxicity, mutagenesis and carcinogenicity
        in mammalian Chinese hamster ovary cells.</ArticleTitle><Pagination><StartPage>336</StartPage><EndPage>345</EndPage><MedlinePgn>336-345</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1093/carcin/bgx009</ELocationID><Abstract><AbstractText>Di-(2-ethylhexyl)
        phthalate (DEHP), the common plasticizer used in the production of polyvinyl
        chloride, can be converted to the more potent metabolite mono-ethylhexyl phthalate
        (MEHP). Epidemiological studies have shown an association with elevated induction
        of rat hepatic cancer and reproductive toxicity in response to MEHP exposure.
        However, the mechanism of genotoxicity and carcinogenicity induced by MEHP
        treatment remains unclear. As a means to elucidate the mechanisms of action,
        lethality and mutagenicity in the adenine phosphoribosyltransferase (aprt+/-)
        gene induced in several CHO cell types by MEHP were assessed. Dose-response
        relationships were determined in the parental AA8 cell line, its nucleotide
        repair-deficient UV5 and base repair-deficient EM9 subclones, and also in
        AS52 cells harboring the bacterial guanine-hypoxanthine phosphoribosyltransferase
        (gpt) gene and its derived AS52-XPD-knockdown and AS52-PARP-1-knockdown cells.
        Treatment of AS52 with MEHP led to intracellular production of reactive oxygen
        species (ROS) and DNA strand breaks in a dose-dependent manner. Separately,
        mutations in the gpt gene of AS52 cells were characterized and found to be
        dominated by G:C to A:T and A:T to G:C transitions. Independent AS52-mutant
        cell (ASMC) clones were collected for the sequential in vivo xenograft tumorigenic
        studies, 4 of total 20 clones had aggressive tumor growth. Moreover, microarray
        analysis indicated miR-let-7a and miR-125b downregulated in ASMC, which might
        raise oncogenic MYC and RAS level and activate ErbB pathway. Comparative evaluation
        of the results indicates that the principal mechanism of this mutagenic action
        is probably to be through generation of ROS, causing base excision damage
        resulting in carcinogenicity.</AbstractText><CopyrightInformation>&#xa9; The
        Author 2017. Published by Oxford University Press. All rights reserved. For
        Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yu-Jung</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department
        of Bioscience Technology, College of Science.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chia-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department
        of Biomedical Engineering, College of Engineering and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Nanotechnology, Chung Yuan Christian University, Taoyuan 32023, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lin</LastName><ForeName>Pei-Ying</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Department
        of Bioscience Technology, College of Science.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chuang</LastName><ForeName>Yu-Chen</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department
        of Biomedical Engineering, College of Engineering and.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chao</LastName><ForeName>Ming-Wei</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department
        of Bioscience Technology, College of Science.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Nanotechnology, Chung Yuan Christian University, Taoyuan 32023, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.4.2.30</RegistryNumber><NameOfSubstance UI="D000071137">Poly (ADP-Ribose)
        Polymerase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016296" MajorTopicYN="N">Mutagenesis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009152" MajorTopicYN="N">Mutagenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000071137" MajorTopicYN="N">Poly (ADP-Ribose) Polymerase-1</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2016</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2017</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">28426879</ArticleId><ArticleId IdType="doi">10.1093/carcin/bgx009</ArticleId><ArticleId
        IdType="pii">2954952</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">17326724</PMID><DateCompleted><Year>2007</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1545-7885</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2007</Year><Month>Jan</Month></PubDate></JournalIssue><Title>PLoS
        biology</Title><ISOAbbreviation>PLoS Biol</ISOAbbreviation></Journal><ArticleTitle>Impaired
        genome maintenance suppresses the growth hormone--insulin-like growth factor
        1 axis in mice with Cockayne syndrome.</ArticleTitle><Pagination><StartPage>e2</StartPage><MedlinePgn>e2</MedlinePgn></Pagination><ELocationID
        EIdType="pii" ValidYN="Y">e2</ELocationID><Abstract><AbstractText>Cockayne
        syndrome (CS) is a photosensitive, DNA repair disorder associated with progeria
        that is caused by a defect in the transcription-coupled repair subpathway
        of nucleotide excision repair (NER). Here, complete inactivation of NER in
        Csb(m/m)/Xpa(-/-) mutants causes a phenotype that reliably mimics the human
        progeroid CS syndrome. Newborn Csb(m/m)/Xpa(-/-) mice display attenuated growth,
        progressive neurological dysfunction, retinal degeneration, cachexia, kyphosis,
        and die before weaning. Mouse liver transcriptome analysis and several physiological
        endpoints revealed systemic suppression of the growth hormone/insulin-like
        growth factor 1 (GH/IGF1) somatotroph axis and oxidative metabolism, increased
        antioxidant responses, and hypoglycemia together with hepatic glycogen and
        fat accumulation. Broad genome-wide parallels between Csb(m/m)/Xpa(-/-) and
        naturally aged mouse liver transcriptomes suggested that these changes are
        intrinsic to natural ageing and the DNA repair-deficient mice. Importantly,
        wild-type mice exposed to a low dose of chronic genotoxic stress recapitulated
        this response, thereby pointing to a novel link between genome instability
        and the age-related decline of the somatotroph axis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Pluijm</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department
        of Genetics, Center for Biomedical Genetics, Erasmus University Medical Center,
        Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Garinis</LastName><ForeName>George A</ForeName><Initials>GA</Initials></Author><Author
        ValidYN="Y"><LastName>Brandt</LastName><ForeName>Renata M C</ForeName><Initials>RM</Initials></Author><Author
        ValidYN="Y"><LastName>Gorgels</LastName><ForeName>Theo G M F</ForeName><Initials>TG</Initials></Author><Author
        ValidYN="Y"><LastName>Wijnhoven</LastName><ForeName>Susan W</ForeName><Initials>SW</Initials></Author><Author
        ValidYN="Y"><LastName>Diderich</LastName><ForeName>Karin E M</ForeName><Initials>KE</Initials></Author><Author
        ValidYN="Y"><LastName>de Wit</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Mitchell</LastName><ForeName>James R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>van Oostrom</LastName><ForeName>Conny</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Beems</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Niedernhofer</LastName><ForeName>Laura J</ForeName><Initials>LJ</Initials></Author><Author
        ValidYN="Y"><LastName>Velasco</LastName><ForeName>Susana</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Friedberg</LastName><ForeName>Errol C</ForeName><Initials>EC</Initials></Author><Author
        ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kiyoji</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>van Steeg</LastName><ForeName>Harry</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Hoeijmakers</LastName><ForeName>Jan H J</ForeName><Initials>JH</Initials></Author><Author
        ValidYN="Y"><LastName>van der Horst</LastName><ForeName>Gijsbertus T J</ForeName><Initials>GT</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>P01 AG017242</GrantID><Acronym>AG</Acronym><Agency>NIA
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01
        ES011044</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>1P01 AG17242-02</GrantID><Acronym>AG</Acronym><Agency>NIA
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1U01
        ES011044</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research
        Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>PLoS Biol</MedlineTA><NlmUniqueID>101183755</NlmUniqueID><ISSNLinking>1544-9173</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000075223">Poly-ADP-Ribose Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D051760">Xeroderma Pigmentosum Group A Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C501002">Xpc protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>67763-96-6</RegistryNumber><NameOfSubstance
        UI="D007334">Insulin-Like Growth Factor I</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-72-6</RegistryNumber><NameOfSubstance
        UI="D013006">Growth Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.6.4.12</RegistryNumber><NameOfSubstance UI="C513075">Ercc6 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        6.5.1.-</RegistryNumber><NameOfSubstance UI="D045643">DNA Repair Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance
        UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections
        RefType="ErratumIn"><RefSource>PLoS Biol. 2008 Nov;6(11):e304</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003057" MajorTopicYN="N">Cockayne Syndrome</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D045643" MajorTopicYN="N">DNA Repair Enzymes</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016678" MajorTopicYN="N">Genome</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013006" MajorTopicYN="N">Growth Hormone</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007334" MajorTopicYN="N">Insulin-Like Growth Factor I</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000075223" MajorTopicYN="N">Poly-ADP-Ribose Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011839" MajorTopicYN="N">Radiation, Ionizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D052683" MajorTopicYN="N">Somatotrophs</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051760" MajorTopicYN="N">Xeroderma Pigmentosum Group A Protein</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>

        <b>Competing interests.</b> The authors have declared that no competing interests
        exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2006</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2006</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2007</Year><Month>3</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2007</Year><Month>4</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2007</Year><Month>3</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">17326724</ArticleId><ArticleId IdType="pmc">PMC1698505</ArticleId><ArticleId
        IdType="doi">10.1371/journal.pbio.0050002</ArticleId><ArticleId IdType="pii">06-PLBI-RA-0854R3</ArticleId><ArticleId
        IdType="sici">plbi-05-01-01</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harman
        D. Aging: A theory based on free radical and radiation chemistry. J Gerontol.
        1956;11:298&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">13332224</ArticleId></ArticleIdList></Reference><Reference><Citation>Schriner
        SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, et al. Extension of murine
        life span by overexpression of catalase targeted to mitochondria. Science.
        2005;308:1909&#x2013;1911.</Citation><ArticleIdList><ArticleId IdType="pubmed">15879174</ArticleId></ArticleIdList></Reference><Reference><Citation>Melov
        S, Ravenscroft J, Malik S, Gill MS, Walker DW, et al. Extension of life-span
        with superoxide dismutase/catalase mimetics. Science. 2000;289:1567&#x2013;1569.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10968795</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr
        WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase
        and catalase in Drosophila melanogaster . Science. 1994;263:1128&#x2013;1130.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8108730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii
        N, Fujii M, Hartman PS, Tsuda M, Yasuda K, et al. A mutation in succinate
        dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes.
        Nature. 1998;394:694&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pubmed">9716135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton
        ML, Van Remmen H, Drake JA, Yang H, Guo ZM, et al. Does oxidative damage to
        DNA increase with age? Proc Natl Acad Sci U S A. 2001;98:10469&#x2013;10474.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC56984</ArticleId><ArticleId IdType="pubmed">11517304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu
        T, Pan Y, Kao SY, Li C, Kohane I, et al. Gene regulation and DNA damage in
        the ageing human brain. Nature. 2004;429:883&#x2013;891.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15190254</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin
        GM. Genetic modulation of senescent phenotypes in Homo sapiens . Cell. 2005;120:523&#x2013;532.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15734684</ArticleId></ArticleIdList></Reference><Reference><Citation>de
        Boer J, Andressoo JO, de Wit J, Huijmans J, Beems RB, et al. Premature aging
        in mice deficient in DNA repair and transcription. Science. 2002;296:1276&#x2013;1279.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11950998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanawalt
        PC. Subpathways of nucleotide excision repair and their regulation. Oncogene.
        2002;21:8949&#x2013;8956.</Citation><ArticleIdList><ArticleId IdType="pubmed">12483511</ArticleId></ArticleIdList></Reference><Reference><Citation>Spivak
        G, Hanawalt PC. Host cell reactivation of plasmids containing oxidative DNA
        lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome
        fibroblasts. DNA Repair (Amst) 2006;5:13&#x2013;22.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16129663</ArticleId></ArticleIdList></Reference><Reference><Citation>de
        Waard H, de Wit J, Gorgels TG, van den Aardweg G, Andressoo JO, et al. Cell
        type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA
        Repair (Amst) 2003;2:13&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">12509265</ArticleId></ArticleIdList></Reference><Reference><Citation>Nance
        MA, Berry SA. Cockayne syndrome: Review of 140 cases. Am J Med Genet. 1992;42:68&#x2013;84.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1308368</ArticleId></ArticleIdList></Reference><Reference><Citation>Bootsma
        D, Kraemer KH, J.E C, Hoeijmakers J. Nucleotide excision repair syndromes:
        Xeroderma Pigmentosum, Cockayne Syndrome and trichthiodystrophy. New York:
        McGraw-Hill Medical Publishing Division; 2002. pp. 211&#x2013;237.</Citation></Reference><Reference><Citation>Vermeulen
        W, Rademakers S, Jaspers NG, Appeldoorn E, Raams A, et al. A temperature-sensitive
        disorder in basal transcription and DNA repair in humans. Nat Genet. 2001;27:299&#x2013;303.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11242112</ArticleId></ArticleIdList></Reference><Reference><Citation>van
        der Horst GT, van Steeg H, Berg RJ, van Gool AJ, de Wit J, et al. Defective
        transcription-coupled repair in Cockayne syndrome B mice is associated with
        skin cancer predisposition. Cell. 1997;89:425&#x2013;435.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9150142</ArticleId></ArticleIdList></Reference><Reference><Citation>van
        der Horst GT, Meira L, Gorgels TG, de Wit J, Velasco-Miguel S, et al. UVB
        radiation-induced cancer predisposition in Cockayne syndrome group A (Csa)
        mutant mice. DNA Repair (Amst) 2002;1:143&#x2013;157.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12509261</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasty
        P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J. Aging and genome maintenance:
        Lessons from the mouse? Science. 2003;299:1355&#x2013;1359.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12610296</ArticleId></ArticleIdList></Reference><Reference><Citation>de
        Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis.
        2000;21:453&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">10688865</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell
        JR, Hoeijmakers JH, Niedernhofer LJ. Divide and conquer: Nucleotide excision
        repair battles cancer and ageing. Curr Opin Cell Biol. 2003;15:232&#x2013;240.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12648680</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheo
        DL, Ruven HJ, Meira LB, Hammer RE, Burns DK, et al. Characterization of defective
        nucleotide excision repair in XPC mutant mice. Mutat Res. 1997;374:1&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9067411</ArticleId></ArticleIdList></Reference><Reference><Citation>de
        Vries A, van Oostrom CT, Hofhuis FM, Dortant PM, Berg RJ, et al. Increased
        susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision
        repair gene XPA. Nature. 1995;377:169&#x2013;173.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7675086</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrinello
        S, Samper E, Krtolica A, Goldstein J, Melov S, et al. Oxygen sensitivity severely
        limits the replicative lifespan of murine fibroblasts. Nat Cell Biol. 2003;5:741&#x2013;747.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4940195</ArticleId><ArticleId IdType="pubmed">12855956</ArticleId></ArticleIdList></Reference><Reference><Citation>Busuttil
        RA, Rubio M, Dolle ME, Campisi J, Vijg J. Oxygen accelerates the accumulation
        of mutations during the senescence and immortalization of murine cells in
        culture. Aging Cell. 2003;2:287&#x2013;294.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14677631</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai
        M, Enokido Y, Inamura N, Yoshino M, Nakatsu Y, et al. Early postnatal ataxia
        and abnormal cerebellar development in mice lacking Xeroderma pigmentosum
        Group A and Cockayne syndrome Group B DNA repair genes. Proc Natl Acad Sci
        U S A. 2001;98:13379&#x2013;13384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60879</ArticleId><ArticleId
        IdType="pubmed">11687625</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh
        M, Hayashi M, Shioda K, Minagawa M, Isa F, et al. Neurodegeneration in hereditary
        nucleotide repair disorders. Brain Dev. 1999;21:326&#x2013;333.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10413020</ArticleId></ArticleIdList></Reference><Reference><Citation>Traboulsi
        EI, De Becker I, Maumenee IH. Ocular findings in Cockayne syndrome. Am J Ophthalmol.
        1992;114:579&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">1443019</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarroll
        SA, Murphy CT, Zou S, Pletcher SD, Chin CS, et al. Comparing genomic expression
        patterns across species identifies shared transcriptional profile in aging.
        Nat Genet. 2004;36:197&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">14730301</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser
        HB, Khaitovich P, Plotkin JB, Paabo S, Eisen MB. Aging and gene expression
        in the primate brain. PLoS Biol. 2005;3((9)):e274.  doi: 10.1371/journal.pbio.0030274.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1371/journal.pbio.0030274</ArticleId><ArticleId IdType="pmc">PMC1181540</ArticleId><ArticleId
        IdType="pubmed">16048372</ArticleId></ArticleIdList></Reference><Reference><Citation>Frystyk
        J. Free insulin-like growth factors&#x2014;measurements and relationships
        to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res.
        2004;14:337&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">15336229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahima
        R, Osei SY. Leptin and appetite control in lipodystrophy. J Clin Endocrinol
        Metab. 2004;89:4254&#x2013;4257.</Citation><ArticleIdList><ArticleId IdType="pubmed">15356017</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth
        PK. Hepatic effects of phthalate esters. Environ Health Perspect. 1982;45:27&#x2013;34.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1568985</ArticleId><ArticleId IdType="pubmed">6754361</ArticleId></ArticleIdList></Reference><Reference><Citation>Horibata
        K, Iwamoto Y, Kuraoka I, Jaspers NG, Kurimasa A, et al. Complete absence of
        Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome
        but not Cockayne syndrome. Proc Natl Acad Sci U S A. 2004;101:15410&#x2013;15415.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC524447</ArticleId><ArticleId IdType="pubmed">15486090</ArticleId></ArticleIdList></Reference><Reference><Citation>Andressoo
        JO, Mitchell JR, de Wit J, Hoogstraten D, Volker M, et al. An Xpd mouse model
        for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer
        predisposition and segmental progeria. Cancer Cell. 2006;10:121&#x2013;132.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16904611</ArticleId></ArticleIdList></Reference><Reference><Citation>van
        de Ven M, Andressoo JO, Holcomb VB, von Lindern M, Jong W, et al. Adaptive
        stress response in segmental progeria resembles long-lived dwarfism and calorie
        restriction in mice. PLoS Genet. 2006. E-pub 2 October 2006.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1698946</ArticleId><ArticleId IdType="pubmed">17173483</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiomi
        N, Mori M, Kito S, Harada YN, Tanaka K, et al. Severe growth retardation and
        short life span of double-mutant mice lacking Xpa and exon 15 of Xpg. DNA
        Repair (Amst) 2005;4:351&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">15661658</ArticleId></ArticleIdList></Reference><Reference><Citation>Arking
        R. Biology of aging; Observations and principles. Sunderland (Massachusetts):
        Sinauer Associates; 1998. 528</Citation></Reference><Reference><Citation>Kalu
        DN. Bone. In: Masoro, editor. Handbook of physiology of aging. New York: Oxford
        University Press; 1995. pp. 395&#x2013;411.</Citation></Reference><Reference><Citation>Weiss
        A, Arbell I, Steinhagen-Thiessen E, Silbermann M. Structural changes in aging
        bone: Osteopenia in the proximal femurs of female mice. Bone. 1991;12:165&#x2013;172.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1910958</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter
        CS, Ramsey MM, Sonntag WE. A critical analysis of the role of growth hormone
        and IGF-1 in aging and lifespan. Trends Genet. 2002;18:295&#x2013;301.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12044358</ArticleId></ArticleIdList></Reference><Reference><Citation>Puigserver
        P, Rhee J, Donovan J, Walkey CJ, Yoon JC, et al. Insulin-regulated hepatic
        gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 2003;423:550&#x2013;555.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12754525</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo
        VD, Finch CE. Evolutionary medicine: From dwarf model systems to healthy centenarians?
        Science. 2003;299:1342&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pubmed">12610293</ArticleId></ArticleIdList></Reference><Reference><Citation>Park
        SK, Chang SH, Cho SB, Baek HS, Lee DY. Cockayne syndrome: A case with hyperinsulinemia
        and growth hormone deficiency. J Korean Med Sci. 1994;9:74&#x2013;77.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3053904</ArticleId><ArticleId IdType="pubmed">8068222</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto
        WY, Green ML, Seegmiller JE. Cockayne''s syndrome: Report of a case with hyperlipoproteinemia,
        hyperinsulinemia, renal disease, and normal growth hormone. J Pediatr. 1969;75:881&#x2013;884.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">5357933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellaway
        CJ, Duggins A, Fung VS, Earl JW, Kamath R, et al. Cockayne syndrome associated
        with low CSF 5-hydroxyindole acetic acid levels. J Med Genet. 2000;37:553&#x2013;557.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1734630</ArticleId><ArticleId IdType="pubmed">10970194</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszlo
        A, Simon M. Serum lipid and lipoprotein levels in premature ageing syndromes:
        Total lipodystrophy and Cockayne syndrome. Arch Gerontol Geriatr. 1986;5:189&#x2013;196.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3800489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenyon
        C. The plasticity of aging: Insights from long-lived mutants. Cell. 2005;120:449&#x2013;460.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15734678</ArticleId></ArticleIdList></Reference><Reference><Citation>Partridge
        L, Gems D, Withers DJ. Sex and death: What is the connection? Cell. 2005;120:461&#x2013;472.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15734679</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown-Borg
        HM, Bode AM, Bartke A. Antioxidative mechanisms and plasma growth hormone
        levels: Potential relationship in the aging process. Endocrine. 1999;11:41&#x2013;48.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10668640</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown-Borg
        HM, Rakoczy SG. Catalase expression in delayed and premature aging mouse models.
        Exp Gerontol. 2000;35:199&#x2013;212.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10767579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartke
        A, Chandrashekar V, Bailey B, Zaczek D, Turyn D. Consequences of growth hormone
        (GH) overexpression and GH resistance. Neuropeptides. 2002;36:201&#x2013;208.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12359510</ArticleId></ArticleIdList></Reference><Reference><Citation>Florini
        JR, Harned JA, Richman RA, Weiss JP. Effect of rat age on serum levels of
        growth hormone and somatomedins. Mech Ageing Dev. 1981;15:165&#x2013;176.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7194952</ArticleId></ArticleIdList></Reference><Reference><Citation>Johanson
        AJ, Blizzard RM. Low somatomedin-C levels in older men rise in response to
        growth hormone administration. Johns Hopkins Med J. 1981;149:115&#x2013;117.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7197311</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudman
        D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, et al. Impaired growth hormone
        secretion in the adult population: relation to age and adiposity. J Clin Invest.
        1981;67:1361&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC370702</ArticleId><ArticleId
        IdType="pubmed">7194884</ArticleId></ArticleIdList></Reference><Reference><Citation>Camougrand
        N, Rigoulet M. Aging and oxidative stress: Studies of some genes involved
        both in aging and in response to oxidative stress. Respir Physiol. 2001;128:393&#x2013;401.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11718766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji
        LL, Leeuwenburgh C, Leichtweis S, Gore M, Fiebig R, et al. Oxidative stress
        and aging. Role of exercise and its influences on antioxidant systems. Ann
        N Y Acad Sci. 1998;854:102&#x2013;117.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9928424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartke
        A. Is growth hormone deficiency a beneficial adaptation to aging? Evidence
        from experimental animals. Trends Endocrinol Metab. 2003;14:340&#x2013;344.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12946877</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrashekar
        V, Zaczek D, Bartke A. The consequences of altered somatotropic system on
        reproduction. Biol Reprod. 2004;71:17&#x2013;27.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15028633</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckman
        KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998;78:547&#x2013;581.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9562038</ArticleId></ArticleIdList></Reference><Reference><Citation>de
        Waard H, de Wit J, Andressoo JO, van Oostrom CTM, Riis B, et al. Different
        effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage.
        Mol Cell Biol. 2003;24:7941&#x2013;7948.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC515046</ArticleId><ArticleId IdType="pubmed">15340056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirosawa
        N, Yano K, Suzuki Y, Sakamoto Y. Endocrine disrupting effect of di-(2-ethylhexyl)phthalate
        on female rats and proteome analyses of their pituitaries. Proteomics. 2006;6:958&#x2013;971.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16400681</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada
        YN, Shiomi N, Koike M, Ikawa M, Okabe M, et al. Postnatal growth failure,
        short life span, and early onset of cellular senescence and subsequent immortalization
        in mice lacking the xeroderma pigmentosum group G gene. Mol Cell Biol. 1999;19:2366&#x2013;2372.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC84028</ArticleId><ArticleId IdType="pubmed">10022922</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian
        M, Shinkura R, Shinkura N, Alt FW. Growth retardation, early death, and DNA
        repair defects in mice deficient for the nucleotide excision repair enzyme
        XPF. Mol Cell Biol. 2004;24:1200&#x2013;1205.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC321450</ArticleId><ArticleId IdType="pubmed">14729965</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnhoven
        SW, Beems RB, Roodbergen M, van den Berg J, Lohman PH, et al. Accelerated
        aging pathology in ad libitum fed Xpd(TTD) mice is accompanied by features
        suggestive of caloric restriction. DNA Repair (Amst) 2005;4:1314&#x2013;1324.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16115803</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostoslavsky
        R, Chua KF, Lombard DB, Pang WW, Fischer MR, et al. Genomic instability and
        aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006;124:315&#x2013;329.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16439206</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheo
        DL, Meira LB, Hammer RE, Burns DK, Doughty AT, et al. Synergistic interactions
        between XPC and p53 mutations in double-mutant mice: Neural tube abnormalities
        and accelerated UV radiation-induced skin cancer. Curr Biol. 1996;6:1691&#x2013;1694.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8994835</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakane
        H, Takeuchi S, Yuba S, Saijo M, Nakatsu Y, et al. High incidence of ultraviolet-B-or
        chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum
        group A gene. Nature. 1995;377:165&#x2013;168.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7675085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe
        SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced
        apoptosis in mouse thymocytes. Nature. 1993;362:847&#x2013;849.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8479522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sijbers
        AM, de Laat WL, Ariza RR, Biggerstaff M, Wei YF, et al. Xeroderma pigmentosum
        group F caused by a defect in a structure-specific DNA repair endonuclease.
        Cell. 1996;86:811&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">8797827</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen
        W, Scott RJ, Rodgers S, Muller HJ, Cole J, et al. Clinical heterogeneity within
        xeroderma pigmentosum associated with mutations in the DNA repair and transcription
        gene ERCC3. Am J Hum Genet. 1994;54:191&#x2013;200.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1918172</ArticleId><ArticleId IdType="pubmed">8304337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma
        GT, Roth ME, Groskopf JC, Tsai FY, Orkin SH, et al. GATA-2 and GATA-3 regulate
        trophoblast-specific gene expression in vivo. Development. 1997;124:907&#x2013;914.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9043071</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter
        RJ, Lione LA, Humby T, Mangiarini L, Mahal A, et al. Characterization of progressive
        motor deficits in mice transgenic for the human Huntington''s disease mutation.
        J Neurosci. 1999;19:3248&#x2013;3257.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC6782264</ArticleId><ArticleId IdType="pubmed">10191337</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11452036</PMID><DateCompleted><Year>2001</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>01</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>29</Volume><Issue>14</Issue><PubDate><Year>2001</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Nucleic
        acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>Localization
        of an exonic splicing enhancer responsible for mammalian natural trans-splicing.</ArticleTitle><Pagination><StartPage>3108</StartPage><EndPage>3115</EndPage><MedlinePgn>3108-15</MedlinePgn></Pagination><Abstract><AbstractText>Carnitine
        octanoyltransferase (COT) produces three different transcripts in rat through
        cis- and trans-splicing reactions, which may lead to the synthesis of two
        proteins. Generation of the three COT transcripts in rat does not depend on
        sex, development, fat feeding, the inclusion of the peroxisome proliferator
        diethylhexyl phthalate in the diet or hyperinsulinemia. In addition, trans-splicing
        was not detected in COT of other mammals, such as human, pig, cow and mouse,
        or in Cos7 cells from monkey. Rat COT exon 2 contains two purine-rich sequences.
        Mutation of the rat COT exon 2 upstream box does not affect the trans-splicing
        in vitro between two truncated constructs containing exon 2 and its adjacent
        intron boundaries. In contrast, mutation of the downstream box from the rat
        sequence (GAAGAAG) to a random sequence or the sequence observed in the other
        mammals (AAAAAAA) decreased trans-splicing in vitro. In contrast, mutation
        of the AAAAAAA box of human COT exon 2 to GAAGAAG increases trans-splicing.
        Heterologous reactions between COT exon 2 from rat and human do not produce
        trans-splicing. HeLa cells transfected with minigenes of rat COT sequences
        produced cis- and trans-spliced bands. Mutation of the GAAGAAG box to AAAAAAA
        abolished trans-splicing and decreased cis-splicing in vivo. We conclude that
        GAAGAAG is an exonic splicing enhancer that could induce natural trans-splicing
        in rat COT.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caudevilla</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, School of Pharmacy, Diagonal 643, University of Barcelona,
        08028 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Codony</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Serra</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Plasencia</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Rom&#xe1;n</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Graessmann</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Asins</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Bach-Elias</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Hegardt</LastName><ForeName>F G</ForeName><Initials>FG</Initials></Author></AuthorList><Language>eng</Language><DataBankList
        CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>AF144397</AccessionNumber><AccessionNumber>AF144398</AccessionNumber><AccessionNumber>AF144399</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic
        Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012322">RNA Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.-</RegistryNumber><NameOfSubstance UI="D002333">Carnitine Acyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.-</RegistryNumber><NameOfSubstance UI="C030162">carnitine octanoyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D017398" MajorTopicYN="Y">Alternative Splicing</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015152" MajorTopicYN="N">Blotting, Northern</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002333" MajorTopicYN="N">Carnitine Acyltransferases</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004742" MajorTopicYN="N">Enhancer Elements, Genetic</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005091" MajorTopicYN="N">Exons</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007422" MajorTopicYN="N">Intestines</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012322" MajorTopicYN="N">RNA Precursors</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012689" MajorTopicYN="N">Sequence Homology, Nucleic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>7</Month><Day>14</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>9</Month><Day>8</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>7</Month><Day>14</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11452036</ArticleId><ArticleId IdType="pmc">PMC55807</ArticleId><ArticleId
        IdType="doi">10.1093/nar/29.14.3108</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bonen
        L. (1993) Trans-splicing of pre-mRNA in plants, animals, and protists. FASEB
        J., 7, 40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">8422973</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzik
        J.P. and Maniatis,T. (1995) Enhancer-dependent interaction between 5&#x2032;
        and 3&#x2032; splice sites in trans. Proc. Natl Acad. Sci. USA, 92, 7056&#x2013;7059.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC41470</ArticleId><ArticleId IdType="pubmed">7624368</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiara
        M.D. and Reed,R. (1995) A two-step mechanism for 5&#x2032; and 3&#x2032; splice-site
        pairing. Nature, 375, 510&#x2013;513.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7777062</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew
        S.L., Liu,H.X., Mayeda,A. and Krainer,A.R. (1999) Evidence for the function
        of an exonic splicing enhancer after the first catalytic step of pre-mRNA
        splicing. Proc. Natl Acad. Sci. USA, 96, 10655&#x2013;10660.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC17938</ArticleId><ArticleId IdType="pubmed">10485881</ArticleId></ArticleIdList></Reference><Reference><Citation>Caudevilla
        C., Serra,D., Miliar,A., Codony,C., Asins,G., Bach,M. and Hegardt,F.G. (1998)
        Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver.
        Proc. Natl Acad. Sci. USA, 95, 12185&#x2013;12190.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC22806</ArticleId><ArticleId IdType="pubmed">9770461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu
        A., Nussenzweig,M.C., Han,H., Sanchez,M. and Honjo,T. (1991) Trans-splicing
        as a possible molecular mechanism for the multiple isotype expression of the
        immunoglobulin gene. J. Exp. Med., 173, 1385&#x2013;1393.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2190851</ArticleId><ArticleId IdType="pubmed">1903429</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan
        P.M., Petrusz,P., Szpirer,C. and Joseph,D.R. (1991) Alternative processing
        of androgen-binding protein RNA transcripts in fetal rat liver. Identification
        of a transcript formed by trans splicing. J. Biol. Chem., 266, 143&#x2013;154.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1702422</ArticleId></ArticleIdList></Reference><Reference><Citation>Vellard
        M., Sureau,A., Soret,J., Martinerie,C. and Perbal,B. (1992) A potential splicing
        factor is encoded by the opposite strand of the trans-spliced c-myb exon.
        Proc. Natl Acad. Sci. USA, 89, 2511&#x2013;2515.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC48691</ArticleId><ArticleId IdType="pubmed">1557353</ArticleId></ArticleIdList></Reference><Reference><Citation>Breen
        M.A. and Ashcroft,S.J.H. (1997) A truncated isoform of Ca2+/calmodulin-dependent
        protein kinase II expressed in human islets of Langerhans may result from
        trans-splicing. FEBS Lett., 409, 375&#x2013;379.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9224693</ArticleId></ArticleIdList></Reference><Reference><Citation>Akopian
        A.N., Okuse,K., Souslova,V., England,S., Ogata,N. and Wood,J.N. (1999) Trans-splicing
        of a voltage-gated sodium channel is regulated by nerve growth factor. FEBS
        Lett., 445, 177&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">10069396</ArticleId></ArticleIdList></Reference><Reference><Citation>Li
        B.-L., Li,X.-L. Duan,Z.-J., Lee,O., Lin,S., Ma,Z.M., Chang,C.C.Y., Yang,X.-Y.,
        Park,J.P., Mohandas,T.K., Noll,W., Chan,L. and Chang,T.-Y. (1999) Human acyl-CoA
        cholesterol acyltransferase-1 (ACAT-1) gene organization and evidence that
        the 4.3-kilobase ACAT-1 mRNA is produced from two different chromosomes. J.
        Biol. Chem., 274, 11060&#x2013;11071.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10196189</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantz
        S.A., Thiara,A.S., Lodwick,D., Ng,L.L., Eperon,I.C. and Samani,N.J. (1999)
        Exon repetition in mRNA. Proc. Natl Acad. Sci. USA, 96, 5400&#x2013;5405.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC21871</ArticleId><ArticleId IdType="pubmed">10318895</ArticleId></ArticleIdList></Reference><Reference><Citation>Asins
        G., Serra,D. and Hegardt,F.G. (1994) The effect of etomoxir on the mRNA levels
        of enzymes involved in ketogenesis and cholesterogenesis in rat liver. Biochem.
        Pharmacol., 47, 1373&#x2013;1379.</Citation><ArticleIdList><ArticleId IdType="pubmed">7910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrook
        J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual,
        2nd edn. Cold Spring Harbor Laboratory Press, Plainview, NY.</Citation></Reference><Reference><Citation>Choi
        S.J., Oh,D.H., Song,C.S., Roy,A.K. and Chatterjee,B. (1995) Molecular cloning
        and sequence analysis of the rat liver carnitine octanoyltransferase cDNA,
        its natural gene and the gene promoter. Biochim. Biophys. Acta, 1264, 215&#x2013;222.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7495866</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta
        A.K. (1995) Efficient amplification using &#x2018;megaprimer&#x2019; by asymmetric
        polymerase chain reaction. Nucleic Acids Res., 23, 4530&#x2013;4531.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC307417</ArticleId><ArticleId IdType="pubmed">7501483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdinandusse
        S., Mulders,J., Ijist,L., Denis,S., Dacremont,G., Waterham,H.R. and Wanders,R.J.
        (1999) Molecular cloning and expression of human carnitine octanoyltransferase:
        evidence for its role in the peroxisomal beta-oxidation of branched-chain
        fatty acids. Biochem. Biophys. Res. Commun., 263, 213&#x2013;218.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10486279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ausubel
        F.M., Brent,R., Kingston,R.E., Moore,D.D., Seidman,J.G., Smith,J.A. and Struhl,K.
        (1987) Current Protocols in Molecular Biology. Green Publishing Associates/Wiley-Interscience,
        New York, NY.</Citation></Reference><Reference><Citation>Miliar A., Serra,D.,
        Casaroli,R., Vilar&#xf3;,S., Asins,G. and Hegardt,F.G. (2001) Developmental
        changes in carnitine octanoyltransferase gene expression in intestine and
        liver of suckling rats. Arch. Biochem. Biophys., 385, 283&#x2013;289.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11368009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun
        Q., Mayeda,A., Hampson,R.K., Krainer,A.R. and Rottman,F.M. (1993) General
        splicing factor SF2/ASF promotes alternative splicing by binding to an exonic
        splicing enhancer. Genes Dev., 7, 2598&#x2013;2608.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8276242</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaal
        T.D. and Maniatis,T. (1999) Multiple distinct splice enhancers in the protein-coding
        sequences of a constitutively spliced pre-mRNA. Mol. Cell. Biol., 19, 261&#x2013;273.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC83884</ArticleId><ArticleId IdType="pubmed">9858550</ArticleId></ArticleIdList></Reference><Reference><Citation>Watakabe
        A., Tanaka,K. and Shimura,Y. (1993) The role of exon sequences in splice site
        selection. Genes Dev., 7, 407&#x2013;418.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8449402</ArticleId></ArticleIdList></Reference><Reference><Citation>Puttaraju
        M., Jamison,S.F., Mansfield,S.G., Garcia-Blanco,M.A. and Mitchell,L.G. (1999)
        Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat. Biotechnol.,
        17, 246&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">10096291</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahler
        A.M., Lane,W.S., Stolk,J.A. and Roth,M.B. (1992) SR proteins: a conserved
        family of pre-mRNA splicing factors. Genes Dev., 6, 837&#x2013;847.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1577277</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka
        K., Watakabe,A. and Shimura,Y. (1994) Polypurine sequences within a downstream
        exon function as a splicing enhancer. Mol. Cell. Biol., 14, 1347&#x2013;1354.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC358489</ArticleId><ArticleId IdType="pubmed">8289812</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2887302</PMID><DateCompleted><Year>1987</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>1987</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Absence
        of gamma-glutamyl transpeptidase activity in neoplastic lesions induced in
        the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator.</ArticleTitle><Pagination><StartPage>1347</StartPage><EndPage>1350</EndPage><MedlinePgn>1347-50</MedlinePgn></Pagination><Abstract><AbstractText>Male
        F-344 rats were fed a diet containing 2% di-(2-ethylhexyl)phthalate (DEHP)
        for 95 weeks. Liver nodules and/or hepatocellular carcinomas (HCC) developed
        in 6/10 rats fed DEHP and none were found in controls (P less than 0.005 by
        chi 2 test). All the nodules and HCC were negative for gamma-glutamyl transpeptidase.
        In the non-tumorous portions of liver, the hepatocytes contained an increased
        number of peroxisomes and extensive accumulation of lipofuscin. By immunocytochemical
        analysis, the liver peroxisomes in rats treated chronically with DEHP had
        visually detectable decrease in the H2O2-degrading catalase and increase in
        H2O2-producing fatty acyl-CoA oxidase. These results show that higher dietary
        level of DEHP, which causes substantially greater degree of peroxisome proliferation
        than the 1.2% dietary level used in the National Toxicology Program bioassay
        (1982, Publication no. NTP-80-37, Tech. Report Series No. 217), can induce
        liver tumors in male rats.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Rao</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author
        ValidYN="Y"><LastName>Usuda</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Subbarao</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author
        ValidYN="Y"><LastName>Reddy</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 32504</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM
        23750</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance
        UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2887302</ArticleId><ArticleId IdType="doi">10.1093/carcin/8.9.1347</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">7590545</PMID><DateCompleted><Year>1995</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>30</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0278-6915</ISSN><JournalIssue
        CitedMedium="Print"><Volume>33</Volume><Issue>11</Issue><PubDate><Year>1995</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Subchronic 90-day oral toxicology
        of di(2-ethylhexyl) terephthalate in the rat.</ArticleTitle><Pagination><StartPage>971</StartPage><EndPage>978</EndPage><MedlinePgn>971-8</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)
        terephthalate (DEHT), the 2-ethylhexyl diester of terephthalic acid (1,4-benzenedicarboxylic
        acid) was administered in the diet to groups of 20 male and female Sprague-Dawley
        rats for 90 days at 1.0, 0.5, 0.1 or 0.0% by weight. No major organ or systemic
        toxicity resulted from consumption of the diets in any group of animals. Changes
        that were observed included slight effects on some haematology parameters
        including haemoglobin, haematocrit, mean corpuscular volume and mean corpuscular
        haemoglobin at the 1.0% dose; and slight increases in relative liver weights
        (11.2% in the males, 8.9% in the females), also at the 1.0% dose level. Marginal
        changes of less than 3% in some red blood cell indices were observed at the
        0.5% dietary dose level; however no anaemia or changes in relative liver weights
        were observed at this dose level. Thus, no significant adverse effects attributable
        to the test material were identified in animals consuming the two lower doses.
        In a morphometric study of liver sections, DEHT was found not to induce hepatic
        peroxisomes at the 1.0% dose level. The positive control material (2-ethylhexanol
        at 1000 mg/kg, 5 days/wk for 3 wk), produced a 30% increase in liver-to-body
        weight ratio, and increases in peroxisome cell fraction, and in peroxisome
        density. The no-effect levels of DEHT in rats consuming the material for 90
        days in the diet were 277 and 309 mg/kg/day in males and females, respectively.
        These results are contrasted with those reported for di(2-ethylhexyl) phthalate
        (DEHP) in similar feeding studies. While DEHP at 1% in the diet is reported
        to produce significant effects on the liver, testes, kidney, brain, stomach
        and adrenal weights, DEHT has been shown in this study to have only a minor
        effect on liver weight in 90 days at 1.0% in the diet.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>E
        D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Health and
        Environment Laboratories, Eastman Kodak Company, Rochester, NY 14652-6272,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Topping</LastName><ForeName>D
        C</ForeName><Initials>DC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>4VS908W98L</RegistryNumber><NameOfSubstance
        UI="C053316">di-(2-ethylhexyl) terephthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1995</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1995</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1995</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7590545</ArticleId><ArticleId IdType="doi">10.1016/0278-6915(95)00060-f</ArticleId><ArticleId
        IdType="pii">027869159500060F</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2731665</PMID><DateCompleted><Year>1989</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0272-0590</ISSN><JournalIssue
        CitedMedium="Print"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>1989</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Fundamental
        and applied toxicology : official journal of the Society of Toxicology</Title><ISOAbbreviation>Fundam
        Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>Reproductive toxicity
        of three phthalic acid esters in a continuous breeding protocol.</ArticleTitle><Pagination><StartPage>508</StartPage><EndPage>518</EndPage><MedlinePgn>508-18</MedlinePgn></Pagination><Abstract><AbstractText>A
        continuous breeding protocol was utilized to examine the reproductive toxicity
        of three phthalate esters. CD-1 mice were given diets with either di-n-propyl
        phthalate (DPrP: 0.0, 1.25, 2.5, or 5.0%), di-n-pentyl phthalate (DPP: 0.0,
        0.5, 1.25, or 2.5%), or di-n-octyl phthalate (DOP: 0.0, 1.25, 2.5, or 5.0%).
        Both male and female mice (20 pairs per treatment group, 40 pairs of control
        animals) were dosed for 7 days prior to and during a 98-day cohabitation period.
        Reproductive function was evaluated during the cohabitation period by measuring
        number of litters per pair, live pups per litter, and pup weight. There was
        no apparent effect on reproductive function in the animals exposed to DOP
        at dose levels sufficient to cause a significant increase in liver weight.
        Both DPP and DPrP were toxic to the reproductive system as evidenced by a
        complete inhibition of fertility at 1.25 and 2.5% DPP or 5.0% DPrP, and reduced
        fertility (litters/pair and live pups/litter, 0.5% DPP; live pups/litter,
        2.5% DPrP). Toxicity of DPP had a strong male component and female component,
        whereas DPrP was more toxic to the female than the male reproductive system.
        DPP and DPrP treatment was associated with decreased body weight, increased
        liver weight, decreased testis and epididymis weights, decreased epididymal
        sperm concentration, and elevated seminiferous tubule atrophy. A comparison
        of seven phthalate esters tested using this continuous breeding protocol indicates
        the relative order of reproductive toxicity as diethylhexyl, dihexyl, dipentyl,
        dibutyl, dipropyl; diethyl and dioctyl are nontoxic.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Heindel</LastName><ForeName>J
        J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Developmental
        and Reproductive Toxicology Group, National Toxicology Program, Research Triangle
        Park, North Carolina 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gulati</LastName><ForeName>D K</ForeName><Initials>DK</Initials></Author><Author
        ValidYN="Y"><LastName>Mounce</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author
        ValidYN="Y"><LastName>Russell</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author
        ValidYN="Y"><LastName>Lamb</LastName><ForeName>J C</ForeName><Initials>JC</Initials><Suffix>4th</Suffix></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>N01-ES-2-5013</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01-ES-9-6515</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013487">Research Support, U.S.
        Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Fundam Appl Toxicol</MedlineTA><NlmUniqueID>8200838</NlmUniqueID><ISSNLinking>0272-0590</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004971" MajorTopicYN="N">Estrus</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005298" MajorTopicYN="N">Fertility</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013094" MajorTopicYN="N">Spermatozoa</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1989</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1989</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2731665</ArticleId><ArticleId IdType="doi">10.1016/0272-0590(89)90024-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2274965</PMID><DateCompleted><Year>1991</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>65</Volume><Issue>1-2</Issue><PubDate><Year>1990</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Effect
        of di(2-ethylhexyl)phthalate on enzyme activity levels in liver and serum
        of rats.</ArticleTitle><Pagination><StartPage>199</StartPage><EndPage>207</EndPage><MedlinePgn>199-207</MedlinePgn></Pagination><Abstract><AbstractText>In
        order to identify non-invasive, biochemical indicators of di(2-ethylhexyl)phthalate
        (DEHP) exposure, we have compared the effects in blood serum with biochemical
        effects in liver in rats fed a diet containing 0, 0.25, 0.75 and 2% DEHP for
        2 weeks. After 3 days of treatment serum arylesterase activity levels and
        serum triglycerides were decreased to 60% and 20% of control values, respectively.
        After a 2-week treatment with DEHP the effects were generally stronger. Compared
        to a control group, serum arylesterase activity levels, serum triglycerides
        and serum cholesterol were decreased to 40%, 20% and 50%, respectively. Serum
        cholinesterase activity levels and serum albumin concentrations were increased
        by the DEHP treatment to 290% and 135% of control values, respectively. In
        the livers a hepatomegaly, an induction of cytochrome P-450 IVA1 and induction
        of the activity of palmitoyl-CoA oxidase and carnitine acetyl-CoA transferase
        was found to be 180%, 1080%, 1300% and 1700% of control values, respectively.
        The liver is a more sensitive target for DEHP exposure compared to the biochemical
        effects in serum, but determination of the serum parameters can be used to
        determine early biological effects of exposure to DEHP.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Dirven</LastName><ForeName>H
        A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department
        of Toxicology, University of Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>van den Broek</LastName><ForeName>P H</ForeName><Initials>PH</Initials></Author><Author
        ValidYN="Y"><LastName>Jongeneelen</LastName><ForeName>F J</ForeName><Initials>FJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.1.-</RegistryNumber><NameOfSubstance UI="D002265">Carboxylic Ester Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.1.2</RegistryNumber><NameOfSubstance UI="C019734">arylesterase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.1.8</RegistryNumber><NameOfSubstance UI="D002802">Cholinesterases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections
        RefType="ErratumIn"><RefSource>Toxicology 1991 Mar 25;67(1):127</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002265" MajorTopicYN="N">Carboxylic Ester Hydrolases</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002802" MajorTopicYN="N">Cholinesterases</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>12</Month><Day>17</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>12</Month><Day>17</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2274965</ArticleId><ArticleId IdType="doi">10.1016/0300-483x(90)90089-y</ArticleId><ArticleId
        IdType="pii">0300-483X(90)90089-Y</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">24180374</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2613</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>95</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International
        journal of experimental pathology</Title><ISOAbbreviation>Int J Exp Pathol</ISOAbbreviation></Journal><ArticleTitle>The
        effects of di(2-ethylhexyl)phthalate on rat liver in relation to selenium
        status.</ArticleTitle><Pagination><StartPage>64</StartPage><EndPage>77</EndPage><MedlinePgn>64-77</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1111/iep.12059</ELocationID><Abstract><AbstractText>This
        study was performed to determine the hepatotoxicity of di(2-ethylhexyl)phthalate
        (DEHP) in relation to selenium status. In 3-week-old Sprague-Dawley rats,
        selenium deficiency was induced by a &#x2264;0.05 selenium mg/kg. A selenium
        supplementation group was given 1&#xa0;mg selenium/kg diet for 5&#xa0;weeks.
        Di(2-ethylhexyl)phthalate-treated groups received 1000&#xa0;mg/kg dose by
        gavage during the last 10&#xa0;days of the experiment. Histopathology, peroxisome
        proliferation, catalase (CAT) immunoreactivity and activity and apoptosis
        were assessed. Activities of antioxidant selenoenzymes [glutathione peroxidase
        1 (GPx1), glutathione peroxidase 4 (GPx4), thioredoxin reductase (TrxR1)],
        superoxide dismutase (SOD), and glutathione S-transferase (GST); aminotransferase,
        total glutathione (tGSH), and lipid peroxidation (LP) levels were measured.
        Di(2-ethylhexyl)phthalate caused cellular disorganization while necrosis and
        inflammatory cell infiltration were observed in Se-deficient DEHP group (DEHP/SeD).
        Catalase activity and immunoreactivity were increased in all DEHP-treated
        groups. Glutathione peroxidase 1 and GPx4 activities decreased significantly
        in DEHP and DEHP/SeD groups, while GST activities decreased in all DEHP-exposed
        groups. Thioredoxin reductase activity increased in DEHP and DEHP/SeS, while
        total SOD activities increased in all DEHP-treated groups. Lipid peroxidation
        levels increased significantly in SeD (26%), DEHP (38%) and DEHP/SeD (71%)
        groups. Selenium supplementation partially ameliorated DEHP-induced hepatotoxicity;
        while in DEHP/SeD group, drastic changes in hepatic histopathology and oxidative
        stress parameters were observed.</AbstractText><CopyrightInformation>&#xa9;
        2013 The Authors. International Journal of Experimental Pathology &#xa9; 2013
        International Journal of Experimental Pathology.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Erkekoglu</LastName><ForeName>P&#x131;nar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department
        of Toxicology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zeybek</LastName><ForeName>Naciye D</ForeName><Initials>ND</Initials></Author><Author
        ValidYN="Y"><LastName>Giray</LastName><ForeName>Belma K</ForeName><Initials>BK</Initials></Author><Author
        ValidYN="Y"><LastName>Rachidi</LastName><ForeName>Walid</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>K&#x131;z&#x131;lg&#xfc;n</LastName><ForeName>Murat</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Hininger-Favier</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Author><Author
        ValidYN="Y"><LastName>Favier</LastName><ForeName>Alain</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Asan</LastName><ForeName>Esin</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Hincal</LastName><ForeName>Filiz</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2013</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int
        J Exp Pathol</MedlineTA><NlmUniqueID>9014042</NlmUniqueID><ISSNLinking>0959-9673</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>H6241UJ22B</RegistryNumber><NameOfSubstance
        UI="D012643">Selenium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D023421" MajorTopicYN="N">Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012643" MajorTopicYN="N">Selenium</DescriptorName><QualifierName UI="Q000172"
        MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">antioxidant enzymes</Keyword><Keyword
        MajorTopicYN="N">di(ethylhexyl)phthalate</Keyword><Keyword MajorTopicYN="N">liver</Keyword><Keyword
        MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">selenium
        deficiency</Keyword><Keyword MajorTopicYN="N">selenium supplementation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2013</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2013</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">24180374</ArticleId><ArticleId IdType="pmc">PMC3919650</ArticleId><ArticleId
        IdType="doi">10.1111/iep.12059</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aebi
        H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. New
        York: Academic press 3; 1974. p. 673.</Citation></Reference><Reference><Citation>Akerboom
        TP, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed
        disulfides in biological samples. Meth. Enzymol. 1981;77:373&#x2013;382.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7329314</ArticleId></ArticleIdList></Reference><Reference><Citation>Akingbemi
        BT, Ge R, Klinefelter GR, Zikrin BR, Hardy MP. Phthalate induced Leydig cell
        hyperplasia is associated with multiple endocrine disturbances. Proc. Natl
        Acad. Sci. USA. 2004;101:775&#x2013;780.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC321757</ArticleId><ArticleId IdType="pubmed">14715905</ArticleId></ArticleIdList></Reference><Reference><Citation>Arn&#xe9;r
        ES, Zhong L, Holmgren A. Preparation and assay of mammalian thioredoxin and
        thioredoxin reductase. Methods Enzymol. 1999;300:226&#x2013;239.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9919525</ArticleId></ArticleIdList></Reference><Reference><Citation>Arn&#xe9;r
        ES. Focus on mammalian thioredoxin reductases&#x2013;important selenoproteins
        with versatile functions. Biochim. Biophys. Acta. 2009;1790:495&#x2013;526.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19364476</ArticleId></ArticleIdList></Reference><Reference><Citation>Arn&#xe9;r
        ES, Holmgren A. The thioredoxin system in cancer. Semin. Cancer Biol. 2006;16:420&#x2013;426.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17092741</ArticleId></ArticleIdList></Reference><Reference><Citation>Botelho
        GG, Bufalo AC, Boareto AC, et al. Vitamin C and resveratrol supplementation
        to rat dams treated with di(2-ethylhexyl)phthalate: impact on reproductive
        and oxidative stress end points in male offspring. Arch. Environ. Contam.
        Toxicol. 2009;57:785&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">19756843</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark
        LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in
        US counties. Arch. Environ. Health. 1991;46:37&#x2013;42.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1992931</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway
        JG, Cattley RC, Popp JA, Butterworth BE. Possible mechanisms in hepatocarcinogenesis
        by the peroxisome proliferator di(2-ethylhexyl)phthalate. Drug Metab. Rev.
        1989;21:65&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">2696637</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini
        S, Lepore MG, Castello G, Colonna G. Has selenium a chemopreventive effect
        on hepatocellular carcinoma? Mini. Rev. Med. Chem. 2011;1:599&#x2013;610.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21699491</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvesh
        AS, Bishayee A. Selenium in the prevention and treatment of hepatocellular
        carcinoma. Anticancer Agents Med. Chem. 2010;10:338&#x2013;345.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20380634</ArticleId></ArticleIdList></Reference><Reference><Citation>Demelash
        A, Karlsson JO, Nilsson M, Bj&#xf6;rkman U. Selenium has a protective role
        in caspase-3-dependent apoptosis induced by H2O2 in primary cultured pig thyrocytes.
        Eur. J. Endocrinol. 2004;50:841&#x2013;849.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15191356</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shinnawy
        NA. The therapeutic applications of celery oil seed extract on the plasticizer
        di(2-ethylhexyl) phthalate toxicity. Toxicol. Ind. Health. 2013 doi:  10.1177/0748233713475515
        (Ahead of print)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0748233713475515</ArticleId><ArticleId
        IdType="pubmed">23377116</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkekoglu
        P, Rachidi W, De Rosa V, Giray B, Favier A, Hincal F. Protective effect of
        selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate
        and mono(2-ethylhexyl)phthalate treatment in LNCaP cells. Free Radic. Biol.
        Med. 2010a;49:559&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">20466057</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkekoglu
        P, Rachidi W, Yuzugullu OG, et al. Evaluation of cytotoxicity and oxidative
        DNA damaging effects of di(2-ethylhexyl)-phthalate (DEHP) and mono(2-ethylhexyl)-phthalate
        (MEHP) on MA-10 Leydig cells and protection by selenium. Toxicol. Appl. Pharmacol.
        2010b;248:52&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">20659492</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkekoglu
        P, Zeybek ND, Giray B, Asan E, Arnaud J, Hincal F. Reproductive toxicity of
        di(2-ethylhexyl) phthalate in selenium-supplemented and selenium-deficient
        rats. Drug Chem. Toxicol. 2011a;34:379&#x2013;389.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21714771</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkekoglu
        P, Giray B, Rachidi W, et al.  Effects of di(2-ethylhexyl)phthalate on testicular
        oxidant/antioxidant status in selenium-deficient and selenium-supplemented
        rats. Environ. Toxicol. 2011b doi:  10.1002/tox.20776.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1002/tox.20776</ArticleId><ArticleId IdType="pubmed">21976414</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkekoglu
        P, Giray BK, K&#x131;zilg&#xfc;n M, et al. Di(2-ethylhexyl)phthalate-induced
        renal oxidative stress in rats and protective effect of selenium. Toxicol.
        Mech. Methods. 2012a;22:415&#x2013;423.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">22394345</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkekoglu
        P, Giray BK, K&#x131;zilg&#xfc;n M, et al. Thyroidal effects of di-(2-Ethylhexyl)
        phthalate in rats at different selenium status. J. Environ. Pathol. Toxicol.
        Oncol. 2012b;31:143&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">23216639</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkhembayar
        S, Mollbrink A, Eriksson LC. The effect of sodium selenite on liver growth
        and thioredoxin reductase expression in regenerative and neoplastic liver
        cell proliferation. Biochem. Pharmacol. 2012;83:687&#x2013;693.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">22177986</ArticleId></ArticleIdList></Reference><Reference><Citation>Floh&#xe9;
        L, G&#xfc;nzler WA. Assays of glutathione peroxidase. Meth. Enzymol. 1984;105:114&#x2013;121.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6727659</ArticleId></ArticleIdList></Reference><Reference><Citation>Fromme
        H, Gruber L, Schlummer M, et al. Intake of phthalates and di(2-ethylhexyl)adipate:
        results of the Integrated Exposure Assessment Survey based on duplicate diet
        samples and biomonitoring data. Environ. Int. 2007;33:1012&#x2013;1020.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17610953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganther
        DE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention:
        complexities with thioredoxin reductase. Carcinogenesis. 1999;20:1657&#x2013;1666.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10469608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayathri
        NS, Dhanya CR, Indu AR, Kurup PA. Changes in some hormones by low doses of
        di (2-ethyl hexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood
        storage bags &amp; medical tubing. Indian J. Med. Res. 2004;119:139&#x2013;144.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15147118</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazouli
        M, Yao ZX, Boujrad N, Corton JC, Culty M, Papadopoulos V. Effect of peroxisome
        proliferators on Leydig cell peripheral-type benzodiazepine receptor gene
        expression, hormone-stimulated cholesterol transport, and steroidogenesis:
        role of the peroxisome proliferator-activator receptor alpha. Endocrinology.
        2002;143:2571&#x2013;2583.</Citation><ArticleIdList><ArticleId IdType="pubmed">12072389</ArticleId></ArticleIdList></Reference><Reference><Citation>Giray
        B, Riondel J, Richard MJ, Favier A, H&#x131;ncal F. Oxidant/antioxidant status
        in relation to thyroid hormone metabolism in selenium-and/or iodine-deficient
        rats. J. Trace Elem. Exp. Med. 2004;17:109&#x2013;121.</Citation></Reference><Reference><Citation>Gromer
        S, Eubel JK, Lee BL, Jacob J. Human selenoproteins at a glance. Cell. Mol.
        Life Sci. 2005;62:2414&#x2013;2437.</Citation><ArticleIdList><ArticleId IdType="pubmed">16231092</ArticleId></ArticleIdList></Reference><Reference><Citation>Habig
        WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step
        in mercapturic acid formation. J. Biol. Chem. 1974;249:7130&#x2013;7139.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4436300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafeman
        DG, Sunde RA, Hoekstra WG. Effect of dietary selenium on erythrocyte and liver
        glutathione peroxidase in the rat. J. Nutr. 1974;104:580&#x2013;587.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4823943</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, Soames AR, Roberts RA. Species differences in response
        to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis
        and peroxisome proliferator activated receptor alpha-mediated gene expression.
        Arch. Toxicol. 2000;74:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">10839475</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-D&#xed;az
        S, Mitchell AA, Kelley KE, Calafat AM, Hauser R. Medications as a potential
        source of exposure to phthalates in the U.S. population. Environ. Health Perspect.
        2009;117:185&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2649218</ArticleId><ArticleId
        IdType="pubmed">19270786</ArticleId></ArticleIdList></Reference><Reference><Citation>Irmak
        MB, Ince G, Ozturk M, Cetin-Atalay R. Acquired tolerance of hepatocellular
        carcinoma cells to selenium deficiency: a selective survival mechanism? Cancer
        Res. 2003;63:6707&#x2013;6715.</Citation><ArticleIdList><ArticleId IdType="pubmed">14583465</ArticleId></ArticleIdList></Reference><Reference><Citation>Isenberg
        JS, Kolaja KL, Ayoubi SA, Watkins JB, 3rd, Klaunig JE. Inhibition of WY-14,643
        induced hepatic lesion growth in mice by rotenone. Carcinogenesis. 1997;18:1511&#x2013;1519.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9276624</ArticleId></ArticleIdList></Reference><Reference><Citation>Jablonska
        E, Gromadzinska J, Reszka E, et al. Association between GPx1 Pro198Leu polymorphism,
        GPx1 activity and plasma selenium concentration in humans. Eur. J. Nutr. 2009;48:383&#x2013;386.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19415410</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Soames AR, Roberts RA. Suppression of hepatocyte apoptosis and induction
        of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate
        (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB) Arch. Toxicol.
        1998;72:784&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">9950075</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Babich MA, Baetcke KP, et al. PPARalpha agonist-induced rodent tumors:
        modes of action and human relevance. Crit. Rev. Toxicol. 2003;33:655&#x2013;780.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14727734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluwe
        WM, Huff JE, Matthews HB, Irwin R, Haseman JK. Comparative chronic toxicities
        and carcinogenic potentials of 2-ethylhexyl-containing compounds in rats and
        mice. Carcinogenesis. 1985;6:1577&#x2013;1583.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4053278</ArticleId></ArticleIdList></Reference><Reference><Citation>Latini
        G. Monitoring phthalate exposure in humans. Clin. Chim. Acta. 2005;361:20&#x2013;29.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16004980</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry
        OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol
        reagent. J. Biol. Chem. 1951;193:265&#x2013;275.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14907713</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiorino
        M, Gregolin C, Ursini F. Phospholipid hydroperoxide glutathione peroxidase.
        Meth. Enzymol. 1990;186:448&#x2013;457.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2233312</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund
        S, Marklund G. Involvement of the superoxide anion radical in the autoxidation
        of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem.
        1974;47:469&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">4215654</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina
        J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic
        liver disease. Drugs. 2005;65:2445&#x2013;2461.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16296871</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick
        RL. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity
        of di(2-ethylhexyl)phthalate (DEHP)? Environ. Health Perspect. 2001;109:437&#x2013;442.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1240301</ArticleId><ArticleId IdType="pubmed">11401753</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody
        DE, Reddy JK. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin,
        tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated
        enzymes. Am. J. Pathol. 1978;90:435&#x2013;446.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2018144</ArticleId><ArticleId IdType="pubmed">623209</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody
        DE, Reddy JK, Lake BG, Popp JA, Reese DH. Peroxisome proliferation and nongenotoxic
        carcinogenesis: commentary on a symposium. Fundam. Appl. Toxicol. 1991;16:233&#x2013;248.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2055355</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushtaq
        M, Srivastava SP, Seth PK. Effect of di-2-ethylhexyl phthalate (DEHP)on glycogen
        metabolism in rat liver. Toxicology. 1980;16:153&#x2013;161.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7414615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustacich
        D, Powis G. Thioredoxin reductase. Biochem. J. 2000;346:1&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1220815</ArticleId><ArticleId IdType="pubmed">10657232</ArticleId></ArticleIdList></Reference><Reference><Citation>National
        Research Council (NRC) Nutrient Requirements of Laboratory Animals. 4th revised
        edn. Washington, DC: National Academy Press; 1995.</Citation></Reference><Reference><Citation>Nose
        K. Role of reactive oxygen species in the regulation of physiological functions.
        Biol. Pharm. Bull. 2000;23:897&#x2013;903.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10963291</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberley
        TD, Zhong W, Szweda LI, Oberley LW. Localization of antioxidant enzymes and
        oxidative damage products in normal and malignant prostate epithelium. Prostate.
        2000;44:144&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">10881024</ArticleId></ArticleIdList></Reference><Reference><Citation>O''Brien
        ML, Spear BT, Glauert HP. Role of oxidative stress in peroxisome proliferator-mediated
        carcinogenesis. Crit. Rev. Toxicol. 2005;35:61&#x2013;88.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15742903</ArticleId></ArticleIdList></Reference><Reference><Citation>O''Brien
        ML, Twaroski TP, Cunningham ML, Glauert HP, Spear BT. Effects of peroxisome
        proliferators on antioxidant enzymes and antioxidant vitamins in rats and
        hamsters. Toxicol Sci. 2001;60:271&#x2013;278.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11248139</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson
        U, Garberg P, Lundgren B, et al. The involvement of selenium in peroxisome
        proliferation caused by dietary administration of clofibrate to rats. Chem.
        Biol. Interact. 1992;5:49&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">1458550</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Rao MS. Oxidative DNA damage caused by persistent peroxisome proliferation:
        its role in hepatocarcinogenesis. Mutat. Res. 1989;214:63&#x2013;68.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2671702</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Rao MS. Peroxisome proliferation and hepatocarcinogenesis. IARC Sci. Publ.
        1992;116:225&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">1428083</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard
        MJ, Portal B, Meo J, Coudray C, Hadjian A, Favier A. Malondialdehyde kit evaluated
        for determining plasma and lipoprotein fractions that react with thiobarbituric
        acid. Clin. Chem. 1992;38:704&#x2013;709.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1582024</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA, James NH, Hasmall SC, et al. Apoptosis and proliferation in nongenotoxic
        carcinogenesis: species differences and role of PPARalpha. Toxicol. Lett.
        2000;112&#x2013;113:49&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">10720712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohr-Udilova
        N, Sieghart W, Eferl R, et al. Antagonistic effects of selenium and lipid
        peroxides on growth control in early hepatocellular carcinoma. Hepatology.
        2012;55:1112&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22105228</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Rusyn I, Bojes HK, Belyea J, Cattley RC, Thurman RG. Role of Kupffer cells
        and oxidants in signaling peroxisome proliferator induced hepatocyte proliferation.
        Mutat. Res. 2000;448:179&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725471</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Rose ML, Bojes HK, Thurman RG. Novel role of oxidants in the molecular
        mechanism of action of peroxisome proliferators. Antioxid. Redox Signal. 2000;2:607&#x2013;621.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11229371</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Kadiiska MB, Dikalova A, et al. Phthalates rapidly increase production
        of reactive oxygen species in vivo: role of Kupffer cells. Mol. Pharmacol.
        2001;59:744&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pubmed">11259618</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Peters JM, Cunningham ML. Modes of action and species-specific effects
        of di-(2-ethylhexyl)phthalate in the liver. Crit. Rev. Toxicol. 2006;36:459&#x2013;479.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2614359</ArticleId><ArticleId IdType="pubmed">16954067</ArticleId></ArticleIdList></Reference><Reference><Citation>Saedi
        MS, Smith CG, Frampton J, Chambers I, Harrison PR, Sunde RA. Effect of selenium
        status on mRNA levels for glutathione peroxidase in rat liver. Biochem. Biophys.
        Res. Commun. 1988;153:855&#x2013;861.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3382406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki
        Y. Does oxidative stress participate in the development of hepatocellular
        carcinoma? J. Gastroenterol. 2006;41:1135&#x2013;1148.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17287893</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo
        KW, Kim KB, Kim YJ, Choi JY, Lee KT, Choi KS. Comparison of oxidative stress
        and changes of xenobiotic metabolizing enzymes induced by phthalates in rats.
        Food Chem. Toxicol. 2004;42:107&#x2013;114.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14630134</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbrenner
        H, Sies H. Protection against reactive oxygen species by selenoproteins. Biochim.
        Biophys. Acta. 2009;1790:1478&#x2013;1485.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19268692</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundae
        RA. Chapter 8. Regulation of selenoprotein expression. In: D Hatfield., editor.
        Selenium: Its Molecular Biology and Role in Human Health. Massachusetts: Kluwer
        Academic Publishers; 2003. pp. 81&#x2013;98.</Citation></Reference><Reference><Citation>Turan
        B, Acan NL, Ulusu NN, Tezcan EF. A comparative study on effect of dietary
        selenium and vitamin E on some antioxidant enzyme activities of liver and
        brain tissues. Biol. Trace Elem. Res. 2001;81:141&#x2013;152.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11554395</ArticleId></ArticleIdList></Reference><Reference><Citation>Urig
        S, Becker K. On the potential of thioredoxin reductase inhibitors for cancer
        therapy. Semin. Cancer Biol. 2006;16:452&#x2013;465.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17056271</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitzel
        F, Ursini F, Wendel A. Phospholipid hydroperoxide glutathione peroxidase in
        various mouse organs during selenium deficiency and repletion. Biochim. Biophys.
        Acta. 1990;1036:88&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">2223835</ArticleId></ArticleIdList></Reference><Reference><Citation>Whanger
        PD. Selenium and its relationship to cancer: an update. Br. J. Nutr. 2004;91:11&#x2013;28.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14748935</ArticleId></ArticleIdList></Reference><Reference><Citation>Willhite
        CC. Weight-of-evidence versus strength-of-evidence in toxicologic hazard identification:
        di(2-ethylhexyl)phthalate (DEHP) Toxicology. 2001;160:219&#x2013;226.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11246142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wormuth
        M, Scheringer M, Vollenweider M, Hungerb&#xfc;hler K. What are the sources
        of exposure to eight frequently used phthalic acid esters in Europeans? Risk
        Anal. 2006;26:803&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pubmed">16834635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeldandi
        AV, Rao MS, Reddy JK. Hydrogen peroxide generation in peroxisome proliferator-induced
        oncogenesis. Mutat. Res. 2000;448:159&#x2013;177.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725470</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo
        MH, Carlson BA, Tsuji P, Irons R, Gladyshev VN, Hatfield DL. Alteration of
        thioredoxin reductase 1 levels in elucidating cancer etiology. Methods Enzymol.
        2010;474:255&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3088101</ArticleId><ArticleId
        IdType="pubmed">20609915</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef
        JA, Bouziane M, Badr MZ. Age-dependent effects of nongenotoxic hepatocarcinogens
        on liver apoptosis in vivo. Mech. Ageing Dev. 2003;124:333&#x2013;340.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12663131</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu
        MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ. Plasma selenium levels
        and risk of hepatocellular carcinoma among men wit chronic hepatitis virus
        infection. Am. J. Epidemiol. 1999;150:367&#x2013;374.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10453813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu
        H, Jia Z, Misra H, Li YR. Oxidative stress and redox signaling mechanisms
        of alcoholic liver disease: updated experimental and clinical evidence. J.
        Dig. Dis. 2012;13:133&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3297983</ArticleId><ArticleId
        IdType="pubmed">22356308</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwolak
        I, Zaporowska H. Selenium interactions and toxicity: a review. Selenium interactions
        and toxicity. Cell Biol. Toxicol. 2012;28:31&#x2013;46.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21913064</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">20077217</PMID><DateCompleted><Year>2010</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2010</Year><Month>01</Month><Day>15</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1528-7394</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>72</Volume><Issue>21-22</Issue><PubDate><Year>2009</Year></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health. Part A</Title><ISOAbbreviation>J Toxicol
        Environ Health A</ISOAbbreviation></Journal><ArticleTitle>Comparative toxicological
        evaluation of phthalate diesters and metabolites in Sprague-Dawley male rats
        for risk assessment.</ArticleTitle><Pagination><StartPage>1446</StartPage><EndPage>1454</EndPage><MedlinePgn>1446-54</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1080/15287390903212923</ELocationID><Abstract><AbstractText>In
        order to comparatively assess the systemic toxicity and sperm parameters,
        nine phthalate diesters, including di(2-ethylhexyl) phthalate (DEHP), di(n-butyl)
        phthalate (DBP), di-n-octyl phthalate (DnOP), diethyl phthalate (DEP), butylbenzyl
        phthalate (BBP), dimethyl phthalate (DMP), di-isodecyl phthalate (DIDP), diundecyl
        phthalate (DUP), and di-isononyl phthalate (DINP), and five phthalate monoesters,
        including mono(2-ethylhexyl) phthalate (MEHP), monobutyl phthalate (MBuP),
        monobenzyl phthalate (MBeP), monoethyl phthalate (MEP), monomethyl phthalate
        (MMP), and phthalic acid (PA) were administered orally to Sprague-Dawley male
        rats at 250 (phthalate monoesters and PA) or 500 mg/kg body weight (bw)/d
        (phthalate diesters) for 4 wk. Liver weights were significantly increased
        in g roups treated with DEHP, DBP, BBP, DIDP, DINP, MEHP, and MBuP compared
        to the control. Testes weights were significantly reduced only in DEHP, DBP,
        and MEHP-treated groups compared to the control. Significant decreases in
        red blood cell (RBC) and hematocrit (Ht) levels were observed in DEHP-treated
        rats, whereas significant increases in mean corpuscular hemoglobin (MCH),
        mean corpuscular hemoglobin concentration (MCHC), and platelet (PLT) levels
        were found in the DEHP-treated group. Hemoglobin (Hb) level was reduced only
        in the DMP group. Similar to effects on testis and epididymal weights, DEHP
        and MEHP significantly reduced sperm numbers and motility. In particular,
        DnOP, DBP, BBP, MEP, MBuP, DUP, DINP, and MBeP significantly lowered the sperm
        counts and sperm motility of epididymal sperm, detected by a change in the
        sperm motion parameters. The strongest to the weakest adverse effects for
        sperm motility were as follows: DEHP &gt; DBP &gt; DnOP &gt; DUP &gt; DIDP
        &gt; BBP among diesters and MBuP &gt; MEP &gt; MEHP among monoesters, respectively.
        These results suggest that the adverse effects of phthalate esters (PEs) on
        sperm parameters in male rats are greater with phthalate diesters than monoesters,
        which may be useful for the risk assessment of phthalates.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwack</LastName><ForeName>Seung
        Jun</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department
        of Toxicological Research, National Institute of Toxicological Research, Seoul,
        Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyu
        Bong</ForeName><Initials>KB</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyung
        Sik</ForeName><Initials>HS</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Byung
        Mu</ForeName><Initials>BM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Toxicol Environ Health A</MedlineTA><NlmUniqueID>100960995</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013076" MajorTopicYN="N">Sperm Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013081" MajorTopicYN="N">Sperm Motility</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2010</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20077217</ArticleId><ArticleId IdType="doi">10.1080/15287390903212923</ArticleId><ArticleId
        IdType="pii">916458385</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1965743</PMID><DateCompleted><Year>1991</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>03</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0901-9928</ISSN><JournalIssue
        CitedMedium="Print"><Volume>67</Volume><Issue>5</Issue><PubDate><Year>1990</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Pharmacology
        &amp; toxicology</Title><ISOAbbreviation>Pharmacol Toxicol</ISOAbbreviation></Journal><ArticleTitle>Effects
        of prolonged treatment with phthalate ester on rat liver.</ArticleTitle><Pagination><StartPage>392</StartPage><EndPage>401</EndPage><MedlinePgn>392-401</MedlinePgn></Pagination><Abstract><AbstractText>Rats
        were fed a diet containing 2%, 0.2% or 0.02% di(2-ethylhexyl)phthalate (DEHP)
        for a period of 102 weeks. Only the 2% diet caused a substantial decrease
        in body weight. Both peroxisomal palmitoyl-CoA dehydrogenase and mitochondrial
        carnitine acetyltransferase activities were greatly induced by exposure to
        the highest dose of phthalate ester, reaching maximal plateau values after
        about 20 weeks of treatment. The diet containing 0.2% DEHP increased both
        activities slowly, but continuously, and at the end of the two-year period
        these increases were almost comparable to those obtained with the highest
        dose. Even the lowest dose gave a slowly increase in these activities. Both
        microsomal NADPH-cytochrome c reductase activity and the level of cytochrome
        P-450 were increased initially by exposure to 2% DEHP, but returned almost
        or completely to the control level after about 30 weeks of exposure. Depending
        on the dose of DEHP in the diet, peroxisomal catalase activity was elevated
        above the control level during the first year of treatment but was about the
        same as in the control animals during the second year. A substantial decrease
        in peroxisomal urate oxidase activity was observed throughout the entire experimental
        period. When treatment was ceased after one year, all activities returned
        to the control values within 2-3 weeks. These results demonstrate the complex
        nature of the effects caused by prolonged treatment with DEHP with cumulative
        increases at low doses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Ganning</LastName><ForeName>A E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, University of Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Olsson</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author
        ValidYN="Y"><LastName>Brunk</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author
        ValidYN="Y"><LastName>Dallner</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pharmacol
        Toxicol</MedlineTA><NlmUniqueID>8702180</NlmUniqueID><ISSNLinking>0901-9928</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.6.99.3</RegistryNumber><NameOfSubstance UI="D009245">NADH Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.9.3.1</RegistryNumber><NameOfSubstance UI="D003576">Electron Transport Complex
        IV</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.7</RegistryNumber><NameOfSubstance
        UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003576" MajorTopicYN="N">Electron Transport Complex IV</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008861" MajorTopicYN="N">Microsomes</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008930" MajorTopicYN="N">Mitochondria, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009245" MajorTopicYN="N">NADH Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997"
        MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1965743</ArticleId><ArticleId IdType="doi">10.1111/j.1600-0773.1990.tb00851.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">31262386</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>08</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">2214-0190</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Biomedical
        and environmental sciences : BES</Title><ISOAbbreviation>Biomed Environ Sci</ISOAbbreviation></Journal><ArticleTitle>Di
        (2-ethylhexyl) phthalate Disorders Lipid Metabolism via TYK2/STAT1 and Autophagy
        in Rats.</ArticleTitle><Pagination><StartPage>406</StartPage><EndPage>418</EndPage><MedlinePgn>406-418</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.3967/bes2019.055</ELocationID><Abstract><AbstractText
        Label="OBJECTIVE" NlmCategory="OBJECTIVE">Previous studies have indicated
        that the plasticizer di (2-ethylhexyl) phthalate (DEHP) affects lipid accumulation;
        however, its underlying mechanism remains unclear. We aim to clarify the effect
        of DEHP on lipid metabolism and the role of TYK2/STAT1 and autophagy.</AbstractText><AbstractText
        Label="METHODS" NlmCategory="METHODS">In total, 160 Wistar rats were exposed
        to DEHP [0, 5, 50, 500 mg/(kg&#x2022;d)] for 8 weeks. Lipid levels, as well
        as mRNA and protein levels of TYK2, STAT1, PPAR&#x3b3;, AOX, FAS, LPL, and
        LC3 were detected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The
        results indicate that DEHP exposure may lead to increased weight gain and
        altered serum lipids. We observed that DEHP exposure affected liver parenchyma
        and increased the volume or number of fat cells. In adipose tissue, decreased
        TYK2 and STAT1 promoted the expression of PPAR&#x3b3; and FAS. The mRNA and
        protein expression of LC3 in 50 and 500 mg/(kg&#x2022;d) groups was increased
        significantly. In the liver, TYK2 and STAT1 increased compensatorily; however,
        the expression of FAS and AOX increased, while LPL expression decreased. Joint
        exposure to both a high-fat diet and DEHP led to complete disorder of lipid
        metabolism.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">It
        is suggested that DEHP induces lipid metabolism disorder by regulating TYK2/STAT1.
        Autophagy may play a potential role in this process as well. High-fat diet,
        in combination with DEHP exposure, may jointly have an effect on lipid metabolism
        disorder.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Editorial
        Board of Biomedical and Environmental Sciences. Published by China CDC. All
        rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yue Zhu</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhao Ming</ForeName><Initials>ZM</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhou</LastName><ForeName>Li Ting</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao Han</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Qi</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ding</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Xu</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Han</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ya Ming</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Song</LastName><ForeName>Xin Yue</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhao</LastName><ForeName>Tian Yang</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ye</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, School of Public Health, Jilin University,
        Changchun 130000, Jilin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Biomed
        Environ Sci</MedlineTA><NlmUniqueID>8909524</NlmUniqueID><ISSNLinking>0895-3988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D052244">Endocrine Disruptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D050794">STAT1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C494081">Stat1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.10.2</RegistryNumber><NameOfSubstance UI="D053634">TYK2 Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.10.2</RegistryNumber><NameOfSubstance UI="C499357">Tyk2 protein, rat</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D059305" MajorTopicYN="N">Diet, High-Fat</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D052244" MajorTopicYN="N">Endocrine Disruptors</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D052439" MajorTopicYN="N">Lipid Metabolism Disorders</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D050794" MajorTopicYN="N">STAT1 Transcription Factor</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D053634" MajorTopicYN="N">TYK2 Kinase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Autophagy</Keyword><Keyword MajorTopicYN="N">DEHP</Keyword><Keyword
        MajorTopicYN="N">High-fat diet</Keyword><Keyword MajorTopicYN="N">Lipid metabolism</Keyword><Keyword
        MajorTopicYN="N">STAT1</Keyword><Keyword MajorTopicYN="N">TYK2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2018</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">31262386</ArticleId><ArticleId IdType="doi">10.3967/bes2019.055</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3657395</PMID><DateCompleted><Year>1987</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0024-4201</ISSN><JournalIssue
        CitedMedium="Print"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>1987</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Lipids</Title><ISOAbbreviation>Lipids</ISOAbbreviation></Journal><ArticleTitle>Alteration
        of hepatic phospholipids in rats and mice by feeding di-(2-ethylhexyl)adipate
        and di-(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>572</StartPage><EndPage>577</EndPage><MedlinePgn>572-7</MedlinePgn></Pagination><Abstract><AbstractText>Effects
        of di-(2-ethylhexyl)adipate (DOA) and di-(2-ethylhexyl)phthalate (DEHP), plasticizers
        for polyvinylchloride products, on concentrations and compositions of hepatic
        phospholipids were studied in rats. When administered to rats at a 2% level
        for 2 wk, both DOA and DEHP caused a hepatomegaly, an increase in hepatic
        phospholipids and a decrease an increase in hepatic phospholipids and a decrease
        in the ratio of phosphatidylcholine (PC) to phosphatidylethanolamine (PE).
        In the comparable study with mice, the alkyl moiety of DOA was found to be
        responsible for these alterations. DOA and DEHP specifically altered fatty
        acid compositions of PC and PE: there was an increase in oleic and palmitic
        acids and a decrease in stearic and docosahexaenoic acids in PC and an increase
        in arachidonic acid at the expense of docosahexaenoic acid in PE. In addition,
        DOA caused an increase in the trienoic and tetraenoic molecular species in
        PC and an increase in the 1-palmitoyl-2-arachidonyl (16:0@20:4) species in
        PE. Thus, the effects of DOA on the lipid dynamics resembled those observed
        with DEHP, although the magnitude was slightly moderated.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Yanagita</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory
        of Nutrition and Food Hygienic Chemistry, Saga University School of Agriculture,
        Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satoh</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Nomura</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Enomoto</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Sugano</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Lipids</MedlineTA><NlmUniqueID>0060450</NlmUniqueID><ISSNLinking>0024-4201</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010743">Phospholipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010743" MajorTopicYN="N">Phospholipids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3657395</ArticleId><ArticleId IdType="doi">10.1007/BF02537283</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur
        J Biochem. 1972 Dec 18;31(3):565-73</Citation><ArticleIdList><ArticleId IdType="pubmed">4650158</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1968 Sep 10;243(17):4440-51</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4971695</ArticleId></ArticleIdList></Reference><Reference><Citation>Fed
        Proc. 1961 Dec;20:934-40</Citation><ArticleIdList><ArticleId IdType="pubmed">14455159</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1975 Nov;67(2PT.1):281-309</Citation><ArticleIdList><ArticleId
        IdType="pubmed">406</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1969 Jun 10;176(4):756-63</Citation><ArticleIdList><ArticleId
        IdType="pubmed">5797088</ArticleId></ArticleIdList></Reference><Reference><Citation>Life
        Sci. 1976 May 1;18(9):941-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1271963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipids.
        1978 Oct;13(10):673-8</Citation><ArticleIdList><ArticleId IdType="pubmed">723479</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Nutr. 1959 Jul 10;68(3):405-18</Citation><ArticleIdList><ArticleId IdType="pubmed">13673303</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1969 Apr 29;176(3):547-56</Citation><ArticleIdList><ArticleId
        IdType="pubmed">5800043</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1980 Jul 14;619(1):20-34</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7417466</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1987 May 13;919(1):64-70</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3032271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipids.
        1979 Jun;14(6):533-4</Citation><ArticleIdList><ArticleId IdType="pubmed">459718</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Pharmacol. 1979 Oct 15;28(20):3115-21</Citation><ArticleIdList><ArticleId
        IdType="pubmed">518710</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1984 May 31;121(1):304-9</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6732809</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biochem. 1978 May;83(5):1361-5</Citation><ArticleIdList><ArticleId IdType="pubmed">659402</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1975 May 10;250(9):3359-67</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1123345</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1975 May;4(2):253-64</Citation><ArticleIdList><ArticleId IdType="pubmed">1154425</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1984 Apr 18;793(2):232-7</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6712968</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1978 Aug;45(2):497-504</Citation><ArticleIdList><ArticleId
        IdType="pubmed">705785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipids.
        1983 Mar;18(3):211-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6855481</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Toxicol Environ Health. 1983 Jul;12(1):159-69</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6355494</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1983 Jul 18;114(1):418-24</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6411083</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biochem. 1978 Jan;83(1):313-20</Citation><ArticleIdList><ArticleId IdType="pubmed">624708</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1970 Sep 25;245(18):4851-4</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4393962</ArticleId></ArticleIdList></Reference><Reference><Citation>Can
        J Biochem Physiol. 1959 Aug;37(8):911-7</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13671378</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1977 Apr;7(2):163-8</Citation><ArticleIdList><ArticleId IdType="pubmed">140478</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1983 Jul 12;752(2):259-64</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6134555</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1957 May;226(1):497-509</Citation><ArticleIdList><ArticleId IdType="pubmed">13428781</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1951 Nov;193(1):265-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14907713</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:35-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6754363</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Biochem. 1968 May;4(4):478-86</Citation><ArticleIdList><ArticleId IdType="pubmed">5660480</ArticleId></ArticleIdList></Reference><Reference><Citation>Can
        J Biochem. 1971 Dec;49(12):1347-56</Citation><ArticleIdList><ArticleId IdType="pubmed">4334540</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">28115639</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-0929</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>156</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Combined Effects of Gestational
        Phthalate Exposure and Zinc Deficiency on Steroid Metabolism and Growth.</ArticleTitle><Pagination><StartPage>469</StartPage><EndPage>479</EndPage><MedlinePgn>469-479</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1093/toxsci/kfx008</ELocationID><Abstract><AbstractText>Disruption
        of steroid hormone signaling has been implicated independently in the developmental
        abnormalities resulting from maternal phthalate plasticizer exposure and developmental
        zinc deficiency. This study investigated if secondary zinc deficiency may
        result from dietary exposure to a low level of di-2-ethylhexyl phthalate (DEHP)
        through gestation and if this could be associated with altered steroid metabolism.
        The interaction between marginal zinc nutrition and DEHP exposure to affect
        pregnancy outcome, zinc status, and steroid metabolism was also assessed.
        For this purpose, rats were fed a diet containing an adequate (25&#x2009;mg/kg)
        or marginal (10&#x2009;mg/kg) level of zinc without or with DEHP (300&#x2009;mg/kg)
        from gestation day (GD) 0 until GD 19. Steroid profiles were measured in dam
        liver, plasma, adrenal glands, and in fetal liver by UPLC/MS-MS. In dams fed
        the adequate zinc diet, DEHP exposure decreased maternal weight gain and led
        to hepatic acute-phase response and zinc accumulation. The latter could compromise
        zinc availability to the fetus. DEHP and marginal zinc deficiency caused several
        adverse effects on the maternal and fetal steroid profiles. Interactions between
        DEHP exposure and marginal zinc deficient nutrition affected 17OH pregnenolone
        and corticosterone, while pregnenolone levels were specifically affected by
        DEHP exposure. Maternal marginal zinc deficiency specifically affected maternal
        progesterone and aldosterone, and presented evidence of increased androgen
        aromatization activity in maternal and fetal tissues. Results stress the potential
        major impact of mild DEHP exposure on maternal/fetal steroid metabolism that
        can be potentiated by nutritional and chronic disease states leading to zinc
        deficiency.</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published
        by Oxford University Press on behalf of the Society of Toxicology. All rights
        reserved. For Permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Nuttall</LastName><ForeName>Johnathan
        R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Departments
        of Nutrition and of Environmental Toxicology, University of California, Davis,
        California 95616.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucera</LastName><ForeName>Heidi
        R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Departments
        of Nutrition and of Environmental Toxicology, University of California, Davis,
        California 95616.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Supasai</LastName><ForeName>Suangsuda</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments
        of Nutrition and of Environmental Toxicology, University of California, Davis,
        California 95616.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaikwad</LastName><ForeName>Nilesh
        W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>Departments
        of Nutrition and of Environmental Toxicology, University of California, Davis,
        California 95616.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oteiza</LastName><ForeName>Patricia
        I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Departments
        of Nutrition and of Environmental Toxicology, University of California, Davis,
        California 95616.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>T32 ES007059</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24
        DK097154</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research
        Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013256">Steroids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance
        UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006130" MajorTopicYN="N">Growth Disorders</DescriptorName><QualifierName
        UI="Q000196" MajorTopicYN="N">embryology</QualifierName><QualifierName UI="Q000209"
        MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018811" MajorTopicYN="N">Maternal Exposure</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="N">Prenatal Exposure Delayed Effects</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013256" MajorTopicYN="N">Steroids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000172"
        MajorTopicYN="Y">deficiency</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">DEHP</Keyword><Keyword MajorTopicYN="N">di-2-ethylhexyl
        phthalate (DEHP)</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword
        MajorTopicYN="N">pregnancy.</Keyword><Keyword MajorTopicYN="N">steroid</Keyword><Keyword
        MajorTopicYN="N">zinc deficiency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">28115639</ArticleId><ArticleId IdType="pmc">PMC5837672</ArticleId><ArticleId
        IdType="doi">10.1093/toxsci/kfx008</ArticleId><ArticleId IdType="pii">kfx008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aimo
        L., Mackenzie G. G., Keenan A. H., Oteiza P. I. (2010). Gestational zinc deficiency
        affects the regulation of transcription factors AP-1, NF-kappaB and NFAT in
        fetal brain. J. Nutr. Biochem. 21, 1069&#x2013;1075.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3506428</ArticleId><ArticleId IdType="pubmed">20092996</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade
        A. J., Grande S. W., Talsness C. E., Grote K., Chahoud I. (2006). A dose-response
        study following in utero and lactational exposure to di-(2-ethylhexyl)-phthalate
        (DEHP): non-monotonic dose-response and low dose effects on rat brain aromatase
        activity. Toxicology 227, 185&#x2013;192.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16949715</ArticleId></ArticleIdList></Reference><Reference><Citation>Blount
        B. C., Silva M. J., Caudill S. P., Needham L. L., Pirkle J. L., Sampson E.
        J., Lucier G. W., Jackson R. J., Brock J. W. (2000). Levels of seven urinary
        phthalate metabolites in a human reference population. Environ. Health Perspect.
        108, 979&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1240132</ArticleId><ArticleId
        IdType="pubmed">11049818</ArticleId></ArticleIdList></Reference><Reference><Citation>Blystone
        C. R., Kissling G. E., Bishop J. B., Chapin R. E., Wolfe G. W., Foster P.
        M. (2010). Determination of the di-(2-ethylhexyl) phthalate NOAEL for reproductive
        development in the rat: importance of the retention of extra animals to adulthood.
        Toxicol. Sci. 116, 640&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2905405</ArticleId><ArticleId
        IdType="pubmed">20484383</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui
        L. M., Taubeneck M. W., Commisso J. F., Uriu-Hare J. Y., Faber W. D., Keen
        C. L. (1998). Altered zinc metabolism contributes to the developmental toxicity
        of 2-ethylhexanoic acid, 2-ethylhexanol and valproic acid. Toxicology 126,
        9&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">9585088</ArticleId></ArticleIdList></Reference><Reference><Citation>Carey
        L. C., Coyle P., Philcox J. C., Rofe A. M. (2000). Maternal ethanol exposure
        is associated with decreased plasma zinc and increased fetal abnormalities
        in normal but not metallothionein-null mice. Alcohol. Clin. Exp. Res. 24,
        213&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">10698374</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael
        S. L., Abrams B. (1997). A critical review of the relationship between gestational
        weight gain and preterm delivery. Obstet. Gynecol. 89, 865&#x2013;873.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9166359</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaffee
        B. W., King J. C. (2012). Effect of zinc supplementation on pregnancy and
        infant outcomes: a systematic review. Paediatr. Perinat. Epidemiol. 26, 118&#x2013;137.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3787719</ArticleId><ArticleId IdType="pubmed">22742606</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauvigne
        F., Menuet A., Lesne L., Chagnon M. C., Chevrier C., Regnier J. F., Angerer
        J., Jegou B. (2009). Time- and dose-related effects of di-(2-ethylhexyl) phthalate
        and its main metabolites on the function of the rat fetal testis in vitro.
        Environ. Health Perspect. 117, 515&#x2013;521.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2679593</ArticleId><ArticleId IdType="pubmed">19440488</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherry
        F. F., Bennett E. A., Bazzano G. S., Johnson L. K., Fosmire G. J., Batson
        H. K. (1981). Plasma zinc in hypertension/toxemia and other reproductive variables
        in adolescent pregnancy. Am. J. Clin. Nutr. 34, 2367&#x2013;2375.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6118062</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi
        K., Joo H., Campbell J. L. Jr., Andersen M. E., Clewell H. J. 3rd (2013).
        In vitro intestinal and hepatic metabolism of Di(2-ethylhexyl) phthalate (DEHP)
        in human and rat. Toxicol. In Vitro 27, 1451&#x2013;1457.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">23545481</ArticleId></ArticleIdList></Reference><Reference><Citation>Clegg
        M. S., Hanna L. A., Niles B. J., Momma T. Y., Keen C. L. (2005). Zinc deficiency-induced
        cell death. IUBMB Life 57, 661&#x2013;669.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16223705</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobellis
        L., Latini G., De Felice C., Razzi S., Paris I., Ruggieri F., Mazzeo P., Petraglia
        F. (2003). High plasma concentrations of di-(2-ethylhexyl)-phthalate in women
        with endometriosis. Hum. Reprod. 18, 1512&#x2013;1515.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12832380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper
        B. W., Cho T. M., Thompson P. M., Wallace A. D. (2008). Phthalate induction
        of CYP3A4 is dependent on glucocorticoid regulation of PXR expression. Toxicol.
        Sci. 103, 268&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">18332045</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyle
        P., Philcox J. C., Rofe A. M. (1993). Corticosterone enhances the zinc and
        interleukin-6-mediated induction of metallothionein in cultured rat hepatocytes.
        J. Nutr. 123, 1464&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pubmed">8360772</ArticleId></ArticleIdList></Reference><Reference><Citation>DePasquale-Jardieu
        P., Fraker P. J. (1979). The role of corticosterone in the loss in immune
        function in the zinc-deficient A/J mouse. J. Nutr. 109, 1847&#x2013;1855.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">315453</ArticleId></ArticleIdList></Reference><Reference><Citation>Duthie
        L., Reynolds R. M. (2013). Changes in the maternal hypothalamic-pituitary-adrenal
        axis in pregnancy and postpartum: influences on maternal and fetal outcomes.
        Neuroendocrinology 98, 106&#x2013;115.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">23969897</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsheikh
        A., Creatsas G., Mastorakos G., Milingos S., Loutradis D., Michalas S. (2001).
        The renin-aldosterone system during normal and hypertensive pregnancy. Arch.
        Gynecol. Obstet. 264, 182&#x2013;185.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11205704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst
        O., Zor T. (2010). Linearization of the bradford protein assay. J. Visual.
        Exp. JoVE doi: 10.3791/1918(38).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3164080</ArticleId><ArticleId
        IdType="pubmed">20386536</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher
        G., Mohaupt M. (2007). Role of aldosterone availability in preeclampsia. Mol.
        Aspects Med. 28, 245&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">17512581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson
        K. K., McElrath T. F., Ko Y. A., Mukherjee B., Meeker J. D. (2014a). Variability
        in urinary phthalate metabolite levels across pregnancy and sensitive windows
        of exposure for the risk of preterm birth. Environ. Int. 70, 118&#x2013;124.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4104181</ArticleId><ArticleId IdType="pubmed">24934852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson
        K. K., McElrath T. F., Meeker J. D. (2014b). Environmental phthalate exposure
        and preterm birth. JAMA Pediatrics 168, 61&#x2013;67.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4005250</ArticleId><ArticleId IdType="pubmed">24247736</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaikwad
        N. W. (2013). Ultra performance liquid chromatography-tandem mass spectrometry
        method for profiling of steroid metabolome in human tissue. Anal. Chem. 85,
        4951&#x2013;4960.</Citation><ArticleIdList><ArticleId IdType="pubmed">23597399</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray
        L. E. Jr., Furr J., Tatum-Gibbs K. R., Lambright C., Sampson H., Hannas B.
        R., Wilson V. S., Hotchkiss A., Foster P. M. (2016). Establishing the &#x201c;Biological
        Relevance&#x201d; of dipentyl phthalate reductions in fetal rat testosterone
        production and plasma and testis testosterone levels. Toxicol. Sci. 149, 178&#x2013;191.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4715258</ArticleId><ArticleId IdType="pubmed">26454885</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdi
        S. A., Nassif O. I., Ardawi M. S. (1997). Effect of marginal or severe dietary
        zinc deficiency on testicular development and functions of the rat. Arch.
        Androl. 38, 243&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">9140621</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang
        Y., Li J., Garcia J. M., Lin H., Wang Y., Yan P., Wang L., Tan Y., Luo J.,
        Qiu Z., et al. (2014). Phthalate levels in cord blood are associated with
        preterm delivery and fetal growth parameters in Chinese women. PloS One 9,
        e87430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3913614</ArticleId><ArticleId
        IdType="pubmed">24503621</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang
        Y. L., Supasai S., Kucera H., Gaikwad N. W., Adamo A. M., Mathieu P., Oteiza
        P. I. (2016). Nutritional marginal zinc deficiency disrupts placental 11beta-hydroxysteroid
        dehydrogenase type 2 modulation. Food Funct. 7, 84&#x2013;92.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">26645329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt
        I. F., Murphy N. J., Cleaver A. E., Faraji B., Swendseid M. E., Browdy B.
        L., Coulson A. H., Clark V. A., Settlage R. H., Smith J. C. Jr. (1985). Zinc
        supplementation during pregnancy in low-income teenagers of Mexican descent:
        effects on selected blood constituents and on progress and outcome of pregnancy.
        Am. J. Clin. Nutr. 42, 815&#x2013;828.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4061343</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang
        M., He J., Kucera H., Gaikwad N. W., Zhang B., Xu M., O''Doherty R. M., Selcer
        K. W., Xie W. (2014). Hepatic overexpression of steroid sulfatase ameliorates
        mouse models of obesity and type 2 diabetes through sex-specific mechanisms.
        J. Biol. Chem. 289, 8086&#x2013;8097.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3961640</ArticleId><ArticleId IdType="pubmed">24497646</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson
        B., Hauge B., Larsen M. F., Hald F. (1996). Zinc supplementation during pregnancy:
        a double blind randomised controlled trial. Acta Obstet. Gynecol. Scand. 75,
        725&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pubmed">8906006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasutani
        K., Itoh N., Kanekiyo M., Muto N., Tanaka K. (1998). Requirement for cooperative
        interaction of interleukin-6 responsive element type 2 and glucocorticoid
        responsive element in the synergistic activation of mouse metallothionein-I
        gene by interleukin-6 and glucocorticoid. Toxicol. Appl. Pharmacol. 151, 143&#x2013;151.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9705897</ArticleId></ArticleIdList></Reference><Reference><Citation>Keen
        C. L., Peters J. M., Hurley L. S. (1989). The effect of valproic acid on 65Zn
        distribution in the pregnant rat. J. Nutr. 119, 607&#x2013;611.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2495343</ArticleId></ArticleIdList></Reference><Reference><Citation>Keen
        C. L., Taubeneck M. W., Daston G. P., Rogers J. M., Gershwin M. E. (1993).
        Primary and secondary zinc deficiency as factors underlying abnormal CNS development.
        Ann. N.Y. Acad. Sci. 678, 37&#x2013;47.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8494291</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim
        J., Kim Y. J., Lee R., Moon J. H., Jo I. (2012). Serum levels of zinc, calcium,
        and iron are associated with the risk of preeclampsia in pregnant women. Nutr.
        Res. 32, 764&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pubmed">23146773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim
        S. H., Chun S., Jang J. Y., Chae H. D., Kim C. H., Kang B. M. (2011). Increased
        plasma levels of phthalate esters in women with advanced-stage endometriosis:
        a prospective case-control study. Fertil. Steril. 95, 357&#x2013;359.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20797718</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch
        H. M., Preuss R., Angerer J. (2006). Di(2-ethylhexyl)phthalate (DEHP): human
        metabolism and internal exposure&#x2013; an update and latest results. Int.
        J. Androl. 29, 155&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">16466535</ArticleId></ArticleIdList></Reference><Reference><Citation>Latini
        G., De Felice C., Presta G., Del Vecchio A., Paris I., Ruggieri F., Mazzeo
        P. (2003). In utero exposure to di-(2-ethylhexyl)phthalate and duration of
        human pregnancy. Environ. Health Perspect. 111, 1783&#x2013;1785.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1241724</ArticleId><ArticleId IdType="pubmed">14594632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee
        J., Park J., Jang B., Knudsen T. B. (2004). Altered expression of genes related
        to zinc homeostasis in early mouse embryos exposed to di-2-ethylhexyl phthalate.
        Toxicol. Lett. 152, 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">15294341</ArticleId></ArticleIdList></Reference><Reference><Citation>Liuzzi
        J. P., Lichten L. A., Rivera S., Blanchard R. K., Aydemir T. B., Knutson M.
        D., Ganz T., Cousins R. J. (2005). Interleukin-6 regulates the zinc transporter
        Zip14 in liver and contributes to the hypozincemia of the acute-phase response.
        PNAS 102, 6843&#x2013;6848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1100791</ArticleId><ArticleId
        IdType="pubmed">15863613</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahomed
        K., James D. K., Golding J., McCabe R. (1989). Zinc supplementation during
        pregnancy: a double blind randomised controlled trial. BMJ 299, 826&#x2013;830.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1837690</ArticleId><ArticleId IdType="pubmed">2510845</ArticleId></ArticleIdList></Reference><Reference><Citation>Om
        A. S., Chung K. W. (1996). Dietary zinc deficiency alters 5 alpha-reduction
        and aromatization of testosterone and androgen and estrogen receptors in rat
        liver. J. Nutr. 126, 842&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">8613886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota
        E., Mori R., Middleton P., Tobe-Gai R., Mahomed K., Miyazaki C., Bhutta Z.
        A. (2015). Zinc supplementation for improving pregnancy and infant outcome.
        Cochrane Datab. Syst. Rev. 2, CD000230.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC7043363</ArticleId><ArticleId IdType="pubmed">25927101</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        J. M., Taubeneck M. W., Keen C. L., Gonzalez F. J. (1997). Di(2-ethylhexyl)
        phthalate induces a functional zinc deficiency during pregnancy and teratogenesis
        that is independent of peroxisome proliferator-activated receptor-alpha. Teratology
        56, 311&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">9451755</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        B. S., Rozati R., Reddy B. V., Raman N. V. (2006). Association of phthalate
        esters with endometriosis in Indian women. BJOG 113, 515&#x2013;520.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16637895</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosmond
        R., Bjorntorp P. (2000). [Low cortisol production in chronic stress. The connection
        stress-somatic disease is a challenge for future research]. Lakartidningen
        97, 4120&#x2013;4124.</Citation><ArticleIdList><ArticleId IdType="pubmed">11068377</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholl
        T. O., Hediger M. L., Schall J. I., Fischer R. L., Khoo C. S. (1993). Low
        zinc intake during pregnancy: its association with preterm and very preterm
        delivery. Am. J. Epidemiol. 137, 1115&#x2013;1124.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8317441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma
        V., McNeill J. H. (2009). To scale or not to scale: the principles of dose
        extrapolation. Br. J. Pharmacol. 157, 907&#x2013;921.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2737649</ArticleId><ArticleId IdType="pubmed">19508398</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui
        A. H., Irani R. A., Zhang W., Wang W., Blackwell S. C., Kellems R. E., Xia
        Y. (2013). Angiotensin receptor agonistic autoantibody-mediated soluble fms-like
        tyrosine kinase-1 induction contributes to impaired adrenal vasculature and
        decreased aldosterone production in preeclampsia. Hypertension 61, 472&#x2013;479.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4131732</ArticleId><ArticleId IdType="pubmed">23283357</ArticleId></ArticleIdList></Reference><Reference><Citation>Skakkebaek
        N. E., Rajpert-De Meyts E., Buck Louis G. M., Toppari J., Andersson A. M.,
        Eisenberg M. L., Jensen T. K., Jorgensen N., Swan S. H., Sapra K. J., et al.
        (2016). Male Reproductive disorders and fertility trends: influences of environment
        and genetic susceptibility. Physiol. Rev. 96, 55&#x2013;97.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4698396</ArticleId><ArticleId IdType="pubmed">26582516</ArticleId></ArticleIdList></Reference><Reference><Citation>Skakkebaek
        N. E., Rajpert-De Meyts E., Main K. M. (2001). Testicular dysgenesis syndrome:
        an increasingly common developmental disorder with environmental aspects.
        Hum. Reprod. 16, 972&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pubmed">11331648</ArticleId></ArticleIdList></Reference><Reference><Citation>Swenerton
        H., Hurley L. S. (1968). Severe zinc deficiency in male and female rats. J.
        Nutr. 95, 8&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">5653280</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda
        A., Tamano H., Kan F., Itoh H., Oku N. (2007). Anxiety-like behavior of young
        rats after 2-week zinc deprivation. Behav. Brain Res. 177, 1&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17166602</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao-feng
        Z., Nai-qiang Q., Jing Z., Zi L., Yang Z. (2009). Di (n-butyl) phthalate inhibits
        testosterone synthesis through a glucocorticoid-mediated pathway in rats.
        Int. J. Toxicol. 28, 448&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">19815848</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie
        T., Tong L., McCann U. D., Yuan J., Becker K. G., Mechan A. O., Cheadle C.,
        Donovan D. M., Ricaurte G. A. (2004). Identification and characterization
        of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced
        toxicity to brain dopaminergic neurons. J. Neurosci. 24, 7043&#x2013;7050.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC6729169</ArticleId><ArticleId IdType="pubmed">15306638</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10499774</PMID><DateCompleted><Year>1999</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1071-5762</ISSN><JournalIssue
        CitedMedium="Print"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>1999</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Free
        radical research</Title><ISOAbbreviation>Free Radic Res</ISOAbbreviation></Journal><ArticleTitle>Effect
        of peroxisome proliferator on extracellular glutathione peroxidase in rat.</ArticleTitle><Pagination><StartPage>181</StartPage><EndPage>190</EndPage><MedlinePgn>181-90</MedlinePgn></Pagination><Abstract><AbstractText>Glutathione
        peroxidase (GPX) activity measured using tert-butyl hydroperoxide as a substrate
        detects solely cellular/classical GPX (cGPX) in rat liver and kidney, and
        extracellular/plasma glutathione peroxidase (EC-GPX) in rat serum. To investigate
        the effect of peroxisome proliferator on EC-GPX, we measured activities of
        GPX and catalase in rat liver, kidney and serum, and then we performed immunoblot
        and Northern blot analyses in the kidney. Rats were fed on a diet containing
        either 2% (w/w) di-2-ethylhexyl phthalate (DEHP) or 0.25% (w/w) clofibrate
        for two or three weeks, respectively. Catalase activity was increased 1.4-fold
        (p &lt; 0.001) in the treated liver, but not in the kidney. GPX activity was
        decreased to 59.2% (DEHP) and 70.4% (clofibrate) of the control (p &lt; 0.001)
        in the serum but was unaltered in the liver and kidney. The immunoreactivity
        for EC-GPX was also significantly decreased in the DEHP-treated kidney compared
        with the control. The mRNA levels of EC-GPX and cGPX were unaltered. The immunostaining
        for 4-hydroxy-2-nonenal, a maker of lipid peroxide, was more intense in the
        treated kidney compared with the control. These results suggest that EC-GPX
        is post-transcriptionally decreased by peroxisome proliferator through the
        oxidative stress in the renal tubules. This may be a new deleterious effect
        of an endocrine disruptor DEHP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Dobashi</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department
        of Pediatrics, Yamanashi Medical University, Tamahocho, Japan. kdobashi@swallow.res.yamanashi-med.ac.jp</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Asayama</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Nakane</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Hayashibe</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Kodera</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Uchida</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Nakazawa</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Free
        Radic Res</MedlineTA><NlmUniqueID>9423872</NlmUniqueID><ISSNLinking>1029-2470</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000447">Aldehydes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005609">Free Radicals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008054">Lipid Peroxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.9</RegistryNumber><NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>K1CVM13F96</RegistryNumber><NameOfSubstance
        UI="C027576">4-hydroxy-2-nonenal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000447" MajorTopicYN="N">Aldehydes</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015152" MajorTopicYN="N">Blotting, Northern</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005109" MajorTopicYN="N">Extracellular Matrix</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005609" MajorTopicYN="N">Free Radicals</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005979" MajorTopicYN="N">Glutathione Peroxidase</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008054" MajorTopicYN="N">Lipid Peroxides</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013194" MajorTopicYN="N">Staining and Labeling</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10499774</ArticleId><ArticleId IdType="doi">10.1080/10715769900300731</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8914623</PMID><DateCompleted><Year>1996</Year><Month>12</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue
        CitedMedium="Print"><Volume>87</Volume><Issue>2-3</Issue><PubDate><Year>1996</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Differential
        effect of peroxisome proliferators on rat glutathione S-transferase isoenzymes.</ArticleTitle><Pagination><StartPage>147</StartPage><EndPage>155</EndPage><MedlinePgn>147-55</MedlinePgn></Pagination><Abstract><AbstractText>We
        have investigated the effects of peroxisome proliferators silvex, nafenopin
        and diethylhexylphthalate (DEHP) on rat liver glutathione S-transferase (GST)
        isoenzyme activities and patterns. Silvex was a more potent in vitro GST inhibitor
        than nafenopin and DEHP. After 14 days oral administration to rats a reduction
        in total GST activity was observed, doses of compounds were chosen so that
        peroxisome proliferation was equivalent between compounds, nevertheless total
        GST activity was altered to different extents: nafenopin approximately silvex
        &gt; DEHP approximately control. GST isoenzyme profiles were also altered,
        the proportion of GST 2-2 increased and 4-4 decreased compared to control
        levels. The results indicated that: (i) the peroxisome proliferators studied
        had similar effects on GST isoenzyme profile: (ii) modulation of the GST activity
        was apparently independent of peroxisome proliferation per se.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Voskoboinik</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Key
        Centre for Applied and Nutritional Toxicology, RMIT-University, Melbourne,
        Vic, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drew</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Ahokas</LastName><ForeName>J T</ForeName><Initials>JT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006540">Herbicides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9Q963S4YMX</RegistryNumber><NameOfSubstance
        UI="D015085">2,4,5-Trichlorophenoxyacetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>D2HZL58IS3</RegistryNumber><NameOfSubstance
        UI="C009264">fenoprop</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.5.1.18</RegistryNumber><NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015085" MajorTopicYN="N">2,4,5-Trichlorophenoxyacetic Acid</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006540" MajorTopicYN="N">Herbicides</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8914623</ArticleId><ArticleId IdType="doi">10.1016/0378-4274(96)03371-1</ArticleId><ArticleId
        IdType="pii">0378-4274(96)03371-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20307648</PMID><DateCompleted><Year>2010</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1708</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2010</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Reproductive
        toxicology (Elmsford, N.Y.)</Title><ISOAbbreviation>Reprod Toxicol</ISOAbbreviation></Journal><ArticleTitle>In
        utero exposure to di-(2-ethylhexyl) phthalate affects liver morphology and
        metabolism in post-natal CD-1 mice.</ArticleTitle><Pagination><StartPage>427</StartPage><EndPage>432</EndPage><MedlinePgn>427-32</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.reprotox.2010.03.002</ELocationID><Abstract><AbstractText>The
        plasticizer di-(2-ethylhexyl)phthalate (DEHP) affects reproductive development,
        glycogen and lipid metabolism. Whereas liver is a main DEHP target in adult
        rodents, the potential impact on metabolic programming is unknown. Effects
        of in utero DEHP exposure on liver development were investigated upon treatment
        of pregnant CD-1 mice on gestational days (GD)11-19. F1 mice were examined
        at post-natal days 21 (weaning) and 35 (start of puberty): parameters included
        liver histopathological, immunocytochemical and alpha-fetoprotein (AFP) gene
        expression analyses. In utero DEHP exposure altered post-natal liver development
        in weanling mice causing significant, dose-related (i) increased hepatosteatosis,
        (ii) decreased glycogen storage, (iii) increased beta-catenin intracytoplasmic
        localization (females only). At puberty, significantly decreased glycogen
        storage was still present in males. A treatment-induced phenotype was identified
        with lack of glycogen accumulation and intracytoplasmic localization of beta-catenin
        which was associated with increased AFP gene expression. Our findings suggested
        that DEHP alters post-natal liver development delaying the programming of
        glycogen metabolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Maranghi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department
        of Food Safety and Veterinary Public Health, Veterinary and Food Toxicology
        Unit Istituto Superiore di Sanit&#xe0;, Rome, Italy. francesca.maranghi@iss.it
        &lt;francesca.maranghi@iss.it&gt;</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lorenzetti</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Tassinari</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Moracci</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Tassinari</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Author><Author
        ValidYN="Y"><LastName>Marcoccia</LastName><ForeName>Daniele</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Di Virgilio</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Eusepi</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Romeo</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Magrelli</LastName><ForeName>Armando</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Salvatore</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Tosto</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Author><Author
        ValidYN="Y"><LastName>Viganotti</LastName><ForeName>Mara</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Antoccia</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Di Masi</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Azzalin</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Tanzarella</LastName><ForeName>Caterina</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Macino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Taruscio</LastName><ForeName>Domenica</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2010</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Reprod Toxicol</MedlineTA><NlmUniqueID>8803591</NlmUniqueID><ISSNLinking>0890-6238</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C495267">CTNNB1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008112">Liver Glycogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D051176">beta Catenin</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005234" MajorTopicYN="N">Fatty Liver</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008112" MajorTopicYN="N">Liver Glycogen</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018811" MajorTopicYN="N">Maternal Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="N">Prenatal Exposure Delayed Effects</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051176" MajorTopicYN="N">beta Catenin</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2009</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2010</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2010</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2010</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20307648</ArticleId><ArticleId IdType="doi">10.1016/j.reprotox.2010.03.002</ArticleId><ArticleId
        IdType="pii">S0890-6238(10)00044-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">18639561</PMID><DateCompleted><Year>2008</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-5107</ISSN><JournalIssue
        CitedMedium="Print"><Volume>644</Volume><Issue>1-2</Issue><PubDate><Year>2008</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Mutation
        research</Title><ISOAbbreviation>Mutat Res</ISOAbbreviation></Journal><ArticleTitle>Mechanisms
        of peroxisome proliferator-induced DNA hypomethylation in rat liver.</ArticleTitle><Pagination><StartPage>17</StartPage><EndPage>23</EndPage><MedlinePgn>17-23</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.mrfmmm.2008.06.009</ELocationID><Abstract><AbstractText>Genomic
        hypomethylation is a consistent finding in both human and animal tumors and
        mounting experimental evidence suggests a key role for epigenetic events in
        tumorigenesis. Furthermore, it has been suggested that early changes in DNA
        methylation and histone modifications may serve as sensitive predictive markers
        in animal testing for carcinogenic potency of environmental agents. Alterations
        in metabolism of methyl donors, disturbances in activity and/or expression
        of DNA methyltransferases, and presence of DNA single-strand breaks could
        contribute to the loss of cytosine methylation during carcinogenesis; however,
        the precise mechanisms of genomic hypomethylation induced by chemical carcinogens
        remain largely unknown. This study examined the mechanism of DNA hypomethylation
        during hepatocarcinogenesis induced by peroxisome proliferators WY-14,643
        (4-chloro-6-(2,3-xylidino)-pyrimidynylthioacetic acid) and DEHP (di-(2-ethylhexyl)phthalate),
        agents acting through non-genotoxic mode of action. In the liver of male Fisher
        344 rats exposed to WY-14,643 (0.1% (w/w), 5 months), the level of genomic
        hypomethylation increased by approximately 2-fold, as compared to age-matched
        controls, while in the DEHP group (1.2% (w/w), 5 months) DNA methylation did
        not change. Global DNA hypomethylation in livers from WY-14,643 group was
        accompanied by the accumulation of DNA single-strand breaks, increased cell
        proliferation, and diminished expression of DNA methyltransferase 1, while
        the metabolism of methyl donors was not affected. In contrast, none of these
        parameters changed significantly in rats fed DEHP. Since WY-14,643 is much
        more potent carcinogen than DEHP, we conclude that the extent of loss of DNA
        methylation may be related to the carcinogenic potential of the chemical agent,
        and that accumulation of DNA single-strand breaks coupled to the increase
        in cell proliferation and altered DNA methyltransferase expression may explain
        genomic hypomethylation during peroxisome proliferator-induced carcinogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Pogribny</LastName><ForeName>Igor
        P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Division
        of Biochemical Toxicology, National Center for Toxicological Research, 3900
        NCTR Road, Jefferson, AR 72079, USA. igor.pogribny@fda.hhs.gov</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tryndyak</LastName><ForeName>Volodymyr P</ForeName><Initials>VP</Initials></Author><Author
        ValidYN="Y"><LastName>Boureiko</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Melnyk</LastName><ForeName>Stepan</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Bagnyukova</LastName><ForeName>Tetyana V</ForeName><Initials>TV</Initials></Author><Author
        ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Beverly</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Rusyn</LastName><ForeName>Ivan</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>ES11660</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES12686</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K22
        ES011660</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>R01 ES012686</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19
        ES011391</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>ES11391</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01
        ES012686-04</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research
        Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2008</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat
        Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009153">Mutagens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018809">Proliferating Cell Nuclear Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.1.1.37</RegistryNumber><NameOfSubstance UI="D000076123">DNA (Cytosine-5-)-Methyltransferase
        1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.37</RegistryNumber><NameOfSubstance
        UI="D004248">DNA (Cytosine-5-)-Methyltransferases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000076123" MajorTopicYN="N">DNA (Cytosine-5-)-Methyltransferase 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004248" MajorTopicYN="N">DNA (Cytosine-5-)-Methyltransferases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D053904" MajorTopicYN="N">DNA Breaks, Single-Stranded</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008745" MajorTopicYN="N">Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009153" MajorTopicYN="N">Mutagens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018809" MajorTopicYN="N">Proliferating Cell Nuclear Antigen</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2008</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2008</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2008</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2008</Year><Month>7</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2008</Year><Month>11</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2008</Year><Month>7</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">18639561</ArticleId><ArticleId IdType="mid">NIHMS73641</ArticleId><ArticleId
        IdType="pmc">PMC2571982</ArticleId><ArticleId IdType="doi">10.1016/j.mrfmmm.2008.06.009</ArticleId><ArticleId
        IdType="pii">S0027-5107(08)00127-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hanahan
        D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57&#x2013;70.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10647931</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones
        PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683&#x2013;692.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3894624</ArticleId><ArticleId IdType="pubmed">17320506</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg
        AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer. 2004;4:143&#x2013;153.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14732866</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivenbark
        AG, Coleman WB. The use of epigenetic biomarkers for pre-clinical detection
        of hepatocellular carcinoma: potential for non-invasive screening of high-risk
        populations. Clin Cancer Res. 2007;13:2309&#x2013;2312.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17438087</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Preston
        R, Santella RM, Blanco A, Desai M, Berdasco M, Fraga M. Global DNA hypomethylation
        in liver cancer cases and controls&#x2014;a phase I pre-clinical biomarker
        development study. Epigenetics. 2007;2:223&#x2013;226.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18032927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao
        CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced
        malignant transformation with DNA hypomethylation and aberrant gene expression.
        Proc Natl Acad Sci USA. 1997;94:10907&#x2013;10912.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC23527</ArticleId><ArticleId IdType="pubmed">9380733</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson
        RE, Curtin GM, Doolittle DJ, Goodman JI. Progressive alterations in global
        and GC-rich DNA methylation during tumorigenesis. Toxicol Sci. 2003;75:289&#x2013;299.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12883089</ArticleId></ArticleIdList></Reference><Reference><Citation>Salnikow
        K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis
        and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol. 2008;21:28&#x2013;44.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2602826</ArticleId><ArticleId IdType="pubmed">17970581</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogribny
        IP, Rusyn I, Beland FA. Epigenetic aspects of genotoxic and non-genotoxic
        hepatocarcinogenesis&#x2014;studies in rodents. Environ Mol Mutagen. 2008;49:9&#x2013;15.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2705440</ArticleId><ArticleId IdType="pubmed">17879298</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvisi
        DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, Schroeder I, Factor VM,
        Thorgeirsson SS. Mechanistic and prognostic significance of aberrant methylation
        in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest.
        2007;117:2713&#x2013;2722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950459</ArticleId><ArticleId
        IdType="pubmed">17717605</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvisi
        DF, Simile MM, Ladu S, Pellegrino R, De VM, Pinna F, Tomasi ML, Frau M, Virdis
        P, De Miglio MR, Muroni MR, Pascale RM, Feo F. Altered methionine metabolism
        and global DNA methylation in liver cancer: relationship with genomic instability
        and prognosis. Int J Cancer. 2007;121:2410&#x2013;2420.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17680562</ArticleId></ArticleIdList></Reference><Reference><Citation>Moggs
        JG, Goodman JI, Trosko JE, Roberts RA. Epigenetics and cancer: implications
        for drug discovery and safety assessment. Toxicol Appl Pharmacol. 2004;196:422&#x2013;430.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15094313</ArticleId></ArticleIdList></Reference><Reference><Citation>Preston
        RJ. Epigenetic processes and cancer risk assessment. Mutat Res. 2007;616:7&#x2013;10.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17147955</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwetz
        BA. Thoughts on carcinogenesis testing&#x2014;the FDA today. Drug Metab Rev.
        2000;32:211&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">10774776</ArticleId></ArticleIdList></Reference><Reference><Citation>Peraza
        MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM. The toxicology of ligands
        for peroxisome proliferator-activated receptors (PPAR) Toxicol Sci. 2006;90:269&#x2013;295.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16322072</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Peters JM, Cunningham ML. Modes of action and species-specific effects
        of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol. 2006;36:459&#x2013;479.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2614359</ArticleId><ArticleId IdType="pubmed">16954067</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez
        FJ, Shah YM. PPARalpha: mechanism of species differences and hepatocarcinogenesis
        of peroxisome proliferators. Toxicology. 2008;246:2&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18006136</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, Deluca JG, Lai DY,
        McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA. PPAR-alpha agonist-induced
        rodent tumors: modes of action and human relevance. Crit Rev Toxicol. 2003;33:655&#x2013;780.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14727734</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogribny
        IP, Tryndyak VP, Woods CG, Witt SE, Rusyn I. Epigenetic effects of the continuous
        exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent
        upon peroxisome proliferator-activated receptor alpha. Mutat Res. 2007;625:62&#x2013;71.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2111058</ArticleId><ArticleId IdType="pubmed">17586532</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman
        JI, Watson RE. Altered DNA methylation&#x2014;a secondary mechanism involved
        in carcinogenesis. Annu Rev Pharmacol Toxicol. 2002;42:501&#x2013;525.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11807181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai
        Y, Hirohashi S. Alterations of DNA methylation associated with abnormalities
        of DNA methyltransferases in human cancers during transition from a pre-cancerous
        to a malignant state. Carcinogenesis. 2007;28:2434&#x2013;2442.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17893234</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, Melnyk S. Mechanisms of
        DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient
        rat model of hepatocarcinogenesis. J Nutr. 2003;133:3740S&#x2013;3747S.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14608108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Denissenko MF, Wong VA, Butterworth BE, Cunningham ML, Upton PB, Thurman
        RG, Swenberg JA. Expression of base excision repair enzymes in rat and mouse
        liver is induced by peroxisome proliferators and is dependent upon carcinogenic
        potency. Carcinogenesis. 2000;21:2141&#x2013;2145.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11133801</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogribny
        IP, Yi P, James SJ. A sensitive new method for rapid detection of abnormal
        methylation patterns in global DNA and within CpG islands. Biochem Biophys
        Res Commun. 1999;262:624&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">10471374</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogribny
        IP, Pogribna M, Christman JK, James SJ. Single-site methylation within the
        p53 promoter region reduces gene expression in a reporter gene construct:
        possible in vivo relevance during tumorigenesis. Cancer Res. 2000;60:588&#x2013;594.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10676641</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnyk
        S, Pogribna M, Pogribny IP, Yi P, James SJ. Measurement of plasma and intracellular
        s-adenosylmethionine and s-adenosylhomocysteine utilizing coulometric electrochemical
        detection: alterations with plasma homocysteine and pyridoxal 5&#x2032;-phosphate
        concentrations. Clin Chem. 2000;46:265&#x2013;272.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10657384</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnakian
        AG, James SJ. Quantification of 3&#x2032;OH DNA breaks by random oligonucleotide-primed
        synthesis (ROPS) assay. DNA Cell Biol. 1996;15:255&#x2013;262.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8634154</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge
        R, Wang W, Kramer PM, Yang S, Tao L, Pereira MA. Wy-14,643-induced hypomethylation
        of the c-myc gene in mouse liver. Toxicol Sci. 2001;62:28&#x2013;35.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11399790</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        DS, Cattley RC, Conway JG, Popp JA. Relationship of hepatic peroxisome proliferation
        and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome
        proliferators di(2-ethylhexyl)phthalate and (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio)
        acetic acid (Wy-14,643) in rats. Cancer Res. 1988;48:6739&#x2013;6744.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3180084</ArticleId></ArticleIdList></Reference><Reference><Citation>Rollins
        RA, Haghighi F, Edwards JR, Das R, Zhang MQ, Ju J, Bestor TH. Large-scale
        structure of genomic methylation patterns. Genome Res. 2006;16:157&#x2013;163.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1361710</ArticleId><ArticleId IdType="pubmed">16365381</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnell
        AN, Goodman JI. The long (LINEs) and the short (SINEs) of it: altered methylation
        as a precursor to toxicity. Toxicol Sci. 2003;75:229&#x2013;235.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12773759</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard
        G, Eiges R, Gaudet F, Jaenisch R, Eden A. Activation and transposition of
        endogenous retroviral elements in hypomethylation-induced tumors in mice.
        Oncogene. 2008;27:404&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">17621273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneda
        A, Tsukamoto T, Takamura-Enya T, Watanabe N, Kaminishi M, Sugimura T, Tatematsu
        M, Ushijima T. Frequent hypomethylation in multiple promoter CpG islands is
        associated with global hypomethylation, but not with frequent promoter hypermethylation.
        Cancer Sci. 2004;95:58&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">14720328</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmetz
        KL, Pogribny IP, James SJ, Pitot HC. Hypomethylation of the rat glutathione
        s-transferase pi (GSTP) promoter region isolated from methyl-deficient livers
        and GSTP-positive liver neoplasms. Carcinogenesis. 1998;19:1487&#x2013;1494.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9744547</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, Glover SE. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following
        exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear
        localization. Carcinogenesis. 1993;14:2495&#x2013;2499.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8269617</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Sola
        D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier
        J, Dalla-Favera R. Non-transcriptional control of DNA replication by c-Myc.
        Nature. 2007;448:445&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">17597761</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerda
        S, Weitzman SA. Influence of oxygen radical injury on DNA methylation. Mutat
        Res. 1997;386:141&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">9113115</ArticleId></ArticleIdList></Reference><Reference><Citation>Valinluck
        V, Sowers LC. Endogenous cytosine damage products alter the site selectivity
        of human DNA maintenance methyltransferase DNMT1. Cancer Res. 2007;67:946&#x2013;950.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17283125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Asakura S, Pachkowski B, Bradford BU, Denissenko MF, Peters JM, Holland
        SM, Reddy JK, Cunningham ML, Swenberg JA. Expression of base excision DNA
        repair genes is a sensitive biomarker for in vivo detection of chemical-induced
        chronic oxidative stress: identification of the molecular source of radicals
        responsible for DNA damage by peroxisome proliferators. Cancer Res. 2004;64:1050&#x2013;1057.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14871837</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada
        Y, Jackson-Grusby L, Linhart H, Meissner A, Eden A, Lin H, Jaenisch R. Opposing
        effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc
        Natl Acad Sci USA. 2005;102:13580&#x2013;13585.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1224663</ArticleId><ArticleId IdType="pubmed">16174748</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao
        L, Wang W, Li L, Kramer PK, Pereira MA. DNA hypomethylation induced by drinking
        water disinfection by-products in mouse and rat kidney. Toxicol Sci. 2005;87:344&#x2013;352.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16014735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachman
        AN, Phillips JM, Goodman JI. Phenobarbital induces progressive patterns of
        GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone
        B6C3F1 mice. Toxicol Sci. 2006;91:393&#x2013;405.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16537655</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez
        J, Frigola J, Vendrell E, Risques RA, Fraga MF, Morales C, Moreno V, Esteller
        M, Capell&#xe0; G, Ribas M, Peinado MA. Chromosomal instability correlates
        with genome-wide DNA demethylation in human primary colorectal cancers. Cancer
        Res. 2006;66:8462&#x2013;8468.</Citation><ArticleIdList><ArticleId IdType="pubmed">16951157</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson
        AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys
        Acta. 2007;1775:138&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">17045745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazazian
        HH. Mobile elements: drivers of genome evolution. Science. 2004;303:1626&#x2013;1632.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15016989</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman
        WB, Tsongalis GJ. Molecular mechanisms of human carcinogenesis. EXS. 2006;96:321&#x2013;349.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16383025</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Moody DE, Azarnoff DL, Rao MS. Di-(2-ethylhexyl)phthalate: an industrial
        plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine
        acetyltransferase activities in rat and mice. Life Sci. 1976;18:941&#x2013;945.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1271963</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang
        G, Chan MF, Tomigahara Y, Tsai YC, Gonzales FA, Li E, Laird PW, Jones PA.
        Cooperativity between DNA methyltransferases in the maintenance methylation
        of repetitive elements. Mol Cell Biol. 2002;22:480&#x2013;491.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC139739</ArticleId><ArticleId IdType="pubmed">11756544</ArticleId></ArticleIdList></Reference><Reference><Citation>Trasler
        J, Deng L, Melnyk S, Pogribny I, Hiou-Tim F, Sibani S, Oakes C, Li E, James
        SJ, Rozen R. Impact of DNMT1 deficiency, with and without low folate diets,
        on tumor numbers and DNA methylation in Min mice. Carcinogenesis. 2003;24:39&#x2013;45.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12538347</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang
        Q, Ito S, Gonzalez FJ. Hepatocyte-restricted constitutive activation of PPAR&#x3b1;
        induces hepatoproliferation but not hepatocarcinogenesis. Carcinogenesis.
        2007;28:1171&#x2013;1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1885989</ArticleId><ArticleId
        IdType="pubmed">17331954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress
        C, Thomassin H, Grange T. Active cytosine demethylation triggered by a nuclear
        receptor involves DNA strand breaks. Proc Natl Acad Sci USA. 2006;103:11112&#x2013;11117.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1544051</ArticleId><ArticleId IdType="pubmed">16840560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">32435917</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0738</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>94</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Constitutive
        androstane receptor (CAR) mediates dieldrin-induced liver tumorigenesis in
        mouse.</ArticleTitle><Pagination><StartPage>2873</StartPage><EndPage>2884</EndPage><MedlinePgn>2873-2884</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1007/s00204-020-02781-8</ELocationID><Abstract><AbstractText>Dieldrin
        has been shown to induce liver tumors selectively in mice. Although the exact
        mechanism is not fully understood, previous studies from our laboratory and
        others have shown that dieldrin induced liver tumors in mice through a non-genotoxic
        mechanism acting on tumor promotion stage. Two studies were performed to examine
        the role of nuclear receptor activation as a possible mode of action (MOA)
        for dieldrin-induced mouse liver tumors. In the initial study, male C57BL/6
        mice (6- to 8-week old) were treated with dieldrin in diet (10&#xa0;ppm) for
        7, 14, and 28&#xa0;days. Phenobarbital (PB), beta-naphthoflavone (BNF) and
        Di (2-ethylhexyl) phthalate (DEHP) were included as positive controls in this
        study for evaluating the involvement of CAR (constitutive androstane receptor),
        AhR (aryl hydrocarbon receptor) or PPAR&#x3b1; (peroxisome proliferator activated
        receptor alpha) in the MOA of dieldrin hepatocarcinogenesis. A significant
        increase in hepatocyte DNA synthesis (BrdU incorporation) was seen in treated
        mice compared with the untreated controls. Analysis of the expression of the
        nuclear receptor responsive genes revealed that dieldrin induced a significant
        increase in the expression of genes specific to CAR activation (Cyp2b10, up
        to 400- to 2700-fold) and PXR activation (Cyp3a11, up to 5- to 11-fold) over
        untreated controls. The AhR target genes Cyp1a1 and Cyp1a2 were also slightly
        induced (2.0- to 3.7-fold and 1.7- to 2.8-fold, respectively). PPAR&#x3b1;
        activation was not seen in the liver following dieldrin treatment. In addition,
        consistent with previous studies in our lab, treatment with dieldrin produced
        significant elevation in the hepatic oxidative stress. In a subsequent study
        using CAR, PXR, and CAR/PXR knockout mice, we confirmed that the dieldrin-induced
        liver effects in mouse were only mediated by the activation of CAR receptor.
        Based on these findings, we propose that dieldrin induced liver tumors in
        mice through a nuclear receptor CAR-mediated mode of action. The previously
        observed oxidative stress/damage may be an associated or modifying factor
        in the process of dieldrin-induced liver tumor formation subsequent to the
        CAR activation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Wang</LastName><ForeName>Zemin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory
        of Investigative Toxicology and Pathology, Department of Environmental Health,
        Indiana University School of Public Health, 1025 E 7th St, Bloomington, IN,
        47405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiangen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Laboratory
        of Investigative Toxicology and Pathology, Department of Environmental Health,
        Indiana University School of Public Health, 1025 E 7th St, Bloomington, IN,
        47405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xilin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Laboratory
        of Investigative Toxicology and Pathology, Department of Environmental Health,
        Indiana University School of Public Health, 1025 E 7th St, Bloomington, IN,
        47405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaunig</LastName><ForeName>James
        E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0002-4736-2223</Identifier><AffiliationInfo><Affiliation>Laboratory
        of Investigative Toxicology and Pathology, Department of Environmental Health,
        Indiana University School of Public Health, 1025 E 7th St, Bloomington, IN,
        47405, USA. jklauni@indiana.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000090702">Constitutive Androstane Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007306">Insecticides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C000625853">Nr1i2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C000630914">Ppara protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000077297">Pregnane X Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.-</RegistryNumber><NameOfSubstance UI="D013250">Steroid Hydroxylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D001189">Aryl Hydrocarbon Hydroxylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="C101679">Cyp2b10 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D000072467">Cytochrome P450
        Family 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>I0246D2ZS0</RegistryNumber><NameOfSubstance
        UI="D004026">Dieldrin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001189" MajorTopicYN="N">Aryl Hydrocarbon Hydroxylases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000090702" MajorTopicYN="N">Constitutive Androstane Receptor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000072467" MajorTopicYN="N">Cytochrome P450 Family 2</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004026" MajorTopicYN="N">Dieldrin</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007306" MajorTopicYN="N">Insecticides</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="N">PPAR alpha</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000077297" MajorTopicYN="N">Pregnane X Receptor</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000819" MajorTopicYN="Y">agonists</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013250" MajorTopicYN="N">Steroid Hydroxylases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Constitutive androstane receptor</Keyword><Keyword
        MajorTopicYN="N">Dieldrin</Keyword><Keyword MajorTopicYN="N">Hepatocarcinogeneis</Keyword><Keyword
        MajorTopicYN="N">Mode of action</Keyword><Keyword MajorTopicYN="N">Mouse liver</Keyword><Keyword
        MajorTopicYN="N">Non-genotoxic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2020</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">32435917</ArticleId><ArticleId IdType="doi">10.1007/s00204-020-02781-8</ArticleId><ArticleId
        IdType="pii">10.1007/s00204-020-02781-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10869455</PMID><DateCompleted><Year>2000</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2000</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Effects of Di-2-ethylhexyl phthalate
        (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis,
        and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver.</ArticleTitle><Pagination><StartPage>73</StartPage><EndPage>85</EndPage><MedlinePgn>73-85</MedlinePgn></Pagination><Abstract><AbstractText>The
        present study evaluated the effect of di-2-ethylhexyl phthalate (DEHP) on
        gap-junctional intercellular communication (GJIC), peroxisomal beta-oxidation
        (PBOX) activity, and replicative DNA synthesis in several rodent species with
        differing susceptibilities to peroxisome proliferator-induced hepatic tumorigenesis.
        A low (non-tumorigenic) and high (tumorigenic) dietary concentration of DEHP
        was administered to male F344 rats for 1, 2, 4, and 6 weeks. Additionally,
        a previously non-tumorigenic dose (1000 ppm) and tumorigenic dose of DEHP
        (12,000 ppm), as determined by chronic bioassay data, were examined following
        2 weeks dietary administration. Male B6C3F1 mice were fed the non-tumorigenic
        concentration, 500 ppm, and the tumorigenic concentration, 6000 ppm, of DEHP
        for two and four weeks. The hepatic effects of low and high concentrations
        of DEHP, 1000 and 6000 ppm, were also examined in male Syrian Golden hamsters
        (refractory to peroxisome proliferator-induced tumorigenicity). In rat and
        mouse liver, a concentration-dependent increase in the relative liver weight,
        PBOX activity, and replicative DNA synthesis was observed at the earliest
        time point examined. Concurrent to these observations was an inhibition of
        GJIC. In hamster liver, a slight increase in the relative liver weight, PBOX
        activity, and replicative DNA synthesis was observed. However, these effects
        were not of the same magnitude or consistency as those observed in rats or
        mice. Furthermore, DEHP had no effect on GJIC in hamster liver at any of the
        time points examined (2 and 4 weeks). HPLC analysis of DEHP and its primary
        metabolites, mono-2-ethylhexyl phthalate (MEHP), and phthalate acid (PA),
        indicated a time- and concentration-dependent increase in the hepatic concentration
        of MEHP. At equivalent dietary concentrations and time points, the presence
        of MEHP, the primary metabolite responsible for the hepatic effects of DEHP,
        demonstrated a species-specific response. The largest increase in the hepatic
        concentration of MEHP was observed in mice, which was greater than the concentration
        observed in rats. The hepatic concentration of MEHP was lowest in hamsters.
        Hepatic concentrations of DEHP and phthalic acid were minimal and did not
        correlate with concentration and time. Collectively, these data demonstrate
        the inhibition of hepatic GJIC and increased replicative DNA synthesis correlated
        with the observed dose- and species-specific tumorigenicity of DEHP and may
        be predictive indicators of the nongenotoxic carcinogenic potential of phthalate
        esters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Isenberg</LastName><ForeName>J
        S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division
        of Toxicology, Department of Pharmacology and Toxicology, Indiana University
        School of Medicine, Indianapolis, Indiana, 46202, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kamendulis</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Author><Author
        ValidYN="Y"><LastName>Smith</LastName><ForeName>J H</ForeName><Initials>JH</Initials></Author><Author
        ValidYN="Y"><LastName>Ackley</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Author><Author
        ValidYN="Y"><LastName>Pugh</LastName><ForeName>G</ForeName><Initials>G</Initials><Suffix>Jr</Suffix></Author><Author
        ValidYN="Y"><LastName>Lington</LastName><ForeName>A W</ForeName><Initials>AW</Initials></Author><Author
        ValidYN="Y"><LastName>Klaunig</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>6O7F7IX66E</RegistryNumber><NameOfSubstance
        UI="C032279">phthalic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004261"
        MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017629" MajorTopicYN="N">Gap Junctions</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015430" MajorTopicYN="N">Weight Gain</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>28</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2000</Year><Month>8</Month><Day>12</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>28</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10869455</ArticleId><ArticleId IdType="doi">10.1093/toxsci/56.1.73</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">31152848</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>03</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3185</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>422</Volume><PubDate><Year>2019</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Study
        on the metabolism toxicity, susceptibility and mechanism of di-(2-ethylhexyl)
        phthalate on rat liver BRL cells with insulin resistance in vitro.</ArticleTitle><Pagination><StartPage>102</StartPage><EndPage>120</EndPage><MedlinePgn>102-120</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.tox.2019.05.011</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0300-483X(18)30639-5</ELocationID><Abstract><AbstractText>Di-(2-ethylhexyl)
        phthalate (DEHP) is the most commonly used plasticizer which could be easily
        absorbed by humans and animals through various channels. It has been found
        that exposure to DEHP could increase the incidence of insulin resistance.
        In this study, therefore, the metabolism toxicity, susceptibility and mechanism
        of DEHP (5500 and 50,000&#x202f;nM exposure for 24&#x202f;h) on normal BRL
        cells (Buffalo Rat Liver cells) and BRL cells with insulin resistance induced
        by insulin were investigated. The results showed that DEHP could cause cell
        damage with ALT and AST activities and MDA levels increased, cell apoptosis
        with Caspase-3 levels increased and insulin resistance with IR-&#x3b2; levels
        decreased in BRL cells with resistance and normal BRL cells. Western-blot
        analysis and Q-PCR showed that the levels and gene expressions of insulin
        signaling proteins (IRS-1, GLUT4, GSK-3&#x3b1;, GSK-3&#x3b2;, PI3K, AKT, mTOR),
        cell signaling proteins (RAS, ERK1/2, MEK1/2, BAD, BAX, BCL-2) and immediate
        early genes in insulin resistance cells and normal cells were significantly
        altered by DEHP. DEHP significantly promoted serine phosphorylation of IRS-1.
        The insulin resistance cells in metabolism toxicity were more sensitive to
        DEHP than normal cells. Intervention with insulin could improve the metabolism
        toxicity and insulin resistance. The results indicated that DEHP exerted metabolic
        toxic effects and increased insulin resistance through interfering with glucose
        metabolism and insulin signaling transduction pathway. Moreover, the risks
        of DEHP-induced metabolic toxicity and insulin resistance in BRL cells with
        insulin resistance were higher than that of normal BRL cells.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Yangyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School
        of the Environment and Safety Engineering, Jiangsu University, Zhenjiang,
        Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yongchao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School
        of the Environment and Safety Engineering, Jiangsu University, Zhenjiang,
        Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fei</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School
        of the Environment and Safety Engineering, Jiangsu University, Zhenjiang,
        Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Liuqing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School
        of Chemistry and Chemical Engineering, Jiangsu University, Zhenjiang, Jiangsu,
        China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Guanghua</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School
        of the Environment and Safety Engineering, Jiangsu University, Zhenjiang,
        Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School
        of Chemistry and Chemical Engineering, Jiangsu University, Zhenjiang, Jiangsu,
        China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhehan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School
        of the Environment and Safety Engineering, Jiangsu University, Zhenjiang,
        Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Mengjiao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School
        of the Environment and Safety Engineering, Jiangsu University, Zhenjiang,
        Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School
        of the Environment and Safety Engineering, Jiangsu University, Zhenjiang,
        Jiangsu, China; Institute of Environmental Health and Ecological Security,
        Jiangsu University, Zhenjiang, Jiangsu, China. Electronic address: fwwujs@126.com.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiangyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School
        of the Environment and Safety Engineering, Jiangsu University, Zhenjiang,
        Jiangsu, China; Institute of Environmental Health and Ecological Security,
        Jiangsu University, Zhenjiang, Jiangsu, China. Electronic address: wuxy@ujs.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.10.1</RegistryNumber><NameOfSubstance UI="D011972">Receptor, Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance
        UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007333" MajorTopicYN="Y">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011972" MajorTopicYN="N">Receptor, Insulin</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">DEHP</Keyword><Keyword MajorTopicYN="N">Insulin</Keyword><Keyword
        MajorTopicYN="N">Resistance</Keyword><Keyword MajorTopicYN="N">Susceptibility</Keyword><Keyword
        MajorTopicYN="N">T2DM</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2018</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">31152848</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2019.05.011</ArticleId><ArticleId
        IdType="pii">S0300-483X(18)30639-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">24180432</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2014</Year><Month>01</Month><Day>01</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1547-6898</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>44</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Critical
        reviews in toxicology</Title><ISOAbbreviation>Crit Rev Toxicol</ISOAbbreviation></Journal><ArticleTitle>Mode
        of action framework analysis for receptor-mediated toxicity: The peroxisome
        proliferator-activated receptor alpha (PPAR&#x3b1;) as a case study.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>49</EndPage><MedlinePgn>1-49</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.3109/10408444.2013.835784</ELocationID><Abstract><AbstractText>Several
        therapeutic agents and industrial chemicals induce liver tumors in rodents
        through the activation of the peroxisome proliferator-activated receptor alpha
        (PPAR&#x3b1;). The cellular and molecular events by which PPAR&#x3b1; activators
        induce rodent hepatocarcinogenesis has been extensively studied and elucidated.
        This review summarizes the weight of evidence relevant to the hypothesized
        mode of action (MOA) for PPAR&#x3b1; activator-induced rodent hepatocarcinogenesis
        and identifies gaps in our knowledge of this MOA. Chemical-specific and mechanistic
        data support concordance of temporal and dose-response relationships for the
        key events associated with many PPAR&#x3b1; activators including a phthalate
        ester plasticizer di(2-ethylhexyl) phthalate (DEHP) and the drug gemfibrozil.
        While biologically plausible in humans, the hypothesized key events in the
        rodent MOA, for PPAR&#x3b1; activators, are unlikely to induce liver tumors
        in humans because of toxicodynamic and biological differences in responses.
        This conclusion is based on minimal or no effects observed on growth pathways,
        hepatocellular proliferation and liver tumors in humans and/or species (including
        hamsters, guinea pigs and cynomolgous monkeys) that are more appropriate human
        surrogates than mice and rats at overlapping dose levels. Overall, the panel
        concluded that significant quantitative differences in PPAR&#x3b1; activator-induced
        effects related to liver cancer formation exist between rodents and humans.
        On the basis of these quantitative differences, most of the workgroup felt
        that the rodent MOA is "not relevant to humans" with the remaining members
        concluding that the MOA is "unlikely to be relevant to humans". The two groups
        differed in their level of confidence based on perceived limitations of the
        quantitative and mechanistic knowledge of the species differences, which for
        some panel members strongly supports but cannot preclude the absence of effects
        under unlikely exposure scenarios.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Corton</LastName><ForeName>J Christopher</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>US
        Environmental Protection Agency , Research Triangle Park, NC , USA .</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cunningham</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials></Author><Author
        ValidYN="Y"><LastName>Hummer</LastName><ForeName>B Timothy</ForeName><Initials>BT</Initials></Author><Author
        ValidYN="Y"><LastName>Lau</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Meek</LastName><ForeName>Bette</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>James A</ForeName><Initials>JA</Initials></Author><Author
        ValidYN="Y"><LastName>Rhomberg</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Seed</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Klaunig</LastName><ForeName>James E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2013</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit
        Rev Toxicol</MedlineTA><NlmUniqueID>8914275</NlmUniqueID><ISSNLinking>1040-8444</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q8X02027X3</RegistryNumber><NameOfSubstance
        UI="D015248">Gemfibrozil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015248" MajorTopicYN="N">Gemfibrozil</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="N">PPAR alpha</DescriptorName><QualifierName UI="Q000819"
        MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">24180432</ArticleId><ArticleId IdType="doi">10.3109/10408444.2013.835784</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">16954067</PMID><DateCompleted><Year>2006</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1040-8444</ISSN><JournalIssue
        CitedMedium="Print"><Volume>36</Volume><Issue>5</Issue><PubDate><Year>2006</Year><Month>May</Month></PubDate></JournalIssue><Title>Critical
        reviews in toxicology</Title><ISOAbbreviation>Crit Rev Toxicol</ISOAbbreviation></Journal><ArticleTitle>Modes
        of action and species-specific effects of di-(2-ethylhexyl)phthalate in the
        liver.</ArticleTitle><Pagination><StartPage>459</StartPage><EndPage>479</EndPage><MedlinePgn>459-79</MedlinePgn></Pagination><Abstract><AbstractText>The
        industrial plasticizer di-(2-ethylhexyl)phthalate (DEHP) is used in manufacturing
        of a wide variety of polyvinyl chloride (PVC)-containing medical and consumer
        products. DEHP belongs to a class of chemicals known as peroxisome proliferators
        (PPs). PPs are a structurally diverse group of compounds that share many (but
        perhaps not all) biological effects and are characterized as non-genotoxic
        rodent carcinogens. This review focuses on the effect of DEHP in liver, a
        primary target organ for the pleiotropic effects of DEHP and other PPs. Specifically,
        liver parenchymal cells, identified herein as hepatocytes, are a major cell
        type that are responsive to exposure to PPs, including DEHP; however, other
        cell types in the liver may also play a role. The PP-induced increase in the
        number and size of peroxisomes in hepatocytes, so called ''peroxisome proliferation''
        that results in elevation of fatty acid metabolism, is a hallmark response
        to these compounds in the liver. A link between peroxisome proliferation and
        tumor formation has been a predominant, albeit questioned, theory to explain
        the cause of a hepatocarcinogenic effect of PPs. Other molecular events, such
        as induction of cell proliferation, decreased apoptosis, oxidative DNA damage,
        and selective clonal expansion of the initiated cells have been also been
        proposed to be critically involved in PP-induced carcinogenesis in liver.
        Considerable differences in the metabolism and molecular changes induced by
        DEHP in the liver, most predominantly the activation of the nuclear receptor
        peroxisome proliferator-activated receptor (PPAR)alpha, have been identified
        between species. Both sexes of rats and mice develop adenomas and carcinomas
        after prolonged feeding with DEHP; however, limited DEHP-specific human data
        are available, even though exposure to DEHP and other phthalates is common
        in the general population. This likely constitutes the largest gap in our
        knowledge on the potential for DEHP to cause liver cancer in humans. Overall,
        it is believed that the sequence of key events that are relevant to DEHP-induced
        liver carcinogenesis in rodents involves the following events whereby the
        combination of the molecular signals and multiple pathways, rather than a
        single hallmark event (such as induction of PPARalpha and peroxisomal genes,
        or cell proliferation) contribute to the formation of tumors: (i) rapid metabolism
        of the parental compound to primary and secondary bioactive metabolites that
        are readily absorbed and distributed throughout the body; (ii) receptor-independent
        activation of hepatic macrophages and production of oxidants; (iii) activation
        of PPARalpha in hepatocytes and sustained increase in expression of peroxisomal
        and non-peroxisomal metabolism-related genes; (iv) enlargement of many hepatocellular
        organelles (peroxisomes, mitochondria, etc.); (v) rapid but transient increase
        in cell proliferation, and a decrease in apoptosis; (vi) sustained hepatomegaly;
        (vii) chronic low-level oxidative stress and accumulation of DNA damage; (viii)
        selective clonal expansion of the initiated cells; (ix) appearance of the
        pre-neoplastic nodules; (x) development of adenomas and carcinomas.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Rusyn</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department
        of Environmental Sciences and Engineering, School of Public Health, University
        of North Carolina, Chapel Hill, 27599-7431, USA. iir@unc.edu</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Cunningham</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>Z01 ES021119-19</GrantID><Agency>Intramural
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES11391</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES11660</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES12686</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research
        Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research
        Support, N.I.H., Intramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit
        Rev Toxicol</MedlineTA><NlmUniqueID>8914275</NlmUniqueID><ISSNLinking>1040-8444</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>4VS908W98L</RegistryNumber><NameOfSubstance
        UI="C053316">di-(2-ethylhexyl) terephthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2006</Year><Month>9</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2006</Year><Month>9</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2006</Year><Month>9</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">16954067</ArticleId><ArticleId IdType="mid">NIHMS11721</ArticleId><ArticleId
        IdType="pmc">PMC2614359</ArticleId><ArticleId IdType="doi">10.1080/10408440600779065</ArticleId><ArticleId
        IdType="pii">R537016P12400766</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fay
        M, Donohue JM, De Rosa C. ATSDR evaluation of health effects of chemicals.
        VI. Di(2-ethylhexyl)phthalate. Agency for Toxic Substances and Disease Registry.
        Toxicol. Ind. Health. 1999;15:651&#x2013;746.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10786378</ArticleId></ArticleIdList></Reference><Reference><Citation>National
        Toxicology Program Carcinogenesis Bioassay of Di(2-ethylhexyl)phthalate (CAS
        No. 117-81-7) in F344 Rats and B6C3F1 Mice (Feed Studies) Natl. Toxicol. Program.
        Tech. Rep. Ser. 1982;217:1&#x2013;127.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12778218</ArticleId></ArticleIdList></Reference><Reference><Citation>Albro
        PW. Absorption, metabolism, and excretion of di(2-ethylhexyl) phthalate by
        rats and mice. Environ. Health Perspect. 1986;65:293&#x2013;298.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474712</ArticleId><ArticleId IdType="pubmed">3086077</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid
        P, Schlatter C. Excretion and metabolism of di(2-ethylhexyl)phthalate in man.
        Xenobiotica. 1985;15:251&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">4024660</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes
        C, Orton TC, Pratt IS, Batten PL, Bratt H, Jackson SJ, Elcombe CR. Comparative
        pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP)
        in rats and marmosets: extrapolation of effects in rodents to man. Environ.
        Health Perspect. 1986;65:299&#x2013;307.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474672</ArticleId><ArticleId IdType="pubmed">3086078</ArticleId></ArticleIdList></Reference><Reference><Citation>Astill
        BD. Metabolism of DEHP: effects of prefeeding and dose variation, and comparative
        studies in rodents and the cynomolgus monkey (CMA studies) Drug Metab Rev.
        1989;21:35&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">2696635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito
        Y, Yokota H, Wang R, Yamanoshita O, Ichihara G, Wang H, Kurata Y, Takagi K,
        Nakajima T. Species differences in the metabolism of di(2-ethylhexyl) phthalate
        (DEHP) in several organs of mice, rats, and marmosets. Arch Toxicol. 2005;79:147&#x2013;154.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15798888</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, Deluca JG, Lai DY,
        McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA. PPARalpha agonist-induced
        rodent tumors: modes of action and human relevance. Crit Rev. Toxicol. 2003;33:655&#x2013;780.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14727734</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka
        A, Adachi T, Takahashi T, Yamaha T. Biochemical studies on phthalic esters
        I. Elimination, distribution and metabolism of di-(2-ethylhexyl)phthalate
        in rats. Toxicology. 1975;4:253&#x2013;264.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1154425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda
        GJ, Sapienza PP, Couvillion JL, Farber TM, van Loon EJ. Comparative distribution,
        excretion and metabolism of di-(2-ethylhexyl) phthalate in rats, dogs and
        miniature pigs. Food Cosmet. Toxicol. 1980;18:637&#x2013;642.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7203310</ArticleId></ArticleIdList></Reference><Reference><Citation>Albro
        PW, Corbett JT, Schroeder JL, Jordan S, Matthews HB. Pharmacokinetics, interactions
        with macromolecules and species differences in metabolism of DEHP. Environ.
        Health Perspect. 1982;45:19&#x2013;25.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1569009</ArticleId><ArticleId IdType="pubmed">7140694</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirven
        HA, van den Broek PH, Jongeneelen FJ. Determination of four metabolites of
        the plasticizer di(2-ethylhexyl)phthalate in human urine samples. Int. Arch
        Occup. Environ. Health. 1993;64:555&#x2013;560.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8314613</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirven
        HA, van den Broek PH, Arends AM, Nordkamp HH, de Lepper AJ, Henderson PT,
        Jongeneelen FJ. Metabolites of the plasticizer di(2-ethylhexyl)phthalate in
        urine samples of workers in polyvinylchloride processing industries. Int.
        Arch Occup. Environ. Health. 1993;64:549&#x2013;554.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8314612</ArticleId></ArticleIdList></Reference><Reference><Citation>Blount
        BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, Lucier GW, Jackson
        RJ, Brock JW. Levels of seven urinary phthalate metabolites in a human reference
        population. Environ. Health Perspect. 2000;108:979&#x2013;982.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1240132</ArticleId><ArticleId IdType="pubmed">11049818</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva
        MJ, Barr DB, Reidy JA, Kato K, Malek NA, Hodge CC, Hurtz D, III, Calafat AM,
        Needham LL, Brock JW. Glucuronidation patterns of common urinary and serum
        monoester phthalate metabolites. Arch Toxicol. 2003;77:561&#x2013;567.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14574443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavlock
        R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M, Henderson
        R, Hinberg I, Little R, Seed J, Shea K, Tabacova S, Tyl R, Williams P, Zacharewski
        T. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates
        expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl)
        phthalate. Reprod. Toxicol. 2002;16:529&#x2013;653.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12406494</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch
        HM, Drexler H, Angerer J. An estimation of the daily intake of di(2-ethylhexyl)phthalate
        (DEHP) and other phthalates in the general population. Int. J Hyg. Environ.
        Health. 2003;206:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">12708228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Diwan BA, Ohshima M, Hu H, Schuller HM, Rice JM. Tumor-initiating and
        promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. Environ.
        Health Perspect. 1986;65:279&#x2013;291.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474721</ArticleId><ArticleId IdType="pubmed">3709454</ArticleId></ArticleIdList></Reference><Reference><Citation>Deangelo
        AB, Garrett CT, Manolukas LA, Yario T. Di-n-octyl phthalate (DOP), a relatively
        ineffective peroxisome inducing straight chain isomer of the environmental
        contaminant di(2-ethylhexyl)phthalate (DEHP), enhances the development of
        putative preneoplastic lesions in rat liver. Toxicology. 1986;41:279&#x2013;288.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2877511</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney
        EK, Waxman DJ. Trans-activation of PPARalpha and PPARgamma by structurally
        diverse environmental chemicals , Toxicol. Appl. Pharmacol. 1999;161:209&#x2013;218.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10581215</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst
        CH, Waxman DJ. Activation of PPARalpha and PPARgamma by environmental phthalate
        monoesters , Toxicol. Sci. 2003;74:297&#x2013;308.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12805656</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Gangolli SD, Grasso P, Lloyd AG. Studies on the hepatic effects of orally
        administered di-(2-ethylhexyl) phthalate in the rat. Toxicol. Appl. Pharmacol.
        1975;32:355&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">168667</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Moody DE, Azarnoff DL, Rao MS. Di-(2-ethylhexyl)phthalate: an industrial
        plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine
        acetyltransferase activities in rat and mice. Life Sci. 1976;18:941&#x2013;945.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1271963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell
        FE, Price SC, Hinton RH, Grasso P, Bridges JW. Time and dose-response study
        of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate. Toxicol.
        Appl. Pharmacol. 1985;81:371&#x2013;392.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2867621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Peters JM, Perella CM, Gonzalez FJ. Receptor and nonreceptor-mediated
        organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome
        proliferator-activated receptor alpha-null mice. Toxicol. Pathol. 1998;26:240&#x2013;246.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9547862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair
        N, Kurup CK. Effect of administration of diethylhexyl phthalate on the function
        and turnover of rat hepatic mitochondria. Biochim. Biophys. Acta. 1987;925:332&#x2013;340.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3040113</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Oliver
        T, Butterworth BE. Correlation of the carcinogenic potential of di(2-ethylhexyl)phthalate
        (DEHP) with induced hyperplasia rather than with genotoxic activity. Mutat.
        Res. 1987;188:21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">3574334</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        DS, Cattley RC, Conway JG, Popp JA. Relationship of hepatic peroxisome proliferation
        and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome
        proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic
        acid (Wy-14,643) in rats. Cancer Res. 1988;48:6739&#x2013;6744.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3180084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Hagiwara A, Anderson LM, Lindsey K, Diwan BA. The chronic hepatic or renal
        toxicity of di(2-ethylhexyl) phthalate, acetaminophen, sodium barbital, and
        phenobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical,
        and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis
        or tumor promotion. Toxicol. Appl. Pharmacol. 1988;96:494&#x2013;506.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3206528</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Soames AR, Roberts RA. Suppression of hepatocyte apoptosis and induction
        of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate
        (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB) Arch Toxicol.
        1998;72:784&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">9950075</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, Soames AR, Roberts RA. Species differences in response
        to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis
        and peroxisome proliferator activated receptor alpha-mediated gene expression.
        Arch Toxicol. 2000;74:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">10839475</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, Moore MR, Cifone MA, Finney DC, Guest D. Chronic peroxisome proliferation
        and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate
        and the effects of recovery. Toxicol. Sci. 1999;50:195&#x2013;205.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10478855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Rice JM, Creasia D, Lynch P, Riggs C. Dissimilar patterns of promotion
        by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia
        initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis. 1983;4:1021&#x2013;1029.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6872148</ArticleId></ArticleIdList></Reference><Reference><Citation>Oesterle
        D, Deml E. Promoting activity of di(2-ethylhexyl)phthalate in rat liver foci
        bioassay. J Cancer Res Clin. Oncol. 1988;114:133&#x2013;136.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2895111</ArticleId></ArticleIdList></Reference><Reference><Citation>Short
        RD, Robinson EC, Lington AW, Chin AE. Metabolic and peroxisome proliferation
        studies with di(2-ethylhexyl)phthalate in rats and monkeys. Toxicol. Ind.
        Health. 1987;3:185&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">3617067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurata
        Y, Kidachi F, Yokoyama M, Toyota N, Tsuchitani M, Katoh M. Subchronic toxicity
        of Di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome
        proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia.
        Toxicol. Sci. 1998;42:49&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">9538047</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugh
        G, Jr., Isenberg JS, Kamendulis LM, Ackley DC, Clare LJ, Brown R, Lington
        AW, Smith JH, Klaunig JE. Effects of di-isononyl phthalate, di-2-ethylhexyl
        phthalate, and clofibrate in cynomolgus monkeys. Toxicol. Sci. 2000;56:181&#x2013;188.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10869467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganning
        AE, Brunk U, Edlund C, Elhammer A, Dallner G. Effects of prolonged administration
        of phthalate ester on the liver. Environ. Health Perspect. 1987;73:251&#x2013;258.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474545</ArticleId><ArticleId IdType="pubmed">3665868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganning
        AE, Brunk U, Dallner G. Phthalate esters and their effect on the liver. Hepatology.
        1984;4:541&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">6373551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanefeld
        M, Kemmer C, Kadner E. Relationship between morphological changes and lipid-lowering
        action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and
        peroxisomes in man. Atherosclerosis. 1983;46:239&#x2013;246.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6838704</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Cheung C, Gonzalez FJ. Peroxisome proliferator-activated receptor-alpha
        and liver cancer: where do we stand? J Mol. Med. 2005;83:774&#x2013;785.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15976920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Rusyn I, Bojes HK, Germolec DR, Luster M, Thurman RG. Role of Kupffer
        cells in peroxisome proliferator-induced hepatocyte proliferation. Drug Metab
        Rev. 1999;31:87&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">10065367</ArticleId></ArticleIdList></Reference><Reference><Citation>Goll
        V, Alexandre E, Viollon-Abadie C, Nicod L, Jaeck D, Richert L. Comparison
        of the effects of various peroxisome proliferators on peroxisomal enzyme activities,
        DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxicol.
        Appl. Pharmacol. 1999;160:21&#x2013;32.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10502499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, West D, Chevalier S, Cosulich SC, Roberts RA. Suppression
        of apoptosis and induction of DNA synthesis in vitro by the phthalate plasticizers
        monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP): a comparison
        of rat and human hepatocytes in vitro. Arch Toxicol. 1999;73:451&#x2013;456.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10650916</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirven
        HA, van den Broek PH, Peeters MC, Peters JG, Mennes WC, Blaauboer BJ, Noordhoek
        J, Jongeneelen FJ. Effects of the peroxisome proliferator mono(2-ethylhexyl)phthalate
        in primary hepatocyte cultures derived from rat, guinea pig, rabbit, and monkey.
        Biochem. Pharmacol. 1993;45:2425&#x2013;2434.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8328980</ArticleId></ArticleIdList></Reference><Reference><Citation>Issemann
        I, Green S. Activation of a member of the steroid hormone receptor superfamily
        by peroxisome proliferators. Nature. 1990;347:645&#x2013;650.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2129546</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger
        JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease.
        Trends Pharmacol. Sci. 2005;26:244&#x2013;251.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15860371</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval
        C, Fruchart JC, Staels B. PPAR alpha, fibrates, lipid metabolism and inflammation.
        Arch Mal Coeur Vaiss. 2004;97:665&#x2013;672.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15283041</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton
        JC, Lapinskas PJ, Gonzalez FJ. Central role of PPARalpha in the mechanism
        of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 2000;448:139&#x2013;151.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725468</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipley
        JM, Waxman DJ. Simultaneous, bidirectional inhibitory crosstalk between PPAR
        and STAT5b. Toxicol. Appl. Pharmacol. 2004;199:275&#x2013;284.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15364543</ArticleId></ArticleIdList></Reference><Reference><Citation>Bility
        MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM.
        Activation of mouse and human peroxisome proliferator-activated receptors
        (PPARs) by phthalate monoesters. Toxicol. Sci. 2004;82:170&#x2013;182.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15310864</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu
        S, Cao WQ, Kashireddy P, Meyer K, Jia Y, Hughes DE, Tan Y, Feng J, Yeldandi
        AV, Rao MS, Costa RH, Gonzalez FJ, Reddy JK. Human peroxisome proliferator-activated
        receptor alpha (PPARalpha) supports the induction of peroxisome proliferation
        in PPARalpha-deficient mouse liver. J Biol. Chem. 2001;276:42485&#x2013;42491.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11551940</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapinskas
        PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, Corton JC.
        Role of PPARalpha in mediating the effects of phthalates and metabolites in
        the liver. Toxicology. 2005;207:149&#x2013;163.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15590130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher
        T, Yi HF, McBride OW, Gonzalez FJ. cDNA cloning, chromosomal mapping, and
        functional characterization of the human peroxisome proliferator activated
        receptor. Biochemistry. 1993;32:5598&#x2013;5604.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7684926</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee
        R, Jow L, Noonan D, McDonnell DP. Human and rat peroxisome proliferator activated
        receptors (PPARs) demonstrate similar tissue distribution but different responsiveness
        to PPAR activators. J Steroid Biochem Mol. Biol. 1994;51:157&#x2013;166.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer
        CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF. Peroxisome proliferator activated
        receptor-alpha expression in human liver. Mol. Pharmacol. 1998;53:14&#x2013;22.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9443928</ArticleId></ArticleIdList></Reference><Reference><Citation>Walgren
        JE, Kurtz DT, McMillan JM. Expression of PPAR(alpha) in human hepatocytes
        and activation by trichloroacetate and dichloroacetate. Res Commun. Mol. Pathol.
        Pharmacol. 2000;108:116&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">11758968</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapone
        A, Peters JM, Sakai S, Tomita S, Papiha SS, Dai R, Friedman FK, Gonzalez FJ.
        The human peroxisome proliferator-activated receptor alpha gene: identification
        and functional characterization of two natural allelic variants. Pharmacogenetics.
        2000;10:321&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">10862523</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA, James NH, Hasmall SC, Holden PR, Lambe K, Macdonald N, West D, Woodyatt
        NJ, Whitcome D. Apoptosis and proliferation in nongenotoxic carcinogenesis:
        species differences and role of PPARalpha. Toxicol. Lett. 2000;112:49&#x2013;57.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10720712</ArticleId></ArticleIdList></Reference><Reference><Citation>Flavell
        DM, Pineda T, Jamshidi I,Y, Evans D, Diamond JR, Elkeles RS, Bujac SR, Miller
        G, Talmud PJ, Staels B, Humphries SE. Variation in the PPARalpha gene is associated
        with altered function in vitro and plasma lipid concentrations in Type II
        diabetic subjects. Diabetologia. 2000;43:673&#x2013;680.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10855543</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohl
        MC, Lepage P, Gaudet D, Brewer CG, Betard C, Perron P, Houde G, Cellier C,
        Faith JM, Despres JP, Morgan K, Hudson TJ. Molecular scanning of the human
        PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia.
        J Lipid Res. 2000;41:945&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pubmed">10828087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervois
        P, Torra IP, Chinetti G, Grotzinger T, Dubois G, Fruchart JC, Fruchart-Najib
        J, Leitersdorf E, Staels B. A truncated human peroxisome proliferator-activated
        receptor alpha splice variant with dominant negative activity. Mol. Endocrinol.
        1999;13:1535&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pubmed">10478844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohli
        V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte
        deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver.
        Transplantation. 1999;67:1099&#x2013;1105.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10232558</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung
        C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ. Diminished
        hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome
        proliferator-activated receptor alpha. Cancer Res. 2004;64:3849&#x2013;3854.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15172993</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodyatt
        NJ, Lambe KG, Myers KA, Tugwood JD, Roberts RA. The peroxisome proliferator
        (PP) response element upstream of the human acyl CoA oxidase gene is inactive
        among a sample human population: significance for species differences in response
        to PPs. Carcinogenesis. 1999;20:369&#x2013;372.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10190548</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu-Dac
        N, Gervois P, Jakel H, Nowak M, Bauge E, Dehondt H, Staels B, Pennacchio LA,
        Rubin EM, Fruchart-Najib J, Fruchart JC. Apolipoprotein A5, a crucial determinant
        of plasma triglyceride levels, is highly responsive to peroxisome proliferatoractivated
        receptor alpha activators. J Biol. Chem. 2003;278:17982&#x2013;17985.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12637506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu-Dac
        N, Chopin-Delannoy S, Gervois P, Bonnelye E, Martin G, Fruchart JC, Laudet
        V, Staels B. The nuclear receptors peroxisome proliferator-activated receptor
        alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein
        A-I expression by fibrates. J Biol. Chem. 1998;273:25713&#x2013;25720.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9748239</ArticleId></ArticleIdList></Reference><Reference><Citation>Roglans
        N, Bellido A, Rodriguez C, Cabrero A, Novell F, Ros E, Zambon D, Laguna JC.
        Fibrate treatment does not modify the expression of acyl coenzyme A oxidase
        in human liver. Clin. Pharmacol. Ther. 2002;72:692&#x2013;701.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12496750</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertz
        R, Bar-Tana J. Peroxisome proliferator-activated receptor (PPAR) &#x3b1; activation
        and its consequences in humans. Toxicol. Lett. 1998;102:85&#x2013;90.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10022237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumanasekera
        WK, Tien ES, Turpey R, Vanden Heuvel JP, Perdew GH. Evidence that peroxisome
        proliferator-activated receptor alpha is complexed with the 90-kDa heat shock
        protein and the hepatitis virus B X-associated protein 2. J Biol. Chem. 2003;278:4467&#x2013;4473.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12482853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumanasekera
        WK, Tien ES, Davis JW, Turpey R, Perdew GH, Vanden Heuvel JP. Heat shock protein-90
        (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha
        (PPARalpha) and PPARbeta activity. Biochemistry. 2003;42:10726&#x2013;10735.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12962497</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Cattley RC, Gonzalez FJ. Role of PPAR alpha in the mechanism of action
        of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis.
        1997;18:2029&#x2013;2033.</Citation><ArticleIdList><ArticleId IdType="pubmed">9395198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays
        T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. Role of
        peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced
        hepatocarcinogenesis and cholestasis. Carcinogenesis. 2005;26:219&#x2013;227.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15447978</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimura
        K, Cheung C, Ward JM, Reddy JK, Gonzalez FJ. Differential susceptibility of
        mice humanized for peroxisome proliferator-activated receptor {alpha} to Wy-14,643-induced
        liver tumorigenesis. Carcinogenesis. 2006</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1447533</ArticleId><ArticleId IdType="pubmed">16377806</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrader
        M, Fahimi HD. Mammalian peroxisomes and reactive oxygen species. Histochem.
        Cell Biol. 2004;122:383&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">15241609</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Chu R. Peroxisome proliferator-induced pleiotropic responses: pursuit
        of a phenomenon. Ann. N Y. Acad. Sci. 1996;804:176&#x2013;201.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8993544</ArticleId></ArticleIdList></Reference><Reference><Citation>Desvergne
        B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of
        metabolism. Endocr. Rev. 1999;20:649&#x2013;688.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10529898</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee
        SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM,
        Westphal H, Gonzalez FJ. Targeted disruption of the alpha isoform of the peroxisome
        proliferator-activated receptor gene in mice results in abolishment of the
        pleiotropic effects of peroxisome proliferators. Mol. Cell Biol. 1995;15:3012&#x2013;3022.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC230532</ArticleId><ArticleId IdType="pubmed">7539101</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Azarnoff DL, Hignite CE. Hypolipidaemic hepatic peroxisome proliferators
        form a novel class of chemical carcinogens. Nature. 1980;283:397&#x2013;398.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6766207</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber
        ED, Astill BD, Moran EJ, Schneider BF, Gray TJ, Lake BG, Evans JG. Peroxisome
        induction studies on seven phthalate esters. Toxicol. Ind. Health. 1987;3:7&#x2013;24.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3617071</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoivik
        DJ, Qualls CW, Jr., Mirabile RC, Cariello NF, Kimbrough CL, Colton HM, Anderson
        SP, Santostefano MJ, Morgan RJ, Dahl RR, Brown AR, Zhao Z, Mudd PN, Jr., Oliver
        WB, Jr., Brown HR, Miller RT. Fibrates induce hepatic peroxisome and mitochondrial
        proliferation without overt evidence of cellular proliferation and oxidative
        stress in cynomolgus monkeys. Carcinogenesis. 2004;25:1757&#x2013;1769.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15131011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandard
        S, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha target
        genes. Cell Mol. Life Sci. 2004;61:393&#x2013;416.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14999402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulick
        T, Cresci S, Caira T, Moore DD, Kelly DP. The peroxisome proliferator-activated
        receptor regulates mitochondrial fatty acid oxidative enzyme gene expression.
        Proc. Natl. Acad. Sci. U. S. A. 1994;91:11012&#x2013;11016.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC45156</ArticleId><ArticleId IdType="pubmed">7971999</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge
        TC, Tugwood JD, Green S. Identification and characterization of DNA elements
        implicated in the regulation of CYP4A1 transcription. Biochem J. (Pt 2) 1995.
        pp. 473&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1136542</ArticleId><ArticleId
        IdType="pubmed">7887901</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroetz
        DL, Yook P, Costet P, Bianchi P, Pineau T. Peroxisome proliferator-activated
        receptor alpha controls the hepatic CYP4A induction adaptive response to starvation
        and diabetes. J Biol. Chem. 1998;273:31581&#x2013;31589.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9813074</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirven
        HA, van den Broek PH, Jongeneelen FJ. Effect of di(2-ethylhexyl)phthalate
        on enzyme activity levels in liver and serum of rats. Toxicology. 1990;65:199&#x2013;207.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2274965</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirven
        HA, van den Broek PH, Peters JG, Noordhoek J, Jongeneelen FJ. Microsomal lauric
        acid hydroxylase activities after treatment of rats with three classical cytochrome
        P450 inducers and peroxisome proliferating compounds. Biochem Pharmacol. 1992;43:2621&#x2013;2629.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1632818</ArticleId></ArticleIdList></Reference><Reference><Citation>Currie
        RA, Bombail V, Oliver JD, Moore DJ, Lim FL, Gwilliam V, Kimber I, Chipman
        K, Moggs JG, Orphanides G. Gene ontology mapping as an unbiased method for
        identifying molecular pathways and processes affected by toxicant exposure:
        application to acute effects caused by the rodent non-genotoxic carcinogen
        diethylhexylphthalate. Toxicol. Sci. 2005 In press.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15901911</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama
        T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ.
        Altered constitutive expression of fatty acid-metabolizing enzymes in mice
        lacking the peroxisome proliferator-activated receptor alpha (PPARalpha) J
        Biol. Chem. 1998;273:5678&#x2013;5684.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9488698</ArticleId></ArticleIdList></Reference><Reference><Citation>Badr
        MZ, Handler JA, Whittaker M, Kauffman FC, Thurman RG. Interactions between
        plasticizers and fatty acid metabolism in the perfused rat liver and in vivo.
        Inhibition of ketogenesis by 2-ethylhexanol. Biochem Pharmacol. 1990;39:715&#x2013;721.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2306279</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller
        BJ, Yamanaka H, Thurman RG. Inhibition of mitochondrial respiration and oxygen-dependent
        hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents.
        Toxicology. 1992;71:49&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">1729767</ArticleId></ArticleIdList></Reference><Reference><Citation>Winberg
        LD, Badr MZ. Mechanism of phthalate-induced inhibition of hepatic mitochondrial
        beta-oxidation. Toxicol. Lett. 1995;76:63&#x2013;69.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7701518</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinton
        RH, Mitchell FE, Mann A, Chescoe D, Price SC, Nunn A, Grasso P, Bridges JW.
        Effects of phthalic acid esters on the liver and thyroid. Environ. Health
        Perspect. 1986;70:195&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1474287</ArticleId><ArticleId
        IdType="pubmed">3830106</ArticleId></ArticleIdList></Reference><Reference><Citation>Seree
        E, Villard PH, Pascussi JM, Pineau T, Maurel P, Nguyen QB, Fallone F, Martin
        PM, Champion S, Lacarelle B, Savouret JF, Barra Y. Evidence for a new human
        CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology.
        2004;127:1436&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pubmed">15521013</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskoboinik
        I, Ooi SG, Drew R, Ahokas JT. Peroxisome proliferators increase the formation
        of BPDE-DNA adducts in isolated rat hepatocytes. Toxicology. 1997;122:81&#x2013;91.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9274804</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaban
        Z, El Shazly S, Ishizuka M, Kimura K, Kazusaka A, Fujita S. PPARalpha-dependent
        modulation of hepatic CYP1A by clofibric acid in rats. Arch Toxicol. 2004;78:496&#x2013;507.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15127182</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Rao MS, Azarnoff DL, Sell S. Mitogenic and carcinogenic effects of a hypolipidemic
        peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic
        acid (Wy-14, 643), in rat and mouse liver. Cancer Res. 1979;39:152&#x2013;161.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">83907</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Rao S, Moody DE. Hepatocellular carcinomas in acatalasemic mice treated
        with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res. 1976;36:1211&#x2013;1217.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">177202</ArticleId></ArticleIdList></Reference><Reference><Citation>Gariot
        P, Barrat E, Drouin P, Genton P, Pointel JP, Foliguet B, Kolopp M, Debry G.
        Morphometric study of human hepatic cell modifications induced by fenofibrate.
        Metabolism. 1987;36:203&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">3821501</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA. Peroxisome proliferators: mechanisms of adverse effects in rodents and
        molecular basis for species differences. Arch Toxicol. 1999;73:413&#x2013;418.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10650911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, Gonzalez FJ, Peters JM, Roberts RA. Suppression
        of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha
        and TNFalpha. Mutat. Res. 2000;448:193&#x2013;200.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725472</ArticleId></ArticleIdList></Reference><Reference><Citation>Weglarz
        TC, Sandgren EP. Cell cross-talk mediates PPARalpha null hepatocyte proliferation
        after peroxisome proliferator exposure. Carcinogenesis. 2004;25:107&#x2013;112.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14514660</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA, James NH, Cosulich S, Hasmall SC, Orphanides G. Role of cytokines in non-genotoxic
        hepatocarcinogenesis: cause or effect? Toxicol. Lett. 2001;120:301&#x2013;306.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11323188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler
        MD, Smutney OM, Check JF, Rusyn I, Schulte-Hermann R, Thurman RG. Impaired
        Ras membrane association and activation in PPARalpha knockout mice after partial
        hepatectomy. Am. J. Physiol Gastrointest. Liver Physiol. 2003;284:G302&#x2013;G312.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12388208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursch
        W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schulte-Hermann
        R. Controlled death (apoptosis) of normal and putative preneoplastic cells
        in rat liver following withdrawal of tumor promoters. Carcinogenesis. 1984;5:453&#x2013;458.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6231134</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbracht
        U, Bursch W, Kraus P, Putz B, Reinacher M, Timmermann-Trosiener I, Schulte-Hermann
        R. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression
        and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis. 1990;11:617&#x2013;624.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1691053</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef
        JA, Bouziane M, Badr MZ. Age-dependent effects of nongenotoxic hepatocarcinogens
        on liver apoptosis in vivo. Mech. Ageing Dev. 2003;124:333&#x2013;340.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12663131</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill
        JH, James NH, Roberts RA, Dive C. The non-genotoxic hepatocarcinogen nafenopin
        suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and
        Fas. Carcinogenesis. 1998;19:299&#x2013;304.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9498280</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA, Soames AR, Gill JH, James NH, Wheeldon EB. Non-genotoxic hepatocarcinogens
        stimulate DNA synthesis and their withdrawal induces apoptosis, but in different
        hepatocyte populations. Carcinogenesis. 1995;16:1693&#x2013;1698.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7634391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        S, James N, Hedley K, Olsen K, Roberts R. Mouse hepatocyte response to peroxisome
        proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator
        activated receptor alpha (PPARalpha) Arch Toxicol. 2001;75:357&#x2013;361.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11570693</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA, James NH, Woodyatt NJ, Macdonald N, Tugwood JD. Evidence for the suppression
        of apoptosis by the peroxisome proliferator activated receptor alpha. Carcinogenesis.
        1998;19:43&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">9472691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, West DA, Olsen K, Roberts RA. Role of hepatic non-parenchymal cells in
        the response of rat hepatocytes to the peroxisome proliferator nafenopin in
        vitro. Carcinogenesis. 2000;21:2159&#x2013;2165.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11133804</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM, Rusyn I, Rose ML, Gonzalez FJ, Thurman RG. Peroxisome proliferator-activated
        receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells:
        implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.
        Carcinogenesis. 2000;21:823&#x2013;826.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10753222</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Rao MS. Oxidative DNA damage caused by persistent peroxisome proliferation:
        its role in hepatocarcinogenesis. Mutat. Res. 1989;214:63&#x2013;68.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2671702</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeldandi
        AV, Rao MS, Reddy JK. Hydrogen peroxide generation in peroxisome proliferator-induced
        oncogenesis. Mutat. Res. 2000;448:159&#x2013;177.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725470</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Rose ML, Bojes HK, Thurman RG. Novel role of oxidants in the molecular
        mechanism of action of peroxisome proliferators. Antiox Redox Signal. 2000;2:607&#x2013;621.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11229371</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemali
        MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK. Comparison
        of constitutive and inducible levels of expression of peroxisomal beta-oxidation
        and catalase genes in liver and extrahepatic tissues of rat. Cancer Res. 1988;48:5316&#x2013;5324.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2900680</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, Sperbeck SJ, Osumi
        T, Hashimoto T, Lalwani ND. Transcription regulation of peroxisomal fatty
        acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in
        rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. U. S. A. 1986;83:1747&#x2013;1751.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC323161</ArticleId><ArticleId IdType="pubmed">3456610</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan
        CY, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK. Steatohepatitis, spontaneous
        peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty
        acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor
        alpha natural ligand metabolism. J. Biol. Chem. 1998;273:15639&#x2013;15645.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9624157</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway
        JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, Popp JA. Relationship
        of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators
        di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis. 1989;10:513&#x2013;519.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2924396</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Kozlen SL, Evans JG, Gray TJ, Young PJ, Gangolli SD. Effect of prolonged
        administration of clofibric acid and di-(2-ethylhexyl)phthalate on hepatic
        enzyme activities and lipid peroxidation in the rat. Toxicology. 1987;44:213&#x2013;228.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3564055</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi
        A, Sai K, Umemura T, Hasegawa R, Kurokawa Y. Significant increase of 8-hydroxydeoxyguanosine
        in liver DNA of rats following short-term exposure to the peroxisome proliferators
        di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn. J. Cancer Res.
        1990;81:213&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5918022</ArticleId><ArticleId
        IdType="pubmed">2112523</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott
        BM, Dodd NJ, Elcombe CR. Increased hydroxyl radical production in liver peroxisomal
        fractions from rats treated with peroxisome proliferators. Carcinogenesis.
        1986;7:795&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pubmed">3009047</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaszewski
        KE, Agarwal DK, Melnick RL. In vitro steady-state levels of hydrogen peroxide
        after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome
        proliferators. Carcinogenesis. 1986;7:1871&#x2013;1876.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3769136</ArticleId></ArticleIdList></Reference><Reference><Citation>Eagon
        PK, Teepe AG, Elm MS, Tadic SD, Epley MJ, Beiler BE, Shinozuka H, Rao KN.
        Hepatic hyperplasia and cancer in rats: alterations in copper metabolism.
        Carcinogenesis. 1999;20:1091&#x2013;1096.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10357793</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, Glover SE. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following
        exposure to peroxisome proliferators: Relationship to carcinogenesis and nuclear
        localization. Carcinogenesis. 1993;14:2495&#x2013;2499.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8269617</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman
        MS, Cunningham ML, Morrow JD, Roberts LJ, Badr MZ. Evidence against peroxisome
        proliferation-induced hepatic oxidative damage. Biochem. Pharmacol. 1997;53:1369&#x2013;1374.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9214698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegi
        ME, Ulrich D, Sagelsdorff P, Richter C, Lutz WK. No measurable increase in
        thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with
        nafenopin or choline-devoid low-methionine diet. Mutat. Res. 1990;238:325&#x2013;329.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2342515</ArticleId></ArticleIdList></Reference><Reference><Citation>Sausen
        PJ, Lee DC, Rose ML, Cattley RC. Elevated 8-hydroxydeoxyguanosine in hepatic
        DNA of rats following exposure to peroxisome proliferators: relationship to
        mitochondrial alterations. Carcinogenesis. 1995;16:1795&#x2013;1801.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7634406</ArticleId></ArticleIdList></Reference><Reference><Citation>Handler
        JA, Seed CB, Bradford BU, Thurman RG. Induction of peroxisomes by treatment
        with perfluorooctanoate does not increase rates of H2O2 production in intact
        liver. Toxicol. Lett. 1992;60:61&#x2013;68.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1539182</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Asakura S, Pachkowski B, Bradford BU, Denissenko MF, Peters JM, Holland
        SM, Reddy JK, Cunningham ML, Swenberg JA. Expression of base excision DNA
        repair genes is a sensitive biomarker for in vivo detection of chemical-induced
        chronic oxidative stress: Identification of the molecular source of radicals
        responsible for DNA damage by peroxisome proliferators. Cancer Res. 2004;64:1050&#x2013;1057.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14871837</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Kadiiska MB, Dikalova A, Kono H, Yin M, Tsuchiya K, Mason RP, Peters JM,
        Gonzalez FJ, Segal BH, Holland SM, Thurman RG. Phthalates rapidly increase
        production of reactive oxygen species in vivo: role of Kupffer cells. Mol.
        Pharmacol. 2001;59:744&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pubmed">11259618</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Rusyn I, Bojes HK, Belyea J, Cattley RC, Thurman RG. Role of Kupffer cells
        and oxidants in signaling peroxisome proliferatorinduced hepatocyte proliferation.
        Mutat. Res. 2000;448:179&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725471</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, Walborg
        EF., Jr. The role of oxidative stress in chemical carcinogenesis. Environ.
        Health Perspect. 1998;106(Suppl 1):289&#x2013;295.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1533298</ArticleId><ArticleId IdType="pubmed">9539021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai
        H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2''-deoxyguanosine,
        as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res.
        1997;387:147&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">9439711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai
        H, Okada Y, Nishimura S, Rao MS, Reddy JK. Formation of 8-hydroxydeoxyguanosine
        in liver DNA of rats following long-term exposure to a peroxisome proliferator.
        Cancer Res. 1989;49:2603&#x2013;2605.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2713844</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu
        B, Li Q, Wong KP, Tan TM, Halliwell B. Mechanism of clofibrate hepatotoxicity:
        mitochondrial damage and oxidative stress in hepatocytes. Free Radic. Biol.
        Med. 2001;31:659&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">11522451</ArticleId></ArticleIdList></Reference><Reference><Citation>Randerath
        E, Randerath K, Reddy R, Danna TF, Rao MS, Reddy JK. Induction of rat liver
        DNA alterations by chronic administration of peroxisome proliferators as detected
        by 32P-postlabeling. Mutat. Res. 1991;247:65&#x2013;76.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2002806</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott
        BM, Elcombe CR. Lack of DNA damage or lipid peroxidation measured in vivo
        in the rat liver following treatment with peroxisomal proliferators. Carcinogenesis.
        1987;8:1213&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pubmed">3621460</ArticleId></ArticleIdList></Reference><Reference><Citation>(ESCODD)
        European Standards Committee on Oxidative DNA Damage, Comparative analysis
        of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods
        in different laboratories: an approach to consensus. Carcinogenesis. 2002;23:2129&#x2013;2133.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12507938</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Denissenko MF, Wong VA, Butterworth BE, Cunningham ML, Upton PB, Thurman
        RG, Swenberg JA. Expression of base excision repair enzymes in rat and mouse
        liver is induced by peroxisome proliferators and is dependent upon carcinogenic
        potency. Carcinogenesis. 2000;21:2141&#x2013;2145.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11133801</ArticleId></ArticleIdList></Reference><Reference><Citation>Posnick
        LM, Samson LD. Imbalanced base excision repair increases spontaneous mutation
        and alkylation sensitivity in Escherichia coli. J. Bacteriol. 1999;181:6763&#x2013;6771.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC94142</ArticleId><ArticleId IdType="pubmed">10542179</ArticleId></ArticleIdList></Reference><Reference><Citation>Canitrot
        Y, Cazaux C, Frechet M, Bouayadi K, Lesca C, Salles B, Hoffmann JS. Overexpression
        of DNA polymerase beta in cell results in a mutator phenotype and a decreased
        sensitivity to anticancer drugs. Proc. Natl. Acad. Sci. U. S. A. 1998;95:12586&#x2013;12590.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC22874</ArticleId><ArticleId IdType="pubmed">9770529</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu. Rev.
        Pharmacol. Toxicol. 2004;44:239&#x2013;267.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14744246</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Ruch RJ. Role of inhibition of intercellular communication in carcinogenesis.
        Lab Invest. 1990;62:135&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">2406502</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith
        JH, Isenberg JS, Pugh G, Jr., Kamendulis LM, Ackley D, Lington AW, Klaunig
        JE. Comparative in vivo hepatic effects of Di-isononyl phthalate (DINP) and
        related C7-C11 dialkyl phthalates on gap junctional intercellular communication
        (GJIC), peroxisomal beta-oxidation (PBOX), and DNA synthesis in rat and mouse
        liver. Toxicol. Sci. 2000;54:312&#x2013;321.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10774813</ArticleId></ArticleIdList></Reference><Reference><Citation>Isenberg
        JS, Kamendulis LM, Ackley DC, Smith JH, Pugh G, Jr., Lington AW, McKee RH,
        Klaunig JE. Reversibility and persistence of di-2-ethylhexyl phthalate (DEHP)-
        and phenobarbital-induced hepatocellular changes in rodents. Toxicol. Sci.
        2001;64:192&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">11719701</ArticleId></ArticleIdList></Reference><Reference><Citation>Isenberg
        JS, Kamendulis LM, Smith JH, Ackley DC, Pugh G, Jr., Lington AW, Klaunig JE.
        Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular
        communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX)
        in rat, mouse, and hamster liver. Toxicol. Sci. 2000;56:73&#x2013;85.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10869455</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Ruch RJ, Deangelo AB, Kaylor WH. Inhibition of mouse hepatocyte intercellular
        communication by phthalate monoesters. Cancer Lett. 1988;43:65&#x2013;71.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3203332</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamendulis
        LM, Isenberg JS, Smith JH, Pugh G, Jr., Lington AW, Klaunig JE. Comparative
        effects of phthalate monoesters on gap junctional intercellular communication
        and peroxisome proliferation in rodent and primate hepatocytes. J Toxicol.
        Environ. Health A. 2002;65:569&#x2013;588.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11995694</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasl-Kraupp
        B, Huber W, Just W, Gibson G, Schulte-Hermann R. Enhancement of peroxisomal
        enzymes, cytochrome P-450 and DNA synthesis in putative preneoplastic foci
        of rat liver treated with the peroxisome proliferator nafenopin. Carcinogenesis.
        1993;14:1007&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pubmed">8099311</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, Popp JA. Differences between the promoting activities of the peroxisome
        proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res. 1989;49:3246&#x2013;3251.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2566380</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasl-Kraupp
        B, Ruttkay-Nedecky B, Mullauer L, Taper H, Huber W, Bursch W, Schulte-Hermann
        R. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis
        and tumor regression. Hepatology. 1997;25:906&#x2013;912.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9096596</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, Marsman DS, Popp JA. Age-related susceptibility to the carcinogenic effect
        of the peroxisome proliferator WY-14,643 in rat liver. Carcinogenesis. 1991;12:469&#x2013;473.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1849052</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Roberts RA. Species differences in the clonal expansion of hepatocytes
        in response to the coaction of epidermal growth factor and nafenopin, a rodent
        hepatocarcinogenic peroxisome proliferator. Fundam. Appl. Toxicol. 1995;26:143&#x2013;149.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7657058</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Roberts RA. The peroxisome proliferator class of non-genotoxic hepatocarcinogens
        synergize with epidermal growth factor to promote clonal expansion of initiated
        rat hepatocytes. Carcinogenesis. 1994;15:2687&#x2013;2694.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8001222</ArticleId></ArticleIdList></Reference><Reference><Citation>Parzefall
        W, Berger W, Kainzbauer E, Teufelhofer O, Schulte-Hermann R, Thurman RG. Peroxisome
        proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis.
        2001;22:519&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">11238195</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Rivera CA, Bradford BU, Graves LM, Cattley RC, Schoonhoven R, Swenberg
        JA, Thurman RG. Kupffer cell oxidant production is central to the mechanism
        of peroxisome proliferators. Carcinogenesis. 1999;20:27&#x2013;33.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9934846</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl
        AM. Cytokine regulation of liver injury and repair. Immunol. Rev. 2000;174:160&#x2013;171.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10807515</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojes
        HK, Thurman RG. Peroxisome proliferators activate Kupffer cells in vivo. Cancer
        Res. 1996;56:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">8548746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojes
        HK, Germolec DR, Simeonova P, Bruccoleri A, Schoonhoven R, Luster MI, Thurman
        RG. Antibodies to tumor necrosis factor alpha prevent increases in cell replication
        in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis.
        1997;18:669&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">9111198</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfe
        M, James NH, Roberts RA. Tumour necrosis factor alpha (TNF alpha) suppresses
        apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the
        hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis. 1997;18:2277&#x2013;2280.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9395232</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Germolec DR, Schoonhoven R, Thurman RG. Kupffer cells are causally responsible
        for the mitogenic effect of peroxisome proliferators. Carcinogenesis. 1997;18:1453&#x2013;1456.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9276615</ArticleId></ArticleIdList></Reference><Reference><Citation>Adinehzadeh
        M, Reo NV. Effects of peroxisome proliferators on rat liver phospholipids:
        sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic
        acid. Chem. Res Toxicol. 1998;11:428&#x2013;440.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9585473</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson
        SP, Dunn CS, Cattley RC, Corton JC. Hepatocellular proliferation in response
        to a peroxisome proliferator does not require TNFalpha signaling. Carcinogenesis.
        2001;22:1843&#x2013;1851.</Citation><ArticleIdList><ArticleId IdType="pubmed">11698348</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Germolec D, Arteel GE, Schoonhoven R, Thurman RG. Dietary glycine prevents
        increases in hepatocyte proliferation caused by the peroxisome proliferator
        WY-14,643. Chem. Res. Toxicol. 1997;10:1198&#x2013;1204.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9348444</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Tsukamoto H, Thurman RG. WY-14,643 rapidly activates nuclear factor kappaB
        in Kupffer cells before hepatocytes. Carcinogenesis. 1998;19:1217&#x2013;1222.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9683180</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker
        K. Biologically active products of stimulated liver macrophages (Kupffer cells)
        Eur. J. Biochem. 1990;192:245&#x2013;261.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2170121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Yamashina S, Segal BH, Schoonhoven R, Holland SM, Cattley RC, Swenberg
        JA, Thurman RG. Oxidants from nicotinamide adenine dinucleotide phosphate
        oxidase are involved in triggering cell proliferation in the liver due to
        peroxisome proliferators. Cancer Res. 2000;60:4798&#x2013;4803.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10987289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence
        JW, Wollenberg GK, Deluca JG. Tumor necrosis factor alpha is not required
        for WY14,643-induced cell proliferation. Carcinogenesis. 2001;22:381&#x2013;386.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11238176</ArticleId></ArticleIdList></Reference><Reference><Citation>Peraza
        MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM. The Toxicology of Ligands
        for Peroxisome Proliferator-Activated Receptors (PPAR) Toxicol. Sci. 2005</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16322072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou
        S, Wallace KB. The effect of peroxisome proliferators on mitochondrial bioenergetics.
        Toxicol. Sci. 1999;48:82&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">10330687</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">26585812</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2015</Year><Month>12</Month><Day>09</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5118</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>63</Volume><Issue>48</Issue><PubDate><Year>2015</Year><Month>Dec</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal
        of agricultural and food chemistry</Title><ISOAbbreviation>J Agric Food Chem</ISOAbbreviation></Journal><ArticleTitle>Curcumin
        Suppresses Phthalate-Induced Metastasis and the Proportion of Cancer Stem
        Cell (CSC)-like Cells via the Inhibition of AhR/ERK/SK1 Signaling in Hepatocellular
        Carcinoma.</ArticleTitle><Pagination><StartPage>10388</StartPage><EndPage>10398</EndPage><MedlinePgn>10388-98</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1021/acs.jafc.5b04415</ELocationID><Abstract><AbstractText>Recent
        evidence indicating that phthalates promote cancer development, including
        cell proliferation, migration, and invasion, has raised public health concerns.
        Here, we show that bis(2-ethylhexyl) phthalate promotes the migration, invasion,
        and epithelial-mesenchymal transition of hepatocellular carcinoma cells. In
        addition, bis(2-ethylhexyl) phthalate increased the proportion of cancer stem
        cell (CSC)-like cells and stemness maintenance in vitro as well as tumor growth
        and metastasis in vivo. The various activities of curcumin, including anticancer,
        anti-inflammation, antioxidation, and immunomodulation, have been investigated
        extensively. Curcumin suppressed phthalate-induced cell migration, invasion,
        and epithelial-mesenchymal transition, decreased the proportion of CSC-like
        cells in hepatocellular carcinoma cell lines in vitro, and inhibited tumor
        growth and metastasis in vivo. We also reveal that curcumin suppressed phthalate-induced
        migration, invasion, and CSC-like cell maintenance through inhibition of the
        aryl hydrocarbon receptor/ERK/SK1/S1P3 signaling pathway. Our results suggest
        that curcumin may be a potential antidote for phthalate-induced cancer progression.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Cheng-Fang</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Graduate
        Institute of Medicine, College of Medicine, Kaohsiung Medical University ,
        Kaohsiung City 807, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Tsung-Hua</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Graduate
        Institute of Medicine, College of Medicine, Kaohsiung Medical University ,
        Kaohsiung City 807, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lee</LastName><ForeName>Jau-Nan</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, Kaohsiung Medical University Hospital , Kaohsiung
        City 807, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Chia-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Graduate
        Institute of Medicine, College of Medicine, Kaohsiung Medical University ,
        Kaohsiung City 807, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wang</LastName><ForeName>Yu-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, Kaohsiung Medical University Hospital , Kaohsiung
        City 807, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Kung-Kai</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Division
        of Hepatobiliary Pancreatic Surgery, Department of Surgery, Kaohsiung Medical
        University Hospital , Kaohsiung 807, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wu</LastName><ForeName>Hua-Lin</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry and Molecular Biology, National Cheng Kung University , Tainan
        701, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Chien-Chih</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department
        of Biotechnology, Kaohsiung Medical University , Kaohsiung 807, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tsai</LastName><ForeName>Eing-Mei</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Graduate
        Institute of Medicine, College of Medicine, Kaohsiung Medical University ,
        Kaohsiung City 807, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, Kaohsiung Medical University Hospital , Kaohsiung
        City 807, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Po-Lin</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Institute
        of Clinical Medicine, College of Medicine, Kaohsiung Medical University ,
        Kaohsiung 807, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Agric Food Chem</MedlineTA><NlmUniqueID>0374755</NlmUniqueID><ISSNLinking>0021-8561</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018336">Receptors, Aryl Hydrocarbon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D051640">Small-Conductance Calcium-Activated Potassium Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>6O7F7IX66E</RegistryNumber><NameOfSubstance
        UI="C032279">phthalic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.24</RegistryNumber><NameOfSubstance UI="D048049">Extracellular Signal-Regulated
        MAP Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>IT942ZTH98</RegistryNumber><NameOfSubstance
        UI="D003474">Curcumin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003474" MajorTopicYN="N">Curcumin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D048049" MajorTopicYN="N">Extracellular Signal-Regulated MAP Kinases</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName><QualifierName
        UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014411" MajorTopicYN="N">Neoplastic Stem Cells</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018336" MajorTopicYN="N">Receptors, Aryl Hydrocarbon</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051640" MajorTopicYN="N">Small-Conductance Calcium-Activated Potassium
        Channels</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer stem cells</Keyword><Keyword
        MajorTopicYN="N">curcumin</Keyword><Keyword MajorTopicYN="N">hepatocellular
        carcinoma</Keyword><Keyword MajorTopicYN="N">metastasis</Keyword><Keyword
        MajorTopicYN="N">phthalate</Keyword><Keyword MajorTopicYN="N">side population</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">26585812</ArticleId><ArticleId IdType="doi">10.1021/acs.jafc.5b04415</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2210515</PMID><DateCompleted><Year>1990</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>28</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0278-6915</ISSN><JournalIssue
        CitedMedium="Print"><Volume>28</Volume><Issue>6</Issue><PubDate><Year>1990</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Hepatic nuclear and cytoplasmic
        effects following intermittent feeding of rats with di(2-ethylhexyl) phthalate.</ArticleTitle><Pagination><StartPage>427</StartPage><EndPage>434</EndPage><MedlinePgn>427-34</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects on rats of intermittent feeding with the peroxisome proliferator and
        hepatocarcinogen di(2-ethylhexyl) phthalate (DEHP) have been examined. Male
        Wistar rats were fed for alternate 7-day periods diets containing 20,000 ppm
        DEHP or the control diet. The rats were examined 3 days after the start or
        recommencement of administration of the DEHP-containing diet or after 7 days
        on the control diet. After the commencement or recommencement of feeding with
        DEHP the expected increases in liver weight and in the number of peroxisomes
        were found. The increase in liver: body-weight ratio in response to administration
        of DEHP-containing diets was greater in rats that had been previously exposed
        to the compound, but re-administration of DEHP had a less marked effect on
        the increase in peroxisome number. Morphometric analysis showed that administration
        of DEHP-containing diets resulted in an increase in cell number in the liver
        and that a fall in the cell number occurred after the rats had been returned
        to the control diet for 7 days. Analysis of nuclear size gave results consistent
        with an increase in tetraploid hepatocytes after treatment with DEHP which
        was reversed when the rats were returned to control diet.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>R S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Robens
        Institute of Health and Safety, University of Surrey, Guildford, UK.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Price</LastName><ForeName>S C</ForeName><Initials>SC</Initials></Author><Author
        ValidYN="Y"><LastName>Grasso</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Hinton</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002452" MajorTopicYN="N">Cell Count</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648"
        MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008938" MajorTopicYN="N">Mitosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2210515</ArticleId><ArticleId IdType="doi">10.1016/0278-6915(90)90089-6</ArticleId><ArticleId
        IdType="pii">0278-6915(90)90089-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10869467</PMID><DateCompleted><Year>2000</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2000</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Effects of di-isononyl phthalate,
        di-2-ethylhexyl phthalate, and clofibrate in cynomolgus monkeys.</ArticleTitle><Pagination><StartPage>181</StartPage><EndPage>188</EndPage><MedlinePgn>181-8</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of the peroxisome proliferators di-isononyl phthalate (DINP) and di-2-ethylhexyl
        phthalate (DEHP) were evaluated in young adult male cynomolgus monkeys after
        14 days of treatment, with emphasis on detecting hepatic and other effects
        seen in rats and mice after treatment with high doses of phthalates. Groups
        of 4 monkeys received DINP (500 mg/kg/day), DEHP (500 mg/kg/day), or vehicle
        (0.5% methyl cellulose, 10 ml/kg) by intragastric intubation for 14 consecutive
        days. Clofibrate (250 mg/kg/day), a hypolipidemic drug used for cholesterol
        reduction in human patients was used as a reference substance. None of the
        test substances had any effect on body weight or liver weights. Histopathological
        examination of tissues from these animals revealed no distinctive treatment-related
        effects in the liver, kidney, or testes. There were also no changes in any
        of the hepatic markers for peroxisomal proliferation, including peroxisomal
        beta-oxidation (PBOX) or replicative DNA synthesis. Additionally, in situ
        dye transfer studies using fresh liver slices revealed that DINP, DEHP, and
        clofibrate had no effect on gap junctional intercellular communication (GJIC).
        None of the test substances produced any toxicologically important changes
        in urinalysis, hematology, or clinical chemistry; however, clofibrate produced
        some emesis, small increases in serum triglyceride, decreased calcium, and
        decreased weights of testes/epididymides and thyroid/parathyroid. The toxicological
        significance of these small changes is questionable. The absence of observable
        hepatic effects in monkeys at doses that produce hepatic effects in rodents
        suggests that DINP, DEHP, and clofibrate would also not elicit in primates
        other effects such as liver cancer. These data, along with results from in
        vitro hepatocyte studies, indicate that rodents are not good animal models
        for predicting the hepatic effects of phthalates in primates, including humans.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Pugh</LastName><ForeName>G</ForeName><Initials>G</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Exxon
        Biomedical Sciences, Inc., East Millstone, New Jersey 08875, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Isenberg</LastName><ForeName>J S</ForeName><Initials>JS</Initials></Author><Author
        ValidYN="Y"><LastName>Kamendulis</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Author><Author
        ValidYN="Y"><LastName>Ackley</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Author><Author
        ValidYN="Y"><LastName>Clare</LastName><ForeName>L J</ForeName><Initials>LJ</Initials></Author><Author
        ValidYN="Y"><LastName>Brown</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Lington</LastName><ForeName>A W</ForeName><Initials>AW</Initials></Author><Author
        ValidYN="Y"><LastName>Smith</LastName><ForeName>J H</ForeName><Initials>JH</Initials></Author><Author
        ValidYN="Y"><LastName>Klaunig</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000924">Anticholesteremic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>4010KIX4CK</RegistryNumber><NameOfSubstance
        UI="C012125">diisononyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000924" MajorTopicYN="N">Anticholesteremic Agents</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017629" MajorTopicYN="N">Gap Junctions</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008252" MajorTopicYN="Y">Macaca fascicularis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>28</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2000</Year><Month>8</Month><Day>12</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>28</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10869467</ArticleId><ArticleId IdType="doi">10.1093/toxsci/56.1.181</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34588381</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>19</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1880-8026</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>59</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>29</Day></PubDate></JournalIssue><Title>Industrial
        health</Title><ISOAbbreviation>Ind Health</ISOAbbreviation></Journal><ArticleTitle>Inhalation
        exposure to 2-ethyl-1-hexanol causes hepatomegaly and transient lipid accumulation
        without induction of peroxisome proliferator-activated receptor alpha in mice.</ArticleTitle><Pagination><StartPage>383</StartPage><EndPage>392</EndPage><MedlinePgn>383-392</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.2486/indhealth.2020-0252</ELocationID><Abstract><AbstractText>2-Ethyl-1-hexanol
        (2EH) is a volatile organic compound known to cause sick building syndrome.
        However, 2EH-induced hepatotoxicity has been mainly evaluated in experiments
        orally administering 2EH as a metabolite of di(2-ethylhexyl) phthalate. To
        evaluate the hepatotoxicity risk of 2EH as an indoor air pollutant, we exposed
        10-wk-old male ICR mice to 2EH by inhalation for 8 h/d, 5 d/wk for 3 months
        (0, 20, 60, or 150 ppm) or 6 months (0, 0.5, 10, or 100 ppm). In both experiments,
        relative liver weights significantly increased in the highest exposure groups.
        The 3-month exposure increased histopathological lipid droplets in the liver
        in a dose-dependent manner, hepatic triglyceride at all exposure levels, hepatic
        phospholipid at 150 ppm, and microsomal triglyceride transfer protein at 60
        and 150 ppm; however, these changes were not observed following the 6-month
        of exposure. Following the 3-month exposure, alanine transaminase and peroxisomal
        bifunctional proteins, known markers of liver injury and peroxisome proliferation,
        respectively, remained unaltered. Therefore, in the present study, the inhalation
        concentration range of 2EH induced a toxic hypertrophic change, revealing
        a limited role of peroxisome proliferator-activated receptor alpha (PPAR&#x3b1;).
        The liver weights may have presumably increased via a mechanism independent
        of PPAR&#x3b1; activation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Wakayama</LastName><ForeName>Takanari</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, Nagoya City University Graduate
        School of Medical Sciences, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Environmental Health, Nagoya City Public Health Research Institute, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ito</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, Nagoya City University Graduate
        School of Medical Sciences, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Miyake</LastName><ForeName>Mio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, Nagoya City University Graduate
        School of Medical Sciences, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nomasa</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, Nagoya City University Graduate
        School of Medical Sciences, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sakai</LastName><ForeName>Kiyoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, Nagoya City University Graduate
        School of Medical Sciences, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Environmental Health, Nagoya City Public Health Research Institute, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Oya</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, Nagoya City University Graduate
        School of Medical Sciences, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research
        Fellow of Japan Society for the Promotion of Science, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sato</LastName><ForeName>Hirotaka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, Nagoya City University Graduate
        School of Medical Sciences, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ohno</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Environmental Health, Nagoya City Public Health Research Institute, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kamijima</LastName><ForeName>Michihiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Occupational and Environmental Health, Nagoya City University Graduate
        School of Medical Sciences, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Ind
        Health</MedlineTA><NlmUniqueID>2985065R</NlmUniqueID><ISSNLinking>0019-8366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006529" MajorTopicYN="Y">Hepatomegaly</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="Y">Hexanols</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019570" MajorTopicYN="N">Inhalation Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="Y">PPAR alpha</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">2-Ethyl-1-hexanol</Keyword><Keyword
        MajorTopicYN="N">Hepatic enlargement</Keyword><Keyword MajorTopicYN="N">Inhalation
        exposure</Keyword><Keyword MajorTopicYN="N">Lipid droplet</Keyword><Keyword
        MajorTopicYN="N">Peroxisome proliferator-activated receptor alpha (PPAR&#x3b1;)</Keyword><Keyword
        MajorTopicYN="N">Volatile organic compound (VOC)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">34588381</ArticleId><ArticleId IdType="pmc">PMC8655744</ArticleId><ArticleId
        IdType="doi">10.2486/indhealth.2020-0252</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kamijima
        M, Sakai K, Shibata E, Yamada T, Itohara S, Ohno H, Hayakawa R, Sugiura M,
        Yamaki K, Takeuchi Y (2002) 2-Ethyl-1-hexanol in indoor air as a possible
        cause of sick building symptoms. J Occup Health 44, 186&#x2013;91.</Citation></Reference><Reference><Citation>Kamijima
        M, Shibata E, Sakai K, Ohno H, Ishihara S, Yamada T, Takeuchi Y, Nakajima
        T (2005) [Indoor air pollution due to 2-ethyl-1-hexanol]. Nihon Koshu Eisei
        Zassi (Jpn J Public Health) 52, 1021&#x2013;31 (in Japanese with English abstract).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16457196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieslander
        G, Norback D, Nordstrom K, Walinder R, Venge P (1999) Nasal and ocular symptoms,
        tear film stability and biomarkers in nasal lavage, in relation to building-dampness
        and building design in hospitals. Int Arch Occup Environ Health 72, 451&#x2013;61.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10541910</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakayama
        T, Ito Y, Sakai K, Miyake M, Shibata E, Ohno H, Kamijima M (2019) Comprehensive
        review of 2-ethyl-1-hexanol as an indoor air pollutant. J Occup Health 61,
        19&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499367</ArticleId><ArticleId
        IdType="pubmed">30698348</ArticleId></ArticleIdList></Reference><Reference><Citation>Chino
        S, Kato S, Seo J, Ataka Y (2009) Study on emission of decomposed chemicals
        of esters contained in PVC flooring and adhesive. Build Environ 44, 1337&#x2013;42.</Citation></Reference><Reference><Citation>Sakai
        K, Kamijima M, Shibata E, Ohno H, Nakajima T (2009) Annual transition and
        seasonal variation of indoor air pollution levels of 2-ethyl-1-hexanol in
        large-scale buildings in Nagoya, Japan. J Environ Monit 11, 2068&#x2013;76.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19890564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakayama
        T, Sakai K, Ohno H, Ito Y, Kamijima M (2019) [Reexamination in a building
        with high concentration of 2-ethyl-1-hexanol]. In: Proceedings of the 89th
        Annual Meeting of the Japanese Society for Hygiene. 74. Nagoya: Organizing
        Committee of 89th Annual Meeting of the Japanese Society for Hygiene; 169.
        (in Japanese).</Citation></Reference><Reference><Citation>Astill BD, Deckardt
        K, Gembardt C, Gingell R, Guest D, Hodgson JR, Mellert W, Murphy SR, Tyler
        TR (1996) Prechronic toxicity studies on 2-ethylhexanol in F334 rats and B6C3F1
        mice. Fund Appl Toxicol 29, 31&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8838637</ArticleId></ArticleIdList></Reference><Reference><Citation>Astill
        BD, Gingell R, Guest D, Hellwig J, Hodgson JR, Kuettler K, Mellert W, Murphy
        SR, Sielken RL Jr, Tyler TR (1996) Oncogenicity testing of 2-ethylhexanol
        in Fischer 344 rats and B6C3F1 mice. Fund Appl Toxicol 31, 29&#x2013;41.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8998951</ArticleId></ArticleIdList></Reference><Reference><Citation>Albro
        PW (1986) Absorption, metabolism, and excretion of di(2-ethylhexyl) phthalate
        by rats and mice. Environ Health Persp 65, 293&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474712</ArticleId><ArticleId IdType="pubmed">3086077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Peters JM, Perella CM, Gonzalez FJ (1998) Receptor and nonreceptor-mediated
        organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome
        proliferator-activated receptor alpha-null mice. Toxicol Pathol 26, 240&#x2013;6.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9547862</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney
        EK, Waxman DJ (1999) trans-Activation of PPAR&#x3b1; and PPAR&#x3b3; by structurally
        diverse environmental chemicals. Toxicol Appl Pharm 161, 209&#x2013;18.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10581215</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber
        ED, Topping DC (1995) Subchronic 90-day oral toxicology of di(2-ethylhexyl)
        terephthalate in the rat. Food Chem Toxicol 33, 971&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7590545</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith
        Y, Cornu MC, Canning PM, Foster J, Lhuguenot JC, Elcombe CR (1992) Peroxisome
        proliferation due to di (2-ethylhexyl) adipate, 2-ethylhexanol and 2-ethylhexanoic
        acid. Arch Toxicol 66, 321&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1610294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Gangolli SD, Grasso P, Lloyd AG (1975) Studies on the hepatic effects
        of orally administered di-(2-ethylhexyl) phthalate in the rat. Toxicol Appl
        Pharm 32, 355&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">168667</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody
        DE, Reddy JK (1978) Hepatic peroxisome (microbody) proliferation in rats fed
        plasticizers and related compounds. Toxicol Appl Pharm 45, 497&#x2013;504.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">705785</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack
        GM, Shen DD, Dorr MB (1989) Contribution of metabolites to the route- and
        time-dependent hepatic effects of di-(2-ethylhexyl)phthalate in the rat. J
        Pharmacol Exp Ther 248, 176&#x2013;81.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2913270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee
        SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM,
        Westphal H, Gonzalez FJ (1995) Targeted disruption of the alpha isoform of
        the peroxisome proliferator-activated receptor gene in mice results in abolishment
        of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15,
        3012&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230532</ArticleId><ArticleId
        IdType="pubmed">7539101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang
        C, Youssef J, Cunningham M, Badr M (2004) Correlation between thyroid hormone
        status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated
        receptor alpha agonist Wy-14,643. J Carcinog 3, 9.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC434527</ArticleId><ArticleId IdType="pubmed">15157275</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake
        M, Ito Y, Sawada M, Sakai K, Suzuki H, Sakamoto T, Sawamoto K, Kamijima M
        (2016) Subchronic inhalation exposure to 2-ethyl-1-hexanol impairs the mouse
        olfactory bulb via injury and subsequent repair of the nasal olfactory epithelium.
        Arch Toxicol 90, 1949&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">27055686</ArticleId></ArticleIdList></Reference><Reference><Citation>Folch
        J, Lees M, Stanley GS (1957) A simple method for the isolation and purification
        of total lipids from animal tissues. J Biol Chem 226, 497&#x2013;509.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13428781</ArticleId></ArticleIdList></Reference><Reference><Citation>Osumi
        T, Hashimoto T (1980) Purification and properties of mitochondrial and peroxisomal
        3-hydroxyacyl-CoA dehydrogenase from rat liver. Arch Biochem Biophys 203,
        372&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">6773478</ArticleId></ArticleIdList></Reference><Reference><Citation>Izai
        K, Uchida Y, Orii T, Yamamoto S, Hashimoto T (1992) Novel fatty acid beta-oxidation
        enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain
        acyl-coenzyme A dehydrogenase. J Biol Chem 267, 1027&#x2013;33.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1730632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda
        Y (2013) Investigation of the freely available easy-to-use software &#x2018;EZR&#x2019;
        for medical statistics. Bone Marrow Transplant 48, 452&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapinskas
        PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, Corton JC
        (2005) Role of PPARalpha in mediating the effects of phthalates and metabolites
        in the liver. Toxicology 207, 149&#x2013;63.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15590130</ArticleId></ArticleIdList></Reference><Reference><Citation>Faiola
        B, Falls JG, Peterson RA, Bordelon NR, Brodie TA, Cummings CA, Romach EH,
        Miller RT (2008) PPAR alpha, more than PPAR delta, mediates the hepatic and
        skeletal muscle alterations induced by the PPAR agonist GW0742. Toxicol Sci
        105, 384&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">18593727</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody
        DE, Reddy JK (1982) Serum triglyceride and cholesterol contents in male rats
        receiving diets containing plasticizers and analogues of the ester 2-ethylhexanol.
        Toxicol Lett 10, 379&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">7089991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson
        JR (1987) Results of peroxisome induction studies on tri(2-ethylhexyl) trimellitate
        and 2-ethylhexanol. Toxicol Ind Health 3, 49&#x2013;61.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3617069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada
        A (1974) Toxicity of phthalic acid esters and hepatotoxicity of di-(2-ethyl
        hexyl) phthalate. J Food Hyg Soc Jpn 15, 147&#x2013;52.</Citation></Reference><Reference><Citation>Scala
        RA, Burtis EG (1973) Acute toxicity of a homologous series of branched-chain
        primary alcohols. Am Ind Hyg Assoc J 34, 493&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4770172</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimisch
        HJ, Deckardt K, Gembardt C, Hildebrand B (1998) Subchronic inhalation toxicity
        study of 2-ethylhexanol vapour in rats. Food Chem Toxicol 36, 165&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9609389</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhshandehroo
        M, Knoch B, Muller M, Kersten S (2010) Peroxisome proliferator-activated receptor
        alpha target genes. PPAR Res 2010, 612089.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2948931</ArticleId><ArticleId IdType="pubmed">20936127</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandard
        S, Muller M, Kersten S (2004) Peroxisome proliferator-activated receptor alpha
        target genes. Cell Mol Life Sci 61, 393&#x2013;416.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14999402</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu
        J, Oveisi F, Gaetani S, Lin E, Piomelli D (2005) Oleoylethanolamide, an endogenous
        PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology
        48, 1147&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">15910890</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaput
        E, Saladin R, Silvestre M, Edgar AD (2000) Fenofibrate and rosiglitazone lower
        serum triglycerides with opposing effects on body weight. Biochem Biophys
        Res Commun 271, 445&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">10799317</ArticleId></ArticleIdList></Reference><Reference><Citation>Albro
        PW (1975) The metabolism of 2-ethylhexanol in rats. Xenobiotica 5, 625&#x2013;36.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1189459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito
        Y, Yokota H, Wang R, Yamanoshita O, Ichihara G, Wang H, Kurata Y, Takagi K,
        Nakajima T (2005) Species differences in the metabolism of di (2-ethylhexyl)
        phthalate (DEHP) in several organs of mice, rats, and marmosets. Arch Toxicol
        79, 147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">15798888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito
        Y, Yamanoshita O, Asaeda N, Tagawa Y, Lee CH, Aoyama T, Ichihara G, Furuhashi
        K, Kamijima M, Gonzalez FJ, Nakajima T (2007) Di(2-ethylhexyl) phthalate induces
        hepatic tumorigenesis through a peroxisome proliferator-activated receptor
        alpha-independent pathway. J Occup Health 49, 172&#x2013;82.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17575397</ArticleId></ArticleIdList></Reference><Reference><Citation>Am&#xe9;en
        C, Edvardsson U, Ljungberg A, Asp L, &#xc5;kerblad P, Tuneld A, Olofsson SO,
        Lind&#xe9;n D, Oscarsson J (2005) Activation of peroxisome proliferator-activated
        receptor &#x3b1; increases the expression and activity of microsomal triglyceride
        transfer protein in the liver. J Biol Chem 280, 1224&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15537571</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagita
        T, Kobayashi K, Enomoto N (1978) Accumulation of hepatic phospholipids in
        rats fed di-2-ethylhexyl phthalate. Biochem Pharmacol 27, 2283&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">728182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang
        AL, Beier JI (2018) Interaction of volatile organic compounds and underlying
        liver disease: a new paradigm for risk. Biol Chem 399, 1237&#x2013;48.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC6181143</ArticleId><ArticleId IdType="pubmed">29924722</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida
        M, Umemura T, Kojima H, Inoue K, Takahashi M, Uramaru N, Kitamura S, Abe K,
        Tohkin M, Ozawa S, Yoshinari K (2015) [Basic Principles of Interpretation
        of Hepatocellular Hypertrophy in Risk Assessment in Japan]. Shokuhin Eiseigaku
        Zasshi 56, 42&#x2013;8 (in Japanese with English abstract).</Citation><ArticleIdList><ArticleId
        IdType="pubmed">25925075</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraets
        L, Bessems JG, Zeilmaker MJ, Bos PM (2014) Human risk assessment of dermal
        and inhalation exposures to chemicals assessed by route-to-route extrapolation:
        the necessity of kinetic data. Regul Toxicol Pharm 70, 54&#x2013;64.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">24912090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">16855774</PMID><DateCompleted><Year>2007</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1008-682X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2007</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Asian
        journal of andrology</Title><ISOAbbreviation>Asian J Androl</ISOAbbreviation></Journal><ArticleTitle>Short-term
        effects of di-(2-ethylhexyl) phthalate on testes, liver, kidneys and pancreas
        in mice.</ArticleTitle><Pagination><StartPage>199</StartPage><EndPage>205</EndPage><MedlinePgn>199-205</MedlinePgn></Pagination><Abstract><AbstractText
        Label="AIM" NlmCategory="OBJECTIVE">To determine the biochemical effect of
        di-(2-ethylhexyl) phthalate (DEHP) on testes, liver, kidneys and pancreas
        on day 10 in the process of degeneration of the seminiferous epithelium.</AbstractText><AbstractText
        Label="METHODS" NlmCategory="METHODS">Diets containing 2% DEHP were given
        to male Crlj:CD1(ICR) mice for 10 days. The dose of DEHP was 0.90 +/- 0.52
        mg/mouse/day. Their testes, livers, kidneys and pancreata were examined for
        detection of mono-(2-ethylhexyl) phthalate (MEHP), nitrogen oxides (NOx) produced
        by peroxidation of nitric oxide (NO) with free radicals, and lipid peroxidation
        induced by the chain reaction of free radicals.</AbstractText><AbstractText
        Label="RESULTS" NlmCategory="RESULTS">Histological observation and serum analysis
        showed the presence of severe spermatogenic disturbance, Leydig cell dysfunction,
        liver dysfunction and dehydration. Unexpectedly, the concentration of MEHP
        in the testes was extremely low compared with that in the liver. However,
        the concentration of the NOx in the testes was as high as the hepatic concentration.
        Furthermore, free radical-induced lipid peroxidation was histochemically detected
        in the testes but not in the liver.</AbstractText><AbstractText Label="CONCLUSION"
        NlmCategory="CONCLUSIONS">The results indicate that DEHP-induced aspermatogenesis
        is caused by the high sensitivity of the testicular tissues to MEHP rather
        than the specific accumulation or uptake of circulating MEHP into the testes.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Miura</LastName><ForeName>Yumi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department
        of Anatomy, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Naito</LastName><ForeName>Munekazu</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Ablake</LastName><ForeName>Maira</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Terayama</LastName><ForeName>Hayato</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Yi</LastName><ForeName>Shuang-Qin</ForeName><Initials>SQ</Initials></Author><Author
        ValidYN="Y"><LastName>Qu</LastName><ForeName>Ning</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Cheng</LastName><ForeName>Lin-Xian</ForeName><Initials>LX</Initials></Author><Author
        ValidYN="Y"><LastName>Suna</LastName><ForeName>Shigeru</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Jitsunari</LastName><ForeName>Fumihiko</ForeName><Initials>F</Initials></Author><Author
        ValidYN="Y"><LastName>Itoh</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2006</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Asian
        J Androl</MedlineTA><NlmUniqueID>100942132</NlmUniqueID><ISSNLinking>1008-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009589">Nitrogen Oxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance
        UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance
        UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance
        UI="D007501">Iron</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance
        UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003300" MajorTopicYN="N">Copper</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007501" MajorTopicYN="N">Iron</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009589" MajorTopicYN="N">Nitrogen Oxides</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013091" MajorTopicYN="N">Spermatogenesis</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2006</Year><Month>7</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2007</Year><Month>5</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2006</Year><Month>7</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">16855774</ArticleId><ArticleId IdType="doi">10.1111/j.1745-7262.2007.00220.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="Publisher" Owner="NLM"><PMID Version="1">12778222</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0888-8051</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>213</Volume><PubDate><Year>1982</Year><Month>Aug</Month></PubDate></JournalIssue><Title>National
        Toxicology Program technical report series</Title><ISOAbbreviation>Natl Toxicol
        Program Tech Rep Ser</ISOAbbreviation></Journal><ArticleTitle>Carcinogenesis
        Bioassay of Butyl Benzyl Phthalate (CAS No. 85-68-7) in F344/N Rats and B6C3F1
        Mice (Feed Study).</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>98</EndPage><MedlinePgn>1-98</MedlinePgn></Pagination><Abstract><AbstractText>A
        carcinogenesis bioassay of butyl benzyl phthalate, a plasticizer for vinyl
        chloride plastics, was accomplished by feeding diets containing 6,000 or 12,000
        ppm of the phthalate to groups of 50 F344/N rats and 50 B6C3F1 mice of each
        sex for 28 to 103 weeks. Mean body weights of dosed female rats and mice of
        each sex were lower than those of the control animals throughout most of the
        study. After week 14, an increasing number of dosed male rats died as a result
        of an unexplained internal hemorrhaging, and all surviving male rats were
        killed at week 29 to 30. Because of compound-related mortality, butyl benzyl
        phthalate was not adequately tested for carcinogenicity in male F344/N rats.
        Mononuclear cell leukemias occurred at a statistically significant (P=0.011)
        increased incidence in the high-dose group of female rats when compared with
        the control group and with a significantly (P=0.006) increasing trend (controls
        7/49, 14%; low-dose 7/49, 14%; high-dose 18/50, 36%). The incidence in the
        high-dose group and the overall trend remained statistically significant (P=0.008
        and P=0.019) when compared with the historical incidence for F344/N female
        rats with leukemia at this laboratory (77/ 399, 19%). Further, this leukoproliferation
        was generally characterized by splenomegaly and often by hepatomegaly. Administration
        of butyl benzyl phthalate was not associated with increased incidences of
        any type of tumor among male or female mice. Tumor rates were decreased in
        female rats for fibroadenomas of the mammary glands (20/49, 14/49, 9/50) and
        in male mice for lymphomas of the hematopoietic system (13/50, 11/49, 4/50)
        and for alveolar/bronchiolar adenomas or carcinomas (17/50, 11/49, 8/50).
        Under the conditions of this bioassay, butyl benzyl phthalate was probably
        carcinogenic for female F344/N rats, causing an increased incidence of mononuclear
        cell leukemias. The male F344/N rat study was considered inadequate for evaluation
        due to compound-related toxicity and early mortality. Butyl benzyl phthalate
        was not carcinogenic for B6C3F1 mice of either sex. Levels of Evidence of
        Carcinogenicity: Male Rats: Inadequate Study Female Rats: Positive Male Mice:
        Negative Female Mice: Negative Synonyms: BBP; benzyl butyl phthalate; phthalic
        acid; benzyl butyl ester; Santicizer 160</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><CollectiveName> National Toxicology Program
        </CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Natl Toxicol Program Tech Rep Ser</MedlineTA><NlmUniqueID>8500747</NlmUniqueID><ISSNLinking>0888-8051</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1982</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1982</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12778222</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10478332</PMID><DateCompleted><Year>1999</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0388-1350</ISSN><JournalIssue
        CitedMedium="Print"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>1999</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The
        Journal of toxicological sciences</Title><ISOAbbreviation>J Toxicol Sci</ISOAbbreviation></Journal><ArticleTitle>Dose-dependent
        induction of carcinomas and glutathione S-transferase placental form negative
        eosinophilic foci in the rat liver by di(2-ethylhexyl)phthalate after diethylnitrosamine
        initiation.</ArticleTitle><Pagination><StartPage>177</StartPage><EndPage>186</EndPage><MedlinePgn>177-86</MedlinePgn></Pagination><Abstract><AbstractText>The
        dose-dependence of di(2-ethylhexyl)phthalate (DEHP) hepatocarcinogenicity
        was investigated in male F344 rats which were initially injected with diethylnitrosamine
        (200 mg/kg, i.p.) and subjected to partial hepatectomy at week 3. The animals
        were administered DEHP in the diet at concentrations of 30, 300, 3,000, or
        12,000 ppm starting 2 weeks after the DEN injection for up to 46 weeks and
        killed at weeks 8, 24, 48 and 52. Additional groups were given clofibrate
        (3,000 ppm in diet) or basal diet instead of the DEHP diet. Incidences of
        hepatocellular carcinomas were 75% (9/12, P &lt; 0.01) for 12,000 ppm, 10%
        (1/10) for 3,000 ppm, 7% (1/14) for 300 ppm, 0% (0/13) for 30 ppm, 15% (2/13)
        for clofibrate, and 8% (1/13) for the basal diet group at week 52, 4 weeks
        after cessation of chemical feeding. Development of glutathione S-transferase
        placental form (GST-P) positive foci was only slightly increased by clofibrate-administration
        at week 52 and consistently lower than the control level in the DEHP-treated
        groups after 24 weeks. In contrast, GST-P negative eosinophilic foci were
        dose-dependently increased in the more than 300 ppm DEHP and clofibrate treated
        groups. At the 30 ppm dose level, however, no morphological changes were apparent
        in the liver. Thus, the non-observed effect level regarding the promotional
        activity of hepatocarcinogenesis was demonstrated at 30 ppm, the effects being
        predictable on the basis of development of GST-P negative eosinophilic foci.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Sano</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>First
        Department of Pathology, Nagoya City University Medical School, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Tamano</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Imaida</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Ito</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Shirai</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J
        Toxicol Sci</MedlineTA><NlmUniqueID>7805798</NlmUniqueID><ISSNLinking>0388-1350</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.5.1.18</RegistryNumber><NameOfSubstance UI="D051549">Glutathione S-Transferase
        pi</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance
        UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.5.1.18</RegistryNumber><NameOfSubstance UI="C496558">Gstp1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>M43H21IO8R</RegistryNumber><NameOfSubstance
        UI="D004128">Dimethylnitrosamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D018248" MajorTopicYN="N">Adenoma, Liver Cell</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003043" MajorTopicYN="N">Cocarcinogenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004128" MajorTopicYN="N">Dimethylnitrosamine</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051549" MajorTopicYN="N">Glutathione S-Transferase pi</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019055" MajorTopicYN="N">No-Observed-Adverse-Effect Level</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>9</Month><Day>9</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>9</Month><Day>9</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10478332</ArticleId><ArticleId IdType="doi">10.2131/jts.24.3_177</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2274048</PMID><DateCompleted><Year>1991</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-8177</ISSN><JournalIssue
        CitedMedium="Print"><Volume>96</Volume><Issue>2</Issue><PubDate><Year>1990</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>Molecular
        and cellular biochemistry</Title><ISOAbbreviation>Mol Cell Biochem</ISOAbbreviation></Journal><ArticleTitle>Alterations
        in the integrity of peroxisomal membranes in livers of mice treated with peroxisome
        proliferators.</ArticleTitle><Pagination><StartPage>153</StartPage><EndPage>161</EndPage><MedlinePgn>153-61</MedlinePgn></Pagination><Abstract><AbstractText>Catalase
        leakage from its particulate compartment within the light mitochondrial fraction
        of liver was used as an index of the integrity of peroxisomes in untreated
        mice and in mice treated with the peroxisome proliferators clofibrate(ethyl-p-chlorophenoxyisobutyrate),
        Wy-14,643(4-chloro-6[2,3-xylidino)-2-pyrimidinylthio]acetic acid) and DEHP(di-(2-ethylhexyl)phthalate).
        Catalase leakage represented about 2% of the total catalase activity when
        fractions from untreated mice were incubated at 4 degrees C, increasing to
        about 5% during 60 min incubation at 37 degrees C. In fractions from livers
        of mice treated with peroxisome proliferators, catalase leakage was significantly
        higher, being 7-11% at 4 degrees C and increasing to approximately 20% after
        60 min incubation at 37 degrees C. The pattern of release was similar for
        all proliferators. Parallel data were obtained for catalase latency in these
        fractions, i.e. following 60 min incubation at 37 degrees C, free (non-latent)
        catalase activity was 18% in control mice and 65, 67, and 83% in fractions
        from clofibrate-, Wy-14,643- and DEHP-treated mice, respectively. Differences
        in catalase leakage from peroxisomes in fractions from untreated mice and
        clofibrate-treated mice were also apparent following treatments designed to
        effect membrane permeabilization, as in freeze-thawing, osmotic rupture, and
        extraction with Triton X-100 and lysophosphatidylcholine. These data are consistent
        with a significant alteration in the integrity of the membranes of peroxisomes
        in livers of mice which have been treated with peroxisome proliferators, and
        furthermore indicate a commonality of effect of these agents.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Crane</LastName><ForeName>D I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Division
        of Science and Technology, Griffith University, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zamattia</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Masters</LastName><ForeName>C J</ForeName><Initials>CJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol
        Cell Biochem</MedlineTA><NlmUniqueID>0364456</NlmUniqueID><ISSNLinking>0300-8177</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008930" MajorTopicYN="N">Mitochondria, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013010" MajorTopicYN="N">Sonication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1990</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1990</Year><Month>8</Month><Day>10</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1990</Year><Month>8</Month><Day>10</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2274048</ArticleId><ArticleId IdType="doi">10.1007/BF00420907</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mol
        Cell Biochem. 1988 Oct;83(2):187-94</Citation><ArticleIdList><ArticleId IdType="pubmed">3200253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1969 Dec 19;168(2):214-28</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4393702</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1983 Aug 17;763(1):72-82</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6307393</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1975 Nov;67(2PT.1):281-309</Citation><ArticleIdList><ArticleId
        IdType="pubmed">406</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Cell Biol. 1981 Apr;24(1):62-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7238535</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu
        Rev Cell Biol. 1985;1:489-530</Citation><ArticleIdList><ArticleId IdType="pubmed">3916321</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1975 Mar 25;415(1):29-79</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1091302</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biochem. 1978 May;83(5):1361-5</Citation><ArticleIdList><ArticleId IdType="pubmed">659402</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1982 Aug 25;690(1):74-80</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7126569</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Theor Biol. 1975 May;51(1):149-67</Citation><ArticleIdList><ArticleId IdType="pubmed">1142779</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal
        Biochem. 1977 Dec;83(2):346-56</Citation><ArticleIdList><ArticleId IdType="pubmed">603028</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1979 Aug 20;559(2-3):259-87</Citation><ArticleIdList><ArticleId
        IdType="pubmed">476122</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Cell Biochem. 1984 Nov;65(1):73-82</Citation><ArticleIdList><ArticleId IdType="pubmed">6521730</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS
        Lett. 1970 Nov 9;11(1):45-48</Citation><ArticleIdList><ArticleId IdType="pubmed">11945446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Cell Biochem. 1988 May;81(1):29-36</Citation><ArticleIdList><ArticleId IdType="pubmed">3173343</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1982 Jan;42(1):259-66</Citation><ArticleIdList><ArticleId IdType="pubmed">7053853</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal
        Biochem. 1985 Aug 1;148(2):436-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3933379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1965 Nov 27;208(5013):856-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5870099</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Pathol. 1978 Feb;90(2):435-46</Citation><ArticleIdList><ArticleId IdType="pubmed">623209</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1988 Nov 22;945(2):135-44</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3191117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1976 Apr;36(4):1211-7</Citation><ArticleIdList><ArticleId IdType="pubmed">177202</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1975 Nov 21;190(4216):787-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1198095</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1985 Jul;101(1):294-304</Citation><ArticleIdList><ArticleId IdType="pubmed">2989301</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1986 Apr 15;876(2):256-63</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3955065</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol
        Rev. 1977 Oct;57(4):816-82</Citation><ArticleIdList><ArticleId IdType="pubmed">333482</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1976 Jun;73(6):2043-6</Citation><ArticleIdList><ArticleId
        IdType="pubmed">180535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8472324</PMID><DateCompleted><Year>1993</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>12</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>1993</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Ability
        of peroxisome proliferators to induce cell transformation, chromosome aberrations
        and peroxisome proliferation in cultured Syrian hamster embryo cells.</ArticleTitle><Pagination><StartPage>611</StartPage><EndPage>618</EndPage><MedlinePgn>611-8</MedlinePgn></Pagination><Abstract><AbstractText>Di(2-ethylhexyl)phthalate
        (DEHP), a commonly used plasticizer, induces proliferation of peroxisomes
        in liver cells and causes hepatocellular carcinomas when chronically administered
        in the diet to rodents. To examine possible mechanisms for DEHP-associated
        cancer, we have measured induction of morphological transformation, chromosome
        aberrations and peroxisome proliferations of cultured Syrian hamster embryo
        (SHE) cells by DEHP and other peroxisome proliferators. Morphological transformation
        of SHE cells was weakly induced by treatment for 48 h with DEHP and its metabolite
        mono(2-ethylhexyl)phthalate (MEHP). The transformation frequency by DEHP was
        enhanced by exogenous metabolic activation using rat liver postmitochondrial
        supernatants. Treatment for 24 h with DEHP resulted in chromosome aberrations
        of the cells only in the presence of exogenous metabolic activation. 2-(p-chlorophenoxy)-2-methylpropionic
        acid ethyl ester (clofibrate), a widely used hypolipidemic drug, failed to
        induce morphological transformation or chromosome aberrations of SHE cells.
        Treatment with [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643),
        which is a more potent carcinogen than DEHP or clofibrate, elicited a lower
        frequency of morphological transformation than DEHP in the presence of exogenous
        metabolic activation but was more active than DEHP at inducing chromosome
        aberrations. Similar levels of peroxisome proliferation, as determined by
        an intensity of diaminobenzidine staining, were observed in cultures treated
        for 2 h with DEHP, MEHP, clofibrate or WY-14,643. These results suggest a
        possible involvement of genetic damage by DEHP metabolites in the induction
        of cell transformation of SHE cells by DEHP; however, no clear relationship
        among induction of peroxisome proliferation, carcinogenicity in vivo and cell
        transformation was observed. Although the ability to induce cell transformation
        and chromosomal mutations is not adequate to explain the carcinogenicity of
        this class of compounds, these biological effects may be contributory to the
        carcinogenic activities of peroxisome proliferators.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsutsui</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department
        of Pharmacology, Nippon Dental University, School of Dentistry, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Watanabe</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Barrett</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001560">Benzidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001560" MajorTopicYN="N">Benzidines</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002869" MajorTopicYN="Y">Chromosome Aberrations</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName><QualifierName
        UI="Q000196" MajorTopicYN="N">embryology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1993</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1993</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1993</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8472324</ArticleId><ArticleId IdType="doi">10.1093/carcin/14.4.611</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">598790</PMID><DateCompleted><Year>1978</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0015-6264</ISSN><JournalIssue
        CitedMedium="Print"><Volume>15</Volume><Issue>5</Issue><PubDate><Year>1977</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Food
        and cosmetics toxicology</Title><ISOAbbreviation>Food Cosmet Toxicol</ISOAbbreviation></Journal><ArticleTitle>Short-term
        toxicity study of di-(2-ethylhexyl) phthalate in rats.</ArticleTitle><Pagination><StartPage>389</StartPage><EndPage>399</EndPage><MedlinePgn>389-99</MedlinePgn></Pagination><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Author><Author
        ValidYN="Y"><LastName>Butterworth</LastName><ForeName>K R</ForeName><Initials>KR</Initials></Author><Author
        ValidYN="Y"><LastName>Gaunt</LastName><ForeName>I F</ForeName><Initials>IF</Initials></Author><Author
        ValidYN="Y"><LastName>Grasso</LastName><ForeName>G P</ForeName><Initials>GP</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Cosmet Toxicol</MedlineTA><NlmUniqueID>0374623</NlmUniqueID><ISSNLinking>0015-6264</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006400" MajorTopicYN="N">Hematocrit</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1977</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1977</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1977</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">598790</ArticleId><ArticleId IdType="doi">10.1016/s0015-6264(77)80003-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">4091660</PMID><DateCompleted><Year>1986</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>03</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0340-5761</ISSN><JournalIssue
        CitedMedium="Print"><Volume>58</Volume><Issue>2</Issue><PubDate><Year>1985</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Effects
        of repeated intravenous infusions of the plasticizer di-(2-ethylhexyl) phthalate
        in young male rats.</ArticleTitle><Pagination><StartPage>78</StartPage><EndPage>83</EndPage><MedlinePgn>78-83</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of six iv infusions of an emulsion containing the plasticizer di(2-ethylhexyl)
        phthalate (DEHP) on the liver and testes were investigated in 40-day-old rats.
        Groups of five to six animals received the emulsion every other day in doses
        of 0, 5, 50 or 500 mg DEHP/kg body weight. Liver effects were studied by histological
        examination and by measuring bromosulfophthalein clearance, peroxisomal proliferation
        and certain enzymes in serum. Testicular effects were evaluated by light and
        electron microscopy. To investigate the possibility of an age-related effect
        on the testis, five 25-day-old rats were given six infusions of 500 mg DEHP/kg.
        Compared with control animals, the high-dose group showed a 36% increase in
        relative liver weight and a 41% increase in the number of peroxisomes. In
        Epon-embedded testicular material from animals given the highest dose, which
        is about 100 times the highest estimated human exposure, some altered Sertoli
        cells and some degenerated primary spermatocytes were observed. No age-related
        effect on the testis similar to that found following oral administration of
        DEHP was observed in this study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Sj&#xf6;berg</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Lindquist</LastName><ForeName>N G</ForeName><Initials>NG</Initials></Author><Author
        ValidYN="Y"><LastName>Montin</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Pl&#xf6;en</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007263" MajorTopicYN="N">Infusions, Parenteral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000648"
        MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012708" MajorTopicYN="N">Sertoli Cells</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000648"
        MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">4091660</ArticleId><ArticleId IdType="doi">10.1007/BF00348313</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:11-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7140682</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp
        Mol Pathol. 1983 Apr;38(2):149-69</Citation><ArticleIdList><ArticleId IdType="pubmed">6832342</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Chem. 1978 May;24(5):741-6</Citation><ArticleIdList><ArticleId IdType="pubmed">647906</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta
        Pharmacol Toxicol (Copenh). 1985 Jan;56(1):30-7</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3976401</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand
        J Clin Lab Invest. 1974 Jun;33(4):291-306</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4369123</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Clin Nutr. 1965 Jan;16:43-61</Citation><ArticleIdList><ArticleId IdType="pubmed">14262119</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Histochem Cytochem. 1969 Oct;17(10):675-80</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4194356</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:27-34</Citation><ArticleIdList><ArticleId IdType="pubmed">6754361</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:77-84</Citation><ArticleIdList><ArticleId IdType="pubmed">6754364</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Clin Nutr. 1965 Jan;16:29-36</Citation><ArticleIdList><ArticleId IdType="pubmed">14270404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1952 Nov 20;55(4):548-73</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13139144</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Clin Nutr. 1964 Jan;14 :28-36</Citation><ArticleIdList><ArticleId IdType="pubmed">14106868</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Toxicol. 1985 Dec;58(2):72-7</Citation><ArticleIdList><ArticleId IdType="pubmed">4091659</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit
        Rev Toxicol. 1984;13(4):283-317</Citation><ArticleIdList><ArticleId IdType="pubmed">6386344</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Chim Acta. 1972 Sep;40(2):503-4</Citation><ArticleIdList><ArticleId IdType="pubmed">5056149</ArticleId></ArticleIdList></Reference><Reference><Citation>Transfusion.
        1985 Sep-Oct;25(5):424-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4049487</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit
        Rev Toxicol. 1983;12(1):1-58</Citation><ArticleIdList><ArticleId IdType="pubmed">6360536</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        1983 Sep;28(1-2):167-79</Citation><ArticleIdList><ArticleId IdType="pubmed">6636199</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1982 Mar 30;63(1):120-32</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7071867</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Pathol. 1983 Mar;139(3):309-21</Citation><ArticleIdList><ArticleId IdType="pubmed">6834175</ArticleId></ArticleIdList></Reference><Reference><Citation>Transfusion.
        1976 Jul-Aug;16(4):330-5</Citation><ArticleIdList><ArticleId IdType="pubmed">985623</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Lab Clin Med. 1977 May;89(5):1066-79</Citation><ArticleIdList><ArticleId IdType="pubmed">404371</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1975 Sep;33(3):514-25</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1188948</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Clin Invest. 1985 Dec;15(6):430-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3938415</ArticleId></ArticleIdList></Reference><Reference><Citation>Food
        Chem Toxicol. 1984 Feb;22(2):123-31</Citation><ArticleIdList><ArticleId IdType="pubmed">6538161</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol
        Reprod. 1970 Dec;3(3):308-26</Citation><ArticleIdList><ArticleId IdType="pubmed">4108372</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Toxicol Suppl. 1980;4:452-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6776936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11597582</PMID><DateCompleted><Year>2001</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-2952</ISSN><JournalIssue
        CitedMedium="Print"><Volume>62</Volume><Issue>8</Issue><PubDate><Year>2001</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Biochemical
        pharmacology</Title><ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Further
        evidence for the involvement of inhibition of cell proliferation and development
        in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic
        acid in mice.</ArticleTitle><Pagination><StartPage>1133</StartPage><EndPage>1140</EndPage><MedlinePgn>1133-40</MedlinePgn></Pagination><Abstract><AbstractText>We
        recently demonstrated that severe thymic and splenic atrophy occur upon dietary
        treatment of mice with potent peroxisome proliferators (PPs), e.g. perfluorooctanoic
        acid (PFOA), WY-14,643, nafenopin, and di(2-ethylhexyl)phthalate (DEHP). In
        the present study, we investigated this phenomenon further employing a relative
        inert PP, PFOA. Comparison of the dose-dependencies and time-courses indicated
        that the peroxisome proliferative effect occurred prior to atrophy of both
        the thymus and spleen. However, following withdrawal of PFOA from the diet,
        the weight of the thymus and spleen rapidly returned to normal within 10 and
        5 days, respectively, in contrast to the more persistent peroxisome proliferation.
        Furthermore, the changes in thymus and spleen weight upon PFOA treatment and
        the following withdrawal from diet paralleled the changes in total thymocyte
        and splenocyte counts, respectively. It was found previously that the decreases
        in the thymocyte populations present in the S and G2/M phases, as well as
        in the number of CD4+CD8+ cells upon PFOA treatment, were the most dramatic,
        perhaps reflecting inhibition of thymocyte proliferation in connection with
        thymocyte development. Here, the recovery of thymocytes began with increases
        in the populations in these same phases of the cell cycle, with CD4+CD8+ cells
        recovering most rapidly, lending further support to our previous hypothesis.
        The possible relationship of these immunotoxic effects of PPs to the changes
        they cause in fatty acid metabolism is discussed.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Q</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Unit
        for Biochemical Toxicology, Department of Biochemistry &amp; Biophysics, Wallenberg
        Laboratory, Stockholm University, S-106 91, Stockholm, Sweden. Qian@dbb.su.se</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Xie</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Eriksson</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author
        ValidYN="Y"><LastName>Nelson</LastName><ForeName>B D</ForeName><Initials>BD</Initials></Author><Author
        ValidYN="Y"><LastName>DePierre</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem
        Pharmacol</MedlineTA><NlmUniqueID>0101032</NlmUniqueID><ISSNLinking>0006-2952</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002210">Caprylates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005466">Fluorocarbons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>947VD76D3L</RegistryNumber><NameOfSubstance
        UI="C023036">perfluorooctanoic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002210" MajorTopicYN="N">Caprylates</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005466" MajorTopicYN="N">Fluorocarbons</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006984" MajorTopicYN="N">Hypertrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D023421" MajorTopicYN="N">Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013375" MajorTopicYN="N">Substance Withdrawal Syndrome</DescriptorName><QualifierName
        UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013950" MajorTopicYN="N">Thymus Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>10</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>11</Month><Day>3</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>10</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11597582</ArticleId><ArticleId IdType="doi">10.1016/s0006-2952(01)00752-3</ArticleId><ArticleId
        IdType="pii">S0006-2952(01)00752-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">16326419</PMID><DateCompleted><Year>2006</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1528-7394</ISSN><JournalIssue
        CitedMedium="Print"><Volume>68</Volume><Issue>23-24</Issue><PubDate><Year>2005</Year><Month>Dec</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health. Part A</Title><ISOAbbreviation>J Toxicol
        Environ Health A</ISOAbbreviation></Journal><ArticleTitle>DNA methylation
        of estrogen receptor alpha gene by phthalates.</ArticleTitle><Pagination><StartPage>1995</StartPage><EndPage>2003</EndPage><MedlinePgn>1995-2003</MedlinePgn></Pagination><Abstract><AbstractText>The
        phthalates are ubiquitous industrial plasticizers and include agents such
        as di(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), and butyl benzyl
        phthalate (BBP), which are classified as endocrine disruptors because of their
        anti-androgenic or pro-estrogenic effects. A recent study suggested that DBP
        produced the hypomethylation of c-myc protooncogene in mouse liver to activate
        c-myc. In the present study, DNA hypomethylation at the promoter region of
        the estrogen receptor alpha (ERalpha) gene was investigated by methylation-specific
        polymerase chain reaction (MSP) in a human breast cancer (MCF7) and in a normal
        (MCF10A) cell line after DBP treatment. Yeast-based estrogen receptor transcription
        assays showed that hERalpha gene expression was induced by BBP but not DBP.
        Moreover, MCF7 cells treated with BBP or DBP at 10(-5)M led to the demethylation
        of ERalpha promoter-associated CpG islands. These data suggest that an altered
        ER mRNA expression by BBP might be related to aberrant DNA methylation in
        the promoter region of ERalpha.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Kang</LastName><ForeName>Se Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Division
        of Toxicology, School of Pharmacy, SungKyunKwan University, Jangan-Gu, Suwon,
        Kyonggi-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Byung
        Mu</ForeName><Initials>BM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Toxicol Environ Health A</MedlineTA><NlmUniqueID>100960995</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047628">Estrogen Receptor alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>2286E5R2KE</RegistryNumber><NameOfSubstance
        UI="D003993">Dibutyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.2.1.23</RegistryNumber><NameOfSubstance UI="D001616">beta-Galactosidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>YPC4PJX59M</RegistryNumber><NameOfSubstance
        UI="C027561">butylbenzyl phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018899" MajorTopicYN="N">CpG Islands</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003993" MajorTopicYN="N">Dibutyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047628" MajorTopicYN="N">Estrogen Receptor alpha</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001616" MajorTopicYN="N">beta-Galactosidase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2005</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2006</Year><Month>1</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2005</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">16326419</ArticleId><ArticleId IdType="doi">10.1080/15287390491008913</ArticleId><ArticleId
        IdType="pii">H65N6PX7207X7L65</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11029268</PMID><DateCompleted><Year>2000</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0273-2300</ISSN><JournalIssue
        CitedMedium="Print"><Volume>32</Volume><Issue>1</Issue><PubDate><Year>2000</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Regulatory
        toxicology and pharmacology : RTP</Title><ISOAbbreviation>Regul Toxicol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The
        role of inhibition of gap junctional intercellular communication in rodent
        liver tumor induction by phthalates: review of data on selected phthalates
        and the potential relevance to man.</ArticleTitle><Pagination><StartPage>51</StartPage><EndPage>55</EndPage><MedlinePgn>51-5</MedlinePgn></Pagination><Abstract><AbstractText>Inhibition
        of gap junctional intercellular communication (GJIC) has been postulated as
        a nongenotoxic carcinogenic mechanism, probably related to tumor promotion.
        Recent studies assessed the role of GJIC in the induction of rodent liver
        tumors by high levels of phthalate esters. Studies with di(2-ethylhexyl) (DEHP)
        and diisononyl (DINP) phthalates demonstrated that inhibition of GJIC in rats
        and mice was well correlated with induction of both liver tumors and markers
        for peroxisomal proliferation. However, GJIC was unaffected in hamsters and
        primates, species in which phthalate treatment does not induce peroxisomal
        proliferation. In vitro studies which extended the database to include human
        liver cells mirrored the in vivo situation; GJIC was inhibited in rat and
        mouse cells but not in cells from unresponsive species including humans. Peroxisomal
        proliferation has been characterized as a species-specific process essential
        for phthalate-induced rodent liver tumor induction. That GJIC was not inhibited
        in primate liver or human liver cells provides evidence for a second species-specific
        carcinogenic process. Thus the GJIC data along with those from studies of
        peroxisomal proliferation support the view that the carcinogenic effects of
        DEHP and DINP in rodents are not relevant to humans.</AbstractText><CopyrightInformation>Copyright
        2000 Academic Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>McKee</LastName><ForeName>R H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Exxon
        Biomedical Sciences, Inc., 1545 Route 22 East, Annandale, New Jersey 08801-0971,
        USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Regul
        Toxicol Pharmacol</MedlineTA><NlmUniqueID>8214983</NlmUniqueID><ISSNLinking>0273-2300</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>4010KIX4CK</RegistryNumber><NameOfSubstance
        UI="C012125">diisononyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017629" MajorTopicYN="N">Gap Junctions</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>46</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>10</Month><Day>13</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>10</Month><Day>13</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11029268</ArticleId><ArticleId IdType="doi">10.1006/rtph.2000.1407</ArticleId><ArticleId
        IdType="pii">S0273-2300(00)91407-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3715859</PMID><DateCompleted><Year>1986</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>84</Volume><Issue>1</Issue><PubDate><Year>1986</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Influence
        of dietary zinc on di(2-ethylhexyl)phthalate-induced testicular atrophy and
        zinc depletion in adult rats.</ArticleTitle><Pagination><StartPage>12</StartPage><EndPage>24</EndPage><MedlinePgn>12-24</MedlinePgn></Pagination><Abstract><AbstractText>Groups
        of 48 adult male F344 rats were maintained on synthetic diets containing 20
        ppm (normal), 2 ppm (low), or 200 ppm (high) zinc. After 1 week of acclimation
        to the various diets, groups of 12 rats from each dietary regimen were gavaged
        for 13 consecutive days with 0.0 (vehicle), 0.33, 1.0, or 3.0 g/kg di(2-ethylhexyl)phthalate
        (DEHP). These were selected as relatively nontoxic, mildly toxic, and moderately
        toxic doses for producing testicular injury in adult male rats. At termination
        on the 14th day, body weight gain was reduced by 3.0 g/kg DEHP dose in the
        normal and low-zinc diet groups but not in the high-zinc diet group. The low-zinc
        diet alone reduced body weight gain, independent of DEHP treatment. DEHP had
        no perceptible effects on the weights of testis, seminal vesicle, prostate,
        or epididymis from rats maintained on normal- or high-zinc diets, but reduced
        the weights of all of these organs from animals on the low-zinc diet in a
        dose-dependent manner. Lactate dehydrogenase activity, total and free sulfhydryl
        contents, and zinc concentrations in testes were also reduced, and testicular
        degeneration was induced by DEHP in the low-zinc diet groups. In contrast,
        dose-dependent liver enlargement and hypolipidemia (reduction of serum cholesterol
        and triglyceride concentrations) were produced by equivalent doses of DEHP
        in all of the three zinc groups. The selectively enhanced susceptibility of
        adult male F344 rats on a zinc deficient diet to the gonadotoxic effects of
        DEHP supports the hypothesis that testicular zinc depletion is causally related
        to the ensuing testicular and accessory sex organ atrophies. Other biological
        effects of DEHP (e.g., hypolipidemia, hepatomegaly) appear to occur independent
        of zinc homeostasis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Agarwal</LastName><ForeName>D K</ForeName><Initials>DK</Initials></Author><Author
        ValidYN="Y"><LastName>Eustis</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Lamb</LastName><ForeName>J C</ForeName><Initials>JC</Initials><Suffix>4th</Suffix></Author><Author
        ValidYN="Y"><LastName>Jameson</LastName><ForeName>C W</ForeName><Initials>CW</Initials></Author><Author
        ValidYN="Y"><LastName>Kluwe</LastName><ForeName>W M</ForeName><Initials>WM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013438">Sulfhydryl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.27</RegistryNumber><NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance
        UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013438" MajorTopicYN="N">Sulfhydryl Compounds</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000172"
        MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>6</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3715859</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(86)90412-6</ArticleId><ArticleId
        IdType="pii">0041-008X(86)90412-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">34303773</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>30</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6351</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>156</Volume><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Di(2-ethylhexyl)phthalate
        exposure exacerbates metabolic disorders in diet-induced obese mice.</ArticleTitle><Pagination><StartPage>112439</StartPage><MedlinePgn>112439</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.fct.2021.112439</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0278-6915(21)00472-5</ELocationID><Abstract><AbstractText>Both
        phthalate exposure and obesity are positively associated with metabolic disorders.
        The study aimed to investigate whether DEHP exposure caused metabolic disorders
        in an obesity-dependent manner. Both lean and diet-induced obese mice were
        subjected to environmentally relevant DEHP exposure. DEHP-treated obese mice
        exhibited higher glucose intolerance and insulin resistance than obese mice;
        the metabolic disorders were accompanied by increased blood levels of leptin,
        LDL cholesterol, and alanine transaminase. In obese mice, DEHP enhanced macrophage
        infiltration into epididymal white adipose tissue (eWAT) and hepatic tissue,
        and promoted hepatic steatosis/steatohepatitis. The DEHP effects were not
        observed in lean mice. Transcriptomic changes in eWAT and hepatic tissue were
        determined with microarray analysis. Results indicated that obesity and DEHP
        synergistically regulated carbohydrate uptake, lipolysis, and abnormality
        of adipose tissue, via the upstream regulators Pparg, Lipe, Cd44, and Irs1.
        Meanwhile, obesity and DEHP differentially modulated transcriptomic changes
        in hepatic tissue. Obesity was associated with lipid/cholesterol synthesis,
        lipid accumulation, and inflammation in hepatic tissue via the upstream regulators
        Zbtb20 and Nr1i2. In obese mice, DEHP exposure caused hepatic injury, cell
        migration, and changes in glycogen quantity mainly via Cd44. Microarray analysis
        suggested the potential mechanism underlying the early onset of metabolic
        disorders in DEHP-treated obese mice.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Jhih-Wei</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>National
        Institute of Environmental Health Sciences, National Health Research Institutes,
        Zhunan, Miaoli, 350, Taiwan; Department of Life Sciences, National Central
        University, Zhongli, Taoyuan City, 320, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nien</LastName><ForeName>Chung-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department
        of Life Sciences, National Central University, Zhongli, Taoyuan City, 320,
        Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hsin-Wei</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>National
        Institute of Environmental Health Sciences, National Health Research Institutes,
        Zhunan, Miaoli, 350, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tsai</LastName><ForeName>Feng-Yuan</ForeName><Initials>FY</Initials><AffiliationInfo><Affiliation>National
        Institute of Environmental Health Sciences, National Health Research Institutes,
        Zhunan, Miaoli, 350, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Yeh</LastName><ForeName>Szu-Ching</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>National
        Institute of Environmental Health Sciences, National Health Research Institutes,
        Zhunan, Miaoli, 350, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kao</LastName><ForeName>Yung-Hsi</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department
        of Life Sciences, National Central University, Zhongli, Taoyuan City, 320,
        Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsou</LastName><ForeName>Tsui-Chun</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>National
        Institute of Environmental Health Sciences, National Health Research Institutes,
        Zhunan, Miaoli, 350, Taiwan. Electronic address: tctsou@nhri.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020738">Leptin</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance
        UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D052436" MajorTopicYN="N">Adipose Tissue, White</DescriptorName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008078" MajorTopicYN="N">Cholesterol, LDL</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005951" MajorTopicYN="N">Glucose Tolerance Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020738" MajorTopicYN="N">Leptin</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008659" MajorTopicYN="N">Metabolic Diseases</DescriptorName><QualifierName
        UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150"
        MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Glucose intolerance</Keyword><Keyword
        MajorTopicYN="N">Hepatic steatosis</Keyword><Keyword MajorTopicYN="N">Insulin
        resistance</Keyword><Keyword MajorTopicYN="N">Macrophage infiltration</Keyword><Keyword
        MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Steatohepatitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2021</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>25</Day><Hour>20</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">34303773</ArticleId><ArticleId IdType="doi">10.1016/j.fct.2021.112439</ArticleId><ArticleId
        IdType="pii">S0278-6915(21)00472-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">7538465</PMID><DateCompleted><Year>1995</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0171-9335</ISSN><JournalIssue
        CitedMedium="Print"><Volume>66</Volume><Issue>1</Issue><PubDate><Year>1995</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European
        journal of cell biology</Title><ISOAbbreviation>Eur J Cell Biol</ISOAbbreviation></Journal><ArticleTitle>Formation
        of autophagosomes during degradation of excess peroxisomes induced by di-(2-ethylhexyl)-phthalate
        treatment. III. Fusion of early autophagosomes with lysosomal compartments.</ArticleTitle><Pagination><StartPage>15</StartPage><EndPage>24</EndPage><MedlinePgn>15-24</MedlinePgn></Pagination><Abstract><AbstractText>Fusion
        of early autophagosomes containing peroxisomes with endosomal and lysosomal
        structures in rat liver cells was investigated. Male Wistar rats were administered
        di-(2-ethylhexyl)phthalate (DEHP) for 14 days to induce proliferation of peroxisomes,
        and then the animals were injected intravenously with horseradish peroxidase
        (HRP)-conjugated asialofetuin to label the lysosomal compartment. Either 30
        min or 60 min after the injection, the animals were treated with leupeptin
        for 20, 40 and 60 min, respectively. Most of autophagic vacuoles containing
        peroxisomes were stained with diaminobenzidine (DAB) endocytosed HRP-asialofetuin
        60 min after leupeptin injection, whereas many of them were negative for DAB
        reaction 20 min after leupeptin injection. Between 20 to 40 min after leupeptin
        treatment many autophagic vacuoles fused with DAB-positive lysosomal compartments,
        including late endosomes. Percoll gradient centrifugation showed that particles
        containing HRP activity migrated from a density of 1.09 g/ml to that of 1.14
        g/ml as the time after leupeptin injection passed. Acid phosphatase activity
        migrated in the same manner. These results clearly show that early autophagosomes
        obtain the lysosomal proteinases by fusion with lysosomal compartments, including
        the late endosomes and that peroxisomes trapped in autophagosomes are degraded
        by these proteinases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Yokota</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Anatomy, Yamanashi Medical School, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Himeno</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Kato</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur
        J Cell Biol</MedlineTA><NlmUniqueID>7906240</NlmUniqueID><ISSNLinking>0171-9335</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001212">Asialoglycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D060748">Fetuins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007976">Leupeptins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C017029">asialofetuin</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.-</RegistryNumber><NameOfSubstance UI="D006735">Horseradish Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>J97339NR3V</RegistryNumber><NameOfSubstance
        UI="C032854">leupeptin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001212" MajorTopicYN="N">Asialoglycoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002451" MajorTopicYN="N">Cell Compartmentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002499" MajorTopicYN="N">Centrifugation, Density Gradient</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D060748" MajorTopicYN="N">Fetuins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006735" MajorTopicYN="N">Horseradish Peroxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007976" MajorTopicYN="N">Leupeptins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1995</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1995</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1995</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7538465</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">4024105</PMID><DateCompleted><Year>1985</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>80</Volume><Issue>1</Issue><PubDate><Year>1985</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Identification
        of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl)
        phthalate.</ArticleTitle><Pagination><StartPage>23</StartPage><EndPage>32</EndPage><MedlinePgn>23-32</MedlinePgn></Pagination><Abstract><AbstractText>A
        primary rat hepatocyte culture system was utilized to determine the proximate
        peroxisome proliferator(s) derived from di(2-ethylhexyl) phthalate (DEHP).
        DEHP was administered to rats and the urinary metabolites were identified
        and isolated. The major metabolites were those resulting from initial omega-
        or omega - 1-carbon oxidation of the mono(2-ethylhexyl) phthalate (MEHP) moiety.
        These metabolites, together with MEHP and 2-ethylhexanol, were added to primary
        rat hepatocyte cultures and the effect on peroxisomal enzyme activity was
        determined. The omega-carbon oxidation products [mono(3-carboxy-2-ethylpropyl)
        phthalate (I) and mono(5-carboxy-2-ethylpentyl) phthalate (V)] and 2-ethylhexanol
        produced little or no effect on CN- -insensitive palmitoyl-CoA oxidation (a
        peroxisomal marker). MEHP and the omega - 1-carbon oxidation products [mono-(2-ethyl-5-oxohexyl)
        phthalate (VI) and mono(2-ethyl-5-hydroxyhexyl) phthalate (IX)] produced a
        large (7- to 11-fold) induction of peroxisomal enzyme activity. Similar structure-activity
        relationships were observed for the induction of cytochrome P-450-mediated
        lauric acid hydroxylase and increase in cellular coenzyme A content. This
        identification of the proximate proliferators will aid in the elucidation
        of the mechanism by which DEHP causes proliferation of peroxisomes in the
        rodent liver. Oral administration of MEHP (150 or 250 mg/kg) to male guinea
        pigs did not produce hepatic peroxisome proliferation. Addition of MEHP (0
        to 0.5 mM) or one of the "active" proliferators in the rat (metabolite IX,
        0 to 0.5 mM) to primary guinea pig hepatocyte cultures also failed to produce
        an induction of peroxisomal beta-oxidation. Possible reasons for this species
        difference are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Mitchell</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author
        ValidYN="Y"><LastName>Lhuguenot</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>Bridges</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author><Author
        ValidYN="Y"><LastName>Elcombe</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">4024105</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(85)90097-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">19756843</PMID><DateCompleted><Year>2010</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-0703</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>57</Volume><Issue>4</Issue><PubDate><Year>2009</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Archives
        of environmental contamination and toxicology</Title><ISOAbbreviation>Arch
        Environ Contam Toxicol</ISOAbbreviation></Journal><ArticleTitle>Vitamin C
        and resveratrol supplementation to rat dams treated with di(2-ethylhexyl)phthalate:
        impact on reproductive and oxidative stress end points in male offspring.</ArticleTitle><Pagination><StartPage>785</StartPage><EndPage>793</EndPage><MedlinePgn>785-93</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1007/s00244-009-9385-9</ELocationID><Abstract><AbstractText>This
        study was carried out to assess the influence of di(2-ethylhexyl)phthalate
        (DEHP) alone or associated with antioxidants on the male reproductive system
        in newborn rats, emphasizing the implications of oxidative stress and hormonal
        balance during prenatal and early postnatal periods. Wistar females were exposed
        by oral route to DEHP alone or associated with antioxidants from gestational
        day 7 to lactational day 2 according to the following treatment regimens:
        (C) vehicle control (canola oil + 1% Tween-80); (V) vitamin C (200 mg/kg)
        + canola oil; (R) resveratrol (10 mg/kg) + canola oil; (D) DEHP (500 mg/kg)
        + 1% Tween-80; (DV) DEHP (500 mg/kg) + vitamin C (200 mg/kg); and (DR) DEHP
        (500 mg/kg) + resveratrol (10 mg/kg). Two male pups per litter were randomly
        selected and necropsied on postnatal day 2. The brain and liver were removed
        and weighed and anogenital distance (AGD) was measured. Additionally, the
        testes were removed for assessment of intratesticular testosterone levels
        and histopathology; the liver was used to measure biomarkers of oxidative
        stress. Vitamin C and resveratrol alone did not affect the reproductive end
        points and did not induce oxidative stress. Exposure of dams to DEHP alone
        and associated with antioxidants resulted in hepatomegaly in offspring and
        significantly increased the incidence of multinucleated gonocytes in seminiferous
        cords. Testosterone and AGD presented a trend to decrease in DEHP-exposed
        groups. Catalase activity increased only in groups exposed to DEHP associated
        with antioxidants, although GST (gluthatione-S-transferase) activity decreased
        in all DEHP-exposed groups. The levels of hydroperoxides increased only in
        group exposed to DEHP associated with vitamin C. These results indicate that
        the association of DEHP with antioxidants was unable to ameliorate DEHP-induced
        reproductive changes, and the coadministration of DEHP and these antioxidants
        might even contribute to an overall increase in oxidative stress.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Botelho</LastName><ForeName>Giuliana
        G K</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Department
        of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil. giu_kasecker@uol.com.br</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bufalo</LastName><ForeName>Aedra C</ForeName><Initials>AC</Initials></Author><Author
        ValidYN="Y"><LastName>Boareto</LastName><ForeName>Ana Claudia</ForeName><Initials>AC</Initials></Author><Author
        ValidYN="Y"><LastName>Muller</LastName><ForeName>Juliane C</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>Morais</LastName><ForeName>Rosana N</ForeName><Initials>RN</Initials></Author><Author
        ValidYN="Y"><LastName>Martino-Andrade</LastName><ForeName>Anderson J</ForeName><Initials>AJ</Initials></Author><Author
        ValidYN="Y"><LastName>Lemos</LastName><ForeName>Karen R</ForeName><Initials>KR</Initials></Author><Author
        ValidYN="Y"><LastName>Dalsenter</LastName><ForeName>Paulo R</ForeName><Initials>PR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Arch Environ Contam Toxicol</MedlineTA><NlmUniqueID>0357245</NlmUniqueID><ISSNLinking>0090-4341</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013267">Stilbenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.5.1.18</RegistryNumber><NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance
        UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q369O8926L</RegistryNumber><NameOfSubstance
        UI="D000077185">Resveratrol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011297" MajorTopicYN="N">Prenatal Exposure Delayed Effects</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000517"
        MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000077185" MajorTopicYN="N">Resveratrol</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013267" MajorTopicYN="N">Stilbenes</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2009</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2009</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2009</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2009</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2010</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">19756843</ArticleId><ArticleId IdType="doi">10.1007/s00244-009-9385-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27454254</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article
        PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2164</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>17 Suppl 6</Volume><Issue>Suppl 6</Issue><PubDate><Year>2016</Year><Month>Jul</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC
        genomics</Title><ISOAbbreviation>BMC Genomics</ISOAbbreviation></Journal><ArticleTitle>Abstracts
        from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) : Jeddah,
        Kingdom of Saudi Arabia. 30 November - 3 December 2015.</ArticleTitle><Pagination><StartPage>487</StartPage><MedlinePgn>487</MedlinePgn></Pagination><ELocationID
        EIdType="pii" ValidYN="Y">487</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12864-016-2858-0</ELocationID><Abstract><AbstractText>O1
        Regulation of genes by telomere length over long distances Jerry W. Shay O2
        The microtubule destabilizer KIF2A regulates the postnatal establishment of
        neuronal circuits in addition to prenatal cell survival, cell migration, and
        axon elongation, and its loss leading to malformation of cortical development
        and severe epilepsy Noriko Homma, Ruyun Zhou, Muhammad Imran Naseer, Adeel
        G. Chaudhary, Mohammed Al-Qahtani, Nobutaka Hirokawa O3 Integration of metagenomics
        and metabolomics in gut microbiome research Maryam Goudarzi, Albert J. Fornace
        Jr. O4 A unique integrated system to discern pathogenesis of central nervous
        system tumors Saleh Baeesa, Deema Hussain, Mohammed Bangash, Fahad Alghamdi,
        Hans-Juergen Schulten, Angel Carracedo, Ishaq Khan, Hanadi Qashqari, Nawal
        Madkhali, Mohamad Saka, Kulvinder S. Saini, Awatif Jamal, Jaudah Al-Maghrabi,
        Adel Abuzenadah, Adeel Chaudhary, Mohammed Al Qahtani, Ghazi Damanhouri O5
        RPL27A is a target of miR-595 and deficiency contributes to ribosomal dysgenesis
        Heba Alkhatabi O6 Next generation DNA sequencing panels for haemostatic and
        platelet disorders and for Fanconi anaemia in routine diagnostic service Anne
        Goodeve, Laura Crookes, Nikolas Niksic, Nicholas Beauchamp O7 Targeted sequencing
        panels and their utilization in personalized medicine Adel M. Abuzenadah O8
        International biobanking in the era of precision medicine Jim Vaught O9 Biobank
        and biodata for clinical and forensic applications Bruce Budowle, Mourad Assidi,
        Abdelbaset Buhmeida O10 Tissue microarray technique: a powerful adjunct tool
        for molecular profiling of solid tumors Jaudah Al-Maghrabi O11 The CEGMR biobanking
        unit: achievements, challenges and future plans Abdelbaset Buhmeida, Mourad
        Assidi, Leena Merdad O12 Phylomedicine of tumors Sudhir Kumar, Sayaka Miura,
        Karen Gomez O13 Clinical implementation of pharmacogenomics for colorectal
        cancer treatment Angel Carracedo, Mahmood Rasool O14 From association to causality:
        translation of GWAS findings for genomic medicine Ahmed Rebai O15 E-GRASP:
        an interactive database and web application for efficient analysis of disease-associated
        genetic information Sajjad Karim, Hend F Nour Eldin, Heba Abusamra, Elham
        M Alhathli, Nada Salem, Mohammed H Al-Qahtani, Sudhir Kumar O16 The supercomputer
        facility &#x201c;AZIZ&#x201d; at KAU: utility and future prospects Hossam
        Faheem O17 New research into the causes of male infertility Ashok Agarwa O18
        The Klinefelter syndrome: recent progress in pathophysiology and management
        Eberhard Nieschlag, Joachim Wistuba, Oliver S. Damm, Mohd A. Beg, Taha A.
        Abdel-Meguid, Hisham A. Mosli, Osama S. Bajouh, Adel M. Abuzenadah, Mohammed
        H. Al-Qahtani O19 A new look to reproductive medicine in the era of genomics
        Serdar Coskun P1 Wnt signalling receptors expression in Saudi breast cancer
        patients Muhammad Abu-Elmagd, Abdelbaset Buhmeida, Ashraf Dallol, Jaudah Al-Maghrabi,
        Sahar Hakamy, Wejdan Al-Qahtani, Asia Al-Harbi, Shireen Hussain, Mourad Assidi,
        Mohammed Al-Qahtani, Adel Abuzenadah P2 Analysis of oxidative stress interactome
        during spermatogenesis: a systems biology approach to reproduction Burak Ozkosem,
        Rick DuBois P3 Interleukin-18 gene variants are strongly associated with idiopathic
        recurrent pregnancy loss. Safia S Messaoudi, Maryam T Dandana, Touhami Mahjoub,
        Wassim Y Almawi P4 Effect of environmental factors on gene-gene and gene-environment
        reactions: model and theoretical study applied to environmental interventions
        using genotype S. Abdalla, M. Nabil Al-Aama P5 Genomics and transcriptomic
        analysis of imatinib resistance in gastrointestinal stromal tumor Asmaa Elzawahry,
        Tsuyoshi Takahashi, Sachiyo Mimaki, Eisaku Furukawa, Rie Nakatsuka, Isao Kurosaka,
        Takahiko Nishigaki, Hiromi Nakamura, Satoshi Serada, Tetsuji Naka, Seiichi
        Hirota, Tatsuhiro Shibata, Katsuya Tsuchihara, Toshirou Nishida, Mamoru Kato
        P6 <i>In-Silico</i> analysis of putative HCV epitopes against Pakistani human
        leukocyte antigen background: an approach towards development of future vaccines
        for Pakistani population Sajid Mehmood, Naeem Mahmood Ashraf, Awais Asif,
        Muhammad Bilal, Malik Siddique Mehmood, Aadil Hussain P7 Inhibition of AChE
        and BuChE with the natural compounds of <i>Bacopa monerri</i> for the treatment
        of Alzheimer&#x2019;s disease: a bioinformatics approach Qazi Mohammad Sajid
        Jamal, Mughees Uddin Siddiqui, Mohammad A. Alzohairy, Mohammad A. Al Karaawi
        P8 Her2 expression in urothelial cell carcinoma of the bladder in Saudi Arabia
        Taoufik Nedjadi, Jaudah Al-Maghrabi, Mourad Assidi, Heba Al-Khattabi, Adel
        Al-Ammari, Ahmed Al-Sayyad, Abdelbaset Buhmeida, Mohammed Al-Qahtani P9 Association
        of angiotensinogen single nucleotide polymorphisms with Preeclampsia in patients
        from North Africa H&#xe9;dia Zitouni, Nozha Raguema, Marwa Ben Ali, Wided
        Malah, Raja Lfalah, Wassim Almawi, Touhami Mahjoub P10 Systems biology analysis
        reveals relations between normal skin, benign nevi and malignant melanoma
        Mohammed Elanbari, Andrey Ptitsyn P11 The apoptotic effect of thymoquinone
        in Jurkat cells Sana Mahjoub, Rabeb El Ghali, Bechir Achour, Nidhal Ben Amor,
        Mourad Assidi, Brahim N''siri, Hamid Morjani P12 Sonic hedgehog contributes
        in bladder cancer invasion in Saudi Arabia Taoufik Nedjadi, Adel Al-Ammari,
        Ahmed Al-Sayyad, Nada Salem, Esam Azhar, Jaudah Al-Maghrabi P13 Association
        of Interleukin 18 gene promoter polymorphisms - 607A/C and -137&#xa0;G/C with
        colorectal cancer onset in a sample of Tunisian population Vera Chayeb, Maryam
        Dendena, Hedia Zitouni, Khedija Zouari-Limayem, Touhami Mahjoub P14 Pathological
        expression of interleukin-6, -11, leukemia inhibitory factor and their receptors
        in tubal gestation with and without tubal cytomegalovirus infection Bassem
        Refaat, Ahmed M Ashshi, Sarah A Batwa P15 Phenotypic and genetic profiling
        of avian pathogenic and human diarrhegenic <i>Escherichia coli</i> in Egypt
        Hazem Ramadan, Amal Awad, Ahmed Ateya P16 Cancer-targeting dual gene virotherapy
        as a promising therapeutic strategy for treatment of hepatocellular carcinoma
        Adel Galal Ahmed El-Shemi, Ahmad Ashshi, Mohammed Basalamah, Youjin Na, Chae-Ok
        YUN P17 Cancer dual gene therapy with oncolytic adenoviruses expressing TRAIL
        and IL-12 transgenes markedly eradicated human hepatocellular carcinoma both
        <i>in vitro</i> and <i>in vivo</i> Adel Galal Ahmed El-Shemi, Ahmad Ashshi,
        Mohammed Basalamah, Youjin Na, Chae-Ok Yun P18 Therapy with paricalcitol attenuates
        tumor growth and augments tumoricidal and anti-oncogenic effects of 5-fluorouracil
        on animal model of colon cancer Adel Galal El-Shemi, Bassem Refaat, Osama
        Kensara, Amr Abdelfattah P19 The effects of <i>Rubus idaeus</i> extract on
        normal human lymphocytes and cancer cell line Batol Imran Dheeb, Mohammed
        M. F. Al-Halbosiy, Rghad Kadhim Al lihabi, Basim Mohammed Khashman P20 Etanercept,
        a TNF-alpha inhibitor, alleviates mechanical hypersensitivity and spontaneous
        pain in a rat model of chemotherapy-induced neuropathic pain Djouhri, Laiche,
        Chaudhary Adeel, Nedjadi, Taoufik P21 Sleeping beauty mutagenesis system identified
        genes and neuronal transcription factor network involved in pediatric solid
        tumour (medulloblastoma) Hani Al-Afghani, Maria &#x141;astowska, Haya H Al-Balool,
        Harsh Sheth, Emma Mercer, Jonathan M Coxhead, Chris PF Redfern, Heiko Peters,
        Alastair D Burt, Mauro Santibanez-Koref, Chris M Bacon, Louis Chesler, Alistair
        G Rust, David J Adams, Daniel Williamson, Steven C Clifford, Michael S Jackson
        P22 Involvement of interleukin-1 in vitiligo pathogenesis Mala Singh, Mohmmad
        Shoab Mansuri, Shahnawaz D. Jadeja, Hima Patel, Yogesh S. Marfatia, Rasheedunnisa
        Begum P23 Cytogenetics abnormalities in 12,884 referred population for chromosomal
        analysis and the role of FISH in refining the diagnosis (cytogenetic experience
        2004-2013) Amal M Mohamed, Alaa K Kamel, Nivin A Helmy, Sayda A Hammad, Hesham
        F Kayed, Marwa I Shehab, Assad El Gerzawy, Maha M. Ead, Ola M Ead, Mona Mekkawy,
        Innas Mazen, Mona El-Ruby P24 Analysis of binding properties of angiotensin-converting
        enzyme 2 through <i>in silico</i> method S. M. A. Shahid, Qazi Mohammad Sajid
        Jamal, J. M. Arif, Mohtashim Lohani P25 Relationship of genetics markers <i>cis</i>
        and <i>trans</i> to the &#x3b2;-S globin gene with fetal hemoglobin expression
        in Tunisian sickle cell patients Moumni Imen, Chaouch Leila, Ouragini Houyem,
        Douzi Kais, Chaouachi Dorra Mellouli Fethi, Bejaoui Mohamed, Abbes Salem P26
        Analysis of estrogen receptor alpha gene polymorphisms in breast cancer: link
        to genetic predisposition in Sudanese women Areeg Faggad, Amanuel T Gebreslasie,
        Hani Y Zaki, Badreldin E Abdalla P27 KCNQI gene polymorphism and its association
        with CVD and T2DM in the Saudi population Maha S AlShammari, Rhaya Al-Ali,
        Nader Al-Balawi , Mansour Al-Enazi, Ali Al-Muraikhi, Fadi Busaleh, Ali Al-Sahwan,
        Francis Borgio, Abdulazeez Sayyed, Amein Al-Ali, Sadananda Acharya P28 Clinical,
        neuroimaging and cytogenetic study of a patient with microcephaly capillary
        malformation syndrome Maha S. Zaki, Hala T. El-Bassyouni, Marwa I. Shehab
        P29 Altered expression of CD200R1 on dendritic cells of patients with inflammatory
        bowel diseases: <i>in silico</i> investigations and clinical evaluations Mohammed
        F. Elshal, Kaleemuddin M., Alia M. Aldahlawi, Omar Saadah, J. Philip McCoy
        P30 Development of real time PCR diagnostic protocol specific for the Saudi
        Arabian H1N1 viral strains Adel E El-Tarras, Nabil S Awad, Abdulla A Alharthi,
        Mohamed M M Ibrahim P31 Identification of novel genetic variations affecting
        Osteoarthritis patients Haneen S Alsehli, Ashraf Dallol, Abdullah M Gari,
        Mohammed M Abbas, Roaa A Kadam, Mazen M. Gari, Mohmmed H Alkaff, Adel M Abuzenadah,
        Mamdooh A Gari P32 An integrated database of GWAS SNVs and their evolutionary
        properties Heba Abusamra, Sajjad Karim, Hend F Nour eldin, Elham M Alhathli,
        Nada Salem, Sudhir Kumar, Mohammed H Al-Qahtani P33 Familial hypercholesterolemia
        in Saudi Arabia: prime time for a national registry and genetic analysis Fatima
        A. Moradi, Omran M. Rashidi, Zuhier A. Awan P34 Comparative genomics and network-based
        analyses of early hepatocellular carcinoma Ibrahim Hamza Kaya, Olfat Al-Harazi,
        Dilek Colak P35 A TALEN-based oncolytic viral vector approach to knock out
        ABCB1 gene mediated chemoresistance in cancer stem cells Nabila A Alkousi,
        Takis Athanasopoulos P36 Cartilage differentiation and gene expression of
        synovial fluid mesenchymal stem cells derived from osteoarthritis patients
        Afnan O Bahmaid, Etimad A Alhwait, Mamdooh A Gari, Haneen S Alsehli, Mohammed
        M Abbas, Mohammed H Alkaf, Roaa Kadam, Ashraf Dallol, Gauthaman Kalamegam
        P37 E-GRASP: Adding an evolutionary component to the genome-wide repository
        of associations (GRASP) resource Hend F Nour Eldin, Sajjad Karim, Heba Abusamra,
        Elham Alhathli, Nada Salem, Mohammed H Al-Qahtani, Sudhir Kumar P38 Screening
        of <i>AGL</i> gene mutation in Saudi family with glycogen storage disease
        Type III Salma N Alsayed, Fawziah H Aljohani, Samaher M Habeeb, Rawan A Almashali,
        Sulman Basit, Samia M Ahmed P39 High throughput proteomic data suggest modulation
        of cAMP dependent protein kinase A and mitochondrial function in infertile
        patients with varicocele Rakesh Sharma, Ashok Agarwal, Damayanthi Durairajanayagam,
        Luna Samanta, Muhammad Abu-Elmagd, Adel M. Abuzenadah, Edmund S. Sabanegh,
        Mourad Assidi, Mohammed Al-Qahtani P40 Significant protein profile alterations
        in men with primary and secondary infertility Ashok Agarwal, Rakesh Sharma,
        Luna Samanta, Damayanthi Durairajanayagam, Mourad Assidi, Muhammad Abu-Elmagd,
        Mohammed Al-Qahtani, Adel M. Abuzenadah, Edmund S. Sabanegh P41 Spermatozoa
        maturation in infertile patients involves compromised expression of heat shock
        proteins Luna Samanta, Ashok Agarwal, Rakesh Sharma, Zhihong Cui, Mourad Assidi,
        Adel M. Abuzenadah, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P42 Array comparative
        genomic hybridization approach to search genomic answers for spontaneous recurrent
        abortion in Saudi Arabia Alaa A Alboogmi, Nuha A Alansari, Maha M Al-Quaiti,
        Fai T Ashgan, Afnan Bandah, Hasan S Jamal, Abdullraheem Rozi<sub>,</sub> Zeenat
        Mirza, Adel M Abuzenadah, Sajjad Karim, Mohammed H Al-Qahtani P43 Global gene
        expression profiling of Saudi kidney cancer patients Sajjad Karim, Hans-Juergen
        Schulten, Ahmad J Al Sayyad, Hasan MA Farsi, Jaudah A Al-Maghrabi, Zeenat
        Mirza, Reem Alotibi, Alaa Al-Ahmadi, Nuha A Alansari, Alaa A Albogmi, Maha
        M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Mohammed H Al-Qahtani P44 Downregulated
        StAR gene and male reproductive dysfunction caused by nifedipine and ethosuximide
        Rasha A Ebiya, Samia M Darwish, Metwally M. Montaser P45 Clustering based
        gene expression feature selection method: A computational approach to enrich
        the classifier efficiency of differentially expressed genes Heba Abusamra,
        Vladimir B. Bajic P46 Prognostic significance of Osteopontin expression profile
        in colorectal carcinoma Jaudah Al-Maghrabi, Wafaey Gomaa, Mehenaz Hanbazazh,
        Mahmoud Al-Ahwal, Asia Al-Harbi, Wejdan Al-Qahtani, Saher Hakamy, Ghali Baba,
        Abdelbaset Buhmeida, Mohammed Al-Qahtani P47 High Glypican-3 expression pattern
        predicts longer disease-specific survival in colorectal carcinoma Jaudah Al-Maghrabi,
        Abdullah Al-Harbi, Mahmoud Al-Ahwal, Asia Al-Harbi, Wejdan Al-Qahtani, Sahar
        Hakamy, Ghalia Baba, Abdelbaset Buhmeida, Mohammed Al-Qahtani P48 An evolutionary
        re-assessment of GWAS single nucleotide variants implicated in the Cholesterol
        traits Elham M Alhathli, Sajjad Karim, Nada Salem, Hend Nour Eldin, Heba Abusamra,
        Sudhir Kumar, Mohammed H Al-Qahtani P49 Derivation and characterization of
        human Wharton&#x2019;s jelly stem cells (hWJSCs) <i>in vitro</i> for future
        therapeutic applications Aisha A Alyamani, Gauthaman Kalamegam, Etimad A Alhwait,
        Mamdooh A Gari, Mohammed M Abbas, Mohammed H Alkaf, Haneen S Alsehli, Roaa
        A Kadam, Mohammed Al-Qahtani P50 Attitudes of healthcare students toward biomedical
        research in the post-genomic era Rawan Gadi, Abdelbaset Buhmeida, Mourad Assidi
        , Adeel Chaudhary, Leena Merdad P51 Evaluation of the immunomodulatory effects
        of thymoquinone on human bone marrow mesenchymal stem cells (BM-MSCs) from
        osteoarthritic patients Saadiah M Alfakeeh, Etimad A Alhwait, Mamdooh A Gari,
        Mohammed M Abbas, Mohammed H Alkaf, Haneen S Alsehli, Roaa Kadam, Gauthaman
        Kalamegam P52 Implication of IL-10 and IL-28 polymorphism with successful
        anti-HCV therapy and viral clearance Rubi Ghazala, Shilu Mathew, M.Haroon
        Hamed, Mourad Assidi, Mohammed Al-Qahtani, Ishtiaq Qadri P53 Selection of
        flavonoids against obesity protein (FTO) using <i>in silico</i> and <i>in
        vitro</i> approaches Shilu Mathew, Lobna Mira, Manal Shaabad, Shireen Hussain,
        Mourad Assidi, Muhammad Abu-Elmagd, Mohammed Al-Qahtani P54 Computational
        selection and <i>in vitro</i> validation of flavonoids as new antidepressant
        agents Shilu Mathew, Manal Shaabad, Lobna Mira, Shireen Hussain, Mourad Assidi,
        Muhammad Abu-Elmagd, Mohammed Al-Qahtani P55 <i>In Silico</i> prediction and
        prioritization of aging candidate genes associated with progressive telomere
        shortening Ahmed Rebai, Mourad Assidi, Abdelbaset Buhmeida, Muhammad Abu-Elmagd,
        Ashraf Dallol, Jerry W Shay P56 Identification of new cancer testis antigen
        genes in diverse types of malignant human tumour cells Mikhlid H Almutairi
        P57 More comprehensive forensic genetic marker analyses for accurate human
        remains identification using massively parallel sequencing (MPS) Angie Ambers,
        Jennifer Churchill, Jonathan King, Monika Stoljarova, Harrell Gill-King, Mourad
        Assidi, Muhammad Abu-Elmagd, Abdelbaset Buhmeida, Muhammad Al-Qatani, Bruce
        Budowle P58 Flow cytometry approach towards treatment men infertility in Saudi
        Arabia Muhammad Abu-Elmagd, Farid Ahmed, Ashraf Dallol, Mourad Assidi, Taha
        Abo Almagd, Sahar Hakamy, Ashok Agarwal, Muhammad Al-Qahtani, Adel Abuzenadah
        P59 Tissue microarray based validation of CyclinD1 expression in renal cell
        carcinoma of Saudi kidney patients Sajjad Karim, Hans-Juergen Schulten, Ahmad
        J Al Sayyad, Hasan MA Farsi, Jaudah A Al-Maghrabi, Abdelbaset Buhmaida, Zeenat
        Mirza, Reem Alotibi, Alaa Al-Ahmadi, Nuha A Alansari, Alaa A Albogmi, Maha
        M Al-Quaiti, Fai T Ashgan, Afnan Bandah, Mohammed H Al-Qahtani P60 Assessment
        of gold nanoparticles in molecular diagnostics and DNA damage studies Rukhsana
        Satar, Mahmood Rasool, Waseem Ahmad, Nazia Nazam, Mohamad I Lone, Muhammad
        I Naseer, Mohammad S Jamal, Syed K Zaidi, Peter N Pushparaj, Mohammad A Jafri,
        Shakeel A Ansari, Mohammed H Alqahtani P61 Surfing the biospecimen management
        and processing workflow at CEGMR Biobank Hanan Bashier, Abrar Al Qahtani,
        Shilu Mathew, Amal M. Nour, Heba Alkhatabi, Adel M. Abu Zenadah, Abdelbaset
        Buhmeida, Mourad Assidi, Muhammed Al Qahtani P62 Autism Spectrum Disorder:
        knowledge, attitude and awareness in Jeddah, Kingdom of Saudi Arabia Muhammad
        Faheem, Shilu Mathew, Shiny Mathew, Peter Natesan Pushparaj, Mohammad H. Al-Qahtani
        P63 Simultaneous genetic screening of the coagulation pathway genes using
        the Thromboscan targeted sequencing panel Hani A. Alhadrami, Ashraf Dallol,
        Adel Abuzenadah P64 Genome wide array comparative genomic hybridization analysis
        in patients with syndromic congenital heart defects Ibtessam R. Hussein, Adeel
        G. Chaudhary, Rima S Bader, Randa Bassiouni, Maha Alquaiti, Fai Ashgan, Hans
        Schulten, Mohamed Nabil Alama, Mohammad H. Al Qahtani P65 Toxocogenetic evaluation
        of 1, 2-Dichloroethane in bone marrow, blood and cells of immune system using
        conventional, molecular and flowcytometric approaches Mohammad I Lone, Nazia
        Nizam, Waseem Ahmad, Mohammad A Jafri, Mahmood Rasool, Shakeel A Ansari, Muhammed
        H Al-Qahtani P66 Molecular cytogenetic diagnosis of sexual development disorders
        in newborn: A case of ambiguous genitalia Eradah Alshihri, Muhammad Abu-Elmagd,
        Lina Alharbi, Mourad Assidi, Mohammed Al-Qahtani P67 Identification of disease
        specific gene expression clusters and pathways in hepatocellular carcinoma
        using <i>In Silico</i> methodologies Shilu Mathew, Peter Pushparaj Natesan,
        Muhammed Al Qahtani P68 Human Wharton&#x2019;s Jelly stem cell conditioned
        medium inhibits primary ovarian cancer cells <i>in vitro:</i> Identification
        of probable targets and mechanisms using systems biology Gauthaman Kalamegam,
        Peter Natesan Pushparaj, Fazal Khan, Roaa Kadam, Farid Ahmed, Mourad Assidi,
        Khalid Hussain Wali Sait, Nisreen Anfinan, Mohammed Al Qahtani P69 Mutation
        spectrum of ASPM (Abnormal Spindle-like, Microcephaly-associated) gene in
        Saudi Arabian population Muhammad I Naseer, Adeel G Chaudhary, Mohammad S
        Jamal, Shilu Mathew, Lobna S Mira, Peter N Pushparaj, Shakeel A Ansari, Mahmood
        Rasool, Mohammed H AlQahtani P70 Identification and characterization of novel
        genes and mutations of primary microcephaly in Saudi Arabian population Muhammad
        I Naseer, Adeel G Chaudhary, Shilu Mathew, Lobna S Mira, Mohammad S Jamal,
        Sameera Sogaty, Randa I Bassiouni, Mahmood Rasool, Mohammed H AlQahtani P71
        Molecular genetic analysis of hereditary nonpolyposis colorectal cancer (Lynch
        Syndrome) in Saudi Arabian population Mahmood Rasool, Shakeel A Ansari, Mohammad
        S Jamal, Peter N Pushparaj, Abdulrahman MS Sibiani, Waseem Ahmad, Abdelbaset
        Buhmeida, Mohammad A Jafri, Mohiuddin K Warsi, Muhammad I Naseer, Mohammed
        H Al-Qahtani P72 Function predication of hypothetical proteins from genome
        database of chlamydia trachomatis Rubi, Kundan Kumar, Ahmad AT Naqvi, Faizan
        Ahmad, Md I Hassan, Mohammad S Jamal, Mahmood Rasool, Mohammed H AlQahtani
        P73 Transcription factors as novel molecular targets for skin cancer Ashraf
        Ali, Jummanah Jarullah, Mahmood Rasool, Abdelbasit Buhmeida, Shahida Khan,
        Ghufrana Abdussami, Maryam Mahfooz, Mohammad A Kamal, Ghazi A Damanhouri,
        Mohammad S Jamal P74 An <i>In Silico</i> analysis of Plumbagin binding to
        apoptosis executioner: Caspase-3 and Caspase-7 Bushra Jarullah, Jummanah Jarullah,
        Mohammad SS Jarullah, Ashraf Ali, Mahmood Rasool, Mohammad S Jamal P75 Single
        cell genomics applications for preimplantation genetic screening optimization:
        Comparative analysis of whole genome amplification technologies Mourad Assidi,
        Muhammad Abu-Elmagd, Osama Bajouh, Peter Natesan Pushparaj, Mohammed Al-Qahtani,
        Adel Abuzenadah P76 ZFP36 regulates miRs-34a in anti-IgM triggered immature
        B cells Mohammad S Jamal, Jummanah Jarullah, Abdulah EA Mathkoor, Hashim MA
        Alsalmi, Anas MM Oun, Ghazi A Damanhauri, Mahmood Rasool, Mohammed H AlQahtani
        P77 Identification of a novel mutation in the <i>STAMBP</i> gene in a family
        with microcephaly-capillary malformation syndrome Muhammad I. Naseer, Mahmood
        Rasool, Sameera Sogaty, Adeel G. Chudhary, Yousif A. Abutalib, Daniele Merico,
        Susan Walker, Christian R. Marshall, Mehdi Zarrei, Stephen W. Scherer, Mohammad
        H. Al-Qahtani P78 Copy number variations in Saudi patients with intellectual
        disability and epilepsy Muhammad I. Naseer, Muhammad Faheem, Adeel G. Chaudhary,
        Mahmood Rasool, Gauthaman Kalamegam, Fai Talal Ashgan, Mourad Assidi, Farid
        Ahmed, Syed Kashif Zaidi, Mohammed M. Jan, Mohammad H. Al-Qahtani P79 Prognostic
        significance of CD44 expression profile in colorectal carcinoma Maryam Al-Zahrani,
        Sahira Lary, Sahar Hakamy, Ashraf Dallol, Mahmoud Al-Ahwal, Jaudah Al-Maghrabi,
        Emmanuel Dermitzakis, Adel Abuzenadah, Abdelbaset Buhmeida, Mohammed Al-Qahtani
        P80 Association of the endothelial nitric oxide synthase (eNOS) gene G894T
        polymorphism with hypertension risk and complications Abeer A Al-refai, Mona
        Saleh, Rehab I Yassien, Mahmmoud Kamel, Rabab M Habeb P81 SNPs array to screen
        genetic variation among diabetic patients Najlaa Filimban, Ashraf Dallol,
        Nadia Ghannam, Mohammed Al-Qahtani, Adel Mohammed Abuzenadah P82 Detection
        and genotyping of <i>Helicobacter pylori</i> among gastric cancer patients
        from Saudi Arabian population Fehmida Bibi, Sana Akhtar, Esam I. Azhar, Muhammad
        Yasir, Muhammad I. Nasser, Asif A. Jiman-Fatani, Ali Sawan P83 Antimicrobial
        drug resistance and molecular detection of susceptibility to Fluoroquinolones
        among clinical isolates of Salmonella species from Jeddah-Saudi Arabia Ruaa
        A Lahzah, Asho Ali P84 Identification of the toxic and virulence nature of
        MAP1138c protein of <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i>
        Syed A Hassan, Seyed E Hasnain, Iftikhar A Tayubi, Hamza A Abujabal, Alaa
        O Magrabi P85 <i>In vitro</i> and <i>in silico</i> evaluation of miR137 in
        human breast cancer Fazal Khan, Gauthaman Kalamegam, Peter Natesan Pushparaj,
        Adel Abuzenada, Taha Abduallah Kumosani, Elie Barbour, Mohammed Al-Qahtani
        P86 Auruka gene is over-expressed in Saudi breast cancer Manal Shabaad, Shilu
        Mathew, Ashraf Dallol, Adnan Merdad, Abdelbaset Buhmeida, Mohammed Al-Qahtani
        P87 The potential of immunogenomics in personalized healthcare Mourad Assidi,
        Muhammad Abu-Elmagd, Kalamegam Gauthaman, Mamdooh Gari, Adeel Chaudhary, Adel
        Abuzenadah, Peter Natesan Pushparaj, Mohammed Al-Qahtani P88 <i>In Silico</i>
        physiochemical and structural characterization of a putative ORF MAP0591 and
        its implication in the pathogenesis of <i>Mycobacterium paratuberculosis</i>
        in ruminants and humans Syed A Hassan, Iftikhar A Tayubi, Hani MA Aljahdali
        P89 Effects of heat shock on human bone marrow mesenchymal stem cells (BM-MSCs):
        Implications in regenerative medicine Reham Al Nono, Mamdooh Gari, Haneen
        Alsehli, Farid Ahmed, Mohammed Abbas, Gauthaman Kalamegam, Mohammed Al-Qahtani
        P90 <i>In Silico</i> analyses of the molecular targets of Resveratrol unravels
        its importance in mast cell mediated allergic responses Shilu Mathew, Fazal
        Khan, Mahmood Rasool, Mohammed Sarwar Jamal, Muhammad Imran Naseer, Zeenat
        Mirza, Sajjad Karim, Shakeel Ansari, Mourad Assidi, Gauthaman Kalamegam, Mamdooh
        Gari, Adeel Chaudhary, Adel Abuzenadah, Peter Natesan Pushparaj, Mohammed
        Al-Qahtani P91 Effects of environmental particulate matter on bone-marrow
        mesenchymal stem cells Muhammad Abu-Elmagd, Gauthaman Kalamegam, Roaa Kadam,
        Mansour A Alghamdi, Magdy Shamy, Max Costa, Mamdouh I Khoder, Mourad Assidi,
        Peter Natesan Pushparaj, Mamdooh Gari, Mohammed Al-Qahtani P92 Distinctive
        charge clusters in human virus proteomes Najla Kharrat, Sabrine Belmabrouk,
        Rania Abdelhedi, Riadh Benmarzoug, Mourad Assidi, Mohammed H. Al Qahtani,
        Ahmed Rebai P93 <i>In vitro</i> experimental model and approach in identification
        of new biomarkers of inflammatory forms of arthritis Ghazi Dhamanhouri, Peter
        Natesan Pushparaj, Abdelwahab Noorwali, Mohammad Khalid Alwasiyah, Afnan Bahamaid,
        Saadiah Alfakeeh, Aisha Alyamani, Haneen Alsehli, Mohammed Abbas, Mamdooh
        Gari, Ali Mobasheri, Gauthaman Kalamegam, Mohammed Al-Qahtani P94 Molecular
        docking of GABA<sub>A</sub> receptor subunit &#x3b3;-2 with novel anti-epileptic
        compounds Muhammad Faheem, Shilu Mathew, Peter Natesan Pushparaj, Mohammad
        H. Al-Qahtani P95 Breast cancer knowledge, awareness, and practices among
        Saudi females residing in Jeddah Shilu Mathew, Muhammad Faheem, Shiny Mathew,
        Peter Natesan Pushparaj, Mohammad H. Al-Qahtani P96 Anti-inflammatory role
        of Sesamin by Attenuation of Iba1/TNF-&#x3b1;/ICAM-1/iNOS signaling in Diabetic
        Retinopathy Mohammad Sarwar Jamal, Syed Kashif Zaidi, Raziuddin Khan, Kanchan
        Bhatia, Mohammed H. Al-Qahtani, Saif Ahmad P97 Identification of drug lead
        molecule against vp35 protein of Ebola virus: An <i>In-Silico</i> approach
        Iftikhar AslamTayubi, Manish Tripathi, Syed Asif Hassan, Rahul Shrivastava
        P98 An approach to personalized medicine from SNP-calling through disease
        analysis using whole exome-sequencing of three sub-continental populations
        Iftikhar A Tayubi, Syed Hassan, Hamza A.S Abujabal P99 Low versus high frequency
        of Glucose &#x2013;6 &#x2013; Phosphate Dehydrogenase (G6PD) deficiency in
        urban against tribal population of Gujarat &#x2013; A signal to natural selection
        Ishani Shah, Bushra Jarullah, Mohammad S Jamal, Jummanah Jarullah P100 Spontaneous
        preterm birth and single nucleotide gene polymorphisms: a recent update Ishfaq
        A Sheikh, Ejaz Ahmad, Mohammad S Jamal, Mohd Rehan, Muhammad Abu-Elmagd, Iftikhar
        A Tayubi, Samera F AlBasri, Osama S Bajouh, Rola F Turki, Adel M Abuzenadah,
        Ghazi A Damanhouri, Mohd A Beg, Mohammed Al-Qahtani P101 Prevalence of congenital
        heart diseases among Down syndrome cases in Saudi Arabia: role of molecular
        genetics in the pathogenesis Sahar AF Hammoudah, Khalid M AlHarbi, Lama M
        El-Attar, Ahmed MZ Darwish P102 Combinatorial efficacy of specific pathway
        inhibitors in breast cancer cells Sara M Ibrahim, Ashraf Dallol<sub>,</sub>
        Hani Choudhry, Adel Abuzenadah, Jalaludden Awlia, Adeel Chaudhary, Farid Ahmed,
        Mohammed Al-Qahtani P103 MiR-143 and miR-145 cluster as potential replacement
        medicine for the treatment of cancer Mohammad A Jafri, Muhammad Abu-Elmagd,
        Mourad Assidi, Mohammed Al-Qahtani P104 Metagenomic profile of gut microbiota
        during pregnancy in Saudi population Imran khan, Muhammad Yasir, Esam I. Azhar,
        Sameera Al-basri, Elie Barbour, Taha Kumosani P105 Exploration of anticancer
        targets of selected metabolites of <i>Phoenix dactylifera L.</i> using systems
        biological approaches Fazal Khan, Gauthaman Kalamegam, Peter Natesan Pushparaj,
        Adel Abuzenada, Taha Abduallah Kumosani, Elie Barbour P106 CD226 and CD40
        gene polymorphism in susceptibility to Juvenile rheumatoid arthritis in Egyptian
        patients Heba M. EL Sayed, Eman A. Hafez P107 Paediatric exome sequencing
        in autism spectrum disorder ascertained in Saudi families Hans-Juergen Schulten,
        Aisha Hassan Elaimi, Ibtessam R Hussein, Randa Ibrahim Bassiouni, Mohammad
        Khalid Alwasiyah, Richard F Wintle, Adeel Chaudhary, Stephen W Scherer, Mohammed
        Al-Qahtani P108 Crystal structure of the complex formed between Phospholipase
        A<sub>2</sub> and the central core hydrophobic fragment of Alzheimer&#x2019;s
        &#x3b2;- amyloid peptide: a reductionist approach Zeenat Mirza, Vikram Gopalakrishna
        Pillai, Sajjad Karim, Sujata Sharma, Punit Kaur, Alagiri Srinivasan, Tej P
        Singh, Mohammed Al-Qahtani P109 Differential expression profiling between
        meningiomas from female and male patients Reem Alotibi, Alaa Al-Ahmadi, Fatima
        Al-Adwani, Deema Hussein, Sajjad Karim, Mona Al-Sharif, Awatif Jamal, Fahad
        Al-Ghamdi, Jaudah Al-Maghrabi, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary,
        Hans-Juergen Schulten, Mohammed Al-Qahtani P110 Neurospheres as models of
        early brain development and therapeutics Muhammad Faheem, Peter Natesan Pushparaj,
        Shilu Mathew, Taha Abdullah Kumosani, Gauthaman Kalamegam, Mohammed Al-Qahtani
        P111 Identification of a recurrent causative missense mutation p.(W577C) at
        the LDLR exon 12 in familial hypercholesterolemia affected Saudi families
        Faisal A Al-Allaf, Zainularifeen Abduljaleel, Abdullah Alashwal, Mohiuddin
        M. Taher, Abdellatif Bouazzaoui, Halah Abalkhail, Faisal A. Ba-Hammam, Mohammad
        Athar P112 Epithelial ovarian carcinoma (EOC): Systems oncological approach
        to identify diagnostic, prognostic and therapeutic biomarkers Gauthaman Kalamegam,
        Peter Natesan Pushparaj, Muhammad Abu-Elmagd, Farid Ahmed Khalid HussainWali
        Sait, Nisreen Anfinan, Mamdooh Gari, Adeel Chaudhary, Adel Abuzenadah, Mourad
        Assidi, Mohammed Al-Qahtani P113 Crohn&#x2019;s disease phenotype in northern
        Tunisian population Naira Ben Mami, Yosr Z Haffani, Mouna Medhioub, Lamine
        Hamzaoui, Ameur Cherif, Msadok Azouz P114 Establishment of <i>In Silico</i>
        approaches to decipher the potential toxicity and mechanism of action of drug
        candidates and environmental agents Gauthaman Kalamegam, Fazal Khan, Shilu
        Mathew, Mohammed Imran Nasser, Mahmood Rasool, Farid Ahmed, Peter Natesan
        Pushparaj, Mohammed Al-Qahtani P115 1q Gain predicts poor prognosis marker
        for young breast cancer patients Shereen A Turkistany, Lina M Al-harbi, Ashraf
        Dallol, Jamal Sabir, Adeel Chaudhary, Adel Abuzenadah P116 Disorders of sex
        chromosomes in a diagnostic genomic medicine unit in Saudi Arabia: Prevalence,
        diagnosis and future guidelines Basmah Al-Madoudi, Bayan Al-Aslani, Khulud
        Al-Harbi, Rwan Al-Jahdali, Hanadi Qudaih, Emad Al Hamzy, Mourad Assidi, Mohammed
        Al Qahtani P117 Combination of WYE354 and Sunitinib demonstrate synergistic
        inhibition of acute myeloid leukemia <i>in vitro</i> Asad M Ilyas, Youssri
        Ahmed, Mamdooh Gari, Farid Ahmed, Mohammed Alqahtani P118 Integrated use of
        evolutionary information in GWAS reveals important SNPs in Asthma Nada Salem,
        Sajjad Karim, Elham M Alhathli, Heba Abusamra, Hend F Nour Eldin, Mohammed
        H Al-Qahtani, Sudhir Kumar P119 Assessment of <i>BRAF</i>, <i>IDH1</i>, <i>IDH2</i>,
        and <i>EGFR</i> mutations in a series of primary brain tumors Fatima Al-Adwani,
        Deema Hussein, Mona Al-Sharif, Awatif Jamal, Fahad Al-Ghamdi, Jaudah Al-Maghrabi,
        Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Mohammed Al-Qahtani, Hans-Juergen
        Schulten P120 Expression profiles distinguish oligodendrogliomas from glioblastoma
        multiformes with or without oligodendroglioma component Alaa Alamandi, Reem
        Alotibi, Deema Hussein, Sajjad Karim, Jaudah Al-Maghrabi, Fahad Al-Ghamdi,
        Awatif Jamal, Saleh S Baeesa, Mohammed Bangash, Adeel Chaudhary, Hans-Juergen
        Schulten, Mohammed Al-Qahtani P121 Hierarchical clustering in thyroid goiters
        and hyperplastic lesions Ohoud Subhi, Nadia Bagatian, Sajjad Karim, Adel Al-Johari,
        Osman Abdel Al-Hamour, Hosam Al-Aradati, Abdulmonem Al-Mutawa, Faisal Al-Mashat,
        Jaudah Al-Maghrabi, Hans-Juergen Schulten, Mohammad Al-Qahtani P122 Differential
        expression analysis in thyroiditis and papillary thyroid carcinomas with or
        without coexisting thyroiditis Nadia Bagatian, Ohoud Subhi, Sajjad Karim,
        Adel Al-Johari, Osman Abdel Al-Hamour, Abdulmonem Al-Mutawa, Hosam Al-Aradati,
        Faisal Al-Mashat, Mohammad Al-Qahtani, Hans-Juergen Schulten, Jaudah Al-Maghrabi
        P123 Metagenomic analysis of waste water microbiome in Sausdi Arabia Muhammad
        W shah, Muhammad Yasir, Esam I Azhar, Saad Al-Masoodi P124 Molecular characterization
        of <i>Helicobacter pylori</i> from faecal samples of Tunisian patients with
        gastric cancer Yosr Z Haffani, Msadok Azouz, Emna Khamla, Chaima Jlassi, Ahmed
        S. Masmoudi, Ameur Cherif, Lassaad Belbahri P125 Diagnostic application of
        the oncoscan<sup>&#xa9;</sup> panel for the identification of hereditary cancer
        syndrome Shadi Al-Khayyat, Roba Attas, Atlal Abu-Sanad, Mohammed Abuzinadah,
        Adnan MerdadAshraf Dallol, Adeel Chaudhary, Mohammed Al-Qahtani, Adel Abuzenadah
        P126 Characterization of clinical and neurocognitive features in a family
        with a novel <i>OGT</i> gene missense mutation c. 1193G&#x2009;&gt;&#x2009;A/
        (p. Ala319Thr) Habib Bouazzi, Carlos Trujillo, Mohammad Khalid Alwasiyah,
        Mohammed Al-Qahtani P127 Case report: a rare homozygous deletion mutation
        of <i>TMEM70</i> gene associated with 3-Methylglutaconic Aciduria and cataract
        in a Saudi patient Maha Alotaibi, Rami Nassir P128 Isolation and purification
        of antimicrobial milk proteins Ishfaq A Sheikh, Mohammad A Kamal, Essam H
        Jiffri, Ghulam M Ashraf, Mohd A Beg P129 Integrated analysis reveals association
        of ATP8B1 gene with colorectal cancer Mohammad A Aziz, Rizwan Ali, Mahmood
        Rasool, Mohammad S Jamal, Nusaibah samman, Ghufrana Abdussami, Sathish Periyasamy,
        Mohiuddin K Warsi, Mohammed Aldress, Majed Al Otaibi, Zeyad Al Yousef, Mohamed
        Boudjelal, Abdelbasit Buhmeida, Mohammed H Al-Qahtani, Ibrahim AlAbdulkarim
        P130 Implication of IL-10 and IL-28 polymorphism with successful anti-HCV
        therapy and viral clearance Rubi Ghazala, Shilu Mathew, M. Haroon Hamed, Mourad
        Assidi, Mohammed Al-Qahtani, Ishtiaq Qadri P131 Interactions of endocrine
        disruptor di-(2-ethylhexyl) phthalate (DEHP) and its metabolite mono-2-ethylhexyl
        phthalate (MEHP) with progesterone receptor Ishfaq A Sheikh, Muhammad Abu-Elmagd,
        Rola F Turki, Ghazi A Damanhouri, Mohd A. Beg P132 Association of HCV nucleotide
        polymorphism in the development of hepatocellular carcinoma Mohd Suhail, Abid
        Qureshi, Adil Jamal, Peter Natesan Pushparaj, Mohammad Al-Qahtani, Ishtiaq
        Qadri P133 Gene expression profiling by DNA microarrays in colon cancer treated
        with chelidonine alkaloid Mahmoud Z El-Readi, Safaa Y Eid, Michael Wink P134
        Successful <i>in vitro</i> fertilization after eight failed trials Ahmed M.
        Isa, Lulu Alnuaim, Johara Almutawa, Basim Abu-Rafae, Saleh Alasiri, Saleh
        Binsaleh P135 Genetic sensitivity analysis using SCGE, cell cycle and mitochondrial
        membrane potential in OPs stressed leukocytes in <i>Rattus norvegicus</i>
        through flow cytometric input Nazia Nazam, Mohamad I Lone, Waseem Ahmad, Shakeel
        A Ansari, Mohamed H Alqahtani</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Shay</LastName><ForeName>Jerry W.</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>University
        of Texas Southwestern Medical Center, Dallas, TX USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Homma</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department
        of Cell Biology and Anatomy, Graduate School of Medicine, the University of
        Tokyo, Tokyo, 113-0033 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ruyun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Cell Biology and Anatomy, Graduate School of Medicine, the University of
        Tokyo, Tokyo, 113-0033 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Naseer</LastName><ForeName>Muhammad Imran</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel
        G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirokawa</LastName><ForeName>Nobutaka</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department
        of Cell Biology and Anatomy, Graduate School of Medicine, the University of
        Tokyo, Tokyo, 113-0033 Japan </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goudarzi</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry and Molecular &amp; Cellular Biology, Lombardi Comprehensive
        Cancer Center, Georgetown University, Washington, DC USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Fornace</LastName><ForeName>Albert J.</ForeName><Initials>AJ</Initials><Suffix>Jr.</Suffix><AffiliationInfo><Affiliation>Department
        of Biochemistry and Molecular &amp; Cellular Biology, Lombardi Comprehensive
        Cancer Center, Georgetown University, Washington, DC USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University,
        Washington, DC USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University,
        Washington, DC USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Baeesa</LastName><ForeName>Saleh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Deema</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangash</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghamdi</LastName><ForeName>Fahad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carracedo</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Ishaq</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qashqari</LastName><ForeName>Hanadi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madkhali</LastName><ForeName>Nawal</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saka</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saini</LastName><ForeName>Kulvinder
        S.</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Awatif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damanhouri</LastName><ForeName>Ghazi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkhatabi</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodeve</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffield
        Diagnostic Genetic Service, Sheffield Children&#x2019;s NHS Foundation Trust,
        Western Bank, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Crookes</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sheffield
        Diagnostic Genetic Service, Sheffield Children&#x2019;s NHS Foundation Trust,
        Western Bank, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Niksic</LastName><ForeName>Nikolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sheffield
        Diagnostic Genetic Service, Sheffield Children&#x2019;s NHS Foundation Trust,
        Western Bank, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Beauchamp</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sheffield
        Diagnostic Genetic Service, Sheffield Children&#x2019;s NHS Foundation Trust,
        Western Bank, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center
        of Innovations in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaught</LastName><ForeName>Jim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>President,
        ISBER, Editor-in-Chief, Biopreservation &amp; Biobanking, &#x115f;, USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Budowle</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute
        of Applied Genetics, Department of Molecular and Medical Genetics, University
        of North Texas Health Science Center, Fort Worth, TX 76107 USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merdad</LastName><ForeName>Leena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department
        of Dental Public Health, Faculty of Dentistry, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute
        for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA
        19122 USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miura</LastName><ForeName>Sayaka</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute
        for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA
        19122 USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute
        for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA
        19122 USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carracedo</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genomic
        Medicine Group- Galician Foundation of Genomic Medicine (SERGAS), CIBERER,
        University of Santiago de Compostela, Santiago de Compostela, Spain </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine, King Abdulaziz University, Jeddah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebai</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory
        of Molecular and Cellular Screening Processes (Bioinformatics Group), Centre
        of Biotechnology of Sfax, P.O. Box &#x201c;1177&#x201d;, Sfax, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Eldin</LastName><ForeName>Hend F. Nour</ForeName><Initials>HFN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abusamra</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alhathli</LastName><ForeName>Elham M.</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Salem</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute
        for Genomics and Evolutionary Medicine, Temple University (SERC 602A), Philadelphia,
        PA 19122 USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faheem</LastName><ForeName>Hossam</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Fujitsu
        Technology Solutions International, &#x115f;, &#x115f; </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Agarwa</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Case
        Western Reserve University, School of Medicine and Lerner College of Medicine,
        Cleveland Clinic Foundation, Cleveland, Ohio USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Andrology Center, Cleveland, Ohio USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nieschlag</LastName><ForeName>Eberhard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center
        for Reproductive Medicine and Andrology, University of M&#xfc;nster, M&#xfc;nster,
        Germany </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wistuba</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center
        for Reproductive Medicine and Andrology, University of M&#xfc;nster, M&#xfc;nster,
        Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damm</LastName><ForeName>Oliver
        S.</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Center for
        Reproductive Medicine and Andrology, University of M&#xfc;nster, M&#xfc;nster,
        Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beg</LastName><ForeName>Mohd
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel-Meguid</LastName><ForeName>Taha
        A.</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department
        of Urology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mosli</LastName><ForeName>Hisham A.</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department
        of Urology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bajouh</LastName><ForeName>Osama S.</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, King Abdulaziz University Hospital, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coskun</LastName><ForeName>Serdar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Assisted
        Reproductive Technology Laboratory, Department of Pathology and Laboratory
        Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakamy</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Wejdan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Harbi</LastName><ForeName>Asia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Shireen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozkosem</LastName><ForeName>Burak</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Biodesign
        Institute, Arizona State University, Tempe, AZ 85281 USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>DuBois</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Chemistry and Biochemistry, Arizona State University, Tempe, AZ 85287 USA
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messaoudi</LastName><ForeName>Safia
        S.</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Forensic
        Biology Department, College of Forensic Sciences, Naif Arab University for
        Security Sciences, Riyadh, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dandana</LastName><ForeName>Maryam T.</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>College
        of Pharmacy of Monastir, Monastir, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mahjoub</LastName><ForeName>Touhami</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>College
        of Pharmacy of Monastir, Monastir, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Almawi</LastName><ForeName>Wassim Y.</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department
        of Medical Biochemistry, Arabian Gulf University, Manama, Bahrain </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abdalla</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Physics, Faculty of Science, King Abdulaziz University Jeddah, P.O. Box
        80203, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Aama</LastName><ForeName>M. Nabil</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Internal
        Medicine and Cardiology, King Abdulaziz University Medical School, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elzawahry</LastName><ForeName>Asmaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Bioinformatics, National Cancer Center Research Institute, 5-1-1 Tsukiji,
        Chuuoo-ku, Tokyo, 104-0045 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Tsuyoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department
        of Gastroenterological Surgery, Osaka University Graduate School of Medicine,
        2-2 E2, Yamadaoka, Suita City, Osaka 565-0871 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mimaki</LastName><ForeName>Sachiyo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division
        of Translational Research, Exploratory Oncology Research and Clinical Trial
        Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577
        Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Eisaku</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department
        of Bioinformatics, National Cancer Center Research Institute, 5-1-1 Tsukiji,
        Chuuoo-ku, Tokyo, 104-0045 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nakatsuka</LastName><ForeName>Rie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Gastroenterological Surgery, Osaka University Graduate School of Medicine,
        2-2 E2, Yamadaoka, Suita City, Osaka 565-0871 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kurosaka</LastName><ForeName>Isao</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department
        of Bioinformatics, National Cancer Center Research Institute, 5-1-1 Tsukiji,
        Chuuoo-ku, Tokyo, 104-0045 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nishigaki</LastName><ForeName>Takahiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department
        of Gastroenterological Surgery, Osaka University Graduate School of Medicine,
        2-2 E2, Yamadaoka, Suita City, Osaka 565-0871 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Hiromi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division
        of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji,
        Chuuoo-ku, Tokyo, 104-0045 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Serada</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division
        of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji,
        Chuuoo-ku, Tokyo, 104-0045 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Naka</LastName><ForeName>Tetsuji</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory
        for Immune Signal, National Institute of Biomedical Innovation, 7-6-8 Saito-Asagi,
        Ibaraki City, Osaka 567-0085 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hirota</LastName><ForeName>Seiichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Surgical Pathology, Hyogo Medical College, 1-1, Mukogawa-cho, Nishinomiya
        City, Hyogo 663-8501 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shibata</LastName><ForeName>Tatsuhiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory
        for Immune Signal, National Institute of Biomedical Innovation, 7-6-8 Saito-Asagi,
        Ibaraki City, Osaka 567-0085 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tsuchihara</LastName><ForeName>Katsuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division
        of Translational Research, Exploratory Oncology Research and Clinical Trial
        Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577
        Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishida</LastName><ForeName>Toshirou</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa,
        Chiba 277-8577 Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Mamoru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Bioinformatics, National Cancer Center Research Institute, 5-1-1 Tsukiji,
        Chuuoo-ku, Tokyo, 104-0045 Japan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mehmood</LastName><ForeName>Sajid</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical
        Biochemistry Group, Department of Biochemistry &amp; Molecular Biology, University
        of Gujrat, Punjab, Pakistan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Naeem Mahmood</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Clinical
        Biochemistry Group, Department of Biochemistry &amp; Molecular Biology, University
        of Gujrat, Punjab, Pakistan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Asif</LastName><ForeName>Awais</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical
        Biochemistry Group, Department of Biochemistry &amp; Molecular Biology, University
        of Gujrat, Punjab, Pakistan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bilal</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical
        Biochemistry Group, Department of Biochemistry &amp; Molecular Biology, University
        of Gujrat, Punjab, Pakistan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mehmood</LastName><ForeName>Malik Siddique</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Clinical
        Biochemistry Group, Department of Biochemistry &amp; Molecular Biology, University
        of Gujrat, Punjab, Pakistan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hussain</LastName><ForeName>Aadil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical
        Biochemistry Group, Department of Biochemistry &amp; Molecular Biology, University
        of Gujrat, Punjab, Pakistan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Qazi Mohammad Sajid</ForeName><Initials>QMS</Initials><AffiliationInfo><Affiliation>Department
        of Health Information Management, College of Applied Medical Sciences, Buraydah
        Colleges, Al Qassim, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Siddiqui</LastName><ForeName>Mughees Uddin</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Department
        of Health Information Management, College of Applied Medical Sciences, Buraydah
        Colleges, Al Qassim, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alzohairy</LastName><ForeName>Mohammad A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department
        of Medical Laboratory, College of Applied Medical Sciences, Buraydah Colleges,
        Al Qassim, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Karaawi</LastName><ForeName>Mohammad A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department
        of Medical Laboratory, College of Applied Medical Sciences, Buraydah Colleges,
        Al Qassim, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nedjadi</LastName><ForeName>Taoufik</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, KAU, Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, KAU, Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, Jeddah, Kingdom of Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Khattabi</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, Jeddah, Kingdom of Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ammari</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Urology, King Faisal Specialist Hospital and research Centre, Jeddah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sayyad</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Urology, KAUH, Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, Jeddah, Kingdom of Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, Jeddah, Kingdom of Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zitouni</LastName><ForeName>H&#xe9;dia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research&#x2019;s
        Laboratory of Human Genome and Multi-factorial diseases LR12ES07, College
        of Pharmacy, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Sciences, Bizerte, 7021 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Raguema</LastName><ForeName>Nozha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research&#x2019;s
        Laboratory of Human Genome and Multi-factorial diseases LR12ES07, College
        of Pharmacy, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Sciences, Bizerte, 7021 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ali</LastName><ForeName>Marwa Ben</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Research&#x2019;s
        Laboratory of Human Genome and Multi-factorial diseases LR12ES07, College
        of Pharmacy, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Sciences, Bizerte, 7021 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Malah</LastName><ForeName>Wided</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Maternity
        and Neonatal Centre, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lfalah</LastName><ForeName>Raja</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Maternity
        and Neonatal Centre, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Almawi</LastName><ForeName>Wassim</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department
        of Medical Biochemistry, College of Medicine and Medical Sciences, Arabian
        Gulf University, P.O. Box 22979, Manama, Bahrain </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mahjoub</LastName><ForeName>Touhami</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research&#x2019;s
        Laboratory of Human Genome and Multi-factorial diseases LR12ES07, College
        of Pharmacy, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Elanbari</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sidra
        Medical and Research Center, PO Box 26999, Doha, Qatar </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ptitsyn</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sidra
        Medical and Research Center, PO Box 26999, Doha, Qatar </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mahjoub</LastName><ForeName>Sana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory
        of Human Genome and Multifactorials diseases, Faculty of Pharmacy, Monastir,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El
        Ghali</LastName><ForeName>Rabeb</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory
        of Human Genome and Multifactorials diseases, Faculty of Pharmacy, Monastir,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achour</LastName><ForeName>Bechir</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory
        of Human Genome and Multifactorials diseases, Faculty of Pharmacy, Monastir,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amor</LastName><ForeName>Nidhal
        Ben</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Laboratory
        of Human Genome and Multifactorials diseases, Faculty of Pharmacy, Monastir,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>N&#x2019;siri</LastName><ForeName>Brahim</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory
        of Human Genome and Multifactorials diseases, Faculty of Pharmacy, Monastir,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morjani</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research
        Unit Extracellular Matrix and Cellular Dynamic, Faculty of Pharmacy, Monastir,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nedjadi</LastName><ForeName>Taoufik</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, KAU, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Ammari</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Urology, King Faisal Specialist Hospital and research Centre, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sayyad</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Urology, KAUH, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Salem</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Azhar</LastName><ForeName>Esam</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, KAU, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, KAU, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chayeb</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Human
        Genome and Multifactorial Diseases Laboratory, Faculty of Pharmacy, University
        of Monastir, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Science of Bizerte, University of Carthage, Jarzouna, 7021 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dendena</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Human
        Genome and Multifactorial Diseases Laboratory, Faculty of Pharmacy, University
        of Monastir, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zitouni</LastName><ForeName>Hedia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Human
        Genome and Multifactorial Diseases Laboratory, Faculty of Pharmacy, University
        of Monastir, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Science of Bizerte, University of Carthage, Jarzouna, 7021 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zouari-Limayem</LastName><ForeName>Khedija</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research
        Unit: Colorectal cancer in Young Subjects - Faculty of Medecine, University
        of Monastir, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgery
        Department, University Hospital Fattouma Bourguiba, University of Monastir,
        Monastir, 5000 Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahjoub</LastName><ForeName>Touhami</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Human
        Genome and Multifactorial Diseases Laboratory, Faculty of Pharmacy, University
        of Monastir, Monastir, 5000 Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Refaat</LastName><ForeName>Bassem</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory
        Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        Makkah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ashshi</LastName><ForeName>Ahmed M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Laboratory
        Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        Makkah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Batwa</LastName><ForeName>Sarah A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Obstertics
        and Gynaecology Department, Maternity and Children Hospital, Jeddah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramadan</LastName><ForeName>Hazem</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hygiene
        and Zoonoses Department, Faculty of Veterinary Medicine, Mansoura University,
        Mansoura, 35516 Egypt </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awad</LastName><ForeName>Amal</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bacteriology,
        Mycology and Immunology Department, Faculty of Veterinary Medicine, Mansoura
        University, Mansoura, 35516 Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ateya</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Animal
        Husbandry and Animal Wealth Development Department, Faculty of Veterinary
        Medicine, Mansoura University, Mansoura, 35516 Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>El-Shemi</LastName><ForeName>Adel Galal Ahmed</ForeName><Initials>AGA</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        PO Box 7607, Holy Makkah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pharmacology, Faculty of Medicine, Assiut University, Asyut, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ashshi</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        PO Box 7607, Holy Makkah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Basalamah</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        PO Box 7607, Holy Makkah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Na</LastName><ForeName>Youjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department
        of Pharmacology, Faculty of Medicine, Assiut University, Asyut, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Yun</LastName><ForeName>Chae-Ok</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>Department
        of Bioengineering, College of Engineering, Hanyang University, 222 Wangsinmi-ro,
        Seongdong-gu, Seoul, 133-791 Republic of Korea </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>El-Shemi</LastName><ForeName>Adel Galal Ahmed</ForeName><Initials>AGA</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm
        Al-Qura University, Makkah, PO Box 7607, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ashshi</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm
        Al-Qura University, Makkah, PO Box 7607, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Basalamah</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm
        Al-Qura University, Makkah, PO Box 7607, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Na</LastName><ForeName>Youjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm
        Al-Qura University, Makkah, PO Box 7607, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Yun</LastName><ForeName>Chae-Ok</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm
        Al-Qura University, Makkah, PO Box 7607, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>El-Shemi</LastName><ForeName>Adel Galal</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        PO Box 7607, Holy Makkah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Refaat</LastName><ForeName>Bassem</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        PO Box 7607, Holy Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kensara</LastName><ForeName>Osama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department
        of Clinical Nutrition, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        PO Box 7607, Holy Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abdelfattah</LastName><ForeName>Amr</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University,
        PO Box 7607, Holy Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dheeb</LastName><ForeName>Batol Imran</ForeName><Initials>BI</Initials><AffiliationInfo><Affiliation>Biology
        Department, College of Education, Iraqia University, Baghdad, Iraq </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Halbosiy</LastName><ForeName>Mohammed M. F.</ForeName><Initials>MMF</Initials><AffiliationInfo><Affiliation>Biotechnology
        Research Center, Al- Nahrain University, Baghdad, Iraq </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al lihabi</LastName><ForeName>Rghad Kadhim</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Biotechnology
        Research Center, Al- Nahrain University, Baghdad, Iraq </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Khashman</LastName><ForeName>Basim Mohammed</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>College
        of dentistry, Baghdad University, Baghdad, Iraq </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Laiche</LastName><ForeName>Djouhri</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department
        of Physiology, College of Medicine, King Saud University, Riyadh, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeel</LastName><ForeName>Chaudhary</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taoufik</LastName><ForeName>Nedjadi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Kingdom of
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Afghani</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Security
        Forces Hospital, General Directorate of Medical Services, Ministry of Interior,
        Makkah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>&#x141;astowska</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Balool</LastName><ForeName>Haya H.</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sheth</LastName><ForeName>Harsh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mercer</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Coxhead</LastName><ForeName>Jonathan M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Redfern</LastName><ForeName>Chris P. F.</ForeName><Initials>CPF</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Burt</LastName><ForeName>Alastair D.</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Santibanez-Koref</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bacon</LastName><ForeName>Chris M.</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chesler</LastName><ForeName>Louis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rust</LastName><ForeName>Alistair G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Adams</LastName><ForeName>David J.</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Williamson</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Clifford</LastName><ForeName>Steven C.</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jackson</LastName><ForeName>Michael S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Institute
        of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Singh</LastName><ForeName>Mala</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, The M.S. University of Baroda, Vadodara,
        390 002 Gujarat India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansuri</LastName><ForeName>Mohmmad
        Shoab</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, The M.S. University of Baroda, Vadodara,
        390 002 Gujarat India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jadeja</LastName><ForeName>Shahnawaz
        D.</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, The M.S. University of Baroda, Vadodara,
        390 002 Gujarat India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Hima</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, The M.S. University of Baroda, Vadodara,
        390 002 Gujarat India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marfatia</LastName><ForeName>Yogesh
        S.</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department
        of Skin andVD, Sir Sayajirao Gaikwad Medical College, The Maharaja Sayajirao
        University of Baroda, Vadodara, Gujarat India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Begum</LastName><ForeName>Rasheedunnisa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, The M.S. University of Baroda, Vadodara,
        390 002 Gujarat India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Amal
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Human Cytogenetics
        Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kamel</LastName><ForeName>Alaa K.</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Helmy</LastName><ForeName>Nivin A.</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hammad</LastName><ForeName>Sayda A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kayed</LastName><ForeName>Hesham F.</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shehab</LastName><ForeName>Marwa I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>El Gerzawy</LastName><ForeName>Assad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ead</LastName><ForeName>Maha M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ead</LastName><ForeName>Ola M.</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mekkawy</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Human
        Cytogenetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mazen</LastName><ForeName>Innas</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical
        Genetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>El-Ruby</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical
        Genetics Department, National Research Centre, Dokki, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shahid</LastName><ForeName>S. M. A.</ForeName><Initials>SMA</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, College of Medicine, University of Hail, Hail, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Qazi
        Mohammad Sajid</ForeName><Initials>QMS</Initials><AffiliationInfo><Affiliation>Department
        of Health Information Management, College of Applied Medical Sciences, Buraydah
        Colleges, Al Qassim, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Arif</LastName><ForeName>J. M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, College of Medicine, University of Hail, Hail, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lohani</LastName><ForeName>Mohtashim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biosciences, Faculty of Applied Science, Integral University, Lucknow,
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imen</LastName><ForeName>Moumni</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory
        of molecular and cellular Hematology, Pasteur Institute of Tunis, University
        of Tunis El-Manar, 74 PO Box. 1002, Belvedere, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Leila</LastName><ForeName>Chaouch</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory
        of molecular and cellular Hematology, Pasteur Institute of Tunis, University
        of Tunis El-Manar, 74 PO Box. 1002, Belvedere, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Houyem</LastName><ForeName>Ouragini</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Laboratory
        of molecular and cellular Hematology, Pasteur Institute of Tunis, University
        of Tunis El-Manar, 74 PO Box. 1002, Belvedere, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kais</LastName><ForeName>Douzi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory
        of molecular and cellular Hematology, Pasteur Institute of Tunis, University
        of Tunis El-Manar, 74 PO Box. 1002, Belvedere, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Fethi</LastName><ForeName>Chaouachi Dorra Mellouli</ForeName><Initials>CDM</Initials><AffiliationInfo><Affiliation>Service
        d&#x2019;Immuno-H&#xe9;matologie p&#xe9;diatrique, Centre National de Greffe
        de Moelle Osseuse, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Bejaoui</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service
        d&#x2019;Immuno-H&#xe9;matologie p&#xe9;diatrique, Centre National de Greffe
        de Moelle Osseuse, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Salem</LastName><ForeName>Abbes</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory
        of molecular and cellular Hematology, Pasteur Institute of Tunis, University
        of Tunis El-Manar, 74 PO Box. 1002, Belvedere, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Faggad</LastName><ForeName>Areeg</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Molecular Biology, National Cancer Institute (NCI-UG), University of Gezira,
        Wad Madani, Sudan </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biochemistry and Nutrition, Faculty of Medicine, University of Gezira,
        Wad Madani, Sudan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebreslasie</LastName><ForeName>Amanuel
        T.</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry and Nutrition, Faculty of Medicine, University of Gezira,
        Wad Madani, Sudan </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biochemistry, Orotta School of Medicine and Dentistry, &#x115f;, Eritrea
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaki</LastName><ForeName>Hani
        Y.</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry and Nutrition, Faculty of Medicine, University of Gezira,
        Wad Madani, Sudan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdalla</LastName><ForeName>Badreldin
        E.</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry and Nutrition, Faculty of Medicine, University of Gezira,
        Wad Madani, Sudan </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlShammari</LastName><ForeName>Maha
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Ali</LastName><ForeName>Rhaya</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Balawi</LastName><ForeName>Nader</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Enazi</LastName><ForeName>Mansour</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Muraikhi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Busaleh</LastName><ForeName>Fadi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Sahwan</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Borgio</LastName><ForeName>Francis</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sayyed</LastName><ForeName>Abdulazeez</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Ali</LastName><ForeName>Amein</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Acharya</LastName><ForeName>Sadananda</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College
        of Medicine, Institute for Research and Medical Consultations, University
        of Dammam, Dammam, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zaki</LastName><ForeName>Maha S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Clinical
        Genetics Department, National Research Centre, Cairo, 12622 Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>El-Bassyouni</LastName><ForeName>Hala T.</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Clinical
        Genetics Department, National Research Centre, Cairo, 12622 Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shehab</LastName><ForeName>Marwa I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Cytogenetics
        Department, National Research Centre, Cairo, 12622 Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Elshal</LastName><ForeName>Mohammed F.</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M.</LastName><ForeName>Kaleemuddin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldahlawi</LastName><ForeName>Alia
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Biological
        Sciences Department - Faculty of Sciences, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saadah</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department
        of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCoy</LastName><ForeName>J.
        Philip</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Flow
        Cytometry Core Facility, National Heart, Lung, and Blood Institute, National
        Institutes of Health, Bethesda, MD USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>El-Tarras</LastName><ForeName>Adel E.</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Biotechnology
        and Genetic Engineering Research Unit, Deanship of Scientific Research, Taif
        University, Taif, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Awad</LastName><ForeName>Nabil S.</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department
        of Genetics, Faculty of Agriculture and Natural Resources, Aswan University,
        Aswan, Egypt </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College
        of Biotechnology, Misr University for Science and Technology, Sixth of October
        City, Egypt </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharthi</LastName><ForeName>Abdulla
        A.</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Biotechnology
        and Genetic Engineering Research Unit, Deanship of Scientific Research, Taif
        University, Taif, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Mohamed M. M.</ForeName><Initials>MMM</Initials><AffiliationInfo><Affiliation>College
        of Biotechnology, Misr University for Science and Technology, Sixth of October
        City, Egypt </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsehli</LastName><ForeName>Haneen
        S.</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Sheikh Salem
        Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem Cells,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gari</LastName><ForeName>Abdullah
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department
        of Hematology, Faculty of Medicine, King Abdulaziz University Hospital, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abbas</LastName><ForeName>Mohammed M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopedic Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadam</LastName><ForeName>Roaa
        A.</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Stem Cell
        Unit, Centre of Excellence in Genomic Medicine Research, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gari</LastName><ForeName>Mazen
        M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Stem Cell
        Unit, Centre of Excellence in Genomic Medicine Research, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkaff</LastName><ForeName>Mohmmed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Sheikh Salem
        Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem Cells,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopedic Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center of
        Innovation in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abusamra</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>eldin</LastName><ForeName>Hend F. Nour</ForeName><Initials>HFN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alhathli</LastName><ForeName>Elham M.</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Salem</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute
        for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA
        19122 USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, PO Box
        80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Moradi</LastName><ForeName>Fatima A.</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department
        of Biology, Genomic and Biotechnology Section, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess
        Al-Jawhara Al-Ibrahim Centre of Excellence in Research of Hereditary Disorders,
        Faculty of Medicine, King Abdul-Aziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rashidi</LastName><ForeName>Omran M.</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Princess
        Al-Jawhara Al-Ibrahim Centre of Excellence in Research of Hereditary Disorders,
        Faculty of Medicine, King Abdul-Aziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Awan</LastName><ForeName>Zuhier A.</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>Department
        of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaya</LastName><ForeName>Ibrahim
        Hamza</ForeName><Initials>IH</Initials><AffiliationInfo><Affiliation>Future
        Scientist Program Trainee at Genetics Department, King Faisal Specialist Hospital
        and Research Centre, Riyadh, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Harazi</LastName><ForeName>Olfat</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department
        of Biostatistics, Epidemiology and Scientific Computing, King Faisal Specialist
        Hospital and Research Centre, Riyadh, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Colak</LastName><ForeName>Dilek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department
        of Biostatistics, Epidemiology and Scientific Computing, King Faisal Specialist
        Hospital and Research Centre, Riyadh, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alkousi</LastName><ForeName>Nabila A.</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>University
        of Wolverhampton, Wolverhampton, West Midlands WV1 1LY UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Athanasopoulos</LastName><ForeName>Takis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University
        of Wolverhampton, Wolverhampton, West Midlands WV1 1LY UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bahmaid</LastName><ForeName>Afnan O.</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhwait</LastName><ForeName>Etimad
        A.</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department
        of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stem
        Cells Unit, Center of Excellence in Genomic Medicine Research (CEGMR), King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alsehli</LastName><ForeName>Haneen S.</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Mohammed
        M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Sheikh Salem
        Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem Cells,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopaedic Surgery, Faculty of Medicine, King Abdulaziz University Hospital,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alkaf</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopaedic Surgery, Faculty of Medicine, King Abdulaziz University Hospital,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kadam</LastName><ForeName>Roaa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Stem
        Cells Unit, Center of Excellence in Genomic Medicine Research (CEGMR), King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stem
        Cells Unit, Center of Excellence in Genomic Medicine Research (CEGMR), King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Eldin</LastName><ForeName>Hend F. Nour</ForeName><Initials>HFN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abusamra</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhathli</LastName><ForeName>Elham</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute
        for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA
        19122 USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsayed</LastName><ForeName>Salma
        N.</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Medical
        Laboratories Technology Department, Applied Medical Science College, Taibah
        University, Al Madinah, Al Munawarah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Aljohani</LastName><ForeName>Fawziah H.</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Medical
        Laboratories Technology Department, Applied Medical Science College, Taibah
        University, Al Madinah, Al Munawarah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Habeeb</LastName><ForeName>Samaher M.</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Medical
        Laboratories Technology Department, Applied Medical Science College, Taibah
        University, Al Madinah, Al Munawarah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Almashali</LastName><ForeName>Rawan A.</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Medical
        Laboratories Technology Department, Applied Medical Science College, Taibah
        University, Al Madinah, Al Munawarah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Basit</LastName><ForeName>Sulman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        for Genetics and Inherited Diseases, Taibah University, Al Madinah, Al Munawarah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Samia
        M.</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Medical
        Laboratories Technology Department, Applied Medical Science College, Taibah
        University, Al Madinah, Al Munawarah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Durairajanayagam</LastName><ForeName>Damayanthi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiology,
        Universiti Teknologi, Sungai Buloh, MARA, Malaysia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Samanta</LastName><ForeName>Luna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Redox
        Biology Laboratory, School of Life Science, Ravenshaw University, Orissa,
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine at King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine at King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabanegh</LastName><ForeName>Edmund
        S.</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Urology
        Department, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine at King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Samanta</LastName><ForeName>Luna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Redox
        Biology Laboratory, School of Life Science, Ravenshaw University, Orissa,
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durairajanayagam</LastName><ForeName>Damayanthi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>American
        Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiology,
        Universiti Teknologi MARA, Sungai Buloh, Malaysia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabanegh</LastName><ForeName>Edmund
        S.</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Urology
        Department, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Samanta</LastName><ForeName>Luna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>American
        Center For Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Redox
        Biology Laboratory, School of Life Science, Ravenshaw University, Orissa,
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>American
        Center For Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>American
        Center For Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cui</LastName><ForeName>Zhihong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>American
        Center For Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute
        of Toxicology, Third Military Medical University, Chongqing, China </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Center of Innovation in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alboogmi</LastName><ForeName>Alaa
        A.</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alansari</LastName><ForeName>Nuha
        A.</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Quaiti</LastName><ForeName>Maha
        M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashgan</LastName><ForeName>Fai
        T.</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandah</LastName><ForeName>Afnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Hasan
        S.</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, King Abdulaziz University Hospital, Faculty
        of Medicine, King Abdulaziz University, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rozi</LastName><ForeName>Abdullraheem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, King Abdulaziz University Hospital, Faculty
        of Medicine, King Abdulaziz University, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mirza</LastName><ForeName>Zeenat</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589 Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al Sayyad</LastName><ForeName>Ahmad J.</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department
        of Urology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farsi</LastName><ForeName>Hasan
        M. A.</ForeName><Initials>HMA</Initials><AffiliationInfo><Affiliation>Department
        of Urology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah
        A.</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirza</LastName><ForeName>Zeenat</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, PO BOX 80216, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotibi</LastName><ForeName>Reem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Ahmadi</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alansari</LastName><ForeName>Nuha A.</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Albogmi</LastName><ForeName>Alaa A.</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Quaiti</LastName><ForeName>Maha M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ashgan</LastName><ForeName>Fai T.</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bandah</LastName><ForeName>Afnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        BOX 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ebiya</LastName><ForeName>Rasha A.</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Zoology
        Department, Women&#x2019;s College for Arts, Science &amp; Education, Ain
        Shams University, Cairo, Egypt </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biology
        Department, Faculty of Applied Science, Umm Al- Qura University, Makka, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darwish</LastName><ForeName>Samia
        M.</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Zoology
        Department, Women&#x2019;s College for Arts, Science &amp; Education, Ain
        Shams University, Cairo, Egypt </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biology
        Department, Faculty of Applied Science, Umm Al- Qura University, Makka, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montaser</LastName><ForeName>Metwally
        M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Zoology
        Department, Faculty of Science, Al-Azhar University, Cairo, Egypt </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biotechnology
        Department, Faculty of Science, Taif University, Taif, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abusamra</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King
        Abdullah University of Science and Technology (KAUST), Computer, Electrical
        and Mathematical Sciences and Engineering Division, Thuwal, 23955-6900 Saudi
        Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bajic</LastName><ForeName>Vladimir B.</ForeName><Initials>VB</Initials><AffiliationInfo><Affiliation>King
        Abdullah University of Science and Technology (KAUST), Computational Bioscience
        Research Center, Thuwal, Jeddah, 23955-6900 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gomaa</LastName><ForeName>Wafaey</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, Minia University, Al Minia, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hanbazazh</LastName><ForeName>Mehenaz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Ahwal</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Harbi</LastName><ForeName>Asia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Wejdan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakamy</LastName><ForeName>Saher</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baba</LastName><ForeName>Ghali</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Harbi</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Ahwal</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Harbi</LastName><ForeName>Asia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Wejdan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakamy</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baba</LastName><ForeName>Ghalia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhathli</LastName><ForeName>Elham
        M.</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, P.O. Box
        80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Salem</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Eldin</LastName><ForeName>Hend Nour</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abusamra</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute
        for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA
        19122 USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, P.O. Box
        80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alyamani</LastName><ForeName>Aisha A.</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Stem
        Cells Unit, Centre of Excellence in Genomic Medicine Research (CEGMR), King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alhwait</LastName><ForeName>Etimad A.</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Stem Cells
        Unit, Centre of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abbas</LastName><ForeName>Mohammed M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopaedic Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkaf</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Sheikh Salem
        Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem Cells,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopaedic Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsehli</LastName><ForeName>Haneen
        S.</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Center of
        Innovation in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadam</LastName><ForeName>Roaa
        A.</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Stem Cells
        Unit, Centre of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stem
        Cells Unit, Centre of Excellence in Genomic Medicine Research (CEGMR), King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gadi</LastName><ForeName>Rawan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty
        of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine at King AbdulAziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine at King AbdulAziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merdad</LastName><ForeName>Leena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dental
        public health department, Faculty of Dentistry, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfakeeh</LastName><ForeName>Saadiah
        M.</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhwait</LastName><ForeName>Etimad
        A.</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department
        of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stem
        Cells Unit, Centre of Excellence in Genomic Medicine Research (CEGMR), King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abbas</LastName><ForeName>Mohammed M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopaedic Surgery, Faculty of Medicine, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkaf</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Sheikh Salem
        Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem Cells,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopaedic Surgery, Faculty of Medicine, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsehli</LastName><ForeName>Haneen
        S.</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Center of
        Innovation in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadam</LastName><ForeName>Roaa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Stem
        Cells Unit, Centre of Excellence in Genomic Medicine Research (CEGMR), King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stem
        Cells Unit, Centre of Excellence in Genomic Medicine Research (CEGMR), King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ghazala</LastName><ForeName>Rubi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Medicine, University of Health Science, Lahore, Pakistan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamed</LastName><ForeName>M.
        Haroon</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department
        of Biology, King Abdul-Aziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biology, King Abdul-Aziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine at King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qadri</LastName><ForeName>Ishtiaq</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdul Aziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira</LastName><ForeName>Lobna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaabad</LastName><ForeName>Manal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Shireen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaabad</LastName><ForeName>Manal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira</LastName><ForeName>Lobna</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Shireen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine at King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebai</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bioinformatics
        Group, Centre of Biotechnology of Sfax, Sfax, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shay</LastName><ForeName>Jerry
        W.</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Cell Biology, The University of Texas Southwestern Medical Center, Dallas,
        TX USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almutairi</LastName><ForeName>Mikhlid
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Zoology
        Department, College of Sciences, King Saud University, Riyadh, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambers</LastName><ForeName>Angie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute
        of Applied Genetics, Department of Molecular and Medical Genetics, University
        of North Texas Health Science Center, Fort Worth, TX 76107 USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Churchill</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute
        of Applied Genetics, Department of Molecular and Medical Genetics, University
        of North Texas Health Science Center, Fort Worth, TX 76107 USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>King</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute
        of Applied Genetics, Department of Molecular and Medical Genetics, University
        of North Texas Health Science Center, Fort Worth, TX 76107 USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Stoljarova</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute
        of Applied Genetics, Department of Molecular and Medical Genetics, University
        of North Texas Health Science Center, Fort Worth, TX 76107 USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute
        of Gene Technology, Department of Molecular Diagnostics, Tallinn University
        of Technology, Akadeemia tee 15A-604, Tallinn, 12618 Estonia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gill-King</LastName><ForeName>Harrell</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory
        of Forensic Anthropology, Center for Human Identification, Department of Biological
        Sciences, University of North Texas, 1511 West Sycamore, Denton, Texas USA
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qatani</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budowle</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute
        of Applied Genetics, Department of Molecular and Medical Genetics, University
        of North Texas Health Science Center, Fort Worth, TX 76107 USA </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almagd</LastName><ForeName>Taha
        Abo</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Urology
        Department, College of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakamy</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        for Reproductive Medicine, Cleveland Clinic, Cleveland, OH USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al Sayyad</LastName><ForeName>Ahmad J.</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department
        of Urology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farsi</LastName><ForeName>Hasan
        M. A.</ForeName><Initials>HMA</Initials><AffiliationInfo><Affiliation>Department
        of Urology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah
        A.</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmaida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mirza</LastName><ForeName>Zeenat</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, PO Box 80216, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotibi</LastName><ForeName>Reem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Ahmadi</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alansari</LastName><ForeName>Nuha A.</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Albogmi</LastName><ForeName>Alaa A.</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Quaiti</LastName><ForeName>Maha M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ashgan</LastName><ForeName>Fai T.</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bandah</LastName><ForeName>Afnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, PO
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Satar</LastName><ForeName>Rukhsana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Ibn Sina National College for Medical Sciences, Jeddah, 21418
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Waseem</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nazam</LastName><ForeName>Nazia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Toxicogemics
        Laboratory, Division of Genetics, Department of Zoology, Aligarh Muslim University,
        Aligarh, India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lone</LastName><ForeName>Mohamad
        I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Toxicogemics
        Laboratory, Division of Genetics, Department of Zoology, Aligarh Muslim University,
        Aligarh, India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naseer</LastName><ForeName>Muhammad
        I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589 Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, 21589 Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaidi</LastName><ForeName>Syed
        K.</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter N.</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jafri</LastName><ForeName>Mohammad A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ansari</LastName><ForeName>Shakeel A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alqahtani</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bashier</LastName><ForeName>Hanan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Qahtani</LastName><ForeName>Abrar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nour</LastName><ForeName>Amal
        M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkhatabi</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zenadah</LastName><ForeName>Adel
        M. Abu</ForeName><Initials>AMA</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Qahtani</LastName><ForeName>Muhammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine (CEGMR), King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faheem</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shiny</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Multimedia Technology, Karunya University, Coimbatore, India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammad
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhadrami</LastName><ForeName>Hani
        A.</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Faculy of
        Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Innovation
        in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculy
        of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Innovation
        in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Ibtessam
        R.</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Centre of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel
        G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Centre of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bader</LastName><ForeName>Rima S.</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Pediatric
        Cardiology Department, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bassiouni</LastName><ForeName>Randa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Children
        Hospital, Genetics Department, Ministry of Health, Taif, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alquaiti</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashgan</LastName><ForeName>Fai</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alama</LastName><ForeName>Mohamed
        Nabil</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Cardiology
        Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al Qahtani</LastName><ForeName>Mohammad H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric
        Cardiology Department, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lone</LastName><ForeName>Mohammad I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Gene-Tox
        Laboratory, Division of Genetics, Department of Zoology, Aligarh Muslim University,
        Aligarh, UP India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nizam</LastName><ForeName>Nazia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gene-Tox
        Laboratory, Division of Genetics, Department of Zoology, Aligarh Muslim University,
        Aligarh, UP India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Waseem</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafri</LastName><ForeName>Mohammad
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansari</LastName><ForeName>Shakeel
        A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Muhammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshihri</LastName><ForeName>Eradah</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharbi</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natesan</LastName><ForeName>Peter
        Pushparaj</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Qahtani</LastName><ForeName>Muhammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Fazal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadam</LastName><ForeName>Roaa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sait</LastName><ForeName>Khalid
        Hussain Wali</ForeName><Initials>KHW</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynaecology, Faculty of Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Anfinan</LastName><ForeName>Nisreen</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynaecology, Faculty of Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naseer</LastName><ForeName>Muhammad
        I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel
        G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira</LastName><ForeName>Lobna
        S.</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        N.</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansari</LastName><ForeName>Shakeel
        A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlQahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naseer</LastName><ForeName>Muhammad
        I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel
        G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira</LastName><ForeName>Lobna
        S.</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sogaty</LastName><ForeName>Sameera</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassiouni</LastName><ForeName>Randa
        I.</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of
        Medical Genetics, King Fahad General Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children
        Hospital, Taif, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>AlQahtani</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansari</LastName><ForeName>Shakeel
        A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter N.</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sibiani</LastName><ForeName>Abdulrahman
        M. S.</ForeName><Initials>AMS</Initials><AffiliationInfo><Affiliation>King
        Abdulaziz University Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Waseem</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafri</LastName><ForeName>Mohammad
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warsi</LastName><ForeName>Mohiuddin
        K.</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Mohammad
        Ali Jauhar University, Rampur, UP India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Naseer</LastName><ForeName>Muhammad I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubi</LastName><AffiliationInfo><Affiliation>Center
        for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia
        Nagar, New Delhi India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Kundan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center
        for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia
        Nagar, New Delhi India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naqvi</LastName><ForeName>Ahmad
        A. T.</ForeName><Initials>AAT</Initials><AffiliationInfo><Affiliation>Department
        of Computer Science, Jamia Millia Islamia, Jamia Nagar, New Delhi India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Faizan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department
        of Computer Science, Jamia Millia Islamia, Jamia Nagar, New Delhi India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hassan</LastName><ForeName>Md I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department
        of Computer Science, Jamia Millia Islamia, Jamia Nagar, New Delhi India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlQahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarullah</LastName><ForeName>Jummanah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbasit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Shahida</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdussami</LastName><ForeName>Ghufrana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Jamia
        Millia Islamia, New Delhi, India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mahfooz</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jamia
        Millia Islamia, New Delhi, India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kamal</LastName><ForeName>Mohammad A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damanhouri</LastName><ForeName>Ghazi
        A.</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarullah</LastName><ForeName>Bushra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department
        of Biotechnology, Kadi Sarva Vishwavidhyalaya, Gandhinagar, Gujarat India
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarullah</LastName><ForeName>Jummanah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarullah</LastName><ForeName>Mohammad
        S. S.</ForeName><Initials>MSS</Initials><AffiliationInfo><Affiliation>Clinical
        Biochemistry Department, College of Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajouh</LastName><ForeName>Osama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Obstetrics
        and Gynecology Department, King AbdulAziz University Hospital, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jarullah</LastName><ForeName>Jummanah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathkoor</LastName><ForeName>Abdulah
        E. A.</ForeName><Initials>AEA</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsalmi</LastName><ForeName>Hashim
        M. A.</ForeName><Initials>HMA</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oun</LastName><ForeName>Anas
        M. M.</ForeName><Initials>AMM</Initials><AffiliationInfo><Affiliation>Applied
        Medical Science Laboratory Department, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damanhauri</LastName><ForeName>Ghazi
        A.</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlQahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naseer</LastName><ForeName>Muhammad
        I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, 21589
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, 21589
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sogaty</LastName><ForeName>Sameera</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Medical Genetics, King Fahad General Hospital, Jeddah, 21196 Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chudhary</LastName><ForeName>Adeel
        G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, 21589
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abutalib</LastName><ForeName>Yousif A.</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Department
        of Pediatric Neurologist, Maternity and Children Hospital, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merico</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The
        Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario
        M5G 1L7 Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The
        Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario
        M5G 1L7 Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Christian
        R.</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>The Centre
        for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario M5G
        1L7 Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarrei</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The
        Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario
        M5G 1L7 Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Stephen
        W.</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, 21589
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The
        Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario
        M5G 1L7 Canada </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McLaughlin
        Centre and Department of Molecular Genetics, University of Toronto, Toronto,
        Ontario M5G 1L7 Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammad
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, 21589
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Naseer</LastName><ForeName>Muhammad I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faheem</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel
        G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashgan</LastName><ForeName>Fai
        Talal</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaidi</LastName><ForeName>Syed
        Kashif</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jan</LastName><ForeName>Mohammed
        M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department
        of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammad
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Zahrani</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biochemistry
        Department, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lary</LastName><ForeName>Sahira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biochemistry
        Department, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hakamy</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ahwal</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dermitzakis</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department
        of Genetic Medicine and Development, Medical School, University of Geneva,
        Geneva, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-refai</LastName><ForeName>Abeer
        A.</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Medical
        Biochemistry Departments, Faculty of Medicine, Menoufia University, Shibin
        Al Kawm, Egypt </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biochemistry
        Departments, Faculty of Medicine, Umm Al-Qura University, Makkha, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saleh</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical
        Biochemistry Departments, Faculty of Medicine, Menoufia University, Shibin
        Al Kawm, Egypt </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yassien</LastName><ForeName>Rehab
        I.</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Departments
        of Cardiology, Faculty of Medicine, Menoufia University, Shibin Al Kawm, Egypt
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamel</LastName><ForeName>Mahmmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments
        of Cardiology, Faculty of Medicine, Menoufia University, Shibin Al Kawm, Egypt
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habeb</LastName><ForeName>Rabab
        M.</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Departments
        of Anesthesia, Faculty of Medicine, Menoufia University, Shibin Al Kawm, Egypt
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filimban</LastName><ForeName>Najlaa</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center
        of Innovations in Personalized Medicine, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Innovations in Personalized Medicine, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghannam</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Diabetes
        &amp; Endocrinology Center of Excellence, Clinical Nutrition Department, International
        Medical Center, Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel
        Mohammed</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center
        of Innovations in Personalized Medicine, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Applied Medical Sciences, King Abdulaziz University, Jeddah, Kingdom of
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bibi</LastName><ForeName>Fehmida</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Special
        Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, 21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Akhtar</LastName><ForeName>Sana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Special
        Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, 21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Azhar</LastName><ForeName>Esam I.</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Special
        Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, 21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Yasir</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Special
        Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, 21589 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Nasser</LastName><ForeName>Muhammad I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jiman-Fatani</LastName><ForeName>Asif A.</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department
        of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sawan</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Anatomical pathology, Faculty of Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lahzah</LastName><ForeName>Ruaa
        A.</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department
        of Microbiology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ali</LastName><ForeName>Asho</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Microbiology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hassan</LastName><ForeName>Syed A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department
        of Computer Science, Faculty of computing and Information Technology Rabigh,
        King Abdulaziz University, Rabigh, 21911 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hasnain</LastName><ForeName>Seyed E.</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Kusuma
        School of biological Sciences, Indian Institute of Technology, Delhi (IITD),
        Hauz Khas, New Delhi, 110016 India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tayubi</LastName><ForeName>Iftikhar A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Department
        of Computer Science, Faculty of computing and Information Technology Rabigh,
        King Abdulaziz University, Rabigh, 21911 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abujabal</LastName><ForeName>Hamza A.</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Mathematics
        Department, Faculty of Sciences, King Abdul Aziz University, P. O. Box 80003,
        Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Magrabi</LastName><ForeName>Alaa O.</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department
        of Information Technology, Faculty of computing and Information Technology
        Rabigh, King Abdulaziz University, Rabigh, 21911 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Khan</LastName><ForeName>Fazal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahd Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Science, Production of Bioproducts for Industrial Applications
        Research Group and Experimental Biochemistry Unit, King Fahd Medical Research
        Center King, Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenada</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahd Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kumosani</LastName><ForeName>Taha Abduallah</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Science, Production of Bioproducts for Industrial Applications
        Research Group and Experimental Biochemistry Unit, King Fahd Medical Research
        Center King, Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Barbour</LastName><ForeName>Elie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department
        of Agriculture, Faculty of Agricultural and Food Sciences, American University
        of Beirut (AUB), Beirut, Lebanon </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adjuncted
        to Biochemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shabaad</LastName><ForeName>Manal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merdad</LastName><ForeName>Adnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbaset</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauthaman</LastName><ForeName>Kalamegam</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Syed
        A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Deaprtment
        of Computer Science, Faculty of computing and Information Technology Rabigh,
        King Abdulaziz University, Rabigh, 21911 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tayubi</LastName><ForeName>Iftikhar A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Deaprtment
        of Computer Science, Faculty of computing and Information Technology Rabigh,
        King Abdulaziz University, Rabigh, 21911 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Aljahdali</LastName><ForeName>Hani M. A.</ForeName><Initials>HMA</Initials><AffiliationInfo><Affiliation>Department
        of Information Systems, Faculty of computing and Information Technology Rabigh,
        King Abdulaziz University, Rabigh, 21911 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al Nono</LastName><ForeName>Reham</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Medical Laboratory Technology and Haematology, Faculty of Applied Medical
        Sciences, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Medical Laboratory Technology and Haematology, Faculty of Applied Medical
        Sciences, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alsehli</LastName><ForeName>Haneen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Orthopaedic Surgery, Faculty of Medicine, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Khan</LastName><ForeName>Fazal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Science, Production of Bioproducts for Industrial Applications
        Research Group and Experimental Biochemistry Unit, King Fahd Medical Research
        Center King, Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammed Sarwar</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, Faculty of Applied Medical Sciences, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Naseer</LastName><ForeName>Muhammad Imran</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mirza</LastName><ForeName>Zeenat</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, Faculty of Applied Medical Sciences, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ansari</LastName><ForeName>Shakeel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadam</LastName><ForeName>Roaa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghamdi</LastName><ForeName>Mansour
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department
        of Environmental sciences, Faculty of Meteorology, Environment and Arid Land
        Agriculture, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shamy</LastName><ForeName>Magdy</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Environmental sciences, Faculty of Meteorology, Environment and Arid Land
        Agriculture, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Costa</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>New
        York University School of Medicine, Nelson Institute of Environmental Medicine,
        New York, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoder</LastName><ForeName>Mamdouh
        I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department
        of Environmental sciences, Faculty of Meteorology, Environment and Arid Land
        Agriculture, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharrat</LastName><ForeName>Najla</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre
        of Biotechnology of Sfax, Laboratory of Molecular and Cellular Screening Processes,
        Bioinformatics Group, Po. Box: 1177, 3018 Sfax, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Belmabrouk</LastName><ForeName>Sabrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre
        of Biotechnology of Sfax, Laboratory of Molecular and Cellular Screening Processes,
        Bioinformatics Group, Po. Box: 1177, 3018 Sfax, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abdelhedi</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre
        of Biotechnology of Sfax, Laboratory of Molecular and Cellular Screening Processes,
        Bioinformatics Group, Po. Box: 1177, 3018 Sfax, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Benmarzoug</LastName><ForeName>Riadh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre
        of Biotechnology of Sfax, Laboratory of Molecular and Cellular Screening Processes,
        Bioinformatics Group, Po. Box: 1177, 3018 Sfax, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Qahtani</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebai</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        of Biotechnology of Sfax, Laboratory of Molecular and Cellular Screening Processes,
        Bioinformatics Group, Po. Box: 1177, 3018 Sfax, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dhamanhouri</LastName><ForeName>Ghazi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre (KFMRC), King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noorwali</LastName><ForeName>Abdelwahab</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Centre (KFMRC), King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alwasiyah</LastName><ForeName>Mohammad
        Khalid</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aziziah
        Maternity and Children Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bahamaid</LastName><ForeName>Afnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfakeeh</LastName><ForeName>Saadiah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alyamani</LastName><ForeName>Aisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsehli</LastName><ForeName>Haneen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Orthopaedic Surgery, Faculty of Medicine, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mobasheri</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The
        D-BOARD European Consortium for Biomarker Discovery, The APPROACH Innovative
        Medicines Initiative (IMI) Consortium, Faculty of Health and Medical Sciences,
        University of Surrey, Guildford, Surrey GU2 7XH UK </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arthritis
        Research UK Centre for Sport, Exercise and Osteoarthritis, Arthritis Research
        UK Pain Centre, Medical Research Council and Arthritis Research UK Centre
        for Musculoskeletal Ageing Research, University of Nottingham, Queen&#x2019;s
        Medical Centre, Nottingham, NG7 2UH UK </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheikh
        Salem Bin Mahfouz Scientific Chair for Treatment of Osteoarthritis by Stem
        Cells, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faheem</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammad
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faheem</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shiny</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Multimedia Technology, Karunya University, Coimbatore, India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammad
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        Sarwar</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King
        Fahad Center for Medical Research, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaidi</LastName><ForeName>Syed
        Kashif</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Raziuddin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Biological Sciences, College of Science and Arts-Rabigh, King Abdulaziz
        University, Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Kanchan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department
        of Biological Sciences, College of Science and Arts-Rabigh, King Abdulaziz
        University, Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Emphasis in Neuroscience, Texas Tech University Health Science Center,
        El Paso, 79905 Texas USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department
        of Biological Sciences, College of Science and Arts-Rabigh, King Abdulaziz
        University, Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Emphasis in Neuroscience, Texas Tech University Health Science Center,
        El Paso, 79905 Texas USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Saif</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Biological Sciences, College of Science and Arts-Rabigh, King Abdulaziz
        University, Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Emphasis in Neuroscience, Texas Tech University Health Science Center,
        El Paso, 79905 Texas USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>AslamTayubi</LastName><ForeName>Iftikhar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculty
        of Computing and Information Technology, King Abdulaziz University, Rabigh,
        21911 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Manish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biological Sciences and Engineering, Maulana Azad National Institute of
        Technology, Bhopal, 462051 India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hassan</LastName><ForeName>Syed Asif</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Faculty
        of Computing and Information Technology, King Abdulaziz University, Rabigh,
        21911 Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shrivastava</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Biological Sciences and Engineering, Maulana Azad National Institute of
        Technology, Bhopal, 462051 India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tayubi</LastName><ForeName>Iftikhar A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Faculty
        of Computing and Information Technology, King Abdulaziz University, Rabigh,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Syed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty
        of Computing and Information Technology, King Abdulaziz University, Rabigh,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abujabal</LastName><ForeName>Hamza
        A. S.</ForeName><Initials>HAS</Initials><AffiliationInfo><Affiliation>Faculty
        of Computing and Information Technology, King Abdulaziz University, Rabigh,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ishani</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department
        of Biotechnology, KadiSarvaVishwavidhyalaya, Gandhinagar, Gujarat India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jarullah</LastName><ForeName>Bushra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department
        of Biotechnology, KadiSarvaVishwavidhyalaya, Gandhinagar, Gujarat India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarullah</LastName><ForeName>Jummanah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Ishfaq
        A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Ejaz</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehan</LastName><ForeName>Mohd</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tayubi</LastName><ForeName>Iftikhar
        A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Faculty
        of Computing and Information Technology, King Abdulaziz University, Rabigh,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlBasri</LastName><ForeName>Samera
        F.</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, Faculty of Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bajouh</LastName><ForeName>Osama S.</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, Faculty of Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Turki</LastName><ForeName>Rola F.</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, Faculty of Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Damanhouri</LastName><ForeName>Ghazi A.</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beg</LastName><ForeName>Mohd
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammoudah</LastName><ForeName>Sahar
        A. F.</ForeName><Initials>SAF</Initials><AffiliationInfo><Affiliation>Department
        of Clinical and Chemical Pathology, Faculty of Medicine, Tanta University,
        Tanta, Egypt </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiogenetic
        Team, Department of Pediatrics, College of Medicine, Taibah University, AL
        Madinah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlHarbi</LastName><ForeName>Khalid
        M.</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Cardiogenetic
        Team, Department of Pediatrics, College of Medicine, Taibah University, AL
        Madinah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Attar</LastName><ForeName>Lama
        M.</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Cardiogenetic
        Team, Department of Pediatrics, College of Medicine, Taibah University, AL
        Madinah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Human Genetics, Medical Research Institute, Alexandria University, Alexandria,
        Egypt </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darwish</LastName><ForeName>Ahmed
        M. Z.</ForeName><Initials>AMZ</Initials><AffiliationInfo><Affiliation>Department
        of Cardiology, Faculty of Medicine, Tanta University, Tanta, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Sara M.</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        for Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhry</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre
        for Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        for Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awlia</LastName><ForeName>Jalaludden</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafri</LastName><ForeName>Mohammad
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center of
        Excellence for Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence for Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence for Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence for Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>khan</LastName><ForeName>Imran</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasir</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Special
        Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Azhar</LastName><ForeName>Esam I.</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Special
        Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical
        Laboratory Technology Department, Faculty of Applied Medical Sciences, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-basri</LastName><ForeName>Sameera</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics &amp; Gynaecology, King Abdul Aziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbour</LastName><ForeName>Elie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty
        of Agriculture, American University of Beirut, Beirut, Lebanon </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adjunct
        to Biochemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumosani</LastName><ForeName>Taha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Fazal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahd Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Science, Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Production of
        Bioproducts for Industrial Applications Research Group, Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental
        Biochemistry Unit, King Fahd Medical Research Center King, Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenada</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahd Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kumosani</LastName><ForeName>Taha Abduallah</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Science, Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Production of
        Bioproducts for Industrial Applications Research Group, Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental
        Biochemistry Unit, King Fahd Medical Research Center King, Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbour</LastName><ForeName>Elie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department
        of Agriculture, Faculty of Agricultural and Food Sciences, American University
        of Beirut (AUB), Beirut, Lebanon </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>adjuncted
        to Biochemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>EL
        Sayed</LastName><ForeName>Heba M.</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Clinical
        Pathology Department, Mansoura University, Faculty of Medicine, Mansoura,
        Egypt </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafez</LastName><ForeName>Eman
        A.</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Rheumatology
        and Rehabilitation Department, Mansoura University, Faculty of Medicine, Mansoura,
        Egypt </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elaimi</LastName><ForeName>Aisha
        Hassan</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Ibtessam
        R.</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassiouni</LastName><ForeName>Randa
        Ibrahim</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Children
        Hospital, Genetics Department, Taif, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alwasiyah</LastName><ForeName>Mohammad Khalid</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aziziah
        Maternity and Children Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wintle</LastName><ForeName>Richard F.</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>The
        Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Stephen
        W.</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>The Centre
        for Applied Genomics, The Hospital for Sick Children, Toronto, Canada </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirza</LastName><ForeName>Zeenat</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah,
        21589 Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>Vikram
        Gopalakrishna</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Department
        of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029
        India </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children&#x2019;s
        Hospital of Philadelphia, Philadelphia, PA 19104 USA </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sharma</LastName><ForeName>Sujata</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Punit</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department
        of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasan</LastName><ForeName>Alagiri</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Tej
        P.</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department
        of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029
        India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alotibi</LastName><ForeName>Reem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ahmadi</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Adwani</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hussein</LastName><ForeName>Deema</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>King
        Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sharif</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Awatif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ghamdi</LastName><ForeName>Fahad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baeesa</LastName><ForeName>Saleh
        S.</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division
        of Neurosurgery, Department of Surgery, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangash</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division
        of Neurosurgery, Department of Surgery, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faheem</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumosani</LastName><ForeName>Taha
        Abdullah</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental
        Biochemistry Unit, King Fahd Medical Research Centre King, Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Allaf</LastName><ForeName>Faisal
        A.</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department
        of Medical Genetics, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science
        and Technology Unit, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Laboratory and Blood Bank, King Abdullah Medical City, Makkah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abduljaleel</LastName><ForeName>Zainularifeen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department
        of Medical Genetics, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science
        and Technology Unit, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alashwal</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King
        Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Taher</LastName><ForeName>Mohiuddin M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department
        of Medical Genetics, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science
        and Technology Unit, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Bouazzaoui</LastName><ForeName>Abdellatif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Medical Genetics, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science
        and Technology Unit, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abalkhail</LastName><ForeName>Halah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King
        Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ba-Hammam</LastName><ForeName>Faisal A.</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department
        of Medical Genetics, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Athar</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Medical Genetics, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science
        and Technology Unit, Umm Al-Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sait</LastName><ForeName>Khalid
        HussainWali</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Gynecological
        Oncology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine,
        King Abdulaziz University Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Anfinan</LastName><ForeName>Nisreen</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gynecological
        Oncology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine,
        King Abdulaziz University Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mami</LastName><ForeName>Naira
        Ben</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole, Sidi Thabet,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haffani</LastName><ForeName>Yosr
        Z.</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole, Sidi Thabet,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medhioub</LastName><ForeName>Mouna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Gastroenterology, Hospital Mohamed Taher Maamouri, Nabeul, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hamzaoui</LastName><ForeName>Lamine</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department
        of Gastroenterology, Hospital Mohamed Taher Maamouri, Nabeul, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cherif</LastName><ForeName>Ameur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole, Sidi Thabet,
        Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azouz</LastName><ForeName>Msadok</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole, Sidi Thabet,
        Tunisia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Gastroenterology, Hospital Mohamed Taher Maamouri, Nabeul, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kalamegam</LastName><ForeName>Gauthaman</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Fazal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahd Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasser</LastName><ForeName>Mohammed
        Imran</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter
        Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biochemistry
        Department, Faculty of Science, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Production
        of Bioproducts for Industrial Applications Research Group, King Fahd Medical
        Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental
        Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turkistany</LastName><ForeName>Shereen
        A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Center of
        Innovation in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-harbi</LastName><ForeName>Lina
        M.</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabir</LastName><ForeName>Jamal</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biology
        Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical
        Laboratory Department, Faculty of Applied Medical Technology, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical
        Laboratory Department, Faculty of Applied Medical Technology, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Madoudi</LastName><ForeName>Basmah</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Aslani</LastName><ForeName>Bayan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Harbi</LastName><ForeName>Khulud</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Jahdali</LastName><ForeName>Rwan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Qudaih</LastName><ForeName>Hanadi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al Hamzy</LastName><ForeName>Emad</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diagnostic
        Genomic Medicine Unit, Center of Excellence in Genomic Medicine Research,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ilyas</LastName><ForeName>Asad M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Youssri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Production
        of Bioproducts for Industrial Applications Research Group and Experimental
        Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbial
        Biotechnology Department, National Research Center, Dokki, Cairo, Egypt </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gari</LastName><ForeName>Mamdooh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alqahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        for Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine, King Abdulaziz University, PO Box 80216,
        Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine, King Abdulaziz University, PO Box 80216,
        Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alhathli</LastName><ForeName>Elham M.</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine, King Abdulaziz University, PO Box 80216,
        Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abusamra</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine, King Abdulaziz University, PO Box 80216,
        Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Eldin</LastName><ForeName>Hend F. Nour</ForeName><Initials>HFN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine, King Abdulaziz University, PO Box 80216,
        Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine, King Abdulaziz University, PO Box 80216,
        Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute
        for Genomics and Evolutionary Medicine, Temple University (SERC 602A), Philadelphia,
        Pennsylvania 19122 USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Adwani</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hussein</LastName><ForeName>Deema</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>King
        Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sharif</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Biology, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Awatif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ghamdi</LastName><ForeName>Fahad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baeesa</LastName><ForeName>Saleh
        S.</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division
        of Neurosurgery, Department of Surgery, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangash</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division
        of Neurosurgery, Department of Surgery, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alamandi</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotibi</LastName><ForeName>Reem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Deema</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>King
        Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ghamdi</LastName><ForeName>Fahad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Awatif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baeesa</LastName><ForeName>Saleh
        S.</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division
        of Neurosurgery, Department of Surgery, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangash</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division
        of Neurosurgery, Department of Surgery, King Abdulaziz University Hospital,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subhi</LastName><ForeName>Ohoud</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagatian</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Johari</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Hamour</LastName><ForeName>Osman
        Abdel</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Aradati</LastName><ForeName>Hosam</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mutawa</LastName><ForeName>Abdulmonem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mashat</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagatian</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subhi</LastName><ForeName>Ohoud</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Johari</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Hamour</LastName><ForeName>Osman
        Abdel</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mutawa</LastName><ForeName>Abdulmonem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Aradati</LastName><ForeName>Hosam</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mashat</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department
        of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulten</LastName><ForeName>Hans-Juergen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Maghrabi</LastName><ForeName>Jaudah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, King Faisal Specialist Hospital and Research Center, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>shah</LastName><ForeName>Muhammad
        W.</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Biology
        Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasir</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Special
        Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Azhar</LastName><ForeName>Esam I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Special
        Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz
        University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical
        Laboratory Technology Department, Faculty of Applied Medical Sciences, King
        Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Masoodi</LastName><ForeName>Saad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biology
        Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haffani</LastName><ForeName>Yosr
        Z.</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole Sidi Thabet,
        Sidi Thabet, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azouz</LastName><ForeName>Msadok</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole Sidi Thabet,
        Sidi Thabet, Tunisia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Gastroenterology, Hospital Mohamed Taher Maamouri, Nabeul, Tunisia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Khamla</LastName><ForeName>Emna</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole Sidi Thabet,
        Sidi Thabet, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jlassi</LastName><ForeName>Chaima</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole Sidi Thabet,
        Sidi Thabet, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masmoudi</LastName><ForeName>Ahmed
        S.</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole Sidi Thabet,
        Sidi Thabet, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherif</LastName><ForeName>Ameur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory
        of Biotechnology and Valorization of Bio/Geo Resources LR11ES31 High Institute
        of Biotechnology Sidi Thabet, University of Manouba, Biotechpole Sidi Thabet,
        Sidi Thabet, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belbahri</LastName><ForeName>Lassaad</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory
        of Soil Biology, University Neuchatel, Neuchatel, Switzerland </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Khayyat</LastName><ForeName>Shadi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty
        of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahad Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Attas</LastName><ForeName>Roba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty
        of Science, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abu-Sanad</LastName><ForeName>Atlal</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty
        of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abuzinadah</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahad Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merdad</LastName><ForeName>Adnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty
        of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dallol</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahad Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abuzenadah</LastName><ForeName>Adel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine, King Fahad Medical Research Center,
        King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty
        of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouazzi</LastName><ForeName>Habib</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>H&#xf4;pital
        Necker-Enfants Malades-Universit&#xe9; Paris descartes-Laboratoire de g&#xe9;n&#xe9;tique,
        Paris, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trujillo</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Erfan
        &amp; Bagedo Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alwasiyah</LastName><ForeName>Mohammad Khalid</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Aziziah
        Maternity and Children Hospital, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdullaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research (CEGMR), King Abdullaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotaibi</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department
        of Clinical Genetic and Metabolic Genetics, King Saud Medical Hospital, Riyadh,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nassir</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department
        of Pathology, School of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Ishfaq
        A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kamal</LastName><ForeName>Mohammad A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiffri</LastName><ForeName>Essam
        H.</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Faculty
        of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Ghulam
        M.</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Beg</LastName><ForeName>Mohd A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Mohammad
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>King Abdullah
        International Medical Research Center/King Saud Bin Abdulaziz University for
        Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Rizwan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King
        Abdullah International Medical Research Center/King Saud Bin Abdulaziz University
        for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasool</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamal</LastName><ForeName>Mohammad
        S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Samman</LastName><ForeName>Nusaibah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>King
        Abdullah International Medical Research Center/King Saud Bin Abdulaziz University
        for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdussami</LastName><ForeName>Ghufrana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department
        of Biosciences, Jamia Milia Islamia, New Delhi, India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Periyasamy</LastName><ForeName>Sathish</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King
        Abdullah International Medical Research Center/King Saud Bin Abdulaziz University
        for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warsi</LastName><ForeName>Mohiuddin
        K.</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Mohammad
        Ali Jauhar University, Rampur, UP India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Aldress</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King
        Abdullah International Medical Research Center/King Saud Bin Abdulaziz University
        for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Otaibi</LastName><ForeName>Majed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King
        Abdullah International Medical Research Center/King Saud Bin Abdulaziz University
        for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al
        Yousef</LastName><ForeName>Zeyad</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>King
        Abdullah International Medical Research Center/King Saud Bin Abdulaziz University
        for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boudjelal</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King
        Abdullah International Medical Research Center/King Saud Bin Abdulaziz University
        for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhmeida</LastName><ForeName>Abdelbasit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Center of
        Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlAbdulkarim</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>King
        Abdullah International Medical Research Center/King Saud Bin Abdulaziz University
        for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghazala</LastName><ForeName>Rubi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School
        of Medicine, University of Health Science, Lahore, Pakistan </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Mathew</LastName><ForeName>Shilu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamed</LastName><ForeName>M.
        Haroon</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department
        of Biology, King Abdul-Aziz University, Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Assidi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center
        of Innovation in Personalized Medicine at King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qadri</LastName><ForeName>Ishtiaq</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>King
        Fahd Medical Research Center, King Abdul Aziz University, Jeddah, Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Ishfaq
        A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Elmagd</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Turki</LastName><ForeName>Rola F.</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>KACST
        Technology Innovation Center in Personalized Medicine, King Abdulaziz University,
        Jeddah, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, King Abdulaziz University Hospital, Jeddah,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damanhouri</LastName><ForeName>Ghazi
        A.</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beg</LastName><ForeName>Mohd
        A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>King Fahd
        Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi
        Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suhail</LastName><ForeName>Mohd</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical
        Biotechnology and Translational Medicine Research, King Fahd Medical Research
        Center, King Abdulaziz University, PO Box 80216, Jeddah, 21589 Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Abid</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute
        of Microbial Technology (IMTECH), Chandigarh, 160036 India </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jamal</LastName><ForeName>Adil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ummul
        Qura University, Makkah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Pushparaj</LastName><ForeName>Peter Natesan</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Al-Qahtani</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center
        of Excellence in Genomic Medicine Research, King Abdulaziz University, P.O.
        Box 80216, Jeddah, 21589 Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Qadri</LastName><ForeName>Ishtiaq</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Medical
        Biotechnology and Translational Medicine Research, King Fahd Medical Research
        Center, King Abdulaziz University, PO Box 80216, Jeddah, 21589 Saudi Arabia
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Readi</LastName><ForeName>Mahmoud
        Z.</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Pharmacy, Al-Azhar University, 71524 Assiut, Egypt
        </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eid</LastName><ForeName>Safaa
        Y.</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Kingdom
        of Saudi Arabia </Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute
        of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer
        Feld 364, 69120 Heidelberg, Germany </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wink</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute
        of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer
        Feld 364, 69120 Heidelberg, Germany </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Isa</LastName><ForeName>Ahmed M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Assisted
        Conception Unit, Obstetrics and Gynecology Department, College of Medicine,
        King Saud University, Riyadh, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alnuaim</LastName><ForeName>Lulu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Assisted
        Conception Unit, Obstetrics and Gynecology Department, College of Medicine,
        King Saud University, Riyadh, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Almutawa</LastName><ForeName>Johara</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Assisted
        Conception Unit, Obstetrics and Gynecology Department, College of Medicine,
        King Saud University, Riyadh, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Abu-Rafae</LastName><ForeName>Basim</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Assisted
        Conception Unit, Obstetrics and Gynecology Department, College of Medicine,
        King Saud University, Riyadh, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Alasiri</LastName><ForeName>Saleh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Assisted
        Conception Unit, Obstetrics and Gynecology Department, College of Medicine,
        King Saud University, Riyadh, Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Binsaleh</LastName><ForeName>Saleh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Urology
        Division, Surgery Department, College of Medicine, King Saud University, Riyadh,
        Kingdom of Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazam</LastName><ForeName>Nazia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Toxicogenomics
        Laboratory, Division of Genetics, Department of Zoology, Aligarh Muslim University,
        Aligarh, India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lone</LastName><ForeName>Mohamad
        I.</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Toxicogenomics
        Laboratory, Division of Genetics, Department of Zoology, Aligarh Muslim University,
        Aligarh, India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Waseem</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Centre
        of Excellence in Genomic and Medicine Research, King Abdulaziz University,
        Jeddah, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansari</LastName><ForeName>Shakeel
        A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Centre of
        Excellence in Genomic and Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alqahtani</LastName><ForeName>Mohamed
        H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Centre of
        Excellence in Genomic and Medicine Research, King Abdulaziz University, Jeddah,
        Saudi Arabia </Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC
        Genomics</MedlineTA><NlmUniqueID>100965258</NlmUniqueID><ISSNLinking>1471-2164</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">27454254</ArticleId><ArticleId IdType="pmc">PMC4959372</ArticleId><ArticleId
        IdType="doi">10.1186/s12864-016-2858-0</ArticleId><ArticleId IdType="pii">10.1186/s12864-016-2858-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12498735</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>185</Volume><Issue>3</Issue><PubDate><Year>2002</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Gene
        expression changes induced in mouse liver by di(2-ethylhexyl) phthalate.</ArticleTitle><Pagination><StartPage>180</StartPage><EndPage>196</EndPage><MedlinePgn>180-96</MedlinePgn></Pagination><Abstract><AbstractText>Increasing
        chemical use necessitates a better understanding of how pollutants, such as
        di(2-ethylhexyl) phthalate (DEHP), a peroxisome proliferator and a phthalate
        plasticizer, affect human health. To understand the effects of DEHP exposure,
        we utilized microarray technology to identify novel DEHP targets in livers
        of male C57BL/6 mice treated with 1.0% dietary DEHP for 13 weeks. We identified
        51 DEHP-regulated genes; these genes are involved in, but not limited to,
        peroxisome proliferation, xenobiotic detoxification, oxidative stress response,
        immune function, steroid hormone metabolism, testis development, and pheromone
        transport. The reproductive toxicity mechanism of DEHP may be due to its effects
        on steroid hormone metabolism and sexual development. Confirmation of microarray
        results with Northern blots demonstrated that both low- and high-dose DEHP
        treatments altered the expression of genes associated with testis development
        and steroid hormone synthesis. Vanin-1, a regulator of testis development,
        was upregulated after exposure to 0.2 and 1.0% DEHP by 1.8- and 2.9-fold,
        respectively. Several genes involved in hormone metabolism were also regulated
        by DEHP. 11betaHSDI was downregulated 1.8- and 3.1-fold by 0.2 and 1.0% DEHP,
        respectively, while HSD3b5 was suppressed similarly by 0.2% DEHP, 1.5-fold,
        and more severely by 1.0% DEHP, 8.0-fold. Interestingly, food restriction
        had a similar effect to DEHP on several genes, including HSD3b5. In addition,
        steroidogenic gene cyp7B1 was downregulated while phospholipid transfer protein
        and cyp2B9 were induced. Genes peripherally associated with steroid hormones
        were also affected: ALDH3, GSTtheta2, and Id2. Collectively, our data validate
        the concern for DEHP as a reproductive developmental toxicant.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Jean
        S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department
        of Cell Biology and Neuroscience, University of California, Riverside 92521,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Sarjeet
        S</ForeName><Initials>SS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015815">Cell Adhesion Molecules</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D058851">GPI-Linked Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D049294">Phospholipid Transfer Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015262">Xenobiotics</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.-</RegistryNumber><NameOfSubstance UI="D006913">Hydroxysteroid Dehydrogenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.146</RegistryNumber><NameOfSubstance UI="D042842">11-beta-Hydroxysteroid
        Dehydrogenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.-</RegistryNumber><NameOfSubstance
        UI="D013250">Steroid Hydroxylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.13.-</RegistryNumber><NameOfSubstance UI="C115867">oxysterol 7-alpha-hydroxylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D001189">Aryl Hydrocarbon Hydroxylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="C121503">Cyp2b9 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D000072467">Cytochrome P450
        Family 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.-</RegistryNumber><NameOfSubstance
        UI="D000581">Amidohydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.5.1.-</RegistryNumber><NameOfSubstance UI="C022314">pantetheinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D042842" MajorTopicYN="N">11-beta-Hydroxysteroid Dehydrogenases</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000581" MajorTopicYN="N">Amidohydrolases</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001189" MajorTopicYN="N">Aryl Hydrocarbon Hydroxylases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015152" MajorTopicYN="N">Blotting, Northern</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015815" MajorTopicYN="N">Cell Adhesion Molecules</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000072467" MajorTopicYN="N">Cytochrome P450 Family 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D058851" MajorTopicYN="N">GPI-Linked Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006913" MajorTopicYN="N">Hydroxysteroid Dehydrogenases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007109" MajorTopicYN="N">Immunity</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D049294" MajorTopicYN="Y">Phospholipid Transfer Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012741" MajorTopicYN="N">Sexual Maturation</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013250" MajorTopicYN="N">Steroid Hydroxylases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015262" MajorTopicYN="N">Xenobiotics</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>15</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12498735</ArticleId><ArticleId IdType="doi">10.1006/taap.2002.9540</ArticleId><ArticleId
        IdType="pii">S0041008X02995402</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3769136</PMID><DateCompleted><Year>1986</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>11</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>7</Volume><Issue>11</Issue><PubDate><Year>1986</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>In
        vitro steady-state levels of hydrogen peroxide after exposure of male F344
        rats and female B6C3F1 mice to hepatic peroxisome proliferators.</ArticleTitle><Pagination><StartPage>1871</StartPage><EndPage>1876</EndPage><MedlinePgn>1871-6</MedlinePgn></Pagination><Abstract><AbstractText>The
        hypothesis that hepatocarcinogenesis resulting from treatment of rats and
        mice with peroxisome proliferators is linked to increased cellular levels
        of hydrogen peroxide from peroxisomal beta-oxidation was investigated. Male
        F344 rats and female B6C3F1 mice were treated for 14 days with di(2-ethylhexyl)phthalate
        (DEHP) or di(2-ethylhexyl)adipate (DEHA), industrial plasticizers, or nafenopin,
        a hypolipidemic drug. Activities of enzymes responsible for the production
        [peroxisomal palmitoyl CoA oxidase (PCO)] and degradation [catalase (Cat)
        and glutathione peroxidase (GSHPx)] of H2O2 were assayed in liver homogenates
        prepared from treated animals. The activities of the peroxisomal enzymes PCO
        and Cat were enhanced 5- to 25-fold and 1.5- to 3-fold respectively by treatment
        with the peroxisome proliferators. The activity of GSHPx, a cytoplasmic enzyme,
        was decreased 40-60% in liver homogenates prepared from treated animals compared
        to control animals. A kinetic treatment of the rates of formation of hydrogen
        peroxide by PCO, and of degradation of hydrogen peroxide by catalase was used
        to estimate steady-state hydrogen peroxide concentrations ([H2O2]) during
        peroxisomal oxidation of palmitoyl CoA. Increases in peroxisomal steady-state
        [H2O2] for the F344 rat liver homogenates correlated well with the carcinogenic
        potential of these chemicals, determined in previous carcinogenicity studies.
        Increases in the steady-state [H2O2] were also calculated for liver homogenates
        prepared from mice treated with these compounds. Decreases in liver lipid
        peroxidation were observed after treatment with each chemical in both species.
        The results of these studies are consistent with an involvement of increased
        peroxisomal hydrogen peroxide in the hepatocarcinogenesis of these compounds.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Tomaszewski</LastName><ForeName>K
        E</ForeName><Initials>KE</Initials></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>D
        K</ForeName><Initials>DK</Initials></Author><Author ValidYN="Y"><LastName>Melnick</LastName><ForeName>R
        L</ForeName><Initials>RL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008054">Lipid Peroxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance
        UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.9</RegistryNumber><NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.-</RegistryNumber><NameOfSubstance UI="C028427">palmitoyl CoA oxidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005979" MajorTopicYN="N">Glutathione Peroxidase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008054" MajorTopicYN="N">Lipid Peroxides</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3769136</ArticleId><ArticleId IdType="doi">10.1093/carcin/7.11.1871</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8269617</PMID><DateCompleted><Year>1994</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>12</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>14</Volume><Issue>12</Issue><PubDate><Year>1993</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Elevated
        8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome
        proliferators: relationship to carcinogenesis and nuclear localization.</ArticleTitle><Pagination><StartPage>2495</StartPage><EndPage>2499</EndPage><MedlinePgn>2495-9</MedlinePgn></Pagination><Abstract><AbstractText>Increased
        oxidative DNA damage due to increased peroxisomal generation of H2O2 is a
        potential mechanism in the carcinogenicity of chemical peroxisome proliferators
        (PP) in rodent liver. In order to determine the relationship between carcinogenicity
        and peroxisome-dependent DNA damage, levels of DNA base oxidation were examined
        by comparing 8-hydroxydeoxyguanosine (8-OHdG) in DNA from unfractionated liver
        of male F344 rats following dietary exposure to PP [WY-14,643, 0.1% or 0.005%;
        di(2-ethylhexyl)phthalate (DEHP), 1.2%; clofibric acid, 0.5%] or phenobarbital
        (0.05%). Exposure-related increases in 8-OHdG were not observed at 3 or 11
        weeks for any of the compounds fed. At 22 weeks, 8-OHdG was similarly elevated
        (2-3x) by WY-14,643 (0.1% and 0.005%) and clofibric acid (0.5%). These equivalent
        increases in 8-OHdG in DNA from unfractionated liver did not parallel the
        divergent carcinogenicity of these different dietary exposures in the present
        or previous studies. The potential oxidation of nuclear DNA was examined by
        comparing levels of 8-OHdG in DNA isolated from purified liver nuclei and
        unfractionated liver. Elevated levels of 8-OHdG were not detected in DNA isolated
        from nuclear fractions of livers from rats fed clofibric acid for 22 weeks,
        indicating the dependence of PP-induced oxidative DNA damage on extranuclear
        components of samples for DNA isolation. The absence of a quantitative relationship
        between PP-induced carcinogenicity and oxidative DNA base damage (as 8-OHdG),
        and the failure to localize this oxidative damage to nuclear DNA, suggest
        two possible conclusions: (1) quantitation of 8-OHdG, a specific and sensitive
        indicator of oxidative DNA damage, does not accurately reflect the potential
        peroxisomal H2O2-dependent DNA damage and carcinogenicity of PP exposure in
        rodents; (2) other hepatic responses may be more critical features of the
        mechanism of PP carcinogenicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, NC 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Glover</LastName><ForeName>S E</ForeName><Initials>SE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>12133JR80S</RegistryNumber><NameOfSubstance
        UI="D006151">Guanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>3868-31-3</RegistryNumber><NameOfSubstance
        UI="C046215">8-hydroxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName
        UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004051"
        MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006151" MajorTopicYN="N">Guanosine</DescriptorName><QualifierName UI="Q000031"
        MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1993</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1993</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1993</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8269617</ArticleId><ArticleId IdType="doi">10.1093/carcin/14.12.2495</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">28284729</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2017</Year><Month>07</Month><Day>26</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6351</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>103</Volume><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Effects of di(2-ethylhexyl)phthalate
        exposure on 1,2-dimethyhydrazine-induced colon tumor promotion in rats.</ArticleTitle><Pagination><StartPage>157</StartPage><EndPage>167</EndPage><MedlinePgn>157-167</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.fct.2017.03.014</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0278-6915(17)30107-2</ELocationID><Abstract><AbstractText>Di(2-ethylhexyl)phthalate
        (DEHP) may cause carcinogenicity in the liver; however, few have detailed
        on the potential effects of DEHP exposure on colorectal cancer. Male Sprague-Dawley
        rats received i.p. injections of 1,2-dimethylhydrazine (DMH) once-a-week for
        the first 4 weeks, and rats in each group were treated with DEHP through oral
        gavage daily for either 7, 10 or 15 weeks; after which, all rats were euthanized
        and their colons were assessed (a) morphologically for aberrant crypt foci
        (ACF) or tumors, (b) cytologically for mitotic index (MI), and (c) immunohistochemically
        for the expression of &#x3b2;-catenin, cyclooygenase (COX)-2, vascular endothelial
        growth factor (VEGF), proliferating cell nuclear antigen (PCNA), cyclin D1,
        and c-myc. Our results indicated that the mean total ACF, tumor incidence,
        and MI were significantly higher in the DEHP-treated DMH compared to control
        and the DEHP-alone groups. The level of &#x3b2;-catenin and cyclin D1 was
        increased in DEHP-exposed rats. Expression of &#x3b2;-catenin, COX-2, VEGF,
        and cyclin D1 was significantly higher in the combined DMH and DEHP-treated
        rats by comparison to that of the DMH group. In conclusion, this study indicates
        that exposure to DEHP may exacerbate DMH-induced colon tumorigenesis and provides
        impetus to evaluate the effect of DEHP in conjunction with other carcinogens.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2017 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hsin-Pao</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department
        of Safety, Health and Environmental Engineering, National Kaohsiung First
        University of Science and Technology, Kaohsiung 811, Taiwan; Division of Colon
        and Rectal Surgery, Department of Surgery, E-DA Hospital, I-Shou University,
        Kaohsiung 824, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Min-Hsiung</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Institute
        of Food Science and Technology, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chou</LastName><ForeName>Yuan-Yi</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department
        of Safety, Health and Environmental Engineering, National Kaohsiung First
        University of Science and Technology, Kaohsiung 811, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Sung</LastName><ForeName>Chieh</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department
        of Safety, Health and Environmental Engineering, National Kaohsiung First
        University of Science and Technology, Kaohsiung 811, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lee</LastName><ForeName>Kuo-Hsin</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department
        of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Leung</LastName><ForeName>Chung-Man</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department
        of Safety, Health and Environmental Engineering, National Kaohsiung First
        University of Science and Technology, Kaohsiung 811, Taiwan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hsu</LastName><ForeName>Ping-Chi</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department
        of Safety, Health and Environmental Engineering, National Kaohsiung First
        University of Science and Technology, Kaohsiung 811, Taiwan. Electronic address:
        pchsu@nkfust.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C530106">Ccnd1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C495268">Ctnnb1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D051176">beta Catenin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C467498">vascular endothelial growth factor A, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>136601-57-5</RegistryNumber><NameOfSubstance
        UI="D019938">Cyclin D1</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.99.1</RegistryNumber><NameOfSubstance UI="C489691">Ptgs2 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>IX068S9745</RegistryNumber><NameOfSubstance
        UI="D019813">1,2-Dimethylhydrazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D019813" MajorTopicYN="N">1,2-Dimethylhydrazine</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D019938" MajorTopicYN="N">Cyclin D1</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051176" MajorTopicYN="N">beta Catenin</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword
        MajorTopicYN="N">Cyclin D1</Keyword><Keyword MajorTopicYN="N">Cyclooygenase-2</Keyword><Keyword
        MajorTopicYN="N">Di(2-ethylhexyl)phthalate</Keyword><Keyword MajorTopicYN="N">Vascular
        endothelial growth factor</Keyword><Keyword MajorTopicYN="N">&#x3b2;-Catenin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2016</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2017</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2017</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">28284729</ArticleId><ArticleId IdType="doi">10.1016/j.fct.2017.03.014</ArticleId><ArticleId
        IdType="pii">S0278-6915(17)30107-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15564602</PMID><DateCompleted><Year>2005</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0006-3363</ISSN><JournalIssue
        CitedMedium="Print"><Volume>72</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Biology
        of reproduction</Title><ISOAbbreviation>Biol Reprod</ISOAbbreviation></Journal><ArticleTitle>Differential
        effects of phthalates on the testis and the liver.</ArticleTitle><Pagination><StartPage>745</StartPage><EndPage>754</EndPage><MedlinePgn>745-54</MedlinePgn></Pagination><Abstract><AbstractText>Phthalates
        have been shown to elicit contrasting effects on the testis and the liver,
        causing testicular degeneration and promoting abnormal hepatocyte proliferation
        and carcinogenesis. In the present study, we compared the effects of phthalates
        on testicular and liver cells to better understand the mechanisms by which
        phthalates cause testicular degeneration. In vivo treatment of rats with di-(2-ethylhexyl)
        phthalate (DEHP) caused a threefold increase of germ cell apoptosis in the
        testis, whereas apoptosis was not changed significantly in livers from the
        same animals. Western blot analyses revealed that peroxisome proliferator-activated
        receptor (PPAR) alpha is equally abundant in the liver and the testis, whereas
        PPAR gamma and retinoic acid receptor (RAR) alpha are expressed more in the
        testis. To determine whether the principal metabolite of DEHP, mono-(2-ethylhexyl)
        phthalate (MEHP), or a strong peroxisome proliferator, 4-chloro-6(2,3-xylindino)-2-pyrimidinylthioacetic
        acid (Wy-14,643), have a differential effect in Sertoli and liver cells by
        altering the function of RAR alpha and PPARs, their nuclear trafficking patterns
        were compared in Sertoli and liver cells after treatment. Both MEHP and Wy-14,643
        increased the nuclear localization of PPAR alpha and PPAR gamma in Sertoli
        cells, but they decreased the nuclear localization of RAR alpha, as previously
        shown. Both PPAR alpha and PPAR gamma were in the nucleus and cytoplasm of
        liver cells, but RAR alpha was predominant in the cytoplasm, regardless of
        the treatment. At the molecular level, MEHP and Wy-14,643 reduced the amount
        of phosphorylated mitogen-activated protein kinase (activated MAPK) in Sertoli
        cells. In comparison, both MEHP and Wy-14,643 increased phosphorylated MAPK
        in liver cells. These results suggest that phthalates may cause contrasting
        effects on the testis and the liver by differential activation of the MAPK
        pathway, RAR alpha, PPAR alpha, and PPAR gamma in these organs.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhattacharya</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School
        of Molecular Biosciences, Center for Reproductive Biology, Washington State
        University, Pullman, Washington 99164, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Dufour</LastName><ForeName>Jannette M</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Vo</LastName><ForeName>My-Nuong</ForeName><Initials>MN</Initials></Author><Author
        ValidYN="Y"><LastName>Okita</LastName><ForeName>Janice</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Okita</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Kim</LastName><ForeName>Kwan Hee</ForeName><Initials>KH</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>ES09978</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H.,
        Extramural</PublicationType><PublicationType UI="D013487">Research Support,
        U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Biol Reprod</MedlineTA><NlmUniqueID>0207224</NlmUniqueID><ISSNLinking>0006-3363</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047495">PPAR gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C000607073">Rara protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018168">Receptors, Retinoic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000072482">Retinoic Acid Receptor alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated
        Protein Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005854" MajorTopicYN="N">Germ Cells</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297"
        MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047495" MajorTopicYN="N">PPAR gamma</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018168" MajorTopicYN="N">Receptors, Retinoic Acid</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000072482" MajorTopicYN="N">Retinoic Acid Receptor alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012708" MajorTopicYN="N">Sertoli Cells</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2004</Year><Month>11</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2005</Year><Month>9</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2004</Year><Month>11</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15564602</ArticleId><ArticleId IdType="doi">10.1095/biolreprod.104.031583</ArticleId><ArticleId
        IdType="pii">biolreprod.104.031583</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">32540476</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>02</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6351</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>144</Volume><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Food
        and chemical toxicology : an international journal published for the British
        Industrial Biological Research Association</Title><ISOAbbreviation>Food Chem
        Toxicol</ISOAbbreviation></Journal><ArticleTitle>Effects of intravenous and
        oral di(2-ethylhexyl) phthalate (DEHP) and 20% Intralipid vehicle on neonatal
        rat testis, lung, liver, and kidney.</ArticleTitle><Pagination><StartPage>111497</StartPage><MedlinePgn>111497</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.fct.2020.111497</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0278-6915(20)30387-2</ELocationID><Abstract><AbstractText>The
        highest human exposures to the plasticizer di(2-ethylhexyl) phthalate (DEHP)
        occur through intravenous (iv) exposure from medical procedures. Rodent toxicity
        studies, mainly using oral exposures, have identified male reproductive toxicity
        after developmental exposure to DEHP as the primary concern. Other organs
        are also affected by DEHP and route may influence the degree of target organ
        involvement. Cammack et al. (2003) reported a critical study focused on testicular
        toxicity using oral and iv exposures of neonatal Sprague-Dawley rats to 60,
        300, or 600&#xa0;mg/kg body weight/day DEHP in Intralipid vehicle. The present
        study followed the same dosing paradigm and included assessment of additional
        organs to evaluate the potential utility of this design for DEHP alternatives.
        Reduction of testis weight was observed in all DEHP treatment groups and germ
        cell and Sertoli cell toxicity was observed at the two highest doses with
        both routes. Lung granulomas occurred in all iv DEHP groups, possibly related
        to increased fat particle size in DEHP lipid emulsions. Lung alveolar development
        was inhibited after both oral and iv high dose DEHP. Toxicity of oral Intralipid
        vehicle was observed in germ and Sertoli cells. The lack of such effects after
        iv vehicle exposure suggested that this may be a gut-mediated effect.</AbstractText><CopyrightInformation>Published
        by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Camacho</LastName><ForeName>Lu&#xed;sa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division
        of Biochemical Toxicology, National Center for Toxicological Research, Jefferson,
        AR, 72079, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latendresse</LastName><ForeName>John
        R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Toxicologic
        Pathology Associates, Jefferson, AR, 72079, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Muskhelishvili</LastName><ForeName>Levan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Toxicologic
        Pathology Associates, Jefferson, AR, 72079, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Law</LastName><ForeName>Charles D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Division
        of Neurotoxicology, National Center for Toxicological Research, Jefferson,
        AR, 72079, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delclos</LastName><ForeName>K
        Barry</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Division
        of Biochemical Toxicology, National Center for Toxicological Research, Jefferson,
        AR, 72079, USA. Electronic address: barry.delclos@fda.hhs.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>FD999999</GrantID><Acronym>ImFDA</Acronym><Agency>Intramural
        FDA HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food
        Chem Toxicol</MedlineTA><NlmUniqueID>8207483</NlmUniqueID><ISSNLinking>0278-6915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006099" MajorTopicYN="N">Granuloma</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019055" MajorTopicYN="N">No-Observed-Adverse-Effect Level</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">DEHP</Keyword><Keyword MajorTopicYN="N">Developmental
        exposure</Keyword><Keyword MajorTopicYN="N">Intralipid</Keyword><Keyword MajorTopicYN="N">Lung
        toxicity</Keyword><Keyword MajorTopicYN="N">Reproductive toxicity</Keyword></KeywordList><CoiStatement>Declaration
        of interests. The authors declare that they have no known competing financial
        interests or personal relationships that could have appeared to influence
        the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2020</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">32540476</ArticleId><ArticleId IdType="mid">NIHMS1603802</ArticleId><ArticleId
        IdType="pmc">PMC7487059</ArticleId><ArticleId IdType="doi">10.1016/j.fct.2020.111497</ArticleId><ArticleId
        IdType="pii">S0278-6915(20)30387-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bancalari
        E, Jain D, 2019. Bronchopulmonary dysplasia: 50 years after the initial description.
        Neonatology 115, 384&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">30974430</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammack
        JN, White RD, Gordon D, Gass J, Hecker L, Conine D, Bruen US, Friedman M,
        Echols C, Yeh TY, Wilson DM, 2003. Evaluation of reproductive development
        following intravenous and oral exposure to DEHP in male neonatal rats. Int
        J Toxicol 22, 159&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">12851149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapin
        RE, Gray TJB, Phelps JL, Dutton SL, 1988. The effects of mono-(2-ethylhexyl)-phthalate
        on rat Sertoli cell-enriched primary cultures. Toxicol Appl Pharmacol 92,
        467&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">3353991</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton
        JC, Cunningham ML, Hummer BT, Lau C, Meek B, Peters JM, Popp JA, Rhomberg
        L, Seed J, Klaunig JE, 2014. Mode of action framework analysis for receptor-mediated
        toxicity: The peroxisome proliferator-activated receptor alpha (PPARalpha)
        as a case study. Crit Rev Toxicol 44, 1&#x2013;49.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">24180432</ArticleId></ArticleIdList></Reference><Reference><Citation>Creasy
        DM, Foster JR, Foster PMD, 1983. The morphological development of di-N-pentyl
        phthalate induced testicular atrophy in the rat. J Pathol 139, 309&#x2013;321.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6834175</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, White RD, Larson MJ, Herman JK, Otter R, 2015. Toxicity of Hexamoll((R))
        DINCH((R)) following intravenous administration. Toxicol Lett 238, 100&#x2013;109.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">26211741</ArticleId></ArticleIdList></Reference><Reference><Citation>Dostal
        LA, Chapin RE, Stefanski SA, Harris MW, Schwetz BA, 1988. Testicular toxicity
        and reduced Sertoli cell numbers in neonatal rats by di(2-ethylhexyl) phthalate
        and the recovery of fertility as adults. Toxicol Appl Pharmacol 95, 104&#x2013;121.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3413790</ArticleId></ArticleIdList></Reference><Reference><Citation>Driscoll
        DF, 2009. The pharmacopeial evolution of intralipid injectable emulsion in
        plastic containers: from a coarse to a fine dispersion. Int J Pharm 368, 193&#x2013;198.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18996455</ArticleId></ArticleIdList></Reference><Reference><Citation>Driscoll
        DF, Ling PR, Bistrian BR, 2006. Pathological consequences to reticuloendothelial
        system organs following infusion of unstable all-in-one mixtures in rats.
        Clin Nutr 25, 842&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">16682100</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA/CDRH,
        2001. Safety assessment of Di(2-ethylhexyl)phthalate (DEHP) released from
        PVC medical devices.</Citation></Reference><Reference><Citation>Foster PMD,
        Foster JR, Cook MW, Thomas LB, Gangolli SD, 1982. Changes in ultrastructure
        and cytochemical localization of zinc in rat testis following the administration
        of di-n-penty phthalate. Toxicol Appl Pharmacol 63, 120&#x2013;132.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7071867</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster
        PMD, Mylchreest E, Gaido KW, Sar M, 2001. Effects of phthalate esters on the
        developing reproductive tract of male rats. Hum Reprod Update 7, 231&#x2013;235.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11392369</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray
        TJB, Beamand JA, 1984. Effect of some phthalate esters and other testicular
        toxins on primary cultures of testicular cells. Food Chem Toxicol 22, 123&#x2013;131.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6538161</ArticleId></ArticleIdList></Reference><Reference><Citation>Greener
        Y, Gillies B, Wienckowski D, Schmitt D, Woods E, Youkilis E, 1987. Assessment
        of the safety of chemicals administered intravenously in the neonatal rat.
        Teratology 35, 187&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">3603403</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahnukainen
        K, Chrysis D, Hou M, Parvinen M, Eksborg S, Soder O, 2004. Increased apoptosis
        occurring during the first wave of spermatogenesis is stage-specific and primarily
        affects midpachytene spermatocytes in the rat testis. Biol Reprod 70, 290&#x2013;296.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14522836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeibmann
        A, Zahedi S, Simoni M, Nieschlag E, Byrne MM, 2005. Glucagon-like peptide-I
        reduces the pulsatile component of testosterone secretion in healthy males.
        Eur J Clin Invest 35, 565&#x2013;572.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16128863</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalikkot
        Thekkeveedu R, Guaman MC, Shivanna B, 2017. Bronchopulmonary dysplasia: A
        review of pathogenesis and pathophysiology. Respir Med 132, 170&#x2013;177.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC5729938</ArticleId><ArticleId IdType="pubmed">29229093</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch
        HM, Angerer J, Drexler H, Eckstein R, Weisbach V, 2005. Di(2-ethylhexyl)phthalate
        (DEHP) exposure of voluntary plasma and platelet donors. Int J Hyg Environ
        Health 208, 489&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">16325559</ArticleId></ArticleIdList></Reference><Reference><Citation>Li
        H, Kim KH, 2003. Effects of mono-(2-ethylhexyl) phthalate on fetal and neonatal
        rat testis organ cultures. Biol Reprod 69, 1964&#x2013;1972.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12904314</ArticleId></ArticleIdList></Reference><Reference><Citation>Li
        LH, Jester WF Jr., Laslett AL, Orth JM, 2000. A single dose of Di-(2-ethylhexyl)
        phthalate in neonatal rats alters gonocytes, reduces sertoli cell proliferation,
        and decreases cyclin D2 expression. Toxicol Appl Pharmacol 166, 222&#x2013;229.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10906286</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang
        Z-J, Wu Q-P, Chen B-T, Lin Z. l., Lin J, Chen S-Q, 2018. Postnatal hyperoxia
        or DEHP exposure leads to growth restriction and delayed lung development
        in newborn rats. Pediatrics &amp; Neonatology 59, 24&#x2013;30.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">28576411</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindgren
        O, Carr RD, Deacon CF, Holst JJ, Pacini G, Mari A, Ahren B, 2011. Incretin
        hormone and insulin responses to oral versus intravenous lipid administration
        in humans. J Clin Endocrinol Metab 96, 2519&#x2013;2524.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21593115</ArticleId></ArticleIdList></Reference><Reference><Citation>Magliozzi
        R, Nardacci R, Scarsella G, Di Carlo V, Stefanini S, 2003. Effects of the
        plasticiser DEHP on lung of newborn rats: catalase immunocytochemistry and
        morphometric analysis. Histochem Cell Biol 120, 41&#x2013;49.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12802597</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallow
        EB, Fox MA, 2014. Phthalates and critically ill neonates: device-related exposures
        and non-endocrine toxic risks. J Perinatol 34, 892&#x2013;897.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">25357096</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardelli
        TC, Albert O, Lalancette C, Culty M, Hales BF, Robaire B, 2017. In Utero and
        Lactational Exposure Study in Rats to Identify Replacements for Di(2-ethylhexyl)
        Phthalate. Scientific Reports 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5478651</ArticleId><ArticleId
        IdType="pubmed">28634325</ArticleId></ArticleIdList></Reference><Reference><Citation>Nauck
        MA, Meier JJ, 2018. Incretin hormones: Their role in health and disease. Diabetes,
        Obesity and Metabolism 20, 5&#x2013;21.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">29364588</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordstrand
        K, Eide TJ, Kristoffersen G, Reikeras O, Giercksky K-E, 1987. Organ changes
        in rats on complete parenteral nutrition. Clin Nutr 6, 75&#x2013;82.</Citation></Reference><Reference><Citation>NTP
        CNTP, Center for the Evaluation of Risks to Human Reproduction), 2006. NTP-CERHR
        monograph on the potential human reproductive and developmental effects of
        di(2-ethylhexyl) phthalate (DEHP). In: Services, U.S.D.o.H.a.H; (Ed.), p.
        308.</Citation><ArticleIdList><ArticleId IdType="pubmed">19407857</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks
        LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, Gray LE
        Jr., 2000. The plasticizer diethylhexyl phthalate induces malformations by
        decreasing fetal testosterone synthesis during sexual differentiation in the
        male rat. Toxicol Sci 58, 339&#x2013;349.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11099646</ArticleId></ArticleIdList></Reference><Reference><Citation>Picut
        CA, Remick AK, de Rijk EP, Simons ML, Stump DG, Parker GA, 2015. Postnatal
        development of the testis in the rat: morphologic study and correlation of
        morphology to neuroendocrine parameters. Toxicol Pathol 43, 326&#x2013;342.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">25217330</ArticleId></ArticleIdList></Reference><Reference><Citation>Picut
        CA, Ziejewski MK, Stanislaus D, 2018. Comparative Aspects of Pre- and Postnatal
        Development of the Male Reproductive System. Birth Defects Res 110, 190&#x2013;227.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">29063715</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack
        GM, Li RC, Ermer JC, Shen DD, 1985. Effects of route of administration and
        repetitive dosing on the disposition kinetics of di(2-ethylhexyl) phthalate
        and its mono-de-esterified metabolite in rats. Toxicol Appl Pharmacol 79,
        246&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">4002226</ArticleId></ArticleIdList></Reference><Reference><Citation>Reagan-Shaw
        S, Nihal M, Ahmad N, 2008. Dose translation form animal to human studies revisited.
        FASEB J 22, 659&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">17942826</ArticleId></ArticleIdList></Reference><Reference><Citation>Richburg
        JH, Boekelheide K, 1996. Mono-(2-ethylhexyl) phthalate rapidly alters both
        Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes.
        Toxicol Appl Pharmacol 137, 42&#x2013;50.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8607140</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosicarelli
        B, Stefanini S, 2009. DEHP effects on histology and cell proliferation in
        lung of newborn rats. Histochem Cell Biol 131, 491&#x2013;500.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19096866</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Peters JM, Cunningham ML, 2008. Modes of Action and Species-Specific Effects
        of Di-(2-ethylhexyl)Phthalate in the Liver. Critical Reviews in Toxicology
        36, 459&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2614359</ArticleId><ArticleId
        IdType="pubmed">16954067</ArticleId></ArticleIdList></Reference><Reference><Citation>SCENIHR,
        2015. Scientific Opinion on the safety of medical devices containing DEHP-plasticized
        PVC or other plasticizers on neonates and other groups possibly at risk. p.
        166.</Citation><ArticleIdList><ArticleId IdType="pubmed">26854686</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellers
        RS, Morton D, Michael B, Roome N, Johnson JK, Yano BL, Perry R, Schafer K,
        2007. Society of Toxicologic Pathology position paper: organ weight recommendations
        for toxicology studies. Toxicol Pathol 35, 751&#x2013;755.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17849358</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe
        RM, McKinnell C, Kivlin C, Fisher JS, 2003. Proliferation and functional maturation
        of Sertoli cells, and their relevance to disorders of testis function in adulthood.
        Reproduction 125, 769&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">12773099</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjoberg
        P, Lindquist NG, Montin G, Ploen L, 1985. Effects of repeated intravenous
        infusions of the plasticizer di-(2-ethylhexyl)phthalate in young male rats.
        Arch Toxicol 58, 78&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">4091660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjoberg
        P, Lindqvist NG, Ploen L, 1986. Age-dependent response of the rat testes to
        di(2-ethylhexyl) phthalate. Environ Health Perspect 65, 237&#x2013;242.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474698</ArticleId><ArticleId IdType="pubmed">3709447</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi
        S, Iida M, Kobayashi S, Jin K, Matsuda T, Kojima H, 2005. Differential effects
        of phthalate esters on transcriptional activities via human estrogen receptors
        &#x3b1; and &#x3b2;, and androgen receptor. Toxicology 210, 223&#x2013;233.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15840436</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas
        JA, Curto KA, Thomas MJ, 1982. MEHP/DEHP: Gonadal toxicity and effects on
        rodent accessory sex organs. Environ Health Perspect 45, 85&#x2013;88.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1569004</ArticleId><ArticleId IdType="pubmed">7140700</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremellen
        K, Hill A, Pearce K, 2019. Mechanistic insights into the aetiology of post-prandial
        decline in testosterone in reproductive&#x2010;aged men. Andrologia.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">31475727</ArticleId></ArticleIdList></Reference><Reference><Citation>Vamvini
        MT, Hamnvik OP, Sahin-Efe A, Gavrieli A, Dincer F, Farr OM, Mantzoros CS,
        2016. Differential Effects of Oral and Intravenous Lipid Administration on
        Key Molecules Related to Energy Homeostasis. J Clin Endocrinol Metab 101,
        1989&#x2013;1997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4870849</ArticleId><ArticleId
        IdType="pubmed">26964729</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang
        W, Craig ZR, Basavarajappa MS, Hafner KS, Flaws JA, 2012. Mono-(2-Ethylhexyl)
        Phthalate Induces Oxidative Stress and Inhibits Growth of Mouse Ovarian Antral
        Follicles1. Biology of Reproduction 87.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4435432</ArticleId><ArticleId IdType="pubmed">23077170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu
        CT, Wang CC, Huang LC, Liu SH, Chiang CK, 2018. Plasticizer Di-(2-Ethylhexyl)Phthalate
        Induces Epithelial-to-Mesenchymal Transition and Renal Fibrosis In Vitro and
        In Vivo. Toxicol Sci 164, 363&#x2013;374.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">29669060</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoder
        SM, Yang Q, Kindel TL, Tso P, 2009. Stimulation of incretin secretion by dietary
        lipid: is it dose dependent? American Journal of Physiology-Gastrointestinal
        and Liver Physiology 297, G299&#x2013;G305.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2724086</ArticleId><ArticleId IdType="pubmed">19520739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang
        E, Xu F, Liang H, Yan J, Xu H, Li Z, Wen X, Weng J, 2015. GLP-1 receptor agonist
        exenatide attenuates the detrimental effects of obesity on inflammatory profile
        in testis and sperm quality in mice. Am J Reprod Immunol 74, 457&#x2013;466.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">26287267</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12151626</PMID><DateCompleted><Year>2002</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>68</Volume><Issue>2</Issue><PubDate><Year>2002</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Downregulation of lactoferrin
        by PPARalpha ligands: role in perturbation of hepatocyte proliferation and
        apoptosis.</ArticleTitle><Pagination><StartPage>304</StartPage><EndPage>313</EndPage><MedlinePgn>304-13</MedlinePgn></Pagination><Abstract><AbstractText>PPARalpha
        (peroxisome proliferator activated receptor alpha) is a transcription factor
        that mediates the rodent liver tumorigenic responses to peroxisome proliferators
        via regulation of genes that remain to be identified. Using microarray gene
        expression profiling of mRNA from wild type versus PPARalpha null mice, we
        detected a 3- to 7-fold downregulation of hepatic lactoferrin (LF) in response
        to the PP, diethylhexylphthalate (DEHP; 1150 mg/kg). Northern blot analyses
        confirmed a significant downregulation of LF mRNA by DEHP in wild type mouse
        liver. Since LF has been reported to repress tumor necrosis factor-alpha (TNF-alpha),
        LF downregulation by PPs may permit TNF-alpha levels to rise, enhancing hepatocyte
        survival and proliferation. To test this hypothesis, we asked if exogenous
        LF could prevent the perturbation of hepatocyte growth by PPs but not by TNF-alpha.
        In vitro, the PPs monoethylhexylphthalate (MEHP; 500 microM, the active metabolite
        of DEHP) and another PP, nafenopin (50 microM) or exogenous TNF-alpha (5000
        U/ml) induced hepatocyte proliferation and suppressed apoptosis. LF (200 microM)
        blocked the growth but not the peroxisome proliferation response to PPs but
        could not block the growth response to TNF-alpha. Immunocytochemistry using
        specific antibodies to LF but also to transferrin (TF), a related gene previously
        shown to contain a PP response element (PPRE), demonstrated that both LF and
        TF are expressed in murine liver. Furthermore, both were downregulated by
        DEHP in both wild type and PPARalpha null mouse liver. These data suggest
        that the regulation of iron binding proteins by PPARalpha ligands plays a
        role in PP-mediated liver growth, but not in peroxisome proliferation.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hasmall</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Syngenta
        Central Toxicology Laboratory, Alderley Park, Macclesfield, SK10 4TJ, England,
        United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orphanides</LastName><ForeName>George</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>James</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Pennie</LastName><ForeName>William</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>Hedley</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Soames</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Kimber</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014168">Transferrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.4.21.-</RegistryNumber><NameOfSubstance UI="D007781">Lactoferrin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007781" MajorTopicYN="N">Lactoferrin</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014168" MajorTopicYN="N">Transferrin</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>12</Month><Day>27</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12151626</ArticleId><ArticleId IdType="doi">10.1093/toxsci/68.2.304</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">30826316</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>17</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0295</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>104</Volume><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Regulatory
        toxicology and pharmacology : RTP</Title><ISOAbbreviation>Regul Toxicol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Systemic
        toxicity of di (2-ethylhexyl) adipate (DEHA) in rats following 28-day intravenous
        exposure.</ArticleTitle><Pagination><StartPage>50</StartPage><EndPage>55</EndPage><MedlinePgn>50-55</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.yrtph.2019.02.016</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0273-2300(19)30061-3</ELocationID><Abstract><AbstractText>Di
        (2-ethylhexyl) adipate (DEHA) is a potential plasticizer alternative for di-2-ethylhexyl
        phthalate (DEHP). Toxicity of DEHA has been studied mostly via oral exposure
        but not assessed after repeated intravenous exposure. The present study shows
        the toxicity effects after intravenous administration for 28 consecutive days
        and the reversibility of the effects following a 14-day recovery period. The
        study was conducted under GLP conditions. Four groups of rats (15/sex/group)
        each received either vehicle or DEHA in vehicle (100, 200, or 450&#x202f;mg/kg/day).
        Criteria for evaluation included clinical observations, body weight, food
        consumption, clinical pathology (hematology, serum chemistry, coagulation,
        urinalyses), gross (necropsy) evaluation, organ weight and histopathological
        evaluation. There were no DEHA-related changes in all the endpoints evaluated
        at 100 or 200&#x202f;mg/kg/day. There were no test article-related changes
        in clinical pathology or gross necropsy observation at 450&#x202f;mg/kg/day.
        At the high-dose, DEHA-related findings included clinical observations, decreased
        body weight gain and food consumption, increased liver weight in females associated
        with minimal hepatocellular hypertrophy, and decreased thymus weight in males
        and females without histopathology findings. All these findings were completely
        reversible within a 14-day recovery period. Therefore, the 200&#x202f;mg/kg/day
        dose is considered to be the No-Observed-Effect Level (NOEL).</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Baxter
        Healthcare Corporation, Suzhou, China. Electronic address: haiyan_xu@baxter.com.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Musi</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Baxter
        Healthcare Corporation, PreClinical, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhimei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>WuXi
        AppTec (Suzhou) Co., Ltd, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhou</LastName><ForeName>Tiansheng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>WuXi
        AppTec (Suzhou) Co., Ltd, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Huang</LastName><ForeName>Qihong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Baxter
        Qiaoguang Healthcare (Guangzhou) Co., Ltd, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Liu</LastName><ForeName>Juanhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Baxter
        Healthcare Corporation, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Li</LastName><ForeName>Tiantian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Baxter
        Healthcare Corporation, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jiang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Baxter
        Healthcare Corporation, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Liao</LastName><ForeName>Songping</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Baxter
        Healthcare Corporation, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Jill</LastName><ForeName>Glosson</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Baxter
        Healthcare Corporation, PreClinical, Roundlake, United States.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Koo</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Baxter
        Healthcare Corporation, PreClinical, Roundlake, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Regul
        Toxicol Pharmacol</MedlineTA><NlmUniqueID>8214983</NlmUniqueID><ISSNLinking>0273-2300</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002149" MajorTopicYN="N">Energy Intake</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013950" MajorTopicYN="N">Thymus Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">DEHA</Keyword><Keyword MajorTopicYN="N">Intravenous
        exposure</Keyword><Keyword MajorTopicYN="N">NOEL</Keyword><Keyword MajorTopicYN="N">Plasticizer</Keyword><Keyword
        MajorTopicYN="N">Rat</Keyword><Keyword MajorTopicYN="N">Toxicity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2018</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">30826316</ArticleId><ArticleId IdType="doi">10.1016/j.yrtph.2019.02.016</ArticleId><ArticleId
        IdType="pii">S0273-2300(19)30061-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">23001933</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-8618</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>31</Volume><Issue>12</Issue><PubDate><Year>2012</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Environmental
        toxicology and chemistry</Title><ISOAbbreviation>Environ Toxicol Chem</ISOAbbreviation></Journal><ArticleTitle>Effects
        of the peroxisome proliferator di(2-ethylhexyl)phthalate on cell turnover
        and peroxisome proliferation in primary chick embryo hepatocytes.</ArticleTitle><Pagination><StartPage>2856</StartPage><EndPage>2860</EndPage><MedlinePgn>2856-60</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1002/etc.2017</ELocationID><Abstract><AbstractText>The
        peroxisome proliferator (PP) di(2-ethylhexyl)phthalate (DEHP) is widely used
        as a plasticizer and can contaminate air, water, and soil. As yet, no data
        have been published on its potential to induce changes in cell growth of nonmammalian
        hepatocytes. In the present study, the effects of DEHP on cell turnover and
        induction of peroxisome proliferation were evaluated in primary hepatocyte
        cultures from chick embryos. Cells were treated after attachment with 0, 25,
        50, 75, and 100 &#xb5;M DEHP for up to 96 h. S-phase increased significantly
        (p&#x2009;&lt;&#x2009;0.01) from a background level of 5.5&#x2009;&#xb1;&#x2009;0.1%
        in solvent-control hepatocytes to a maximum level of 7.1&#x2009;&#xb1;&#x2009;0.1%
        in cells exposed for 48 h to 100 &#xb5;M DEHP and decreased to near 6% by
        96 h. Lower (p&#x2009;&lt;&#x2009;0.05) levels of induction were seen at 50
        and 75 &#xb5;M DEHP. Spontaneous apoptosis showed a slight (p&#x2009;&lt;&#x2009;0.05)
        decrease in hepatocytes treated with &#x2265;75 &#xb5;M dosages, as measured
        at 72 to 96 h. Induction of peroxisome proliferation was observed for cultures
        treated with &#x2265;75 &#xb5;M dosages at 48 h onwards. The results of the
        present study indicate that avian species may be responsive to the effects
        of PPs and may thus be affected by the presence of DEHP in the environment,
        but that this species is less sensitive than rodents.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2012 SETAC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Arias</LastName><ForeName>Elio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department
        of Bioscience, State University of Milan, Milan, Italy. elio.arias@unimi.it</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2012</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Toxicol Chem</MedlineTA><NlmUniqueID>8308958</NlmUniqueID><ISSNLinking>0730-7268</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002642" MajorTopicYN="N">Chick Embryo</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2012</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2012</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2012</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">23001933</ArticleId><ArticleId IdType="doi">10.1002/etc.2017</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">21714771</PMID><DateCompleted><Year>2012</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>16</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-6014</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>34</Volume><Issue>4</Issue><PubDate><Year>2011</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Drug
        and chemical toxicology</Title><ISOAbbreviation>Drug Chem Toxicol</ISOAbbreviation></Journal><ArticleTitle>Reproductive
        toxicity of di(2-ethylhexyl) phthalate in selenium-supplemented and selenium-deficient
        rats.</ArticleTitle><Pagination><StartPage>379</StartPage><EndPage>389</EndPage><MedlinePgn>379-89</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.3109/01480545.2010.547499</ELocationID><Abstract><AbstractText>Phthalates
        are abundantly produced plasticizers, and di(ethylhexyl) phthalate (DEHP)
        is the most widely used derivative in various consumer products and medical
        devices. Animal studies show that DEHP and various other phthalates cause
        reproductive and developmental toxicity. Although the evidences are limited,
        it seems reasonable that DEHP may have a potential for similar adverse effects
        in humans. Such concerns are increasing, particularly for the developing reproductive
        system of male infants and children. By taking into account the essentiality
        of selenium (Se) in testicular structure and functions and the high prevalence
        of inadequate Se intake in various part of the world, this study was designed
        to investigate the testicular toxicity of DEHP in Se-deficient male rats and
        to examine the possible preventive effects of Se supplementation on phthalate
        toxicity. Se deficiency was generated by feeding 3-week-old Sprague-Dawley
        rats with a &#x2264;0.05 Se mg/kg diet for 5 weeks. Supplementation groups
        were on a 1 mg Se/kg diet, and DEHP-treated groups received a 1,000 mg/kg
        dose by gavage during the last 10 days of the feeding period. Testicular histopathology,
        sperm count and motility, and sperm morphology were examined, and plasma levels
        of sex hormones were measured. Toxicity and antiandrogenic effects of DEHP
        were evidenced by disturbed testicular histology and spermatogenesis, diminished
        testosterone, leutinizing hormone (LH) and follicle stimulating hormone (FSH)
        levels, and sperm motility. The effects of DEHP were much more pronounced
        in Se-deficient rats, whereas Se supplementation was found to be protective,
        reflecting its regulating role in cellular redox equilibrium.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Erkekoglu</LastName><ForeName>Pinar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty
        of Pharmacy, Department of Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zeybek</LastName><ForeName>N Dilara</ForeName><Initials>ND</Initials></Author><Author
        ValidYN="Y"><LastName>Giray</LastName><ForeName>Belma</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Asan</LastName><ForeName>Esin</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Arnaud</LastName><ForeName>Josiane</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Hincal</LastName><ForeName>Filiz</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2011</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Drug Chem Toxicol</MedlineTA><NlmUniqueID>7801723</NlmUniqueID><ISSNLinking>0148-0545</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D052244">Endocrine Disruptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-67-9</RegistryNumber><NameOfSubstance
        UI="D007986">Luteinizing Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-68-0</RegistryNumber><NameOfSubstance
        UI="D005640">Follicle Stimulating Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>H6241UJ22B</RegistryNumber><NameOfSubstance
        UI="D012643">Selenium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D052244" MajorTopicYN="N">Endocrine Disruptors</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004822" MajorTopicYN="N">Epididymis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005640" MajorTopicYN="N">Follicle Stimulating Hormone</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007986" MajorTopicYN="N">Luteinizing Hormone</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012643" MajorTopicYN="Y">Selenium</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000172" MajorTopicYN="N">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013076" MajorTopicYN="N">Sperm Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013081" MajorTopicYN="N">Sperm Motility</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013094" MajorTopicYN="N">Spermatozoa</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">21714771</ArticleId><ArticleId IdType="doi">10.3109/01480545.2010.547499</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">7800660</PMID><DateCompleted><Year>1995</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0901-9928</ISSN><JournalIssue
        CitedMedium="Print"><Volume>75</Volume><Issue>3-4</Issue><PubDate><Year>1994</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Pharmacology
        &amp; toxicology</Title><ISOAbbreviation>Pharmacol Toxicol</ISOAbbreviation></Journal><ArticleTitle>Age
        related effects of di(2-ethylhexyl)phthalate on hepatic cytochrome P450 monooxygenases
        in Wistar rats.</ArticleTitle><Pagination><StartPage>177</StartPage><EndPage>180</EndPage><MedlinePgn>177-80</MedlinePgn></Pagination><Abstract><AbstractText>Age
        related response of di(2-ethylhexyl)phthalate (DEHP) was studied by administering
        the plasticizer (2000 mg/kg, orally) to 3, 6 and 10 week old wistar rats for
        1, 7 or 15 days and determining the activity of hepatic P450 monooxygenases.
        Single administration of DEHP decreased the cytochrome P450 contents and activity
        of arylhydrocarbon hydroxylase, aniline hydroxylase and ethylmorphine N-demethylase
        at all the age groups while repeated exposure induced them with maximum alterations
        occurring in 3 week old rats. Repeated administration for 15 days, on the
        other hand, caused a decrease in the cytochrome P450 content and the activity
        of arylhydrocarbon hydroxylase, aniline hydroxylase and ethylmorphine N-demethylase
        only in the 3 week old rats. The 6 and 10 week old rats exposed to the same
        schedule of DEHP showed an inhibition in the activity of arylhydrocarbon hydroxylase
        and an increase in the activity of aniline hydroxylase and ethylmorphine N-demethylase,
        which was however lower than that seen after 7 days of exposure to DEHP in
        the respective age group of animals. Our data have indicated the differences
        in the sensitivity of the P450 monooxygenases towards DEHP and its metabolites
        amongst 3, 6 and 10 week old animals.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Parmar</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Industrial
        Toxicology Research Center, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Srivastava</LastName><ForeName>S P</ForeName><Initials>SP</Initials></Author><Author
        ValidYN="Y"><LastName>Seth</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pharmacol
        Toxicol</MedlineTA><NlmUniqueID>8702180</NlmUniqueID><ISSNLinking>0901-9928</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D001189">Aryl Hydrocarbon Hydroxylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.5.3.-</RegistryNumber><NameOfSubstance UI="D005037">Ethylmorphine-N-Demethylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001189" MajorTopicYN="N">Aryl Hydrocarbon Hydroxylases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005037" MajorTopicYN="N">Ethylmorphine-N-Demethylase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1994</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1994</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1994</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7800660</ArticleId><ArticleId IdType="doi">10.1111/j.1600-0773.1994.tb00343.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">769879</PMID><DateCompleted><Year>1976</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0077-4715</ISSN><JournalIssue
        CitedMedium="Print"><Issue>93</Issue><PubDate><Year>1975</Year></PubDate></JournalIssue><Title>Eisei
        Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences</Title><ISOAbbreviation>Eisei
        Shikenjo Hokoku</ISOAbbreviation></Journal><ArticleTitle>[Safety of phthalic
        acid esters--especially DEHP--, plasticizer of polyvinyl chloride for medical
        devices (author''s transl)].</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>25</EndPage><MedlinePgn>1-25</MedlinePgn></Pagination><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Oba</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Omori</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Kuwamura</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Yamaha</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>jpn</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Eisei
        Shikenjo Hokoku</MedlineTA><NlmUniqueID>0421152</NlmUniqueID><ISSNLinking>0077-4715</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000014" MajorTopicYN="N">Abnormalities, Drug-Induced</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001793" MajorTopicYN="N">Blood Preservation</DescriptorName><QualifierName
        UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002869" MajorTopicYN="N">Chromosome Aberrations</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004864" MajorTopicYN="Y">Equipment and Supplies</DescriptorName><QualifierName
        UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007274" MajorTopicYN="N">Injections, Intraperitoneal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007928" MajorTopicYN="N">Lethal Dose 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011817" MajorTopicYN="N">Rabbits</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>135</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1975</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1975</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1975</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">769879</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">17929048</PMID><DateCompleted><Year>2009</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0948-6143</ISSN><JournalIssue
        CitedMedium="Print"><Volume>129</Volume><Issue>1</Issue><PubDate><Year>2008</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Histochemistry
        and cell biology</Title><ISOAbbreviation>Histochem Cell Biol</ISOAbbreviation></Journal><ArticleTitle>Induction
        of peroxisomal Lon protease in rat liver after di-(2-ethylhexyl)phthalate
        treatment.</ArticleTitle><Pagination><StartPage>73</StartPage><EndPage>83</EndPage><MedlinePgn>73-83</MedlinePgn></Pagination><Abstract><AbstractText>Previously,
        we identified a peroxisome-specific isoform of Lon protease using subcellular
        proteomics. In the present study, we investigated changes in the level of
        the Lon protease in peroxisomes during recovery from peroxisomal proliferation
        induced by di-(2-ethylhexyl)phthalate (DEHP) to elucidate the function of
        peroxisomal Lon protease (PSLP). Following a 2-week treatment with DEHP, the
        level of PSLP was monitored for 15 days. The amount of protease was greatly
        increased after the 2-week treatment, followed by a further increase 3 days
        after cessation of the treatment. Afterward, it decreased and reached the
        control level on day 15. On the other hand, level peroxisomal beta-oxidation
        enzymes induced to express by DEHP started to decrease soon after discontinuation
        of treatment. The results suggest that PSLP functions to degrade beta-oxidation
        enzymes induced by DEHP during recovery from perxisomal proliferation.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Yokota</LastName><ForeName>Sadaki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department
        of Functional Morphology, Faculty of Pharmaceutical Science, Nagasaki International
        University, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki, 859-3298, Japan. syokota@niu.ac.jp</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Haraguchi</LastName><ForeName>Celina M</ForeName><Initials>CM</Initials></Author><Author
        ValidYN="Y"><LastName>Oda</LastName><ForeName>Toshiaki</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2007</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Histochem
        Cell Biol</MedlineTA><NlmUniqueID>9506663</NlmUniqueID><ISSNLinking>0948-6143</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.4.21.53</RegistryNumber><NameOfSubstance UI="D049070">Protease La</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016253" MajorTopicYN="N">Microscopy, Immunoelectron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D049070" MajorTopicYN="N">Protease La</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="accepted"><Year>2007</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2007</Year><Month>10</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2009</Year><Month>1</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2007</Year><Month>10</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">17929048</ArticleId><ArticleId IdType="doi">10.1007/s00418-007-0328-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Annu
        Rev Biochem. 1992;61:157-97</Citation><ArticleIdList><ArticleId IdType="pubmed">1353950</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 2006 Feb 17;281(7):4035-41</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16332691</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 2005 May 9;169(3):425-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15866887</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Cell Biol. 1995 Jan;66(1):15-24</Citation><ArticleIdList><ArticleId IdType="pubmed">7538465</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO
        J. 2007 Feb 7;26(3):835-45</Citation><ArticleIdList><ArticleId IdType="pubmed">17255948</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Cell Biol. 1993 Dec;62(2):372-83</Citation><ArticleIdList><ArticleId IdType="pubmed">7925493</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 2002 Jan 30;1542(1-3):160-72</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11853889</ArticleId></ArticleIdList></Reference><Reference><Citation>Autophagy.
        2007 Mar-Apr;3(2):96-105</Citation><ArticleIdList><ArticleId IdType="pubmed">17172804</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1975 Nov 21;190(4216):787-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1198095</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes
        Dev. 1998 May 1;12(9):1338-47</Citation><ArticleIdList><ArticleId IdType="pubmed">9573050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1996 Dec 27;804:214-30</Citation><ArticleIdList><ArticleId IdType="pubmed">8993546</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1964 Dec 4;146(3649):1316-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14207461</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO
        J. 2000 Nov 1;19(21):5720-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11060023</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Histochem Cytochem. 2001 May;49(5):613-22</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11304799</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Cell Biol. 1993 Jun;61(1):67-80</Citation><ArticleIdList><ArticleId IdType="pubmed">8223709</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 2004 Jan 2;279(1):421-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14561759</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat
        Cell Biol. 2002 Sep;4(9):674-80</Citation><ArticleIdList><ArticleId IdType="pubmed">12198491</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochemistry.
        1979 Nov;64(1):51-66</Citation><ArticleIdList><ArticleId IdType="pubmed">521315</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Histochem Cytochem. 1987 Nov;35(11):1191-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3655323</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO
        J. 1997 Dec 15;16(24):7317-25</Citation><ArticleIdList><ArticleId IdType="pubmed">9405361</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1996 Feb 16;271(5251):990-3</Citation><ArticleIdList><ArticleId IdType="pubmed">8584937</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 2002 Dec 6;299(3):494-7</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12445829</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1998 Sep 1;95(18):10584-9</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9724747</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1994 Apr 8;264(5156):273-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8146662</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 2004 Sep 24;279(39):40584-92</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15277523</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1994 Jan 7;269(1):238-42</Citation><ArticleIdList><ArticleId IdType="pubmed">8276800</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochemistry.
        1986;85(2):145-55</Citation><ArticleIdList><ArticleId IdType="pubmed">3744897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1996 Dec 27;804:202-13</Citation><ArticleIdList><ArticleId IdType="pubmed">8993545</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1975 Nov;67(2PT.1):281-309</Citation><ArticleIdList><ArticleId
        IdType="pubmed">406</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 2000 Feb 4;275(5):3455-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10652339</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1965 Nov 27;208(5013):856-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5870099</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO
        J. 2001 Sep 17;20(18):5049-59</Citation><ArticleIdList><ArticleId IdType="pubmed">11566870</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 2001 Jan 19;276(3):1701-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11096062</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Biol Cell. 1999 May;10(5):1367-79</Citation><ArticleIdList><ArticleId IdType="pubmed">10233150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell.
        2004 Oct 1;119(1):9-18</Citation><ArticleIdList><ArticleId IdType="pubmed">15454077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1982;386:111-35</Citation><ArticleIdList><ArticleId IdType="pubmed">6953842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1982;386:5-12</Citation><ArticleIdList><ArticleId IdType="pubmed">6953852</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochem
        Cell Biol. 2000 Dec;114(6):433-46</Citation><ArticleIdList><ArticleId IdType="pubmed">11201604</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 2007 Aug 10;282(32):23055-69</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17522052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">22333284</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2012</Year><Month>02</Month><Day>15</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0529-567X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>46</Volume><Issue>12</Issue><PubDate><Year>2011</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Zhonghua
        fu chan ke za zhi</Title><ISOAbbreviation>Zhonghua Fu Chan Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Study
        on the effect of di-(2-ethylhexyl) phthalate on pregnant rats and the protection
        of zinc against it in pregnancy].</ArticleTitle><Pagination><StartPage>928</StartPage><EndPage>930</EndPage><MedlinePgn>928-30</MedlinePgn></Pagination><Abstract><AbstractText
        Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the effect of di-(2-ethylhexyl)
        phthalate (DEHP) on pregnant rat and the protection of zinc.</AbstractText><AbstractText
        Label="METHODS" NlmCategory="METHODS">Fifty rats were randomized equally into
        5 groups consisting of blank (given 1 ml 0.9% sodium chloride), corn oil (given
        1 ml corn oil), zinc (given 1 ml zinc gluconate including 1.2 mg zinc), DEHP
        (given 50 mg&#xd7;kg(-1)&#xd7;d(-1) DEHP) and DEHP + zinc (given 50 mg&#xd7;kg(-1)&#xd7;d(-1)
        DEHP + zinc gluconate). At the beginning of the experiment (about 7 d before
        pregnancy), the female rats were administered with corresponding drugs everyday.
        The pregnant rats were killed and the fetal rats were removed on 19th day.
        The following results in each group were recorded: the body weight and the
        organic weight of the female rats, the number and the weight of fetus rats
        and the placental weight.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The
        weight and the coefficient of female rats'' kidney/body, spleen/body, brain/body,
        and heart/body in DEHP group compared with other groups were not statistical
        significance (all P &gt; 0.05). The coefficient of female rats'' liver/body,
        uterus/body, and ovary/body of blank group were (4.4 &#xb1; 0.7)%, (1.26 &#xb1;
        0.09)%, (0.083 &#xb1; 0.009)% respectively, corn oil group were (4.5 &#xb1;
        0.6)%, (1.29 &#xb1; 0.10)%, (0.084 &#xb1; 0.008)%, zinc group were (4.4 &#xb1;
        0.4)%, (1.26 &#xb1; 0.08)%, (0.084 &#xb1; 0.009)%, DEHP group were (5.4 &#xb1;
        1.0)%, (1.11 &#xb1; 0.08)%, (0.074 &#xb1; 0.012)%, and DEHP + zinc group were
        (4.4 &#xb1; 1.0)%, (1.28 &#xb1; 0.10)%, (0.082 &#xb1; 0.007)%; in DEHP group
        the coefficient of female rats'' liver/body, uterus/body, and ovary/body compared
        with other groups was statistical significance (P &lt; 0.05). The fetal quantity,
        fetal weight and placental weight of female rats of blank group were 12.8
        &#xb1; 2.7, (6.03 &#xb1; 0.16) g, (1.00 &#xb1; 0.03) g respectively, corn
        oil group were 13.6 &#xb1; 3.1, (6.07 &#xb1; 0.20) g, (1.00 &#xb1; 0.04) g,
        zinc group were 13.3 &#xb1; 3.1, (6.16 &#xb1; 0.18) g, (1.00 &#xb1; 0.05)
        g, DEHP group were 9.2 &#xb1; 4.1, (4.03 &#xb1; 0.09) g, (0.95 &#xb1; 0.03)
        g, and zinc + DEHP group were 12.1 &#xb1; 2.9, (6.09 &#xb1; 0.17) g, (0.99
        &#xb1; 0.03) g. In DEHP group the fetal quantity, fetal weight and placental
        weight of female rats compared with other groups were statistical significance
        (P &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">DEHP
        can damage female rats and fetal rats in gestation period. Zinc supplied before
        pregnancy can relieve the influence by DEHP.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department
        of Obstetrics and Gynecology, Beijing Command General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Shang</LastName><ForeName>Li-xin</ForeName><Initials>LX</Initials></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials></Author><Author
        ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiao-dong</ForeName><Initials>XD</Initials></Author><Author
        ValidYN="Y"><LastName>Huo</LastName><ForeName>Xiao-xi</ForeName><Initials>XX</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType
        UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua
        Fu Chan Ke Za Zhi</MedlineTA><NlmUniqueID>16210370R</NlmUniqueID><ISSNLinking>0529-567X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005942">Gluconates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance
        UI="D015032">Zinc</NameOfSubstance></Chemical><Chemical><RegistryNumber>R4R8J0Q44B</RegistryNumber><NameOfSubstance
        UI="C030691">gluconic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005333" MajorTopicYN="N">Fetus</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005942" MajorTopicYN="N">Gluconates</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014599" MajorTopicYN="N">Uterus</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2012</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2012</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">22333284</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2924396</PMID><DateCompleted><Year>1989</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>1989</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Relationship
        of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators
        di(2-ethylhexyl)phthalate and Wy-14,643.</ArticleTitle><Pagination><StartPage>513</StartPage><EndPage>519</EndPage><MedlinePgn>513-9</MedlinePgn></Pagination><Abstract><AbstractText>Quantitative
        comparisons of the time course of biochemical and morphological changes induced
        by peroxisome proliferators resulting in low and high incidences of hepatic
        cancer have not been conducted previously under bioassay conditions. [4-Chloro-6-(2,3-xylidino)-2-pyrimidyl-thio]acetic
        acid (Wy-14,643) at 0.1% in the diet produced a much higher incidence of hepatic
        cancer in male rats than 1.2% di(2-ethylhexyl)phthalate (DEHP) in the diet.
        Both diets, however, caused similar degrees of peroxisome proliferation. To
        investigate this difference in carcinogenicity, H2O2-detoxification mechanisms
        and indices of oxidative damage were evaluated in male F-344 rats fed 1.2%
        DEHP or 0.1% Wy-14,643 for up to one year. DEHP or Wy-14,643 treatment increased
        hepatic catalase activity approximately 25% from 8 to 365 days. DEHP or Wy-14,643
        treatment decreased hepatic glutathione peroxidase activity by 50% from 8
        to 365 days. Glutathione concentrations were not affected by 151 days of DEHP
        or Wy-14,643 feeding. The similar effects of DEHP and Wy on H2O2 detoxification
        enzymes and glutathione concentrations suggests that these factors are not
        responsible for the widely different carcinogenicities of Wy-14,643 and DEHP.
        Hepatic vitamin E concentrations were 50% lower in rats receiving Wy-14,643
        for 151 days as compared to rats fed DEHP or control diets. Lipofuscin, which
        was contained within lysosomes, was increased 3-fold after 39 days of DEHP
        and remained at this level up to 365 days of treatment. In comparison, lipofuscin
        was increased 4-fold after 18 days of Wy-14,643 and continued to accumulate
        in a linear manner reaching values 30-fold over controls after 365 days of
        treatment. DEHP treatment for 39-365 days increased the activities of the
        lysosomal enzymes alpha-fucosidase, beta-galactosidase and N-acetylglucosaminidase
        50-100%. The same enzyme activities were increased approximately 4-fold after
        39-365 days of Wy-14,643. Lysosomal cathepsin B activity was unchanged by
        DEHP but doubled by 151 and 365 days of Wy-14,643. Acid phosphatase activity
        was unchanged by DEHP but increased by 50% after 151 and 365 days of Wy-14,643.
        In addition, conjugated dienes were increased (approximately 45%) only in
        rats receiving Wy-14,643 for 151 and 365 days. These data show for the first
        time that the magnitude and time course of lipofuscin deposition, induction
        of lysosomal enzymes and conjugated diene accumulation, is correlated closely
        with the degree of carcinogenicity. Wy-14,643-induced decreases in hepatic
        vitamin E concentrations could contribute to the observed accumulation of
        conjugated dienes at later time points.(ABSTRACT TRUNCATED AT 400 WORDS)</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Conway</LastName><ForeName>J
        G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, National Institute of Environmental Health
        Sciences, Research Triangle Park, NC 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Tomaszewski</LastName><ForeName>K E</ForeName><Initials>KE</Initials></Author><Author
        ValidYN="Y"><LastName>Olson</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author
        ValidYN="Y"><LastName>Marsman</LastName><ForeName>D S</ForeName><Initials>DS</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000924">Anticholesteremic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008062">Lipofuscin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-18-4</RegistryNumber><NameOfSubstance
        UI="D014810">Vitamin E</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance
        UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000924" MajorTopicYN="N">Anticholesteremic Agents</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008062" MajorTopicYN="N">Lipofuscin</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014810" MajorTopicYN="N">Vitamin E</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1989</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1989</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1989</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2924396</ArticleId><ArticleId IdType="doi">10.1093/carcin/10.3.513</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">7397231</PMID><DateCompleted><Year>1980</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-3002</ISSN><JournalIssue
        CitedMedium="Print"><Volume>630</Volume><Issue>3</Issue><PubDate><Year>1980</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>Biochimica
        et biophysica acta</Title><ISOAbbreviation>Biochim Biophys Acta</ISOAbbreviation></Journal><ArticleTitle>Turnover
        of enzymes of peroxisomal beta-oxidation in rat liver.</ArticleTitle><Pagination><StartPage>367</StartPage><EndPage>374</EndPage><MedlinePgn>367-74</MedlinePgn></Pagination><Abstract><AbstractText>Male
        Wistar rats were given a diet containing 2% (w/w) di-ethylhexyl)-phthalate
        (DEHP), a peroxisomal proliferator, for 4 weeks. The activities of enzymes
        of peroxisomal beta-oxidation and of catalase were markedly increased by the
        DEHP administration. The time required to reach halfway to the maximal induction
        for enzymes of peroxisomal beta-oxidation was 5--7 days, whereas that for
        catalase was 3 days. A separate DEHP group was placed on the control diet
        after 14 days of feeding with the DEHP diet. On the withdrawal of DEHP, activities
        of enzymes of the beta-oxidation system and of catalase decreased to the control
        levels with a half-life of 2--3 days. Responses of some mitochondrial enzymes
        involved in fatty acid oxidation are also described.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Miyazawa</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Furuta</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Osumi</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biochim
        Biophys Acta</MedlineTA><NlmUniqueID>0217513</NlmUniqueID><ISSNLinking>0006-3002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009940" MajorTopicYN="N">Organoids</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1980</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1980</Year><Month>7</Month><Day>3</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1980</Year><Month>7</Month><Day>3</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7397231</ArticleId><ArticleId IdType="doi">10.1016/0304-4165(80)90285-8</ArticleId><ArticleId
        IdType="pii">0304-4165(80)90285-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10930035</PMID><DateCompleted><Year>2001</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0192-6233</ISSN><JournalIssue
        CitedMedium="Print"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2000</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Toxicologic
        pathology</Title><ISOAbbreviation>Toxicol Pathol</ISOAbbreviation></Journal><ArticleTitle>The
        nongenotoxic hepatocarcinogens diethylhexylphthalate and methylclofenapate
        induce DNA synthesis preferentially in octoploid rat hepatocytes.</ArticleTitle><Pagination><StartPage>503</StartPage><EndPage>509</EndPage><MedlinePgn>503-9</MedlinePgn></Pagination><Abstract><AbstractText>Diethylhexylphthalate
        (DEHP), a rodent carcinogen, and 1,4-dichlorobenzene (DCB), a noncarcinogen
        in rat liver, are potent hepatomitogens. We have reported previously that
        7-day dosing with DEHP induced a higher bromodeoxyuridine labeling index (LI)
        in binuclear octoploid (2x4N) rat hepatocytes than did DCB, suggesting that
        induction of DNA synthesis in 2x4N hepatocytes might represent a more substantial
        carcinogenic risk. We compared 2 additional rodent hepatocarcinogens, methylclofenapate
        (MCP) and phenobarbitone, with ethylene thiourea (ETU), a noncarcinogenic
        hepatomitogen in rat. All 3 chemicals increased hepatic LI; the 8N population
        had the highest LI, but only the carcinogens increased LI in the 2x4N and
        4N populations. To identify the target population for induction of DNA synthesis,
        we used a 1-hour pulse label at the peak of induction. The results were consistent
        with the 7-day data, and again the highest LI was in the 8N population. The
        nongenotoxic rodent carcinogens MCP and DEHP induced a significant increase
        in the LI in the 2x4N population, whereas ETU and DCB did not. These data
        support the hypothesis that increased DNA synthesis within the minority 2x4N
        population may be more significant for subsequent hepatocarcinogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hasmall</LastName><ForeName>S
        C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>AstraZeneca
        Central Toxicology Laboratory, Macclesfield, Cheshire, United Kingdom. sue.hasmall@ctl.zeneca.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Pathol</MedlineTA><NlmUniqueID>7905907</NlmUniqueID><ISSNLinking>0192-6233</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000963">Antimetabolites</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>21340-68-1</RegistryNumber><NameOfSubstance
        UI="D002992">Clofenapate</NameOfSubstance></Chemical><Chemical><RegistryNumber>6158TKW0C5</RegistryNumber><NameOfSubstance
        UI="D010672">Phenytoin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>G34N38R2N1</RegistryNumber><NameOfSubstance
        UI="D001973">Bromodeoxyuridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000963" MajorTopicYN="N">Antimetabolites</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001973" MajorTopicYN="N">Bromodeoxyuridine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002992" MajorTopicYN="N">Clofenapate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010672" MajorTopicYN="N">Phenytoin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011123" MajorTopicYN="Y">Polyploidy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2000</Year><Month>8</Month><Day>10</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2000</Year><Month>8</Month><Day>10</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10930035</ArticleId><ArticleId IdType="doi">10.1177/019262330002800401</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9950075</PMID><DateCompleted><Year>1999</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>05</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0340-5761</ISSN><JournalIssue
        CitedMedium="Print"><Volume>72</Volume><Issue>12</Issue><PubDate><Year>1998</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Suppression
        of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse
        hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen
        1,4-dichlorobenzene (DCB).</ArticleTitle><Pagination><StartPage>784</StartPage><EndPage>790</EndPage><MedlinePgn>784-90</MedlinePgn></Pagination><Abstract><AbstractText>Nongenotoxic
        rodent hepatocarcinogens do not damage DNA but cause liver tumours in the
        rat and mouse, associated with the induction of hepatic DNA synthesis. Previously,
        we have demonstrated that nongenotoxic hepatocarcinogens such as phenobarbitone
        and the peroxisome proliferator (PP), nafenopin, also suppress rat hepatocyte
        apoptosis. The nongenotoxic chemicals 1,4-dichlorobenzene (DCB) and the PP,
        diethylhexyl phthalate (DEHP), both induce high levels of DNA synthesis in
        rat liver in vivo, but only DEHP is hepatocarcinogenic in this species. Here,
        we investigate whether the difference in rat carcinogenicity of these two
        hepatic mitogens may be due to differences in their ability to suppress hepatocyte
        apoptosis. In rat hepatocytes in vitro, MEHP (the active metabolite of DEHP)
        induced DNA synthesis 2.5-fold (P = 0.001) and suppressed 10- and 4-fold,
        respectively both spontaneous (P = 0.0008) and transforming growth factor
        beta1 (TGFbeta1)-induced (P = 0.0001) apoptosis. DCB gave a small (1.7-fold)
        increase in DNA synthesis (P = 0.03) and a small (1.7- to 2-fold) suppression
        of both spontaneous (P = 0.022) and TGFbeta1-induced (P = 0.015) apoptosis.
        We next analysed the induction of DNA synthesis and the suppression of apoptosis
        in rat liver in vivo. Both DEHP and DCB were able to induce DNA synthesis
        although, as seen in vitro, the induction by DCB (4.2-fold; P = 0.023) was
        less marked than that with DEHP (13.4-fold; P = 0.007). Similarly, DEHP and
        DCB were both able to suppress rat hepatocyte apoptosis in vivo but the magnitude
        of the suppression was comparable; apoptosis was reduced to undetectable levels
        in four out of five animals with DCB and three out of five with DEHP. Since
        both chemicals suppressed apoptosis and induced DNA synthesis in rat liver
        but, overall, DCB was less potent, the disparate hepatocarcinogenic potential
        of these two chemicals could arise from differences in the magnitude of growth
        perturbation. To test this hypothesis, we repeated the studies in mouse, a
        species where both DCB and DEHP are hepatocarcinogenic. Both in vitro and
        in vivo, DCB and DEHP/MEHP were able to suppress apoptosis and induce hepatocyte
        DNA synthesis in the mouse with comparable potencies. The data support the
        hypothesis that the carcinogenicity of nongenotoxic hepatocarcinogens is associated
        strongly with the ability to perturb hepatocyte growth regulation. However,
        the ability to effect such changes is not unique to nongenotoxic carcinogens
        and is common to some noncarcinogenic chemicals, such as DCB, suggesting that
        the growth perturbation may need to exceed a threshold for carcinogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>James</LastName><ForeName>N H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Zeneca
        Central Toxicology Laboratory, Macclesfield, Cheshire, UK.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Soames</LastName><ForeName>A R</ForeName><Initials>AR</Initials></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002722">Chlorobenzenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>D149TYB5MK</RegistryNumber><NameOfSubstance
        UI="C018511">4-dichlorobenzene</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001682" MajorTopicYN="N">Biological Availability</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002722" MajorTopicYN="N">Chlorobenzenes</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003864" MajorTopicYN="N">Depression, Chemical</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>2</Month><Day>9</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>2</Month><Day>9</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9950075</ArticleId><ArticleId IdType="doi">10.1007/s002040050574</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="Publisher" Owner="NLM"><PMID Version="1">12748680</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0888-8051</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>274</Volume><PubDate><Year>1984</Year><Month>Aug</Month></PubDate></JournalIssue><Title>National
        Toxicology Program technical report series</Title><ISOAbbreviation>Natl Toxicol
        Program Tech Rep Ser</ISOAbbreviation></Journal><ArticleTitle>NTP Toxicology
        and Carcinogenesis Studies of Tris(2-ethylhexyl)phosphate (CAS No. 78-42-2)
        In F344/N Rats and B6C3F1 Mice (Gavage Studies).</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>178</EndPage><MedlinePgn>1-178</MedlinePgn></Pagination><Abstract><AbstractText>Tris(2-ethylhexyl)phosphate
        is one of a family of triakyl phosphates that have been widely used as fire
        retardants and plasticizers. Another triakyl phosphate, tris(2,3-dibromopropyl)phosphate
        (Tris-BP), once used as a flame retardant in children''s sleepwear, has been
        shown to be carcinogenic, but tris(2-ethylhexyl)phosphate has not been previously
        studied. Tris(2-ethylhexyl)phosphate, a clear, viscous liquid, is used as
        a component of vinyl stabilizers, grease additives, and flame-proofing compositions;
        however, it is used primarily as a plasticizer for vinyl plastic and synthetic
        rubber compounds. In 1974, approximately 3 million pounds of tris(2-ethylhexyl)phosphate
        was produced in the United States; imports during that year were negligible.
        Substantial human exposure probably occurs during production of tris(2-ethylhexyl)phosphate
        and during the manufacture and use of products containing it, but data on
        the magnitude of exposure are not available. Two-year toxicology and carcinogenesis
        studies of tris(2-ethylhexyl)phosphate were conducted by administering the
        test chemical in corn oil by gavage, 5 days per week for 103 weeks, to groups
        of 50 male and 50 female F344/N rats and B6C3F1 mice. Male rats received doses
        of 2,000 or 4,000 mg/kg body weight, female rats received 1,000 or 2,000 mg/kg,
        and male and female mice received 500 or 1,000 mg/kg. Fifty vehicle control
        animals of each sex and species received 10 ml/kg body weight (rats) or 3.3
        ml/kg (mice) corn oil by gavage on the same schedule. Inflammation of the
        gastric mucosa in mice and mild weight depression in rats and mice were the
        only dose-related effects observed in the preliminary studies. In the 2-year
        studies, survival rates and mean body weight gains of dosed female rats and
        dosed mice were comparable to those of their perspective controls. Survival
        rates of dosed male rats were comparable to that of the vehicle controls,
        but body weight gains were depressed. One nonneoplastic lesion, follicular
        cell hyperplasia of the thyroid, was observed at increased incidences in dosed
        male and female mice. Two compound-related increased incidences of neoplasms
        could not be discounted. In male rats, the incidence of pheochromocytoma of
        adrenal glands increased with dose (2/50, 4%; 9/50, 18%; 12/50, 24%). There
        were also two additional malignant pheochromocytomas in the high dose group.
        However, the incidence of adrenal pheochromocytoma in vehicle controls of
        this study (2/50, 4%) was low compared with the 25% incidence observed in
        two previous studies in this laboratory or the overall historical incidence
        of 18% observed throughout the Program, and thus the evidence of carcinogenicity
        was considered to be equivocal. In female mice, the incidence of hepatocellular
        carcinoma (0/48; 4/50; 7/50) in high dose animals (1,000 mg/kg) was significantly
        increased relative to that of the vehicle controls. Decreased incidences were
        observed for acinar cell adenomas of the pancreas in dosed male rats (14/50,
        28%; 5/48, 10%; 2/49, 4%) and for fibroadenomas of the mammary glands in low
        dose female rats (11/50, 22%; 2/50, 4%; 7/50, 14%). Hemangiosarcomas of the
        circulatory system in male mice (7/50, 14%; 0/50; 1/49, 2%) and lymphomas
        of the hematopoietic system in female mice (14/49, 29%; 10/50, 20%; 6/50,
        12%) were decreased compared with vehicle controls. A decrease in the incidence
        of lymphomas and an increased incidence of carcinomas of the liver in female
        mice (both seen in this study) were observed in studies of di(2-ethylhexyl)adipate.
        Increased incidences of liver carcinomas and decreased incidences of mammary
        fibroadenomas were observed also in female rats in the di(2-ethylhexyl)phthalate
        studies. A possible link among these three chemicals may be metabolic conversion
        to 2-ethylhexanol. Tris(2-ethylhexyl)phosphate was not mutagenic in Salmonella
        typhimurium strains TA98, TA100, TA1535, or TA1537 in the presence or absence
        of 9000 x g (S9) fractions from Aroclor 1254-induced Sprague-Dawley rat or
        Syrian hamster liver. An audit of the experimental data from these carcinogeneoclor
        1254-induced Sprague-Dawley rat or Syrian hamster liver. An audit of the experimental
        data from these carcinogenesis studies was conducted by the National Toxicology
        Program. No data discrepancies were found that significantly influenced the
        final interpretations of these experiments. Under the conditions of these
        studies, a comparison of concurrent and historical controls indicated that
        there was equivocal evidence of carcinogenicity in male F344/N rats receiving
        2,000 and 4,000 mg/kg tris(2-ethylhexyl)phosphate, as evidenced by increased
        incidences of pheochromocytomas of the adrenal glands. There was no evidence
        of carcinogenicity in female F344/N rats or in male B6C3F1 mice receiving
        tris(2-ethylhexyl)phosphate. There was some evidence of carcinogenicity in
        female B6C3F1 mice that received 1,000 mg/kg tris(2-ethylhexyl)phosphate,
        as shown by an increased incidence of hepatocellular carcinoma. Tris(2-ethylhexyl)phosphate
        was associated with increased incidences of follicular cell hyperplasia of
        the thyroid gland in male and female B6C3F1 mice. Synonyms and Trade Names:
        TOF; trioctyl phosphate; phosphoric acid tri(2-ethylhexyl) ester; Flexolreg.
        TOF; Kronitexreg.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><CollectiveName> National Toxicology Program </CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Natl Toxicol Program Tech Rep Ser</MedlineTA><NlmUniqueID>8500747</NlmUniqueID><ISSNLinking>0888-8051</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12748680</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">20600714</PMID><DateCompleted><Year>2010</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3169</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>198</Volume><Issue>2</Issue><PubDate><Year>2010</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>The
        individual and combined metabolite profiles (metabolomics) of dibutylphthalate
        and di(2-ethylhexyl)phthalate following a 28-day dietary exposure in rats.</ArticleTitle><Pagination><StartPage>159</StartPage><EndPage>170</EndPage><MedlinePgn>159-70</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.toxlet.2010.06.009</ELocationID><Abstract><AbstractText>Metabolite
        profiles (metabolomics) of plasma samples of Wistar rats dosed with di(2-ethylhexyl)phthalate
        (DEHP - 3000ppm) and dibutylphthalate (DBP - 150, 1000 and 7000ppm) were individually
        determined in 28 days dietary studies. In addition, profiles of combined exposure
        to 3000ppm DEHP and either 150, 1000 or 7000ppm DBP were determined. High
        dose levels induced more profound metabolite changes in males than in females
        for both compounds. At 150ppm DBP (NOEL for toxicity) there were very few
        (&lt;false positives rate), inconsistent changes, demonstrating a metabolomic
        NOEL. A part of the total metabolite profile was consistent with a pattern
        of changes indicative of peroxisome proliferation, confirmed by increased
        cyanide-insensitive Palmitoyl-CoA oxidation. Simultaneous administration of
        3000ppm DEHP and 150ppm DBP did not result in relevant changes when compared
        to the metabolite profile of 3000ppm DEHP alone. Co-administration of 1000ppm
        DBP induced marginal additional changes relative to the profile of 3000ppm
        DEHP alone. Simultaneous exposure to high dose levels of DEHP and DBP resulted
        in a profile that was significantly different compared to the individual compounds.
        A quantitative statistical analysis of the data revealed that the effect of
        combined treatment on the metabolites was less than additive.</AbstractText><CopyrightInformation>Copyright
        2010 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>van Ravenzwaay</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>BASF
        SE, Experimental Toxicology and Ecology, Z 470, D-67056 Ludwigshafen, Germany.
        bennard.ravenzwaay@basf.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Coelho-Palermo Cunha</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Strauss</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author
        ValidYN="Y"><LastName>Wiemer</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Leibold</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Kamp</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Walk</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Mellert</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>Looser</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Prokoudine</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Fabian</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Krennrich</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Herold</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2010</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>2286E5R2KE</RegistryNumber><NameOfSubstance
        UI="D003993">Dibutyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003993" MajorTopicYN="N">Dibutyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004357" MajorTopicYN="N">Drug Synergism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008401" MajorTopicYN="N">Gas Chromatography-Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D036401" MajorTopicYN="N">Toxicity Tests, Chronic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2010</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2010</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2010</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2010</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20600714</ArticleId><ArticleId IdType="doi">10.1016/j.toxlet.2010.06.009</ArticleId><ArticleId
        IdType="pii">S0378-4274(10)01567-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11428750</PMID><DateCompleted><Year>2001</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0231-424X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>87</Volume><Issue>3</Issue><PubDate><Year>2000</Year></PubDate></JournalIssue><Title>Acta
        physiologica Hungarica</Title><ISOAbbreviation>Acta Physiol Hung</ISOAbbreviation></Journal><ArticleTitle>Effect
        of glycerol-induced acute renal failure and di-2-ethylhexyl phthalate on the
        enzymes involved in biotransformation of xenobiotixs.</ArticleTitle><Pagination><StartPage>253</StartPage><EndPage>265</EndPage><MedlinePgn>253-65</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of di-(2-ethylhexyl)-phthalate (DEPH) on the levels of cytochrome
        P-450 and b5 monooxygenases were studied in the rat kidney and liver in acute
        renal failure induced by glycerol. Intramuscular injection of glycerol (50%,10
        ml x kg(-1)) to rats produced proximal tubular damage and acute renal failure.
        The indicators of renal function, serum urea and creatinine significantly
        increased (480 and 350 percent, respectively). In control and glycerol-treated
        animals DEPH had no significant effect on the concentrations of serum urea
        and creatinine. Twenty-four hours after glycerol injection the total amount
        of cytochrome P-450 and b5 significantly decreased in renal but increased
        in liver microsomal fractions. Moreover, 48 and 72 hours after glycerol injection
        the level of cytochrome P-450 and b5 significantly increased in both organs.
        A single dose of DEPH (2 ml x kg(-1), i.p.) also elevated the total cytochrome
        P-450 and b5 in control animals. This enhancing effect of DEPH was additive
        to that of glycerol in glycerol-induced acute renal failure. These results
        indicate that DEPH and glycerol evoked pathological changes may affect the
        metabolism of xenobiotics plus endogenous hormones in the liver and in kidney.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Kertai</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department
        of Pharmaceutical Technology, University of Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Holl&#xf3;si</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author
        ValidYN="Y"><LastName>Kov&#xe1;cs</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Varga</LastName><ForeName>V</ForeName><Initials>V</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Hungary</Country><MedlineTA>Acta
        Physiol Hung</MedlineTA><NlmUniqueID>8309201</NlmUniqueID><ISSNLinking>0231-424X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015262">Xenobiotics</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W8T17847W</RegistryNumber><NameOfSubstance
        UI="D014508">Urea</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-39-6</RegistryNumber><NameOfSubstance
        UI="D015786">Cytochromes b5</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance
        UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>PDC6A3C0OX</RegistryNumber><NameOfSubstance
        UI="D005990">Glycerol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001711" MajorTopicYN="N">Biotransformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015786" MajorTopicYN="N">Cytochromes b5</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005990" MajorTopicYN="N">Glycerol</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008861" MajorTopicYN="N">Microsomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009212" MajorTopicYN="N">Myoglobinuria</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012206" MajorTopicYN="N">Rhabdomyolysis</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014508" MajorTopicYN="N">Urea</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015262" MajorTopicYN="N">Xenobiotics</DescriptorName><QualifierName UI="Q000493"
        MajorTopicYN="Y">pharmacokinetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>6</Month><Day>29</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>7</Month><Day>13</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>6</Month><Day>29</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11428750</ArticleId><ArticleId IdType="doi">10.1556/APhysiol.87.2000.3.4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1755031</PMID><DateCompleted><Year>1992</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue
        CitedMedium="Print"><Volume>59</Volume><Issue>1-3</Issue><PubDate><Year>1991</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Wy-14,643
        but not 2-ethylhexanol increases intracellular free calcium in cultured Kupffer
        cells.</ArticleTitle><Pagination><StartPage>239</StartPage><EndPage>244</EndPage><MedlinePgn>239-44</MedlinePgn></Pagination><Abstract><AbstractText>Hypolipidemic
        drugs and phthalic ester plasticizers induce peroxisomes and cause hepatocellular
        carcinoma in rodents by mechanisms which remain unknown. Recent evidence from
        this laboratory suggests that many agents in this class of chemicals are uncouplers
        of mitochondrial oxidative phosphorylation both in vitro and in vivo. Uncoupling
        of oxidative phosphorylation decreases ATP required for ion pumps and could
        thereby indirectly increase intracellular free calcium. The goal of these
        experiments, therefore, was to compare the effect of the potent uncoupler
        and non-genotoxic carcinogen Wy-14,643 with the weaker agent 2-ethylhexanol
        on intracellular free calcium in cultured Kupffer cells. Kupffer cells, the
        resident hepatic macrophages, are activated by calcium and release a variety
        of mitogenic growth factors that may modulate cell proliferation. In this
        study, the cytosolic free calcium concentration in Fura-2-loaded cultured
        Kupffer cells was increased significantly from 78 +/- 11 to 838 +/- 112 nM
        following incubation with Wy-14,643 (1.25 mM). The increase in intracellular
        calcium due to Wy-14,643 was both time- and dose-dependent. At equimolar concentrations,
        ethylhexanol had no effect on intracellular calcium (65 +/- 20 nM). However,
        at higher concentrations (3 mM), ethylhexanol also increased intracellular
        calcium. These data suggest that elevation of intracellular calcium in Kupffer
        cells may be involved in the mechanism of action of this interesting class
        of non-genotoxic carcinogens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Hijioka</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department
        of Pharmacology, University of North Carolina, Chapel Hill 27599-7365.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Keller</LastName><ForeName>B J</ForeName><Initials>BJ</Initials></Author><Author
        ValidYN="Y"><LastName>Thurman</LastName><ForeName>R G</ForeName><Initials>RG</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>ES-04325</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013487">Research Support, U.S.
        Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000924">Anticholesteremic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance
        UI="D002118">Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000924" MajorTopicYN="N">Anticholesteremic Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007728" MajorTopicYN="N">Kupffer Cells</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1991</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1991</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1991</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1755031</ArticleId><ArticleId IdType="doi">10.1016/0378-4274(91)90077-j</ArticleId><ArticleId
        IdType="pii">0378-4274(91)90077-J</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6178713</PMID><DateCompleted><Year>1982</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0018-2214</ISSN><JournalIssue
        CitedMedium="Print"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>1982</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The
        Histochemical journal</Title><ISOAbbreviation>Histochem J</ISOAbbreviation></Journal><ArticleTitle>Nucleic
        acid synthesis in proliferating peroxisomes of rat liver as revealed by electron
        microscopical radioautography.</ArticleTitle><Pagination><StartPage>197</StartPage><EndPage>204</EndPage><MedlinePgn>197-204</MedlinePgn></Pagination><Abstract><AbstractText>Thirty
        albino rats were fed with a diet containing 1, 2 or 4% di-(2-ethylhexyl)-phthalate
        (DEHP), a peroxisome-proliferating agent. Others were fed with normal diet
        as controls. Both groups were sacrificed at varying intervals from 3 days
        to 4 weeks. The livers were either removed and fixed in glutaraldehyde and
        osmium tetroxide or fixed in glutaraldehyde, incubated in a diaminobenzidine
        (DAB) medium, postfixed, embedded in Epon, and sectioned. Other tissues were
        incubated in Eagle''s MEM containing either [P3H-thymidine or [3H]uridine,
        fixed, embedded in Epon, sectioned, and radioautographed. Specimens were observed
        in a Hitachi H-700 electron microscope. The number of peroxisomes showing
        DAB reactivity increased in DEHP-fed animals as compared with normal controls.
        In radioautograms of normal rats labelled with [3H]thymidine, no silver grains
        were observed, whereas grains were observed overt some nuclei, mitochondria
        and peroxisomes of DEHP-fed animals. In contrast, radioautograms of tissue
        labelled with [3H]uridine revealed a few grains in nuclei and mitochondria
        or endoplasmic reticulum of normal rats, although grains appeared in nuclei,
        mitochondria, endoplasmic reticulum and peroxisomes of DEHP-fed animals more
        frequently. From these results, it is concluded that [3H]thymidine and [3H]uridine
        were incorporated in the proliferating peroxisomes, suggesting that nucleic
        acid synthesis had taken place.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Nagata</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Ohno</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Yoshida</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Murata</LastName><ForeName>F</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Histochem
        J</MedlineTA><NlmUniqueID>0163161</NlmUniqueID><ISSNLinking>0018-2214</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance
        UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>VC2W18DGKR</RegistryNumber><NameOfSubstance
        UI="D013936">Thymidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WHI7HQ7H85</RegistryNumber><NameOfSubstance
        UI="D014529">Uridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001345" MajorTopicYN="N">Autoradiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006651" MajorTopicYN="N">Histocytochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009940" MajorTopicYN="N">Organoids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013936" MajorTopicYN="N">Thymidine</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014529" MajorTopicYN="N">Uridine</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1982</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1982</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1982</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6178713</ArticleId><ArticleId IdType="doi">10.1007/BF01041214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J
        Biophys Biochem Cytol. 1961 Feb;9:409-14</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13764136</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochemistry.
        1978 Aug 15;57(1):93-6</Citation><ArticleIdList><ArticleId IdType="pubmed">689928</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Histochem Cytochem. 1977 May;25(5):359-70</Citation><ArticleIdList><ArticleId
        IdType="pubmed">68069</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Histochem Cytochem. 1969 Oct;17(10):675-80</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4194356</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1964 Aug;22:469-77</Citation><ArticleIdList><ArticleId IdType="pubmed">14203391</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1963 Apr;17:208-12</Citation><ArticleIdList><ArticleId IdType="pubmed">13986422</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biophys Biochem Cytol. 1958 Jul 25;4(4):475-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13563554</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochemie.
        1967;10(4):305-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5589633</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochemistry.
        1976 Feb 26;46(3):189-96</Citation><ArticleIdList><ArticleId IdType="pubmed">1248951</ArticleId></ArticleIdList></Reference><Reference><Citation>Int
        Rev Cytol. 1969;26:235-302</Citation><ArticleIdList><ArticleId IdType="pubmed">4899604</ArticleId></ArticleIdList></Reference><Reference><Citation>Naturwissenschaften.
        1966 Jun;53(11):268-71</Citation><ArticleIdList><ArticleId IdType="pubmed">5987029</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1977 Sep;74(3):665-89</Citation><ArticleIdList><ArticleId IdType="pubmed">903369</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11312035</PMID><DateCompleted><Year>2001</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue
        CitedMedium="Print"><Volume>121</Volume><Issue>1</Issue><PubDate><Year>2001</Year><Month>Apr</Month><Day>08</Day></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>Effects
        on male rats of di-(2-ethylhexyl) phthalate and di-n-hexylphthalate administered
        alone or in combination.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>43</EndPage><MedlinePgn>35-43</MedlinePgn></Pagination><Abstract><AbstractText>The
        effects of phthalate esters of branched chain alcohols, typified by di-(2-ethylhexyl)phthalate
        (DEHP) differ from those of esters of straight chain alcohols typified by
        di-n-hexyl phthalate (DnHP). The former induce liver enlargement and proliferation
        of hepatic peroxisomes, while the latter cause no peroxisome proliferation
        but cause fat accumulation in the liver. Both classes of phthalate esters
        are hypolipidaemic and cause thyroid changes associated with an increased
        rate of thyroglobulin turnover. As phthalate esters are used as mixtures,
        we have examined the effect of mixtures of the compounds. Groups of five male
        Wistar albino rats were administered either control diet or diets containing
        either 10000 ppm of DEHP, 10000 ppm of DnHP or 10000 ppm DEHP plus 10000 ppm
        DnHP for 14 days. Rats receiving diets containing DEHP showed the expected
        increase in relative liver weight, in "peroxisomal" fatty acid oxidation and
        in CYP4A1. Serum triglyceride and serum cholesterol were also reduced, and
        the thyroid showed the histological changes mentioned above. Rats consuming
        diets containing DnHP showed no increase in relative liver weight and no induction
        of peroxisomal fatty acid oxidation or CYP4A1. However, there was a marked
        accumulation of fat in the liver. The fall in serum cholesterol was similar
        to that in rats treated with DEHP, but the fall of serum triglyceride was
        more pronounced. Thyroidal changes were again observed. In general, changes
        in rats treated with a mixture of DEHP and DnHP were very similar to those
        found with rats treated with DEHP alone. The liver was enlarged, and peroxisomal
        fatty acid oxidation and CYP4A1 were both induced. The amount of fat in the
        liver was much less than in rats receiving DnHP alone. Thyroid changes were
        similar to those in rats receiving the individual compounds. The effect on
        serum cholesterol seemed additive, but the levels of serum triglyceride were
        intermediate between the groups receiving the single compounds.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Howarth</LastName><ForeName>J
        A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>School of
        Biomedical and Life Sciences, University of Surrey, GU2 7XH, Guildford, UK.
        j.howarth@surrey.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>S
        C</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Dobrota</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Kentish</LastName><ForeName>P A</ForeName><Initials>PA</Initials></Author><Author
        ValidYN="Y"><LastName>Hinton</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance
        UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008111" MajorTopicYN="N">Liver Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>4</Month><Day>20</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>5</Month><Day>26</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>4</Month><Day>20</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11312035</ArticleId><ArticleId IdType="doi">10.1016/s0378-4274(01)00313-7</ArticleId><ArticleId
        IdType="pii">S0378427401003137</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6845354</PMID><DateCompleted><Year>1983</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>27</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>67</Volume><Issue>1</Issue><PubDate><Year>1983</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Peroxisome
        proliferation in primary cultures of rat hepatocytes.</ArticleTitle><Pagination><StartPage>15</StartPage><EndPage>25</EndPage><MedlinePgn>15-25</MedlinePgn></Pagination><Abstract><AbstractText>Primary
        cultures of rat hepatocytes were exposed to a range of chemicals known to
        cause peroxisome proliferation in vivo. Peroxisomal palmitoyl-CoA oxidation
        and carnitine acetyltransferase (CAT) activity were increased within 12 to
        24 hr of adding 0.5 mM clofibrate to the culture medium, reaching about 20
        times control levels after 72 hr. Stimulation of CAT activity was dose related
        over a concentration range of 0.05 to 2 mM clofibrate and 0.02 to 0.2 mM mono-2-ethylhexylphthalate
        (MEHP). Higher concentrations of MEHP were cytotoxic. The stimulation of CAT
        activity and palmitoyl-CoA oxidation produced by clofibrate and MEHP was inhibited
        by cycloheximide. In further studies with clofibrate and a range of other
        known peroxisome proliferators (nafenopin, tiadenol, BR-931, Wy-14,643, and
        acetylsalicylic acid), induction of CAT and palmitoyl-CoA oxidation was observed
        with no increase in activity of another peroxisomal enzyme, D-amino acid oxidase.
        This differential effect on peroxisomal enzyme activity is typical of that
        seen in vivo. Furthermore, the relative potencies of the different peroxisome
        proliferators in vitro agreed well with what is known from studies in vivo.
        Mitochondrial and microsomal marker enzymes showed little change in activity.
        Electron microscopy of treated cultures revealed increased numbers of peroxisomes,
        some of which lacked the characteristic nucleoid. The results indicate that
        primary cultures of rat hepatocytes provide a rapid, sensitive means of identifying
        chemicals that cause peroxisome proliferation and a potentially valuable system
        for studies aimed at clarifying the toxicological significance of this phenomenon.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Author><Author
        ValidYN="Y"><LastName>Lake</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Beamand</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author
        ValidYN="Y"><LastName>Foster</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1763-10-6</RegistryNumber><NameOfSubstance
        UI="D010171">Palmitoyl Coenzyme A</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009940" MajorTopicYN="N">Organoids</DescriptorName><QualifierName UI="Q000648"
        MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010171" MajorTopicYN="N">Palmitoyl Coenzyme A</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1983</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1983</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1983</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6845354</ArticleId><ArticleId IdType="doi">10.1016/0041-008x(83)90240-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9194412</PMID><DateCompleted><Year>1997</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>144</Volume><Issue>2</Issue><PubDate><Year>1997</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Hepatic
        ploidy, nuclearity, and distribution of DNA synthesis: a comparison of nongenotoxic
        hepatocarcinogens with noncarcinogenic liver mitogens.</ArticleTitle><Pagination><StartPage>287</StartPage><EndPage>293</EndPage><MedlinePgn>287-93</MedlinePgn></Pagination><Abstract><AbstractText>Most
        nongenotoxic hepatocarcinogens such as diethylhexyl phthalate (DEHP) and chlorendic
        acid (CEA) induce hepatocyte replicative DNA synthesis. However, not all mitogens
        are carcinogenic; in National Toxicology Program (NTP) studies 1,4-dichlorobenzene
        (DCB) was not hepatocarcinogenic in the rat despite the induction of substantial
        hepatic DNA synthesis. We have examined the hypothesis that the profile of
        hepatocyte labeling index (LI) may dictate hepatocarcinogenic potential. Using
        flow cytometry, we investigated the effects of DEHP, CEA, and DCB on hepatocyte
        ploidy, nuclearity, and LI distribution among the ploidy/nuclearity classes
        in male Fischer 344 rats. Dosing was for 7 days at the dose and route employed
        previously in the NTP cancer bioassays. Unlike DEHP and CEA, DCB reduced the
        proportion of tetraploid cells (4N plus 2 x 2N) and increased the proportion
        of mononucleated octoploid (8N) cells. DCB and DEHP increased the mean hepatic
        LI (17 +/- 2 and 23 +/- 3%, respectively, compared with 1.4 +/- 0.4% in controls),
        whereas, as expected for a chronic inducer of S-phase, CEA did not. LI was
        increased in all hepatocyte ploidy/nuclearity classes except the binucleated
        tetraploid cells (2 x 2N) and was elevated most in the mononucleated octoploid
        population (8N) (LI = 44 +/- 11, 49 +/- 14, and 1.3 +/- 0.4% of 8N hepatocytes
        for DCB, DEHP, and control, respectively). In general, the effects of DCB
        on LI could not be distinguished from those of DEHP. However, DEHP tended
        to induce DNA synthesis in a greater proportion of 2N and 2 x 4N cells; future
        studies will analyze whether the induction of DNA synthesis in these small
        populations may be more relevant to hepatocarcinogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hasmall</LastName><ForeName>S
        C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Zeneca Central
        Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, United Kingdom.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002722">Chlorobenzenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008934">Mitogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009153">Mutagens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009636">Norbornanes</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>D149TYB5MK</RegistryNumber><NameOfSubstance
        UI="C018511">4-dichlorobenzene</NameOfSubstance></Chemical><Chemical><RegistryNumber>IAC1H0N39L</RegistryNumber><NameOfSubstance
        UI="C035377">chlorendic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002722" MajorTopicYN="N">Chlorobenzenes</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008934" MajorTopicYN="N">Mitogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009153" MajorTopicYN="N">Mutagens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009636" MajorTopicYN="N">Norbornanes</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011003" MajorTopicYN="Y">Ploidies</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1997</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1997</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1997</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9194412</ArticleId><ArticleId IdType="doi">10.1006/taap.1997.8133</ArticleId><ArticleId
        IdType="pii">S0041-008X(97)98133-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10086319</PMID><DateCompleted><Year>1999</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>23</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-2952</ISSN><JournalIssue
        CitedMedium="Print"><Volume>57</Volume><Issue>8</Issue><PubDate><Year>1999</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Biochemical
        pharmacology</Title><ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Effects
        of tiadenol and di-(2-ethylhexyl)phthalate on the metabolism of phosphatidylcholine
        and phosphatidylethanolamine in the liver of rats: comparison with clofibric
        acid.</ArticleTitle><Pagination><StartPage>869</StartPage><EndPage>876</EndPage><MedlinePgn>869-76</MedlinePgn></Pagination><Abstract><AbstractText>Metabolic
        changes induced by 2,2''-(decamethylenedithio)diethanol (tiadenol) and di-(2-ethylhexyl)phthalate
        (DEHP) in the biosynthesis of phosphatidylcholine (PtdCho) and phosphatidylethanolamine
        (PtdEtn) in rat liver were compared with changes induced by p-chlorophenoxyisobutyric
        acid (clofibric acid). Treatment of rats with either tiadenol or DEHP increased
        the hepatic contents of PtdCho and PtdEtn, as was observed with clofibric
        acid treatment. The administration of tiadenol, DEHP, or clofibric acid slightly,
        but significantly, increased, in common, the activity of CTP:phosphocholine
        cytidylyltransferase, a key enzyme for the synthesis de novo of PtdCho, and
        suppressed the activity of PtdEtn N-methyltransferase. With regard to the
        enzymes involved in the synthesis of PtdEtn, the three peroxisome proliferators
        enhanced the activity of phosphatidylserine (PtdSer) decarboxylase and markedly
        decreased the activity of CTP:phosphoethanolamine cytidylyltransferase. Treatment
        of rats with the three compounds markedly increased, in common, the content
        and the proportion of the molecular species of PtdCho containing oleic acid
        (18:1), but considerably decreased the proportion of the molecular species
        of PtdCho containing linoleic acid (18:2) in the liver, resulting in a striking
        decrease in the concentration of the molecular species of PtdCho containing
        18:2 in the serum. The present study suggests that the administration of peroxisome
        proliferators to rats increases the contents of hepatic PtdCho and PtdEtn
        for hepatomegaly and proliferation of organelles by the same mechanism, irrespective
        of their chemical structures.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Mizuguchi</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research
        Laboratories, Torii Pharmaceutical Co., Ltd., Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Kudo</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Ohya</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Kawashima</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S.
        Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem
        Pharmacol</MedlineTA><NlmUniqueID>0101032</NlmUniqueID><ISSNLinking>0006-2952</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005233">Fatty Alcohols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000960">Hypolipidemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010713">Phosphatidylcholines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010714">Phosphatidylethanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>22251270CX</RegistryNumber><NameOfSubstance
        UI="C004568">tiadenol</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005233" MajorTopicYN="N">Fatty Alcohols</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000960" MajorTopicYN="N">Hypolipidemic Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010713" MajorTopicYN="N">Phosphatidylcholines</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010714" MajorTopicYN="N">Phosphatidylethanolamines</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>3</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>3</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10086319</ArticleId><ArticleId IdType="doi">10.1016/s0006-2952(98)00365-7</ArticleId><ArticleId
        IdType="pii">S0006-2952(98)00365-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2772924</PMID><DateCompleted><Year>1989</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue
        CitedMedium="Print"><Volume>48</Volume><Issue>2</Issue><PubDate><Year>1989</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>The
        influence of di(2-ethylhexyl)phthalate on protein turnover in rat liver.</ArticleTitle><Pagination><StartPage>185</StartPage><EndPage>192</EndPage><MedlinePgn>185-92</MedlinePgn></Pagination><Abstract><AbstractText>Treatment
        of rats with the plasticizer di(2-ethylhexyl)phthalate increases liver weight
        and leads to proliferation of mitochondria and peroxisomes. Using in vivo
        labelling with [3H]leucine, an increased rate of incorporation into the total
        protein of mitochondria and microsomes was observed. The half-lives of proteins
        in subcellular fractions were determined using [35S]methionine labelling.
        The half-lives for the total protein of mitochondria, microsomes, and supernatant
        were increased from 6 to 25 days, from 3.5 to 5.5 days and from 2.5 to 5 days
        upon treatment with phthalate esters. Experiments with [14C]guanidino-L-arginine
        indicated that some reutilization of [35S]methionine occurred, but this did
        not influence the results substantially. It appears that phthalate esters
        increase protein synthesis and decrease protein breakdown, the former effect
        being of greater importance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Ganning</LastName><ForeName>A E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department
        of Biochemistry, University of Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Olsson</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author
        ValidYN="Y"><LastName>Elhammer</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Dallner</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008930" MajorTopicYN="N">Mitochondria, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014176" MajorTopicYN="Y">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1989</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1989</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1989</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2772924</ArticleId><ArticleId IdType="doi">10.1016/0378-4274(89)90173-2</ArticleId><ArticleId
        IdType="pii">0378-4274(89)90173-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">21721021</PMID><DateCompleted><Year>2011</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0844</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>29</Volume><Issue>6</Issue><PubDate><Year>2011</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cell
        biochemistry and function</Title><ISOAbbreviation>Cell Biochem Funct</ISOAbbreviation></Journal><ArticleTitle>Plant-originated
        glycoprotein (24 kDa) has an inhibitory effect on proliferation of BNL CL.2
        cells in response to di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>496</StartPage><EndPage>505</EndPage><MedlinePgn>496-505</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1002/cbf.1777</ELocationID><Abstract><AbstractText>Di(2-ethylhexyl)phthalate
        (DEHP) is one of the many environmental chemicals that are widely used in
        polyvinyl chloride products, vinyl flooring, food packaging and infant toys.
        They cause cell proliferation or dysfunction of human liver. The purpose of
        this study is to investigate the inhibitory effect of a glycoprotein (24 kDa)
        isolated from Zanthoxylum piperitum DC (ZPDC) on proliferation of liver cell
        in the DEHP-induced BNL CL. 2 cells. [&#xb3;H]-thymidine incorporation, intracellular
        reactive oxygen species (ROS), intracellular Ca&#xb2;&#x207a; mobilization
        and activity of protein kinase C (PKC) were measured using radioactivity and
        fluorescence method respectively. The expression of mitogen-activated protein
        kinases [extracellular signal-regulated kinase (ERK) and c-Jun N-terminal
        kinase (JNK)], activator protein (AP)-1 (c-Jun and c-Fos), proliferating cell
        nuclear antigen (PCNA) and cell cycle-related factors (cyclin D1/cyclin-dependent
        kinase [CDK] 4) were evaluated using Western blotting or electrophoretic mobility
        shift assay. The results in this study showed that the levels of [&#xb3;H]-thymidine
        incorporation, intracellular ROS, intracellular Ca&#xb2;&#x207a; mobilization
        and activity of PKC&#x3b1; were inhibited by ZPDC glycoprotein (100&#x2009;&#xb5;g/ml)
        in the DEHP-induced BNL CL. 2 cells. Also, activities of ERK, JNK and AP-1
        were reduced by ZPDC glycoprotein (100 &#xb5;g/ml). With regard to cell proliferation,
        activities of PCNA and cyclin D1/CDK4 were significantly suppressed at treatment
        with ZPDC glycoprotein (100&#x2009;&#xb5;g/ml) in the presence of DEHP. Taken
        together, these findings suggest that ZPDC glycoprotein significantly normalized
        activities of PCNA and cyclin D1/CDK4, which relate to cell proliferation
        factors. Thus, ZPDC glycoprotein appears to be one of the compounds derived
        from natural products that are able to inhibit cell proliferation in the phthalate-induced
        BNL CL. 2 cells.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011
        John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Molecular
        Biochemistry Laboratory, Biotechnology Research Institute and Center for the
        Control of Animal Hazards Using Biotechnology (BK21), Chonnam National University,
        Gwangju, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Kye-Taek</ForeName><Initials>KT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2011</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell
        Biochem Funct</MedlineTA><NlmUniqueID>8305874</NlmUniqueID><ISSNLinking>0263-6484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010940">Plant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>10028-17-8</RegistryNumber><NameOfSubstance
        UI="D014316">Tritium</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated
        Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance
        UI="D002118">Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>VC2W18DGKR</RegistryNumber><NameOfSubstance
        UI="D013936">Thymidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010940" MajorTopicYN="N">Plant Proteins</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013936" MajorTopicYN="N">Thymidine</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014316" MajorTopicYN="N">Tritium</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D032106" MajorTopicYN="N">Zanthoxylum</DescriptorName><QualifierName UI="Q000737"
        MajorTopicYN="N">chemistry</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2011</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2011</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2011</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2011</Year><Month>12</Month><Day>13</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">21721021</ArticleId><ArticleId IdType="doi">10.1002/cbf.1777</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">4004798</PMID><DateCompleted><Year>1985</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>01</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0264-6021</ISSN><JournalIssue
        CitedMedium="Print"><Volume>227</Volume><Issue>3</Issue><PubDate><Year>1985</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>The
        Biochemical journal</Title><ISOAbbreviation>Biochem J</ISOAbbreviation></Journal><ArticleTitle>Specific
        changes in the protein composition of rat liver in response to the peroxisome
        proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>767</StartPage><EndPage>775</EndPage><MedlinePgn>767-75</MedlinePgn></Pagination><Abstract><AbstractText>The
        hypolipidaemic agents ciprofibrate and Wy-14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic
        acid) and the phthalate-ester plasticizer di-(2-ethylhexyl)-phthalate (DEHP),
        like other peroxisome proliferators, produce a significant hepatomegaly and
        induce the peroxisomal fatty acid beta-oxidation enzyme system together with
        profound proliferation of peroxisomes in hepatic parenchymal cells. Changes
        in the profile of liver proteins in rats following induction of peroxisome
        proliferation by ciprofibrate, Wy-14,643 and DEHP have been analysed by high-resolution
        two-dimensional gel electrophoresis. The proteins of whole liver homogenates
        from normal and peroxisome-proliferator-treated rats were separated by two-dimensional
        gel electrophoresis using isoelectric focusing for acidic proteins and nonequilibrium
        pH gradient electrophoresis for basic proteins. In the whole liver homogenates,
        the quantities of six proteins in acidic gels and six proteins in the basic
        gels increased following induction of peroxisome proliferation. Peroxisome
        proliferator administration caused a repression of three acidic proteins in
        the liver homogenates. By the immunoblot method using polyspecific antiserum
        against soluble peroxisomal proteins and monospecific antiserum against peroxisome
        proliferation associated Mr 80000 polypeptide (polypeptide PPA-80), the majority
        of basic proteins induced by these peroxisome proliferators appeared to be
        peroxisomal proteins. Polypeptide PPA-80 becomes the most abundant protein
        in the total liver homogenates of peroxisome-proliferator-treated rats. These
        results indicate that ciprofibrate, DEHP and Wy-14,643 induce marked changes
        in the profile of specific hepatic proteins and that some of these changes
        should serve as a baseline to identify a set of gene products that may assist
        in defining the specific ''peroxisome proliferator domain''.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Lalwani</LastName><ForeName>N D</ForeName><Initials>ND</Initials></Author><Author
        ValidYN="Y"><LastName>Reddy</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 32504</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM
        23750</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem
        J</MedlineTA><NlmUniqueID>2984726R</NlmUniqueID><ISSNLinking>0264-6021</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002499" MajorTopicYN="N">Centrifugation, Density Gradient</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">4004798</ArticleId><ArticleId IdType="pmc">PMC1144904</ArticleId><ArticleId
        IdType="doi">10.1042/bj2270767</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biochem
        J. 1964 Jul;92(1):179-84</Citation><ArticleIdList><ArticleId IdType="pubmed">4378796</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Lab Clin Med. 1964 Oct;64:634-42</Citation><ArticleIdList><ArticleId IdType="pubmed">14233152</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1967 Oct;35(1):127-52</Citation><ArticleIdList><ArticleId IdType="pubmed">4964831</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        J. 1970 Mar;116(5):773-9</Citation><ArticleIdList><ArticleId IdType="pubmed">5441366</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1970 Aug 15;227(5259):680-5</Citation><ArticleIdList><ArticleId IdType="pubmed">5432063</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1972 Nov 30;280(3):434-9</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4643343</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1974 Oct 25;249(20):6495-504</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4370900</ArticleId></ArticleIdList></Reference><Reference><Citation>Res
        Commun Chem Pathol Pharmacol. 1974 Nov;9(3):501-10</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4445568</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1975 May 25;250(10):4007-21</Citation><ArticleIdList><ArticleId
        IdType="pubmed">236308</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1975 Jul 18;189(4198):186-94</Citation><ArticleIdList><ArticleId IdType="pubmed">1138375</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1975 Jul 25;250(14):5375-85</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1141235</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1975 Nov 21;190(4216):787-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1198095</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1976 Jun;73(6):2043-6</Citation><ArticleIdList><ArticleId
        IdType="pubmed">180535</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1976 Dec;71(3):768-80</Citation><ArticleIdList><ArticleId IdType="pubmed">993270</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1977 Aug 8;77(3):824-9</Citation><ArticleIdList><ArticleId
        IdType="pubmed">901515</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell.
        1977 Dec;12(4):1133-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23215</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell.
        1978 Jan;13(1):41-55</Citation><ArticleIdList><ArticleId IdType="pubmed">23216</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Pathol. 1978 Feb;90(2):435-46</Citation><ArticleIdList><ArticleId IdType="pubmed">623209</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1978 Mar 10;253(5):1522-8</Citation><ArticleIdList><ArticleId IdType="pubmed">627552</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biochem. 1979 Mar;85(3):847-56</Citation><ArticleIdList><ArticleId IdType="pubmed">429267</ArticleId></ArticleIdList></Reference><Reference><Citation>Atherosclerosis.
        1979 Feb;32(2):155-63</Citation><ArticleIdList><ArticleId IdType="pubmed">454514</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1979 Jul 27;89(2):580-4</Citation><ArticleIdList><ArticleId
        IdType="pubmed">486181</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1979 Nov 10;254(21):10896-900</Citation><ArticleIdList><ArticleId
        IdType="pubmed">500614</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1979 Sep;76(9):4350-4</Citation><ArticleIdList><ArticleId
        IdType="pubmed">388439</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1980 Jan;40(1):36-41</Citation><ArticleIdList><ArticleId IdType="pubmed">6765917</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1980 Jan 24;283(5745):397-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6766207</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur
        J Biochem. 1980 Feb;103(3):589-96</Citation><ArticleIdList><ArticleId IdType="pubmed">6766863</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1980 Jul 16;95(1):7-12</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7417271</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1981 Jun;89(3):406-17</Citation><ArticleIdList><ArticleId IdType="pubmed">6788778</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu
        Rev Biochem. 1981;50:133-57</Citation><ArticleIdList><ArticleId IdType="pubmed">7023357</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods
        Enzymol. 1981;72:315-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7031421</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1982 Apr;93(1):103-10</Citation><ArticleIdList><ArticleId IdType="pubmed">7068748</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu
        Rev Med. 1982;33:417-33</Citation><ArticleIdList><ArticleId IdType="pubmed">7044276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1982;386:170-82</Citation><ArticleIdList><ArticleId IdType="pubmed">7046569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1982;386:81-110</Citation><ArticleIdList><ArticleId IdType="pubmed">7046570</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1982 Mar 30;105(2):639-46</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6178408</ArticleId></ArticleIdList></Reference><Reference><Citation>Lab
        Invest. 1982 Oct;47(4):364-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7120922</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS
        Lett. 1982 Dec 27;150(2):307-10</Citation><ArticleIdList><ArticleId IdType="pubmed">7160475</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1983 Apr;43(4):1680-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6831413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum
        Toxicol. 1983 Jan;2(1):27-48</Citation><ArticleIdList><ArticleId IdType="pubmed">6840792</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        J. 1983 Sep 15;214(3):879-83</Citation><ArticleIdList><ArticleId IdType="pubmed">6626161</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1983 Oct 31;116(2):388-93</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6651818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1984 Mar;44(3):1072-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6692393</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1984 Jun;44(6):2582-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6372995</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1951 Nov;193(1):265-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14907713</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1962 Jun 9;194:948-9</Citation><ArticleIdList><ArticleId IdType="pubmed">13921051</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1965 Nov 27;208(5013):856-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5870099</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">22198209</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-5107</ISSN><JournalIssue
        CitedMedium="Print"><Volume>750</Volume><Issue>2</Issue><PubDate><Year>2012</Year><Season>Apr-Jun</Season></PubDate></JournalIssue><Title>Mutation
        research</Title><ISOAbbreviation>Mutat Res</ISOAbbreviation></Journal><ArticleTitle>Mechanistic
        considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate.</ArticleTitle><Pagination><StartPage>141</StartPage><EndPage>158</EndPage><MedlinePgn>141-158</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.mrrev.2011.12.004</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S1383-5742(11)00102-5</ELocationID><Abstract><AbstractText>Di(2-ethylhexyl)
        phthalate (DEHP) is a peroxisome proliferator agent that is widely used as
        a plasticizer to soften polyvinylchloride plastics and non-polymers. Both
        occupational (e.g., by inhalation during its manufacture and use as a plasticizer
        of polyvinylchloride) and environmental (medical devices, contamination of
        food, or intake from air, water and soil) routes of exposure to DEHP are of
        concern for human health. There is sufficient evidence for carcinogenicity
        of DEHP in the liver in both rats and mice; however, there is little epidemiological
        evidence on possible associations between exposure to DEHP and liver cancer
        in humans. Data are available to suggest that liver is not the only target
        tissue for DEHP-associated toxicity and carcinogenicity in both humans and
        rodents. The debate regarding human relevance of the findings in rats or mice
        has been informed by studies on the mechanisms of carcinogenesis of the peroxisome
        proliferator class of chemicals, including DEHP. Important additional mechanistic
        information became available in the past decade, including, but not limited
        to, sub-acute, sub-chronic and chronic studies with DEHP in peroxisome proliferator-activated
        receptor (PPAR) &#x3b1;-null mice, as well as experiments utilizing several
        transgenic mouse lines. Activation of PPAR&#x3b1; and the subsequent downstream
        events mediated by this transcription factor represent an important mechanism
        of action for DEHP in rats and mice. However, additional data from animal
        models and studies in humans exposed to DEHP from the environment suggest
        that multiple molecular signals and pathways in several cell types in the
        liver, rather than a single molecular event, contribute to the cancer in rats
        and mice. In addition, the toxic and carcinogenic effects of DEHP are not
        limited to liver. The International Agency for Research on Cancer working
        group concluded that the human relevance of the molecular events leading to
        cancer elicited by DEHP in several target tissues (e.g., liver and testis)
        in rats and mice can not be ruled out and DEHP was classified as possibly
        carcinogenic to humans (Group 2B).</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2011 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Rusyn</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department
        of Environmental Sciences and Engineering, University of North Carolina, Chapel
        Hill, NC 27599-7431, USA. Electronic address: iir@unc.edu.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Corton</LastName><ForeName>J Christopher</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Integrated
        Systems Toxicology Division, National Health and Environmental Effects Research
        Laboratory, US Environmental Protection Agency, Research Triangle Park, NC
        27711, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>P30 ES010126</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P42
        ES005948-19</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>R01 ES012686</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01
        ES012686-04</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant><Grant><GrantID>P42 ES005948</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2011</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat
        Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007107" MajorTopicYN="N">Immune System</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013736" MajorTopicYN="N">Testicular Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2011</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2011</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2011</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2011</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2011</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">22198209</ArticleId><ArticleId IdType="mid">NIHMS345694</ArticleId><ArticleId
        IdType="pmc">PMC3348351</ArticleId><ArticleId IdType="doi">10.1016/j.mrrev.2011.12.004</ArticleId><ArticleId
        IdType="pii">S1383-5742(11)00102-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wittassek
        M, Wiesmuller GA, Koch HM, Eckard R, Dobler L, Muller J, Angerer J, Schluter
        C. Internal phthalate exposure over the last two decades--a retrospective
        human biomonitoring study. Int J Hyg Environ Health. 2007;210:319&#x2013;333.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17400024</ArticleId></ArticleIdList></Reference><Reference><Citation>Colacino
        JA, Harris TR, Schecter A. Dietary intake is associated with phthalate body
        burden in a nationally representative sample. Environ Health Perspect. 2010;118:998&#x2013;1003.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2920922</ArticleId><ArticleId IdType="pubmed">20392686</ArticleId></ArticleIdList></Reference><Reference><Citation>Selenskas
        S, Teta MJ, Vitale JN. Pancreatic cancer among workers processing synthetic
        resins. Am J Ind Med. 1995;28:385&#x2013;398.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7485192</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell
        L, Teta MJ. Mortality among workers at a plastics manufacturing and research
        and development facility: 1946&#x2013;1988. Am J Ind Med. 1995;28:373&#x2013;384.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7485191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardell
        L, Ohlson CG, Fredrikson M. Occupational exposure to polyvinyl chloride as
        a risk factor for testicular cancer evaluated in a case-control study. Int
        J Cancer. 1997;73:828&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">9399660</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagmar
        L, Akesson B, Nielsen J, Andersson C, Linden K, Attewell R, Moller T. Mortality
        and cancer morbidity in workers exposed to low levels of vinyl chloride monomer
        at a polyvinyl chloride processing plant. Am J Ind Med. 1990;17:553&#x2013;565.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2337081</ArticleId></ArticleIdList></Reference><Reference><Citation>Riboli
        E, Bai E, Berrino F, Merisi A. Mortality from lung cancer in an acetylene
        and phthalic anhydride plant. A case-referent study. Scand J Work Environ
        Health. 1983;9:455&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">6673103</ArticleId></ArticleIdList></Reference><Reference><Citation>Heineman
        EF, Olsen JH, Pottern LM, Gomez M, Raffn E, Blair A. Occupational risk factors
        for multiple myeloma among Danish men. Cancer Causes Control. 1992;3:555&#x2013;568.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1420859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Carrillo
        L, Hernandez-Ramirez RU, Calafat AM, Torres-Sanchez L, Galvan-Portillo M,
        Needham LL, Ruiz-Ramos R, Cebrian ME. Exposure to phthalates and breast cancer
        risk in northern Mexico. Environ Health Perspect. 2010;118:539&#x2013;544.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2854732</ArticleId><ArticleId IdType="pubmed">20368132</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds
        P, Urayama KY, Von Behren J, Feusner J. Birth characteristics and hepatoblastoma
        risk in young children. Cancer. 2004;100:1070&#x2013;1076.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14983504</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama
        K, Ikeda H, Koizumi T, Tsuchida Y. Prenatal and postnatal histories of very
        low birthweight infants who developed hepatoblastoma. Pediatr Int. 1999;41:82&#x2013;89.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10200142</ArticleId></ArticleIdList></Reference><Reference><Citation>Oue
        T, Kubota A, Okuyama H, Kawahara H, Nara K, Kawa K, Kitajima H. Hepatoblastoma
        in children of extremely low birth weight: a report from a single perinatal
        center. J Pediatr Surg. 2003;38:134&#x2013;137.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12592636</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick
        RL, Morrissey RE, Tomaszewski KE. Studies by the National Toxicology Program
        on di(2-ethylhexyl)phthalate. Toxicol Ind Health. 1987;3:99&#x2013;118.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3617073</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, Moore MR, Finney DC, Guest D. Chronic toxicity of di(2-ethylhexyl)phthalate
        in mice. Toxicol Sci. 2000;58:377&#x2013;385.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11099649</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, Moore MR, Finney DC, Guest D. Chronic toxicity of di(2-ethylhexyl)phthalate
        in rats. Toxicol Sci. 2000;55:433&#x2013;443.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10828276</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss
        C, Zerban H, Bannasch P, Berger MR. Lifelong exposure to di-(2-ethylhexyl)-phthalate
        induces tumors in liver and testes of Sprague-Dawley rats. Toxicology. 2005;206:359&#x2013;371.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15588926</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson
        VS, Blystone CR, Hotchkiss AK, Rider CV, Gray LE., Jr Diverse mechanisms of
        anti-androgen action: impact on male rat reproductive tract development. Int
        J Androl. 2008;31:178&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">18315717</ArticleId></ArticleIdList></Reference><Reference><Citation>Karle
        VA, Short BL, Martin GR, Bulas DI, Getson PR, Luban NL, O&#x2019;Brien AM,
        Rubin RJ. Extracorporeal membrane oxygenation exposes infants to the plasticizer,
        di(2-ethylhexyl)phthalate. Crit Care Med. 1997;25:696&#x2013;703.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9142038</ArticleId></ArticleIdList></Reference><Reference><Citation>von
        Rettberg H, Hannman T, Subotic U, Brade J, Schaible T, Waag KL, Loff S. Use
        of di(2-ethylhexyl)phthalate-containing infusion systems increases the risk
        for cholestasis. Pediatrics. 2009;124:710&#x2013;716.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19651587</ArticleId></ArticleIdList></Reference><Reference><Citation>Backes
        JM, Gibson CA, Ruisinger JF, Moriarty PM. Fibrates: what have we learned in
        the past 40 years? Pharmacotherapy. 2007;27:412&#x2013;424.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17316152</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttunen
        JK, Heinonen OP, Manninen V, Koskinen P, Hakulinen T, Teppo L, Manttari M,
        Frick MH. The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.
        J Intern Med. 1994;235:31&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">8283157</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick
        MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi
        P, Koskinen P, Manninen V. Helsinki Heart Study: primary-prevention trial
        with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment,
        changes in risk factors, and incidence of coronary heart disease. N Engl J
        Med. 1987;317:1237&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pubmed">3313041</ArticleId></ArticleIdList></Reference><Reference><Citation>.
        WHO cooperative trial on primary prevention of ischaemic heart disease with
        clofibrate to lower serum cholesterol: final mortality follow-up. Report of
        the Committee of Principal Investigators. Lancet. 1984;2:600&#x2013;604.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6147641</ArticleId></ArticleIdList></Reference><Reference><Citation>.
        A co-operative trial in the primary prevention of ischaemic heart disease
        using clofibrate. Report from the Committee of Principal Investigators. Br
        Heart J. 1978;40:1069&#x2013;1118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC483536</ArticleId><ArticleId
        IdType="pubmed">361054</ArticleId></ArticleIdList></Reference><Reference><Citation>.
        W.H.O. cooperative trial on primary prevention of ischaemic heart disease
        using clofibrate to lower serum cholesterol: mortality follow-up. Report of
        the Committee of Principal Investigators. Lancet. 1980;2:379&#x2013;385.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6105515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash
        LH, Fisher JW, Lipscomb JC, Parker JC. Metabolism of trichloroethylene. Environ
        Health Perspect. 2000;108(Suppl 2):177&#x2013;200.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1637769</ArticleId><ArticleId IdType="pubmed">10807551</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash
        LH, Qian W, Putt DA, Hueni SE, Elfarra AA, Krause RJ, Parker JC. Renal and
        hepatic toxicity of trichloroethylene and its glutathione-derived metabolites
        in rats and mice: sex-, species-, and tissue-dependent differences. J Pharmacol
        Exp Ther. 2001;297:155&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">11259540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramdhan
        DH, Komijima M, Wang D, Ito Y, Naito H, Yanagiba Y, Hayashi Y, Tanaka N, Aoyama
        T, Gonzalez FJ, Nakajima T. Differential response to trichloroethylene-induced
        hepatosteatosis in wild-type and PPARa-humanized Mice. Environ Health Perspect.
        2010;118:1557&#x2013;1563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2974693</ArticleId><ArticleId
        IdType="pubmed">20709644</ArticleId></ArticleIdList></Reference><Reference><Citation>National
        Toxicology Program. Carcinogenesis Studies of Trichloroethylene (Without Epichlorohydrin)
        (CAS No. 79-01-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies) Natl Toxicol
        Program Tech Rep Ser. 1990;243:1&#x2013;174.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12750750</ArticleId></ArticleIdList></Reference><Reference><Citation>National
        Research Council. Assessing the human health risks of trichloroethylene: Key
        scientific issues. The National Academies Press; Washington, D.C.: 2006.</Citation></Reference><Reference><Citation>Scott
        CS, Jinot J. Trichloroethylene and Cancer: Systematic and Quantitative Review
        of Epidemiologic Evidence for Identifying Hazards. Int J Environ Res Public
        Health. 2011;8:4238&#x2013;4271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228569</ArticleId><ArticleId
        IdType="pubmed">22163205</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson
        MS, Kevy SV, Grand RJ. Effects of a plasticizer leached from polyvinyl chloride
        on the subhuman primate: a consequence of chronic transfusion therapy. J Lab
        Clin Med. 1977;89:1066&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">404371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kevy
        SV, Jacobson MS. Hepatic effects of a phthalate ester plasticizer leached
        from poly(vinyl chloride) blood bags following transfusion. Environ Health
        Perspect. 1982;45:57&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569017</ArticleId><ArticleId
        IdType="pubmed">7140697</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugh
        G, Jr, Isenberg JS, Kamendulis LM, Ackley DC, Clare LJ, Brown R, Lington AW,
        Smith JH, Klaunig JE. Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate,
        and clofibrate in cynomolgus monkeys. Toxicol Sci. 2000;56:181&#x2013;188.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10869467</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura
        Y, Katayama H, Goto M. Studies on the metabolism of rat ascites hepatoma,
        with special reference of the metabolic difference between nitrogen mustard
        sensitive and insensitive strains. Acta Unio Int Contra Cancrum. 1959;15(Suppl
        1):199&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">14423065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Peters JM, Perella CM, Gonzalez FJ. Receptor and nonreceptor-mediated
        organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome
        proliferator-activated receptor alpha-null mice. Toxicol Pathol. 1998;26:240&#x2013;246.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9547862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair
        KG, Deepadevi KV, Arun P, Kumar VM, Santhosh A, Lekshmi LR, Kurup PA. Toxic
        effect of systemic administration of low doses of the plasticizer di-(2-ethyl
        hexyl) phthalate [DEHP] in rats. Indian J Exp Biol. 1998;36:264&#x2013;272.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9754059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito
        Y, Yamanoshita O, Asaeda N, Tagawa Y, Lee CH, Aoyama T, Ichihara G, Furuhashi
        K, Kamijima M, Gonzalez FJ, Nakajima T. Di(2-ethylhexyl)phthalate induces
        hepatic tumorigenesis through a peroxisome proliferator-activated receptor
        alpha-independent pathway. J Occup Health. 2007;49:172&#x2013;182.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17575397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays
        T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. Role of
        peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced
        hepatocarcinogenesis and cholestasis. Carcinogenesis. 2005;26:219&#x2013;227.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15447978</ArticleId></ArticleIdList></Reference><Reference><Citation>National
        Toxicology Program. Carcinogenesis Bioassay of Di(2-ethylhexyl)phthalate (CAS
        No. 117-81-7) in F344 Rats and B6C3F1 Mice (Feed Studies) Natl Toxicol Program
        Tech Rep Ser. 1982;217:1&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">12778218</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, Moore MR, Cifone MA, Finney DC, Guest D. Chronic peroxisome proliferation
        and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate
        and the effects of recovery. Toxicol Sci. 1999;50:195&#x2013;205.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10478855</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig
        JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, Deluca JG, Lai DY,
        McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA. PPARalpha agonist-induced
        rodent tumors: modes of action and human relevance. Crit Rev Toxicol. 2003;33:655&#x2013;780.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14727734</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA. Peroxisome proliferators: mechanisms of adverse effects in rodents and
        molecular basis for species differences. Arch Toxicol. 1999;73:413&#x2013;418.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10650911</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters
        JM. Mechanistic evaluation of PPARa-mediated hepatocarcinogenesis: Are we
        there yet? Toxicol Sci. 2008;101:1&#x2013;3.</Citation></Reference><Reference><Citation>Guyton
        KZ, Chiu WA, Bateson TF, Jinot J, Scott CS, Brown RC, Caldwell JC. A reexamination
        of the PPAR-alpha activation mode of action as a basis for assessing human
        cancer risks of environmental contaminants. Environ Health Perspect. 2009;117:1664&#x2013;1672.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2801168</ArticleId><ArticleId IdType="pubmed">20049115</ArticleId></ArticleIdList></Reference><Reference><Citation>Issemann
        I, Green S. Activation of a member of the steroid hormone receptor superfamily
        by peroxisome proliferators. Nature. 1990;347:645&#x2013;650.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2129546</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyer
        C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal
        beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell.
        1992;68:879&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pubmed">1312391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher
        T, Yi HF, McBride OW, Gonzalez FJ. cDNA cloning, chromosomal mapping, and
        functional characterization of the human peroxisome proliferator activated
        receptor. Biochemistry. 1993;32:5598&#x2013;5604.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7684926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapinskas
        PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, Corton JC.
        Role of PPARalpha in mediating the effects of phthalates and metabolites in
        the liver. Toxicology. 2005;207:149&#x2013;163.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15590130</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney
        EK, Waxman DJ. Trans-activation of PPARalpha and PPARgamma by structurally
        diverse environmental chemicals. Toxicol Appl Pharmacol. 1999;161:209&#x2013;218.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10581215</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst
        CH, Waxman DJ. Activation of PPARalpha and PPARgamma by environmental phthalate
        monoesters. Toxicol Sci. 2003;74:297&#x2013;308.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12805656</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampen
        A, Zimnik S, Nau H. Teratogenic phthalate esters and metabolites activate
        the nuclear receptors PPARs and induce differentiation of F9 cells. Toxicol
        Appl Pharmacol. 2003;188:14&#x2013;23.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12668118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bility
        MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM.
        Activation of mouse and human peroxisome proliferator&#x2013;zactivated receptors
        (PPARs) by phthalate monoesters. Toxicol Sci. 2004;82:170&#x2013;182.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15310864</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C, Anghel SI, Grosdidier
        A, Lathion C, Engelborghs Y, Michielin O, Wahli W, Desvergne B. The endocrine
        disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated
        receptor gamma modulator that promotes adipogenesis. J Biol Chem. 2007;282:19152&#x2013;19166.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17468099</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotroff
        DM, Beam AL, Dix DJ, Farmer A, Freeman KM, Houck KA, Judson RS, LeCluyse EL,
        Martin MT, Reif DM, Ferguson SS. Xenobiotic-metabolizing enzyme and transporter
        gene expression in primary cultures of human hepatocytes modulated by ToxCast
        chemicals. J Toxicol Environ Health B Crit Rev. 2010;13:329&#x2013;346.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20574906</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin
        MT, Dix DJ, Judson RS, Kavlock RJ, Reif DM, Richard AM, Rotroff DM, Romanov
        S, Medvedev A, Poltoratskaya N, Gambarian M, Moeser M, Makarov SS, Houck KA.
        Impact of environmental chemicals on key transcription regulators and correlation
        to toxicity end points within EPA&#x2019;s ToxCast program. Chem Res Toxicol.
        2010;23:578&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">20143881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito
        Y, Yamanoshita O, Kurata Y, Kamijima M, Aoyama T, Nakajima T. Induction of
        peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes
        by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets.
        Arch Toxicol. 2007;81:219&#x2013;226.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16937134</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer
        CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF. Peroxisome proliferator activated
        receptor-alpha expression in human liver. Mol Pharmacol. 1998;53:14&#x2013;22.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9443928</ArticleId></ArticleIdList></Reference><Reference><Citation>Walgren
        JE, Kurtz DT, McMillan JM. Expression of PPAR(alpha) in human hepatocytes
        and activation by trichloroacetate and dichloroacetate. Res Commun Mol Pathol
        Pharmacol. 2000;108:116&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">11758968</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury
        AI, Sims HM, Horley NJ, Roberts RA, Tomlinson SR, Salter AM, Bruce M, Shaw
        PN, Kendall D, Barrett DA, Bell DR. Molecular analysis of peroxisome proliferation
        in the hamster. Toxicol Appl Pharmacol. 2004;197:9&#x2013;18.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15126070</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee
        R, Jow L, Noonan D, McDonnell DP. Human and rat peroxisome proliferator activated
        receptors (PPARs) demonstrate similar tissue distribution but different responsiveness
        to PPAR activators. J Steroid Biochem Mol Biol. 1994;51:157&#x2013;166.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tugwood
        JD, Aldridge TC, Lambe KG, Macdonald N, Woodyatt NJ. Peroxisome proliferator-activated
        receptors: structures and function. Ann N Y Acad Sci. 1996;804:252&#x2013;265.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8993548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervois
        P, Torra IP, Chinetti G, Grotzinger T, Dubois G, Fruchart JC, Fruchart-Najib
        J, Leitersdorf E, Staels B. A truncated human peroxisome proliferator-activated
        receptor alpha splice variant with dominant negative activity. Mol Endocrinol.
        1999;13:1535&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pubmed">10478844</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanselman
        JC, Vartanian MA, Koester BP, Gray SA, Essenburg AD, Rea TJ, Bisgaier CL,
        Pape ME. Expression of the mRNA encoding truncated PPAR alpha does not correlate
        with hepatic insensitivity to peroxisome proliferators. Mol Cell Biochem.
        2001;217:91&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">11269670</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen
        MB, Abbott BD, Wolf DC, Corton JC, Wood CR, Schmid JE, Das KP, Zehr RD, Blair
        ET, Lau C. Gene profiling in the livers of wild-type and PPARalpha-null mice
        exposed to perfluorooctanoic acid. Toxicol Pathol. 2008;36:592&#x2013;607.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18467677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganning
        AE, Brunk U, Dallner G. Phthalate esters and their effect on the liver. Hepatology.
        1984;4:541&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">6373551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganning
        AE, Brunk U, Edlund C, Elhammer A, Dallner G. Effects of prolonged administration
        of phthalate ester on the liver. Environ Health Perspect. 1987;73:251&#x2013;258.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474545</ArticleId><ArticleId IdType="pubmed">3665868</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber
        WW, Grasl-Kraupp B, Schulte-Hermann R. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate
        in rodents and its implications on human risk. Crit Rev Toxicol. 1996;26:365&#x2013;481.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8817083</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomonari
        Y, Kurata Y, David RM, Gans G, Kawasuso T, Katoh M. Effect of di(2-ethylhexyl)
        phthalate (DEHP) on genital organs from juvenile common marmosets: I. Morphological
        and biochemical investigation in 65-week toxicity study. J Toxicol Environ
        Health A. 2006;69:1651&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pubmed">16854791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Gangolli SD, Grasso P, Lloyd AG. Studies on the hepatic effects of orally
        administered di-(2-ethylhexyl) phthalate in the rat. Toxicol Appl Pharmacol.
        1975;32:355&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">168667</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Moody DE, Azarnoff DL, Rao MS. Di-(2-ethylhexyl)phthalate: an industrial
        plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine
        acetyltransferase activities in rat and mice. Life Sci. 1976;18:941&#x2013;945.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1271963</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, Sperbeck SJ, Osumi
        T, Hashimoto T, Lalwani ND. Transcription regulation of peroxisomal fatty
        acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in
        rat liver by peroxisome proliferators. Proc Natl Acad Sci U S A. 1986;83:1747&#x2013;1751.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC323161</ArticleId><ArticleId IdType="pubmed">3456610</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki
        T, Hirose A, Sakamoto T, Okazaki M, Mitsumoto A, Kudo N, Kawashima Y. Peroxisome
        proliferators attenuate free arachidonic acid pool in the kidney through inducing
        lysophospholipid acyltransferases. J Pharmacol Sci. 2009;111:201&#x2013;210.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19809218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong
        JS, Gill SS. Gene expression changes induced in mouse liver by di(2-ethylhexyl)
        phthalate. Toxicol Appl Pharmacol. 2002;185:180&#x2013;196.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12498735</ArticleId></ArticleIdList></Reference><Reference><Citation>Currie
        RA, Bombail V, Oliver JD, Moore DJ, Lim FL, Gwilliam V, Kimber I, Chipman
        K, Moggs JG, Orphanides G. Gene ontology mapping as an unbiased method for
        identifying molecular pathways and processes affected by toxicant exposure:
        application to acute effects caused by the rodent non-genotoxic carcinogen
        diethylhexylphthalate. Toxicol Sci. 2005;86:453&#x2013;469.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15901911</ArticleId></ArticleIdList></Reference><Reference><Citation>Dostal
        LA, Jenkins WL, Schwetz BA. Hepatic peroxisome proliferation and hypolipidemic
        effects of di(2-ethylhexyl)phthalate in neonatal and adult rats. Toxicol Appl
        Pharmacol. 1987;87:81&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">3798454</ArticleId></ArticleIdList></Reference><Reference><Citation>Dostal
        LA, Weaver RP, Schwetz BA. Transfer of di(2-ethylhexyl) phthalate through
        rat milk and effects on milk composition and the mammary gland. Toxicol Appl
        Pharmacol. 1987;91:315&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">2892284</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimini
        AM, Sulli A, Stefanini S, Serafini B, Moreno S, Rossi L, Giorgi M, Ceru MP.
        Effects of di-(2-ethylhexyl)phthalate on peroxisomes of liver, kidney and
        brain of lactating rats and their pups. Cell Mol Biol (Noisy -le-grand) 1994;40:1063&#x2013;1076.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7873979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurata
        Y, Kidachi F, Yokoyama M, Toyota N, Tsuchitani M, Katoh M. Subchronic toxicity
        of Di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome
        proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia.
        Toxicol Sci. 1998;42:49&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">9538047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray
        TJ, Beamand JA, Lake BG, Foster JR, Gangolli SD. Peroxisome proliferation
        in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolites.
        Toxicol Lett. 1982;10:273&#x2013;279.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7080097</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray
        TJ, Lake BG, Beamand JA, Foster JR, Gangolli SD. Peroxisome proliferation
        in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol. 1983;67:15&#x2013;25.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6845354</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolier
        P, Elcombe CR. In vitro inhibition of carnitine acyltransferase activity in
        mitochondria from rat and mouse liver by a diethylhexylphthalate metabolite.
        Biochem Pharmacol. 1993;45:827&#x2013;832.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8452557</ArticleId></ArticleIdList></Reference><Reference><Citation>Osumi
        T, Hashimoto T. Enhancement of fatty acyl-CoA oxidizing activity in rat liver
        peroxisomes by di-(i-ethylhexyl)phthalate. J Biochem. 1978;83:1361&#x2013;1365.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">659402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, Soames AR, Roberts RA. Species differences in response
        to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis
        and peroxisome proliferator activated receptor alpha-mediated gene expression.
        Arch Toxicol. 2000;74:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">10839475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Gray TJ, Foster JR, Stubberfield CR, Gangolli SD. Comparative studies
        on di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation in
        the rat and hamster. Toxicol Appl Pharmacol. 1984;72:46&#x2013;60.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6710484</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes
        C, Orton TC, Pratt IS, Batten PL, Bratt H, Jackson SJ, Elcombe CR. Comparative
        pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP)
        in rats and marmosets: extrapolation of effects in rodents to man. Environ
        Health Perspect. 1986;65:299&#x2013;307.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474672</ArticleId><ArticleId IdType="pubmed">3086078</ArticleId></ArticleIdList></Reference><Reference><Citation>Short
        RD, Robinson EC, Lington AW, Chin AE. Metabolic and peroxisome proliferation
        studies with di(2-ethylhexyl)phthalate in rats and monkeys. Toxicol Ind Health.
        1987;3:185&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">3617067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell
        FE, Price SC, Hinton RH, Grasso P, Bridges JW. Time and dose-response study
        of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate. Toxicol
        Appl Pharmacol. 1985;81:371&#x2013;392.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2867621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Gray TJ, Gangolli SD. Hepatic effects of phthalate esters and related
        compounds--in vivo and in vitro correlations. Environ Health Perspect. 1986;67:283&#x2013;290.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474416</ArticleId><ArticleId IdType="pubmed">3757955</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirven
        HA, van den Broek PH, Peeters MC, Peters JG, Mennes WC, Blaauboer BJ, Noordhoek
        J, Jongeneelen FJ. Effects of the peroxisome proliferator mono(2-ethylhexyl)phthalate
        in primary hepatocyte cultures derived from rat, guinea pig, rabbit, and monkey.
        Biochem Pharmacol. 1993;45:2425&#x2013;2434.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8328980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornu
        MC, Lhuguenot JC, Brady AM, Moore R, Elcombe CR. Identification of the proximate
        peroxisome proliferator(s) derived from di(2-ethylhexyl)adipate and species
        differences in response. Biochem Pharmacol. 1992;43:2129&#x2013;2134.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1599500</ArticleId></ArticleIdList></Reference><Reference><Citation>Goll
        V, Alexandre E, Viollon-Abadie C, Nicod L, Jaeck D, Richert L. Comparison
        of the effects of various peroxisome proliferators on peroxisomal enzyme activities,
        DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxicol
        Appl Pharmacol. 1999;160:21&#x2013;32.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10502499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharewski
        TR, Meek MD, Clemons JH, Wu ZF, Fielden MR, Matthews JB. Examination of the
        in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
        Toxicol Sci. 1998;46:282&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">10048131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghisari
        M, Bonefeld-Jorgensen EC. Effects of plasticizers and their mixtures on estrogen
        receptor and thyroid hormone functions. Toxicol Lett. 2009;189:67&#x2013;77.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19463926</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi
        S, Iida M, Kobayashi S, Jin K, Matsuda T, Kojima H. Differential effects of
        phthalate esters on transcriptional activities via human estrogen receptors
        alpha and beta, and androgen receptor. Toxicology. 2005;210:223&#x2013;233.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15840436</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang
        SC, Lee BM. DNA methylation of estrogen receptor alpha gene by phthalates.
        J Toxicol Environ Health A. 2005;68:1995&#x2013;2003.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16326419</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks
        LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, Gray LE.,
        Jr The plasticizer diethylhexyl phthalate induces malformations by decreasing
        fetal testosterone synthesis during sexual differentiation in the male rat.
        Toxicol Sci. 2000;58:339&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">11099646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger
        T, Long M, Bonefeld-Jorgensen EC. Plastic components affect the activation
        of the aryl hydrocarbon and the androgen receptor. Toxicology. 2008;246:112&#x2013;123.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18294747</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita
        A, Koibuchi N, Oka J, Taguchi M, Shishiba Y, Ozawa Y. Bisphenol-A, an environmental
        estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic
        receptor-mediated transcription. Eur J Endocrinol. 2001;145:513&#x2013;517.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11581012</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita
        A, Inagaki K, Igarashi-Migitaka J, Ozawa Y, Koibuchi N. The endocrine disrupting
        chemical, diethylhexyl phthalate, activates MDR1 gene expression in human
        colon cancer LS174T cells. J Endocrinol. 2006;190:897&#x2013;902.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17003290</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper
        BW, Cho TM, Thompson PM, Wallace AD. Phthalate induction of CYP3A4 is dependent
        on glucocorticoid regulation of PXR expression. Toxicol Sci. 2008;103:268&#x2013;277.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18332045</ArticleId></ArticleIdList></Reference><Reference><Citation>Mnif
        W, Pascussi JM, Pillon A, Escande A, Bartegi A, Nicolas JC, Cavailles V, Duchesne
        MJ, Balaguer P. Estrogens and antiestrogens activate hPXR. Toxicol Lett. 2007;170:19&#x2013;29.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17379461</ArticleId></ArticleIdList></Reference><Reference><Citation>Auerbach
        SS, Dekeyser JG, Stoner MA, Omiecinski CJ. CAR2 displays unique ligand binding
        and RXRalpha heterodimerization characteristics. Drug Metab Dispos. 2007;35:428&#x2013;439.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC4105022</ArticleId><ArticleId IdType="pubmed">17194715</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekeyser
        JG, Stagliano MC, Auerbach SS, Prabhu KS, Jones AD, Omiecinski CJ. Di(2-ethylhexyl)
        phthalate is a highly potent agonist for the human constitutive androstane
        receptor splice variant CAR2. Mol Pharmacol. 2009;75:1005&#x2013;1013.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2672810</ArticleId><ArticleId IdType="pubmed">19211671</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveillard
        A, Mselli-Lakhal L, Mogha A, Lasserre F, Polizzi A, Pascussi JM, Guillou H,
        Martin PG, Pineau T. Di-(2-ethylhexyl)-phthalate (DEHP) activates the constitutive
        androstane receptor (CAR): a novel signalling pathway sensitive to phthalates.
        Biochem Pharmacol. 2009;77:1735&#x2013;1746.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19428328</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekeyser
        JG, Laurenzana EM, Peterson EC, Chen T, Omiecinski CJ. Selective phthalate
        activation of naturally occurring human constitutive androstane receptor splice
        variants and the pregnane &#xd7; receptor. Toxicol Sci. 2011;120:381&#x2013;391.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3107492</ArticleId><ArticleId IdType="pubmed">21227907</ArticleId></ArticleIdList></Reference><Reference><Citation>Seree
        E, Villard PH, Pascussi JM, Pineau T, Maurel P, Nguyen QB, Fallone F, Martin
        PM, Champion S, Lacarelle B, Savouret JF, Barra Y. Evidence for a new human
        CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology.
        2004;127:1436&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pubmed">15521013</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskoboinik
        I, Ooi SG, Drew R, Ahokas JT. Peroxisome proliferators increase the formation
        of BPDE-DNA adducts in isolated rat hepatocytes. Toxicology. 1997;122:81&#x2013;91.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9274804</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaban
        Z, El Shazly S, Ishizuka M, Kimura K, Kazusaka A, Fujita S. PPARalpha-dependent
        modulation of hepatic CYP1A by clofibric acid in rats. Arch Toxicol. 2004;78:496&#x2013;507.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15127182</ArticleId></ArticleIdList></Reference><Reference><Citation>Eagon
        PK, Chandar N, Epley MJ, Elm MS, Brady EP, Rao KN. Di(2-ethylhexyl)phthalate-induced
        changes in liver estrogen metabolism and hyperplasia. Int J Cancer. 1994;58:736&#x2013;743.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7915705</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang
        Q, Ito S, Gonzalez FJ. Hepatocyte-restricted constitutive activation of PPAR
        alpha induces hepatoproliferation but not hepatocarcinogenesis. Carcinogenesis.
        2007;28:1171&#x2013;1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1885989</ArticleId><ArticleId
        IdType="pubmed">17331954</ArticleId></ArticleIdList></Reference><Reference><Citation>Weglarz
        TC, Sandgren EP. Cell cross-talk mediates PPARalpha null hepatocyte proliferation
        after peroxisome proliferator exposure. Carcinogenesis. 2004;25:107&#x2013;112.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14514660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung
        C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ. Diminished
        hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome
        proliferator-activated receptor alpha. Cancer Res. 2004;64:3849&#x2013;3854.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15172993</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimura
        K, Cheung C, Ward JM, Reddy JK, Gonzalez FJ. Differential susceptibility of
        mice humanized for peroxisome proliferator-activated receptor {alpha} to Wy-14,643-induced
        liver tumorigenesis. Carcinogenesis. 2006</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1447533</ArticleId><ArticleId IdType="pubmed">16377806</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan
        LQ, You L, Brown-Borg H, Brown S, Edwards RJ, Corton JC. Regulation of phase
        I and phase II steroid metabolism enzymes by PPAR alpha activators. Toxicology.
        2004;204:109&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">15388238</ArticleId></ArticleIdList></Reference><Reference><Citation>Howroyd
        P, Swanson C, Dunn C, Cattley RC, Corton JC. Decreased longevity and enhancement
        of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated
        receptor alpha (PPARalpha) Toxicol Pathol. 2004;32:591&#x2013;599.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15603543</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashima
        K, Ito Y, Gonzalez FJ, Nakajima T. Different mechanisms of DEHP-induced hepatocellular
        adenoma tumorigenesis in wild-type and Ppar alpha-null mice. J Occup Health.
        2008;50:169&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217336</ArticleId><ArticleId
        IdType="pubmed">18403868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren
        H, Aleksunes LM, Wood C, Vallanat B, George MH, Klaassen CD, Corton JC. Characterization
        of peroxisome proliferator-activated receptor alpha--independent effects of
        PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also
        activates the constitutive-activated receptor. Toxicol Sci. 2010;113:45&#x2013;59.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2794335</ArticleId><ArticleId IdType="pubmed">19850644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim
        NY, Kim TH, Lee E, Patra N, Lee J, Shin MO, Kwack SJ, Park KL, Han SY, Kang
        TS, Kim SH, Lee BM, Kim HS. Functional role of phospholipase D (PLD) in di(2-ethylhexyl)
        phthalate-induced hepatotoxicity in Sprague-Dawley rats. J Toxicol Environ
        Health A. 2010;73:1560&#x2013;1569.</Citation><ArticleIdList><ArticleId IdType="pubmed">20954081</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin
        WS, Roling JA. A concentration addition model for the activation of the constitutive
        androstane receptor by xenobiotic mixtures. Toxicol Sci. 2009;107:93&#x2013;105.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2735418</ArticleId><ArticleId IdType="pubmed">18832183</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen
        O, Du G, Sun H, Wu W, Jiang Y, Song L, Wang X. Comparison of in vitro hormone
        activities of selected phthalates using reporter gene assays. Toxicol Lett.
        2009;191:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">19643168</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmar
        D, Srivastava SP, Seth PK. Effect of di(2-ethylhexyl)phthalate (DEHP) on hepatic
        mixed function oxidases in different animal species. Toxicol Lett. 1988;40:209&#x2013;217.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3354005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst
        CH, Waxman DJ. Environmental phthalate monoesters activate pregnane X receptor-mediated
        transcription. Toxicol Appl Pharmacol. 2004;199:266&#x2013;274.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15364542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasmall
        SC, James NH, Macdonald N, West D, Chevalier S, Cosulich SC, Roberts RA. Suppression
        of apoptosis and induction of DNA synthesis in vitro by the phthalate plasticizers
        monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP): a comparison
        of rat and human hepatocytes in vitro. Arch Toxicol. 1999;73:451&#x2013;456.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10650916</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Oliver
        T, Butterworth BE. Correlation of the carcinogenic potential of di(2-ethylhexyl)phthalate
        (DEHP) with induced hyperplasia rather than with genotoxic activity. Mutat
        Res. 1987;188:21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">3574334</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        DS, Cattley RC, Conway JG, Popp JA. Relationship of hepatic peroxisome proliferation
        and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome
        proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-
        pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 1988;48:6739&#x2013;6744.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3180084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Hagiwara A, Anderson LM, Lindsey K, Diwan BA. The chronic hepatic or renal
        toxicity of di(2-ethylhexyl) phthalate, acetaminophen, sodium barbital, and
        phenobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical,
        and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis
        or tumor promotion. Toxicol Appl Pharmacol. 1988;96:494&#x2013;506.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3206528</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah
        YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez FJ. Peroxisome proliferator-activated
        receptor alpha regulates a microRNA-mediated signaling cascade responsible
        for hepatocellular proliferation. Mol Cell Biol. 2007;27:4238&#x2013;4247.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1900062</ArticleId><ArticleId IdType="pubmed">17438130</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA, James NH, Cosulich SC. The role of protein kinase B and mitogen-activated
        protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated
        rat hepatocyte survival and apoptosis. Hepatology. 2000;31:420&#x2013;427.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10655266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Yamashina S, Segal BH, Schoonhoven R, Holland SM, Cattley RC, Swenberg
        JA, Thurman RG. Oxidants from nicotinamide adenine dinucleotide phosphate
        oxidase are involved in triggering cell proliferation in the liver due to
        peroxisome proliferators. Cancer Res. 2000;60:4798&#x2013;4803.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10987289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler
        MD, Smutney OM, Check JF, Rusyn I, Schulte-Hermann R, Thurman RG. Impaired
        Ras membrane association and activation in PPARalpha knockout mice after partial
        hepatectomy. Am J Physiol Gastrointest Liver Physiol. 2003;284:G302&#x2013;G312.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12388208</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts
        RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE. Role of the Kupffer
        cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci. 2007;96:2&#x2013;15.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17122412</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama
        Y, Okubo T, Kano I, Sato S, Kano K. Induction of apoptosis by mono(2-ethylhexyl)phthalate
        (MEHP) in U937 cells. Toxicol Lett. 2003;144:371&#x2013;381.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12927354</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Shea
        SH, Schwarz J, Kosyk O, Ross PK, Ha MJ, Wright FA, Rusyn I. In vitro screening
        for population variability in chemical toxicity. Toxicol Sci. 2011;119:398&#x2013;407.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC3023564</ArticleId><ArticleId IdType="pubmed">20952501</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Soames AR, Roberts RA. Suppression of hepatocyte apoptosis and induction
        of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate
        (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB) Arch Toxicol.
        1998;72:784&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">9950075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim
        IY, Han SY, Moon A. Phthalates inhibit tamoxifen-induced apoptosis in MCF-7
        human breast cancer cells. J Toxicol Environ Health A. 2004;67:2025&#x2013;2035.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15513900</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinasso
        G, Maggiora M, Trombetta A, Canuto RA, Muzio G. Effects of di(2-ethylhexyl)
        phthalate, a widely used peroxisome proliferator and plasticizer, on cell
        growth in the human keratinocyte cell line NCTC 2544. J Toxicol Environ Health
        A. 2006;69:353&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">16455614</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Peters JM, Cunningham ML. Modes of action and species-specific effects
        of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol. 2006;36:459&#x2013;479.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2614359</ArticleId><ArticleId IdType="pubmed">16954067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake
        BG, Kozlen SL, Evans JG, Gray TJ, Young PJ, Gangolli SD. Effect of prolonged
        administration of clofibric acid and di-(2- ethylhexyl)phthalate on hepatic
        enzyme activities and lipid peroxidation in the rat. Toxicology. 1987;44:213&#x2013;228.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3564055</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattley
        RC, Conway JG, Popp JA. Association of persistent peroxisome proliferation
        and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate
        for 2 years. Cancer Lett. 1987;38:15&#x2013;22.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3690505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinton
        RH, Mitchell FE, Mann A, Chescoe D, Price SC, Nunn A, Grasso P, Bridges JW.
        Effects of phthalic acid esters on the liver and thyroid. Environ Health Perspect.
        1986;70:195&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1474287</ArticleId><ArticleId
        IdType="pubmed">3830106</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway
        JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, Popp JA. Relationship
        of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators
        di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis. 1989;10:513&#x2013;519.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2924396</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo
        KW, Kim KB, Kim YJ, Choi JY, Lee KT, Choi KS. Comparison of oxidative stress
        and changes of xenobiotic metabolizing enzymes induced by phthalates in rats.
        Food Chem Toxicol. 2004;42:107&#x2013;114.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14630134</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi
        A, Sai K, Umemura T, Hasegawa R, Kurokawa Y. Significant increase of 8-hydroxydeoxyguanosine
        in liver DNA of rats following short-term exposure to the peroxisome proliferators
        di(2- ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn J Cancer Res.
        1990;81:213&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5918022</ArticleId><ArticleId
        IdType="pubmed">2112523</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi
        A, Sai K, Umemura T, Hasegawa R, Kurokawa Y. Relationship between hepatic
        peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA
        of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl)
        phthalate, aluminium clofibrate and simfibrate. Cancer Lett. 1990;53:33&#x2013;38.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2397479</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Kadiiska MB, Dikalova A, Kono H, Yin M, Tsuchiya K, Mason RP, Peters JM,
        Gonzalez FJ, Segal BH, Holland SM, Thurman RG. Phthalates rapidly increase
        production of reactive oxygen species in vivo: role of Kupffer cells. Mol
        Pharmacol. 2001;59:744&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pubmed">11259618</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods
        CG, Burns AM, Maki A, Bradford BU, Cunningham ML, Connor HD, Kadiiska MB,
        Mason RP, Peters JM, Rusyn I. Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone
        radical adducts in mouse liver by peroxisome proliferators is dependent upon
        peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase. Free
        Radic Biol Med. 2007;42:335&#x2013;342.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1829322</ArticleId><ArticleId IdType="pubmed">17210446</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell
        CL, Swenberg JA, Rusyn I. Expression of base excision DNA repair genes as
        a biomarker of oxidative DNA damage. Cancer Lett. 2005;229:1&#x2013;11.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16157213</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Denissenko MF, Wong VA, Butterworth BE, Cunningham ML, Upton PB, Thurman
        RG, Swenberg JA. Expression of base excision repair enzymes in rat and mouse
        liver is induced by peroxisome proliferators and is dependent upon carcinogenic
        potency. Carcinogenesis. 2000;21:2141&#x2013;2145.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11133801</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Asakura S, Pachkowski B, Bradford BU, Denissenko MF, Peters JM, Holland
        SM, Reddy JK, Cunningham ML, Swenberg JA. Expression of base excision DNA
        repair genes is a sensitive biomarker for in vivo detection of chemical-induced
        chronic oxidative stress: Identification of the molecular source of radicals
        responsible for DNA damage by peroxisome proliferators. Cancer Res. 2004;64:1050&#x2013;1057.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14871837</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaszewski
        KE, Heindel SW, Jenkins WL, Melnick RL. Induction of peroxisomal acyl CoA
        oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
        Toxicology. 1990;65:49&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">2274969</ArticleId></ArticleIdList></Reference><Reference><Citation>Isenberg
        JS, Kamendulis LM, Smith JH, Ackley DC, Pugh G, Jr, Lington AW, Klaunig JE.
        Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular
        communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX)
        in rat, mouse, and hamster liver. Toxicol Sci. 2000;56:73&#x2013;85.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10869455</ArticleId></ArticleIdList></Reference><Reference><Citation>Isenberg
        JS, Kamendulis LM, Ackley DC, Smith JH, Pugh G, Jr, Lington AW, McKee RH,
        Klaunig JE. Reversibility and persistence of di-2-ethylhexyl phthalate (DEHP)-
        and phenobarbital-induced hepatocellular changes in rodents. Toxicol Sci.
        2001;64:192&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">11719701</ArticleId></ArticleIdList></Reference><Reference><Citation>Malcolm
        AR, Mills LJ. Inhibition of gap-junctional intercellular communication between
        Chinese hamster lung fibroblasts by di(2-ethylhexyl) phthalate (DEHP) and
        trisodium nitrilotriacetate monohydrate (NTA) Cell Biol Toxicol. 1989;5:145&#x2013;153.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">2766028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikalsen
        SO, Sanner T. Intercellular communication in colonies of Syrian hamster embryo
        cells and the susceptibility for morphological transformation. Carcinogenesis.
        1993;14:251&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">8435866</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruciani
        V, Mikalsen SO, Vasseur P, Sanner T. Effects of peroxisome proliferators and
        12-O-tetradecanoyl phorbol-13-acetate on intercellular communication and connexin43
        in two hamster fibroblast systems. Int J Cancer. 1997;73:240&#x2013;248.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9335450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamendulis
        LM, Isenberg JS, Smith JH, Pugh G, Jr, Lington AW, Klaunig JE. Comparative
        effects of phthalate monoesters on gap junctional intercellular communication
        and peroxisome proliferation in rodent and primate hepatocytes. J Toxicol
        Environ Health A. 2002;65:569&#x2013;588.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11995694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Rivera CA, Bradford BU, Graves LM, Cattley RC, Schoonhoven R, Swenberg
        JA, Thurman RG. Kupffer cell oxidant production is central to the mechanism
        of peroxisome proliferators. Carcinogenesis. 1999;20:27&#x2013;33.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9934846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose
        ML, Rusyn I, Bojes HK, Germolec DR, Luster M, Thurman RG. Role of Kupffer
        cells in peroxisome proliferator-induced hepatocyte proliferation. Drug Metab
        Rev. 1999;31:87&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">10065367</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusyn
        I, Rose ML, Bojes HK, Thurman RG. Novel role of oxidants in the molecular
        mechanism of action of peroxisome proliferators. Antiox Redox Signal. 2000;2:607&#x2013;621.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11229371</ArticleId></ArticleIdList></Reference><Reference><Citation>Flavell
        DM, Pineda T, Jamshidi IY, Evans D, Diamond JR, Elkeles RS, Bujac SR, Miller
        G, Talmud PJ, Staels B, Humphries SE. Variation in the PPARalpha gene is associated
        with altered function in vitro and plasma lipid concentrations in Type II
        diabetic subjects. Diabetologia. 2000;43:673&#x2013;680.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10855543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacquemant
        C, Lepretre F, Pineda T, Manraj IM, Charpentier G, Ruiz J, Staels B, Froguel
        P. Mutation screening of the PPARalpha gene in type 2 diabetes associated
        with coronary heart disease. Diabetes Metab. 2000;26:393&#x2013;401.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11119019</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai
        ES, Demissie S, Cupples LA, Corella D, Wilson PW, Schaefer EJ, Ordovas JM.
        Association between the PPARA L162V polymorphism and plasma lipid levels:
        the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2002;22:805&#x2013;810.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12006394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapone
        A, Peters JM, Sakai S, Tomita S, Papiha SS, Dai R, Friedman FK, Gonzalez FJ.
        The human peroxisome proliferator-activated receptor alpha gene: identification
        and functional characterization of two natural allelic variants. Pharmacogenetics.
        2000;10:321&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">10862523</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa-Kobayashi
        K, Ishiguro H, Arinami T, Miyazaki R, Hamaguchi H. A Val227Ala polymorphism
        in the peroxisome proliferator activated receptor alpha (PPARalpha) gene is
        associated with variations in serum lipid levels. J Med Genet. 2002;39:189&#x2013;191.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1735067</ArticleId><ArticleId IdType="pubmed">11897821</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan
        E, Tan CS, Deurenberg-Yap M, Chia KS, Chew SK, Tai ES. The V227A polymorphism
        at the PPARA locus is associated with serum lipid concentrations and modulates
        the association between dietary polyunsaturated fatty acid intake and serum
        high density lipoprotein concentrations in Chinese women. Atherosclerosis.
        2006;187:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16288935</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu
        MH, Li J, Shen P, Husna B, Tai ES, Yong EL. A natural polymorphism in peroxisome
        proliferator-activated receptor-alpha hinge region attenuates transcription
        due to defective release of nuclear receptor corepressor from chromatin. Mol
        Endocrinol. 2008;22:1078&#x2013;1092.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC5419521</ArticleId><ArticleId IdType="pubmed">18292238</ArticleId></ArticleIdList></Reference><Reference><Citation>James
        NH, Gill JH, Brindle R, Woodyatt NJ, Macdonald N, Rolfe M, Hasmall SC, Tugwood
        JD, Holden PR, Roberts RA. Peroxisome proliferator-activated receptor (PPAR)
        a-regulated growth responses and their importance to hepatocarcinogenesis.
        Toxicol Lett. 1998;102&#x2013;103:91&#x2013;96.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10022238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyche
        JL, Gutleb AC, Bergman A, Eriksen GS, Murk AJ, Ropstad E, Saunders M, Skaare
        JU. Reproductive and developmental toxicity of phthalates. J Toxicol Environ
        Health B Crit Rev. 2009;12:225&#x2013;249.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20183522</ArticleId></ArticleIdList></Reference><Reference><Citation>Toppari
        J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as
        a sign of testicular dysgenesis syndrome (TDS): environmental connection.
        Birth Defects Res A Clin Mol Teratol. 2010;88:910&#x2013;919.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20865786</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathyanarayana
        S. Phthalates and children&#x2019;s health. Curr Prob Pediatr Adolesc Health
        Care. 2008;38:34&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">18237855</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanini
        S, Serafini B, Nardacci R, Vecchioli SF, Moreno S, Sartori C. Morphometric
        analysis of liver and kidney peroxisomes in lactating rats and their pups
        after treatment with the peroxisomal proliferator di-(2-ethylhexyl)phthalate.
        Biol Cell. 1995;85:167&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">8785518</ArticleId></ArticleIdList></Reference><Reference><Citation>Maranghi
        F, Lorenzetti S, Tassinari R, Moracci G, Tassinari V, Marcoccia D, Di Viglio
        A, Eusepi A, Romeo A, Magrelli A, Salvatore M, Tosto F, Viganotti M, Antoccia
        A, Di Masi A, Azzalin G, Tanzarella C, Macino G, Taruscio D, Mantovani A.
        In utero exposure to di-(2-ethylhexyl) phthalate affects liver morphology
        and metabolism in post-natal CD-1 mice. Reprod Toxicol. 2010;29:427&#x2013;432.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20307648</ArticleId></ArticleIdList></Reference><Reference><Citation>Pak
        VM, Nailon RE, McCauley LA. Controversy: neonatal exposure to plasticizers
        in the NICU. MCN Am J Matern Child Nurs. 2007;32:244&#x2013;249.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17667290</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaakkola
        JJ, Knight TL. The role of exposure to phthalates from polyvinyl chloride
        products in the development of asthma and allergies: a systematic review and
        meta-analysis. Environ Health Perspect. 2008;116:845&#x2013;853.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2453150</ArticleId><ArticleId IdType="pubmed">18629304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppin
        JA, Ulmer R, London SJ. Phthalate exposure and pulmonary function. Environ
        Health Perspect. 2004;112:571&#x2013;574.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1241923</ArticleId><ArticleId IdType="pubmed">15064163</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimisch
        HJ, Gamer AO, Hellwig J, Kaufmann W, Jackh R. Di-(2-ethylhexyl) phthalate:
        a short-term repeated inhalation toxicity study including fertility assessment.
        Food Chem Toxicol. 1992;30:915&#x2013;919.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1473784</ArticleId></ArticleIdList></Reference><Reference><Citation>Doelman
        CJ, Borm PJ, Bast A. Plasticisers and bronchial hyperreactivity. Lancet. 1990;335:725.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1969080</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan
        G, Hanaoka T, Yoshimura M, Zhang S, Wang P, Tsukino H, Inoue K, Nakazawa H,
        Tsugane S, Takahashi K. Decreased serum free testosterone in workers exposed
        to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate
        (DEHP): a cross-sectional study in China. Environ Health Perspect. 2006;114:1643&#x2013;1648.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1665432</ArticleId><ArticleId IdType="pubmed">17107847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozati
        R, Reddy PP, Reddanna P, Mujtaba R. Role of environmental estrogens in the
        deterioration of male factor fertility. Fertil Steril. 2002;78:1187&#x2013;1194.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12477510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang
        YH, Zheng LX, Chen BH. Phthalate exposure and human semen quality in Shanghai:
        a cross-sectional study. Biomed Environ Sci. 2006;19:205&#x2013;209.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16944777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser
        R, Meeker JD, Singh NP, Silva MJ, Ryan L, Duty S, Calafat AM. DNA damage in
        human sperm is related to urinary levels of phthalate monoester and oxidative
        metabolites. Hum Reprod. 2007;22:688&#x2013;695.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17090632</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeker
        JD, Calafat AM, Hauser R. Urinary metabolites of di(2-ethylhexyl) phthalate
        are associated with decreased steroid hormone levels in adult men. J Androl.
        2009;30:287&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772199</ArticleId><ArticleId
        IdType="pubmed">19059903</ArticleId></ArticleIdList></Reference><Reference><Citation>Colon
        I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the
        serum of young Puerto Rican girls with premature breast development. Environ
        Health Perspect. 2000;108:895&#x2013;900.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2556932</ArticleId><ArticleId IdType="pubmed">11017896</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobellis
        L, Latini G, De Felice C, Razzi S, Paris I, Ruggieri F, Mazzeo P, Petraglia
        F. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with
        endometriosis. Hum Reprod. 2003;18:1512&#x2013;1515.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12832380</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        BS, Rozati R, Reddy BV, Raman NV. Association of phthalate esters with endometriosis
        in Indian women. BJOG. 2006;113:515&#x2013;520.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16637895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim
        SH, Chun S, Jang JY, Chae HD, Kim CH, Kang BM. Increased plasma levels of
        phthalate esters in women with advanced-stage endometriosis: a prospective
        case-control study. Fertil Steril. 2011;95:357&#x2013;359.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">20797718</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon
        R, Lecavalier P, Mueller R, Valli VE, Procter BG, Chu I. Subchronic oral toxicity
        of di-n-octyl phthalate and di(2-Ethylhexyl) phthalate in the rat. Food Chem
        Toxicol. 1997;35:225&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">9146736</ArticleId></ArticleIdList></Reference><Reference><Citation>Howdeshell
        KL, Wilson VS, Furr J, Lambright CR, Rider CV, Blystone CR, Hotchkiss AK,
        Gray LE., Jr A mixture of five phthalate esters inhibits fetal testicular
        testosterone production in the sprague-dawley rat in a cumulative, dose-additive
        manner. Toxicol Sci. 2008;105:153&#x2013;165.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18411233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara
        M, Itoh M, Miyamoto K, Suna S, Takeuchi Y, Takenaka I, Jitsunari F. Spermatogenic
        disturbance induced by di-(2-ethylhexyl) phthalate is significantly prevented
        by treatment with antioxidant vitamins in the rat. Int J Androl. 2000;23:85&#x2013;94.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10762434</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffit
        JS, Bryant BH, Hall SJ, Boekelheide K. Dose-dependent effects of sertoli cell
        toxicants 2,5-hexanedione, carbendazim, and mono-(2-ethylhexyl) phthalate
        in adult rat testis. Toxicol Pathol. 2007;35:719&#x2013;727.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17763286</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahousse
        SA, Wallace DG, Liu D, Gaido KW, Johnson KJ. Testicular gene expression profiling
        following prepubertal rat mono-(2-ethylhexyl) phthalate exposure suggests
        a common initial genetic response at fetal and prepubertal ages. Toxicol Sci.
        2006;93:369&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">16809437</ArticleId></ArticleIdList></Reference><Reference><Citation>Richburg
        JH, Boekelheide K. Mono-(2-ethylhexyl) phthalate rapidly alters both Sertoli
        cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol
        Appl Pharmacol. 1996;137:42&#x2013;50.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8607140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge
        RS, Chen GR, Tanrikut C, Hardy MP. Phthalate ester toxicity in Leydig cells:
        developmental timing and dosage considerations. Reprod Toxicol. 2007;23:366&#x2013;373.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17258888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Diwan BA, Ohshima M, Hu H, Schuller HM, Rice JM. Tumor-initiating and
        promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. Environ
        Health Perspect. 1986;65:279&#x2013;291.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1474721</ArticleId><ArticleId IdType="pubmed">3709454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Konishi N, Diwan BA. Renal tubular cell or hepatocyte hyperplasia is not
        associated in B6C3F1 mice after transplacental initiation with N-nitrosoethylurea.
        Exp Pathol. 1990;40:138.</Citation><ArticleIdList><ArticleId IdType="pubmed">2097173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno
        S, Fujii Y, Usuda N, Murata F, Nagata T. Peroxisomal proliferation in rat
        kidney induced with DEHP. I. Numerical change by light microscopic morphometry.
        Acta Histochem Cytochem. 1982;15:40&#x2013;57.</Citation></Reference><Reference><Citation>Reubsaet
        FA, Veerkamp JH, Bruckwilder ML, Trijbels JM, Monnens LA. Peroxisomal oxidases
        and catalase in liver and kidney homogenates of normal and di(ethylhexyl)phthalate-fed
        rats. Int J Biochem. 1991;23:961&#x2013;967.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1773902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lington
        AW, Bird MG, Plutnick RT, Stubbefield WA, Scala RA. Chronic toxicity and carcinogenic
        evaluation of diisononyl phthalate in rats. Fundam Appl Toxicol. 1997;36:79&#x2013;89.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9073470</ArticleId></ArticleIdList></Reference><Reference><Citation>Jepsen
        KF, Abildtrup A, Larsen ST. Monophthalates promote IL-6 and IL-8 production
        in the human epithelial cell line A549. Toxicol In Vitro. 2004;18:265&#x2013;269.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15046772</ArticleId></ArticleIdList></Reference><Reference><Citation>Glue
        C, Millner A, Bodtger U, Jinquan T, Poulsen LK. In vitro effects of monophthalates
        on cytokine expression in the monocytic cell line THP-1 and in peripheral
        blood mononuclear cells from allergic and non-allergic donors. Toxicol In
        Vitro. 2002;16:657&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">12423647</ArticleId></ArticleIdList></Reference><Reference><Citation>Glue
        C, Platzer MH, Larsen ST, Nielsen GD, Skov PS, Poulsen LK. Phthalates potentiate
        the response of allergic effector cells. Basic Clin Pharmacol Toxicol. 2005;96:140&#x2013;142.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15679477</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen
        ST, Hansen JS, Thygesen P, Begtrup M, Poulsen OM, Nielsen GD. Adjuvant and
        immuno-suppressive effect of six monophthalates in a subcutaneous injection
        model with BALB/c mice. Toxicology. 2001;169:37&#x2013;51.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11696408</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen
        ST, Nielsen GD. The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated
        through a PPARalpha-independent mechanism. Toxicol Lett. 2007;170:223&#x2013;228.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17462839</ArticleId></ArticleIdList></Reference><Reference><Citation>Dearman
        RJ, Beresford L, Bailey L, Caddick HT, Betts CJ, Kimber I. Di-(2-ethylhexyl)
        phthalate is without adjuvant effect in mice on ovalbumin. Toxicology. 2008;244:231&#x2013;241.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18179854</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen
        ST, Hansen JS, Hammer M, Alarie Y, Nielsen GD. Effects of mono-2-ethylhexyl
        phthalate on the respiratory tract in BALB/c mice. Hum Exp Toxicol. 2004;23:537&#x2013;545.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15625780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bally
        MB, Opheim DJ, Shertzer HG. Di-(2-ethylhexyl) phthalate enhances the release
        of lysosomal enzymes from alveolar macrophages during phagocytosis. Toxicology.
        1980;18:49&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">7210023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura
        R, Teshima R, Sawada J. Effect of dialkyl phthalates on the degranulation
        and Ca2+ response of RBL-2H3 mast cells. Immunol Lett. 2002;80:119&#x2013;124.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11750043</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton
        JC, Lapinskas PJ, Gonzalez FJ. Central role of PPARalpha in the mechanism
        of action of hepatocarcinogenic peroxisome proliferators. Mutat Res. 2000;448:139&#x2013;151.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10725468</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy
        JK, Azarnoff DL, Hignite CE. Hypolipidaemic hepatic peroxisome proliferators
        form a novel class of chemical carcinogens. Nature. 1980;283:397&#x2013;398.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6766207</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsman
        DS, Goldsworthy TL, Popp JA. Contrasting hepatocytic peroxisome proliferation,
        lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643
        and clofibric acid. Carcinogenesis. 1992;13:1011&#x2013;1017.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1600604</ArticleId></ArticleIdList></Reference><Reference><Citation>International
        Agency for Research on Cancer. Some industrial chemicals. IARC Press; Lyon,
        France: 2000.</Citation></Reference><Reference><Citation>Peters JM, Cattley
        RC, Gonzalez FJ. Role of PPAR alpha in the mechanism of action of the nongenotoxic
        carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis. 1997;18:2029&#x2013;2033.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9395198</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosse
        Y, Baan R, Secretan-Lauby B, Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha
        N, Islami F, Galichet L, Straif K WHO International Agency for Research on
        Cancer Monograph Working Group. . Carcinogenicity of chemicals in industrial
        and consumer products, food contaminants and flavourings, and water chlorination
        byproducts. Lancet Oncol. 2011;12:328&#x2013;329.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">21598447</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6517701</PMID><DateCompleted><Year>1985</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0340-5761</ISSN><JournalIssue
        CitedMedium="Print"><Volume>55</Volume><Issue>4</Issue><PubDate><Year>1984</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>Factors
        influencing peroxisome proliferation in cultured rat hepatocytes.</ArticleTitle><Pagination><StartPage>239</StartPage><EndPage>246</EndPage><MedlinePgn>239-46</MedlinePgn></Pagination><Abstract><AbstractText>A
        primary rat hepatocyte culture system has been developed for the study of
        peroxisome proliferation. Maximal induction of peroxisomal activity requires
        supplementation of the culture medium with hydrocortisone. The addition of
        clofibric acid (0.01-1 mM), mono-(2-ethylhexyl)phthalate (0.01-0.5 mM) and
        trichloroacetic acid (0.1-5 mM) to cultured rat hepatocytes resulted in a
        time- and dose-related increase in CN- insensitive palmitoyl CoA oxidation
        (maximal increases: 27-, 15.5-, and 5-fold respectively) and mitochondrial
        alpha-glycerophosphate dehydrogenase activity (maximal increases: 7.3-, 5.8-,
        and 1.6-fold respectively). Electron microscopic examination revealed smooth
        endoplasmic reticulum proliferation and morphometric analysis indicated an
        increase in fractional peroxisomal volume of X 8 and X 4 for clofibric acid
        (1 mM) and trichloroacetic acid (2.5 mM), respectively. SDS-PAGE of cell homogenates
        revealed an intensified protein band of mol. wt. 76-78,000. The induction
        of peroxisomal beta-oxidation by clofibric acid was elevated from 9- to 12-fold
        by supplementation of the medium with L-carnitine (2 mM).</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>A
        M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Bridges</LastName><ForeName>J
        W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Elcombe</LastName><ForeName>C
        R</ForeName><Initials>CR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1763-10-6</RegistryNumber><NameOfSubstance
        UI="D010171">Palmitoyl Coenzyme A</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>5V2JDO056X</RegistryNumber><NameOfSubstance
        UI="D014238">Trichloroacetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.49</RegistryNumber><NameOfSubstance UI="D005954">Glucosephosphate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>S7UI8SM58A</RegistryNumber><NameOfSubstance
        UI="D002331">Carnitine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance
        UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002331" MajorTopicYN="N">Carnitine</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005954" MajorTopicYN="N">Glucosephosphate Dehydrogenase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010171" MajorTopicYN="N">Palmitoyl Coenzyme A</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014238" MajorTopicYN="N">Trichloroacetic Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6517701</ArticleId><ArticleId IdType="doi">10.1007/BF00341018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J
        Cell Biol. 1981 Dec;91(3 Pt 2):271s-283s</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7033240</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Pharmacol. 1979 Sep 15;28(18):2829-33</Citation><ArticleIdList><ArticleId
        IdType="pubmed">497031</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods
        Enzymol. 1981;72:315-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7031421</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1973 May 15;52(2):537-43</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4711169</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1983 Jan;67(1):15-25</Citation><ArticleIdList><ArticleId IdType="pubmed">6845354</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1959 Nov;234:3051-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14415220</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1975 Nov;72(11):4385-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">1060116</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1980 Mar 13;93(1):179-85</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6769436</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1979 Sep;39(9):3419-28</Citation><ArticleIdList><ArticleId IdType="pubmed">582575</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Physiol. 1962 Jan;202:117-21</Citation><ArticleIdList><ArticleId IdType="pubmed">13895427</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1965 Mar;240:1427-36</Citation><ArticleIdList><ArticleId IdType="pubmed">14284758</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1969 Jul;42(1):68-91</Citation><ArticleIdList><ArticleId IdType="pubmed">4891915</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol
        Rev. 1966 Apr;46(2):323-57</Citation><ArticleIdList><ArticleId IdType="pubmed">5325972</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Natl Cancer Inst. 1977 Dec;59(6):1645-50</Citation><ArticleIdList><ArticleId
        IdType="pubmed">200757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann
        N Y Acad Sci. 1982;386:81-110</Citation><ArticleIdList><ArticleId IdType="pubmed">7046570</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Mol Biol. 1973 Nov 15;80(4):575-99</Citation><ArticleIdList><ArticleId IdType="pubmed">4204102</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Lett. 1982 Feb;10(2-3):273-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7080097</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1979 Jun 13;88(3):1030-6</Citation><ArticleIdList><ArticleId
        IdType="pubmed">465070</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1973 May 25;248(10):3426-32</Citation><ArticleIdList><ArticleId
        IdType="pubmed">4702872</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1976 Nov 2;448(4):562-77</Citation><ArticleIdList><ArticleId
        IdType="pubmed">974147</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1980 Mar 21;617(3):363-70</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7370283</ArticleId></ArticleIdList></Reference><Reference><Citation>Br
        J Cancer. 1979 Sep;40(3):476-82</Citation><ArticleIdList><ArticleId IdType="pubmed">508572</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1980 Jan 24;283(5745):397-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6766207</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1965 Nov 27;208(5013):856-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5870099</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Pharmacol. 1977 Sep 15;26(18):1697-702</Citation><ArticleIdList><ArticleId
        IdType="pubmed">901588</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1975 May;32(2):355-67</Citation><ArticleIdList><ArticleId
        IdType="pubmed">168667</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem
        Biophys Res Commun. 1977 Aug 8;77(3):824-9</Citation><ArticleIdList><ArticleId
        IdType="pubmed">901515</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1975 Nov 21;190(4216):787-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1198095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lab
        Invest. 1982 Jul;47(1):19-26</Citation><ArticleIdList><ArticleId IdType="pubmed">7087394</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1980 Jan;40(1):36-41</Citation><ArticleIdList><ArticleId IdType="pubmed">6765917</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1951 Nov;193(1):265-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14907713</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol
        Rev. 1977 Oct;57(4):816-82</Citation><ArticleIdList><ArticleId IdType="pubmed">333482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppe
        Seylers Z Physiol Chem. 1976 Apr;357(4):573-84</Citation><ArticleIdList><ArticleId
        IdType="pubmed">964917</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biochem. 1981 Dec;90(6):1691-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7334004</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30384071</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>28</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6424</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>244</Volume><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Environmental
        pollution (Barking, Essex : 1987)</Title><ISOAbbreviation>Environ Pollut</ISOAbbreviation></Journal><ArticleTitle>Pubertal
        exposure to the endocrine disruptor mono-2-ethylhexyl ester at body burden
        level caused cholesterol imbalance in mice.</ArticleTitle><Pagination><StartPage>657</StartPage><EndPage>666</EndPage><MedlinePgn>657-666</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1016/j.envpol.2018.08.091</ELocationID><ELocationID
        EIdType="pii" ValidYN="Y">S0269-7491(18)32153-5</ELocationID><Abstract><AbstractText>Metabolic
        disturbance is the prerequisite to developing metabolic disease. An increasing
        number of reports have shown that exposure to environmental endocrine-disrupting
        chemicals (EDCs) can cause metabolic syndrome and may be related to metabolic
        disease. However, the potential mechanism of EDC-related lipid metabolism
        disruption in the endocrine organs (especially gut microbiome) during pubertal
        exposure remains elusive at the body burden level. We observed that male mice
        fed with 0.05&#x202f;mg/kg b.w. MEHP under a high-fat diet caused enhancement
        in the fat mass, total cholesterol, high- and low-density lipoprotein cholesterol.
        MEHP intake induced a significant shift in microbiota composition, including
        the relative abundance of Firmicutes and reduction of Verrucomicrobia. Statistical
        analysis showed a positive correlation between several bacterial taxa and
        cholesterol body burden. Also, MEHP intake induced adipocyte hypertrophy and
        cholesterol overloading, which sense cholesterol synthesis genes such as Srebp2
        and Hmgcr. That caused adipocyte dysfunction. Finally, cholesterol deposition
        and transportation was imbalance in the mice liver. Conclusively, by targeting
        the endocrine organs, EDCs would increase the risk of cholesterol burden even
        at a low concentration when coupled with a high-fat diet during pubertal period
        in male mice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018. Published
        by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Wang</LastName><ForeName>Cui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College
        of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Yue</LastName><ForeName>Siqing</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College
        of Environment, Zhejiang University of Technology, Hangzhou, 310032, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Hao</LastName><ForeName>Zhengliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College
        of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Ren</LastName><ForeName>Guangyan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>College
        of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lu</LastName><ForeName>Dezhao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College
        of Life Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College
        of Environment, Zhejiang University of Technology, Hangzhou, 310032, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhao</LastName><ForeName>Meirong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College
        of Environment, Zhejiang University of Technology, Hangzhou, 310032, China.
        Electronic address: Zhaomr@zjut.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Environ
        Pollut</MedlineTA><NlmUniqueID>8804476</NlmUniqueID><ISSNLinking>0269-7491</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008076">Cholesterol, HDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D052244">Endocrine Disruptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="C497391">Srebf2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D051782">Sterol Regulatory Element Binding Protein 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>16501-01-2</RegistryNumber><NameOfSubstance
        UI="C041141">mono(2-methoxyethyl) phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.1.1.-</RegistryNumber><NameOfSubstance UI="D006903">Hydroxymethylglutaryl
        CoA Reductases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D017667" MajorTopicYN="N">Adipocytes</DescriptorName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001822" MajorTopicYN="N">Body Burden</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008076" MajorTopicYN="N">Cholesterol, HDL</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008078" MajorTopicYN="N">Cholesterol, LDL</DescriptorName><QualifierName
        UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D059305" MajorTopicYN="N">Diet, High-Fat</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D052244" MajorTopicYN="N">Endocrine Disruptors</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000068536" MajorTopicYN="N">Firmicutes</DescriptorName><QualifierName
        UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006903" MajorTopicYN="N">Hydroxymethylglutaryl CoA Reductases</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051782" MajorTopicYN="N">Sterol Regulatory Element Binding Protein 2</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D061327" MajorTopicYN="N">Verrucomicrobia</DescriptorName><QualifierName
        UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading></MeshHeadingList><KeywordList
        Owner="NOTNLM"><Keyword MajorTopicYN="N">Body burden level</Keyword><Keyword
        MajorTopicYN="N">Cholesterol accumulation</Keyword><Keyword MajorTopicYN="N">Gut
        microbiome</Keyword><Keyword MajorTopicYN="N">MEHP</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2018</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">30384071</ArticleId><ArticleId IdType="doi">10.1016/j.envpol.2018.08.091</ArticleId><ArticleId
        IdType="pii">S0269-7491(18)32153-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12036039</PMID><DateCompleted><Year>2002</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0916-8451</ISSN><JournalIssue
        CitedMedium="Print"><Volume>66</Volume><Issue>4</Issue><PubDate><Year>2002</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Bioscience,
        biotechnology, and biochemistry</Title><ISOAbbreviation>Biosci Biotechnol
        Biochem</ISOAbbreviation></Journal><ArticleTitle>Elucidation of the toxic
        mechanism of the plasticizers, phthalic acid esters, putative endocrine disrupters:
        effects of dietary di(2-ethylhexyl)phthalate on the metabolism of tryptophan
        to niacin in rats.</ArticleTitle><Pagination><StartPage>705</StartPage><EndPage>710</EndPage><MedlinePgn>705-10</MedlinePgn></Pagination><Abstract><AbstractText>We
        have previously reported that the administration of a large amount of di(n-butyl)phthalate
        (DBP) increased the conversion ratio of tryptophan to niacin in rats. In the
        present experiment, the effect of di(2-ethylhexyl)phthalate (DEHP) on the
        conversion ratio and how altering the conversion ratio of tryptophan to niacin
        depended on the concentration of DEHP were investigated to elucidate the toxic
        mechanism of phthalic acid esters (PhE). Rats were fed with a diet containing
        0%, 0.01%, 0.05%, 0.1%, 0.5%, 1.0%, or 3.0% DEHP for 21 days. To assess the
        conversion ratio of tryptophan to niacin, urine samples were collected at
        the last day of the experiment and measured for metabolites on the tryptophan-niacin
        pathway. The conversion ratio increased with increasing dietary concentration
        of DEHP above 0.05%; the conversion ratio was about 2% in the control group,
        whereas it was 28% in the 3.0% DEHP group. It is suggested that the inhibition
        of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD)
        by DEHP or its metabolites caused this increase in the conversion ratio. We
        conclude that PhE such as DEHP and DBP disturbed the tryptophan-niacin metabolism.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Fukuwatari</LastName><ForeName>Tsutomu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department
        of Life Style Studies, School of Human Cultures, The University of Shiga Prefecture,
        Hikone, Japan. fukkie@shc.usp.ac.jp</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Sugimoto</LastName><ForeName>Etsuro</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Shibata</LastName><ForeName>Katsumi</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biosci
        Biotechnol Biochem</MedlineTA><NlmUniqueID>9205717</NlmUniqueID><ISSNLinking>0916-8451</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0U46U6E8UK</RegistryNumber><NameOfSubstance
        UI="D009243">NAD</NameOfSubstance></Chemical><Chemical><RegistryNumber>2679MF687A</RegistryNumber><NameOfSubstance
        UI="D009525">Niacin</NameOfSubstance></Chemical><Chemical><RegistryNumber>53-59-8</RegistryNumber><NameOfSubstance
        UI="D009249">NADP</NameOfSubstance></Chemical><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance
        UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002149" MajorTopicYN="N">Energy Intake</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000033"
        MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009243" MajorTopicYN="N">NAD</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009249" MajorTopicYN="N">NADP</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009525" MajorTopicYN="N">Niacin</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>5</Month><Day>31</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>11</Month><Day>26</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>5</Month><Day>31</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12036039</ArticleId><ArticleId IdType="doi">10.1271/bbb.66.705</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3802057</PMID><DateCompleted><Year>1987</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0304-3835</ISSN><JournalIssue
        CitedMedium="Print"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>1986</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cancer
        letters</Title><ISOAbbreviation>Cancer Lett</ISOAbbreviation></Journal><ArticleTitle>Effect
        of peroxisome proliferator carcinogens on unscheduled DNA synthesis in rat
        hepatocytes determined by autoradiography.</ArticleTitle><Pagination><StartPage>269</StartPage><EndPage>277</EndPage><MedlinePgn>269-77</MedlinePgn></Pagination><Abstract><AbstractText>The
        potent peroxisome proliferator hepatocarcinogens WY-14,643, BR-931, and nafenopin,
        as well as mono(ethylhexyl)phthalate (MEHP), the principle metabolite of the
        weaker hepatocarcinogen di(2-ethylhexyl)phthalate) (DEHP), were evaluated
        in the in vitro rat hepatocyte DNA repair assay by quantitative autoradiography.
        None of these carcinogens induced unscheduled DNA synthesis (UDS). These results
        failed to confirm the previously reported induction of UDS by WY-14,643 and
        BR-931 as determined by nuclear liquid scintillation counting. Hydroxyurea
        (HU, 10 mM) is commonly employed to inhibit replicative DNA synthesis (RDS)
        when using scintillation counting techniques for UDS. Autoradiographs revealed
        incomplete inhibition of RDS by HU.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author
        ValidYN="Y"><LastName>Richardson</LastName><ForeName>K K</ForeName><Initials>KK</Initials></Author><Author
        ValidYN="Y"><LastName>Smith-Oliver</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author
        ValidYN="Y"><LastName>Butterworth</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 07945</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES
        07017</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Cancer
        Lett</MedlineTA><NlmUniqueID>7600053</NlmUniqueID><ISSNLinking>0304-3835</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>969LVT6GJ2</RegistryNumber><NameOfSubstance
        UI="C016908">pirinixil</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001345" MajorTopicYN="N">Autoradiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="Y">Carcinogens</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3802057</ArticleId><ArticleId IdType="doi">10.1016/0304-3835(86)90066-2</ArticleId><ArticleId
        IdType="pii">0304-3835(86)90066-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12851149</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1091-5818</ISSN><JournalIssue
        CitedMedium="Print"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>International
        journal of toxicology</Title><ISOAbbreviation>Int J Toxicol</ISOAbbreviation></Journal><ArticleTitle>Evaluation
        of reproductive development following intravenous and oral exposure to DEHP
        in male neonatal rats.</ArticleTitle><Pagination><StartPage>159</StartPage><EndPage>174</EndPage><MedlinePgn>159-74</MedlinePgn></Pagination><Abstract><AbstractText>Di-(2-ethylhexyl)phthalate
        (DEHP) was administered to 3- to 5-day-old male Sprague-Dawley rats by daily
        intravenous injections of 60, 300, or 600 mg/kg/day or by daily oral gavage
        of 300 or 600 mg/kg/day for 21 days. Histopathological evaluation and organ
        weight measurements were performed on some animals after 21 days of dosing
        (primary group) and later on the recovery group animals that were held without
        further treatment until sexual maturity at approximately 90 days of age. No
        effects of any type were observed in animals treated intravenously with 60
        mg/kg/day. Testicular changes, consisting of a partial depletion of the germinal
        epithelium and/or decrease in diameter of seminiferous tubules, were present
        in all animals of the 300- and 600-mg/kg/day groups after the 21-day dosing
        period. Testes weight decreased and liver weight increased in these animals.
        Testes changes were dose-related and generally more severe among animals dosed
        orally versus intravenously. In the recovery animals, a residual DEHP-induced
        decrease in seminiferous tubule diameter was present in the testis of several
        animals dosed orally at 300 and 600 mg/kg/day, but not in animals dosed intravenously.
        There was no germinal cell depletion or Sertoli cell alteration observed in
        any dose group at any time. Notably, no effects on sperm count, sperm morphology,
        or sperm motility were observed at 90 days of age in any of the groups.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Cammack</LastName><ForeName>Jon
        N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Baxter Healthcare
        Corporation, Round Lake, Illinois 60073, USA. Jon_Cammack@baxter.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>White</LastName><ForeName>Randy D</ForeName><Initials>RD</Initials></Author><Author
        ValidYN="Y"><LastName>Gordon</LastName><ForeName>Donovan</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Gass</LastName><ForeName>Jerome</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Hecker</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Conine</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Bruen</LastName><ForeName>Uma Swamy</ForeName><Initials>US</Initials></Author><Author
        ValidYN="Y"><LastName>Friedman</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Echols</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Yeh</LastName><ForeName>Tony Y</ForeName><Initials>TY</Initials></Author><Author
        ValidYN="Y"><LastName>Wilson</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Int J Toxicol</MedlineTA><NlmUniqueID>9708436</NlmUniqueID><ISSNLinking>1091-5818</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012098" MajorTopicYN="N">Reproduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502"
        MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012671" MajorTopicYN="N">Seminiferous Tubules</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473"
        MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013081" MajorTopicYN="N">Sperm Motility</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013094" MajorTopicYN="N">Spermatozoa</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018675" MajorTopicYN="N">Toxicity Tests</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12851149</ArticleId><ArticleId IdType="doi">10.1080/10915810305098</ArticleId><ArticleId
        IdType="pii">1BBV71GG3TP83Q6G</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3173343</PMID><DateCompleted><Year>1988</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-8177</ISSN><JournalIssue
        CitedMedium="Print"><Volume>81</Volume><Issue>1</Issue><PubDate><Year>1988</Year><Month>May</Month></PubDate></JournalIssue><Title>Molecular
        and cellular biochemistry</Title><ISOAbbreviation>Mol Cell Biochem</ISOAbbreviation></Journal><ArticleTitle>Changes
        to the integral membrane protein composition of mouse liver peroxisomes in
        response to the peroxisome proliferators clofibrate, Wy-14,643 and di(2-ethyl-hexyl)phthalate.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>36</EndPage><MedlinePgn>29-36</MedlinePgn></Pagination><Abstract><AbstractText>Peroxisomes
        were purified from livers of control mice and from mice treated with three
        agents which induce proliferation of hepatic peroxisomes - namely two structurally
        unrelated hypolipidemic drugs, clofibrate (ethyl-alpha-p-chlorophenoxyisobutyrate)
        and Wy-14,643 (4-chloro-6[2,3-xylidino)-2-pyrimidinylthio]acetic acid), and
        a plasticizer, DEHP (di-(2-ethylhexyl)phthalate). Membranes were isolated
        from these purified peroxisomes and analysed by SDS-polyacrylamide gel electrophoresis.
        All membranes which were tested, displayed two predominant integral membrane
        proteins of apparent molecular weights of 68 kDa and 70 kDa respectively,
        as well as a number of minor components. Treatment of animals with clofibrate,
        Wy-14,643 and DEHP was observed to result in each case in an increased proportion
        of the 70 kDa protein in the peroxisomal membranes. These treatments also
        resulted in increased peroxisomal fatty acid oxidation in livers and an increase
        in the proportion of catalase activity in the cytosolic fraction of liver
        cells. These results have been discussed in relation to alterations in the
        molecular composition of the membranes, the mechanisms of peroxisome proliferation
        and the inducibility of peroxisomal membrane proteins.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Crane</LastName><ForeName>D I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>School
        of Science, Griffith University, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Chen</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Masters</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol
        Cell Biochem</MedlineTA><NlmUniqueID>0364456</NlmUniqueID><ISSNLinking>0300-8177</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3173343</ArticleId><ArticleId IdType="doi">10.1007/BF00225650</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature.
        1970 Aug 15;227(5259):680-5</Citation><ArticleIdList><ArticleId IdType="pubmed">5432063</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1983 Aug 17;763(1):72-82</Citation><ArticleIdList><ArticleId
        IdType="pubmed">6307393</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1975 Nov;67(2PT.1):281-309</Citation><ArticleIdList><ArticleId
        IdType="pubmed">406</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods
        Enzymol. 1981;72:315-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7031421</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1982 Jul 20;712(1):57-64</Citation><ArticleIdList><ArticleId
        IdType="pubmed">7115747</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch
        Biochem Biophys. 1987 May 15;255(1):109-19</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3592654</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1982 Apr;93(1):97-102</Citation><ArticleIdList><ArticleId IdType="pubmed">7068762</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1968 May;37(2):482-513</Citation><ArticleIdList><ArticleId IdType="pubmed">4297786</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biochem. 1978 May;83(5):1361-5</Citation><ArticleIdList><ArticleId IdType="pubmed">659402</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal
        Biochem. 1977 Dec;83(2):346-56</Citation><ArticleIdList><ArticleId IdType="pubmed">603028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Cell Biochem. 1984 Nov;65(1):73-82</Citation><ArticleIdList><ArticleId IdType="pubmed">6521730</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1982 Jan;42(1):259-66</Citation><ArticleIdList><ArticleId IdType="pubmed">7053853</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Cell Biol. 1982 Apr;93(1):103-10</Citation><ArticleIdList><ArticleId IdType="pubmed">7068748</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal
        Biochem. 1985 Aug 1;148(2):436-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3933379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1965 Nov 27;208(5013):856-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5870099</ArticleId></ArticleIdList></Reference><Reference><Citation>Am
        J Pathol. 1978 Feb;90(2):435-46</Citation><ArticleIdList><ArticleId IdType="pubmed">623209</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1986 Mar;83(6):1747-51</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3456610</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal
        Biochem. 1978 May;86(1):327-31</Citation><ArticleIdList><ArticleId IdType="pubmed">655394</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer
        Res. 1976 Apr;36(4):1211-7</Citation><ArticleIdList><ArticleId IdType="pubmed">177202</ArticleId></ArticleIdList></Reference><Reference><Citation>Science.
        1975 Nov 21;190(4216):787-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1198095</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim
        Biophys Acta. 1986 Apr 15;876(2):256-63</Citation><ArticleIdList><ArticleId
        IdType="pubmed">3955065</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc
        Natl Acad Sci U S A. 1976 Jun;73(6):2043-6</Citation><ArticleIdList><ArticleId
        IdType="pubmed">180535</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Biol Chem. 1974 Jan 25;249(2):634-44</Citation><ArticleIdList><ArticleId IdType="pubmed">4129205</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8209376</PMID><DateCompleted><Year>1994</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2012</Year><Month>11</Month><Day>15</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0041-008X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>126</Volume><Issue>2</Issue><PubDate><Year>1994</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Toxicology
        and applied pharmacology</Title><ISOAbbreviation>Toxicol Appl Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Peroxisomal
        proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in
        vivo.</ArticleTitle><Pagination><StartPage>233</StartPage><EndPage>239</EndPage><MedlinePgn>233-9</MedlinePgn></Pagination><Abstract><AbstractText>The
        mechanism by which hypolipidemic drugs and industrial plasticizers cause hepatic
        tumors in rodents remains unknown. It is known, however, that protein kinase
        C is elevated during hepatic cell turnover, and sustained cellular replication
        is correlated with an increased incidence of hepatic tumors. Therefore, several
        peroxisomal proliferators varying in their tumorigenic potency in chronic
        feeding studies were examined for their ability to increase protein kinase
        C activity. Intragastric administration of (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio)acetic
        acid (Wy-14,643; 100 mg/kg) increased protein kinase C activity threefold
        in 5 hr and fivefold in 10 hr. Perfluorooctanoate also increased protein kinase
        C activity significantly in microsomes at 5 hr. Wy-14,643 and perfluorooctanoate
        also diminished acyl CoA synthetase activity significantly, with Wy-14,643
        exhibiting competitive type kinetics. Other peroxisomal proliferators were
        examined [e.g., ciprofibrate, clofibrate, 2-ethylhexanol, valproate, and di(ethylhexyl)phthalate
        (DEHP)] and collectively an inverse relationship between their ability to
        stimulate protein kinase C activity and inhibit acyl CoA synthetase was observed
        (r = -0.80). All chemicals examined had no direct effect on protein kinase
        C activity in vitro. Interestingly, those compounds which are more potent
        as hepatocarcinogens (e.g., Wy-14,643) in long-term feeding studies decreased
        acyl CoA synthetase and elevated protein kinase C activity to a greater extent
        than their weaker counterparts (e.g., DEHP). It is proposed that inhibition
        of acyl CoA synthetase by peroxisomal proliferators elevates free fatty acids
        which stimulate protein kinase C activity and ultimately promote tumor formation.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Bojes</LastName><ForeName>H K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department
        of Pharmacology, University of North Carolina at Chapel Hill 27599-7365.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Thurman</LastName><ForeName>R G</ForeName><Initials>RG</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>NIEHS 5T32 ES-071260</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NIEHS
        ES-04325</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United
        States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Appl Pharmacol</MedlineTA><NlmUniqueID>0416575</NlmUniqueID><ISSNLinking>0041-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012097">Repressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D029701">Saccharomyces cerevisiae Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.6</RegistryNumber><NameOfSubstance UI="D042962">Acyl-CoA Oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        6.2.1.-</RegistryNumber><NameOfSubstance UI="D003066">Coenzyme A Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        6.2.1.3</RegistryNumber><NameOfSubstance UI="C090799">FAA2 protein, S cerevisiae</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        6.2.1.3</RegistryNumber><NameOfSubstance UI="C019143">long-chain-fatty-acid-CoA
        ligase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D042962" MajorTopicYN="N">Acyl-CoA Oxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003066" MajorTopicYN="N">Coenzyme A Ligases</DescriptorName><QualifierName
        UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug
        effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012097" MajorTopicYN="Y">Repressor Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D029701" MajorTopicYN="Y">Saccharomyces cerevisiae Proteins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1994</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1994</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1994</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8209376</ArticleId><ArticleId IdType="doi">10.1006/taap.1994.1112</ArticleId><ArticleId
        IdType="pii">S0041-008X(84)71112-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">20954081</PMID><DateCompleted><Year>2010</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1528-7394</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>73</Volume><Issue>21-22</Issue><PubDate><Year>2010</Year></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health. Part A</Title><ISOAbbreviation>J Toxicol
        Environ Health A</ISOAbbreviation></Journal><ArticleTitle>Functional role
        of phospholipase D (PLD) in di(2-ethylhexyl) phthalate-induced hepatotoxicity
        in Sprague-Dawley rats.</ArticleTitle><Pagination><StartPage>1560</StartPage><EndPage>1569</EndPage><MedlinePgn>1560-9</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1080/15287394.2010.511582</ELocationID><Abstract><AbstractText>Phospholipase
        D (PLD) is an enzyme that catalyzes the hydrolysis of phosphatidyl choline
        (PC) to generate phosphatidic acid (PA) and choline. PLD is believed to play
        an important role in cell proliferation, survival signaling, cell transformation,
        and tumor progression. However, it remains to be determined whether enhanced
        expression of PLD in liver is sufficient to induce hepatotoxicity. The aim
        of this study was to investigate the possible role of PLD in di(2-ethylhexyl)
        phthalate (DEHP)-induced hepatotoxicity in Sprague-Dawley rats. The phthalate,
        DEHP (500 mg/kg/d), was administered orally, daily to prepubertal rats (4
        wk of age, weighing approximately 70-90 g) for 1, 7, or 28 d. In this study,
        protein expression levels of PLD1/2, peroxisome proliferator-activated receptor
        (PPAR), and cytochrome P-450 (CYP) were determined by Western blot analysis
        using specific antibodies. Liver weight was significantly increased in the
        DEHP treatment groups. Immunohistochemical analysis demonstrated that DEHP
        produced strong staining of proliferating cell nuclear antigen (PCNA) at 28
        d of exposure, suggestive of hepatocyte proliferation. A significant rise
        in PLD1/2 expression was observed in liver of DEHP-exposed rats after 7 d.
        Further, PPAR&#x3b1;, constitutive androstane receptor (CAR), pregnane X receptor
        (PXR), and CYP2B1 protein expression levels were markedly elevated in DEHP-treated
        groups. Our results suggest that DEHP significantly enhanced the expression
        of PLD, which may be correlated with PPAR&#x3b1;-induced hepatotoxicity through
        a complex interaction with nuclear receptors including CAR and PXR.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Na Young</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Laboratory
        of Molecular Toxicology, College of Pharmacy, Pusan National University, Busan,
        South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae
        Hyung</ForeName><Initials>TH</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ena</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Patra</LastName><ForeName>Nabanita</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Lee</LastName><ForeName>Jaewon</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Shin</LastName><ForeName>Mi Ok</ForeName><Initials>MO</Initials></Author><Author
        ValidYN="Y"><LastName>Kwack</LastName><ForeName>Seung Jun</ForeName><Initials>SJ</Initials></Author><Author
        ValidYN="Y"><LastName>Park</LastName><ForeName>Kui Lea</ForeName><Initials>KL</Initials></Author><Author
        ValidYN="Y"><LastName>Han</LastName><ForeName>Soon Young</ForeName><Initials>SY</Initials></Author><Author
        ValidYN="Y"><LastName>Kang</LastName><ForeName>Tae Seok</ForeName><Initials>TS</Initials></Author><Author
        ValidYN="Y"><LastName>Kim</LastName><ForeName>Seung Hee</ForeName><Initials>SH</Initials></Author><Author
        ValidYN="Y"><LastName>Lee</LastName><ForeName>Byung Mu</ForeName><Initials>BM</Initials></Author><Author
        ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyung Sik</ForeName><Initials>HS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Toxicol Environ Health A</MedlineTA><NlmUniqueID>100960995</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047492">Peroxisome Proliferator-Activated Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018809">Proliferating Cell Nuclear Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.24</RegistryNumber><NameOfSubstance UI="D019950">Mitogen-Activated
        Protein Kinase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.24</RegistryNumber><NameOfSubstance UI="D048052">Mitogen-Activated
        Protein Kinase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.4.4</RegistryNumber><NameOfSubstance UI="D010739">Phospholipase D</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.4.4</RegistryNumber><NameOfSubstance UI="C106801">phospholipase D1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName
        UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000209"
        MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019950" MajorTopicYN="N">Mitogen-Activated Protein Kinase 1</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D048052" MajorTopicYN="N">Mitogen-Activated Protein Kinase 3</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047492" MajorTopicYN="N">Peroxisome Proliferator-Activated Receptors</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010739" MajorTopicYN="N">Phospholipase D</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018809" MajorTopicYN="N">Proliferating Cell Nuclear Antigen</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2010</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20954081</ArticleId><ArticleId IdType="doi">10.1080/15287394.2010.511582</ArticleId><ArticleId
        IdType="pii">928046067</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">20123618</PMID><DateCompleted><Year>2010</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Electronic">1552-9924</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>118</Volume><Issue>2</Issue><PubDate><Year>2010</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>The
        pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific
        PPARalpha-dependent mechanisms.</ArticleTitle><Pagination><StartPage>234</StartPage><EndPage>241</EndPage><MedlinePgn>234-41</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1289/ehp.0901217</ELocationID><Abstract><AbstractText
        Label="BACKGROUND" NlmCategory="BACKGROUND">The modulation of energetic homeostasis
        by pollutants has recently emerged as a potential contributor to the onset
        of metabolic disorders. Diethylhexyl phthalate (DEHP) is a widely used industrial
        plasticizer to which humans are widely exposed. Phthalates can activate the
        three peroxisome proliferator-activated receptor (PPAR) isotypes on cellular
        models and induce peroxisome proliferation in rodents.</AbstractText><AbstractText
        Label="OBJECTIVES" NlmCategory="OBJECTIVE">In this study, we aimed to evaluate
        the systemic and metabolic consequences of DEHP exposure that have remained
        so far unexplored and to characterize the underlying molecular mechanisms
        of action.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">As
        a proof of concept and mechanism, genetically engineered mouse models of PPARs
        were exposed to high doses of DEHP, followed by metabolic and molecular analyses.</AbstractText><AbstractText
        Label="RESULTS" NlmCategory="RESULTS">DEHP-treated mice were protected from
        diet-induced obesity via PPARalpha-dependent activation of hepatic fatty acid
        catabolism, whereas the activity of neither PPARbeta nor PPARgamma was affected.
        However, the lean phenotype observed in response to DEHP in wild-type mice
        was surprisingly abolished in PPARalpha-humanized mice. These species differences
        are associated with a different pattern of coregulator recruitment.</AbstractText><AbstractText
        Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results demonstrate that
        DEHP exerts species-specific metabolic actions that rely to a large extent
        on PPARalpha signaling and highlight the metabolic importance of the species-specific
        activation of PPARalpha by xenobiotic compounds.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Feige</LastName><ForeName>J&#xe9;r&#xf4;me
        N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Center for
        Integrative Genomics, National Research Center Frontiers in Genetics, University
        of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Gerber</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Casals-Casas</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Yang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials></Author><Author
        ValidYN="Y"><LastName>Winkler</LastName><ForeName>Carine</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Bedu</LastName><ForeName>Elodie</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Bueno</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Gelman</LastName><ForeName>Laurent</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Auwerx</LastName><ForeName>Johan</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials></Author><Author
        ValidYN="Y"><LastName>Desvergne</LastName><ForeName>B&#xe9;atrice</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research
        Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D047493">PPAR alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections
        RefType="CommentIn"><RefSource>Environ Health Perspect. 2010 Feb;118(2):A81</RefSource><PMID
        Version="1">20123631</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005951" MajorTopicYN="N">Glucose Tolerance Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000517"
        MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D047493" MajorTopicYN="N">PPAR alpha</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2009</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2009</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2010</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20123618</ArticleId><ArticleId IdType="pmc">PMC2831923</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.0901217</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akingbemi
        BT, Ge R, Klinefelter GR, Zirkin BR, Hardy MP. Phthalate-induced Leydig cell
        hyperplasia is associated with multiple endocrine disturbances. Proc Natl
        Acad Sci USA. 2004;101(3):775&#x2013;780.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC321757</ArticleId><ArticleId IdType="pubmed">14715905</ArticleId></ArticleIdList></Reference><Reference><Citation>Badman
        MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast
        growth factor 21 is regulated by PPAR&#x3b1; and is a key mediator of hepatic
        lipid metabolism in ketotic states. Cell Metab. 2007;5(6):426&#x2013;437.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17550778</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillie-Hamilton
        PF. Chemical toxins: a hypothesis to explain the global obesity epidemic.
        J Altern Complement Med. 2002;8(2):185&#x2013;192.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12006126</ArticleId></ArticleIdList></Reference><Reference><Citation>Bility
        MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, et al. Activation
        of mouse and human peroxisome proliferator-activated receptors (PPARs) by
        phthalate monoesters. Toxicol Sci. 2004;82(1):170&#x2013;182.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15310864</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung
        C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, et al. Diminished
        hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome
        proliferator-activated receptor &#x3b1;. Cancer Res. 2004;64(11):3849&#x2013;3854.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15172993</ArticleId></ArticleIdList></Reference><Reference><Citation>David
        RM, Moore MR, Cifone MA, Finney DC, Guest D. Chronic peroxisome proliferation
        and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate
        and the effects of recovery. Toxicol Sci. 1999;50(2):195&#x2013;205.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10478855</ArticleId></ArticleIdList></Reference><Reference><Citation>Desvergne
        B, Michalik L, Wahli W. Be fit or be sick: peroxisome proliferator-activated
        receptors are down the road. Mol Endocrinol. 2004;18(6):1321&#x2013;1332.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15087471</ArticleId></ArticleIdList></Reference><Reference><Citation>Desvergne
        B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol
        Rev. 2006;86(2):465&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">16601267</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans
        RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med.
        2004;10(4):355&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">15057233</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveillard
        A, Lasserre F, de Tayrac M, Polizzi A, Claus S, Canlet C, et al. Identification
        of potential mechanisms of toxicity after di-(2-ethylhexyl)-phthalate (DEHP)
        adult exposure in the liver using a systems biology approach. Toxicol Appl
        Pharmacol. 2009;236(3):282&#x2013;292.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19245819</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Auwerx J. Transcriptional coregulators in the control of energy homeostasis.
        Trends Cell Biol. 2007;17(6):292&#x2013;301.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17475497</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological
        outputs: peroxisome proliferator-activated receptors are nuclear receptors
        at the crossroads of key cellular functions. Prog Lipid Res. 2006;45(2):120&#x2013;159.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16476485</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C, et al. The endocrine
        disruptor monoethyl-hexyl-phthalate is a selective peroxisome peroxisome proliferator-activated
        receptor &#x3b3; modulator that promotes adipogenesis. J Biol Chem. 2007;282:19152&#x2013;19166.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17468099</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Gelman L, Tudor C, Engelborghs Y, Wahli W, Desvergne B. Fluorescence imaging
        reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid
        X receptor heterodimers in the absence and presence of ligand. J Biol Chem.
        2005;280(18):17880&#x2013;17890.</Citation><ArticleIdList><ArticleId IdType="pubmed">15731109</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige
        JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC, et al. Specific SIRT1
        activation mimics low energy levels and protects against diet-induced metabolic
        disorders by enhancing fat oxidation. Cell Metab. 2008;8(5):347&#x2013;358.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">19046567</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman
        L, Feige JN, Desvergne B. Molecular basis of selective PPAR&#x3b3; modulation
        for the treatment of type 2 diabetes. Biochim Biophys Acta. 2007;1771(8):1094&#x2013;1107.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17459763</ArticleId></ArticleIdList></Reference><Reference><Citation>Grun
        F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens
        as emerging factors in the obesity crisis. Rev Endocr Metab Disord. 2007;8(2):161&#x2013;171.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17657605</ArticleId></ArticleIdList></Reference><Reference><Citation>Grun
        F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, et al. Endocrine-disrupting
        organotin compounds are potent inducers of adipogenesis in vertebrates. Mol
        Endocrinol. 2006;20(9):2141&#x2013;2155.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16613991</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan
        HP, Ishizuka T, Chui PC, Lehrke M, Lazar MA. Corepressors selectively control
        the transcriptional activity of PPAR&#x3b3; in adipocytes. Genes Dev. 2005;19(4):453&#x2013;461.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC548946</ArticleId><ArticleId IdType="pubmed">15681609</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatch
        EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M, et al. Association
        of urinary phthalate metabolite concentrations with body mass index and waist
        circumference: a cross-sectional study of NHANES data, 1999&#x2013;2002. Environ
        Health. 2008;7:27. doi: 10.1186/1476-069X-7-27.</Citation><ArticleIdList><ArticleId
        IdType="doi">10.1186/1476-069X-7-27</ArticleId><ArticleId IdType="pmc">PMC2440739</ArticleId><ArticleId
        IdType="pubmed">18522739</ArticleId></ArticleIdList></Reference><Reference><Citation>Heindel
        JJ. Endocrine disruptors and the obesity epidemic. Toxicol Sci. 2003;76(2):247&#x2013;249.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">14677558</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden
        PR, Tugwood JD. Peroxisome proliferator-activated receptor alpha: role in
        rodent liver cancer and species differences. J Mol Endocrinol. 1999;22(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9924174</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber
        WW, Grasl-Kraupp B, Schulte-Hermann R. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate
        in rodents and its implications on human risk. Crit Rev Toxicol. 1996;26(4):365&#x2013;481.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">8817083</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst
        CH, Waxman DJ. Activation of PPAR&#x3b1; and PPAR&#x3b3; by environmental
        phthalate monoesters. Toxicol Sci. 2003;74(2):297&#x2013;308.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12805656</ArticleId></ArticleIdList></Reference><Reference><Citation>Inagaki
        T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, et al. Endocrine regulation
        of the fasting response by PPAR&#x3b1;-mediated induction of fibroblast growth
        factor 21. Cell Metab. 2007;5(6):415&#x2013;425.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17550777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanayama
        T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J. Organotin compounds promote
        adipocyte differentiation as agonists of the peroxisome proliferator-activated
        receptor &#x3b3;/retinoid X receptor pathway. Mol Pharmacol. 2005;67(3):766&#x2013;774.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15611480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharitonenkov
        A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21
        as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627&#x2013;1635.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1088017</ArticleId><ArticleId IdType="pubmed">15902306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagouge
        M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol
        improves mitochondrial function and protects against metabolic disease by
        activating SIRT1 and PGC-1&#x3b1;. Cell. 2006;127(6):1109&#x2013;1122.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17112576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapinskas
        PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, et al. Role
        of PPAR&#x3b1; in mediating the effects of phthalates and metabolites in the
        liver. Toxicology. 2005;207(1):149&#x2013;163.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">15590130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrke
        M, Lazar MA. The many faces of PPAR&#x3b3;. Cell. 2005;123(6):993&#x2013;999.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16360030</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney
        EK, Waxman DJ. trans-Activation of PPAR&#x3b1; and PPAR&#x3b3; by structurally
        diverse environmental chemicals. Toxicol Appl Pharmacol. 1999;161(2):209&#x2013;218.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10581215</ArticleId></ArticleIdList></Reference><Reference><Citation>Markey
        CM, Rubin BS, Soto AM, Sonnenschein C. Endocrine disruptors: from Wingspread
        to environmental developmental biology. J Steroid Biochem Mol Biol. 2002;83(1&#x2013;5):235&#x2013;244.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">12650721</ArticleId></ArticleIdList></Reference><Reference><Citation>Newbold
        RR, Padilla-Banks E, Snyder RJ, Phillips TM, Jefferson WN. Developmental exposure
        to endocrine disruptors and the obesity epidemic. Reprod Toxicol. 2007;23(3):290&#x2013;296.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1931509</ArticleId><ArticleId IdType="pubmed">17321108</ArticleId></ArticleIdList></Reference><Reference><Citation>NTP-CERHR
        (National Toxicology Program Center for the Evaluation of Risks to Human Reproduction)
        NTP-CERHR Expert Panel Report on Di(2-Ethylhexyl) Phthalate. 2000.  [[accessed
        18 December 2009]].  Available:  http://cerhr.niehs.nih.gov/chemicals/dehp/DEHP-final.pdf.</Citation></Reference><Reference><Citation>Rusyn
        I, Peters JM, Cunningham ML. Modes of action and species-specific effects
        of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol. 2006;36(5):459&#x2013;479.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2614359</ArticleId><ArticleId IdType="pubmed">16954067</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah
        YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez FJ. Peroxisome proliferator-activated
        receptor &#x3b1; regulates a microRNA-mediated signaling cascade responsible
        for hepatocellular proliferation. Mol Cell Biol. 2007;27(12):4238&#x2013;4247.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1900062</ArticleId><ArticleId IdType="pubmed">17438130</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahlhut
        RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary
        phthalate metabolites are associated with increased waist circumference and
        insulin resistance in adult U.S. males. Environ Health Perspect. 2007;115:876&#x2013;882.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC1892109</ArticleId><ArticleId IdType="pubmed">17589594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabb
        MM, Blumberg B. New modes of action for endocrine-disrupting chemicals. Mol
        Endocrinol. 2006;20(3):475&#x2013;482.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16037129</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi
        S, Matsuda T, Kobayashi S, Takahashi T, Kojima H. In vitro screening of 200
        pesticides for agonistic activity via mouse peroxisome proliferator-activated
        receptor (PPAR)&#x3b1; and PPAR&#x3b3; and quantitative analysis of in vivo
        induction pathway. Toxicol Appl Pharmacol. 2006;217(3):235&#x2013;244.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17084873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward
        JM, Peters JM, Perella CM, Gonzalez FJ. Receptor and nonreceptor-mediated
        organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome
        proliferator- activated receptor alpha-null mice. Toxicol Pathol. 1998;26(2):240&#x2013;246.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9547862</ArticleId></ArticleIdList></Reference><Reference><Citation>Waring
        RH, Harris RM. Endocrine disrupters: a human risk? Mol Cell Endocrinol. 2005;244(1&#x2013;2):2&#x2013;9.</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16271281</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang
        Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ. The PPAR&#x3b1;-humanized
        mouse: a model to investigate species differences in liver toxicity mediated
        by PPAR&#x3b1;. Toxicol Sci. 2008;101(1):132&#x2013;139.</Citation><ArticleIdList><ArticleId
        IdType="pmc">PMC2197159</ArticleId><ArticleId IdType="pubmed">17690133</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">15486947</PMID><DateCompleted><Year>2005</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0899-1987</ISSN><JournalIssue
        CitedMedium="Print"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2005</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Molecular
        carcinogenesis</Title><ISOAbbreviation>Mol Carcinog</ISOAbbreviation></Journal><ArticleTitle>In
        vivo mutational analysis of liver DNA in gpt delta transgenic rats treated
        with the hepatocarcinogens N-nitrosopyrrolidine, 2-amino-3-methylimidazo[4,5-f]quinoline,
        and di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>9</StartPage><EndPage>17</EndPage><MedlinePgn>9-17</MedlinePgn></Pagination><Abstract><AbstractText>In
        order to cast light on carcinogen-specific molecular mechanisms underlying
        experimental hepatocarcinogenesis in rats, in vivo mutagenicity and mutation
        spectra of known genotoxic rat hepatocarcinogens N-nitrosopyrrolidine (NPYR),
        and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), as well as the nongenotoxic
        hepatocarcinogen di(2-ethylhexyl)phthalate (DEHP) and the noncarcinogen acetaminophen
        (AAP), were investigated in guanine phosphoribosyltransferase (gpt) delta
        transgenic rats, a recently developed animal model for genotoxicity analysis.
        After 13-wk treatment, glutathione S-transferase placental form (GST-P)-positive
        liver cell foci were significantly increased in NPYR-treated and IQ-treated
        rats. In the DEHP-treated rats, marked hepatomegaly with centrilobular hypertrophy
        of hepatocytes occurred, although GST-P staining was consistently negative.
        Positive mutagenicity was detected in IQ- and NPYR-treated rats. Mutant frequencies
        (MFs) in the liver DNA were 188.0 x 10(-6) and 56.5 x 10(-6), approximately
        35-fold and 10-fold higher, respectively, than that of nontreatment control
        rats (5.5 x 10(-6)). There were no increases in MFs in the DEHP- or AAP-treated
        rats as compared to the nontreatment control value. IQ induced mainly base
        substitutions leading to G:C to T:A transversions (56.9%) and deletions of
        G:C base pairs. In contrast, NPYR primarily caused specific A:T to G:C transitions
        (49.3%), which are very rare in the other groups. These data provided support
        for the conclusion that IQ and NPYR hepatocarcinogenesis depends on genotoxic
        processes and specific DNA adduct formation while DEHP exerts its influence
        via a nongenotoxic promotional pathway. Our data also indicate that analysis
        of specific in vivo mutational responses with transgenic animal models can
        provide crucial information for understanding the molecular mechanisms underlying
        chemical carcinogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Kanki</LastName><ForeName>Keita</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division
        of Pathology, National Institute of Health Sciences, Setagaya-ku, Tokyo 158-8501,
        Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishikawa</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials></Author><Author
        ValidYN="Y"><LastName>Masumura</LastName><ForeName>Ken-Ichi</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Umemura</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Imazawa</LastName><ForeName>Takayoshi</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Kitamura</LastName><ForeName>Yasuki</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Nohmi</LastName><ForeName>Takehiko</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Hirose</LastName><ForeName>Masao</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Mol Carcinog</MedlineTA><NlmUniqueID>8811105</NlmUniqueID><ISSNLinking>0899-1987</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009153">Mutagens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011804">Quinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>30GL3D3T0G</RegistryNumber><NameOfSubstance
        UI="C029216">2-amino-3-methylimidazo(4,5-f)quinoline</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>SZ4J5WK201</RegistryNumber><NameOfSubstance
        UI="D009242">N-Nitrosopyrrolidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009153" MajorTopicYN="N">Mutagens</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009242" MajorTopicYN="N">N-Nitrosopyrrolidine</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011804" MajorTopicYN="N">Quinolines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2004</Year><Month>10</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2005</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2004</Year><Month>10</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">15486947</ArticleId><ArticleId IdType="doi">10.1002/mc.20061</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2917345</PMID><DateCompleted><Year>1989</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0008-5472</ISSN><JournalIssue
        CitedMedium="Print"><Volume>49</Volume><Issue>5</Issue><PubDate><Year>1989</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Cancer
        research</Title><ISOAbbreviation>Cancer Res</ISOAbbreviation></Journal><ArticleTitle>Use
        of primary cultures of human hepatocytes in toxicology studies.</ArticleTitle><Pagination><StartPage>1075</StartPage><EndPage>1084</EndPage><MedlinePgn>1075-84</MedlinePgn></Pagination><Abstract><AbstractText>Often
        results from toxicological studies using rodent models cannot be directly
        extrapolated to probable effects in human beings. In order to examine the
        genotoxic potential of chemicals in human liver cells, a human hepatocyte
        DNA repair assay has been defined. Procedures were optimized to prepare primary
        cultures of human hepatocytes from discarded surgical material. On eight different
        occasions human hepatocyte cultures of sufficient viability to measure DNA
        repair were successfully prepared by collagenase perfusion techniques. The
        cells were allowed to attach to plastic or collagen substrata for periods
        of 1.5 to 24 h and subsequently incubated with [3H]thymidine and test chemicals
        for periods of 18 to 24 h. Chemically induced DNA repair, measured as unscheduled
        DNA synthesis, was quantitated autoradiographically. The following compounds
        were tested: 2-acetylaminofluorene, aflatoxin B1, 2-aminobenzyl alcohol, aniline,
        benzo(a)pyrene, carbon tetrachloride, chloroform, 2,4-diaminotoluene, 2,6-diaminotoluene,
        di(2-ethylhexyl)phthalate, dimethylnitrosamine, 1,6-dinitropyrene, 2,4-dinitrotoluene,
        2,6-dinitrotoluene, methyl chloride, 5-methylchrysene, mono(2-ethylhexyl)phthalate,
        2-methyl-2-P-(1,2,3,4-tetrahydro-1-naphthyl)phenoxypropionic acid (nafenopin),
        beta-naphthylamine, nitrobenzene, 2-nitrobenzyl alcohol, 2-nitrotoluene, 2,3,7,8-tetrachlorodibenzo-p-dioxin,
        unleaded gasoline, and 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid
        (Wy-14,643). In only one of eight cases did some of the chemicals generally
        regarded as genotoxic fail to give a positive response. For purposes of comparison,
        all test chemicals were evaluated in the in vitro rat hepatocyte DNA repair
        assay. Individual-to-individual variation in the DNA repair response was far
        greater for the human cultures than for cultures derived from rats. For only
        three chemicals was there a qualitative difference in the response between
        the rodent and the human cells; beta-naphthylamine was positive in the rat
        but in none of the human cultures examined, whereas the opposite was seen
        for 2,6-diaminotoluene and 5-methylchrysene. Clofibric acid, mono(2-ethylhexyl)phthalate,
        and Wy-14,643 induced enzymes indicative of peroxisomal proliferation in primary
        rat hepatocyte cultures, but not in two human hepatocyte cultures. These results
        indicate that, in general, the in vitro rat hepatocyte DNA repair assay is
        a valid model for predicting potential genotoxic effects in human beings.
        However, rodent hepatocytes may not be appropriate for assessing the potential
        of chemicals to elicit nongenotoxic effects in human beings such as the induction
        of hepatocyte peroxisomal proliferation.</AbstractText></Abstract><AuthorList
        CompleteYN="N"><Author ValidYN="Y"><LastName>Butterworth</LastName><ForeName>B
        E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Smith-Oliver</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Earle</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Loury</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Author><Author
        ValidYN="Y"><LastName>White</LastName><ForeName>R D</ForeName><Initials>RD</Initials></Author><Author
        ValidYN="Y"><LastName>Doolittle</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Author><Author
        ValidYN="Y"><LastName>Working</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author
        ValidYN="Y"><LastName>Jirtle</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Michalopoulos</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA30241</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013487">Research Support, U.S.
        Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Cancer Res</MedlineTA><NlmUniqueID>2984705R</NlmUniqueID><ISSNLinking>0008-5472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9M98QLJ2DL</RegistryNumber><NameOfSubstance
        UI="D015073">2-Acetylaminofluorene</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015073" MajorTopicYN="N">2-Acetylaminofluorene</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297"
        MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014116" MajorTopicYN="Y">Toxicology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1989</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1989</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1989</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2917345</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">7161829</PMID><DateCompleted><Year>1983</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0098-4108</ISSN><JournalIssue
        CitedMedium="Print"><Volume>10</Volume><Issue>4-5</Issue><PubDate><Year>1982</Year><Season>Oct-Nov</Season></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health</Title><ISOAbbreviation>J Toxicol Environ
        Health</ISOAbbreviation></Journal><ArticleTitle>The carcinogenicity of dietary
        di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice.</ArticleTitle><Pagination><StartPage>797</StartPage><EndPage>815</EndPage><MedlinePgn>797-815</MedlinePgn></Pagination><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Kluwe</LastName><ForeName>W M</ForeName><Initials>WM</Initials></Author><Author
        ValidYN="Y"><LastName>Haseman</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author
        ValidYN="Y"><LastName>Douglas</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Author><Author
        ValidYN="Y"><LastName>Huff</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Toxicol Environ Health</MedlineTA><NlmUniqueID>7513622</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010902" MajorTopicYN="N">Pituitary Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010911" MajorTopicYN="N">Pituitary Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1982</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1982</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1982</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">7161829</ArticleId><ArticleId IdType="doi">10.1080/15287398209530296</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25913319</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1614-7499</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>22</Volume><Issue>16</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Environmental
        science and pollution research international</Title><ISOAbbreviation>Environ
        Sci Pollut Res Int</ISOAbbreviation></Journal><ArticleTitle>DEHP reduces thyroid
        hormones via interacting with hormone synthesis-related proteins, deiodinases,
        transthyretin, receptors, and hepatic enzymes in rats.</ArticleTitle><Pagination><StartPage>12711</StartPage><EndPage>12719</EndPage><MedlinePgn>12711-9</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1007/s11356-015-4567-7</ELocationID><Abstract><AbstractText>Di-(2-ethylhexyl)
        phthalate (DEHP) is used extensively in many personal care and consumer products,
        resulting in widespread nonoccupational human exposure through multiple routes
        and media. Limited studies suggest that exposure to DEHP may be associated
        with altered thyroid function, but detailed mechanisms are unclear. In order
        to elucidate potential mechanisms by which DEHP disturbs thyroid hormone homeostasis,
        Sprague-Dawley (SD) rats were dosed with DEHP by gavage at 0, 250, 500, and
        750 mg/kg/day for 30 days and sacrificed within 24 h after the last dose.
        Gene expressions of thyroid hormone receptors, deiodinases, transthyretin,
        and hepatic enzymes were measured by RT-PCR; protein levels of transthyretin
        were also analyzed by Western blot. Results showed that DEHP caused histological
        changes in the thyroid and follicular epithelial cell hypertrophy and hyperplasia
        were observed. DEHP significantly reduced thyroid hormones (T3, T4) and thyrotropin
        releasing hormone (TRH) levels, whereas thyroid stimulating hormone (TSH)
        was not affected. After exposure to DEHP, biosynthesis of thyroid hormones
        was suppressed, and sodium iodide symporter (NIS) and thyroid peroxidase (TPO)
        levels were significantly reduced. Additionally, levels of deiodinases and
        transthyretin were also affected. TSH receptor (TSHr) level was downregulated,
        while TRH receptor (TRHr) level was upregulated. Metabolism of thyroid hormones
        was accelerated due to elevated gene expression of hepatic enzymes (UDPGTs
        and CYP2B1) by DEHP. Taken together, observed findings indicate that DEHP
        could reduce thyroid hormones through influencing biosynthesis, biotransformation,
        biotransport, receptor levels, and metabolism of thyroid hormones.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Changjiang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Key
        Lab of Birth Defects and Reproductive Health of National Health and Family
        Planning Commission, Chongqing Population and Family Planning Science and
        Technology Research Institute, 18 Honghuang Road, Chongqing, 400020, People''s
        Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Letian</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Wei</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Li</LastName><ForeName>Lianbing</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Environ
        Sci Pollut Res Int</MedlineTA><NlmUniqueID>9441769</NlmUniqueID><ISSNLinking>0944-1344</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011228">Prealbumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011988">Receptors, Thyroid Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D013963">Thyroid Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-71-5</RegistryNumber><NameOfSubstance
        UI="D013972">Thyrotropin</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.8</RegistryNumber><NameOfSubstance UI="D007453">Iodide Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.14.1</RegistryNumber><NameOfSubstance UI="D019362">Cytochrome P-450 CYP2B1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019362" MajorTopicYN="N">Cytochrome P-450 CYP2B1</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007453" MajorTopicYN="N">Iodide Peroxidase</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011228" MajorTopicYN="N">Prealbumin</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011988" MajorTopicYN="N">Receptors, Thyroid Hormone</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013963" MajorTopicYN="N">Thyroid Hormones</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013972" MajorTopicYN="N">Thyrotropin</DescriptorName><QualifierName UI="Q000235"
        MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2014</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">25913319</ArticleId><ArticleId IdType="doi">10.1007/s11356-015-4567-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Environ
        Toxicol. 2007 Jun;22(3):245-55</Citation><ArticleIdList><ArticleId IdType="pubmed">17497641</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst
        Biol Reprod Med. 2008 May-Jun;54(3):143-54</Citation><ArticleIdList><ArticleId
        IdType="pubmed">18570050</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Clin Endocrinol Metab. 1997 Feb;82(2):329-34</Citation><ArticleIdList><ArticleId
        IdType="pubmed">9024211</ArticleId></ArticleIdList></Reference><Reference><Citation>Horm
        Metab Res. 2011 Jun;43(6):391-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21512963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Cell Endocrinol. 2005 Dec 1;244(1-2):75-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16257484</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinology.
        2009 Mar;150(3):1084-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19196800</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinology.
        2009 Jan;150(1):540-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18787028</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain
        Res. 2005 Sep 14;1056(1):97-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16095572</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Androl. 2007 Jul-Aug;28(4):513-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17287459</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Lett. 2001 Apr 8;121(1):35-43</Citation><ArticleIdList><ArticleId IdType="pubmed">11312035</ArticleId></ArticleIdList></Reference><Reference><Citation>Int
        J Androl. 2011 Aug;34(4):369-78</Citation><ArticleIdList><ArticleId IdType="pubmed">20633195</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Sci. 2003 Jun;73(2):431-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12700402</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Cell Endocrinol. 2005 Dec 1;244(1-2):63-71</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16289305</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS
        Lett. 2005 Aug 29;579(21):4654-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16098513</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1999 Apr;107(4):273-8</Citation><ArticleIdList><ArticleId
        IdType="pubmed">10090705</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin
        Chim Acta. 2008 Feb;388(1-2):15-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18060877</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen
        Comp Endocrinol. 2008 Feb 1;155(3):650-7</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17950733</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemosphere.
        2015 Jan;118:229-38</Citation><ArticleIdList><ArticleId IdType="pubmed">25278044</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Sci. 2001 May;61(1):76-82</Citation><ArticleIdList><ArticleId IdType="pubmed">11294977</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology.
        2012 Dec 8;302(1):68-76</Citation><ArticleIdList><ArticleId IdType="pubmed">22889935</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 2007 Jul;115(7):1029-34</Citation><ArticleIdList><ArticleId
        IdType="pubmed">17637918</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum
        Reprod. 2007 Oct;22(10 ):2715-22</Citation><ArticleIdList><ArticleId IdType="pubmed">17704099</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen
        Comp Endocrinol. 2003 Oct 15;134(1):36-43</Citation><ArticleIdList><ArticleId
        IdType="pubmed">13129501</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends
        Endocrinol Metab. 2001 Jan-Feb;12(1):10-6</Citation><ArticleIdList><ArticleId
        IdType="pubmed">11137035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol
        Cell Endocrinol. 2005 Oct 20;242(1-2):10-5</Citation><ArticleIdList><ArticleId
        IdType="pubmed">16150534</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1591274</PMID><DateCompleted><Year>1992</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-3002</ISSN><JournalIssue
        CitedMedium="Print"><Volume>1135</Volume><Issue>1</Issue><PubDate><Year>1992</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>Biochimica
        et biophysica acta</Title><ISOAbbreviation>Biochim Biophys Acta</ISOAbbreviation></Journal><ArticleTitle>Involvement
        of calmodulin- and protein kinase C-related mechanism in an induction process
        of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome
        proliferators.</ArticleTitle><Pagination><StartPage>84</StartPage><EndPage>90</EndPage><MedlinePgn>84-90</MedlinePgn></Pagination><Abstract><AbstractText>Trifluoperazine,
        a calmodulin antagonist, suppressed the clofibric acid-evoked induction of
        the peroxisomal cyanide-insensitive fatty acyl-CoA oxidizing system and carnitine
        acetyltransferase in rat liver and also in cultured rat hepatocytes. H-7,
        a potent inhibitor of protein kinase C, also suppressed the induction of these
        enzymes by clofibric acid, bezafibrate, Wyl4,643 or mono(2-ethylhexyl)phthalate
        in cultured rat hepatocytes. This suppressive effect was also confirmed by
        the protein composition of hepatocytes treated with clofibric acid and these
        antagonists, where the increase in the amount of peroxisomal bifunctional
        enzyme by peroxisome proliferator was markedly suppressed by above two antagonists.
        Profile of the time-dependent changes in the activities of the two enzymes
        after clofibric acid treatment showed that there might be two phases in the
        induction process. The initial phase (0-3 days after the treatment) showed
        a relative low inducing rate and subsequent phase (3-5 days after the treatment)
        showed an abrupt induction. The suppressive effect of the above two antagonists
        was significant in the later phase. In a time course study of the induction
        process of peroxisomal catalase, bifunctional enzyme or 69 kDa integral membrane
        protein using immunochemical detection, the induction of the membrane protein
        by clofibric acid was delayed compared with that of the bifunctional enzyme,
        where the induction was inhibited almost completely by nicardipine. These
        experimental results suggest that calmodulin- and protein kinase C-dependent
        processes play an important role in the process of marked induction of peroxisomal
        enzymes and membrane protein by drugs in rat liver.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department
        of Clinical Biochemistry, Tokyo College of Pharmacy, Hachioji, Japan.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Okawa</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Itoga</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Imanaka</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Suga</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biochim
        Biophys Acta</MedlineTA><NlmUniqueID>0217513</NlmUniqueID><ISSNLinking>0006-3002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002147">Calmodulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007546">Isoquinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>214IZI85K3</RegistryNumber><NameOfSubstance
        UI="D014268">Trifluoperazine</NameOfSubstance></Chemical><Chemical><RegistryNumber>84477-87-2</RegistryNumber><NameOfSubstance
        UI="D019307">1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>Y9449Q51XH</RegistryNumber><NameOfSubstance
        UI="D001629">Bezafibrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D019307" MajorTopicYN="N">1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001629" MajorTopicYN="N">Bezafibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002147" MajorTopicYN="N">Calmodulin</DescriptorName><QualifierName UI="Q000037"
        MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007546" MajorTopicYN="N">Isoquinolines</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName
        UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName
        UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014268" MajorTopicYN="N">Trifluoperazine</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1591274</ArticleId><ArticleId IdType="doi">10.1016/0167-4889(92)90170-g</ArticleId><ArticleId
        IdType="pii">0167-4889(92)90170-G</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6719482</PMID><DateCompleted><Year>1984</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0378-4274</ISSN><JournalIssue
        CitedMedium="Print"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>1984</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Toxicology
        letters</Title><ISOAbbreviation>Toxicol Lett</ISOAbbreviation></Journal><ArticleTitle>The
        absence of testicular atrophy and in vivo and in vitro effects on hepatocyte
        morphology and peroxisomal enzyme activities in male rats following the administration
        of several alkanols.</ArticleTitle><Pagination><StartPage>103</StartPage><EndPage>109</EndPage><MedlinePgn>103-9</MedlinePgn></Pagination><Abstract><AbstractText>Previous
        studies have shown that ethylhexanol (2-EH) and its oxidation products, but
        not n-hexanol, produce hepatomegaly, peroxisomal proliferation and hypotriglyceridaemia.
        In the present studies we have confirmed that at 1 mmol/kg doses, neither
        the linear nor branched chain alcohols induce testicular atrophy, hepatomegaly,
        peroxisome proliferation or hypolipidaemia. In vivo, neither the free alcohols
        nor their metabolic products seem to be responsible for the activity of the
        parent plasticiser. The released monoesters are probably the more potent metabolic
        products responsible for the hepatomegaly, peroxisomal proliferation and hypolipidaemia.
        This contention is supported by the in vitro hepatocyte data which demonstrate
        the induction of peroxisomal oxidative enzymes by MEHP whereas the alcohols
        were without effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Rhodes</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author
        ValidYN="Y"><LastName>Soames</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Stonard</LastName><ForeName>M D</ForeName><Initials>MD</Initials></Author><Author
        ValidYN="Y"><LastName>Simpson</LastName><ForeName>M G</ForeName><Initials>MG</Initials></Author><Author
        ValidYN="Y"><LastName>Vernall</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author><Author
        ValidYN="Y"><LastName>Elcombe</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Toxicol
        Lett</MedlineTA><NlmUniqueID>7709027</NlmUniqueID><ISSNLinking>0378-4274</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000438">Alcohols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000438" MajorTopicYN="N">Alcohols</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000139"
        MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013733" MajorTopicYN="N">Testicular Diseases</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6719482</ArticleId><ArticleId IdType="doi">10.1016/0378-4274(84)90230-3</ArticleId><ArticleId
        IdType="pii">0378-4274(84)90230-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3536893</PMID><DateCompleted><Year>1986</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0021-924X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>100</Volume><Issue>2</Issue><PubDate><Year>1986</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal
        of biochemistry</Title><ISOAbbreviation>J Biochem</ISOAbbreviation></Journal><ArticleTitle>Purification
        of membrane polypeptides of rat liver peroxisomes.</ArticleTitle><Pagination><StartPage>301</StartPage><EndPage>310</EndPage><MedlinePgn>301-10</MedlinePgn></Pagination><Abstract><AbstractText>Peroxisomes
        were obtained by sucrose density gradient centrifugation from the livers of
        di(2-ethylhexyl)phthalate-fed rats, and the membranes were prepared by carbonate
        extraction (Fujiki, Y., Fowler, S., Shio, H., Hubbard, A.L., &amp; Lazarow,
        P.B. (1982) J. Cell Biol. 93, 103-110). The integrated membrane polypeptides
        were solubilized with sodium dodecyl sulfate, and purified by repeated polyacrylamide
        gel electrophoresis in the presence of sodium dodecyl sulfate. Separation
        of 70 and 68 kDa polypeptides was not attempted in the present study because
        of their close migration in polyacrylamide gel electrophoresis. Other polypeptides
        with apparent molecular masses of 41, 27, 26, and 22 kDa were purified to
        near homogeneity. Antibodies were raised against these purified preparations.
        The 68 kDa polypeptide is suggested to be produced by the proteolytic modification
        of 70 kDa polypeptide, since the former increased concomitantly with decrease
        of the latter when the liver homogenate was incubated, and this change was
        prevented in the presence of leupeptin during the incubation. The 41 kDa polypeptide
        was a minor component. The 70 and 68 kDa polypeptides and 41 kDa polypeptide
        and their antibodies were cross-reactive, but the relation of these polypeptides
        was not clear. The 27 and 26 kDa polypeptides seemed to be another species
        of membrane polypeptides, although the relationship of these two polypeptides
        remains to be clarified. The 22 kDa polypeptide is not related to other membrane
        polypeptides. The results of immunoblot analysis of subcellular fractions
        of the liver and an electron microscopic immunocytochemical study to locate
        the antigenic sites with protein A-gold complex suggest that all of these
        polypeptides are localized on peroxisomal membranes. On proliferation of rat
        liver peroxisomes by administration of di(2-ethylhexyl)phthalate, a peroxisome
        proliferator, all of these polypeptides were markedly increased.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Kuwabara</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Usuda</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author
        ValidYN="Y"><LastName>Nagata</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Biochem</MedlineTA><NlmUniqueID>0376600</NlmUniqueID><ISSNLinking>0021-924X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007163" MajorTopicYN="N">Immunosorbent Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName
        UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000032"
        MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000302"
        MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3536893</ArticleId><ArticleId IdType="doi">10.1093/oxfordjournals.jbchem.a121716</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">9934846</PMID><DateCompleted><Year>1999</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>12</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>1999</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Kupffer
        cell oxidant production is central to the mechanism of peroxisome proliferators.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>33</EndPage><MedlinePgn>27-33</MedlinePgn></Pagination><Abstract><AbstractText>Increased
        cell proliferation most likely plays a key role in peroxisome proliferator-induced
        liver cancer. Recently, Kupffer cells were shown to be responsible for Wy-14,643-induced
        cell proliferation. However, the mechanism by which peroxisome proliferators
        activate Kupffer cells is unknown. Since gut-derived endotoxin is a known
        activator of Kupffer cells, the hypothesis that it is involved was evaluated.
        Increased cell proliferation and peroxisome induction were unaffected by gut
        sterilization. Moreover, endotoxin was not detectable in portal blood following
        treatment with Wy-14,643. Therefore, it is concluded that gut-derived endotoxin
        is not responsible for Kupffer cell activation. To test the hypothesis that
        Kupffer cells are activated by Wy-14,643 directly, Kupffer cell superoxide
        production was measured following treatment in vitro. Wy-14,643 increased
        superoxide production in a dose-dependent manner (0.1 and 50 microM) with
        half-maximal stimulation at 2.5 microM. Diethylhexylphthalate (DEHP) and ethylhexanol
        did not increase superoxide production even at doses 50 times higher than
        Wy-14,643; however, monoethylhexylphthalate (MEHP) activated superoxide production
        as effectively as Wy-14,643 with half-maximal stimulation at 5 microM. Treatment
        with Wy-14,643 for 21 days caused a 2-fold increase in Kupffer cell superoxide
        production while DEHP did not. Pretreatment of Kupffer cells with staurosporine
        (0.01-10 pM) completely blocked generation of superoxide demonstrating that
        protein kinase C is required. Moreover, Wy-14,643 increased Kupffer cell protein
        kinase C activity 3-fold. Pretreatment of Kupffer cells with the amino acid
        glycine (0.01-3 mM), which blunts calcium signaling, inhibited Wy-14,643-stimulated
        superoxide production and increased protein kinase C activity completely.
        These data are consistent with the hypothesis that potent peroxisome proliferators
        (Wy-14,643 and MEHP) directly activate Kupffer cell production of oxidants
        via mechanisms involving protein kinase C. Further, peroxisome proliferator
        treatments that sustain elevated rates of cell proliferation (e.g. Wy-14,643)
        activate Kupffer cell superoxide production following long-term dietary treatment
        supporting the hypothesis that Kupffer cell-derived oxidants are involved
        in peroxisome proliferator-induced neoplasia.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Rose</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Laboratory
        of Hepatobiology and Toxicology, CB#7365, MEJB, Curriculum in Toxicology,
        University of North Carolina, Chapel Hill 27599-7365, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Rivera</LastName><ForeName>C A</ForeName><Initials>CA</Initials></Author><Author
        ValidYN="Y"><LastName>Bradford</LastName><ForeName>B U</ForeName><Initials>BU</Initials></Author><Author
        ValidYN="Y"><LastName>Graves</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author
        ValidYN="Y"><LastName>Schoonhoven</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Swenberg</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author
        ValidYN="Y"><LastName>Thurman</LastName><ForeName>R G</ForeName><Initials>RG</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>ES-04325</GrantID><Acronym>ES</Acronym><Agency>NIEHS
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D013487">Research Support, U.S.
        Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004731">Endotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D016877">Oxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>11062-77-4</RegistryNumber><NameOfSubstance
        UI="D013481">Superoxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>H88EPA0A3N</RegistryNumber><NameOfSubstance
        UI="D019311">Staurosporine</NameOfSubstance></Chemical><Chemical><RegistryNumber>TE7660XO1C</RegistryNumber><NameOfSubstance
        UI="D005998">Glycine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004731" MajorTopicYN="N">Endotoxins</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005998" MajorTopicYN="N">Glycine</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007422" MajorTopicYN="N">Intestines</DescriptorName><QualifierName UI="Q000382"
        MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007728" MajorTopicYN="N">Kupffer Cells</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821"
        MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016877" MajorTopicYN="N">Oxidants</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName
        UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName
        UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D019311" MajorTopicYN="N">Staurosporine</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013481" MajorTopicYN="N">Superoxides</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>2</Month><Day>6</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>2</Month><Day>6</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">9934846</ArticleId><ArticleId IdType="doi">10.1093/carcin/20.1.27</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2443263</PMID><DateCompleted><Year>1987</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>8</Volume><Issue>10</Issue><PubDate><Year>1987</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Stimulation
        of DNA synthesis in rat and mouse liver by various tumor promoters.</ArticleTitle><Pagination><StartPage>1433</StartPage><EndPage>1437</EndPage><MedlinePgn>1433-7</MedlinePgn></Pagination><Abstract><AbstractText>In
        order to investigate whether the stimulation of liver DNA synthesis might
        be used to detect one class of hepatic tumor promoters, the incorporation
        of orally administered radiolabelled thymidine into liver DNA was determined
        in rats and mice 24 h after a single oral gavage of test compounds at various
        dose levels. Three DNA-binding hepatocarcinogens, aflatoxin B1, benzidine
        and carbon tetrachloride, did not stimulate but rather inhibited DNA synthesis
        (not for CCl4). Four hepatic tumor promoters, clofibrate, DDT, phenobarbital
        and thioacetamide, gave rise to a stimulation in a dose-dependent manner.
        Single oral doses between 0.02 and 0.3 mmol/kg were required to double the
        level of thymidine incorporation into liver DNA (= doubling dose, DD). Differences
        between species or sex as observed in long-term carcinogenicity studies were
        reflected by a different stimulation of liver DNA synthesis. In agreement
        with the bioassay data, aldrin was positive only in male mice (DD = 0.007
        mmol/kg) but not in male rats of female mice. 2,3,7,8-TCDD was positive in
        male mice (DD = 10(-6) mmol/kg) and in female rats (DD = 2 X 10(-6) mmol/kg)
        but not in male rats. The assay was also able to distinguish between structural
        isomers with different carcinogenicities. [alpha]Hexachlorocyclohexane stimulated
        liver DNA synthesis with a doubling dose of about 0.2 mmol/kg in male rats
        whereas the [gamma]-isomer was ineffective even at 1 mmol/kg. So far, only
        one result was inconsistent with carcinogenicity bioassay data. The different
        carcinogenicity of di(2-ethylhexyl)adipate (negative in rats) and di(2-ethylhexyl)phthalate
        (positive) was not detectable. Both plasticizers were positive in this short-term
        system with DD''s of 0.7 mmol/kg for DEHA and 0.5 mmol/kg for DEHP. The proposed
        assay is discussed as an attempt to devise short-term assays for carcinogens
        not detected by the routine genotoxicity test systems.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>B&#xfc;sser</LastName><ForeName>M
        T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Institute
        of Toxicology, Swiss Federal Institute of Technology, Schwerzenbach.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Lutz</LastName><ForeName>W K</ForeName><Initials>WK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000348">Aflatoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001560">Benzidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000072317">Polychlorinated Dibenzodioxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>075T165X8M</RegistryNumber><NameOfSubstance
        UI="D013853">Thioacetamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical><Chemical><RegistryNumber>2X02101HVF</RegistryNumber><NameOfSubstance
        UI="C029876">benzidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>59NEE7PCAB</RegistryNumber><NameOfSubstance
        UI="D001556">Hexachlorocyclohexane</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9N2N2Y55MH</RegistryNumber><NameOfSubstance
        UI="D016604">Aflatoxin B1</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>CIW5S16655</RegistryNumber><NameOfSubstance
        UI="D003634">DDT</NameOfSubstance></Chemical><Chemical><RegistryNumber>CL2T97X0V0</RegistryNumber><NameOfSubstance
        UI="D002251">Carbon Tetrachloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>OZE3CLY605</RegistryNumber><NameOfSubstance
        UI="D000452">Aldrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016604" MajorTopicYN="N">Aflatoxin B1</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000348" MajorTopicYN="N">Aflatoxins</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000452" MajorTopicYN="N">Aldrin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001560" MajorTopicYN="N">Benzidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001682" MajorTopicYN="N">Biological Availability</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002251" MajorTopicYN="N">Carbon Tetrachloride</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003634" MajorTopicYN="N">DDT</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001556" MajorTopicYN="N">Hexachlorocyclohexane</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007536" MajorTopicYN="N">Isomerism</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000072317" MajorTopicYN="N">Polychlorinated Dibenzodioxins</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013853" MajorTopicYN="N">Thioacetamide</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1987</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1987</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1987</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2443263</ArticleId><ArticleId IdType="doi">10.1093/carcin/8.10.1433</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - X-RateLimit-Limit,X-RateLimit-Remaining
      Cache-Control:
      - private
      Connection:
      - Keep-Alive
      Content-Security-Policy:
      - upgrade-insecure-requests
      Content-Type:
      - text/xml; charset=UTF-8
      Date:
      - Tue, 20 Feb 2024 16:38:16 GMT
      Keep-Alive:
      - timeout=4, max=40
      NCBI-PHID:
      - 322C45D975EA9B45000053DB90B27C3A.1.1.m_3
      NCBI-SID:
      - 32D08667D66FBBF2_A818SID
      Referrer-Policy:
      - origin-when-cross-origin
      Server:
      - Finatra
      Set-Cookie:
      - ncbi_sid=32D08667D66FBBF2_A818SID; domain=.nih.gov; path=/; expires=Thu, 20
        Feb 2025 16:38:16 GMT
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains; preload
      Transfer-Encoding:
      - chunked
      X-RateLimit-Limit:
      - '10'
      X-RateLimit-Remaining:
      - '8'
      X-UA-Compatible:
      - IE=Edge
      X-XSS-Protection:
      - 1; mode=block
      content-encoding:
      - gzip
    status:
      code: 200
      message: OK
version: 1
